{
  "category": "Anatomic Pathology",
  "subject": {
    "name": "Pancreas, Biliary, Liver",
    "url": "https://app.pathprimer.com/curriculum/636816a0-2048-4531-a641-efa5a5fe52fa",
    "lessons": {
      "Liver Nonneoplastic Lesions: Inherited/Metabolic Diseases": {
        "name": "Liver Nonneoplastic Lesions: Inherited/Metabolic Diseases",
        "url": "https://app.pathprimer.com/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
        "topics": {
          "Glycogen Storage Disease, Hepatic": {
            "name": "Glycogen Storage Disease, Hepatic",
            "url": "https://app.pathprimer.com/document/46b8ec3d-4b89-404a-9b8f-8b01eb776057/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Glycogen storage disease (GSD) refers to group of disorders caused by mutations in genes that control carbohydrate metabolismHepatic GSD refers to those types that largely or prominently affect liver",
                    "sub_points": [
                      "Hepatic GSD refers to those types that largely or prominently affect liver"
                    ]
                  },
                  {
                    "text": "All forms are autosomal recessive, except GSD IXa, which is X-linked"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most patients present with hepatomegaly and fasting hypoglycemia"
                  },
                  {
                    "text": "Other features vary by type, including cardiomyopathy, hypotonia, or neutropenia"
                  },
                  {
                    "text": "Risk of hepatic adenoma or hepatocellular carcinoma in some types"
                  },
                  {
                    "text": "Prognosis varies based on type and severity"
                  },
                  {
                    "text": "Treatment for most types is dietary management, symptom control, or liver transplant"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Most often, liver shows enlarged, pale, swollen hepatocytes with prominent cell membranes causing \"mosaic pattern\" with steatosis and glycogenated nuclei"
                  },
                  {
                    "text": "Likelihood of fibrosis and cirrhosis varies by type"
                  },
                  {
                    "text": "Type IV has characteristic histology with prominent cytoplasmic inclusions"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Electron microscopy shows increased glycogen-displacing organelles"
                  },
                  {
                    "text": "Genetic testing has supplanted enzymatic activity assay for diagnosis"
                  },
                  {
                    "text": "PAS- and PAD-D stains can be used to support that the cytoplasmic pallor is due to glycogen"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Glycogenic hepatopathy in patients with poorly controlled diabetes mellitus"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Glycogen storage disease (GSD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Glycogenoses"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Group of disorders characterized by inborn errors in carbohydrate metabolismHepatic glycogenoses are GSDs that primarily or significantly affect liver, including types I, III, IV, VI, IX, and 0",
                    "sub_points": [
                      "Hepatic glycogenoses are GSDs that primarily or significantly affect liver, including types I, III, IV, VI, IX, and 0"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Mutation": [
                  {
                    "text": "Mutations in any one of genes involved in carbohydrate metabolism that results in glycogen accumulation, abnormal glycogen structure, or impaired glycogen/glucose utilizationGSD type 0 is no-storage disorder; defect results in inability to produce hepatic glycogen and marked decrease in glycogenType IX group of disorders is distinguished by which subunit of phosphorylase kinase is affected; type IXa accounts for 75% of cases",
                    "sub_points": [
                      "GSD type 0 is no-storage disorder; defect results in inability to produce hepatic glycogen and marked decrease in glycogen",
                      "Type IX group of disorders is distinguished by which subunit of phosphorylase kinase is affected; type IXa accounts for 75% of cases"
                    ]
                  },
                  {
                    "text": "Most forms are autosomal recessive with exception of some subtypes of IX (notably IXa), which are X-linked"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Estimated incidence of all GSD is 1 in 20,000-40,000 live births"
                  },
                  {
                    "text": "Incidence of specific types varies widely: Type VI is 1:65,000-85,000; types I, III, IX are 1:100,000; type IV is 1:600,000-800,000; type 0 is extraordinarily rare"
                  }
                ],
                "Age": [
                  {
                    "text": "Most patients diagnosed within 1st decade of life, depending on subtype and its severity"
                  }
                ],
                "Sex": [
                  {
                    "text": "Type IXa is sex-linked"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Specific subtypes occur in certain populations: Type I in Ashkenazi Jews; type III in non-Ashkenazi Jews of North African descent; type VI in Mennonites"
                  }
                ],
                "Presentation": [
                  {
                    "text": "HepatomegalyType 0 is exception, presenting with small liver",
                    "sub_points": [
                      "Type 0 is exception, presenting with small liver"
                    ]
                  },
                  {
                    "text": "Fasting hypoglycemiaSevere forms of childhood GSD are associated with seizures induced by hypoglycemia with very short fasting intervals (< 4 hours)",
                    "sub_points": [
                      "Severe forms of childhood GSD are associated with seizures induced by hypoglycemia with very short fasting intervals (< 4 hours)"
                    ]
                  },
                  {
                    "text": "Failure to thrive, difficulty in settling down, awakening for feeds, short stature, motor delays, muscle weakness, and obesity are other presenting signs, depending on type"
                  },
                  {
                    "text": "Specific types may have additional characteristic findingsRecurrent infections and inflammatory bowel disease due to neutropenia and neutrophil dysfunction characterize type IbCardiomyopathy is seen most often in type III, but also IV, VI, XILiver forms and muscle forms characterize the different subtypes of type IX",
                    "sub_points": [
                      "Recurrent infections and inflammatory bowel disease due to neutropenia and neutrophil dysfunction characterize type Ib",
                      "Cardiomyopathy is seen most often in type III, but also IV, VI, XI",
                      "Liver forms and muscle forms characterize the different subtypes of type IX"
                    ]
                  },
                  {
                    "text": "Type IV is multisystem disorderUsually presents as progressive liver disease with hepatomegaly, cirrhosis, and liver failureCan present with nonprogressive liver disease, or with severe myopathy with hypotonia and dilated cardiomyopathy",
                    "sub_points": [
                      "Usually presents as progressive liver disease with hepatomegaly, cirrhosis, and liver failure",
                      "Can present with nonprogressive liver disease, or with severe myopathy with hypotonia and dilated cardiomyopathy"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases, hypoglycemia, and hyperlipidemia common"
                  },
                  {
                    "text": "During fasting, lactic acidosis, ketosis, &/or hyperuricemia characterize the various types"
                  },
                  {
                    "text": "Elevated serum creatine kinase is seen in some types, including III and IX"
                  },
                  {
                    "text": "Neutropenia is seen in type Ib"
                  },
                  {
                    "text": "Hypoalbuminemia and prolonged prothrombin time (PT) and partial thromboplastin time (PTT) are seen when there is liver failure, such as in type IV"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Improvement of metabolic parameters results in catch-up growth, symptom improvement, and reduced liver size"
                  },
                  {
                    "text": "Long-term complications depend on the type: Includes renal damage ( type I), inflammatory bowel disease or recurrent infections (type Ib), cardiomyopathy (types III, IV, VI, IX), and cirrhosis"
                  },
                  {
                    "text": "Cirrhosis develops in 12-15% of patients (types III, IV, IX)"
                  },
                  {
                    "text": "Increased incidence of hepatocellular neoplasia in some typesHepatic adenoma occurs most often in type I, and less often in types III, VI, IXRegression has been observed with improvement in metabolic hemostasisMalignant transformation has been documentedHepatocellular carcinoma occurs in type I and reported in types III, IV, VI",
                    "sub_points": [
                      "Hepatic adenoma occurs most often in type I, and less often in types III, VI, IXRegression has been observed with improvement in metabolic hemostasisMalignant transformation has been documented",
                      "Regression has been observed with improvement in metabolic hemostasis",
                      "Malignant transformation has been documented",
                      "Hepatocellular carcinoma occurs in type I and reported in types III, IV, VI"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Dietary therapy, with frequent feeds, avoidance of simple sugars, and use of complex carbohydrates to ensure normoglycemiaUncooked cornstarch is a mainstay of dietary therapy",
                    "sub_points": [
                      "Uncooked cornstarch is a mainstay of dietary therapy"
                    ]
                  },
                  {
                    "text": "Specific therapies targeted to specific complications, such as allopurinol for hyperuricemia or G-CSF for neutropenia"
                  },
                  {
                    "text": "Liver transplantation for patients with poor metabolic control despite adherence to diet, adenoma with malignant transformation, or cirrhosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Variable based on type of GSDGood prognosis for milder types that can be controlled through diet, and, with therapy, most patients survive to adulthoodSpecific types can have additional complications that affect prognosis, such as renal damage (type I), neutropenia (type Ib), cirrhosis (type IV), cardiomyopathy (type III), or hepatocellular carcinoma (types I, III, IV)",
                    "sub_points": [
                      "Good prognosis for milder types that can be controlled through diet, and, with therapy, most patients survive to adulthood",
                      "Specific types can have additional complications that affect prognosis, such as renal damage (type I), neutropenia (type Ib), cirrhosis (type IV), cardiomyopathy (type III), or hepatocellular carcinoma (types I, III, IV)"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Enlarged, hyperechoic liver is common"
                  },
                  {
                    "text": "Often used to assess for steatosis, fibrosis (by transient elastography), and liver lesions"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Most types show enlarged and pale hepatocytesDue to increased glycogen that displaces cytoplasmThis results in thickened cell membrane with mosaic pattern",
                    "sub_points": [
                      "Due to increased glycogen that displaces cytoplasmThis results in thickened cell membrane with mosaic pattern",
                      "This results in thickened cell membrane with mosaic pattern"
                    ]
                  },
                  {
                    "text": "Varying degrees of steatosis and glycogenated nucleiMore pronounced in type I",
                    "sub_points": [
                      "More pronounced in type I"
                    ]
                  },
                  {
                    "text": "Fibrosis and cirrhosis depend on type"
                  },
                  {
                    "text": "GSD IV is distinctiveHepatocytes have weakly basophilic cytoplasmic inclusionsInclusions are PAS(+) and partially digested on PAS-D",
                    "sub_points": [
                      "Hepatocytes have weakly basophilic cytoplasmic inclusions",
                      "Inclusions are PAS(+) and partially digested on PAS-D"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Glycogen is PAS(+) and PAD-D(-)Helps support that intrahepatocytic cytoplasmic pallor is due to accumulated glycogen",
                    "sub_points": [
                      "Helps support that intrahepatocytic cytoplasmic pallor is due to accumulated glycogen"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Genetic testing has supplanted enzymatic activity assay for diagnosisSingle-gene testing or targeted analysis for pathogenic variants may be appropriate in specific populations or when subtype is strongly suspectedMultigene panels or comprehensive genomic testing may be necessary to establish diagnosis",
                    "sub_points": [
                      "Single-gene testing or targeted analysis for pathogenic variants may be appropriate in specific populations or when subtype is strongly suspected",
                      "Multigene panels or comprehensive genomic testing may be necessary to establish diagnosis"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Hepatocytes with increased glycogen often displacing organelles, cytoplasmic lipid, and intranuclear glycogen"
                  },
                  {
                    "text": "GSD type 0: Sparse hepatocyte glycogen"
                  },
                  {
                    "text": "GSD type IV: Fibrillary aggregates of electron-dense amylopectin-like material within hepatocytes"
                  }
                ],
                "Enzyme Activity Assay": [
                  {
                    "text": "Enzyme activity assays on snap-frozen liver tissue, muscle, or skin fibroblasts were historically performed to establish which enzyme is deficient"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Glycogenic Hepatopathy": [
                  {
                    "text": "Resembles GSD, but in patients with poorly controlled type 1 diabetes mellitus"
                  }
                ],
                "Fanconi-Bickel Syndrome": [
                  {
                    "text": "Defect in GLUT2, a glucose transporter"
                  },
                  {
                    "text": "Leads to accumulation of glycogen in liver and kidney, proximal renal tubular dysfunction, and impaired utilization of glucose and galactose"
                  },
                  {
                    "text": "Sometimes designated GSD type XIThis is discouraged because accumulation of glycogen is due to nonfunctional transport issue rather than defect in metabolism",
                    "sub_points": [
                      "This is discouraged because accumulation of glycogen is due to nonfunctional transport issue rather than defect in metabolism"
                    ]
                  }
                ],
                "Lafora Disease": [
                  {
                    "text": "Lafora bodies mimic GSD type IV"
                  },
                  {
                    "text": "Lafora bodies are more eosinophilic and stain homogeneously with colloidal iron"
                  },
                  {
                    "text": "Lafora disease is largely neurodegenerative disorder"
                  }
                ],
                "Fibrinogen Storage Disease or Reactive Fibrinogen Accumulation": [
                  {
                    "text": "Fibrinogen inclusions in primary storage disorder or as response to injury: Resembles pseudo ground glass inclusions and resembles GSD type IV"
                  },
                  {
                    "text": "Clinical picture, immunohistochemistry for fibrinogen if available, and EM may help distinguish"
                  }
                ],
                "Treated Urea Cycle Defects": [
                  {
                    "text": "Can result in hepatocyte glycogen accumulation, possibly related to therapeutic dietary modificationNonuniform distribution of glycogen and no displacement of organelles",
                    "sub_points": [
                      "Nonuniform distribution of glycogen and no displacement of organelles"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Types differ with regard to development of fibrosis or cirrhosis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "The key finding in most hepatic GSDRarefied and distended hepatocytes with increased glycogen that displace cytoplasm to cell membrane, causing mosaic pattern with variable fat and glycogenated nuclei",
                    "sub_points": [
                      "Rarefied and distended hepatocytes with increased glycogen that displace cytoplasm to cell membrane, causing mosaic pattern with variable fat and glycogenated nuclei"
                    ]
                  },
                  {
                    "text": "Unique histologic appearance in GSD type IV due to conspicuous cytoplasmic inclusion"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Niemann-Pick Disease": {
            "name": "Niemann-Pick Disease",
            "url": "https://app.pathprimer.com/document/67db77f8-c77b-43d3-9c9b-219c33a24c7e/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Types A and B are related, whereas type C is distinct"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Types A/B: Mutations ofSMPD1gene that encodes for acid sphingomyelinase, lysosomal enzyme that hydrolyzes sphingomyelin, with lysosomal accumulation of sphingomyelin"
                  },
                  {
                    "text": "Type C: Mutations inNPC1orNPC2that are required for lysosomal cholesterol trafficking with lysosomal accumulation of cholesterol and lipids"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Common to all types is hepatosplenomegaly with variable neurodegeneration"
                  },
                  {
                    "text": "Types A and B are distinguished by age of onset and severity"
                  },
                  {
                    "text": "Type A shows severe progressive neurodegenerative symptoms with death in infancy, whereas type B is chronic, visceral form of disease"
                  },
                  {
                    "text": "Type C presentation varies with age but typically shows progressive neurologic deterioration with death in infants, or psychiatric manifestations in adults"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Mild fibrosis to cirrhosis"
                  },
                  {
                    "text": "Foam cells (lipid-laden macrophages) in liver"
                  },
                  {
                    "text": "Hepatocytes and bile duct epithelium may also appear foamy"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "EM: Concentrically lamellated inclusions in lysosomes"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Gaucher disease: Gaucher cells have striated, fibrillary cytoplasmic inclusions within histiocytes"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Foam cells accumulate in various organs, including liver, spleen, lymph nodes, adrenal cortex, lungs, bone marrow"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Niemann-Pick disease (NPD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Types A and B: Acid sphingomyelinase deficiency"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Group of lipid storage disorders characterized by accumulation of lipid-laden macrophages in tissues"
                  }
                ],
                "Subtypes": [
                  {
                    "text": "Types A and B are genetically related"
                  },
                  {
                    "text": "Type C is genetically distinct"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Mutation": [
                  {
                    "text": "Types A/B: Mutations ofSMPD1gene that encodes for acid sphingomyelinase, lysosomal enzyme that hydrolyzes sphingomyelinAccumulation of sphingomyelin in lysosomesMost prominent in histiocytes, but also occurs in other cell types, including hepatocytes",
                    "sub_points": [
                      "Accumulation of sphingomyelin in lysosomesMost prominent in histiocytes, but also occurs in other cell types, including hepatocytes",
                      "Most prominent in histiocytes, but also occurs in other cell types, including hepatocytes"
                    ]
                  },
                  {
                    "text": "Type C: Mutations inNPC1(95%) orNPC2(5%) that are required for endosomal-lysosomal cholesterol and lipid traffickingAccumulation of cholesterol and lipids in late endosomes and lysosomes",
                    "sub_points": [
                      "Accumulation of cholesterol and lipids in late endosomes and lysosomes"
                    ]
                  }
                ],
                "Mode of Inheritance": [
                  {
                    "text": "Autosomal recessive"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Types A/B: 1:200,000"
                  },
                  {
                    "text": "Type C: 1:100,000"
                  }
                ],
                "Age": [
                  {
                    "text": "Varies from neonatal to adult"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Panethnic"
                  },
                  {
                    "text": "Types A/B: Increased prevalence among Ashkenazi Jews"
                  },
                  {
                    "text": "Type C: Increased frequency among Acadians in Nova Scotia and Hispanics in Colorado and New Mexico."
                  }
                ],
                "Presentation": [
                  {
                    "text": "Common to all types is hepatosplenomegaly with variable neurodegeneration"
                  },
                  {
                    "text": "Types A and B are distinguished by age of onset and severityType A: Severe progressive neurodegenerative symptoms in 1st year of lifeType B: Chronic progressive visceral form of diseaseHepatomegaly, splenomegaly, interstitial lung disease, joint pain, coronary artery diseaseLiver disease (40%) manifests as fulminant liver failure or cirrhosisVariant form of type B has neurologic manifestations",
                    "sub_points": [
                      "Type A: Severe progressive neurodegenerative symptoms in 1st year of life",
                      "Type B: Chronic progressive visceral form of diseaseHepatomegaly, splenomegaly, interstitial lung disease, joint pain, coronary artery diseaseLiver disease (40%) manifests as fulminant liver failure or cirrhosisVariant form of type B has neurologic manifestations",
                      "Hepatomegaly, splenomegaly, interstitial lung disease, joint pain, coronary artery disease",
                      "Liver disease (40%) manifests as fulminant liver failure or cirrhosis",
                      "Variant form of type B has neurologic manifestations"
                    ]
                  },
                  {
                    "text": "Type C presentation varies with agePre- or perinatal period: Cholestatic jaundice, hepatosplenomegaly, acute liver failure, and pulmonary diseaseInfantile or juvenile period (2-15 years): Neurologic manifestations, hepatosplenomegaly, and history of neonatal cholestasisAdults (> 15 years): Psychiatric illness and cognitive impairment, neurologic manifestations, or visceral signs, such as hepatomegaly and splenomegalyVisceral manifestations may be less prominent or asymptomatic in adults",
                    "sub_points": [
                      "Pre- or perinatal period: Cholestatic jaundice, hepatosplenomegaly, acute liver failure, and pulmonary disease",
                      "Infantile or juvenile period (2-15 years): Neurologic manifestations, hepatosplenomegaly, and history of neonatal cholestasis",
                      "Adults (> 15 years): Psychiatric illness and cognitive impairment, neurologic manifestations, or visceral signs, such as hepatomegaly and splenomegalyVisceral manifestations may be less prominent or asymptomatic in adults",
                      "Visceral manifestations may be less prominent or asymptomatic in adults"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Types A/B: Hyperlipidemia, low high-density lipoprotein, thrombocytopenia"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Type A: Progressive neurologic impairment with death by age 3"
                  },
                  {
                    "text": "Type B: Progressive deterioration of pulmonary function and liver failureLeading causes of death include respiratory failure, liver failure, bleeding complications, and cardiac disease",
                    "sub_points": [
                      "Leading causes of death include respiratory failure, liver failure, bleeding complications, and cardiac disease"
                    ]
                  },
                  {
                    "text": "Type C: Most commonly characterized by progressive neurologic deterioration with death by age 4"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive"
                  },
                  {
                    "text": "Types A/B: Bone marrow transplant or liver transplant occasionally performed"
                  },
                  {
                    "text": "Types A/B: Enzyme replacement therapy in clinical development"
                  },
                  {
                    "text": "Type C: Substrate reduction therapy with Miglustat"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Generalized cortical atrophy of brain"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Mild fibrosis to cirrhosis"
                  },
                  {
                    "text": "Foam cells (lipid-laden macrophages) in liver"
                  },
                  {
                    "text": "Hepatocytes and bile duct epithelium may also appear foamy"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "Type A/B: SequencingSMPD1gene> 180 mutations described, with numerous private mutations and mutations of unknown significanceSome genotype/phenotype correlations have been described",
                    "sub_points": [
                      "> 180 mutations described, with numerous private mutations and mutations of unknown significance",
                      "Some genotype/phenotype correlations have been described"
                    ]
                  },
                  {
                    "text": "Type C: Mutational analysis ofNPC1andNPC2~ 700 variants ofNPC1are described, of which 420 are considered pathogenicSome genotype/phenotype correlations have been described, such as p.I1061T with juvenile neurologic onset",
                    "sub_points": [
                      "~ 700 variants ofNPC1are described, of which 420 are considered pathogenic",
                      "Some genotype/phenotype correlations have been described, such as p.I1061T with juvenile neurologic onset"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Concentrically lamellated inclusions in lysosomes"
                  }
                ],
                "Diagnostic Tests": [
                  {
                    "text": "Types A/B: Quantifying ASM activity in circulating leukocytes or cultured skin cells"
                  },
                  {
                    "text": "Type C: Plasma biomarkers include oxysterols, lyso-sphingomyelin-509, and chitotriosidase activity"
                  },
                  {
                    "text": "Type C: Filipin staining of cultured fibroblasts shows accumulation of unesterified cholesterol in lysosomesFilipin test has been replaced by biomarkers and molecular analysis",
                    "sub_points": [
                      "Filipin test has been replaced by biomarkers and molecular analysis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Gaucher Disease": [
                  {
                    "text": "Gaucher cells have striated, fibrillary cytoplasm rather than foamy cytoplasm"
                  },
                  {
                    "text": "Assay for glucocerebrosidase activity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Foam cells accumulate in various organs, including liver, spleen, lymph nodes, adrenal cortex, lungs, bone marrowFoam cells are known as sea-blue histiocytes in marrow aspirates",
                    "sub_points": [
                      "Foam cells are known as sea-blue histiocytes in marrow aspirates"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neonatal Hemochromatosis": {
            "name": "Neonatal Hemochromatosis",
            "url": "https://app.pathprimer.com/document/560eebd8-631a-4868-8de1-dd5ad78d867a/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Gestational alloimmune liver disease (GALD)"
                  },
                  {
                    "text": "Neonatal severe liver disease associated with iron deposition in liver and extrahepatic sites"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most cases attributed to alloimmune liver injury from maternal IgG antibodies crossing placenta and targeting unknown fetal antigen"
                  },
                  {
                    "text": "Destruction of fetal liver causes reduced hepcidin synthesis, leading to increased iron transfer across placenta and iron accumulation in extrahepatic sites"
                  },
                  {
                    "text": "NH phenotype can occur in other infectious, metabolic, or genetic disorders that result in neonatal acute liver failure"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "In utero onset with manifestations within 1st hours or days of life"
                  },
                  {
                    "text": "Evidence of fetal insult, including intrauterine growth restriction, oligohydramnios, and prematurity"
                  },
                  {
                    "text": "Neonatal acute liver failure or fetal demise"
                  },
                  {
                    "text": "Generally poor survival (< 25%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Cirrhosis, shrunken liver"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cirrhosis or marked fibrosis with giant cell or pseudoacinar transformation"
                  },
                  {
                    "text": "Iron deposition in residual hepatocytes and in extrahepatic organs"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Iron stain shows iron in hepatocytes and duct epithelium but sparing of Kupffer cells"
                  },
                  {
                    "text": "Iron stain of extrahepatic sites, such as minor salivary gland (any amount is abnormal)"
                  },
                  {
                    "text": "Immunohistochemistry with antibodies directed against human SC5b-9 of terminal complement cascade [membrane attack complex (MAC)] stains hepatocyte cytoplasm in cases associated with GALD"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Tyrosinemia"
                  },
                  {
                    "text": "Niemann-Pick disease, type C"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Neonatal hemochromatosis (NH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Gestational alloimmune liver disease (GALD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Neonatal severe liver disease or liver failure associated with iron deposition in extrahepatic sites"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Immune Mediated": [
                  {
                    "text": "Most cases attributed to alloimmune liver injuryMaternal IgG antibodies cross placenta and target unknown fetal liver antigenDestruction of fetal liver cells causes reduced transferrin and hepcidin synthesisReduced hepcidin leads to unregulated ferroportin in placental trophoblast cells and fetal reticuloendothelial systemAllows increased iron to cross placenta into fetusResults in sparing of the reticuloendothelial system from iron accumulationReduced transferrin results in high transferrin saturation and increased nontransferrin bound ironIron accumulates in extrahepatic tissuesPancreatic acinar epithelium, myocardium, thyroid follicular cells, and minor salivary glandTissues that accumulate iron are characterized by expression of ZIP14, a non-transferrin iron receptor, but not ferroportin",
                    "sub_points": [
                      "Maternal IgG antibodies cross placenta and target unknown fetal liver antigen",
                      "Destruction of fetal liver cells causes reduced transferrin and hepcidin synthesisReduced hepcidin leads to unregulated ferroportin in placental trophoblast cells and fetal reticuloendothelial systemAllows increased iron to cross placenta into fetusResults in sparing of the reticuloendothelial system from iron accumulationReduced transferrin results in high transferrin saturation and increased nontransferrin bound ironIron accumulates in extrahepatic tissuesPancreatic acinar epithelium, myocardium, thyroid follicular cells, and minor salivary glandTissues that accumulate iron are characterized by expression of ZIP14, a non-transferrin iron receptor, but not ferroportin",
                      "Reduced hepcidin leads to unregulated ferroportin in placental trophoblast cells and fetal reticuloendothelial systemAllows increased iron to cross placenta into fetusResults in sparing of the reticuloendothelial system from iron accumulation",
                      "Allows increased iron to cross placenta into fetus",
                      "Results in sparing of the reticuloendothelial system from iron accumulation",
                      "Reduced transferrin results in high transferrin saturation and increased nontransferrin bound iron",
                      "Iron accumulates in extrahepatic tissuesPancreatic acinar epithelium, myocardium, thyroid follicular cells, and minor salivary glandTissues that accumulate iron are characterized by expression of ZIP14, a non-transferrin iron receptor, but not ferroportin",
                      "Pancreatic acinar epithelium, myocardium, thyroid follicular cells, and minor salivary gland",
                      "Tissues that accumulate iron are characterized by expression of ZIP14, a non-transferrin iron receptor, but not ferroportin"
                    ]
                  }
                ],
                "Various": [
                  {
                    "text": "NH phenotype can occur in other infectious, metabolic, or genetic disorders that result in neonatal acute liver failureReported conditions include perinatal infection (CMV, HSV, parvovirus B19), mitochondrial disorder [mitochondrial DNA depletion due to deoxyguanosine kinase deficiency (DGUOKgene mutations), mitochondrial respiratory chain disorder, GRACILE syndrome (BCS1Lmutation)], bile acid synthetic defect delta 4-3-oxosteroid 5 beta-reductase deficiency (SRD5B1mutations), trisomy 21, hemophagocytosis lymphohistiocytosis, myofibromatosis, trichohepatoenteric syndrome, transaldolase deficiency, and Martinez-Frias syndrome",
                    "sub_points": [
                      "Reported conditions include perinatal infection (CMV, HSV, parvovirus B19), mitochondrial disorder [mitochondrial DNA depletion due to deoxyguanosine kinase deficiency (DGUOKgene mutations), mitochondrial respiratory chain disorder, GRACILE syndrome (BCS1Lmutation)], bile acid synthetic defect delta 4-3-oxosteroid 5 beta-reductase deficiency (SRD5B1mutations), trisomy 21, hemophagocytosis lymphohistiocytosis, myofibromatosis, trichohepatoenteric syndrome, transaldolase deficiency, and Martinez-Frias syndrome"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Extremely rare"
                  },
                  {
                    "text": "Subsequent babies born to mother have 90% chance of being affected"
                  }
                ],
                "Age": [
                  {
                    "text": "In utero onset with manifestations within 1st hours or days of life"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Evidence of fetal insult, including intrauterine growth restriction, oligohydramnios, and prematurity"
                  },
                  {
                    "text": "Neonatal acute liver failure and, usually, multiorgan failureHypoglycemia, coagulopathy, hypoalbuminemia, edema, oliguria, jaundice",
                    "sub_points": [
                      "Hypoglycemia, coagulopathy, hypoalbuminemia, edema, oliguria, jaundice"
                    ]
                  },
                  {
                    "text": "Fetal demise"
                  },
                  {
                    "text": "Persistent patency of the ductus venosus"
                  },
                  {
                    "text": "Maternal history of prior fetal loss"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Hypotransferrinemia and hyperferritinemia"
                  },
                  {
                    "text": "Transaminase elevations are relatively mild"
                  },
                  {
                    "text": "Elevated α-fetoprotein"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive care"
                  },
                  {
                    "text": "Antioxidants and iron chelator"
                  },
                  {
                    "text": "Exchange transfusions and IVIg administration"
                  },
                  {
                    "text": "Liver transplantation"
                  },
                  {
                    "text": "Mother is given intravenous immunoglobulin for subsequent pregnancies"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally poor with overall survival < 25%"
                  },
                  {
                    "text": "Survival may be improved with exchange transfusion and IVIg to 75%"
                  },
                  {
                    "text": "Liver transplantation has a reported survival of 45% to 68%"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Iron deposition may be found in extrahepatic sites, including liver, pancreas, heart"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Cirrhosis, shrunken liver"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cirrhosis or marked fibrosisResidual or regenerating hepatocytes may have giant cell or pseudoacinar transformation",
                    "sub_points": [
                      "Residual or regenerating hepatocytes may have giant cell or pseudoacinar transformation"
                    ]
                  },
                  {
                    "text": "Some cases due to GALD show panacinar hepatic necrosis with little or no fibrosisIn these cases, hepatic and extrahepatic siderosis is variable",
                    "sub_points": [
                      "In these cases, hepatic and extrahepatic siderosis is variable"
                    ]
                  },
                  {
                    "text": "Iron deposition in residual hepatocytes and in ductules"
                  },
                  {
                    "text": "Iron deposition in other organs"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Iron stain shows iron in hepatocytes and duct epithelium but sparing of Kupffer cells"
                  },
                  {
                    "text": "Iron stain of extrahepatic sites, such as minor salivary gland (any amount is abnormal)"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Immunohistochemistry with antibodies directed against human SC5b-9 of terminal complement cascade [membrane attack complex (MAC)] stains hepatocyte cytoplasm in cases associated with GALDStudies have questioned the specificity of the stain, but in the correct context, positive staining is supportive",
                    "sub_points": [
                      "Studies have questioned the specificity of the stain, but in the correct context, positive staining is supportive"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Tyrosinemia": [
                  {
                    "text": "NH can have elevated serum tyrosine levels due to failed hepatic metabolic function"
                  },
                  {
                    "text": "Succinylacetone is absent in urine in NH"
                  }
                ],
                "Niemann-Pick Disease, Type C": [
                  {
                    "text": "Presentation with neonatal liver failure can mimic NH"
                  },
                  {
                    "text": "Foamy macrophages in liver in Niemann-Pick disease type C"
                  },
                  {
                    "text": "Genetic analysis forNPC1orNPC2mutations"
                  }
                ],
                "Post-mortem changes": [
                  {
                    "text": "Hepatic necrosis without fibrosis can be mistaken for autolysis."
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Severe acute, subacute, or chronic liver injury with iron deposition in liver and extrahepatic sites"
                  },
                  {
                    "text": "Diagnosis is confirmed by extrahepatic iron or immunostain for C5b-9 MAC"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Iron accumulation in extrahepatic tissues is more meaningful than hepatic iron deposition, as latter can occur in other conditions with severe liver injury"
                  },
                  {
                    "text": "Because the final stage of renal development is dependent upon liver function, affected babies may have renal hypoplasia, with proximal tubular dysgenesis and paucity of peripheral glomeruli"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Progressive Familial Intrahepatic Cholestasis": {
            "name": "Progressive Familial Intrahepatic Cholestasis",
            "url": "https://app.pathprimer.com/document/116d1f65-1f92-4f12-af67-193b6a7e3664/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Progressive familial intrahepatic cholestasis (PFIC) type 1 (PFIC1): Mutations ofATP8B1that encode FIC1"
                  },
                  {
                    "text": "PFIC type 2 (PFIC2): Mutations ofABCB11that encode BSEP"
                  },
                  {
                    "text": "PFIC type 3 (PFIC3): Mutations ofABCB4that encode MDR3"
                  },
                  {
                    "text": "Additional genes associated with cholestasis are being identified, includingTJP2,NR1H4, andMYO5D"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "PFIC presents in 1st year of life with pruritus and jaundice"
                  },
                  {
                    "text": "Most PFICs are characterized by normal γ-glutamyltransferase (GGT), whereas PFIC3 is associated with elevated GGT"
                  },
                  {
                    "text": "BSEP disease is associated with hepatocellular carcinoma"
                  },
                  {
                    "text": "Wide array of other clinical presentations associated with mutations in these genes, including benign recurrent intrahepatic cholestasis, intrahepatic cholestasis of pregnancy, drug-induced cholestasis, and adulthood ductopenia and biliary cirrhosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "PFIC1 is characterized by relatively bland canalicular cholestasis"
                  },
                  {
                    "text": "PFIC2 is characterized by pattern of neonatal giant cell hepatitis"
                  },
                  {
                    "text": "PFIC3 is characterized by ductular reaction and bile plugs in ductules"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "FIC1 disease reveals coarsely granular bile with electron microscopy"
                  },
                  {
                    "text": "Immunohistochemistry for canalicular proteins BSEP and MDR3 can be useful for diagnosis but are not completely reliable"
                  },
                  {
                    "text": "Genetic testing for genes implicated in childhood cholestatic liver diseases may be necessary to establish exact diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Progressive familial intrahepatic cholestasis (PFIC)"
                  },
                  {
                    "text": "Benign recurrent intrahepatic cholestasis (BRIC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "PFIC type 1 (PFIC1)Familial intrahepatic cholestasis 1 (FIC1) diseaseByler disease, Byler syndromeGreenland familial cholestasis",
                    "sub_points": [
                      "Familial intrahepatic cholestasis 1 (FIC1) disease",
                      "Byler disease, Byler syndrome",
                      "Greenland familial cholestasis"
                    ]
                  },
                  {
                    "text": "PFIC type 2 (PFIC2)Bile salt export pump (BSEP) disease",
                    "sub_points": [
                      "Bile salt export pump (BSEP) disease"
                    ]
                  },
                  {
                    "text": "PFIC type 3 (PFIC3)Multidrug resistance protein 3 (MDR3) disease",
                    "sub_points": [
                      "Multidrug resistance protein 3 (MDR3) disease"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "PFIC is heterogeneous group of genetic disorders characterized by chronic cholestasis and variable progression to liver failure and cirrhosisPFIC1, PFIC2, and PFIC3 are widely recognizedPFIC type 6 has been proposed",
                    "sub_points": [
                      "PFIC1, PFIC2, and PFIC3 are widely recognized",
                      "PFIC type 6 has been proposed"
                    ]
                  },
                  {
                    "text": "BRIC is nonprogressive form of cholestatic liver disease that lies on spectrum of disease with PFICAssociated with missense-type mutations or mutations located in less conserved regions of these genes",
                    "sub_points": [
                      "Associated with missense-type mutations or mutations located in less conserved regions of these genes"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Autosomal Recessive Genetic Disorder": [
                  {
                    "text": "PFIC1: Mutations ofATP8B1gene that encode FIC1FIC1 is expressed on variety of tissues, including liver, intestine, pancreasFunctions as flippase, flipping aminophospholipids, such as phosphatidylserine from outer to inner lipid layer of cell membrane, enhancing membrane resistance to detergent actions of bile saltsMutations result in loss of membrane bilayer lipid asymmetry, decreased resistance of canalicular membrane to bile salt detergent action, and impaired BSEP activity or farnesoid X receptor (FXR) signaling",
                    "sub_points": [
                      "FIC1 is expressed on variety of tissues, including liver, intestine, pancreasFunctions as flippase, flipping aminophospholipids, such as phosphatidylserine from outer to inner lipid layer of cell membrane, enhancing membrane resistance to detergent actions of bile saltsMutations result in loss of membrane bilayer lipid asymmetry, decreased resistance of canalicular membrane to bile salt detergent action, and impaired BSEP activity or farnesoid X receptor (FXR) signaling",
                      "Functions as flippase, flipping aminophospholipids, such as phosphatidylserine from outer to inner lipid layer of cell membrane, enhancing membrane resistance to detergent actions of bile salts",
                      "Mutations result in loss of membrane bilayer lipid asymmetry, decreased resistance of canalicular membrane to bile salt detergent action, and impaired BSEP activity or farnesoid X receptor (FXR) signaling"
                    ]
                  },
                  {
                    "text": "PFIC2: Mutations ofABCB11gene that encode for BSEPBSEP is ATP-dependent bile acid transporter on canalicular membraneMutations cause impaired bile salt-dependent bile flowD482G variant causes somewhat milder disease",
                    "sub_points": [
                      "BSEP is ATP-dependent bile acid transporter on canalicular membrane",
                      "Mutations cause impaired bile salt-dependent bile flowD482G variant causes somewhat milder disease",
                      "D482G variant causes somewhat milder disease"
                    ]
                  },
                  {
                    "text": "PFIC3: Mutations ofABCB4gene that encode MDR3 glycoproteinMDR3 is flippase that flips phosphatidylcholine from inner to outer lipid leaflet of canalicular membrane, increasing phospholipids in bile, which reduces its detergent actionsMutations in MDR3 result in decreased concentration of phospholipids in bile, increasing its detergent propertiesDecreased phospholipids destabilize micelles and promote lithogenicity of bile with crystallization of cholesterol",
                    "sub_points": [
                      "MDR3 is flippase that flips phosphatidylcholine from inner to outer lipid leaflet of canalicular membrane, increasing phospholipids in bile, which reduces its detergent actionsMutations in MDR3 result in decreased concentration of phospholipids in bile, increasing its detergent propertiesDecreased phospholipids destabilize micelles and promote lithogenicity of bile with crystallization of cholesterol",
                      "Mutations in MDR3 result in decreased concentration of phospholipids in bile, increasing its detergent properties",
                      "Decreased phospholipids destabilize micelles and promote lithogenicity of bile with crystallization of cholesterol"
                    ]
                  },
                  {
                    "text": "PFIC type 4 (PFIC4): Mutations inTJP2gene that encode for tight junction protein 2 (TJP2)TJP2 is involved in organization of epithelial and endothelial intercellular junctionsMutations result in impaired localization of claudin-1 and poorly formed intercellular tight junctions between cholangiocytes and canaliculi",
                    "sub_points": [
                      "TJP2 is involved in organization of epithelial and endothelial intercellular junctions",
                      "Mutations result in impaired localization of claudin-1 and poorly formed intercellular tight junctions between cholangiocytes and canaliculi"
                    ]
                  },
                  {
                    "text": "PFIC type 5 (PFIC5): Mutations inNR1H4gene that encode for FXRFXR is nuclear bile acid receptor that regulates bile acid homeostasisFXR is highly expressed in ileum and liverFXR decreases de novo biosynthesis of bile acids in liver and increases its excretion in small intestine",
                    "sub_points": [
                      "FXR is nuclear bile acid receptor that regulates bile acid homeostasisFXR is highly expressed in ileum and liverFXR decreases de novo biosynthesis of bile acids in liver and increases its excretion in small intestine",
                      "FXR is highly expressed in ileum and liver",
                      "FXR decreases de novo biosynthesis of bile acids in liver and increases its excretion in small intestine"
                    ]
                  },
                  {
                    "text": "PFIC type 6 (PFIC6) (proposed): Mutations inMYO5Bgene that encode for myosin 5BMyosin 5B is essential for proper functioning of polarized cellsMutations lead to impaired targeting of BSEP and MDR3 to canalicular membrane of hepatocytes",
                    "sub_points": [
                      "Myosin 5B is essential for proper functioning of polarized cells",
                      "Mutations lead to impaired targeting of BSEP and MDR3 to canalicular membrane of hepatocytes"
                    ]
                  }
                ],
                "De Novo Antibody Production": [
                  {
                    "text": "BSEP disease recurrence in allograft is attributed to production of de novo antibodies directed against BSEP that impede function of BSEP in allograft"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1:50,000-100,000"
                  }
                ],
                "Age": [
                  {
                    "text": "Generally presents in 1st year of life"
                  },
                  {
                    "text": "Mild forms and manifestations of heterozygosity, such as intrahepatic cholestasis of pregnancy or adulthood ductopenia, may present in adulthood"
                  }
                ],
                "Sex": [
                  {
                    "text": "M = F"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Patients can present along spectrum of clinical severity, ranging from severe progressive cholestatic disease in infancy (PFIC) to bouts of cholestasis and pruritus with less injury to liver (BRIC)"
                  },
                  {
                    "text": "PFIC presents during infancy with pruritus, jaundice, pale stools, and hepatomegalyExtrahepatic manifestations are common in FIC1, including pancreatitis, diarrhea, respiratory symptoms, failure to thrive, delayed sexual development, and hearing lossSpecific types of PFIC may have additional findings, such as cholelithiasis or diarrhea",
                    "sub_points": [
                      "Extrahepatic manifestations are common in FIC1, including pancreatitis, diarrhea, respiratory symptoms, failure to thrive, delayed sexual development, and hearing loss",
                      "Specific types of PFIC may have additional findings, such as cholelithiasis or diarrhea"
                    ]
                  },
                  {
                    "text": "BRIC presents during early stages of life with intermittent bouts of cholestasis and pruritus but without progressive liver diseaseCases presenting on continuum between BRIC and PFIC, or initially as BRIC that progresses to PFIC, have been described",
                    "sub_points": [
                      "Cases presenting on continuum between BRIC and PFIC, or initially as BRIC that progresses to PFIC, have been described"
                    ]
                  },
                  {
                    "text": "Other manifestations of mutation in various genes (including missense mutations, genetic variants, or heterozygosity) include juvenile cholelithiasis, intrahepatic cholestasis of pregnancy, drug-induced cholestasis, adulthood ductopenia, and biliary cirrhosisIntrahepatic cholestasis of pregnancy is characterized by intense pruritus, typically of palms and soles, during pregnancyAssociated with increased rate of adverse fetal outcomes, including fetal distress and intrauterine fetal deathDrug-induced cholestasis is associated with variants ofABCB4Oral contraceptive-induced cholestasis in particular is associated with variants ofABCB4and with history of intrahepatic cholestasis of pregnancyLow phospholipid-associated cholelithiasis is characterized by development of symptomatic gallstones early in life, intrahepatic stones, and recurrence after cholecystectomyDiagnostic criteria include 2 of followingBiliary symptoms before age of 40 yearsDetection of intrahepatic microlithiasis/sludge by ultrasound (hyperechogenic foci)Recurrence of biliary symptoms after cholecystectomyMicroscopic examination of bile shows aggregated cholesterol crystals or microliths",
                    "sub_points": [
                      "Intrahepatic cholestasis of pregnancy is characterized by intense pruritus, typically of palms and soles, during pregnancyAssociated with increased rate of adverse fetal outcomes, including fetal distress and intrauterine fetal death",
                      "Associated with increased rate of adverse fetal outcomes, including fetal distress and intrauterine fetal death",
                      "Drug-induced cholestasis is associated with variants ofABCB4Oral contraceptive-induced cholestasis in particular is associated with variants ofABCB4and with history of intrahepatic cholestasis of pregnancy",
                      "Oral contraceptive-induced cholestasis in particular is associated with variants ofABCB4and with history of intrahepatic cholestasis of pregnancy",
                      "Low phospholipid-associated cholelithiasis is characterized by development of symptomatic gallstones early in life, intrahepatic stones, and recurrence after cholecystectomyDiagnostic criteria include 2 of followingBiliary symptoms before age of 40 yearsDetection of intrahepatic microlithiasis/sludge by ultrasound (hyperechogenic foci)Recurrence of biliary symptoms after cholecystectomyMicroscopic examination of bile shows aggregated cholesterol crystals or microliths",
                      "Diagnostic criteria include 2 of followingBiliary symptoms before age of 40 yearsDetection of intrahepatic microlithiasis/sludge by ultrasound (hyperechogenic foci)Recurrence of biliary symptoms after cholecystectomy",
                      "Biliary symptoms before age of 40 years",
                      "Detection of intrahepatic microlithiasis/sludge by ultrasound (hyperechogenic foci)",
                      "Recurrence of biliary symptoms after cholecystectomy",
                      "Microscopic examination of bile shows aggregated cholesterol crystals or microliths"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "γ-glutamyltransferase (GGT) is used to distinguish various typesNormal or nearly normal in all types except MDR3 diseaseElevated in PFIC3 (MDR3 disease)",
                    "sub_points": [
                      "Normal or nearly normal in all types except MDR3 diseaseElevated in PFIC3 (MDR3 disease)",
                      "Elevated in PFIC3 (MDR3 disease)"
                    ]
                  },
                  {
                    "text": "Elevated serum bile acids"
                  },
                  {
                    "text": "FIC1 disease may be associated with elevated sweat chloride"
                  },
                  {
                    "text": "MDR3 disease is characterized by low concentrations of phospholipids in bile analysis"
                  },
                  {
                    "text": "PFIC5 is associated with vitamin K-independent coagulopathy and elevated AFP"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Progressive forms can result in worsening hepatic function, liver failure, cirrhosis, and death before adulthoodChronic cholestasis leads to complications of fat malabsorption, such as deficiencies of fat-soluble vitamins and weight loss",
                    "sub_points": [
                      "Chronic cholestasis leads to complications of fat malabsorption, such as deficiencies of fat-soluble vitamins and weight loss"
                    ]
                  },
                  {
                    "text": "Hepatocellular carcinoma and intrahepatic cholangiocarcinoma develop in some forms of PFICBSEP disease carries highest risk, affecting 5-15% of severely affected patients, especially those with non-D482G mutationsLiver cancer also reported in MDR3 disease and PFIC4",
                    "sub_points": [
                      "BSEP disease carries highest risk, affecting 5-15% of severely affected patients, especially those with non-D482G mutations",
                      "Liver cancer also reported in MDR3 disease and PFIC4"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Removal of pathogenic serum antibodiesRecurrent BSEP disease in allografts is often treated with plasmapheresis, rituximab, or immunoadsorption to reduce serum antibodies directed against BSEP",
                    "sub_points": [
                      "Recurrent BSEP disease in allografts is often treated with plasmapheresis, rituximab, or immunoadsorption to reduce serum antibodies directed against BSEP"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Partial external biliary diversion (PEBD)Short jejunal conduit connects gallbladder fundus and stoma, allowing for external drainage of bile from gallbladder",
                    "sub_points": [
                      "Short jejunal conduit connects gallbladder fundus and stoma, allowing for external drainage of bile from gallbladder"
                    ]
                  },
                  {
                    "text": "Partial internal biliary diversion (PIBD) is novel technique that avoids stomaShort jejunal conduit connects gallbladder fundus and colon or other intestinal segment",
                    "sub_points": [
                      "Short jejunal conduit connects gallbladder fundus and colon or other intestinal segment"
                    ]
                  },
                  {
                    "text": "Ileal exclusion~ 15% of terminal ileum is bypassed, reducing bile acid reabsorption",
                    "sub_points": [
                      "~ 15% of terminal ileum is bypassed, reducing bile acid reabsorption"
                    ]
                  },
                  {
                    "text": "Liver transplantationMay result in intractable diarrhea and steatohepatitis in FIC1 patientsBSEP disease may recur in allograftAttributed to formation of autoantibodies to BSEP, which develop in 8% of patientsCharacterized by refractory pruritus, which is not resolved by retransplantation",
                    "sub_points": [
                      "May result in intractable diarrhea and steatohepatitis in FIC1 patients",
                      "BSEP disease may recur in allograftAttributed to formation of autoantibodies to BSEP, which develop in 8% of patientsCharacterized by refractory pruritus, which is not resolved by retransplantation",
                      "Attributed to formation of autoantibodies to BSEP, which develop in 8% of patients",
                      "Characterized by refractory pruritus, which is not resolved by retransplantation"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Ursodeoxycholic acid (UDCA), rifampin, cholestyramine, and phenobarbital are used to treat pruritus"
                  },
                  {
                    "text": "Novel therapies include apical sodium-dependent bile acid transport (ASBT) inhibitors and FXR agonists"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "FIC1 diseaseCanalicular cholestasis accentuated around central veins with variable hepatocyte rosetting and compact hepatocytesBile ducts may be hypoplasticLobular fibrosis and cirrhosis develop in later stages",
                    "sub_points": [
                      "Canalicular cholestasis accentuated around central veins with variable hepatocyte rosetting and compact hepatocytes",
                      "Bile ducts may be hypoplastic",
                      "Lobular fibrosis and cirrhosis develop in later stages"
                    ]
                  },
                  {
                    "text": "BSEP diseaseNeonatal hepatitis pattern with canalicular cholestasis, giant cell transformation, hepatocyte swelling, hepatocyte rosetting, lobular inflammation, and variable numbers of necrotic hepatocytesBile duct injury, bile ductular reaction, bile plugging in cholangioles, and bile duct hypoplasia or paucity may be presentFibrosis and, eventually, cirrhosisFibrosis can be both portal based and centrilobular sinusoidalAllograft biopsies may demonstrate recurrent disease, steatosis, or steatohepatitis",
                    "sub_points": [
                      "Neonatal hepatitis pattern with canalicular cholestasis, giant cell transformation, hepatocyte swelling, hepatocyte rosetting, lobular inflammation, and variable numbers of necrotic hepatocytes",
                      "Bile duct injury, bile ductular reaction, bile plugging in cholangioles, and bile duct hypoplasia or paucity may be present",
                      "Fibrosis and, eventually, cirrhosisFibrosis can be both portal based and centrilobular sinusoidal",
                      "Fibrosis can be both portal based and centrilobular sinusoidal",
                      "Allograft biopsies may demonstrate recurrent disease, steatosis, or steatohepatitis"
                    ]
                  },
                  {
                    "text": "MDR3 diseaseExpanded portal tracts with ductular proliferation and mixed inflammatory infiltratesCholestasis and giant cell transformation of hepatocytes may be seenLate stages characterized by biliary cirrhosis, bile plugs in ductules, and fibroobliterative duct lesionsMay see cholesterol clefts in bile ducts",
                    "sub_points": [
                      "Expanded portal tracts with ductular proliferation and mixed inflammatory infiltrates",
                      "Cholestasis and giant cell transformation of hepatocytes may be seen",
                      "Late stages characterized by biliary cirrhosis, bile plugs in ductules, and fibroobliterative duct lesions",
                      "May see cholesterol clefts in bile ducts"
                    ]
                  },
                  {
                    "text": "PFIC4Lobular cholestasis with patchy inflammation and cholestatic rosettesDuctular reaction and patchy, portal-based fibrosis",
                    "sub_points": [
                      "Lobular cholestasis with patchy inflammation and cholestatic rosettes",
                      "Ductular reaction and patchy, portal-based fibrosis"
                    ]
                  },
                  {
                    "text": "PFIC5Lobular cholestasis with giant cell transformation of hepatocytesDuctular reaction, portal fibrosis, eventually progressing to cirrhosisAllograft biopsies with steatosis have been described",
                    "sub_points": [
                      "Lobular cholestasis with giant cell transformation of hepatocytes",
                      "Ductular reaction, portal fibrosis, eventually progressing to cirrhosis",
                      "Allograft biopsies with steatosis have been described"
                    ]
                  },
                  {
                    "text": "PFIC6Canalicular cholestasis with giant cell transformation of hepatocytes, portal and lobular fibrosis, and absence of bile duct proliferation",
                    "sub_points": [
                      "Canalicular cholestasis with giant cell transformation of hepatocytes, portal and lobular fibrosis, and absence of bile duct proliferation"
                    ]
                  },
                  {
                    "text": "BRICCentrilobular cholestasis with variable cholestatic rosettes and compact hepatocytes without prominent giant cell transformationAbsent fibrosis",
                    "sub_points": [
                      "Centrilobular cholestasis with variable cholestatic rosettes and compact hepatocytes without prominent giant cell transformation",
                      "Absent fibrosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "BSEP immunohistochemistryCanalicular expression may be lost in BSEP disease and PFIC5May be patchy with granular subcanalicular staining in PFIC6",
                    "sub_points": [
                      "Canalicular expression may be lost in BSEP disease and PFIC5",
                      "May be patchy with granular subcanalicular staining in PFIC6"
                    ]
                  },
                  {
                    "text": "MDR3 immunohistochemistryCanalicular expression may be lost in MDR3 diseaseMay show thickened canalicular staining with granular subcanalicular staining in PFIC6",
                    "sub_points": [
                      "Canalicular expression may be lost in MDR3 disease",
                      "May show thickened canalicular staining with granular subcanalicular staining in PFIC6"
                    ]
                  },
                  {
                    "text": "Limitations of BSEP and MDR3 immunostainingImmunostains do not replace molecular diagnosis, since stains are not completely reliablePreserved immunostaining for BSEP and MDR3 does not exclude PFIC, since deleterious mutations may render protein nonfunctioningImmunostains for BSEP and MDR3 are not able to detect heterozygosity in adult patients",
                    "sub_points": [
                      "Immunostains do not replace molecular diagnosis, since stains are not completely reliable",
                      "Preserved immunostaining for BSEP and MDR3 does not exclude PFIC, since deleterious mutations may render protein nonfunctioning",
                      "Immunostains for BSEP and MDR3 are not able to detect heterozygosity in adult patients"
                    ]
                  },
                  {
                    "text": "Claudin-1 and TJP2 immunohistochemistry: Expression in cholangiocytes and canaliculi tight junctions is substantially reduced in PFIC4"
                  }
                ],
                "Immunofluorescence": [
                  {
                    "text": "May be useful to diagnose recurrent BSEP disease in allograftImmunofluorescence with antibodies directed against IgG demonstrates staining of canaliculi in patient liver, indicating deposition of immunoglobulin in canaliculiImmunofluorescence using patient sera and normal human liver as substrate detects staining of canaliculi, indicating de novo antibody targeting canalicular protein",
                    "sub_points": [
                      "Immunofluorescence with antibodies directed against IgG demonstrates staining of canaliculi in patient liver, indicating deposition of immunoglobulin in canaliculi",
                      "Immunofluorescence using patient sera and normal human liver as substrate detects staining of canaliculi, indicating de novo antibody targeting canalicular protein"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Genetic testing for genes implicated in childhood cholestatic liver diseases may be necessary to establish exact diagnosis"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "FIC1 disease reveals coarsely granular bile, referred to as Byler bile"
                  },
                  {
                    "text": "MDR3 disease may show cholesterol clefts in bile ducts or canaliculi"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Biliary Atresia": [
                  {
                    "text": "Histology shows obstructive pattern with bile ductular reaction, inspissated bile in ducts"
                  },
                  {
                    "text": "Hepatobiliary imaging confirms atretic bile duct"
                  }
                ],
                "Bile Acid Synthesis Defect": [
                  {
                    "text": "Also shows low GGT, but, unlike PFIC, serum bile acid concentration is low"
                  }
                ],
                "Other Childhood Cholestatic Disorders": [
                  {
                    "text": "Histology of many cholestatic childhood disorders is indistinguishable from PFIC, and their distinction requires serologic, biochemical, and genetic testsAmong conditions that should be considered are syndromic bile duct paucity (Alagille syndrome), Dubin-Johnson syndrome, type 2 citrullinemia, arthrogryposis-renal dysfunction cholestasis (ARC) syndrome",
                    "sub_points": [
                      "Among conditions that should be considered are syndromic bile duct paucity (Alagille syndrome), Dubin-Johnson syndrome, type 2 citrullinemia, arthrogryposis-renal dysfunction cholestasis (ARC) syndrome"
                    ]
                  }
                ],
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Histology shows periductal fibrosis"
                  },
                  {
                    "text": "Cholangiogram shows strictures and dilatations"
                  }
                ],
                "Cystic Fibrosis": [
                  {
                    "text": "Evidence suggests thatATP8B1may be required for apical surface localization of CFTR in epithelial cells"
                  },
                  {
                    "text": "Combination of elevated sweat chloride, cholestasis, and lung disease in FIC1 disease may suggest cystic fibrosis"
                  },
                  {
                    "text": "Low GGT is suggestive of PFIC"
                  },
                  {
                    "text": "Focal biliary fibrosis with PAS-positive inspissated secretions is typical of cystic fibrosis"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Prolonged cholestasis in MDR3 disease may be associated with increased tissue copper and urine copper, mimicking Wilson disease"
                  },
                  {
                    "text": "Wilson disease shows more steatosis and less prominent duct disease"
                  }
                ],
                "TPN-Induced Cholestasis": [
                  {
                    "text": "Infants on TPN may develop cholestasis, and this may be difficult to distinguish from PFIC"
                  },
                  {
                    "text": "Biopsies may show more steatosis, duct proliferation, and ceroid-laden macrophages in lobules"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "BRIC is characterized by cholestasis during attacks but no histologic progression"
                  },
                  {
                    "text": "PFIC is characterized by increasing fibrosis and may show duct paucity, giant cell hepatitis, or bile ductules with bile plugging, depending on subtype"
                  },
                  {
                    "text": "Neonatal cholestatic disorder with normal GGT and elevated serum bile acids suggests PFIC1 or PFIC2, whereas elevated GGT suggests possibility of PFIC3"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "PFIC1 shows bland cholestasis, PFIC2 shows pattern of giant cell hepatitis, and PFIC3 shows duct proliferation with bile plugs"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hereditary Hemochromatosis": {
            "name": "Hereditary Hemochromatosis",
            "url": "https://app.pathprimer.com/document/b38ba272-c105-48a3-992e-fdf5c94b1aa7/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hereditary hemochromatosis (HH)"
                  },
                  {
                    "text": "Group of inherited disorders of iron metabolism"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Type 1:HFE-related HH"
                  },
                  {
                    "text": "Mutations inHFEcause decreased hepcidin synthesis"
                  },
                  {
                    "text": "C282Y is most significant pathogenic allele"
                  },
                  {
                    "text": "C282Y/C282Y homozygosity underlies most clinically significantHFE-related iron overload"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Affects 1:200-300 persons"
                  },
                  {
                    "text": "Generally presents ~ 40-50 years of age"
                  },
                  {
                    "text": "Due toHFEgene testing, HH usually presents asymptomatically or with mild symptoms of fatigue, malaise, arthralgia, and hepatosplenomegaly"
                  },
                  {
                    "text": "Phlebotomy and iron chelation are mainstays of treatment"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Histologically, iron deposition within hepatocytes is hallmark of disease, beginning in periportal hepatocytes and progressing to all zones"
                  },
                  {
                    "text": "Variable portal-based fibrosis progressing to cirrhosis"
                  },
                  {
                    "text": "Iron-free foci are sublobular nodules of hepatocytes that are devoid of iron and may indicate higher risk of developing HCC"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Iron stain demonstrates iron in hepatocytes and allows for semiquantitative assessment"
                  },
                  {
                    "text": "Testing for mutations inHFEhas become key diagnostic test"
                  },
                  {
                    "text": "Hepatic iron concentration (HIC) is useful to determine baseline iron overload, but its diagnostic utility has been supplanted byHFEmutation testing"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hereditary hemochromatosis (HH)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Group of inherited disorders of iron metabolism"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Mutation": [
                  {
                    "text": "Type 1:HFE-related HHHFE binds β-2-microglobulin and interacts with transferrin receptor (TFR)-1 on cell surface for iron sensing and regulation of hepcidinMutations inHFEcause decreased hepcidin synthesisReduced degradation of ferroportin on basolateral membrane of enterocytesIncreased iron absorption in duodenumC282Y is most significant pathogenic alleleC282Y/C282Y homozygosity underlies most clinically significantHFE-related iron overloadH63D and S65C alleles may cause increased serum iron and ferritin levels but do not cause clinically significant iron overload in isolationCompound heterozygosity for C282Y/H63D causes clinically significant overload in < 2% of casesRare variants inHFEmay explain HH in patients who do not have C282Y homozygosity",
                    "sub_points": [
                      "HFE binds β-2-microglobulin and interacts with transferrin receptor (TFR)-1 on cell surface for iron sensing and regulation of hepcidin",
                      "Mutations inHFEcause decreased hepcidin synthesisReduced degradation of ferroportin on basolateral membrane of enterocytesIncreased iron absorption in duodenum",
                      "Reduced degradation of ferroportin on basolateral membrane of enterocytes",
                      "Increased iron absorption in duodenum",
                      "C282Y is most significant pathogenic alleleC282Y/C282Y homozygosity underlies most clinically significantHFE-related iron overload",
                      "C282Y/C282Y homozygosity underlies most clinically significantHFE-related iron overload",
                      "H63D and S65C alleles may cause increased serum iron and ferritin levels but do not cause clinically significant iron overload in isolationCompound heterozygosity for C282Y/H63D causes clinically significant overload in < 2% of cases",
                      "Compound heterozygosity for C282Y/H63D causes clinically significant overload in < 2% of cases",
                      "Rare variants inHFEmay explain HH in patients who do not have C282Y homozygosity"
                    ]
                  },
                  {
                    "text": "Type 2 HH: Juvenile hemochromatosisType 2A: Mutations in hemojuvelin (HJV) geneHemojuvelin functions as enhancer for iron signaling to hepcidinType 2B: Mutations in hepatic antimicrobial protein (HAMP) gene that encodes for hepcidinAssociated with early onset and severe form of HH",
                    "sub_points": [
                      "Type 2A: Mutations in hemojuvelin (HJV) geneHemojuvelin functions as enhancer for iron signaling to hepcidin",
                      "Hemojuvelin functions as enhancer for iron signaling to hepcidin",
                      "Type 2B: Mutations in hepatic antimicrobial protein (HAMP) gene that encodes for hepcidin",
                      "Associated with early onset and severe form of HH"
                    ]
                  },
                  {
                    "text": "Type 3 HH: Mutations inTERF2gene, which encodes for TRF2 that is involved in iron signalingPhenotypically similar toHFE-related HH",
                    "sub_points": [
                      "Phenotypically similar toHFE-related HH"
                    ]
                  },
                  {
                    "text": "Type 4 HH: Gain-of-function mutations inSLC40A1gene (FPN1) that encodes for ferroportinAutosomal dominantCauses resistance to hepcidin with inability to internalize and degrade ferroportinIron absorption across enterocytes is increased",
                    "sub_points": [
                      "Autosomal dominant",
                      "Causes resistance to hepcidin with inability to internalize and degrade ferroportinIron absorption across enterocytes is increased",
                      "Iron absorption across enterocytes is increased"
                    ]
                  },
                  {
                    "text": "Ferroportin disease: Loss-of-function mutation inSLC40A1Autosomal dominantIron retention in enterocytes and reticuloendothelial cells due to decreased export function of ferroportin",
                    "sub_points": [
                      "Autosomal dominant",
                      "Iron retention in enterocytes and reticuloendothelial cells due to decreased export function of ferroportin"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "HFE-related HH: 1:200-300 persons"
                  },
                  {
                    "text": "Non-HFE-related HH: Very rareHJVorTEFR2mutations in 1 in 5-6 million people; mutations inHAMPare even more rare",
                    "sub_points": [
                      "HJVorTEFR2mutations in 1 in 5-6 million people; mutations inHAMPare even more rare"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "HFE-related HH: 40-50 years of age"
                  },
                  {
                    "text": "Juvenile HH: < 30 years of age"
                  }
                ],
                "Sex": [
                  {
                    "text": "HFE-related HH: Men affected more than women, who lose iron due to menses"
                  },
                  {
                    "text": "Non-HFE-related HH: Men and women have more equal distribution"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "HFE-related HH: Prevalence is highest among people of Irish and Scandinavian descent and lowest among people of African descent"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Due toHFEgene testing, HH usually presents asymptomatically or with mild symptoms of fatigue, malaise, arthralgia, and hepatosplenomegaly"
                  },
                  {
                    "text": "Juvenile HH may present with cardiomyopathy, endocrine failure, and subclinical hepatic fibrosis/cirrhosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Transferrin saturation > 45% (screening test)"
                  },
                  {
                    "text": "Unbound iron-binding capacity < 26 µmol/L"
                  },
                  {
                    "text": "Serum ferritin (> 300 µg/L in men and 200 µg/L in women)Serum ferritin > 1,000 µg/L, increased AST levels, and platelets < 200 x 10⁹/L: Predicts cirrhosis in > 80% of patients",
                    "sub_points": [
                      "Serum ferritin > 1,000 µg/L, increased AST levels, and platelets < 200 x 10⁹/L: Predicts cirrhosis in > 80% of patients"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Disease modifiers may affect risk of complications, including male sex, total body iron stores, alcohol use, obesity, diabetes, viral infection, dietary iron consumption, and polymorphisms in modifier genes"
                  },
                  {
                    "text": "Most common complications include liver fibrosis/cirrhosis, diabetes, arthropathy, skin hyperpigmentation, and, less commonly, cardiomyopathy and hypogonadismCardiomyopathy and hypogonadism are more prominent in non-HFEHH",
                    "sub_points": [
                      "Cardiomyopathy and hypogonadism are more prominent in non-HFEHH"
                    ]
                  },
                  {
                    "text": "Hepatocellular carcinoma (HCC) is complication in cirrhotics and rarely in noncirrhotics"
                  }
                ],
                "Treatment": [
                  {
                    "text": "PhlebotomyPerformed every 1-3 weeks until desirable serum ferritin level is reached and maintained over lifetimeNot indicated for patients with ferroportin disease or iron metabolic disorders with anemia",
                    "sub_points": [
                      "Performed every 1-3 weeks until desirable serum ferritin level is reached and maintained over lifetime",
                      "Not indicated for patients with ferroportin disease or iron metabolic disorders with anemia"
                    ]
                  },
                  {
                    "text": "Iron chelation therapy (deferoxamine, deferiprone, deferasirox)"
                  },
                  {
                    "text": "Liver transplantation for advanced liver disease or HCC"
                  },
                  {
                    "text": "Erythrocytopheresis removes red blood cells and returns to patient plasma proteins, clotting factors, and plateletsUseful in patients with hypoproteinemia or thrombocytopenia",
                    "sub_points": [
                      "Useful in patients with hypoproteinemia or thrombocytopenia"
                    ]
                  },
                  {
                    "text": "Proton pump inhibitors inhibit absorption of iron in duodenum and may reduce number of phlebotomies required to maintain serum ferritin below target levels"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Varies according to degree of organ damageIf therapy is implemented before organ damage, life expectancy is normalPhlebotomy improves liver fibrosis in patients with mild to moderate fibrosis at baselineDiabetes, arthropathy, and hypogonadism do not improve with phlebotomy",
                    "sub_points": [
                      "If therapy is implemented before organ damage, life expectancy is normal",
                      "Phlebotomy improves liver fibrosis in patients with mild to moderate fibrosis at baseline",
                      "Diabetes, arthropathy, and hypogonadism do not improve with phlebotomy"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Elastography": [
                  {
                    "text": "Noninvasive method of assessing liver fibrosis"
                  }
                ],
                "Quantitative MR": [
                  {
                    "text": "Noninvasive estimation of tissue iron content"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Cirrhotic with dark, rust-brown color"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Iron deposition, beginning in periportal (zone 1) hepatocytes and progressing to all zonesIron preferentially accumulates in canalicular aspect of hepatocytesSideronecrosis describes necrotic iron-laden hepatocytesClusters of iron-laden macrophages may be present",
                    "sub_points": [
                      "Iron preferentially accumulates in canalicular aspect of hepatocytes",
                      "Sideronecrosis describes necrotic iron-laden hepatocytes",
                      "Clusters of iron-laden macrophages may be present"
                    ]
                  },
                  {
                    "text": "Iron may be present in bile duct epithelium, Kupffer cells, and endothelium"
                  },
                  {
                    "text": "Variable portal-based fibrosis, bridging fibrosis, or cirrhosis"
                  },
                  {
                    "text": "Iron-free foci: Sublobular nodules of hepatocytes that are devoid of ironMay show features of hepatocellular dysplasia",
                    "sub_points": [
                      "May show features of hepatocellular dysplasia"
                    ]
                  },
                  {
                    "text": "Ferroportin disease is characterized by iron predominantly in Kupffer cells"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Iron stain demonstrates iron in hepatocytes and allows for semiquantitative assessment"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Testing for mutations inHFEor other genes ifHFEmutations are absent"
                  }
                ],
                "Tissue Iron Quantification": [
                  {
                    "text": "Measured in dry tissue or paraffin-embedded tissue"
                  },
                  {
                    "text": "Hepatic iron concentration (HIC) is useful to determine baseline iron overload"
                  },
                  {
                    "text": "HIC > 71 μmol/g dry weight and hepatic iron index (HIC normalized to age) > 1.9 are characteristic of HH"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Iron-Loading Anemias": [
                  {
                    "text": "Anemias with ineffective erythropoiesis or chronic hemolysis, such as β-thalassemia and spherocytosis, can have increased liver iron due to increased iron absorption, hemolysis, and transfusions"
                  }
                ],
                "Transfusion-Related Iron Overload": [
                  {
                    "text": "Iron deposition predominantly in Kupffer cells"
                  }
                ],
                "Other Chronic Liver Diseases": [
                  {
                    "text": "Increased iron absorption occurs in many chronic liver diseases, including hepatitis C, alcoholic liver disease, and nonalcoholic fatty liver disease"
                  }
                ],
                "Siderosis of Cirrhosis": [
                  {
                    "text": "Cirrhosis can cause increased iron absorption, attributed to reduced hepcidin production that can result in increased iron in hepatocytes sufficient to suggest HH"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Iron overload inHFE-related HH affects hepatocytes; iron predominantly in Kupffer cells is inconsistent withHFE-related HHSemiquantitative assessment of iron is generally reported using 4-tier grading scheme",
                    "sub_points": [
                      "Semiquantitative assessment of iron is generally reported using 4-tier grading scheme"
                    ]
                  },
                  {
                    "text": "Iron-free foci should be reported, as they may indicate increased risk for HCC"
                  },
                  {
                    "text": "HFEmutations may act as \"second hits\" in patients with other chronic liver diseases, resulting in worse fibrosis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Moderately to markedly increased iron in hepatocytes in any liver biopsy may be related toHFEmutations, and recommendation to perform genetic testing may be appropriate"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Wilson Disease": {
            "name": "Wilson Disease",
            "url": "https://app.pathprimer.com/document/08ec8a37-0653-437b-9d4e-74f58b4d2810/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations ofATP7Bthat codes for copper transporting ATPase found on Golgi apparatus and canalicular membrane"
                  },
                  {
                    "text": "Inability to excrete copper in bile leads to its accumulation in liver and various tissues"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most patients present between 5-35 years of age"
                  },
                  {
                    "text": "Acute liver failure, ± Coombs-negative hemolytic anemia"
                  },
                  {
                    "text": "Chronic liver disease with fibrosis/cirrhosis, ± decompensation"
                  },
                  {
                    "text": "Neurologic or psychiatric signs with Kayser-Fleischer rings"
                  },
                  {
                    "text": "Ceruloplasmin is characteristically low in chronic WD, but is not perfectly reliable test"
                  },
                  {
                    "text": "24-hour urinary copper is increased in WD"
                  },
                  {
                    "text": "Copper chelators (D-penicillamine, trientine, ammonium tetrathiomolybdate)"
                  },
                  {
                    "text": "Without treatment, progresses to cirrhosis and death, but with treatment, has good prognosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Early disease is characterized by steatosis, glycogenated nuclei, and mild fibrosis, mimicking nonalcoholic fatty liver disease"
                  },
                  {
                    "text": "Chronic active hepatitis pattern with variable steatosis, portal/periportal fibrosis, septal inflammation, and acidophil bodies near limiting plate"
                  },
                  {
                    "text": "Patients presenting with acute liver failure show cirrhosis with numerous bile ducts and inflammation in septa, hepatocyte swelling with oncocytic appearance to hepatocytes, patchy steatosis, cholestasis, and Mallory-Denk bodies"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Copper stain detects copper only in subset of WD, and negative stain does not exclude WD"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Wilson disease (WD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hepatolenticular degeneration"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autosomal recessive disorder of copper metabolism"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Defect": [
                  {
                    "text": "Mutations ofATP7Bon chromosome 13 at q14-q21 that codes for copper transporting ATPase found on Golgi apparatus and canalicular membraneInability to excrete copper in bile leads to its accumulation in liver and various tissuesIncreased copper causes cell damage through oxidative stress and creation of free radicalsIncreased copper may disrupt mitochondrial copper homeostasis, leading to inhibition of mitochondrial function and steatosisInability to transport copper into Golgi apparatus makes it unavailable for synthesis of ceruloplasmin, leading to release of apoceruloplasmin into serum and its rapid degradationCeruloplasmin is plasma ferroxidase, oxidizing ferrous iron to ferric iron, which is required for iron transport by transferrin",
                    "sub_points": [
                      "Inability to excrete copper in bile leads to its accumulation in liver and various tissuesIncreased copper causes cell damage through oxidative stress and creation of free radicalsIncreased copper may disrupt mitochondrial copper homeostasis, leading to inhibition of mitochondrial function and steatosis",
                      "Increased copper causes cell damage through oxidative stress and creation of free radicals",
                      "Increased copper may disrupt mitochondrial copper homeostasis, leading to inhibition of mitochondrial function and steatosis",
                      "Inability to transport copper into Golgi apparatus makes it unavailable for synthesis of ceruloplasmin, leading to release of apoceruloplasmin into serum and its rapid degradationCeruloplasmin is plasma ferroxidase, oxidizing ferrous iron to ferric iron, which is required for iron transport by transferrin",
                      "Ceruloplasmin is plasma ferroxidase, oxidizing ferrous iron to ferric iron, which is required for iron transport by transferrin"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1:30,000 to 1:40,000"
                  },
                  {
                    "text": "Some countries report higher prevalence, including Israel, Croatia, Costa Rica, and Sardinia"
                  }
                ],
                "Age": [
                  {
                    "text": "Most patients present between 5-35 years of age (mean: 13 years)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Equal sex distributionHepatic presentation may be more common in females, whereas neurologic presentation may be more common in males",
                    "sub_points": [
                      "Hepatic presentation may be more common in females, whereas neurologic presentation may be more common in males"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Highly variable presentation, depending on age, sex, and disease modifiers"
                  },
                  {
                    "text": "Hepatic manifestations predominate in 1st 2 decades of life, whereas neurologic or psychiatric symptoms typically appear in 2nd or 3rd decades of lifeAsymptomatic individuals with increased transaminasesAcute liver failure, ± Coombs-negative hemolytic anemiaChronic liver disease with fibrosis/cirrhosis, ± decompensationNeurologic or psychiatric signs with Kayser-Fleischer rings",
                    "sub_points": [
                      "Asymptomatic individuals with increased transaminases",
                      "Acute liver failure, ± Coombs-negative hemolytic anemia",
                      "Chronic liver disease with fibrosis/cirrhosis, ± decompensation",
                      "Neurologic or psychiatric signs with Kayser-Fleischer rings"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Relatively low alkaline phosphatase and low alkaline phosphatase:total bilirubin (< 4) is typical of WDLow alkaline phosphatase is believed to be result of zinc deficiency",
                    "sub_points": [
                      "Low alkaline phosphatase is believed to be result of zinc deficiency"
                    ]
                  },
                  {
                    "text": "Ceruloplasmin is characteristically low in chronic WDCeruloplasmin levels are not reliable in setting of acute liver failure, because ceruloplasmin is acute phase reactantLow ceruloplasmin can also be due to low hepatic synthetic function, renal or enteric protein loss, copper deficiency, aceruloplasminemia, malabsorption, glycosylation disorders, or Menkes diseaseHeterozygotes can have low ceruloplasmin levels that overlap with values obtained in WD",
                    "sub_points": [
                      "Ceruloplasmin levels are not reliable in setting of acute liver failure, because ceruloplasmin is acute phase reactant",
                      "Low ceruloplasmin can also be due to low hepatic synthetic function, renal or enteric protein loss, copper deficiency, aceruloplasminemia, malabsorption, glycosylation disorders, or Menkes disease",
                      "Heterozygotes can have low ceruloplasmin levels that overlap with values obtained in WD"
                    ]
                  },
                  {
                    "text": "Total serum copper is usually decreased in WD in proportion to decreased ceruloplasminTotal serum copper can be normal or elevated in fulminant WD due to hepatic necrosis and release of tissue copper",
                    "sub_points": [
                      "Total serum copper can be normal or elevated in fulminant WD due to hepatic necrosis and release of tissue copper"
                    ]
                  },
                  {
                    "text": "Serum-free copper is elevated in WD"
                  },
                  {
                    "text": "24-hour urinary copper is increased in WDIncreased urine copper can also be seen in other conditions with hepatic necrosis due to release of tissue copperIf urine copper is mildly increased, it can be remeasured after penicillamine, in which case it is often elevated in WD",
                    "sub_points": [
                      "Increased urine copper can also be seen in other conditions with hepatic necrosis due to release of tissue copper",
                      "If urine copper is mildly increased, it can be remeasured after penicillamine, in which case it is often elevated in WD"
                    ]
                  },
                  {
                    "text": "Exchangeable copper and relative exchangeable copper are new tests of copper overload for diagnosis of WD and measuring its severityExchangeable copper corresponds to labile fraction of copper in serum complexed to albumin and other peptidesRelative exchangeable copper refers to ratio between exchangeable copper and total copper",
                    "sub_points": [
                      "Exchangeable copper corresponds to labile fraction of copper in serum complexed to albumin and other peptides",
                      "Relative exchangeable copper refers to ratio between exchangeable copper and total copper"
                    ]
                  },
                  {
                    "text": "Low-titer antinuclear antibodies have been reported"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Without treatment, progresses to cirrhosis and death"
                  },
                  {
                    "text": "Rarely, patients develop hepatocellular carcinoma or intrahepatic cholangiocarcinoma"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Foods high in copper should be avoided"
                  },
                  {
                    "text": "Liver transplant for patients with acute liver failure, chronic liver disease unresponsive to medical therapy, or significant portal hypertensionLiver transplant for neurological complications without liver failure is controversialNeuropsychiatric symptoms may improve, stabilize, fail to improve, or paradoxically worsen after liver transplant",
                    "sub_points": [
                      "Liver transplant for neurological complications without liver failure is controversialNeuropsychiatric symptoms may improve, stabilize, fail to improve, or paradoxically worsen after liver transplant",
                      "Neuropsychiatric symptoms may improve, stabilize, fail to improve, or paradoxically worsen after liver transplant"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Copper chelators (D-penicillamine, trientine, ammonium tetrathiomolybdate)"
                  },
                  {
                    "text": "Zinc for presymptomatic patients and maintenance therapyZinc induces hepatocytic and intestinal metallothioneinInduction of hepatic metallothionein results in sequestration of copper in nontoxic formInduction of intestinal metallothionein results in binding of copper within enterocytes and its loss when enterocytes are shed",
                    "sub_points": [
                      "Zinc induces hepatocytic and intestinal metallothioneinInduction of hepatic metallothionein results in sequestration of copper in nontoxic formInduction of intestinal metallothionein results in binding of copper within enterocytes and its loss when enterocytes are shed",
                      "Induction of hepatic metallothionein results in sequestration of copper in nontoxic form",
                      "Induction of intestinal metallothionein results in binding of copper within enterocytes and its loss when enterocytes are shed"
                    ]
                  },
                  {
                    "text": "Bis-choline tetrathiomolybdate increases biliary copper excretion through formation of stable complex with copper and albumin"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally excellent prognosis with early diagnosis and adequate compliance to therapy"
                  },
                  {
                    "text": "Nonadherence or discontinuation of medical therapy may cause intractable hepatic decompensation"
                  },
                  {
                    "text": "Fulminant presentation carries risk of death, unless patient can be supported or transplanted"
                  },
                  {
                    "text": "Posttransplant 1- and 5-year survival is 88% and 83%, respectively"
                  }
                ],
                "Diagnostic Criteria": [
                  {
                    "text": "Diagnosis of WD can be challenging due to variability of presentation, insensitive clinical tests, and large number of genetic polymorphisms"
                  },
                  {
                    "text": "Ferenci scoring system describes probability of patient's having WD based on clinical findings, laboratory testing, and genetic results"
                  }
                ],
                "Family Screening": [
                  {
                    "text": "Genetic counseling for 1st-degree relatives of patients with WD is recommended"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Explanted livers generally show macronodular or mixed micronodular-macronodular cirrhosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Early disease is characterized by steatosis, glycogenated nuclei, and mild fibrosis, mimicking nonalcoholic fatty liver disease"
                  },
                  {
                    "text": "Chronic active hepatitis pattern with variable steatosis, portal/periportal fibrosis, septal inflammation, and acidophil bodies near limiting plate"
                  },
                  {
                    "text": "Patients presenting with acute liver failure show cirrhosis with numerous bile ducts and inflammation in septa, hepatocyte swelling with oncocytic appearance to hepatocytes, occasional necrotic hepatocytes, patchy steatosis, cholestasis, and in some cases, Mallory-Denk bodiesCentral or sublobular endophlebitis or subintimal fibrosis may be observedPatchy coagulative necrosis (pseudolobular necrosis) may be seen",
                    "sub_points": [
                      "Central or sublobular endophlebitis or subintimal fibrosis may be observed",
                      "Patchy coagulative necrosis (pseudolobular necrosis) may be seen"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Rhodanine or rubeanic acid stains identify copper, whereas orcein and aldehyde fuchsin stain copper-associated protein (metallothionein)"
                  },
                  {
                    "text": "Copper stains detect copper bound in lysosomes, whereas copper in cytoplasm (toxic form) is removed in tissue processing"
                  },
                  {
                    "text": "Copper stain detects copper only in subset of WD; negative stain does not exclude WDEarly disease that resembles fatty liver disease is often negative for stainable copperFulminant disease shows patchy staining of periportal hepatocytes, and copper-laden macrophages adjacent to lobules with heavy copper depositionCirrhotic liver can show widespread copper staining, or only patchy staining of occasional nodules",
                    "sub_points": [
                      "Early disease that resembles fatty liver disease is often negative for stainable copper",
                      "Fulminant disease shows patchy staining of periportal hepatocytes, and copper-laden macrophages adjacent to lobules with heavy copper deposition",
                      "Cirrhotic liver can show widespread copper staining, or only patchy staining of occasional nodules"
                    ]
                  },
                  {
                    "text": "Iron stain shows staining of hepatocytes &/or Kupffer cells in WD patients, particularly after chelation therapyMay be related to hypoceruloplasminemia, which is exacerbated by copper removalSiderosis does not correlate withHFEgene mutationsKupffer cell iron may be related to hemolysis",
                    "sub_points": [
                      "May be related to hypoceruloplasminemia, which is exacerbated by copper removal",
                      "Siderosis does not correlate withHFEgene mutations",
                      "Kupffer cell iron may be related to hemolysis"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Over 700 mutations have been described, of which minority are known to be pathogenic, with most patients being compound heterozygotesComplete sequencing of gene and its promoter increases sensitivity, although variants of uncertain significance make interpretation of results challengingMutations that cause absent or nonfunctional ATP7B are associated with severe disease, hepatic disease, and early presentationEpigenetic factors and modifying genes may explain clinical heterogeneityCertain mutations are more frequent in specific populations, which can be used to tailor genetic testingH1069Qis most common mutation in Europe and North AmericaArg778Lis most common in Asia",
                    "sub_points": [
                      "Complete sequencing of gene and its promoter increases sensitivity, although variants of uncertain significance make interpretation of results challenging",
                      "Mutations that cause absent or nonfunctional ATP7B are associated with severe disease, hepatic disease, and early presentation",
                      "Epigenetic factors and modifying genes may explain clinical heterogeneity",
                      "Certain mutations are more frequent in specific populations, which can be used to tailor genetic testingH1069Qis most common mutation in Europe and North AmericaArg778Lis most common in Asia",
                      "H1069Qis most common mutation in Europe and North America",
                      "Arg778Lis most common in Asia"
                    ]
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Ultrastructural studies show large pleomorphic mitochondria with inclusions and dilated intracristal space"
                  }
                ],
                "Hepatic Copper Concentration": [
                  {
                    "text": "Can be performed on dedicated core placed on piece of paper for drying or on paraffin block"
                  },
                  {
                    "text": "Normal hepatic concentration is 50 μg/g dry weight; value of > 250 μg/g is considered confirmatory for WD (in absence of chronic cholestasis), with 83% sensitivity"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Nonalcoholic Fatty Liver Disease": [
                  {
                    "text": "Histologic features of early WD closely mimic fatty liver disease"
                  },
                  {
                    "text": "Clinical features distinguish WD and NASH"
                  },
                  {
                    "text": "Laboratory and tissue evidence for copper overload can be pursued in unclear cases"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Septal inflammation and positive autoimmune serologies in young patient may suggest autoimmune hepatitis (AIH)"
                  },
                  {
                    "text": "Plasma cells and elevated autoimmune serologies favor AIH, although both can be seen in WD"
                  },
                  {
                    "text": "Absence of tissue or laboratory evidence of copper overload and negative copper stain favor AIH (although latter does not exclude WD)"
                  }
                ],
                "Chronic Cholestatic Diseases": [
                  {
                    "text": "Stainable copper in periportal hepatocytes in chronic cholestatic diseases can cause confusion with WD"
                  },
                  {
                    "text": "Clinical features, laboratory data, LFT pattern, and histologic features suggest primary biliary disease"
                  }
                ],
                "Aceruloplasminemia": [
                  {
                    "text": "Low ceruloplasmin and neurologic symptoms can mimic WD"
                  },
                  {
                    "text": "Shows increased iron in liver parenchyma due to absence of ceruloplasmin oxidase activity"
                  }
                ],
                "Hereditary Hemochromatosis": [
                  {
                    "text": "Siderosis in some patients with WD, particularly those treated with chelators, can mimic hemochromatosis"
                  },
                  {
                    "text": "Clinical history or genetic testing helps distinguish"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Early WD closely resembles nonalcoholic fatty liver disease"
                  },
                  {
                    "text": "Septa in fulminant WD often show numerous bile ducts and inflammation, suggesting recent parenchymal collapse superimposed on chronic fibrosing liver disease"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Copper staining can be patchy, and negative copper stain does not exclude WD"
                  },
                  {
                    "text": "Copper-laden macrophages in septa is unusual in copper deposition due to chronic cholestasis"
                  },
                  {
                    "text": "Patients with WD can have marked hepatic siderosis, particularly after chelation therapy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Alpha-1-Antitrypsin Deficiency": {
            "name": "Alpha-1-Antitrypsin Deficiency",
            "url": "https://app.pathprimer.com/document/ed249eaa-c31e-4d70-8f04-900c88d7d42d/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Alpha-1-antitrypsin (A1AT): Glycoprotein, inhibitor of leukocyte elastase"
                  },
                  {
                    "text": "A1AT deficiency: Genetic disorder characterized by decreased circulating A1AT levels"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal recessive with codominant allele expression"
                  },
                  {
                    "text": "Most common deficiency alleles are PiS and PiZ"
                  },
                  {
                    "text": "Abnormal polymerization of glycoprotein, preventing export from hepatocyte"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common cause of genetic liver disease in children and adults"
                  },
                  {
                    "text": "Pulmonary: Panacinar emphysema"
                  },
                  {
                    "text": "Adults: highly variable ranging from elevated transaminases to cirrhosis"
                  },
                  {
                    "text": "Neonates: hepatitis/cholestasis is most common liver presentation"
                  },
                  {
                    "text": "Treatment: Liver transplantation"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "A1AT inclusions in hepatocyte cytoplasmPAS(+), diastase-resistant eosinophilic round globules",
                    "sub_points": [
                      "PAS(+), diastase-resistant eosinophilic round globules"
                    ]
                  },
                  {
                    "text": "Adults: Lymphocyte-predominant portal inflammation, occasional interface activity, cirrhosis"
                  },
                  {
                    "text": "Neonatal presentation: Hepatocyte injury and cholestasis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Alpha-1-antichymotrypsin deficiency"
                  },
                  {
                    "text": "Lafora disease"
                  },
                  {
                    "text": "Fibrinogen storage disease"
                  },
                  {
                    "text": "Antithrombin III deficiency"
                  },
                  {
                    "text": "Biliary atresia"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Consider A1AT deficiency in all cases of neonatal cholestasis or in adults with unexplained chronic liver disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "α-1-antitrypsin (A1AT)"
                  },
                  {
                    "text": "Protease inhibitor (Pi)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "A1AT: 52-kDa glycoprotein, serine protease inhibitor of leukocyte elastase that protects tissues from nonspecific inflammatory injurySynthesized in liver",
                    "sub_points": [
                      "Synthesized in liver"
                    ]
                  },
                  {
                    "text": "A1AT deficiency: Genetic disorder characterized by decreased circulating A1AT levels"
                  },
                  {
                    "text": "SERPINA1:Encodes A1AT"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inherited Metabolic Disorder": [
                  {
                    "text": "SERPINA1is highly polymorphic with many recognized variantsMutations result in Glu342Lys substitutionAutosomal recessive with codominant allele expressionGene variants comprise Pi systemMost common variant is PiMPresent in > 90% of USA populationAssociated with normal serum A1AT levelsMost common deficiency alleles are PiZ and PiS~ 2% of individuals are heterozygous for Z alleleRisk of liver disease in heterozygotes is variablePiMMalton and PiMDuarteHeterozygous conditions that rarely cause liver disease",
                    "sub_points": [
                      "Mutations result in Glu342Lys substitution",
                      "Autosomal recessive with codominant allele expression",
                      "Gene variants comprise Pi systemMost common variant is PiMPresent in > 90% of USA populationAssociated with normal serum A1AT levelsMost common deficiency alleles are PiZ and PiS~ 2% of individuals are heterozygous for Z alleleRisk of liver disease in heterozygotes is variablePiMMalton and PiMDuarteHeterozygous conditions that rarely cause liver disease",
                      "Most common variant is PiMPresent in > 90% of USA populationAssociated with normal serum A1AT levels",
                      "Present in > 90% of USA population",
                      "Associated with normal serum A1AT levels",
                      "Most common deficiency alleles are PiZ and PiS",
                      "~ 2% of individuals are heterozygous for Z alleleRisk of liver disease in heterozygotes is variable",
                      "Risk of liver disease in heterozygotes is variable",
                      "PiMMalton and PiMDuarteHeterozygous conditions that rarely cause liver disease",
                      "Heterozygous conditions that rarely cause liver disease"
                    ]
                  }
                ],
                "Accumulation of Mutant Protein": [
                  {
                    "text": "Abnormal polymerization of glycoprotein, preventing export from hepatocyteMutant protein accumulates in endoplasmic reticulum of hepatocyteSubsequent decrease in serum A1ATSpecific mechanism of hepatocyte injury is unknown",
                    "sub_points": [
                      "Mutant protein accumulates in endoplasmic reticulum of hepatocyteSubsequent decrease in serum A1ATSpecific mechanism of hepatocyte injury is unknown",
                      "Subsequent decrease in serum A1AT",
                      "Specific mechanism of hepatocyte injury is unknown"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Obesity is risk factor for more severe disease"
                  }
                ],
                "Incidence": [
                  {
                    "text": "PiZZ genotype in 1/2000 individuals in Northern Europe"
                  },
                  {
                    "text": "~ 4 million heterozygous (PiMZ) carriers worldwide"
                  }
                ],
                "Age": [
                  {
                    "text": "Bimodal distributionMost common cause of genetic liver disease in children and adultsAccounts for 5-10% of neonatal cholestasis/hepatitis~ 2% of A1AT-deficient persons between ages of 20-40 develop liver disease; increases thereafter",
                    "sub_points": [
                      "Most common cause of genetic liver disease in children and adultsAccounts for 5-10% of neonatal cholestasis/hepatitis~ 2% of A1AT-deficient persons between ages of 20-40 develop liver disease; increases thereafter",
                      "Accounts for 5-10% of neonatal cholestasis/hepatitis",
                      "~ 2% of A1AT-deficient persons between ages of 20-40 develop liver disease; increases thereafter"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "No predilection until age 50, then male predominance"
                  },
                  {
                    "text": "Male heterozygotes are at higher risk of clinical disease"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Most common in White people of Northern European ancestry"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Risks of developing lung and liver disease in A1AT-deficient patients appear to be independentPresence of one manifestation does not exclude possibility of developing other",
                    "sub_points": [
                      "Presence of one manifestation does not exclude possibility of developing other"
                    ]
                  },
                  {
                    "text": "Pulmonary: Panacinar emphysemaMost common manifestation of diseaseOften early in adulthoodParticularly in smokers",
                    "sub_points": [
                      "Most common manifestation of disease",
                      "Often early in adulthoodParticularly in smokers",
                      "Particularly in smokers"
                    ]
                  },
                  {
                    "text": "Liver diseaseAlmost always associated with PiZZ phenotypePiSZ less commonLess common manifestation than pulmonary diseaseAdultsHighly variable ranging from elevated transaminases to cirrhosisRisk of cirrhosis appears to increase with ageIncreased risk of hepatocellular and cholangiocarcinomaNeonatesHepatitis/cholestasis is most common liver presentationMajority of PiZZ infants have abnormal liver tests10-20% develop overt liver disease with jaundice, hepatomegaly, acholic stoolsComodifier of concomitant liver diseasesSignificant association between H63D mutation for hemochromatosis and cirrhosis secondary to A1AT deficiencyPiMZ linked to higher risk of cirrhosis in alcoholic and nonalcoholic fatty liver disease and cystic fibrosis",
                    "sub_points": [
                      "Almost always associated with PiZZ phenotype",
                      "PiSZ less common",
                      "Less common manifestation than pulmonary disease",
                      "AdultsHighly variable ranging from elevated transaminases to cirrhosisRisk of cirrhosis appears to increase with ageIncreased risk of hepatocellular and cholangiocarcinoma",
                      "Highly variable ranging from elevated transaminases to cirrhosis",
                      "Risk of cirrhosis appears to increase with age",
                      "Increased risk of hepatocellular and cholangiocarcinoma",
                      "NeonatesHepatitis/cholestasis is most common liver presentationMajority of PiZZ infants have abnormal liver tests10-20% develop overt liver disease with jaundice, hepatomegaly, acholic stools",
                      "Hepatitis/cholestasis is most common liver presentationMajority of PiZZ infants have abnormal liver tests10-20% develop overt liver disease with jaundice, hepatomegaly, acholic stools",
                      "Majority of PiZZ infants have abnormal liver tests",
                      "10-20% develop overt liver disease with jaundice, hepatomegaly, acholic stools",
                      "Comodifier of concomitant liver diseasesSignificant association between H63D mutation for hemochromatosis and cirrhosis secondary to A1AT deficiencyPiMZ linked to higher risk of cirrhosis in alcoholic and nonalcoholic fatty liver disease and cystic fibrosis",
                      "Significant association between H63D mutation for hemochromatosis and cirrhosis secondary to A1AT deficiency",
                      "PiMZ linked to higher risk of cirrhosis in alcoholic and nonalcoholic fatty liver disease and cystic fibrosis"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum levels of A1AT < 35% of normalA1AT is acute-phase reactant, thus may be elevated secondary to inflammation, causing normal levels in heterozygotes",
                    "sub_points": [
                      "A1AT is acute-phase reactant, thus may be elevated secondary to inflammation, causing normal levels in heterozygotes"
                    ]
                  },
                  {
                    "text": "Pi phenotyping by polyacrylamide gel isoelectric focusing"
                  },
                  {
                    "text": "DNA sequencing"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Liver transplantationPatients assume donor phenotype and revert to normal serum levels of A1AT",
                    "sub_points": [
                      "Patients assume donor phenotype and revert to normal serum levels of A1AT"
                    ]
                  },
                  {
                    "text": "A1AT augmentation therapy and gene therapy are active areas of investigation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Children~ 25% spontaneously regress by 6 months of age~ 50% have persistent biochemical abnormalities, jaundice, &/or hepatomegalyMinority (20-30%) develop cirrhosis &/or liver failure",
                    "sub_points": [
                      "~ 25% spontaneously regress by 6 months of age",
                      "~ 50% have persistent biochemical abnormalities, jaundice, &/or hepatomegaly",
                      "Minority (20-30%) develop cirrhosis &/or liver failure"
                    ]
                  },
                  {
                    "text": "AdultsPoor prognosis after diagnosis of cirrhosisSmall but definite increased risk of hepatocellular carcinomaPatients with cirrhosis secondary to A1AT deficiency should be screened for hepatocellular carcinoma",
                    "sub_points": [
                      "Poor prognosis after diagnosis of cirrhosis",
                      "Small but definite increased risk of hepatocellular carcinomaPatients with cirrhosis secondary to A1AT deficiency should be screened for hepatocellular carcinoma",
                      "Patients with cirrhosis secondary to A1AT deficiency should be screened for hepatocellular carcinoma"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hepatomegaly, cirrhosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "A1AT inclusions in hepatocyte cytoplasmPresent in homozygotes and heterozygotes with PiZ allele and in patients with and without liver diseaseEosinophilic round globulesMost prominent in periportal/periseptal hepatocytesVariable size (1-40 μm in diameter)Strongly PAS(+), diastase resistant",
                    "sub_points": [
                      "Present in homozygotes and heterozygotes with PiZ allele and in patients with and without liver disease",
                      "Eosinophilic round globulesMost prominent in periportal/periseptal hepatocytesVariable size (1-40 μm in diameter)Strongly PAS(+), diastase resistant",
                      "Most prominent in periportal/periseptal hepatocytes",
                      "Variable size (1-40 μm in diameter)",
                      "Strongly PAS(+), diastase resistant"
                    ]
                  },
                  {
                    "text": "AdultsVariably present portal inflammation, occasional interface activityPredominance of lymphocytesSteatosis, mild cholestasis may be presentCirrhosis often present at diagnosisNonspecific mixed micronodular and macronodular patternLivers explanted for A1AT often show increased iron",
                    "sub_points": [
                      "Variably present portal inflammation, occasional interface activityPredominance of lymphocytes",
                      "Predominance of lymphocytes",
                      "Steatosis, mild cholestasis may be present",
                      "Cirrhosis often present at diagnosisNonspecific mixed micronodular and macronodular pattern",
                      "Nonspecific mixed micronodular and macronodular pattern",
                      "Livers explanted for A1AT often show increased iron"
                    ]
                  },
                  {
                    "text": "Neonatal presentationVarying degree of hepatocyte injury (ballooning and necrosis)Giant cell change may be presentSome cases show paucity of intrahepatic bile ductsBile ductular reaction resembling biliary atresiaCholestasisHepatocellular and canalicularCholate stasisCopper accumulation in periseptal hepatocytesPortal inflammationGlobules are difficult to detect in infants < 12 weeks of ageMay see more nonspecific granules rather than well-formed globulesFibrosis typically mild",
                    "sub_points": [
                      "Varying degree of hepatocyte injury (ballooning and necrosis)Giant cell change may be present",
                      "Giant cell change may be present",
                      "Some cases show paucity of intrahepatic bile ductsBile ductular reaction resembling biliary atresia",
                      "Bile ductular reaction resembling biliary atresia",
                      "CholestasisHepatocellular and canalicular",
                      "Hepatocellular and canalicular",
                      "Cholate stasisCopper accumulation in periseptal hepatocytes",
                      "Copper accumulation in periseptal hepatocytes",
                      "Portal inflammation",
                      "Globules are difficult to detect in infants < 12 weeks of ageMay see more nonspecific granules rather than well-formed globules",
                      "May see more nonspecific granules rather than well-formed globules",
                      "Fibrosis typically mild"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "A1AT immunostain can be used to highlight globulesBackground staining is often high; thus, stain may be difficult to interpret",
                    "sub_points": [
                      "Background staining is often high; thus, stain may be difficult to interpret"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Alpha-1-Antichymotrypsin Deficiency": [
                  {
                    "text": "Rare cause of liver and lung disease"
                  },
                  {
                    "text": "Granular inclusions are weakly PAS-D positive"
                  }
                ],
                "Lafora Disease": [
                  {
                    "text": "Progressive epilepsy"
                  },
                  {
                    "text": "Misfolded protein ligases and glycogen phosphatases"
                  },
                  {
                    "text": "Inclusions are pale and round or kidney-shaped; displace nucleiStain with with colloidal iron and silver stains",
                    "sub_points": [
                      "Stain with with colloidal iron and silver stains"
                    ]
                  }
                ],
                "Fibrinogen Storage Disease": [
                  {
                    "text": "Low plasma fibrinogen leads to severe bleeding"
                  },
                  {
                    "text": "Pale, weakly eosinophilic, PAS(-) ground-glass bodies"
                  },
                  {
                    "text": "Immunohistochemical stain for fibrinogen strongly positive"
                  }
                ],
                "Antithrombin III Deficiency": [
                  {
                    "text": "Propensity for venous thromboemboli"
                  },
                  {
                    "text": "Inclusions are PAS(+) but negative for A1AT immunostains"
                  }
                ],
                "Congestion-Associated Globules": [
                  {
                    "text": "Associated with sinusoidal congestion and hepatic hypoxia"
                  },
                  {
                    "text": "Centrilobular distribution of PAS(+), diastase-resistant globules rather than periportal/periseptal distribution"
                  }
                ],
                "Megamitochondria": [
                  {
                    "text": "In glycogenic hepatopathy, small, bright pink globules of megamitochondria within cytoplasm can resemble A1AT globules; PAS with diastase is negative in megamitochondria"
                  }
                ],
                "Biliary Atresia": [
                  {
                    "text": "Abnormal imaging studiesNotably, however, biliary imaging studies in A1AT deficiency may be abnormal",
                    "sub_points": [
                      "Notably, however, biliary imaging studies in A1AT deficiency may be abnormal"
                    ]
                  },
                  {
                    "text": "Normal serum A1AT levels, absence of cytoplasmic inclusions"
                  }
                ],
                "Other Causes of Neonatal Hepatitis": [
                  {
                    "text": "Typically infectious (e.g., CMV, HSV, rubella)Normal serum A1AT levelsLack abnormal A1AT inclusions, although this may be difficult to evaluate in very young infants",
                    "sub_points": [
                      "Normal serum A1AT levels",
                      "Lack abnormal A1AT inclusions, although this may be difficult to evaluate in very young infants"
                    ]
                  }
                ],
                "Overproduction of A1AT": [
                  {
                    "text": "May be seen in severely ill elderly patients"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Consider A1AT deficiencyIn all cases of neonatal cholestasisIn adults with unexplained chronic liver disease",
                    "sub_points": [
                      "In all cases of neonatal cholestasis",
                      "In adults with unexplained chronic liver disease"
                    ]
                  },
                  {
                    "text": "Serum A1AT levels may be normal secondary to inflammation"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "PAS(+), diastase-resistant, eosinophilic globules in periportal/periseptal distribution"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Congenital Hepatic Fibrosis": {
            "name": "Congenital Hepatic Fibrosis",
            "url": "https://app.pathprimer.com/document/f4ec52f4-dd90-432d-8167-b14e115caf27/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Ductal plate malformation characterized by diffuse persistence of ductal plate remnants within dense fibrous tissueFibrosis progresses with age to broad bridging septa",
                    "sub_points": [
                      "Fibrosis progresses with age to broad bridging septa"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal recessive ciliopathy: mutations inPKHD1Encodes fibrocystin/polyductin in primary ciliaInvolved in development of collecting ducts in kidney and bile ducts in liverFrequent association with autosomal recessive polycystic kidney disease (ARPKD) and Caroli disease",
                    "sub_points": [
                      "Encodes fibrocystin/polyductin in primary cilia",
                      "Involved in development of collecting ducts in kidney and bile ducts in liver",
                      "Frequent association with autosomal recessive polycystic kidney disease (ARPKD) and Caroli disease"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most commonly presents in adolescence/young adulthood with bleeding esophageal varices"
                  },
                  {
                    "text": "Presents in early childhood when associated with ARPKD"
                  },
                  {
                    "text": "May present as incidental hepatosplenomegaly in asymptomatic patients"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Firm, enlarged liver, but may be of normal size"
                  },
                  {
                    "text": "Reticular white fibrous bands dividing liver parenchyma into irregular islandsNo regenerative nodules",
                    "sub_points": [
                      "No regenerative nodules"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse persistence of ductal plate remnantsIrregularly shaped, branching, and anastomosing ductal structures with open lumina",
                    "sub_points": [
                      "Irregularly shaped, branching, and anastomosing ductal structures with open lumina"
                    ]
                  },
                  {
                    "text": "Marked portal expansion by fibrous tissueBridging broad fibrous septa",
                    "sub_points": [
                      "Bridging broad fibrous septa"
                    ]
                  },
                  {
                    "text": "Portal vein branches hypoplastic &/or reduced in number"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cirrhosis"
                  },
                  {
                    "text": "von Meyenburg complexes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Congenital hepatic fibrosis (CHF)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Ductal plate malformation characterized by diffuse persistence of ductal plate remnants within dense fibrous tissueFibrosis progresses with age to broad bridging septaProgression neither inevitable nor uniform",
                    "sub_points": [
                      "Fibrosis progresses with age to broad bridging septaProgression neither inevitable nor uniform",
                      "Progression neither inevitable nor uniform"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Autosomal recessive ciliopathy; mutations inPKHD1Encodes fibrocystin/polyductin in primary ciliaInvolved in development of collecting ducts in kidney and bile ducts in liver",
                    "sub_points": [
                      "Encodes fibrocystin/polyductin in primary cilia",
                      "Involved in development of collecting ducts in kidney and bile ducts in liver"
                    ]
                  }
                ],
                "Disease Associations": [
                  {
                    "text": "Autosomal recessive polycystic kidney disease (ARPKD)Most common coexisting condition1 in 20,000 live births",
                    "sub_points": [
                      "Most common coexisting condition",
                      "1 in 20,000 live births"
                    ]
                  },
                  {
                    "text": "Autosomal dominant polycystic kidney disease (rare)"
                  },
                  {
                    "text": "Caroli disease (Caroli disease + CHF = Caroli syndrome)"
                  },
                  {
                    "text": "Meckel-Gruber syndrome"
                  },
                  {
                    "text": "Joubert syndrome and related disorders, including COACH"
                  },
                  {
                    "text": "Bardet-Biedl, Jeune, and oral-facial-digital syndromes"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Uncommon, exact incidence not known"
                  }
                ],
                "Presentation": [
                  {
                    "text": "May present at any ageMost commonly in adolescence/young adulthoodIn childhood when associated with ARPKDIncidental hepatosplenomegaly in asymptomatic patients",
                    "sub_points": [
                      "Most commonly in adolescence/young adulthood",
                      "In childhood when associated with ARPKD",
                      "Incidental hepatosplenomegaly in asymptomatic patients"
                    ]
                  },
                  {
                    "text": "Portal hypertensionBleeding esophageal varices &/or thrombocytopeniaAscites, encephalopathy uncommon",
                    "sub_points": [
                      "Bleeding esophageal varices &/or thrombocytopenia",
                      "Ascites, encephalopathy uncommon"
                    ]
                  },
                  {
                    "text": "Recurrent cholangitis if coexistent Caroli disease"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Normal or modestly elevated liver tests"
                  },
                  {
                    "text": "Thrombocytopenia in patients with splenomegaly"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Management of portal hypertensionEndoscopic banding or sclerotherapy for varicesTransjugular intrahepatic portosystemic shunts (TIPS)",
                    "sub_points": [
                      "Endoscopic banding or sclerotherapy for varices",
                      "Transjugular intrahepatic portosystemic shunts (TIPS)"
                    ]
                  },
                  {
                    "text": "Antibiotics for cholangitis"
                  },
                  {
                    "text": "Liver transplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on severity of portal hypertension, biliary infection, renal disease"
                  },
                  {
                    "text": "Hepatocellular carcinoma, cholangiocarcinoma reported but rare"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Hypertrophic left and caudate lobes"
                  },
                  {
                    "text": "Increased echogenicity on ultrasound"
                  },
                  {
                    "text": "Periportal cuffing indicative of fibrosis on CT"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Firm and enlarged liver, but may be of normal size"
                  },
                  {
                    "text": "Reticular white fibrous bands dividing liver parenchyma into irregularly shaped islandsNo regenerative nodules",
                    "sub_points": [
                      "No regenerative nodules"
                    ]
                  },
                  {
                    "text": "Dilated ducts or cysts if coexistent Caroli disease"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diffuse persistence of ductal plate remnantsIrregularly shaped, branching, and anastomosing ductal structures with open luminaArranged circumferentially around a hypoplastic portal vein branchPresent at interface of portal tracts or fibrous septa with hepatocytesMay be microcystic and contain a fibrovascular coreMay contain inspissated bile",
                    "sub_points": [
                      "Irregularly shaped, branching, and anastomosing ductal structures with open luminaArranged circumferentially around a hypoplastic portal vein branchPresent at interface of portal tracts or fibrous septa with hepatocytesMay be microcystic and contain a fibrovascular coreMay contain inspissated bile",
                      "Arranged circumferentially around a hypoplastic portal vein branch",
                      "Present at interface of portal tracts or fibrous septa with hepatocytes",
                      "May be microcystic and contain a fibrovascular core",
                      "May contain inspissated bile"
                    ]
                  },
                  {
                    "text": "Marked portal expansion by fibrous tissueBroad bridging septa dividing hepatic parenchyma into irregular islandsNo regenerative nodules or parenchymal remodeling",
                    "sub_points": [
                      "Broad bridging septa dividing hepatic parenchyma into irregular islandsNo regenerative nodules or parenchymal remodeling",
                      "No regenerative nodules or parenchymal remodeling"
                    ]
                  },
                  {
                    "text": "Portal vein branches hypoplastic &/or reduced in number"
                  },
                  {
                    "text": "Hepatic artery branches hypertrophic &/or numerous"
                  },
                  {
                    "text": "No inflammation in portal tracts or fibrous septa, unless associated with cholangitis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cirrhosis": [
                  {
                    "text": "Diffuse nodular regeneration of hepatocytes and remodeling of hepatic architecture"
                  },
                  {
                    "text": "Compromised liver function"
                  },
                  {
                    "text": "No association with polycystic kidney disease"
                  }
                ],
                "Non-Cirrhotic Portal Hypertension": [
                  {
                    "text": "Lack of bridging fibrosis"
                  },
                  {
                    "text": "Lack of ductal plate remnants"
                  },
                  {
                    "text": "Absent or narrowed portal vein branches"
                  }
                ],
                "von Meyenburg Complexes": [
                  {
                    "text": "Resemble lesions of CHF but not diffuseIncidental finding, especially at frozen section",
                    "sub_points": [
                      "Incidental finding, especially at frozen section"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Caroli Disease": {
            "name": "Caroli Disease",
            "url": "https://app.pathprimer.com/document/dfacc576-e28a-460c-a0d5-1c95315c160c/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Caroli disease: Congenital, nonobstructive dilatation of intrahepatic bile ducts"
                  },
                  {
                    "text": "Caroli syndrome: Caroli disease + congenital hepatic fibrosis"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Total or partial arrest of remodeling of ductal plates during embryogenesis"
                  },
                  {
                    "text": "Primarily autosomal recessive inheritance but may be autosomal dominant"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Characterized by recurrent cholangitis, abscess formation, hepatolithiasis, and biliary cirrhosis"
                  },
                  {
                    "text": "Cholangiocarcinoma develops in 7% of patients"
                  },
                  {
                    "text": "Association with polycystic kidney disease"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Intrahepatic saccular cysts"
                  },
                  {
                    "text": "May show characteristic central dot sign or intracystic fibrovascular bridges"
                  },
                  {
                    "text": "Continuity of cysts to biliary system"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Segmental saccular dilatations of larger intrahepatic ductsMay contain bile sludge, stones, pusMay affect entire liver or be limited to 1 lobe, more commonly left",
                    "sub_points": [
                      "May contain bile sludge, stones, pus",
                      "May affect entire liver or be limited to 1 lobe, more commonly left"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Dilated ducts may show periductal fibrosis, acute and chronic inflammation, ulceration, abscess formation"
                  },
                  {
                    "text": "Background liver may show features of congenital hepatic fibrosis or biliary cirrhosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary sclerosing cholangitis"
                  },
                  {
                    "text": "Recurrent pyogenic cholangitis"
                  },
                  {
                    "text": "Polycystic liver disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Congenital cystic dilatation of intrahepatic biliary tree"
                  },
                  {
                    "text": "Type V choledochal cyst"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Caroli disease: Congenital, nonobstructive dilatation of intrahepatic bile ducts"
                  },
                  {
                    "text": "Caroli syndrome: Caroli disease + congenital hepatic fibrosis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Total or partial arrest of remodeling of ductal plates during embryogenesis"
                  },
                  {
                    "text": "Primarily autosomal recessive inheritance but may be autosomal dominant"
                  }
                ],
                "Disease Associations": [
                  {
                    "text": "Autosomal recessive polycystic kidney disease"
                  },
                  {
                    "text": "Autosomal dominant polycystic kidney disease"
                  },
                  {
                    "text": "Medullary sponge kidney"
                  },
                  {
                    "text": "Choledochal cyst (type IVa)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Incidence: 1 in 1 million persons"
                  },
                  {
                    "text": "0-82 years, but often diagnosed between 5-20 years"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fever, abdominal pain: Indicates cholangitis"
                  },
                  {
                    "text": "Jaundice: Indicates obstruction due to cholelithiasis"
                  },
                  {
                    "text": "Portal hypertension indicatesConcomitant congenital hepatic fibrosisCirrhosis due to recurrent cholangitis &/or obstruction",
                    "sub_points": [
                      "Concomitant congenital hepatic fibrosis",
                      "Cirrhosis due to recurrent cholangitis &/or obstruction"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "MedicalAntibiotics to treat cholangitisUrsodeoxycholic acid to promote bile flow",
                    "sub_points": [
                      "Antibiotics to treat cholangitis",
                      "Ursodeoxycholic acid to promote bile flow"
                    ]
                  },
                  {
                    "text": "SurgicalSphincterectomy, stone extraction, lithotripsyPartial hepatectomy for limited segmental/lobar involvementLiver transplantation for diffuse liver disease, cirrhosis, congenital hepatic fibrosisLiver-kidney transplantation for associated kidney disease",
                    "sub_points": [
                      "Sphincterectomy, stone extraction, lithotripsy",
                      "Partial hepatectomy for limited segmental/lobar involvement",
                      "Liver transplantation for diffuse liver disease, cirrhosis, congenital hepatic fibrosis",
                      "Liver-kidney transplantation for associated kidney disease"
                    ]
                  }
                ],
                "Complications": [
                  {
                    "text": "Recurrent cholangitis, abscess formation, sepsis"
                  },
                  {
                    "text": "Hepatolithiasis, biliary obstruction, biliary cirrhosis"
                  },
                  {
                    "text": "Portal hypertension"
                  },
                  {
                    "text": "Cholangiocarcinoma"
                  },
                  {
                    "text": "Amyloidosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Uncontrolled biliary infection may lead to death within 5-10 years after onset of recurrent cholangitis"
                  },
                  {
                    "text": "Cholangiocarcinoma: 6.6% in systemic metaanalysisHepatic resection or transplantation; recurrence: 75%, 1-year survival: 36%",
                    "sub_points": [
                      "Hepatic resection or transplantation; recurrence: 75%, 1-year survival: 36%"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Intrahepatic saccular cysts by ultrasound, CT, and MRCharacteristic central dot sign or intracystic bridges",
                    "sub_points": [
                      "Characteristic central dot sign or intracystic bridges"
                    ]
                  },
                  {
                    "text": "Cysts continuous with biliary system"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Segmental saccular dilatations of larger intrahepatic ducts"
                  },
                  {
                    "text": "Separated by segments of normal-appearing ducts"
                  },
                  {
                    "text": "May contain bile sludge, stones, &/or pus"
                  },
                  {
                    "text": "May affect entire liver or be limited to 1 lobe, more commonly left lobe"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Dilated ducts with periductal fibrosis and mixed inflammationLining epithelium may be ulcerated, reactive, hyperplastic, dysplasticTransluminal fibrovascular bridges or polypoid intraluminal protrusionsCorrespond to central dot sign on imagingInspissated bile or calcareous material in luminaCholangitis, abscess formationProliferation of peribiliary glands",
                    "sub_points": [
                      "Lining epithelium may be ulcerated, reactive, hyperplastic, dysplastic",
                      "Transluminal fibrovascular bridges or polypoid intraluminal protrusionsCorrespond to central dot sign on imaging",
                      "Correspond to central dot sign on imaging",
                      "Inspissated bile or calcareous material in lumina",
                      "Cholangitis, abscess formation",
                      "Proliferation of peribiliary glands"
                    ]
                  },
                  {
                    "text": "Background liver may showCongenital hepatic fibrosisBiliary cirrhosis",
                    "sub_points": [
                      "Congenital hepatic fibrosis",
                      "Biliary cirrhosis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Characteristic beaded appearance by cholangiography"
                  },
                  {
                    "text": "Frequent association with inflammatory bowel disease"
                  },
                  {
                    "text": "Concentric periductal fibrosis (\"onion skinning\")"
                  }
                ],
                "Recurrent Pyogenic Cholangitis": [
                  {
                    "text": "Primarily seen in Far East or among Asian immigrants"
                  }
                ],
                "Polycystic Liver Disease": [
                  {
                    "text": "Cysts rarely, if ever, communicate with bile ducts"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Tyrosinemia": {
            "name": "Tyrosinemia",
            "url": "https://app.pathprimer.com/document/1b287f60-9996-46b2-b597-50ba06e61335/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hereditary tyrosinemia, type I"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations in gene encoding FAH, last enzyme in tyrosine catabolic pathway"
                  },
                  {
                    "text": "Accumulation of highly reactive metabolites"
                  },
                  {
                    "text": "About 100 mutations are known, with specific mutations common to particular populations"
                  },
                  {
                    "text": "Autosomal recessive inheritance"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1/100,000 to 1/120,000 worldwide but higher in Scandinavian countries and Quebec"
                  },
                  {
                    "text": "Presymptomatic cases diagnosed on newborn screening or testing, based on family history of affected siblings"
                  },
                  {
                    "text": "Acute liver failure in infancy with synthetic dysfunction"
                  },
                  {
                    "text": "Subacute liver disease with coagulopathy, failure to thrive, hepatosplenomegaly, and rickets"
                  },
                  {
                    "text": "Chronic liver disease with cirrhosis, renal disease, and neurologic crises"
                  },
                  {
                    "text": "15-37% risk of developing hepatocellular carcinoma"
                  },
                  {
                    "text": "If untreated, death generally occurs before age 10 (liver failure, neurologic crisis, or hepatocellular carcinoma)"
                  },
                  {
                    "text": "Treated with dietary restriction of phenylalanine and tyrosine, nitisinone (NTBC), and liver transplantation"
                  },
                  {
                    "text": "Outcome improved by early initiation of therapy"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Nodules with ductular structures in septa, blending with hepatocytes that show pseudoacinar arrangement"
                  },
                  {
                    "text": "Giant cell transformation can be present"
                  },
                  {
                    "text": "Patchy steatosis or hepatocyte cytoplasmic clearing"
                  },
                  {
                    "text": "Liver cell dysplasia or hepatocellular carcinoma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Elevated succinylacetone in plasma is basis for newborn screening"
                  },
                  {
                    "text": "Molecular testing ofFAHgene"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Fibrosis with ductular reaction, acinar transformation, and variable steatosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Fumarylacetoacetate hydroxylase (FAH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hereditary tyrosinemia, type I"
                  },
                  {
                    "text": "Hepatorenal tyrosinemia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Inherited disorder of tyrosine catabolism"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder": [
                  {
                    "text": "Mutations in gene encoding FAH, last enzyme in tyrosine catabolic pathwayAccumulation of metabolites, such as maleylacetoacetate, fumarylacetoacetate, succinylacetoacetate, and succinylacetoneMetabolites are highly reactive compounds → hepatic, renal, and neurologic damage",
                    "sub_points": [
                      "Accumulation of metabolites, such as maleylacetoacetate, fumarylacetoacetate, succinylacetoacetate, and succinylacetone",
                      "Metabolites are highly reactive compounds → hepatic, renal, and neurologic damage"
                    ]
                  },
                  {
                    "text": "~ 100 mutations are known with specific mutations common to particular populations"
                  },
                  {
                    "text": "Autosomal recessive inheritance"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1/100,000 to 1/120,000 worldwide, higher in Scandinavian countries and Quebec"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Founder mutations in specific populations"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Presymptomatic, diagnosed on newborn screening or testing, based on history of affected siblings"
                  },
                  {
                    "text": "Presentation varies with ageIn infancy: Acute liver failure with hepatic synthetic dysfunctionHyperbilirubinemia occurs late, so patients with marked hyperbilirubinemia and relative preservation of synthetic function are unlikely to have HT1In 1st year of life: Subacute liver disease with coagulopathy, failure to thrive, hepatosplenomegaly, and ricketsAfter 1st year of life: Chronic liver disease with cirrhosis, renal disease with hypophosphatemic rickets, and neurologic crises with episodic, severe neuropathic pain and paralysis",
                    "sub_points": [
                      "In infancy: Acute liver failure with hepatic synthetic dysfunctionHyperbilirubinemia occurs late, so patients with marked hyperbilirubinemia and relative preservation of synthetic function are unlikely to have HT1",
                      "Hyperbilirubinemia occurs late, so patients with marked hyperbilirubinemia and relative preservation of synthetic function are unlikely to have HT1",
                      "In 1st year of life: Subacute liver disease with coagulopathy, failure to thrive, hepatosplenomegaly, and rickets",
                      "After 1st year of life: Chronic liver disease with cirrhosis, renal disease with hypophosphatemic rickets, and neurologic crises with episodic, severe neuropathic pain and paralysis"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated succinylacetone in plasma (basis for newborn screening) or urine"
                  },
                  {
                    "text": "Increased PT, PTT, INR due to hepatic synthetic dysfunction"
                  },
                  {
                    "text": "Elevated serum α-fetoprotein"
                  },
                  {
                    "text": "Elevated urinary 5-aminolevulinic acid"
                  },
                  {
                    "text": "Tyrosinemia and methioninemia on urinary amino acid analysis"
                  }
                ],
                "Natural History": [
                  {
                    "text": "15-37% risk of developing hepatocellular carcinoma"
                  },
                  {
                    "text": "Untreated: Death generally occurs by age 10, from liver failure, neurologic crisis, or hepatocellular carcinoma"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Dietary restriction of phenylalanine and tyrosine, which are present in all natural proteinsNormalizes plasma amino acids and improves acute symptoms only, but does not prevent complications",
                    "sub_points": [
                      "Normalizes plasma amino acids and improves acute symptoms only, but does not prevent complications"
                    ]
                  },
                  {
                    "text": "Nitisinone (NTBC) inhibits proximal enzymatic step in tyrosine catabolic pathway, reducing metabolitesPrevents complications in presymptomatic patients and ameliorates disease if started later",
                    "sub_points": [
                      "Prevents complications in presymptomatic patients and ameliorates disease if started later"
                    ]
                  },
                  {
                    "text": "Liver transplantation for liver failure, hepatocellular carcinoma, or refractory disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Varies according to timing of initiation of therapy and compliance"
                  },
                  {
                    "text": "Excellent medium-term outcome if NTBC and diet restrictions are initiated earlyResidual cognitive effects are documented",
                    "sub_points": [
                      "Residual cognitive effects are documented"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Screening for Hepatocellular Carcinoma": [
                  {
                    "text": "Abdominal ultrasound or MRI are used to evaluate nodules"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "In acute disease, liver can appear pale and enlarged, or shrunken and brown, and nodular"
                  },
                  {
                    "text": "In chronic disease, liver shows cirrhosis, usually mixed micro- and macronodular"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Early diseaseUniform micronodules with ductular-like structures in septa blending with hepatocytesHepatocytes in nodules may show pseudoacinar arrangement around dilated canaliculi with bile stasisGiant cell transformation can be presentVariable steatosisVariable iron in Kupffer cells and hepatocytes",
                    "sub_points": [
                      "Uniform micronodules with ductular-like structures in septa blending with hepatocytes",
                      "Hepatocytes in nodules may show pseudoacinar arrangement around dilated canaliculi with bile stasis",
                      "Giant cell transformation can be present",
                      "Variable steatosis",
                      "Variable iron in Kupffer cells and hepatocytes"
                    ]
                  },
                  {
                    "text": "Chronic diseaseMixed micro- and macronodular cirrhosisPatchy steatosis or hepatocyte cytoplasmic clearingLiver cell dysplasia or hepatocellular carcinoma",
                    "sub_points": [
                      "Mixed micro- and macronodular cirrhosis",
                      "Patchy steatosis or hepatocyte cytoplasmic clearing",
                      "Liver cell dysplasia or hepatocellular carcinoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "Molecular testing ofFAHgene"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Nonspecific changes, including fat in hepatocytes, relative loss of mitochondrial matrical bodies and decreased matrix density, and dilated endoplasmic reticulum"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Metabolic Diseases": [
                  {
                    "text": "GalactosemiaRequires clinical distinction",
                    "sub_points": [
                      "Requires clinical distinction"
                    ]
                  },
                  {
                    "text": "Hereditary fructose intoleranceUltrastructural changes in fructose intoleranceFructose holes: Ovoid to irregular lucent, partially membrane-bound areas of cytoplasm; up to 2 μmDistinctive concentric arrays of endoplasmic reticulum with central rarefaction and glycogen particles",
                    "sub_points": [
                      "Ultrastructural changes in fructose intoleranceFructose holes: Ovoid to irregular lucent, partially membrane-bound areas of cytoplasm; up to 2 μmDistinctive concentric arrays of endoplasmic reticulum with central rarefaction and glycogen particles",
                      "Fructose holes: Ovoid to irregular lucent, partially membrane-bound areas of cytoplasm; up to 2 μm",
                      "Distinctive concentric arrays of endoplasmic reticulum with central rarefaction and glycogen particles"
                    ]
                  }
                ],
                "Neonatal Hemochromatosis": [
                  {
                    "text": "Neonatal hemochromatosis characterized by extrahepatic iron deposition"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "High risk of hepatocellular carcinoma in untreated patients"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Fibrosis with ductular reaction, acinar transformation, and variable steatosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gaucher Disease": {
            "name": "Gaucher Disease",
            "url": "https://app.pathprimer.com/document/b38640bb-19db-4601-841c-0145bd9d5315/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Lysosomal storage disorder caused by reduced glucocerebrosidase activity"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations inGBA1on chromosome 1 that encodes lysosomal enzyme glucocerebrosidase, which hydrolyzes glucosylceramide into ceramide and glucose"
                  },
                  {
                    "text": "Marked reduction in activity of lysosomal glucocerebrosidase"
                  },
                  {
                    "text": "Accumulation of glucosylceramide in lysosomes, particularly in macrophages"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1/40,000 to 1/100,000 in general population, and 1/850 among Ashkenazi Jewish population"
                  },
                  {
                    "text": "Hepatosplenomegaly, cytopenia, bone disease, and, in certain forms, neurologic impairment"
                  },
                  {
                    "text": "Enzyme replacement therapy or substrate reduction therapy are main forms of treatment"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Scattered storage cells with amphophilic cytoplasm with wrinkled tissue paper appearance"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAS-D highlights Gaucher cells"
                  },
                  {
                    "text": "Electron microscopy demonstrates lysosomes filled with tubules"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Niemann-Pick diseaseStorage cells are foamy",
                    "sub_points": [
                      "Storage cells are foamy"
                    ]
                  },
                  {
                    "text": "Wolman diseaseStorage cells are foamyFrozen section slide stained with oil red O reveals abundant lipid, and polarized light highlights needle-shaped cholesterol crystals",
                    "sub_points": [
                      "Storage cells are foamy",
                      "Frozen section slide stained with oil red O reveals abundant lipid, and polarized light highlights needle-shaped cholesterol crystals"
                    ]
                  },
                  {
                    "text": "Pseudo-Gaucher cells in bone marrow biopsy"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Glucocerebrosidase deficiency"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Lysosomal storage disorder caused by reduced glucocerebrosidase activity"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inborn Error of Metabolism": [
                  {
                    "text": "Mutations inGBA1on chromosome 1 that encodes lysosomal enzyme glucocerebrosidase (GCase or acid β-glucosidase), which hydrolyzes glucosylceramide into ceramide and glucoseMarked reduction in activity of lysosomal glucocerebrosidaseMisfolding of enzyme also reduces its transport and delivery to lysosomeAccumulation of glucosylceramide in lysosomes, particularly in macrophages of reticuloendothelial system, due to their role in elimination of erythrocytes and leukocytes that contain large amounts of glycosphingolipidsFew genotype-phenotype correlationsN370S mutation is protective for development of neurological involvementN370S homozygosity tends to be milderD409H homozygosity associated with cardiovascular form",
                    "sub_points": [
                      "Marked reduction in activity of lysosomal glucocerebrosidase",
                      "Misfolding of enzyme also reduces its transport and delivery to lysosome",
                      "Accumulation of glucosylceramide in lysosomes, particularly in macrophages of reticuloendothelial system, due to their role in elimination of erythrocytes and leukocytes that contain large amounts of glycosphingolipids",
                      "Few genotype-phenotype correlationsN370S mutation is protective for development of neurological involvementN370S homozygosity tends to be milderD409H homozygosity associated with cardiovascular form",
                      "N370S mutation is protective for development of neurological involvement",
                      "N370S homozygosity tends to be milder",
                      "D409H homozygosity associated with cardiovascular form"
                    ]
                  },
                  {
                    "text": "Rarely, caused by mutations inPSAPgene that encodes saposin C (GCase activator)Patients have signs of Gaucher disease but normal GCase activity",
                    "sub_points": [
                      "Patients have signs of Gaucher disease but normal GCase activity"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1/40,000 to 1/100,000 in general population"
                  }
                ],
                "Age": [
                  {
                    "text": "Generally diagnosed in childhood or young adulthood"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Particularly common among Ashkenazi Jewish population (1/850 births)Four most common mutations account for 90% of pathogenic variants in this population",
                    "sub_points": [
                      "Four most common mutations account for 90% of pathogenic variants in this population"
                    ]
                  }
                ],
                "Site": [
                  {
                    "text": "Liver, spleen, bone, and bone marrow"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Highly variable presentation, with hepatosplenomegaly, cytopenia, bone disease, and, in some forms, neurologic impairment"
                  },
                  {
                    "text": "3 classic clinical variantsType 1 (nonneuronopathic) is most commonTypes 2 and 3 (neuronopathic) are differentiated by severity",
                    "sub_points": [
                      "Type 1 (nonneuronopathic) is most common",
                      "Types 2 and 3 (neuronopathic) are differentiated by severity"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Anemia and thrombocytopenia"
                  },
                  {
                    "text": "Dyslipidemia with low high-density lipoprotein"
                  },
                  {
                    "text": "Hyperferritinemia"
                  },
                  {
                    "text": "Hypergammaglobulinemia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Enzyme replacement therapy"
                  },
                  {
                    "text": "Substrate reduction therapy"
                  },
                  {
                    "text": "Emerging therapiesSmall molecule chaperones bind to enzyme to prevent misfolding, enhancing translocation of enzyme to lysosomes and, in some cases, restoring its activityGene replacement therapy",
                    "sub_points": [
                      "Small molecule chaperones bind to enzyme to prevent misfolding, enhancing translocation of enzyme to lysosomes and, in some cases, restoring its activity",
                      "Gene replacement therapy"
                    ]
                  },
                  {
                    "text": "Supportive care includes transfusions and analgesics"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Variable disease progression"
                  },
                  {
                    "text": "Early diagnosis and treatment improves outcome"
                  },
                  {
                    "text": "Splenectomy exacerbates hepatic involvement"
                  }
                ],
                "Associated Conditions": [
                  {
                    "text": "Myeloma and hepatocellular carcinoma"
                  },
                  {
                    "text": "Parkinson disease"
                  },
                  {
                    "text": "Cholelithiasis"
                  }
                ],
                "Diagnostic Tests": [
                  {
                    "text": "Peripheral white blood cell enzyme assay"
                  },
                  {
                    "text": "Genetic testing"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Useful for monitoring hepatosplenomegaly"
                  },
                  {
                    "text": "May detect steatosis in up to 40% of patients"
                  },
                  {
                    "text": "Detects cholelithiasis"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Useful to detect iron overload"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Scattered clusters of Gaucher storage cells (macrophages with amphophilic, striated cytoplasm resembling wrinkled tissue paper)Storage cells predominate in zone 3Storage cells may have slight iron accumulation",
                    "sub_points": [
                      "Storage cells predominate in zone 3",
                      "Storage cells may have slight iron accumulation"
                    ]
                  },
                  {
                    "text": "Pericellular fibrosis, fibrous septa, or cirrhosis may be presentRarely, causes massive confluent fibrosis with calcifications in central region of liver",
                    "sub_points": [
                      "Rarely, causes massive confluent fibrosis with calcifications in central region of liver"
                    ]
                  },
                  {
                    "text": "Gaucheroma is conglomerate of storage cells"
                  },
                  {
                    "text": "Additional findings may include steatosis and iron in hepatocytes or Kupffer cells"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS-D highlights Gaucher cells"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Gaucher cells have rod-shaped lysosomes filled with tubules"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Niemann-Pick Disease": [
                  {
                    "text": "Storage cells are foamy"
                  },
                  {
                    "text": "Electron microscopy shows lamellar inclusions in lysosomes"
                  }
                ],
                "Wolman Disease": [
                  {
                    "text": "Storage cells are foamy"
                  },
                  {
                    "text": "Frozen section slide stained with oil red O reveals abundant lipid, and polarized light highlights needle-shaped cholesterol crystals"
                  },
                  {
                    "text": "Electron microscopy shows lipid droplets and cholesterol crystals in hepatocytes and Kupffer cells"
                  }
                ],
                "Pseudo Gaucher cells in bone marrow biopsies": [
                  {
                    "text": "Entities such as crystal storing histiocytosis or sea-blue histiocytosis can mimic Gaucher cells"
                  },
                  {
                    "text": "In conditions with rapid cell turnover, glucocerebrosidase in macrophages can be overwhelmed, resulting in macrophages with foamy cytoplasm that mimic Gaucher cells"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Clusters of Gaucher storage cells with wrinkled tissue paper cytoplasm in parenchyma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Porphyrin Metabolism Disorders": {
            "name": "Porphyrin Metabolism Disorders",
            "url": "https://app.pathprimer.com/document/2de35b4a-ac5d-456f-9ea4-96fcf4c5ae39/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Heterogeneous group of disorders of heme synthesisPorphyria cutanea tarda (PCT), erythropoietic protoporphyria (EP), and X-linked protoporphyria (XLP)",
                    "sub_points": [
                      "Porphyria cutanea tarda (PCT), erythropoietic protoporphyria (EP), and X-linked protoporphyria (XLP)"
                    ]
                  },
                  {
                    "text": "All associated with hepatic pathology"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Genetic: Defect in 1 of 8 enzymes involved in heme synthesisErythropoietic protoporphyria (EP): Partial deficiency of ferrochelatase activityAccumulation of protoporphyrin IX in liver leads to toxicity and bile duct obstructionFamilial porphyria cutanea tarda (PCT): Deficiency of UROD activity in all tissuesX-linked protoporphyria (XLP): Mutation inALAS2gene",
                    "sub_points": [
                      "Erythropoietic protoporphyria (EP): Partial deficiency of ferrochelatase activityAccumulation of protoporphyrin IX in liver leads to toxicity and bile duct obstruction",
                      "Accumulation of protoporphyrin IX in liver leads to toxicity and bile duct obstruction",
                      "Familial porphyria cutanea tarda (PCT): Deficiency of UROD activity in all tissues",
                      "X-linked protoporphyria (XLP): Mutation inALAS2gene"
                    ]
                  },
                  {
                    "text": "Sporadic (80% PCT patients): Acquired disorder resulting in inhibition of hepatic URODPrecipitating factors include HCV,HFEmutations, alcohol, and drugs",
                    "sub_points": [
                      "Precipitating factors include HCV,HFEmutations, alcohol, and drugs"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Photosensitivity, liver disease of variable severity"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "EP: Liver is black due to massive protoporphyrin deposition"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "PCT: Nonspecific siderosis, steatosis, ± changes typical of HCVNeedle-shaped crystals formed by accumulated porphyrins hard to see on H&E",
                    "sub_points": [
                      "Needle-shaped crystals formed by accumulated porphyrins hard to see on H&E"
                    ]
                  },
                  {
                    "text": "EP: Cholestasis; red-brown aggregates of protoporphyrin in canaliculi, hepatocytes, Kupffer cellsMaltese cross appearance on polarization",
                    "sub_points": [
                      "Maltese cross appearance on polarization"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PCTElectron or polarization microscopyFerric ferricyanide stain may help visualizeLaboratory testing for porphyrins",
                    "sub_points": [
                      "Electron or polarization microscopy",
                      "Ferric ferricyanide stain may help visualize",
                      "Laboratory testing for porphyrins"
                    ]
                  },
                  {
                    "text": "EP and XLPPolarization microscopyLaboratory testing for porphyrins, genetic testing",
                    "sub_points": [
                      "Polarization microscopy",
                      "Laboratory testing for porphyrins, genetic testing"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Porphyria cutanea tarda (PCT)"
                  },
                  {
                    "text": "Erythropoietic protoporphyria (EP)Also termed erythrohepatic protoporphyria or protoporphyria",
                    "sub_points": [
                      "Also termed erythrohepatic protoporphyria or protoporphyria"
                    ]
                  },
                  {
                    "text": "X-linked protoporphyria (XLP)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Porphyrias are heterogeneous set of disorders of heme biosynthesis, resulting in accumulation of heme precursorsEP, XLP, and PCT associated with hepatic pathologyTerms \"hepatic\" or \"erythropoietic\" porphyria based on site of heme precursor accumulation",
                    "sub_points": [
                      "EP, XLP, and PCT associated with hepatic pathologyTerms \"hepatic\" or \"erythropoietic\" porphyria based on site of heme precursor accumulation",
                      "Terms \"hepatic\" or \"erythropoietic\" porphyria based on site of heme precursor accumulation"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder: EP, XLP, and Type II (Familial) PCT": [
                  {
                    "text": "Defect in 1 of 8 enzymes involved in heme synthesis"
                  },
                  {
                    "text": "EP: Mutation in gene encoding ferrochelatase results in insufficient levels of activityFerrochelatase is final enzyme in heme biosynthesis pathwayConverts protoporphyrin IX into heme by inserting iron (Fe++) into protoporphyrin IX ringDeficient levels result in lack of heme formation, with loss of negative feedback in heme synthesis pathwayWithout negative feedback loop, heme synthesis pathway continues trying to make heme, and protoporphyrin IX is excreted into bileExcess protoporphyrin IX precipitates in liver, causing bile duct obstruction and tissue damage (protoporphyric hepatopathy)",
                    "sub_points": [
                      "Ferrochelatase is final enzyme in heme biosynthesis pathwayConverts protoporphyrin IX into heme by inserting iron (Fe++) into protoporphyrin IX ring",
                      "Converts protoporphyrin IX into heme by inserting iron (Fe++) into protoporphyrin IX ring",
                      "Deficient levels result in lack of heme formation, with loss of negative feedback in heme synthesis pathwayWithout negative feedback loop, heme synthesis pathway continues trying to make heme, and protoporphyrin IX is excreted into bileExcess protoporphyrin IX precipitates in liver, causing bile duct obstruction and tissue damage (protoporphyric hepatopathy)",
                      "Without negative feedback loop, heme synthesis pathway continues trying to make heme, and protoporphyrin IX is excreted into bile",
                      "Excess protoporphyrin IX precipitates in liver, causing bile duct obstruction and tissue damage (protoporphyric hepatopathy)"
                    ]
                  },
                  {
                    "text": "XLP: Mutation inALAS2gene affecting 1st enzyme in heme synthesis pathway, aminolevulinic acid synthaseLike EP, leads to excess protoporphyrin IXX linked, so all males affected",
                    "sub_points": [
                      "Like EP, leads to excess protoporphyrin IX",
                      "X linked, so all males affected"
                    ]
                  },
                  {
                    "text": "Type II (familial) PCT20% of PCT patientsHeterozygous uroporphyrinogen decarboxylase (UROD) mutation",
                    "sub_points": [
                      "20% of PCT patients",
                      "Heterozygous uroporphyrinogen decarboxylase (UROD) mutation"
                    ]
                  }
                ],
                "Acquired Disorder: Type I (Sporadic) PCT": [
                  {
                    "text": "80% of PCT patients lack genetic defect, but have acquired UROD deficiency in liver only"
                  },
                  {
                    "text": "Associated with various other genetic and acquired conditionsConditions that increase iron absorption (e.g.,HFEmutations)Hepatitis C virus (HCV) infectionAlcohol, HIV, estrogen use, smoking, low vitamin C, and carotenoid statusMany of these conditions trigger oxidative stress on hepatocytes, resulting in UROD inhibitor formationUROD inhibitors result in decreased UROD activity and build-up of toxic heme precursor",
                    "sub_points": [
                      "Conditions that increase iron absorption (e.g.,HFEmutations)",
                      "Hepatitis C virus (HCV) infection",
                      "Alcohol, HIV, estrogen use, smoking, low vitamin C, and carotenoid status",
                      "Many of these conditions trigger oxidative stress on hepatocytes, resulting in UROD inhibitor formationUROD inhibitors result in decreased UROD activity and build-up of toxic heme precursor",
                      "UROD inhibitors result in decreased UROD activity and build-up of toxic heme precursor"
                    ]
                  }
                ],
                "Cause Unknown: Type III PCT": [
                  {
                    "text": "< 5% of PCT patients have positive family history but no known underlying genetic defect"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "PCT: 1/25,000 persons in North AmericaHigher in some European countries and South African Bantu population",
                    "sub_points": [
                      "Higher in some European countries and South African Bantu population"
                    ]
                  },
                  {
                    "text": "EP : 1/75,000-200,000 persons among some Western European populations"
                  },
                  {
                    "text": "XLP: Rare, accounts for 2-10% of those with EP symptoms"
                  }
                ],
                "Age": [
                  {
                    "text": "Sporadic PCT: 40-50 years of age"
                  },
                  {
                    "text": "Familial PCT: Occurs early, sometimes in childhood"
                  },
                  {
                    "text": "EP: Photosensitivity presents in childhood, but liver disease usually presents after age 30"
                  }
                ],
                "Sex": [
                  {
                    "text": "Sporadic PCT and EP occur more often in male patients"
                  }
                ],
                "Presentation": [
                  {
                    "text": "PCTBlistering skin condition on sun-exposed areasAbnormal liver function tests",
                    "sub_points": [
                      "Blistering skin condition on sun-exposed areas",
                      "Abnormal liver function tests"
                    ]
                  },
                  {
                    "text": "EP and XLPTransient cutaneous erythema and swelling immediately after sun exposureProtoporphyrin IX absorbs UV wavelength (400-420 nm range) with free radical formation and oxidative damage to skin25% have mildly abnormal liver tests11% of patients not diagnosed until liver abnormality manifestsMinority of patients develop protoporphyrin hepatopathySevere rapidly progressive form of liver disease with severe RUQ pain, jaundice, nausea, vomiting from high amount of porphyrin accumulationXLP slightly higher risk for liver dysfunction than EP",
                    "sub_points": [
                      "Transient cutaneous erythema and swelling immediately after sun exposureProtoporphyrin IX absorbs UV wavelength (400-420 nm range) with free radical formation and oxidative damage to skin",
                      "Protoporphyrin IX absorbs UV wavelength (400-420 nm range) with free radical formation and oxidative damage to skin",
                      "25% have mildly abnormal liver tests11% of patients not diagnosed until liver abnormality manifests",
                      "11% of patients not diagnosed until liver abnormality manifests",
                      "Minority of patients develop protoporphyrin hepatopathySevere rapidly progressive form of liver disease with severe RUQ pain, jaundice, nausea, vomiting from high amount of porphyrin accumulationXLP slightly higher risk for liver dysfunction than EP",
                      "Severe rapidly progressive form of liver disease with severe RUQ pain, jaundice, nausea, vomiting from high amount of porphyrin accumulation",
                      "XLP slightly higher risk for liver dysfunction than EP"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "PCTElevated porphyrin levels in urine and plasmaSamples must not be exposed to light, as porphyrins are light sensitiveFurther confirmation by fractionation of porphyrins in urine, feces, plasma, and erythrocytes by high-performance liquid chromatography to identify pattern specific to PCT vs. other porphyrias and other disorders with elevated urine porphyrinErythrocyte porphyrin levels normal or only mildly elevated in PCT",
                    "sub_points": [
                      "Elevated porphyrin levels in urine and plasmaSamples must not be exposed to light, as porphyrins are light sensitive",
                      "Samples must not be exposed to light, as porphyrins are light sensitive",
                      "Further confirmation by fractionation of porphyrins in urine, feces, plasma, and erythrocytes by high-performance liquid chromatography to identify pattern specific to PCT vs. other porphyrias and other disorders with elevated urine porphyrinErythrocyte porphyrin levels normal or only mildly elevated in PCT",
                      "Erythrocyte porphyrin levels normal or only mildly elevated in PCT"
                    ]
                  },
                  {
                    "text": "EPFECHgene sequencing to confirm mutationWhole blood total erythrocyte protoporphyrin levelsIncreased metal-free protoporphyrin IX due to lack of ferrochelatase",
                    "sub_points": [
                      "FECHgene sequencing to confirm mutation",
                      "Whole blood total erythrocyte protoporphyrin levelsIncreased metal-free protoporphyrin IX due to lack of ferrochelatase",
                      "Increased metal-free protoporphyrin IX due to lack of ferrochelatase"
                    ]
                  },
                  {
                    "text": "XLPALAS2gene sequencingWhole blood total erythrocyte protoporphyrin levelsLower levels of metal-free protoporphyrin IX since ferrochelatase is functioning",
                    "sub_points": [
                      "ALAS2gene sequencing",
                      "Whole blood total erythrocyte protoporphyrin levelsLower levels of metal-free protoporphyrin IX since ferrochelatase is functioning",
                      "Lower levels of metal-free protoporphyrin IX since ferrochelatase is functioning"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "PCTPhlebotomy, low-dose hydroxychloroquineAvoid sun exposure, alcohol, estrogens",
                    "sub_points": [
                      "Phlebotomy, low-dose hydroxychloroquine",
                      "Avoid sun exposure, alcohol, estrogens"
                    ]
                  },
                  {
                    "text": "EP and XLPPlasmapheresis to remove excess protoporphyrin IXHematin: Initiates negative feedback loop on futile heme synthesis driveβ-carotene & afamelanotide to mitigate photosensitivityCholestyramine and other bile salts to solubilize protoporphyrin IXBone marrow or stem cell transplantTransplanted cells produce normal enzyme levels and reverse disease manifestations",
                    "sub_points": [
                      "Plasmapheresis to remove excess protoporphyrin IX",
                      "Hematin: Initiates negative feedback loop on futile heme synthesis drive",
                      "β-carotene & afamelanotide to mitigate photosensitivity",
                      "Cholestyramine and other bile salts to solubilize protoporphyrin IX",
                      "Bone marrow or stem cell transplantTransplanted cells produce normal enzyme levels and reverse disease manifestations",
                      "Transplanted cells produce normal enzyme levels and reverse disease manifestations"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "PCTGood prognosis overallIncreased risk of cirrhosis and hepatocellular carcinoma (especially with concomitant HCV)",
                    "sub_points": [
                      "Good prognosis overallIncreased risk of cirrhosis and hepatocellular carcinoma (especially with concomitant HCV)",
                      "Increased risk of cirrhosis and hepatocellular carcinoma (especially with concomitant HCV)"
                    ]
                  },
                  {
                    "text": "EP, XLPPrognosis varies with presence and degree of liver damageLiver transplantation improves survival, but is not curative since excess porphyrin continues to be produced in bone marrow",
                    "sub_points": [
                      "Prognosis varies with presence and degree of liver damage",
                      "Liver transplantation improves survival, but is not curative since excess porphyrin continues to be produced in bone marrow"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "EP: Liver is black due to massive protoporphyrin deposition"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "PCTNeedle-shaped cytoplasmic hepatocyte inclusionsDifficult to identify on H&ERarely seen on unstained sections by light microscopy or polarizing lightFerric ferricyanide stain may help visualizeSteatosis, variable siderosis, and fibrosisFeatures of concomitant HCV infection if HCV positive",
                    "sub_points": [
                      "Needle-shaped cytoplasmic hepatocyte inclusionsDifficult to identify on H&ERarely seen on unstained sections by light microscopy or polarizing lightFerric ferricyanide stain may help visualize",
                      "Difficult to identify on H&E",
                      "Rarely seen on unstained sections by light microscopy or polarizing lightFerric ferricyanide stain may help visualize",
                      "Ferric ferricyanide stain may help visualize",
                      "Steatosis, variable siderosis, and fibrosis",
                      "Features of concomitant HCV infection if HCV positive"
                    ]
                  },
                  {
                    "text": "EP and XLPCholestasisRed-brown protoporphyrin deposits in canaliculi, hepatocytes, and Kupffer cellsBirefringent on polarizing microscopySome show Maltese cross configurationVariable fibrosis or cirrhosis",
                    "sub_points": [
                      "Cholestasis",
                      "Red-brown protoporphyrin deposits in canaliculi, hepatocytes, and Kupffer cellsBirefringent on polarizing microscopySome show Maltese cross configuration",
                      "Birefringent on polarizing microscopy",
                      "Some show Maltese cross configuration",
                      "Variable fibrosis or cirrhosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "PCT shows needle-like structures in hepatocytes"
                  },
                  {
                    "text": "EP and XLP: Protoporphyrin deposits are aggregates of radiating crystals in dilated canaliculi, hepatocyte vacuoles, and Kupffer cells"
                  }
                ],
                "Biochemical Measurement in Liver Tissue": [
                  {
                    "text": "In PCT, needle-shaped crystals of accumulated porphyrins may be altered due to fixation"
                  },
                  {
                    "text": "Biochemical measurement for uroporphyrin and heptacarboxyl porphyrin in liver tissue may help demonstrate that there is massive porphyrin accumulation"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatitis C Infection": [
                  {
                    "text": "No needle-like crystals in hepatocytes; no skin blistering"
                  }
                ],
                "Hemochromatosis": [
                  {
                    "text": "No needle-like or Maltese cross crystals in hepatocytes; no skin blistering"
                  }
                ],
                "Cholestasis": [
                  {
                    "text": "Inspissated material of EP is more reddish-brown"
                  },
                  {
                    "text": "Polarization microscopy shows birefringence and Maltese cross configuration in deposits"
                  }
                ],
                "Dubin-Johnson": [
                  {
                    "text": "Liver can also be grossly black like EP due to lipomelanin"
                  },
                  {
                    "text": "Innocuous condition that does not cause liver injury"
                  },
                  {
                    "text": "MRP2abnormality leads to asymptomatic conjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Coarse granular pigment on histology"
                  },
                  {
                    "text": "No Maltese cross crystals"
                  },
                  {
                    "text": "Loss of canalicular multispecific organic anion transporter (cMOAT) can be demonstrated by immunohistochemical staining"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Patients have photosensitivity, variable degree of liver disease"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "PCT: Nonspecific siderosis, ± features of HCV; inclusions difficult to identify on H&E"
                  },
                  {
                    "text": "EP and XLP: Look for red-brown inclusions in hepatocytes with Maltese cross crystals on polarization"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Dubin-Johnson Syndrome": {
            "name": "Dubin-Johnson Syndrome",
            "url": "https://app.pathprimer.com/document/7e9adf72-970d-4d00-818b-708dc84dce25/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations inABCC2(CMOAT/MRP2) cause impaired biliary transport of conjugated bilirubin"
                  },
                  {
                    "text": "Results in impaired biliary canalicular transport of organic anions including conjugated bilirubin"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Chronic or intermittent jaundice"
                  },
                  {
                    "text": "Isolated conjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Shift in urine coproporphyrin isomers from isomer III to isomer I"
                  },
                  {
                    "text": "Most patients asymptomatic; neonates can present with prolonged jaundice"
                  },
                  {
                    "text": "Jaundice can be precipitated by pregnancy or by drugs that decrease hepatic excretion of organic anions (e.g., oral contraceptives)"
                  },
                  {
                    "text": "No treatment necessary"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Grossly pigmented liver"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Coarse granular pigment in centrilobular hepatocytes"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PAS with diastase digestion and Fontana-Masson stains highlight pigment"
                  },
                  {
                    "text": "Absent immunohistochemical staining of canalicular membrane with MRP2 confirms diagnosis"
                  },
                  {
                    "text": "Membrane-bound, electron-dense lysosomal granules within cytoplasm of hepatocytes"
                  },
                  {
                    "text": "Pathogenic mutation inABCC2confirms diagnosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Erythropoietic protoporphyria"
                  },
                  {
                    "text": "Gilbert syndrome"
                  },
                  {
                    "text": "Bilirubinostasis"
                  },
                  {
                    "text": "Hemochromatosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Defect in hepatocellular secretion of conjugated bilirubin"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder": [
                  {
                    "text": "Autosomal recessive"
                  },
                  {
                    "text": "Homozygous or compound heterozygous mutations inABCC2(CMOAT/MRP2) gene, which codes for ATP-dependent organic anion transport localized to canalicular membraneResults in impaired biliary canalicular transport of organic anions including conjugated bilirubinImpaired glutathione excretion reduces bile salt-independent bile flow",
                    "sub_points": [
                      "Results in impaired biliary canalicular transport of organic anions including conjugated bilirubin",
                      "Impaired glutathione excretion reduces bile salt-independent bile flow"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare"
                  }
                ],
                "Sex": [
                  {
                    "text": "M = F"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "All ethnicities, with highest prevalence among Moroccan and Iranian Jews (1:1,300)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most patients are asymptomatic or have mild right upper quadrant abdominal pain"
                  },
                  {
                    "text": "Presents in young adulthood as chronic or intermittent jaundice"
                  },
                  {
                    "text": "Initial presentation can have cholestatic features, with persistence of isolated conjugated hyperbilirubinemiaJaundice or cholestasis can be precipitated by pregnancy or by drugs that decrease hepatic excretion of organic anions (e.g., oral contraceptives)Neonates may present with severe cholestasis, ± acholic stools",
                    "sub_points": [
                      "Jaundice or cholestasis can be precipitated by pregnancy or by drugs that decrease hepatic excretion of organic anions (e.g., oral contraceptives)",
                      "Neonates may present with severe cholestasis, ± acholic stools"
                    ]
                  },
                  {
                    "text": "Serum bile acids are not increased, so pruritus is absent"
                  },
                  {
                    "text": "Urine may be darker than normal"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Measurement of urine coproporphyrin isomers shows shift from isomer III to isomer I"
                  },
                  {
                    "text": "Conjugated hyperbilirubinemia, generally mild due to urinary excretion of bilirubin glucuronides"
                  },
                  {
                    "text": "Normal alkaline phosphatase and γ-glutamyl transpeptidasePatients whose initial presentation is cholestatic may temporarily have elevated alkaline phosphatase or GGT",
                    "sub_points": [
                      "Patients whose initial presentation is cholestatic may temporarily have elevated alkaline phosphatase or GGT"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "None necessary"
                  },
                  {
                    "text": "In neonates with significant cholestasis, phenobarbital and ursodeoxycholic acid is recommended"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Attenuation of liver"
                  }
                ],
                "Hepatobiliary Iminodiacetic Acid Scan": [
                  {
                    "text": "Prolonged, intense visualization of liver and delayed or no visualization of gallbladder"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Grossly, liver is darkly pigmented and can appear green, slate blue, dark gray, or black"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Coarse granular pigment in centrizonal hepatocytes"
                  },
                  {
                    "text": "Pigment was earlier thought to be form of melanin or lipofuscin"
                  },
                  {
                    "text": "Likely composed of polymers of epinephrine metabolites"
                  },
                  {
                    "text": "In neonatal cases, there may be bile stasis in canaliculi, steatosis, or pigment in hepatocytes"
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Pigment accumulation"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Centrizonal region"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS with diastase digestionAccentuates cytoplasmic pigment",
                    "sub_points": [
                      "Accentuates cytoplasmic pigment"
                    ]
                  },
                  {
                    "text": "Fontana-MassonStains cytoplasmic granules black",
                    "sub_points": [
                      "Stains cytoplasmic granules black"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "MRP2: Absence of staining of canalicular membraneAvailable through referral centersHelpful in neonates and young children whose livers have not accumulated pigment",
                    "sub_points": [
                      "Available through referral centers",
                      "Helpful in neonates and young children whose livers have not accumulated pigment"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Pathogenic mutation inABCC2confirms diagnosis"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Membrane-bound, electron-dense lysosomal granules within cytoplasm of hepatocytes"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Erythropoietic Protoporphyria": [
                  {
                    "text": "Can also show grossly pigmented liver but has distinct clinical and histologic features"
                  }
                ],
                "Gilbert Syndrome": [
                  {
                    "text": "Pigment in centrizonal hepatocytes is not as coarse"
                  },
                  {
                    "text": "Unconjugated hyperbilirubinemia"
                  }
                ],
                "Bilirubinostasis": [
                  {
                    "text": "Inspissated bile in canaliculi"
                  },
                  {
                    "text": "Swelling (feathery degeneration) of hepatocytes in cholestatic area"
                  }
                ],
                "Hemochromatosis": [
                  {
                    "text": "Prussian blue (+) pigment in periportal hepatocytes"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Coarse pigment in centrizonal hepatocytes in patient with isolated conjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Pigment may disappear during episode of hepatitis and reaccumulate after recovery"
                  },
                  {
                    "text": "Biopsies may be performed for evaluation of unexplained hyperbilirubinemia, cholestasis of pregnancy, or neonatal jaundice"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gilbert Disease": {
            "name": "Gilbert Disease",
            "url": "https://app.pathprimer.com/document/881741a4-87f1-4943-8541-d1460c217e6d/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Inherited, unconjugated hyperbilirubinemia due to mutation of promoter of B-UGT gene (UGT1A1)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal recessive disorder caused by homozygous or compound heterozygous mutations ofUGT1A1gene"
                  },
                  {
                    "text": "Decreased transcription ofUGT1A1gene results in decreased conjugation of bilirubin"
                  },
                  {
                    "text": "Over 130 mutations implicated with prevalence of different mutations varying among ethnic groups"
                  },
                  {
                    "text": "Among White patients, most common mutation is extra bases (TA) in TATAA box ofUGT1A1promoter (UGT1A1*28)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "No treatment necessary"
                  },
                  {
                    "text": "Decreased conjugation of some drugs results in increased risk of adverse effect to those drugs"
                  },
                  {
                    "text": "Mild, unconjugated nonhemolytic hyperbilirubinemia with higher levels during illness or stress"
                  },
                  {
                    "text": "Often diagnosed at puberty, possibly related to increased hemoglobin turnover and inhibition of bilirubin glucuronidation by endogenous steroid hormones"
                  },
                  {
                    "text": "Can present in neonatal period, especially if there is concurrent hemolytic disease"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Increased lipofuscin in zone 3"
                  },
                  {
                    "text": "No inflammation, hepatocellular injury, or fibrosis"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Genetic testing may be performed in evaluation of prolonged neonatal jaundice"
                  },
                  {
                    "text": "Testing for UGT1A1*28 often done to identify patients at risk for certain drug toxicities"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Lipofuscin deposition as variant of normal or drug ingestion"
                  },
                  {
                    "text": "Dubin-Johnson syndrome"
                  },
                  {
                    "text": "Crigler-Najjar, types 1 and 2"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Inherited, unconjugated hyperbilirubinemia due to mutations of bilirubin uridine diphosphate glucuronosyltransferase (B-UGT orUGT1A1) gene"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder": [
                  {
                    "text": "Autosomal recessive disorder caused by homozygous or compound heterozygous mutations ofUGT1A1geneOver 130 mutations implicated with prevalence of different mutations varying among ethnic groupsDecreased conjugation of bilirubinDecreased conjugation of some drugs (irinotecan, atazanavir, TAS-103, indinavir, tolbutamide, rifamycin)",
                    "sub_points": [
                      "Over 130 mutations implicated with prevalence of different mutations varying among ethnic groups",
                      "Decreased conjugation of bilirubin",
                      "Decreased conjugation of some drugs (irinotecan, atazanavir, TAS-103, indinavir, tolbutamide, rifamycin)"
                    ]
                  },
                  {
                    "text": "Among White patients, most common mutation is extra bases (TA) in TATAA box ofUGT1A1promoter (UGT1A1*28)Results in decreased transcription of gene to 10-35% of normalOnly 40% of patients homozygous for mutation have hyperbilirubinemiaAffected patients often have 2nd condition causing increased bilirubin load, such as reduced red cell lifespan or impaired hepatic bilirubin uptake",
                    "sub_points": [
                      "Results in decreased transcription of gene to 10-35% of normal",
                      "Only 40% of patients homozygous for mutation have hyperbilirubinemia",
                      "Affected patients often have 2nd condition causing increased bilirubin load, such as reduced red cell lifespan or impaired hepatic bilirubin uptake"
                    ]
                  },
                  {
                    "text": "Among East Asian patients, most common mutation is Gly71Arg mutation (G71R;UGT1A1*6) in exon 1"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Prevalence is ~ 8% in general population"
                  },
                  {
                    "text": "UGT1A1*28 homozygosity incidence varies depending on ethnicity16% European, 23% Black, 8% Egyptian, and rare in Asia",
                    "sub_points": [
                      "16% European, 23% Black, 8% Egyptian, and rare in Asia"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Often diagnosed at puberty, possibly related to increased hemoglobin turnover and inhibition of bilirubin glucuronidation by endogenous steroid hormones"
                  },
                  {
                    "text": "Can present as neonatal hyperbilirubinemia, especially if there is concurrent hemolytic disease"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male patients affected more than female patients, possible due to higher rate of bilirubin production in male patients"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Mild, unconjugated nonhemolytic hyperbilirubinemia, usually fluctuating and < 3 mg/dL"
                  },
                  {
                    "text": "Higher bilirubin can occur during illness, stress, fasting, or menstrual period"
                  },
                  {
                    "text": "Otherwise normal liver function"
                  },
                  {
                    "text": "Jaundice is only finding on physical examination"
                  },
                  {
                    "text": "Associated with prolonged neonatal jaundice and development of gallstones in patients with hereditary spherocytosis or other hemolytic anemia"
                  },
                  {
                    "text": "Associated with increased risk of toxicity from drugs metabolized by B-UGTIrinotecan has been associated with severe diarrhea and neutropeniaIncreased risk of hyperbilirubinemia with atazanavir",
                    "sub_points": [
                      "Irinotecan has been associated with severe diarrhea and neutropenia",
                      "Increased risk of hyperbilirubinemia with atazanavir"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Mild, unconjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Normal alkaline phosphatase, aspartate aminotransferase, alanine aminotransferase, γ-glutamyl transpeptidase"
                  },
                  {
                    "text": "Increased proportion of bilirubin monoglucuronide in bile"
                  },
                  {
                    "text": "Rifampin or nicotinic acid (niacin) administration causes disproportionate unconjugated hyperbilirubinemia relative to normal patients"
                  },
                  {
                    "text": "Caloric restriction causes disproportionate unconjugated hyperbilirubinemia relative to normal patients"
                  }
                ],
                "Treatment": [
                  {
                    "text": "No treatment necessary"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "No macroscopic findings"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Either normal-appearing or increased lipofuscin in centrizonal hepatocytes"
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Pigment accumulation"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Hepatocyte"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "May be helpful in evaluation of prolonged neonatal jaundice"
                  },
                  {
                    "text": "Testing for UGT1A1*28 often done to identify patients at risk for certain drug toxicities and to tailor dose"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal": [
                  {
                    "text": "Increased lipofuscin can be seen in normal individuals, more often in those of advanced age or on chronic medications"
                  }
                ],
                "Dubin-Johnson Syndrome": [
                  {
                    "text": "Pigment is considerably more coarse"
                  }
                ],
                "Crigler-Najjar, Types 1 and 2": [
                  {
                    "text": "Severe, unconjugated hyperbilirubinemia characterized by total or near-total absence of B-UGT activity"
                  },
                  {
                    "text": "Mutations in exons 1-5 ofUGT1A1gene"
                  },
                  {
                    "text": "Biopsy can show cholestasis or appear normal"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Does not lead to liver inflammation, fibrosis, cirrhosis, or liver failure"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Increased lipofuscin in centrizonal hepatocytes"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Polycystic Liver Disease": {
            "name": "Polycystic Liver Disease",
            "url": "https://app.pathprimer.com/document/2b96313c-fd1b-41e1-ad0e-da4495d9af20/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Autosomal dominant disorder characterized by progressive development of multiple liver cystsComponent of autosomal dominant polycystic kidney disease (ADPKD), isolated liver involvement less common",
                    "sub_points": [
                      "Component of autosomal dominant polycystic kidney disease (ADPKD), isolated liver involvement less common"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal dominant inheritanceAssociated with ADPKD; mutations inPKD1encoding polycystin-1 (80-85%), or inPKD2encoding polycystin-2 (15-20%)Isolated polycystic liver disease (PLD): Mutations inPRKCSHencoding hepatocystin, or inSEC63encoding Sec63p, or inLRP5encoding transmembrane protein",
                    "sub_points": [
                      "Associated with ADPKD; mutations inPKD1encoding polycystin-1 (80-85%), or inPKD2encoding polycystin-2 (15-20%)",
                      "Isolated polycystic liver disease (PLD): Mutations inPRKCSHencoding hepatocystin, or inSEC63encoding Sec63p, or inLRP5encoding transmembrane protein"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "ADPKD affects 1 in 500-1,000 individualsPLD occurs in 30-90% of patientsAge-dependent increase in number and size of liver cystsHigher prevalence of PLD in females",
                    "sub_points": [
                      "PLD occurs in 30-90% of patients",
                      "Age-dependent increase in number and size of liver cysts",
                      "Higher prevalence of PLD in females"
                    ]
                  },
                  {
                    "text": "Isolated PLD affects < 0.01% of population"
                  },
                  {
                    "text": "Asymptomatic in ~ 80% of patients"
                  },
                  {
                    "text": "Hepatomegaly with compression of adjacent structures"
                  },
                  {
                    "text": "Renal failure is main complication of ADPKD"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Hepatomegaly weighing up to 13 kg"
                  },
                  {
                    "text": "Cysts varying from < 1 mm to > 12 cm in diameter"
                  },
                  {
                    "text": "Occasionally 1 lobe involved (usually left lobe)"
                  },
                  {
                    "text": "Clear, colorless, or straw-colored cyst fluid"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Numerous variably sized cysts lined by single layer of cuboidal or flattened biliary epithelium"
                  },
                  {
                    "text": "Lack of communication with biliary tree"
                  },
                  {
                    "text": "von Meyenburg complexes commonly present"
                  },
                  {
                    "text": "Fibrosis and hyalinization in collapsed cysts, which may resemble corpora atretica/ fibrosa of ovary"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Polycystic liver disease (PLD)"
                  },
                  {
                    "text": "Autosomal dominant polycystic kidney disease (ADPKD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autosomal dominant disorder characterized by progressive development of multiple liver cystsAssociated with multiple kidney cysts in majority of cases",
                    "sub_points": [
                      "Associated with multiple kidney cysts in majority of cases"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hereditary Anomaly": [
                  {
                    "text": "Associated with ADPKDMutations inPKD1gene encoding polycystin-1 seen in 80-85% of casesMutations inPKD2gene encoding polycystin-2 seen in 15-20% of cases",
                    "sub_points": [
                      "Mutations inPKD1gene encoding polycystin-1 seen in 80-85% of cases",
                      "Mutations inPKD2gene encoding polycystin-2 seen in 15-20% of cases"
                    ]
                  },
                  {
                    "text": "Isolated PLD: Also autosomal dominantMutations inPRKCSHgene encoding hepatocystinMutations inSEC63gene encoding Sec63p proteinMutation inLRP5gene encoding transmembrane protein",
                    "sub_points": [
                      "Mutations inPRKCSHgene encoding hepatocystin",
                      "Mutations inSEC63gene encoding Sec63p protein",
                      "Mutation inLRP5gene encoding transmembrane protein"
                    ]
                  },
                  {
                    "text": "Develop from embryonic ductal plate malformation (von Meyenburg complexes)Evolve through overgrowth and dilatation into cystsLose continuity with biliary tree",
                    "sub_points": [
                      "Evolve through overgrowth and dilatation into cysts",
                      "Lose continuity with biliary tree"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "ADPKD affects 1 in 500-1,000 individualsPLD occurs in 30-90% of patients with ADPKD",
                    "sub_points": [
                      "PLD occurs in 30-90% of patients with ADPKD"
                    ]
                  },
                  {
                    "text": "Isolated PLD affects < 0.01% of population"
                  }
                ],
                "Age": [
                  {
                    "text": "Age-dependent increase in number and size of liver cysts in ADPKD20% in 3rd decade of life75% by 7th decade of life",
                    "sub_points": [
                      "20% in 3rd decade of life",
                      "75% by 7th decade of life"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Higher prevalence of PLD in females with ADPKD58-75% in females vs. 42-62% in males",
                    "sub_points": [
                      "58-75% in females vs. 42-62% in males"
                    ]
                  },
                  {
                    "text": "More numerous and larger liver cysts in females, presumably due to stimulatory effects of estrogenHistory of multiple pregnanciesProlonged exposure to oral contraceptives or hormone replacement therapy",
                    "sub_points": [
                      "History of multiple pregnancies",
                      "Prolonged exposure to oral contraceptives or hormone replacement therapy"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Asymptomatic in ~ 80% of patients"
                  },
                  {
                    "text": "Hepatomegaly with compression of adjacent structuresAbdominal painEarly satietyNausea and vomitingSupine dyspneaLower body edema and ascites",
                    "sub_points": [
                      "Abdominal pain",
                      "Early satiety",
                      "Nausea and vomiting",
                      "Supine dyspnea",
                      "Lower body edema and ascites"
                    ]
                  },
                  {
                    "text": "Other associated medical conditionsAsymptomatic cysts in other organs, including pancreas, spleen, ovaries, seminal vesicles, and lungsIntracranial aneurysmsValvular heart disease, such as mitral valve prolapse",
                    "sub_points": [
                      "Asymptomatic cysts in other organs, including pancreas, spleen, ovaries, seminal vesicles, and lungs",
                      "Intracranial aneurysms",
                      "Valvular heart disease, such as mitral valve prolapse"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Usually, normal liver tests"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Percutaneous aspiration of large dominant cyst"
                  },
                  {
                    "text": "Sclerotherapy"
                  },
                  {
                    "text": "Cyst fenestration"
                  },
                  {
                    "text": "Somatostatin analogues (lanreotide, octreotide)"
                  },
                  {
                    "text": "Partial hepatectomy"
                  },
                  {
                    "text": "Liver transplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Rupture of cyst"
                  },
                  {
                    "text": "Intracystic hemorrhage"
                  },
                  {
                    "text": "Cyst infection"
                  },
                  {
                    "text": "Rarely, portal hypertension or hepatic failure"
                  },
                  {
                    "text": "Renal failure is main complication of ADPKD"
                  }
                ]
              },
              "IMAGING": {
                "Gigot Radiographic Classification": [
                  {
                    "text": "Type 1: Limited number (< 10) of large cysts with large areas of noncystic liver parenchyma"
                  },
                  {
                    "text": "Type 2: Diffuse involvement by medium-sized cysts with large areas of noncystic liver parenchyma"
                  },
                  {
                    "text": "Type 3: Massive involvement by small- and medium-sized cysts with few areas of noncystic liver parenchyma"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hepatomegaly weighing up to 13 kg"
                  },
                  {
                    "text": "Cysts varying from < 1 mm to > 12 cm in diameterNo communication with biliary tree",
                    "sub_points": [
                      "No communication with biliary tree"
                    ]
                  },
                  {
                    "text": "Occasionally 1 lobe involved (usually left lobe)"
                  },
                  {
                    "text": "Clear, colorless, or straw-colored cyst fluid"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variably sized cysts lined by single layer of cuboidal or flattened biliary epithelium"
                  },
                  {
                    "text": "Varying amounts of supporting connective tissue"
                  },
                  {
                    "text": "von Meyenburg complexes commonly present"
                  },
                  {
                    "text": "Neutrophil infiltration in infected cysts"
                  },
                  {
                    "text": "Fibrosis and hyalinization in collapsed cysts, which may resemble corpora atretica/fibrosa of ovary"
                  },
                  {
                    "text": "Dystrophic calcification may be seen in cyst wall"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Simple Biliary (Unilocular) Cyst": [
                  {
                    "text": "Fewer in number with abundant liver parenchyma"
                  },
                  {
                    "text": "Nonhereditary"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Usually occurs in setting of ADPKD"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diffuse liver involvement by numerous cysts lined by single layer of biliary epithelium"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cystic Fibrosis, Hepatic": {
            "name": "Cystic Fibrosis, Hepatic",
            "url": "https://app.pathprimer.com/document/a53ee8a4-32bd-4a92-b9af-5194eae2877e/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Various forms of liver disease in patients with cystic fibrosis (CF), including steatosis, focal biliary fibrosis, and multilobular cirrhosis"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Autosomal recessive mutation inCFTRthat encodes CF transmembrane conductance regulator (CFTR) protein"
                  },
                  {
                    "text": "Leads to impaired chloride secretion, affecting various organs"
                  },
                  {
                    "text": "ΔF508 accounts for 75% of mutated alleles"
                  },
                  {
                    "text": "Altered bile fluidity or composition may lead to inspissated bile, accumulation of toxic bile components, inflammation, and fibrosis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Some form of CFLD is detected in 60% of CF patients, but clinically significant liver disease occurs in 5-10% of patients"
                  },
                  {
                    "text": "Patients rarely present with liver disease as primary manifestation of CF"
                  },
                  {
                    "text": "Presentation is variable, ranging from asymptomatic abnormal liver biochemical tests to advanced fibrosis with portal hypertension"
                  },
                  {
                    "text": "Mean age at diagnosis of portal hypertension is 10 years old, and 90% present by age 18"
                  },
                  {
                    "text": "Liver transplantation in patients with multilobular cirrhosis with portal hypertension or those whose liver disease compromises lung function"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Ranges from isolated, depressed, green or gray scars to livers that resemble hepar lobatum with large, depressed, connecting scars separated by nodules of normal liver tissue"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hepatic steatosis is most common finding in CF and is often marked without zonal predilection"
                  },
                  {
                    "text": "Focal biliary fibrosis is characteristic of CF and consists of focal portal/periportal fibrosis with duct proliferation, inspissated eosinophilic secretions, and inflammation"
                  },
                  {
                    "text": "Multilobular biliary cirrhosis is characterized by regenerative nodules with variable size, including large nodules composed of multiple lobules"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Cystic fibrosis (CF)"
                  },
                  {
                    "text": "CF-related liver disease (CFLD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Mucoviscidosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Various forms of liver disease in patients with CF"
                  },
                  {
                    "text": "Diagnostic criteria include 2 of following: (1) hepatomegaly or splenomegaly, (2) persistent (> 12 months) elevation of serum alanine aminotransferase &/or γ-glutamyltransferase, (3) abnormal liver ultrasound"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder": [
                  {
                    "text": "Autosomal recessive mutation inCFTRon chromosome 7 that encodes CF transmembrane conductance regulator (CFTR) proteinCFTR is protein of ATP-binding cassette transporter superfamily that functions as protein kinase A/cAMP-activated chloride ion channel primarily on secretory epitheliaMutations inCFTRlead to impaired chloride secretion affecting various organs, including exocrine pancreas, lung, hepatobiliary system, sweat glands, and myeloid cells~ 2,000 mutations identified, but functional importance is known for fewer than 300Mutations grouped into 6 classes, depending on type of mutation and its effectPhe508del (ΔF508) accounts for 75% of mutated alleles in European and North American populationsOther mutations account for < 5% of population each, suggesting wide spectrum of compound mutations and variable presentation",
                    "sub_points": [
                      "CFTR is protein of ATP-binding cassette transporter superfamily that functions as protein kinase A/cAMP-activated chloride ion channel primarily on secretory epithelia",
                      "Mutations inCFTRlead to impaired chloride secretion affecting various organs, including exocrine pancreas, lung, hepatobiliary system, sweat glands, and myeloid cells",
                      "~ 2,000 mutations identified, but functional importance is known for fewer than 300Mutations grouped into 6 classes, depending on type of mutation and its effectPhe508del (ΔF508) accounts for 75% of mutated alleles in European and North American populationsOther mutations account for < 5% of population each, suggesting wide spectrum of compound mutations and variable presentation",
                      "Mutations grouped into 6 classes, depending on type of mutation and its effect",
                      "Phe508del (ΔF508) accounts for 75% of mutated alleles in European and North American populations",
                      "Other mutations account for < 5% of population each, suggesting wide spectrum of compound mutations and variable presentation"
                    ]
                  },
                  {
                    "text": "Exact mechanism of liver disease is poorly understoodCFTRmutations in cholangiocytes may lead to altered bile fluidity or composition, inspissated bile, accumulation of toxic bile components, inflammation, and fibrosisCFTRmutations in gut may lead to \"leaky gut,\" translocation of bacteria into portal circulation, and hepatic inflammation and fibrosisDysbiotic microbiome in CF may lead to steatosis and fibrosisIt has been hypothesized that frequent antibiotic use in CF patients plays role by reducing microbial diversity",
                    "sub_points": [
                      "CFTRmutations in cholangiocytes may lead to altered bile fluidity or composition, inspissated bile, accumulation of toxic bile components, inflammation, and fibrosis",
                      "CFTRmutations in gut may lead to \"leaky gut,\" translocation of bacteria into portal circulation, and hepatic inflammation and fibrosis",
                      "Dysbiotic microbiome in CF may lead to steatosis and fibrosisIt has been hypothesized that frequent antibiotic use in CF patients plays role by reducing microbial diversity",
                      "It has been hypothesized that frequent antibiotic use in CF patients plays role by reducing microbial diversity"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "CF is most common autosomal recessive disorder in White populationAffects 1 in 2,000-4,000 births",
                    "sub_points": [
                      "Affects 1 in 2,000-4,000 births"
                    ]
                  },
                  {
                    "text": "Some form of CFLD is detected in 60% of CF patients, but clinically significant liver disease occurs in 5-10% of patients"
                  },
                  {
                    "text": "Risk factors for severe CFLDMale sex, history of meconium ileus at birthMutations associated with severe phenotypeCarrying α-1-antitrypsin (SERPINA1) Z allele",
                    "sub_points": [
                      "Male sex, history of meconium ileus at birth",
                      "Mutations associated with severe phenotype",
                      "Carrying α-1-antitrypsin (SERPINA1) Z allele"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Patients rarely present with liver disease as primary manifestation of CF"
                  },
                  {
                    "text": "Can present in neonatal period as neonatal cholestasis"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "White"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Variable, ranging from asymptomatic abnormal liver biochemical tests to advanced fibrosis with portal hypertensionPortal hypertensionEnlarged liver, splenomegaly, or variceal bleedOften associated with malnutrition due to combination ofAnorexiaIncreased catabolism from chronic liver diseaseEarly satiety due to organomegalyNeonatal cholestasis or neonatal hepatitisMeconium ileus is risk factor0.7% of infants with neonatal cholestasisHepatolithiasis and stricturing biliary disease in adults",
                    "sub_points": [
                      "Portal hypertensionEnlarged liver, splenomegaly, or variceal bleedOften associated with malnutrition due to combination ofAnorexiaIncreased catabolism from chronic liver diseaseEarly satiety due to organomegaly",
                      "Enlarged liver, splenomegaly, or variceal bleed",
                      "Often associated with malnutrition due to combination ofAnorexiaIncreased catabolism from chronic liver diseaseEarly satiety due to organomegaly",
                      "Anorexia",
                      "Increased catabolism from chronic liver disease",
                      "Early satiety due to organomegaly",
                      "Neonatal cholestasis or neonatal hepatitisMeconium ileus is risk factor0.7% of infants with neonatal cholestasis",
                      "Meconium ileus is risk factor",
                      "0.7% of infants with neonatal cholestasis",
                      "Hepatolithiasis and stricturing biliary disease in adults"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Genetic testingCFTRmutation testing",
                    "sub_points": [
                      "CFTRmutation testing"
                    ]
                  },
                  {
                    "text": "Screening test for CFChloride sweat test",
                    "sub_points": [
                      "Chloride sweat test"
                    ]
                  },
                  {
                    "text": "To screen for liver diseaseRoutine assessment of transaminases, alkaline phosphatase, γ-glutamyltransferase, and platelet count",
                    "sub_points": [
                      "Routine assessment of transaminases, alkaline phosphatase, γ-glutamyltransferase, and platelet count"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "CFLD is 3rd leading cause of mortality in patients with CF, accounting for 3% of deaths after pulmonary and transplant-related issues"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Ursodeoxycholic acid helps some patients although there is insufficient evidence to justify its routine use"
                  },
                  {
                    "text": "Liver transplantation in patients with portal hypertension or multilobular cirrhosis or those whose liver disease compromises lung function"
                  },
                  {
                    "text": "Novel therapies that restore or enhance CFTR function have not been well studied in CFLD"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Patients who develop multilobular cirrhosis with portal hypertension have higher risk of lung function decline and death"
                  },
                  {
                    "text": "Liver transplantation in patients with multilobular cirrhosis carries 5-year survival of 86%"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Heterogeneous pattern of increased echogenicity or nodularity"
                  },
                  {
                    "text": "May not distinguish between steatosis and evolving biliary fibrosis"
                  },
                  {
                    "text": "Transient elastography may be useful to assess liver fibrosis"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Altered gallbladder morphology, periportal tracking, and periportal fat deposition"
                  }
                ],
                "ERCP/MRCP": [
                  {
                    "text": "Stenosis, strictures, and beading that may mimic primary sclerosing cholangitis"
                  },
                  {
                    "text": "Stones within bile ducts may be detected"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Ranges from isolated, depressed, green or gray scars to livers that resemble hepar lobatum with large, depressed, connecting scars separated by nodules of normal liver tissue"
                  },
                  {
                    "text": "Gallbladder abnormalities include microgallbladder, absent gallbladder, distended gallbladder, or cholelithiasis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hepatic steatosis (20-60% of patients) is most common finding in CFOften moderate to marked, with large- &/or small-droplet fatNo zonal predilectionLacks other features of steatohepatitisAssociated with malnutrition and essential fatty acid, carnitine, or choline deficiency but also seen in patients with adequate nutritional status",
                    "sub_points": [
                      "Often moderate to marked, with large- &/or small-droplet fat",
                      "No zonal predilection",
                      "Lacks other features of steatohepatitis",
                      "Associated with malnutrition and essential fatty acid, carnitine, or choline deficiency but also seen in patients with adequate nutritional status"
                    ]
                  },
                  {
                    "text": "Focal biliary fibrosis (also known by misnomer focal biliary \"cirrhosis\")Focal portal/periportal fibrosis that does not distort lobular architecture or isolate lobules from one anotherExpanded portal tracts with ductular reaction and variable inflammation with cholangitis or pericholangitisInspissated eosinophilic secretions in dilated ductulesReported in 20-30% of patients but higher in autopsy studies",
                    "sub_points": [
                      "Focal portal/periportal fibrosis that does not distort lobular architecture or isolate lobules from one another",
                      "Expanded portal tracts with ductular reaction and variable inflammation with cholangitis or pericholangitis",
                      "Inspissated eosinophilic secretions in dilated ductules",
                      "Reported in 20-30% of patients but higher in autopsy studies"
                    ]
                  },
                  {
                    "text": "Multilobular biliary cirrhosis (5-10%)Characterized by diffuse regenerative nodules throughout liverVariable fibrosis with areas of distorted lobular architectureBroad fibrous scars, nodularity, and biliary obstructive changesSuch areas alternate with other regions that are relatively normalExcessive mucus may be found in large intrahepatic or extrahepatic ducts at porta hepatis",
                    "sub_points": [
                      "Characterized by diffuse regenerative nodules throughout liver",
                      "Variable fibrosis with areas of distorted lobular architectureBroad fibrous scars, nodularity, and biliary obstructive changesSuch areas alternate with other regions that are relatively normal",
                      "Broad fibrous scars, nodularity, and biliary obstructive changes",
                      "Such areas alternate with other regions that are relatively normal",
                      "Excessive mucus may be found in large intrahepatic or extrahepatic ducts at porta hepatis"
                    ]
                  },
                  {
                    "text": "Obliterative portal venopathy with nodular regenerative hyperplasiaMay explain portal hypertension in patients without cirrhosis",
                    "sub_points": [
                      "May explain portal hypertension in patients without cirrhosis"
                    ]
                  },
                  {
                    "text": "PAS(+), diastase-digestible, pseudo-ground-glass inclusions have been described"
                  },
                  {
                    "text": "Mucocele or mucous hyperplasia in gallbladder may be seen"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Inspissated secretions are PAS(+), diastase resistant"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Biliary Atresia or Other Causes of Neonatal Cholestasis": [
                  {
                    "text": "Hepatobiliary iminodiacetic acid scan to detect biliary atresia"
                  },
                  {
                    "text": "Microbiologic and molecular tests to exclude other causes of neonatal cholestasis"
                  }
                ],
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "ERCP findings may be similar"
                  },
                  {
                    "text": "Primary sclerosing cholangitis is often associated with inflammatory bowel disease but does not involve lungs, skin, pancreas"
                  }
                ],
                "Congenital Hepatic Fibrosis": [
                  {
                    "text": "Biliary pattern of fibrosis with dilated irregular ducts may suggest congenital hepatic fibrosis (CHF)"
                  },
                  {
                    "text": "CHF lacks eosinophilic inspissated secretions and may be associated with liver or kidney cysts"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "CFLD is heterogeneous throughout liverSampling limitations may be more relevant than in other liver diseasesDual-pass liver biopsy more reliably detects patchy fibrosis",
                    "sub_points": [
                      "Sampling limitations may be more relevant than in other liver diseases",
                      "Dual-pass liver biopsy more reliably detects patchy fibrosis"
                    ]
                  },
                  {
                    "text": "Drug-induced liver injuryPatients with CF are on multiple medications, including antibiotics, and can experience drug-induced liver injury",
                    "sub_points": [
                      "Patients with CF are on multiple medications, including antibiotics, and can experience drug-induced liver injury"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Focal biliary fibrosis lesion is virtually pathognomonic"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Langerhans Cell Histiocytosis": {
            "name": "Langerhans Cell Histiocytosis",
            "url": "https://app.pathprimer.com/document/56e20596-7745-4479-9d3b-77d09fd24136/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Clonal proliferation of Langerhans cellsMolecular studies favor neoplastic processLikely derived from bone marrow-derived myeloid dendritic precursors",
                    "sub_points": [
                      "Molecular studies favor neoplastic process",
                      "Likely derived from bone marrow-derived myeloid dendritic precursors"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Affects infants and children, rarely adults"
                  },
                  {
                    "text": "Unisystem disease most often involves bone followed by skin, lymph node, and lung"
                  },
                  {
                    "text": "Multisystem disease is subdivided into low and high risk according to involvement of \"risk\" organsHigh-risk organs: Liver, spleen, bone marrowLiver is involved in 40-60% of multisystem LCHInvolvement of high-risk organs is associated with poorer prognosis",
                    "sub_points": [
                      "High-risk organs: Liver, spleen, bone marrow",
                      "Liver is involved in 40-60% of multisystem LCH",
                      "Involvement of high-risk organs is associated with poorer prognosis"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Infiltration of portal tracts and lobules by Langerhans cellsMay form small granulomatous nodules or large tumorsLangerhans cells typically show eosinophilic cytoplasm and nuclei with prominent nuclear grooves and folds, fine chromatin, and indistinct nucleoliOften accompanied by varying numbers of eosinophils, lymphocytes, neutrophils, plasma cells, non-Langerhans histiocytes",
                    "sub_points": [
                      "May form small granulomatous nodules or large tumors",
                      "Langerhans cells typically show eosinophilic cytoplasm and nuclei with prominent nuclear grooves and folds, fine chromatin, and indistinct nucleoli",
                      "Often accompanied by varying numbers of eosinophils, lymphocytes, neutrophils, plasma cells, non-Langerhans histiocytes"
                    ]
                  },
                  {
                    "text": "Bile duct infiltration and destructionDisplacement or replacement of duct epithelial cells by Langerhans cellsPortal, periportal, and periduct concentric fibrosis, duct loss, ductular reactionMay progress to biliary cirrhosis",
                    "sub_points": [
                      "Displacement or replacement of duct epithelial cells by Langerhans cells",
                      "Portal, periportal, and periduct concentric fibrosis, duct loss, ductular reaction",
                      "May progress to biliary cirrhosis"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Langerhans cells stain with S100, CD1a, langerin (CD207)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary sclerosing cholangitis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Langerhans cell histiocytosis (LCH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Histiocytosis X"
                  },
                  {
                    "text": "Eosinophilic granuloma (unifocal LCH)"
                  },
                  {
                    "text": "Hans-Schüller-Christian disease (multifocal unisystem LCH)"
                  },
                  {
                    "text": "Letterer-Siwe disease (multifocal multisystem LCH)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Langerhans cell proliferation involving liver"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Clonal Proliferation": [
                  {
                    "text": "Molecular and genetic studies favor neoplastic processBRAFV600E mutations seen in 25-64% of casesCauses MAPK pathway to be constitutively activeInhibitsCCR7, which encodes chemokine receptor necessary for dendritic-cell migrationDrivesBCL2L1expression, leading to resistance to apoptosisMAP2K1mutations seen in 27.5% of cases",
                    "sub_points": [
                      "BRAFV600E mutations seen in 25-64% of casesCauses MAPK pathway to be constitutively activeInhibitsCCR7, which encodes chemokine receptor necessary for dendritic-cell migrationDrivesBCL2L1expression, leading to resistance to apoptosis",
                      "Causes MAPK pathway to be constitutively active",
                      "InhibitsCCR7, which encodes chemokine receptor necessary for dendritic-cell migration",
                      "DrivesBCL2L1expression, leading to resistance to apoptosis",
                      "MAP2K1mutations seen in 27.5% of cases"
                    ]
                  }
                ],
                "Cell Origin": [
                  {
                    "text": "Likely bone marrow-derived myeloid dendritic cellsGene expression profiling suggests LCH cells are not derived from activated epidermal Langerhans cells as originally thought",
                    "sub_points": [
                      "Gene expression profiling suggests LCH cells are not derived from activated epidermal Langerhans cells as originally thought"
                    ]
                  },
                  {
                    "text": "Stage of differentiation that precursor cells are in when they acquire somatic MAPK activating mutation may define severity of disease\"Misguided myeloid differentiation\" modelIf activatingMAPKmutation occurs in pluripotent hematopoietic stem cell precursor stage: High-risk LCHMutation occurring in committed precursor stage: Multifocal low-risk LCHMutations occurring in precursors in specific location: Single LCH lesion",
                    "sub_points": [
                      "\"Misguided myeloid differentiation\" modelIf activatingMAPKmutation occurs in pluripotent hematopoietic stem cell precursor stage: High-risk LCHMutation occurring in committed precursor stage: Multifocal low-risk LCHMutations occurring in precursors in specific location: Single LCH lesion",
                      "If activatingMAPKmutation occurs in pluripotent hematopoietic stem cell precursor stage: High-risk LCH",
                      "Mutation occurring in committed precursor stage: Multifocal low-risk LCH",
                      "Mutations occurring in precursors in specific location: Single LCH lesion"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Incidence5/1,000,000 pediatric cases per yearMajority < 2 years of age1-2/1,000,000 adult cases per yearIncreased incidence in Hispanic patients",
                    "sub_points": [
                      "5/1,000,000 pediatric cases per yearMajority < 2 years of age",
                      "Majority < 2 years of age",
                      "1-2/1,000,000 adult cases per year",
                      "Increased incidence in Hispanic patients"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Hepatomegaly, jaundice, ascitesElevated alkaline phosphatase, γ-glutamyltransferase if sclerosing cholangitis occursERCP may show primary sclerosing cholangitis-type findings",
                    "sub_points": [
                      "Elevated alkaline phosphatase, γ-glutamyltransferase if sclerosing cholangitis occursERCP may show primary sclerosing cholangitis-type findings",
                      "ERCP may show primary sclerosing cholangitis-type findings"
                    ]
                  },
                  {
                    "text": "Unisystem LCH most often involves bone followed by skin, lymph node, and lungUnisystem disease involving liver is rare",
                    "sub_points": [
                      "Unisystem disease involving liver is rare"
                    ]
                  },
                  {
                    "text": "Multisystem LCH is subdivided into low- and high-risk categories based on organ involvementHigh-risk organs (implies greater risk of mortality): Liver, spleen, bone marrowLiver is involved in 40-60% of multisystem LCH",
                    "sub_points": [
                      "High-risk organs (implies greater risk of mortality): Liver, spleen, bone marrowLiver is involved in 40-60% of multisystem LCH",
                      "Liver is involved in 40-60% of multisystem LCH"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Early stage: Infiltration by Langerhans cells"
                  },
                  {
                    "text": "Late stage: Fibrosis, sclerosing cholangitis, biliary cirrhosis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Systemic chemotherapyVinblastine & prednisone for multisystem low-risk organ LCHMercaptopurine added if patient has high-risk multisystem LCH",
                    "sub_points": [
                      "Vinblastine & prednisone for multisystem low-risk organ LCH",
                      "Mercaptopurine added if patient has high-risk multisystem LCH"
                    ]
                  },
                  {
                    "text": "Liver transplantation (although disease recurs in ~ 30%)"
                  },
                  {
                    "text": "MAPK-targeted therapy results in high relapse rate afterBRAFV600E inhibitor therapy is stopped"
                  },
                  {
                    "text": "Allogeneic hematopoietic cell transplantation for refractory or relapsed LCH"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Very good overall survival in single-system LCH"
                  },
                  {
                    "text": "Involvement of high-risk organs (including liver) associated with poorer prognosis3-year survival decreases from 96.7% to 51.8% with liver involvementLack of response to chemotherapy at 6 weeks is marker of decreased survival",
                    "sub_points": [
                      "3-year survival decreases from 96.7% to 51.8% with liver involvement",
                      "Lack of response to chemotherapy at 6 weeks is marker of decreased survival"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Cystic dilation of large bile ducts, inflammatory masses, hepatomegaly"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Infiltration of portal tracts and lobules by Langerhans histiocytesMay form small granulomatous nodules or large mass-like lesionsLCH cells have eosinophilic cytoplasm & irregular nuclei with nuclear grooves and folds, fine chromatin, indistinct nucleoli, abundant eosinophilic cytoplasmNuclear folds impart coffee bean or twisted towel appearanceOften accompanied by eosinophils, lymphocytes, neutrophils, plasma cells, non-Langerhans histiocytes",
                    "sub_points": [
                      "May form small granulomatous nodules or large mass-like lesions",
                      "LCH cells have eosinophilic cytoplasm & irregular nuclei with nuclear grooves and folds, fine chromatin, indistinct nucleoli, abundant eosinophilic cytoplasmNuclear folds impart coffee bean or twisted towel appearance",
                      "Nuclear folds impart coffee bean or twisted towel appearance",
                      "Often accompanied by eosinophils, lymphocytes, neutrophils, plasma cells, non-Langerhans histiocytes"
                    ]
                  },
                  {
                    "text": "Bile duct infiltration and destruction by Langerhans cellsPortal, periportal, periductal concentric fibrosis; duct loss; ductular reactionSecondary sclerosing cholangitis may develop in ducts without direct Langerhans cell infiltrationMay progress to biliary cirrhosisInjury to large bile ducts may lead to cystic dilation, rupture, xanthogranulomatous responseLCH-associated sclerosing cholangitis may progress even when other manifestations of LCH respond to treatment",
                    "sub_points": [
                      "Portal, periportal, periductal concentric fibrosis; duct loss; ductular reaction",
                      "Secondary sclerosing cholangitis may develop in ducts without direct Langerhans cell infiltration",
                      "May progress to biliary cirrhosis",
                      "Injury to large bile ducts may lead to cystic dilation, rupture, xanthogranulomatous response",
                      "LCH-associated sclerosing cholangitis may progress even when other manifestations of LCH respond to treatment"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "S100, CD1a, and langerin (CD207) (+)"
                  },
                  {
                    "text": "BRAFV600E immunostain or PD-L1 immunostain may help with treatment options in patients refractory to management"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Characteristic Birbeck granules: Tennis racket-shaped structures with striated appearance"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "No evidence of multisystem LCH or increased Langerhans cells"
                  },
                  {
                    "text": "Frequent association with inflammatory bowel disease"
                  }
                ],
                "Biliary Atresia": [
                  {
                    "text": "Absence of extrahepatic bile ducts and gallbladder"
                  },
                  {
                    "text": "More pronounced ductular reaction, bile plugs; no Langerhans cell infiltrate"
                  }
                ],
                "Rosai-Dorfman": [
                  {
                    "text": "Both Rosai-Dorfman and LCH cells are S100(+), but Rosai-Dorfman disease does not show CD1a expression"
                  },
                  {
                    "text": "Rosai-Dorfman disease features large histiocytic cells engulfing other cells (emperipolesis)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Immunostains to exclude LCH are recommended in all clinically &/or histologically diagnosed sclerosing cholangitis cases in children"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hemophagocytic Syndromes": {
            "name": "Hemophagocytic Syndromes",
            "url": "https://app.pathprimer.com/document/2c263d17-16c9-42d1-8fcb-8a0c58fadbcf/lesson/b892c2d2-721e-4d96-85c8-1ec1a5c2b561",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Proliferation and activation of macrophages with hemophagocytosis in reticuloendothelial system"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Familial or primary hemophagocytic syndrome (FHL)Mutation inPRF1,UNC13D,STX11,STXBP2,RAB27A, orSH2D1Agene",
                    "sub_points": [
                      "Mutation inPRF1,UNC13D,STX11,STXBP2,RAB27A, orSH2D1Agene"
                    ]
                  },
                  {
                    "text": "Secondary hemophagocytic lymphohistiocytosis (HLH)Infections, malignancies, rheumatologic diseases, immunodeficiency diseases, medications (rare cause)",
                    "sub_points": [
                      "Infections, malignancies, rheumatologic diseases, immunodeficiency diseases, medications (rare cause)"
                    ]
                  },
                  {
                    "text": "Hyperproduction of cytokines and chemokines due to T-cell and NK-cell dysregulation that causes \"cytokine storm\" with proliferation and activation of macrophages"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "PrognosisInvariably fatal for FHL if untreated with median survival of 2-6 months after diagnosisVaried outcomes for secondary HLH depending on underlying disease",
                    "sub_points": [
                      "Invariably fatal for FHL if untreated with median survival of 2-6 months after diagnosis",
                      "Varied outcomes for secondary HLH depending on underlying disease"
                    ]
                  },
                  {
                    "text": "Can be diagnosed if there is mutation in known causative gene, or if ≥ 5 of following criteria are metFeverSplenomegalyCytopenia affecting ≥ 2 cell lineagesHypertriglyceridemia &/or hypofibrinogenemiaLow or absent NK-cell activityHyperferritinemiaElevated soluble CD25 levelsHemophagocytosis in biopsy (bone marrow, liver, etc.)",
                    "sub_points": [
                      "Fever",
                      "Splenomegaly",
                      "Cytopenia affecting ≥ 2 cell lineages",
                      "Hypertriglyceridemia &/or hypofibrinogenemia",
                      "Low or absent NK-cell activity",
                      "Hyperferritinemia",
                      "Elevated soluble CD25 levels",
                      "Hemophagocytosis in biopsy (bone marrow, liver, etc.)"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Kupffer cell hyperplasia and hypertrophyCytoplasmic engulfment of erythrocytes, leukocytes, and platelets, as well as cell fragments",
                    "sub_points": [
                      "Cytoplasmic engulfment of erythrocytes, leukocytes, and platelets, as well as cell fragments"
                    ]
                  },
                  {
                    "text": "Features of underlying diseases, such as EBV hepatitis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hemophagocytic lymphohistiocytosis (HLH); familial HLH (FHL)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hemophagocytic syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Proliferation and activation of macrophages with hemophagocytosis in reticuloendothelial system"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Primary or Familial HLH": [
                  {
                    "text": "Mutation in 1 of these genes:PRF1,UNC13D,STX11,STXBP2,RAB27A,SH2D1A"
                  },
                  {
                    "text": "Autosomal recessive inheritance"
                  }
                ],
                "Secondary HLH": [
                  {
                    "text": "InfectionsViruses (EBV, CMV, HSV, HIV, SARS-CoV-2, etc.), bacteria, fungi, and parasites",
                    "sub_points": [
                      "Viruses (EBV, CMV, HSV, HIV, SARS-CoV-2, etc.), bacteria, fungi, and parasites"
                    ]
                  },
                  {
                    "text": "Malignancies (lymphoma, leukemia, carcinoma)"
                  },
                  {
                    "text": "Rheumatologic diseasesSystemic juvenile idiopathic arthritis, systemic lupus erythematosus, seronegative spondyloarthropathiesOften termed \"macrophage activation syndrome\" in this context",
                    "sub_points": [
                      "Systemic juvenile idiopathic arthritis, systemic lupus erythematosus, seronegative spondyloarthropathies",
                      "Often termed \"macrophage activation syndrome\" in this context"
                    ]
                  },
                  {
                    "text": "Immunodeficiency diseasesChediak-Higashi syndrome, Hermansky-Pudlak syndrome, X-linked lymphoproliferative disease, Griscelli syndrome type 2, organ transplantation",
                    "sub_points": [
                      "Chediak-Higashi syndrome, Hermansky-Pudlak syndrome, X-linked lymphoproliferative disease, Griscelli syndrome type 2, organ transplantation"
                    ]
                  },
                  {
                    "text": "Medications: Lamotrigine as rare example"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Dysregulation of CD8(+) T cells and NK cells"
                  },
                  {
                    "text": "Hyperproduction of cytokines and chemokines (interferon-γ, TNF-α, IL-1, IL-6, etc.) that cause \"cytokine storm\""
                  },
                  {
                    "text": "Proliferation and activation of macrophages"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1 in 50,000 live births for FHL; unknown for secondary HLH"
                  }
                ],
                "Age": [
                  {
                    "text": "FHL: Typically seen in infants and young children"
                  },
                  {
                    "text": "Secondary HLH: Typically seen in adolescents and adults"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Unremitting fever, jaundice, skin rash, and easy bruising"
                  },
                  {
                    "text": "Neurologic abnormalities"
                  },
                  {
                    "text": "Multiorgan failure"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Combined immunosuppressive/chemotherapeutic drugs and biologicsMitigate \"cytokine storm,\" eliminate activated T-cell and macrophage populations",
                    "sub_points": [
                      "Mitigate \"cytokine storm,\" eliminate activated T-cell and macrophage populations"
                    ]
                  },
                  {
                    "text": "Hematopoietic stem cell transplantation"
                  },
                  {
                    "text": "Treatment of underlying diseases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "FHL fatal if untreated (median survival 2-6 months after diagnosis)"
                  },
                  {
                    "text": "Varied outcomes for secondary HLH, but full recovery can be achieved"
                  },
                  {
                    "text": "Treatment options include steroids, etoposide, antithymocyte globulin, and cyclosporine"
                  },
                  {
                    "text": "3-year overall survival rate for patients treated with stem cell transplantation is 62%"
                  }
                ],
                "Diagnosis": [
                  {
                    "text": "Requires identifying mutation in known causative gene, or if ≥ 5 of following criteria are metFeverSplenomegalyCytopenia affecting ≥ 2 cell lineagesHypertriglyceridemia &/or hypofibrinogenemiaLow or absent NK-cell activityHyperferritinemia (> 500 ng/mL)Elevated soluble CD25 levelsHemophagocytosis in biopsy (bone marrow, liver, etc.)",
                    "sub_points": [
                      "Fever",
                      "Splenomegaly",
                      "Cytopenia affecting ≥ 2 cell lineages",
                      "Hypertriglyceridemia &/or hypofibrinogenemia",
                      "Low or absent NK-cell activity",
                      "Hyperferritinemia (> 500 ng/mL)",
                      "Elevated soluble CD25 levels",
                      "Hemophagocytosis in biopsy (bone marrow, liver, etc.)"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Sinusoidal dilatation"
                  },
                  {
                    "text": "Kupffer cell hyperplasia/hypertrophyCytoplasmic engulfment of erythrocytes, leukocytes, platelets, cell fragmentsThough characteristic, histologic findings are not necessary or sufficient for clinical diagnosis",
                    "sub_points": [
                      "Cytoplasmic engulfment of erythrocytes, leukocytes, platelets, cell fragmentsThough characteristic, histologic findings are not necessary or sufficient for clinical diagnosis",
                      "Though characteristic, histologic findings are not necessary or sufficient for clinical diagnosis"
                    ]
                  },
                  {
                    "text": "Variably prominent portal lymphohistiocytic infiltrates"
                  },
                  {
                    "text": "Features of underlying diseases, such as EBV hepatitis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "FHL vs. Secondary HLH": [
                  {
                    "text": "Age of onset, family history, molecular genetic testing"
                  }
                ],
                "Rosai-Dorfman Disease": [
                  {
                    "text": "Multiple small S100(+) histiocytic aggregates, or larger histiocytic nodules"
                  },
                  {
                    "text": "Characteristic phagocytosis of intact lymphocytes and red cells (emperipolesis)"
                  }
                ],
                "Hepatic Involvement by Leukemia or Lymphoma": [
                  {
                    "text": "Infiltration by atypical lymphoid or myeloid cells"
                  },
                  {
                    "text": "Flow cytometry and immunohistochemistry are helpful"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Abnormal activation of benign macrophages by genetic or reactive mechanisms"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Kupffer cell hyperplasia with phagocytosed hematopoietic cells, which can be easily overlooked"
                  },
                  {
                    "text": "Macrophage markers (e.g., CD163) are helpful"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Nonneoplastic Lesions: Autoimmune Hepatitis and Infectious Disease": {
        "name": "Liver Nonneoplastic Lesions: Autoimmune Hepatitis and Infectious Disease",
        "url": "https://app.pathprimer.com/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
        "topics": {
          "Overview of Hepatitis": {
            "name": "Overview of Hepatitis",
            "url": "https://app.pathprimer.com/document/ee11ad36-3f82-4e54-b14a-cfe400c82ea6/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute hepatitisActive hepatocellular damage and necrosisMost often due to viral infection or adverse drug reactionInfrequently biopsied because diagnosis usually made by clinical or laboratory dataHistologic hallmark: Lobular disarray and hepatocyte necrosis of variable severity, regenerative featuresUsually of short &/or self-limited duration",
                    "sub_points": [
                      "Active hepatocellular damage and necrosis",
                      "Most often due to viral infection or adverse drug reaction",
                      "Infrequently biopsied because diagnosis usually made by clinical or laboratory data",
                      "Histologic hallmark: Lobular disarray and hepatocyte necrosis of variable severity, regenerative features",
                      "Usually of short &/or self-limited duration"
                    ]
                  },
                  {
                    "text": "Chronic hepatitisPersistent, often progressive inflammatory process with elevated transaminases of at least 6 months' durationHistologic hallmark: Portal tract-based chronic inflammation, generally milder lobular activityChronicity judged in several ways: Clinical, laboratory, morphologic",
                    "sub_points": [
                      "Persistent, often progressive inflammatory process with elevated transaminases of at least 6 months' duration",
                      "Histologic hallmark: Portal tract-based chronic inflammation, generally milder lobular activity",
                      "Chronicity judged in several ways: Clinical, laboratory, morphologic"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Viral Hepatitis": [
                  {
                    "text": "Hepatotropic viruses (A, B, C, D, E)"
                  },
                  {
                    "text": "Other viruses, such as Epstein-Barr virus, CMV, herpes simplex virus (HSV), adenoviruses"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "T-cell-mediated liver injury in genetically susceptible individuals; often associated with circulating autoantibodies"
                  },
                  {
                    "text": "Type 1: ANA/anti-SMA (+), hypergammaglobulinemia"
                  },
                  {
                    "text": "Type 2: Anti-LKM antibodies, more likely to develop cirrhosis"
                  },
                  {
                    "text": "Type 3: Less well characterized; anti-SLA/LP antibodies; may be AMA(+)"
                  }
                ],
                "Drug-Associated Hepatitis": [
                  {
                    "text": "NecroinflammatoryAcetaminophen, phenytoin, macrodantin, sulphonamides",
                    "sub_points": [
                      "Acetaminophen, phenytoin, macrodantin, sulphonamides"
                    ]
                  },
                  {
                    "text": "CholestaticMany antibiotics, steroids",
                    "sub_points": [
                      "Many antibiotics, steroids"
                    ]
                  },
                  {
                    "text": "GranulomatousAllopurinol, many antibiotics, phenytoin",
                    "sub_points": [
                      "Allopurinol, many antibiotics, phenytoin"
                    ]
                  },
                  {
                    "text": "Autoimmune hepatitis-like syndromeMinocycline, nitrofurantoin, infliximab, and other biologic agents",
                    "sub_points": [
                      "Minocycline, nitrofurantoin, infliximab, and other biologic agents"
                    ]
                  }
                ],
                "Other": [
                  {
                    "text": "Wilson disease"
                  },
                  {
                    "text": "α-1-antitrypsin deficiency"
                  },
                  {
                    "text": "Nonspecific reactive hepatitis: Reaction to systemic illness or to adjacent mass lesion in liver"
                  }
                ]
              },
              "CLINICAL IMPLICATIONS": {
                "Clinical Presentation": [
                  {
                    "text": "Constitutional symptoms (fever, fatigue, malaise)"
                  },
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Nausea, anorexia, abdominal pain"
                  },
                  {
                    "text": "Signs and symptoms of liver failure"
                  },
                  {
                    "text": "Many patients are asymptomatic"
                  }
                ],
                "Laboratory Findings": [
                  {
                    "text": "Elevated transaminases"
                  },
                  {
                    "text": "Alkaline phosphatase may be mildly elevated"
                  },
                  {
                    "text": "Viral serologies positive in viral hepatitis"
                  },
                  {
                    "text": "Autoimmune serologies usually positive in autoimmune hepatitis"
                  },
                  {
                    "text": "Other serologic tests, such as urinary copper, ceruloplasmin, serum α-1-antitrypsin, may be helpful"
                  }
                ]
              },
              "MICROSCOPIC": {
                "General Features": [
                  {
                    "text": "Broad range of histologic appearances with some features in common; predominant pattern may point to etiology"
                  },
                  {
                    "text": "Portal inflammationViral etiology: Infiltrate consists primarily of lymphocytesMay have admixed plasma cells, histiocytes, and granulocytesLymphoid follicles common in hepatitis CImmune mediated: Prominent plasma cells with interface activity as described belowDrug induced: Highly variable, often mixed inflammation, including eosinophilsNonspecific ductular reaction may be present at periphery of portal tract",
                    "sub_points": [
                      "Viral etiology: Infiltrate consists primarily of lymphocytesMay have admixed plasma cells, histiocytes, and granulocytesLymphoid follicles common in hepatitis C",
                      "May have admixed plasma cells, histiocytes, and granulocytes",
                      "Lymphoid follicles common in hepatitis C",
                      "Immune mediated: Prominent plasma cells with interface activity as described below",
                      "Drug induced: Highly variable, often mixed inflammation, including eosinophils",
                      "Nonspecific ductular reaction may be present at periphery of portal tract"
                    ]
                  },
                  {
                    "text": "Piecemeal necrosis (interface activity)Defined as extension of inflammation into adjacent parenchyma with destruction of individual hepatocytes at interfaceResults in ragged interface between portal tract and hepatic parenchyma",
                    "sub_points": [
                      "Defined as extension of inflammation into adjacent parenchyma with destruction of individual hepatocytes at interface",
                      "Results in ragged interface between portal tract and hepatic parenchyma"
                    ]
                  },
                  {
                    "text": "Lobular inflammation/necrosisNecrosis may be spotty (acidophil bodies) or confluent and bridgingMay be accompanied by ballooning degeneration, reactive hepatocellular changes",
                    "sub_points": [
                      "Necrosis may be spotty (acidophil bodies) or confluent and bridging",
                      "May be accompanied by ballooning degeneration, reactive hepatocellular changes"
                    ]
                  },
                  {
                    "text": "Fibrosis"
                  },
                  {
                    "text": "Inflammatory process may be sporadically distributed within liver, resulting in sampling bias"
                  }
                ],
                "Differential Diagnoses": [
                  {
                    "text": "Chronic biliary disease (primary sclerosing cholangitis, primary biliary cholangitis)Bile duct damage or loss, cholestasisPeriportal copper depositionElevation of alkaline phosphatase out of proportion to transaminasesAppropriate serologic studies &/or imaging studies may be helpful",
                    "sub_points": [
                      "Bile duct damage or loss, cholestasis",
                      "Periportal copper deposition",
                      "Elevation of alkaline phosphatase out of proportion to transaminases",
                      "Appropriate serologic studies &/or imaging studies may be helpful"
                    ]
                  },
                  {
                    "text": "Large bile duct obstructionNeutrophils, portal edema may be prominentUsually lacks increased fibrosisElevated alkaline phosphatase, gamma-glutamyltransferase, and bilirubinImaging studies helpful",
                    "sub_points": [
                      "Neutrophils, portal edema may be prominent",
                      "Usually lacks increased fibrosis",
                      "Elevated alkaline phosphatase, gamma-glutamyltransferase, and bilirubin",
                      "Imaging studies helpful"
                    ]
                  },
                  {
                    "text": "Lymphoma/leukemiaInfiltrates composed of atypical lymphocytes; portal tracts with circumferential and severe interface activityImmunohistochemistry, gene rearrangement studies may be required",
                    "sub_points": [
                      "Infiltrates composed of atypical lymphocytes; portal tracts with circumferential and severe interface activity",
                      "Immunohistochemistry, gene rearrangement studies may be required"
                    ]
                  },
                  {
                    "text": "Allograft rejectionHistory of liver transplantEndothelialitis, lymphocytic cholangitis with duct damage, mixed portal inflammation with eosinophils",
                    "sub_points": [
                      "History of liver transplant",
                      "Endothelialitis, lymphocytic cholangitis with duct damage, mixed portal inflammation with eosinophils"
                    ]
                  }
                ],
                "Reporting": [
                  {
                    "text": "Chronic hepatitis must be graded and staged in pathology report\"Chronic persistent\" and \"chronic active\" hepatitis should no longer be used",
                    "sub_points": [
                      "\"Chronic persistent\" and \"chronic active\" hepatitis should no longer be used"
                    ]
                  },
                  {
                    "text": "Comments regarding etiology, if possible"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Hepatitis": {
            "name": "Autoimmune Hepatitis",
            "url": "https://app.pathprimer.com/document/c0ae6528-4eee-4d87-ba08-2aa084602ea3/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Chronic autoimmune T-cell-mediated hepatitis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Affects patients of all ages, including children and adolescents"
                  },
                  {
                    "text": "Strong female predominance"
                  },
                  {
                    "text": "Associated with other autoimmune disorders"
                  },
                  {
                    "text": "Presentation ranges from asymptomatic liver enzyme elevation to acute liver failure"
                  },
                  {
                    "text": "Elevated transaminases"
                  },
                  {
                    "text": "Serum autoantibodies (antinuclear, anti-smooth muscle, anti-liver/kidney microsomal)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Plasma cell-rich portal tract inflammation"
                  },
                  {
                    "text": "Interface activity"
                  },
                  {
                    "text": "Lobular inflammation and hepatocyte necrosis"
                  },
                  {
                    "text": "Fibrosis"
                  },
                  {
                    "text": "Perivenular parenchymal necrosis"
                  },
                  {
                    "text": "Variant syndromesAIH/primary biliary cholangitis overlap syndromeAIH/primary sclerosing cholangitis overlap syndrome",
                    "sub_points": [
                      "AIH/primary biliary cholangitis overlap syndrome",
                      "AIH/primary sclerosing cholangitis overlap syndrome"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chronic viral hepatitisLess severe interface activity and hepatocyte necrosis than untreated AIH",
                    "sub_points": [
                      "Less severe interface activity and hepatocyte necrosis than untreated AIH"
                    ]
                  },
                  {
                    "text": "Drug-induced hepatitisMedications may incite AIH-like syndrome, which may or may not abate after removal of drug",
                    "sub_points": [
                      "Medications may incite AIH-like syndrome, which may or may not abate after removal of drug"
                    ]
                  },
                  {
                    "text": "Immune-mediated cholangitidesPrimary biliary cholangitis; primary sclerosing cholangitisMay show periportal copper deposits and CK7(+) hepatocytes",
                    "sub_points": [
                      "Primary biliary cholangitis; primary sclerosing cholangitis",
                      "May show periportal copper deposits and CK7(+) hepatocytes"
                    ]
                  },
                  {
                    "text": "Wilson diseaseNonspecific chronic hepatitis should be considered in young patients",
                    "sub_points": [
                      "Nonspecific chronic hepatitis should be considered in young patients"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Autoimmune hepatitis (AIH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Plasma cell hepatitis"
                  },
                  {
                    "text": "Lupus/lupoid hepatitis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Chronic T-cell-mediated hepatitis of presumed autoimmune etiology"
                  },
                  {
                    "text": "2 types, based on identification of serum autoantibodiesType 1Most common formBimodal age distribution with peaks from 10-20 and 45-70 years of ageAntinuclear antibodies (ANAs) &/or anti-smooth muscle antibodies (SMAs), anti-soluble-liver antibodies (SLAs), antilipoprotein antibodies (LPs), perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCAs)Soluble liver antigen (anti-SLA) or liver pancreas antigen (LP) antibodiesSLA is sole marker of disease in 15-20%, associated with severe disease and relapse after drug withdrawalType 2Most commonly affects children (ages 2-14) but also affects adultsMore severe disease with greater frequency of relapseAnti-liver/kidney microsomal antibodies (anti-LKM-1, anti-LKM-3)Subtyping of AIH is of descriptive value only and has no bearing on disease management",
                    "sub_points": [
                      "Type 1Most common formBimodal age distribution with peaks from 10-20 and 45-70 years of ageAntinuclear antibodies (ANAs) &/or anti-smooth muscle antibodies (SMAs), anti-soluble-liver antibodies (SLAs), antilipoprotein antibodies (LPs), perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCAs)Soluble liver antigen (anti-SLA) or liver pancreas antigen (LP) antibodiesSLA is sole marker of disease in 15-20%, associated with severe disease and relapse after drug withdrawal",
                      "Most common form",
                      "Bimodal age distribution with peaks from 10-20 and 45-70 years of age",
                      "Antinuclear antibodies (ANAs) &/or anti-smooth muscle antibodies (SMAs), anti-soluble-liver antibodies (SLAs), antilipoprotein antibodies (LPs), perinuclear anti-neutrophil cytoplasmic antibodies (p-ANCAs)",
                      "Soluble liver antigen (anti-SLA) or liver pancreas antigen (LP) antibodiesSLA is sole marker of disease in 15-20%, associated with severe disease and relapse after drug withdrawal",
                      "SLA is sole marker of disease in 15-20%, associated with severe disease and relapse after drug withdrawal",
                      "Type 2Most commonly affects children (ages 2-14) but also affects adultsMore severe disease with greater frequency of relapseAnti-liver/kidney microsomal antibodies (anti-LKM-1, anti-LKM-3)",
                      "Most commonly affects children (ages 2-14) but also affects adults",
                      "More severe disease with greater frequency of relapse",
                      "Anti-liver/kidney microsomal antibodies (anti-LKM-1, anti-LKM-3)",
                      "Subtyping of AIH is of descriptive value only and has no bearing on disease management"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Inciting Event Unknown": [
                  {
                    "text": "Loss of self-tolerance in genetically susceptible individualsMajor histocompatibility genes increase susceptibilityAIH type 1: AIH type 1:HLA-DRB1*0301, *0401, *1301, *0404, *0405AIH type 2: AIH type 2:HLA-DRB1*07, HLA-DQB1 *0201",
                    "sub_points": [
                      "Major histocompatibility genes increase susceptibilityAIH type 1: AIH type 1:HLA-DRB1*0301, *0401, *1301, *0404, *0405AIH type 2: AIH type 2:HLA-DRB1*07, HLA-DQB1 *0201",
                      "AIH type 1: AIH type 1:HLA-DRB1*0301, *0401, *1301, *0404, *0405",
                      "AIH type 2: AIH type 2:HLA-DRB1*07, HLA-DQB1 *0201"
                    ]
                  },
                  {
                    "text": "May be triggered by exposure to infectious agents, drugs, or toxins"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Associated with other autoimmune disordersDiabetes mellitus, type 1Celiac diseaseAddison diseaseAutoimmune polyendocrine syndrome, type 1 (APS-1)Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)",
                    "sub_points": [
                      "Diabetes mellitus, type 1",
                      "Celiac disease",
                      "Addison disease",
                      "Autoimmune polyendocrine syndrome, type 1 (APS-1)",
                      "Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED)"
                    ]
                  }
                ],
                "Incidence": [
                  {
                    "text": "0.1-1.0 per 100,000 per year in North American and European populations"
                  },
                  {
                    "text": "Higher in some native North American populations"
                  },
                  {
                    "text": "Accounts for up to 20% of chronic hepatitis where viral infection rates are low"
                  }
                ],
                "Age": [
                  {
                    "text": "Affects patients of all ages, including children and adolescents"
                  }
                ],
                "Sex": [
                  {
                    "text": "Strong female predominanceM:F = 1:4",
                    "sub_points": [
                      "M:F = 1:4"
                    ]
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "All ethnicities affected"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Ranges from asymptomatic liver enzyme elevation to acute liver failure"
                  },
                  {
                    "text": "Acute presentation simulates acute viral hepatitisMore common in younger patientsMay reflect flare of subclinical diseasePatients may have clinical, laboratory, &/or histologic signs of chronic liver disease",
                    "sub_points": [
                      "More common in younger patients",
                      "May reflect flare of subclinical diseasePatients may have clinical, laboratory, &/or histologic signs of chronic liver disease",
                      "Patients may have clinical, laboratory, &/or histologic signs of chronic liver disease"
                    ]
                  },
                  {
                    "text": "Presentation with cirrhosis reflects long-standing subclinical diseaseMore common in older patients",
                    "sub_points": [
                      "More common in older patients"
                    ]
                  },
                  {
                    "text": "General signs and symptomsFatigue and lethargyUpper abdominal discomfortHepatomegalyJaundice",
                    "sub_points": [
                      "Fatigue and lethargy",
                      "Upper abdominal discomfort",
                      "Hepatomegaly",
                      "Jaundice"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases, often markedly so"
                  },
                  {
                    "text": "Hyperbilirubinemia may be seen but is usually mild"
                  },
                  {
                    "text": "Serum autoantibodiesANASMALKM-1, -3p-ANCA in type 1 AIH only",
                    "sub_points": [
                      "ANA",
                      "SMA",
                      "LKM-1, -3",
                      "p-ANCA in type 1 AIH only"
                    ]
                  },
                  {
                    "text": "Polyclonal hypergammaglobulinemiaUsually elevated IgG",
                    "sub_points": [
                      "Usually elevated IgG"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Progressive diseaseOngoing hepatic injury and scarring with development of cirrhosis and end-stage liver disease",
                    "sub_points": [
                      "Ongoing hepatic injury and scarring with development of cirrhosis and end-stage liver disease"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Liver transplantation indicated for patients with fulminant hepatitis, end-stage disease with decompensation, or hepatocellular carcinomaRecurrent AIH occurs in 20-30% of patients",
                    "sub_points": [
                      "Recurrent AIH occurs in 20-30% of patients"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "1st-line therapy is corticosteroids in combination with azathioprine"
                  },
                  {
                    "text": "Treatment reduces disease activity and improves survival65% of patients achieve clinical, biochemical, and histologic remission within 3 yearsHistologic, symptomatic, and biochemical improvement in 80% of patientsImproves patient 5-year survival from 40% to > 90%",
                    "sub_points": [
                      "65% of patients achieve clinical, biochemical, and histologic remission within 3 years",
                      "Histologic, symptomatic, and biochemical improvement in 80% of patients",
                      "Improves patient 5-year survival from 40% to > 90%"
                    ]
                  },
                  {
                    "text": "Over time, treatment regimen minimized disease activity and mitigated medication side effects"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Prognosis mainly relates to severity of hepatitis at initial presentation"
                  },
                  {
                    "text": "Most patients improve dramatically with immunosuppressive therapySmall percentage of compliant patients worsen despite therapyFailure to respond is associated with early age at onset, acute or fulminant presentation, and hyperbilirubinemia",
                    "sub_points": [
                      "Small percentage of compliant patients worsen despite therapy",
                      "Failure to respond is associated with early age at onset, acute or fulminant presentation, and hyperbilirubinemia"
                    ]
                  },
                  {
                    "text": "Decompensated liver disease, ascites, or hepatic encephalopathy predicts poor prognosis"
                  },
                  {
                    "text": "Progressive disease associated with increasing fibrosis, ultimately leading to cirrhosis and liver failure"
                  }
                ],
                "Clinical and Pathologic Diagnosis": [
                  {
                    "text": "Depends on constellation of clinical, serologic, and biopsy findings"
                  },
                  {
                    "text": "Compatible histology required for diagnosis by American Association for Study of Liver Diseases (AASLD)"
                  },
                  {
                    "text": "International Autoimmune Hepatitis Group (IAIHG) proposed scoring system that includes clinical and pathologic features to reflect certainty of diagnosisWeighted scoring system based on combination of histologic, clinical, and laboratory findings that either provide evidence in support of or against diagnosis of AIHUsed for diagnosis in many major centersHighly sensitive and specific but may have lower sensitivity in some pediatric cases",
                    "sub_points": [
                      "Weighted scoring system based on combination of histologic, clinical, and laboratory findings that either provide evidence in support of or against diagnosis of AIH",
                      "Used for diagnosis in many major centers",
                      "Highly sensitive and specific but may have lower sensitivity in some pediatric cases"
                    ]
                  },
                  {
                    "text": "Grade: Severity and extent of necroinflammatory activity, defined as periportal interface activity and lobular inflammation and hepatocyte injuryMany practitioners issue descriptive diagnoses that include these elements but do not report formal score",
                    "sub_points": [
                      "Many practitioners issue descriptive diagnoses that include these elements but do not report formal score"
                    ]
                  },
                  {
                    "text": "Stage: Extent of fibrosis, as assessed with Masson trichrome stainBatts and Ludwig, Ishak, Metavir or Knodell",
                    "sub_points": [
                      "Batts and Ludwig, Ishak, Metavir or Knodell"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Dense portal inflammatory cell infiltratesMostly composed of lymphocytes and plasma cellsPlasma cells may be prominent, present in large sheets or clustersPlasma cells are typical but not constant feature of AIH",
                    "sub_points": [
                      "Mostly composed of lymphocytes and plasma cells",
                      "Plasma cells may be prominent, present in large sheets or clustersPlasma cells are typical but not constant feature of AIH",
                      "Plasma cells are typical but not constant feature of AIH"
                    ]
                  },
                  {
                    "text": "Interface activityInflammation extending beyond portal tract, crossing limiting plate, and inciting hepatocyte injury or necrosisAlso termed \"piecemeal necrosis\" because hepatocytes undergo necrosis in piecemeal fashionOften prominent feature in untreated AIH but usually improves with immunosuppressive therapy",
                    "sub_points": [
                      "Inflammation extending beyond portal tract, crossing limiting plate, and inciting hepatocyte injury or necrosisAlso termed \"piecemeal necrosis\" because hepatocytes undergo necrosis in piecemeal fashion",
                      "Also termed \"piecemeal necrosis\" because hepatocytes undergo necrosis in piecemeal fashion",
                      "Often prominent feature in untreated AIH but usually improves with immunosuppressive therapy"
                    ]
                  },
                  {
                    "text": "Lobular inflammation and hepatocyte necrosisMay be severe, particularly in untreated patientsMay see single-cell apoptosis (\"acidophil bodies\") or confluent necrosisAreas of confluent hepatocyte necrosis may extend between adjacent lobules as \"bridging necrosis\"Plasma cells may be prominent component of lobular inflammatory cell infiltrates but not invariably present",
                    "sub_points": [
                      "May be severe, particularly in untreated patientsMay see single-cell apoptosis (\"acidophil bodies\") or confluent necrosisAreas of confluent hepatocyte necrosis may extend between adjacent lobules as \"bridging necrosis\"",
                      "May see single-cell apoptosis (\"acidophil bodies\") or confluent necrosis",
                      "Areas of confluent hepatocyte necrosis may extend between adjacent lobules as \"bridging necrosis\"",
                      "Plasma cells may be prominent component of lobular inflammatory cell infiltrates but not invariably present"
                    ]
                  },
                  {
                    "text": "FibrosisPortal-based fibrosis similar to that in other forms of chronic hepatitisFibrosis progresses in stellate or periportal fashionProgressive fibrosis results in bridging fibrous septa between lobules and, ultimately, cirrhosis",
                    "sub_points": [
                      "Portal-based fibrosis similar to that in other forms of chronic hepatitis",
                      "Fibrosis progresses in stellate or periportal fashion",
                      "Progressive fibrosis results in bridging fibrous septa between lobules and, ultimately, cirrhosis"
                    ]
                  },
                  {
                    "text": "Collapse of reticulin framework and parenchymal loss, especially in fulminant diseaseShould not be misinterpreted as fibrosisType 3 collagen of reticulin fibers stains pale gray-blue with trichromeStains black with reticulin stainsType 1 collagen in fibrosis stains intense blue with trichromeStains gray with reticulin stainsResidual areas of viable or regenerating hepatocytes should not be misinterpreted as cirrhotic nodulesOrcein staining shows abundant elastic fibers in areas of fibrosis but not in collapse",
                    "sub_points": [
                      "Should not be misinterpreted as fibrosisType 3 collagen of reticulin fibers stains pale gray-blue with trichromeStains black with reticulin stainsType 1 collagen in fibrosis stains intense blue with trichromeStains gray with reticulin stains",
                      "Type 3 collagen of reticulin fibers stains pale gray-blue with trichromeStains black with reticulin stains",
                      "Stains black with reticulin stains",
                      "Type 1 collagen in fibrosis stains intense blue with trichromeStains gray with reticulin stains",
                      "Stains gray with reticulin stains",
                      "Residual areas of viable or regenerating hepatocytes should not be misinterpreted as cirrhotic nodules",
                      "Orcein staining shows abundant elastic fibers in areas of fibrosis but not in collapse"
                    ]
                  },
                  {
                    "text": "Perivenular parenchymal necrosisFoci of inflammation and hepatocyte necrosis around central veins very characteristic of AIHSometimes termed \"centrilobular piecemeal necrosis\"Rare cases of central zone only involvement occur",
                    "sub_points": [
                      "Foci of inflammation and hepatocyte necrosis around central veins very characteristic of AIH",
                      "Sometimes termed \"centrilobular piecemeal necrosis\"",
                      "Rare cases of central zone only involvement occur"
                    ]
                  },
                  {
                    "text": "CholestasisAIH may present as cholestatic hepatitisParticularly in patients who present with acute onsetMild bile duct damage may occurDoes not imply an overlap syndromeMarked injury and ductopenia are not features of AIH",
                    "sub_points": [
                      "AIH may present as cholestatic hepatitisParticularly in patients who present with acute onset",
                      "Particularly in patients who present with acute onset",
                      "Mild bile duct damage may occurDoes not imply an overlap syndromeMarked injury and ductopenia are not features of AIH",
                      "Does not imply an overlap syndrome",
                      "Marked injury and ductopenia are not features of AIH"
                    ]
                  },
                  {
                    "text": "Giant cell transformation of hepatocytesNumerous large multinucleated hepatocytes seen in selected cases (postinfantile giant cell hepatitis)Nonspecific feature probably reflecting extensive hepatocyte injury and regeneration",
                    "sub_points": [
                      "Numerous large multinucleated hepatocytes seen in selected cases (postinfantile giant cell hepatitis)",
                      "Nonspecific feature probably reflecting extensive hepatocyte injury and regeneration"
                    ]
                  },
                  {
                    "text": "Rosettes of reactive hepatocytes in lobulesNonspecific regenerative finding, may be seen in any form of injury",
                    "sub_points": [
                      "Nonspecific regenerative finding, may be seen in any form of injury"
                    ]
                  },
                  {
                    "text": "EmperipolesisLymphocytes and plasma cells in cytoplasm of hepatocytesDifficult to assess by light microscopy",
                    "sub_points": [
                      "Lymphocytes and plasma cells in cytoplasm of hepatocytes",
                      "Difficult to assess by light microscopy"
                    ]
                  },
                  {
                    "text": "Fatty liver disease coexists in 17-30%"
                  },
                  {
                    "text": "RemissionMild, nonspecific portal tract inflammationDecreased lobular inflammationFibrosis may reverse",
                    "sub_points": [
                      "Mild, nonspecific portal tract inflammation",
                      "Decreased lobular inflammation",
                      "Fibrosis may reverse"
                    ]
                  },
                  {
                    "text": "RelapseHeralded by reappearance of plasma cells and interface activity",
                    "sub_points": [
                      "Heralded by reappearance of plasma cells and interface activity"
                    ]
                  }
                ],
                "Variant Patterns": [
                  {
                    "text": "AIH and biliary disease may be concurrent or occur sequentially"
                  },
                  {
                    "text": "AIH/primary biliary cholangitis (PBC) overlap syndromeShows typical features of AIH along with poorly formed granulomas and bile duct injuryRequirements for diagnosis not well establishedSome require probable or definite AIH and cholestatic liver tests",
                    "sub_points": [
                      "Shows typical features of AIH along with poorly formed granulomas and bile duct injury",
                      "Requirements for diagnosis not well established",
                      "Some require probable or definite AIH and cholestatic liver tests"
                    ]
                  },
                  {
                    "text": "Proposed \"Paris criteria\" require 2 of 3 features of each diseaseAIHAlanine aminotransferase 5x upper limit of normalIgG 2x upper limit of normal or SMAModerate or severe interface activity or lobular acidophil bodies on biopsyPBCAlkaline phosphatase 2x upper limit of normal or gamma-glutamyl transferase 5x upper limit of normalAntimitochondrial antibodies (AMAs)May be positive in pure AIH, insufficient for the diagnosis of overlap syndrome on its ownFlorid duct lesion on biopsyNot fully validated; no uniformed criteria put forth by AASLD or IAIHGDiagnosis more often based on clinical, laboratory, and pathologic data",
                    "sub_points": [
                      "AIHAlanine aminotransferase 5x upper limit of normalIgG 2x upper limit of normal or SMAModerate or severe interface activity or lobular acidophil bodies on biopsy",
                      "Alanine aminotransferase 5x upper limit of normal",
                      "IgG 2x upper limit of normal or SMA",
                      "Moderate or severe interface activity or lobular acidophil bodies on biopsy",
                      "PBCAlkaline phosphatase 2x upper limit of normal or gamma-glutamyl transferase 5x upper limit of normalAntimitochondrial antibodies (AMAs)May be positive in pure AIH, insufficient for the diagnosis of overlap syndrome on its ownFlorid duct lesion on biopsy",
                      "Alkaline phosphatase 2x upper limit of normal or gamma-glutamyl transferase 5x upper limit of normal",
                      "Antimitochondrial antibodies (AMAs)May be positive in pure AIH, insufficient for the diagnosis of overlap syndrome on its own",
                      "May be positive in pure AIH, insufficient for the diagnosis of overlap syndrome on its own",
                      "Florid duct lesion on biopsy",
                      "Not fully validated; no uniformed criteria put forth by AASLD or IAIHG",
                      "Diagnosis more often based on clinical, laboratory, and pathologic data"
                    ]
                  },
                  {
                    "text": "AIH/primary sclerosing cholangitis (PSC) overlap syndromeRequires probable or definite AIH and cholangiographic evidence of PSCMore common in pediatric age groupHistologic features of AIHBile duct injury or lossClassic periductal \"onion skinning\" fibrosis of PSC rarely seen",
                    "sub_points": [
                      "Requires probable or definite AIH and cholangiographic evidence of PSC",
                      "More common in pediatric age group",
                      "Histologic features of AIH",
                      "Bile duct injury or loss",
                      "Classic periductal \"onion skinning\" fibrosis of PSC rarely seen"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Viral Hepatitis": [
                  {
                    "text": "Distinguished by laboratory testing for viral vs. autoimmune markers"
                  },
                  {
                    "text": "Typically exhibits less severe interface activity and hepatocyte necrosis than untreated AIH, fewer plasma cells"
                  }
                ],
                "Drug-Induced Hepatitis": [
                  {
                    "text": "Medications most strongly associated with AIH-like patternMinocycline, nitrofurantoin, oxyphenisatin, alpha-methyl-dopa, infliximab, adalimumab, halothane, dihydralazine, tienilic acid",
                    "sub_points": [
                      "Minocycline, nitrofurantoin, oxyphenisatin, alpha-methyl-dopa, infliximab, adalimumab, halothane, dihydralazine, tienilic acid"
                    ]
                  },
                  {
                    "text": "Many others variably implicated"
                  },
                  {
                    "text": "Clinically distinguished based on autoimmune markers and presence of offending agent"
                  },
                  {
                    "text": "Medications may incite AIH-like syndrome, which may or may not abate after removal of drug"
                  }
                ],
                "Immune-Mediated Cholangitides": [
                  {
                    "text": "PBCAntimitochondrial antibody positive in > 90% of casesBile duct injury, often with granulomas and ductopeniaAbsence of hepatocyte injury or necrosisMust distinguish from AIH because therapies differ",
                    "sub_points": [
                      "Antimitochondrial antibody positive in > 90% of cases",
                      "Bile duct injury, often with granulomas and ductopenia",
                      "Absence of hepatocyte injury or necrosis",
                      "Must distinguish from AIH because therapies differ"
                    ]
                  },
                  {
                    "text": "PSCFibrous obliteration of bile ducts and ductopeniaCharacteristic strictures on imaging studies of large bile ducts",
                    "sub_points": [
                      "Fibrous obliteration of bile ducts and ductopenia",
                      "Characteristic strictures on imaging studies of large bile ducts"
                    ]
                  },
                  {
                    "text": "Periportal copper deposits (copper stain) and CK7-positive (\"ductulized\") hepatocytes support biliary etiologyMay also be seen in AIH with advanced fibrosis",
                    "sub_points": [
                      "May also be seen in AIH with advanced fibrosis"
                    ]
                  }
                ],
                "IgG4 Disease": [
                  {
                    "text": "Features prominence of IgG4(+) plasma cells and variably elevated serum IgG4"
                  },
                  {
                    "text": "Often affects multiple organsHistologic criteria for liver disease not well defined",
                    "sub_points": [
                      "Histologic criteria for liver disease not well defined"
                    ]
                  },
                  {
                    "text": "IgG4(+) plasma cells also well documented in otherwise classic AIHNot clear if this is subset of AIH or separate entity",
                    "sub_points": [
                      "Not clear if this is subset of AIH or separate entity"
                    ]
                  },
                  {
                    "text": "Involvement of other organs supports IgG4-related disease"
                  },
                  {
                    "text": "IgG4 sclerosing cholangitis usually effects large, extrahepatic bile ducts with secondary effects in liver"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Nonspecific chronic hepatitis pattern"
                  },
                  {
                    "text": "Mallory Denk bodies"
                  },
                  {
                    "text": "Urine copper, ceruloplasmin, quantitative hepatic copper studies"
                  },
                  {
                    "text": "Should always be considered in young patients"
                  }
                ],
                "Nonalcoholic Steatohepatitis": [
                  {
                    "text": "May feature portal tract inflammation with readily identifiable plasma cellsDoes not necessarily imply concomitant AIH, although 2 disorders may coexistProminent macrovesicular steatosis, ballooning degeneration, zone 3 pericellular fibrosis",
                    "sub_points": [
                      "Does not necessarily imply concomitant AIH, although 2 disorders may coexist",
                      "Prominent macrovesicular steatosis, ballooning degeneration, zone 3 pericellular fibrosis"
                    ]
                  },
                  {
                    "text": "Patients with nonalcoholic steatohepatitis (NASH) may have elevated serum ANA and ASMA"
                  }
                ],
                "Systemic Lupus Erythematosus": [
                  {
                    "text": "AIH patients may experience arthralgias"
                  },
                  {
                    "text": "Patients with systemic lupus erythematosus (SLE) may develop mild nonspecific hepatitisMinimal interface hepatitisLess lobular inflammation than AIH",
                    "sub_points": [
                      "Minimal interface hepatitis",
                      "Less lobular inflammation than AIH"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Viral Hepatitis": {
            "name": "Acute Viral Hepatitis",
            "url": "https://app.pathprimer.com/document/9fb5dc1c-e622-44d5-82c7-ebfed6ea941e/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute viral hepatitis: Hepatocyte necrosis and inflammation resulting from acute viral infection"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Hepatitis A, B, and E viruses are most common causesVariable prevalence depending on geographic location",
                    "sub_points": [
                      "Variable prevalence depending on geographic location"
                    ]
                  },
                  {
                    "text": "Hepatitis D virus pathogenic only in the setting of HBV coinfection"
                  },
                  {
                    "text": "Hepatitis C virus rarely causes symptomatic acute hepatitis"
                  },
                  {
                    "text": "Cytomegalovirus, Epstein-Barr virus, herpes simplex virus, varicella zoster virus, adenovirus"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Nonspecific systemic symptoms: Malaise, fatigue, nausea, fever, right upper quadrant pain"
                  },
                  {
                    "text": "Rarely, fulminant hepatic failure"
                  },
                  {
                    "text": "Elevated transaminases at 5-10x normal values followed by rise in bilirubin and INR"
                  },
                  {
                    "text": "Serologic testing for antiviral immunoglobulins, viral antigens, and viral nucleic acids"
                  },
                  {
                    "text": "Supportive care is mainstay of treatment"
                  },
                  {
                    "text": "Most patients fully recover within weeks to months"
                  },
                  {
                    "text": "Hepatitis D virus infection carries poor prognosis"
                  },
                  {
                    "text": "Hepatitis E virus particularly severe in pregnant women"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Lobular disarray"
                  },
                  {
                    "text": "Hepatocyte necrosis of variable severity"
                  },
                  {
                    "text": "Kupffer cell hyperplasia"
                  },
                  {
                    "text": "Mild portal inflammation"
                  },
                  {
                    "text": "Hepatocellular and canalicular cholestasis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Autoimmune hepatitis"
                  },
                  {
                    "text": "Drug- or toxin-induced hepatitis"
                  },
                  {
                    "text": "Ischemia"
                  },
                  {
                    "text": "Idiopathic hepatitis or hepatic failure"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute viral hepatitis: Hepatocyte necrosis and inflammation resulting from acute viral infection"
                  },
                  {
                    "text": "Acute liver failure: Coagulopathy and encephalopathy without preexisting cirrhosis and with symptom duration < 26 weeks"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hepatitis A Virus (HAV)": [
                  {
                    "text": "Single-stranded RNA virus in Picornaviridae family"
                  },
                  {
                    "text": "Usually spreads via oral or fecal-oral transmissionCommunity outbreaks related to contaminated food or water in areas with poor sanitation",
                    "sub_points": [
                      "Community outbreaks related to contaminated food or water in areas with poor sanitation"
                    ]
                  },
                  {
                    "text": "Accounts for ~ 1/2 of acute viral hepatitis cases in USA"
                  },
                  {
                    "text": "At least 4 genotypes described, but only 1 serotype existsInfection with 1 genotype confers immunity against all genotypes",
                    "sub_points": [
                      "Infection with 1 genotype confers immunity against all genotypes"
                    ]
                  },
                  {
                    "text": "Never results in chronic infection"
                  }
                ],
                "Hepatitis B Virus (HBV)": [
                  {
                    "text": "Partially double-stranded DNA virus in Hepadnaviridae family"
                  },
                  {
                    "text": "Parenteral, perinatal, and sexual transmission"
                  },
                  {
                    "text": "Increased risk in healthcare providers and those with tattoos, piercings, and intravenous drug use"
                  },
                  {
                    "text": "Up to 40% of acute hepatitis cases in USA attributable to hepatitis B"
                  },
                  {
                    "text": "~ 10% of infected patients develop chronic infection"
                  }
                ],
                "Hepatitis C Virus (HCV)": [
                  {
                    "text": "RNA virus of Flaviviridae family"
                  },
                  {
                    "text": "Parenteral, perinatal, and sexual transmission"
                  },
                  {
                    "text": "Only 10-15% of infected individuals develop symptomatic acute hepatitis"
                  },
                  {
                    "text": "If untreated, ~ 85% of infected patients develop chronic infection"
                  }
                ],
                "Hepatitis D Virus (HDV)": [
                  {
                    "text": "Defective RNA virus endemic in Middle East, South America, Central Asia, and Central Africa"
                  },
                  {
                    "text": "Parenteral and sexual transmission"
                  },
                  {
                    "text": "Requires coinfection with HBV; uses surface antigen to encapsulate its own genome"
                  }
                ],
                "Hepatitis E Virus (HEV)": [
                  {
                    "text": "Single-stranded, nonenveloped RNA virus in Caliciviridae family"
                  },
                  {
                    "text": "4 routes of infectionVertical, parenteral, foodborne (undercooked meat), waterborne transmission",
                    "sub_points": [
                      "Vertical, parenteral, foodborne (undercooked meat), waterborne transmission"
                    ]
                  },
                  {
                    "text": "Endemic in parts of Asia, Africa, and IndiaAccounts for up to 40% of acute liver failure in endemic regions",
                    "sub_points": [
                      "Accounts for up to 40% of acute liver failure in endemic regions"
                    ]
                  }
                ],
                "Other Viruses": [
                  {
                    "text": "Cytomegalovirus, Epstein-Barr virus, herpes simplex virus, varicella zoster virus, adenovirusesPatients usually have involvement of other target tissues",
                    "sub_points": [
                      "Patients usually have involvement of other target tissues"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Nonspecific systemic symptoms: Malaise, fatigue, nausea, vomiting, anorexia, low-grade fever, right upper quadrant pain"
                  },
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Rarely, fulminant hepatic failure"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases at 5-10x normal values followed by rise in bilirubin and INR"
                  },
                  {
                    "text": "Serologic testingHAVDetection of antihepatitis A virus immunoglobulin (Ig) M in patient with hepatitis or elevated serum aminotransferases is diagnostic of acute HAV infectionHBVHepatitis B surface antigen (HBsAg) positivityMarkers of virus replication [hepatitis B e antigen (HBeAg) and hepatitis B virus DNA]Antihepatitis B core antigen IgM detectable at symptom onsetHCVHepatitis C RNA detectable in serum within 2 weeks after exposureAntibodies unreliable in diagnosis of acute HCV infection, as antibody production may be delayedPositive hepatitis C serology must be confirmed with RNA testing because false-positives can occurHDVDetection of antihepatitis D virus IgMHEVUsually diagnosis of exclusionDetection of antihepatitis E virus IgM available in some settings",
                    "sub_points": [
                      "HAVDetection of antihepatitis A virus immunoglobulin (Ig) M in patient with hepatitis or elevated serum aminotransferases is diagnostic of acute HAV infection",
                      "Detection of antihepatitis A virus immunoglobulin (Ig) M in patient with hepatitis or elevated serum aminotransferases is diagnostic of acute HAV infection",
                      "HBVHepatitis B surface antigen (HBsAg) positivityMarkers of virus replication [hepatitis B e antigen (HBeAg) and hepatitis B virus DNA]Antihepatitis B core antigen IgM detectable at symptom onset",
                      "Hepatitis B surface antigen (HBsAg) positivity",
                      "Markers of virus replication [hepatitis B e antigen (HBeAg) and hepatitis B virus DNA]",
                      "Antihepatitis B core antigen IgM detectable at symptom onset",
                      "HCVHepatitis C RNA detectable in serum within 2 weeks after exposureAntibodies unreliable in diagnosis of acute HCV infection, as antibody production may be delayedPositive hepatitis C serology must be confirmed with RNA testing because false-positives can occur",
                      "Hepatitis C RNA detectable in serum within 2 weeks after exposure",
                      "Antibodies unreliable in diagnosis of acute HCV infection, as antibody production may be delayed",
                      "Positive hepatitis C serology must be confirmed with RNA testing because false-positives can occur",
                      "HDVDetection of antihepatitis D virus IgM",
                      "Detection of antihepatitis D virus IgM",
                      "HEVUsually diagnosis of exclusionDetection of antihepatitis E virus IgM available in some settings",
                      "Usually diagnosis of exclusion",
                      "Detection of antihepatitis E virus IgM available in some settings"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "GeneralSupportive care is mainstay of treatmentHospitalization recommended for severe or persistent nausea and for patients with signs of developing liver failureLiver transplantation considered for patients with acute liver failure",
                    "sub_points": [
                      "Supportive care is mainstay of treatment",
                      "Hospitalization recommended for severe or persistent nausea and for patients with signs of developing liver failure",
                      "Liver transplantation considered for patients with acute liver failure"
                    ]
                  },
                  {
                    "text": "HAV: No specific treatment, vaccines available"
                  },
                  {
                    "text": "HBV: Nucleoside analogues (entecavir, lamivudine); corticosteroids and other immune modulators (interferon) have variable efficacy, vaccines available"
                  },
                  {
                    "text": "HCV: Direct acting antivirals may be used, but no clear advantage in acute phase because up to 50% of infected individuals spontaneously clear virus"
                  },
                  {
                    "text": "HDV: No approved therapy"
                  },
                  {
                    "text": "HEV: No approved therapy, vaccines in development"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "HAV: Most patients fully recover within 2 months of disease onset85% of patients with acute HAV infection improve with supportive careFulminant hepatic failure with coagulopathy and encephalopathy is rareDisease severity related to patient ageIncreased mortality in patients > 40 years of agePatients with preexisting chronic liver disease at increased risk of complications and deathAtypical variants are well recognizedRelapsing variant in 3-20% of patients in whom recovery is followed by relapse at 4-15 weeks after initial episode~ 10% develop prolonged cholestasis lasting > 2 weeksPossible extrahepatic manifestations include leukocytoclastic vasculitis, arthritis, and glomerulonephritisInfection confers lifelong immunity",
                    "sub_points": [
                      "85% of patients with acute HAV infection improve with supportive care",
                      "Fulminant hepatic failure with coagulopathy and encephalopathy is rare",
                      "Disease severity related to patient ageIncreased mortality in patients > 40 years of agePatients with preexisting chronic liver disease at increased risk of complications and death",
                      "Increased mortality in patients > 40 years of age",
                      "Patients with preexisting chronic liver disease at increased risk of complications and death",
                      "Atypical variants are well recognizedRelapsing variant in 3-20% of patients in whom recovery is followed by relapse at 4-15 weeks after initial episode~ 10% develop prolonged cholestasis lasting > 2 weeksPossible extrahepatic manifestations include leukocytoclastic vasculitis, arthritis, and glomerulonephritis",
                      "Relapsing variant in 3-20% of patients in whom recovery is followed by relapse at 4-15 weeks after initial episode",
                      "~ 10% develop prolonged cholestasis lasting > 2 weeks",
                      "Possible extrahepatic manifestations include leukocytoclastic vasculitis, arthritis, and glomerulonephritis",
                      "Infection confers lifelong immunity"
                    ]
                  },
                  {
                    "text": "HBV: ~ 90% of patients recover fully1% of acutely infected patients develop fulminant hepatic failure",
                    "sub_points": [
                      "1% of acutely infected patients develop fulminant hepatic failure"
                    ]
                  },
                  {
                    "text": "HCV: Acute phase may last 2-12 weeksAlmost never causes acute liver failureDisease is self-limiting in 15% of patients infected with hepatitis CCoinfection exacerbates acute HBV infection",
                    "sub_points": [
                      "Almost never causes acute liver failure",
                      "Disease is self-limiting in 15% of patients infected with hepatitis C",
                      "Coinfection exacerbates acute HBV infection"
                    ]
                  },
                  {
                    "text": "HDV: Acute liver failure in setting of HBV coinfection with poor prognosis"
                  },
                  {
                    "text": "HEV: Acute hepatitis follows 2- to 10-week incubation periodIllness usually lasts 1-4 weeksPregnant women and infants at increased risk of mortality",
                    "sub_points": [
                      "Illness usually lasts 1-4 weeks",
                      "Pregnant women and infants at increased risk of mortality"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "In severe cases with massive necrosis, liver is shrunken, and capsule is flaccid"
                  },
                  {
                    "text": "Islands of regenerating hepatocytes may form grossly visible nodules that cause concern for malignancy"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Lobular disarrayDiffuse, mixed lobular inflammatory cell infiltratesPredominantly mononuclear inflammatory cell infiltratesHepatocyte necrosis of variable severityPatchy with scattered acidophil bodiesFoci of parenchymal collapse evident on trichrome or reticulin stainsAreas of confluent hepatocyte necrosis in severe casesHepatocyte swellingHepatocyte regenerationKupffer cell hyperplasiaPigment-laden macrophages (highlighted on periodic acid-Schiff stain)",
                    "sub_points": [
                      "Diffuse, mixed lobular inflammatory cell infiltratesPredominantly mononuclear inflammatory cell infiltrates",
                      "Predominantly mononuclear inflammatory cell infiltrates",
                      "Hepatocyte necrosis of variable severityPatchy with scattered acidophil bodiesFoci of parenchymal collapse evident on trichrome or reticulin stainsAreas of confluent hepatocyte necrosis in severe cases",
                      "Patchy with scattered acidophil bodies",
                      "Foci of parenchymal collapse evident on trichrome or reticulin stains",
                      "Areas of confluent hepatocyte necrosis in severe cases",
                      "Hepatocyte swelling",
                      "Hepatocyte regeneration",
                      "Kupffer cell hyperplasiaPigment-laden macrophages (highlighted on periodic acid-Schiff stain)",
                      "Pigment-laden macrophages (highlighted on periodic acid-Schiff stain)"
                    ]
                  },
                  {
                    "text": "May see mild portal and periportal inflammation, particularly in acute HAV infectionPortal inflammation usually less prominent than lobular inflammation and injury",
                    "sub_points": [
                      "Portal inflammation usually less prominent than lobular inflammation and injury"
                    ]
                  },
                  {
                    "text": "Hepatocellular and canalicular cholestasis present in some cases"
                  },
                  {
                    "text": "Fibrosis characteristically absent unless there is preexisting chronic liver disease"
                  },
                  {
                    "text": "Usually recognized clinically, so liver biopsy seldom performed"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Autoimmune Hepatitis": [
                  {
                    "text": "Although by definition chronic disease, initial clinical presentation may reflect acute or fulminant hepatitis"
                  },
                  {
                    "text": "Characterized clinically by positive autoimmune serologies (ANA, anti-SMA, anti-LKM)"
                  },
                  {
                    "text": "Polyclonal hypergammaglobulinemia often seen"
                  },
                  {
                    "text": "Portal and periportal hepatitis is often present in addition to lobular hepatitis, often with prominent plasma cells"
                  },
                  {
                    "text": "Fibrosis often present at presentation"
                  },
                  {
                    "text": "Most cases highly responsive to immunosuppressive therapy"
                  },
                  {
                    "text": "Acute viral serologies negative"
                  }
                ],
                "Drug- or Toxin-Induced Hepatitis": [
                  {
                    "text": "Usually cannot be reliably distinguished from acute viral hepatitis based on histology"
                  },
                  {
                    "text": "Eosinophils may be prominent but are not sensitive or specific feature"
                  },
                  {
                    "text": "Generally self-limited and resolves after withdrawal of drug"
                  },
                  {
                    "text": "Diagnosis requires clinical history of exposure"
                  },
                  {
                    "text": "Acute viral serologies negative"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Rarely presents as fulminant hepatitis"
                  },
                  {
                    "text": "Quantitative copper testing shows elevated liver copper level"
                  },
                  {
                    "text": "Acute viral serologies negative"
                  }
                ],
                "Ischemia": [
                  {
                    "text": "Characterized clinically by sharp and marked rise in serum aminotransferasesAminotransferases also decline quickly with recovery",
                    "sub_points": [
                      "Aminotransferases also decline quickly with recovery"
                    ]
                  },
                  {
                    "text": "Focal or diffuse centrilobular hepatocyte necrosis"
                  },
                  {
                    "text": "Lobular inflammation and hepatocyte swelling are not major features"
                  },
                  {
                    "text": "Often associated with vascular injury or hypercoagulable state"
                  },
                  {
                    "text": "Acute viral serologies negative"
                  }
                ],
                "Idiopathic Hepatitis or Hepatic Failure": [
                  {
                    "text": "Subset of cases in which etiology cannot be determined"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatitis B": {
            "name": "Hepatitis B",
            "url": "https://app.pathprimer.com/document/9332a276-d510-4786-9b13-da75f1d36948/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Partially double-stranded DNA virusTypically transmitted vertically, parenterally, or sexually",
                    "sub_points": [
                      "Typically transmitted vertically, parenterally, or sexually"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "10% of infected patients become chronically infected400 million people worldwide have chronic HBV",
                    "sub_points": [
                      "400 million people worldwide have chronic HBV"
                    ]
                  },
                  {
                    "text": "Symptoms include mild flu-like syndrome, nausea, vomiting, jaundice> 50% are asymptomatic",
                    "sub_points": [
                      "> 50% are asymptomatic"
                    ]
                  },
                  {
                    "text": "Lifelong risk of developing cirrhosis &/or hepatocellular carcinoma"
                  },
                  {
                    "text": "Useful laboratory tests include serology for HBV viral antigens, anti-HBV antibodies, and HBV DNA viral load"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Acute hepatitis BHepatocytic swelling, predominantly lobular inflammation, spotty necrosisSevere cases may show confluent and bridging necrosis, collapse of hepatocytic cords, hepatocytic regeneration",
                    "sub_points": [
                      "Hepatocytic swelling, predominantly lobular inflammation, spotty necrosis",
                      "Severe cases may show confluent and bridging necrosis, collapse of hepatocytic cords, hepatocytic regeneration"
                    ]
                  },
                  {
                    "text": "Chronic hepatitis BPortal-based inflammation with variably present ground-glass hepatocytes, sanded nuclei in hepatocytes, variable fibrosisStage of fibrosis indicates disease progression and is important therapeutic and prognostic indicator",
                    "sub_points": [
                      "Portal-based inflammation with variably present ground-glass hepatocytes, sanded nuclei in hepatocytes, variable fibrosisStage of fibrosis indicates disease progression and is important therapeutic and prognostic indicator",
                      "Stage of fibrosis indicates disease progression and is important therapeutic and prognostic indicator"
                    ]
                  },
                  {
                    "text": "Immunohistochemistry for HBcAg and HBsAg may be useful but not invariably positive"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatitis A, hepatitis C, autoimmune hepatitisHistologic features may be very nonspecific, so correlation with history and serology is crucial",
                    "sub_points": [
                      "Histologic features may be very nonspecific, so correlation with history and serology is crucial"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Moderate to severe inflammatory activity and advanced fibrosis (≥ A3, ≥ F2): Patient will get antiviral treatment"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatitis B virus (HBV)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Australia antigen: HBsAg"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hepatitis caused by partially double-stranded DNA virus of Hepadnaviridae family"
                  },
                  {
                    "text": "Chronic HBV: Evidence of hepatitis B surface antigen (HBsAg) for > 6 monthsImmune-tolerant chronic HBVHBsAg for > 6 months, hepatitis B e antigen (HBeAg)(+), very high HBV DNA levels, minimal increase in transaminasesBiopsy: Minimal activity and no fibrosisImmune-active chronic HBVHBsAg for > 6 months, HBV DNA > 20,000 IU/mL if HBeAg(+) chronic hepatitis &/or HVD DNA > 2,000 IU/mL if HBeAg(-), increased transaminasesBiopsy: Chronic hepatitis with moderate to severe activity, ± fibrosisInactive chronic HBVHBsAg for > 6 months, HBeAg(-), anti-HBe(+), HBV DNA < 2,000 IU/mL, normal transaminasesBiopsy: No inflammatory activity, ± fibrosis",
                    "sub_points": [
                      "Immune-tolerant chronic HBVHBsAg for > 6 months, hepatitis B e antigen (HBeAg)(+), very high HBV DNA levels, minimal increase in transaminasesBiopsy: Minimal activity and no fibrosis",
                      "HBsAg for > 6 months, hepatitis B e antigen (HBeAg)(+), very high HBV DNA levels, minimal increase in transaminases",
                      "Biopsy: Minimal activity and no fibrosis",
                      "Immune-active chronic HBVHBsAg for > 6 months, HBV DNA > 20,000 IU/mL if HBeAg(+) chronic hepatitis &/or HVD DNA > 2,000 IU/mL if HBeAg(-), increased transaminasesBiopsy: Chronic hepatitis with moderate to severe activity, ± fibrosis",
                      "HBsAg for > 6 months, HBV DNA > 20,000 IU/mL if HBeAg(+) chronic hepatitis &/or HVD DNA > 2,000 IU/mL if HBeAg(-), increased transaminases",
                      "Biopsy: Chronic hepatitis with moderate to severe activity, ± fibrosis",
                      "Inactive chronic HBVHBsAg for > 6 months, HBeAg(-), anti-HBe(+), HBV DNA < 2,000 IU/mL, normal transaminasesBiopsy: No inflammatory activity, ± fibrosis",
                      "HBsAg for > 6 months, HBeAg(-), anti-HBe(+), HBV DNA < 2,000 IU/mL, normal transaminases",
                      "Biopsy: No inflammatory activity, ± fibrosis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Transmission": [
                  {
                    "text": "Through blood and body fluidsVertical transmission: Mothers to infantsHorizontal transmission: Between persons of same generationSexual contact, IV drug use, contaminated blood products",
                    "sub_points": [
                      "Vertical transmission: Mothers to infants",
                      "Horizontal transmission: Between persons of same generationSexual contact, IV drug use, contaminated blood products",
                      "Sexual contact, IV drug use, contaminated blood products"
                    ]
                  }
                ],
                "Mechanism of Liver Injury": [
                  {
                    "text": "Appears to be immune mediated, as virus is not directly cytotoxic"
                  },
                  {
                    "text": "HBV-specific T cells play key role in pathogenesis and viral clearance"
                  },
                  {
                    "text": "Chronic liver inflammation and poor immune-mediated viral eradication lead to cirrhosis, hepatocellular carcinoma (HCC)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "400 million people worldwide are chronically infected with HBV"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute hepatitis BMild flu-like symptoms, nausea, vomiting, jaundice> 50% are asymptomatic< 1% develop fulminant liver failure, leading to death or liver transplantationSerum HBsAg and anti-HBc virus IgM Ab (+)",
                    "sub_points": [
                      "Mild flu-like symptoms, nausea, vomiting, jaundice> 50% are asymptomatic",
                      "> 50% are asymptomatic",
                      "< 1% develop fulminant liver failure, leading to death or liver transplantation",
                      "Serum HBsAg and anti-HBc virus IgM Ab (+)"
                    ]
                  },
                  {
                    "text": "Chronic hepatitis BSerum HBsAg(+) and anti-HBc virus IgM Ab (-)",
                    "sub_points": [
                      "Serum HBsAg(+) and anti-HBc virus IgM Ab (-)"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serology for HBV viral antigens: HBsAg, HBcAg, HBeAg"
                  },
                  {
                    "text": "Serology for anti-HBV antibodies: Anti-HBs, anti-HBc, anti-HBe"
                  },
                  {
                    "text": "Serum HBV DNA and viral load"
                  },
                  {
                    "text": "Elevated transaminasesChronic HBV patients can transition through multiple clinical phasesCharacterized by variable elevations of serum ALT, HBV DNA, HBV antigens",
                    "sub_points": [
                      "Chronic HBV patients can transition through multiple clinical phasesCharacterized by variable elevations of serum ALT, HBV DNA, HBV antigens",
                      "Characterized by variable elevations of serum ALT, HBV DNA, HBV antigens"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "10% of infected individuals develop chronic disease"
                  },
                  {
                    "text": "Life-long risk of developing cirrhosis &/or HCC in chronic hepatitis BCirrhosis is not prerequisite for developing HCCHBV viral genome can act as oncoprotein and integrate into host genome",
                    "sub_points": [
                      "Cirrhosis is not prerequisite for developing HCCHBV viral genome can act as oncoprotein and integrate into host genome",
                      "HBV viral genome can act as oncoprotein and integrate into host genome"
                    ]
                  },
                  {
                    "text": "Coinfection with HIV, hepatitis C virus (HCV), and hepatitis D virus (HDV) is common, as they share common transmission route"
                  },
                  {
                    "text": "Levels of ALT, HBV DNA, fibrosis are predictors of long-term outcomeUsed to guide treatment decisions and monitor response to treatment",
                    "sub_points": [
                      "Used to guide treatment decisions and monitor response to treatment"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Entecavir, nucleoside analog"
                  },
                  {
                    "text": "Tenofovir disoproxil fumarate, tenofovir alafenamide, nucleotide analogs"
                  },
                  {
                    "text": "Interferon"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Cirrhosis": [
                  {
                    "text": "Nodularity (macronodular or mixed macro- and micronodular) and scarring"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Acute hepatitis BHepatocytic swelling, lobular disarray, and predominantly lobular inflammationMainly mononuclear, including lymphocytes, plasma cells, and Kupffer cellsApoptotic hepatocytes and spotty necrosisOccasional marked cholestasisConfluent and bridging necrosis in severe cases with parenchymal collapse and hepatocyte regenerationCollapse best demonstrated by reticulin stainImmunohistochemistry generally not useful in acute HBV, as virus is rapidly eliminated and thus not detectable",
                    "sub_points": [
                      "Hepatocytic swelling, lobular disarray, and predominantly lobular inflammationMainly mononuclear, including lymphocytes, plasma cells, and Kupffer cells",
                      "Mainly mononuclear, including lymphocytes, plasma cells, and Kupffer cells",
                      "Apoptotic hepatocytes and spotty necrosis",
                      "Occasional marked cholestasis",
                      "Confluent and bridging necrosis in severe cases with parenchymal collapse and hepatocyte regenerationCollapse best demonstrated by reticulin stain",
                      "Collapse best demonstrated by reticulin stain",
                      "Immunohistochemistry generally not useful in acute HBV, as virus is rapidly eliminated and thus not detectable"
                    ]
                  },
                  {
                    "text": "Chronic hepatitis BDense, portal-based, lymphocyte-predominant inflammationAdmixed with macrophages and plasma cellsInterface hepatitis (previously termed piecemeal necrosis)Mononuclear inflammatory cells and apoptotic hepatocytes beyond limiting plateLobular hepatitisAggregates of mononuclear inflammatory cells, apoptotic hepatocytes, hepatocytic debrisFibrosisBegins in portal regions, extends beyond limiting plate, then forms bridging septa between portal-portal and portal-central regions, ultimately cirrhosisGround-glass hepatocytesFinely granular cytoplasmic inclusionDue to proliferation of smooth endoplasmic reticulum in response to abundant HBsAgPushes cellular contents and nucleus to sideCan be highlighted by Shikata Orcein stain, Victoria Blue stain, and anti-HBs immunohistochemical stainIndicates chronic hepatitis B infectionNot specific for hepatitis BSanded nuclei of hepatocytesPale pink granular inclusions in hepatocytic nuclei containing HBcAgCan be highlighted by anti-HBc immunohistochemical stainExtensive nuclear staining for anti-HBc indicates active HBV viral replication and may suggest immunosuppression status",
                    "sub_points": [
                      "Dense, portal-based, lymphocyte-predominant inflammationAdmixed with macrophages and plasma cells",
                      "Admixed with macrophages and plasma cells",
                      "Interface hepatitis (previously termed piecemeal necrosis)Mononuclear inflammatory cells and apoptotic hepatocytes beyond limiting plate",
                      "Mononuclear inflammatory cells and apoptotic hepatocytes beyond limiting plate",
                      "Lobular hepatitisAggregates of mononuclear inflammatory cells, apoptotic hepatocytes, hepatocytic debris",
                      "Aggregates of mononuclear inflammatory cells, apoptotic hepatocytes, hepatocytic debris",
                      "FibrosisBegins in portal regions, extends beyond limiting plate, then forms bridging septa between portal-portal and portal-central regions, ultimately cirrhosis",
                      "Begins in portal regions, extends beyond limiting plate, then forms bridging septa between portal-portal and portal-central regions, ultimately cirrhosis",
                      "Ground-glass hepatocytesFinely granular cytoplasmic inclusionDue to proliferation of smooth endoplasmic reticulum in response to abundant HBsAgPushes cellular contents and nucleus to sideCan be highlighted by Shikata Orcein stain, Victoria Blue stain, and anti-HBs immunohistochemical stainIndicates chronic hepatitis B infectionNot specific for hepatitis B",
                      "Finely granular cytoplasmic inclusion",
                      "Due to proliferation of smooth endoplasmic reticulum in response to abundant HBsAg",
                      "Pushes cellular contents and nucleus to side",
                      "Can be highlighted by Shikata Orcein stain, Victoria Blue stain, and anti-HBs immunohistochemical stain",
                      "Indicates chronic hepatitis B infection",
                      "Not specific for hepatitis B",
                      "Sanded nuclei of hepatocytesPale pink granular inclusions in hepatocytic nuclei containing HBcAgCan be highlighted by anti-HBc immunohistochemical stainExtensive nuclear staining for anti-HBc indicates active HBV viral replication and may suggest immunosuppression status",
                      "Pale pink granular inclusions in hepatocytic nuclei containing HBcAg",
                      "Can be highlighted by anti-HBc immunohistochemical stain",
                      "Extensive nuclear staining for anti-HBc indicates active HBV viral replication and may suggest immunosuppression status"
                    ]
                  },
                  {
                    "text": "Fibrosing cholestatic hepatitis BVariant of viral hepatitis B that often has more progressive course and worse outcomePathogenesis thought to be due to viral cytopathic effectTypically occurs following orthotopic liver transplantation but also occurs in other immunosuppressed statesOccurrence is currently less common due to better prevention and antiviral regimensUnique histopathologyHepatocytic swelling due to cholestasisCanalicular and bile ductal cholestasisMarked bile ductular reactionExtensive fibrosis extending from portal tracts, pericellular pattern",
                    "sub_points": [
                      "Variant of viral hepatitis B that often has more progressive course and worse outcome",
                      "Pathogenesis thought to be due to viral cytopathic effect",
                      "Typically occurs following orthotopic liver transplantation but also occurs in other immunosuppressed statesOccurrence is currently less common due to better prevention and antiviral regimens",
                      "Occurrence is currently less common due to better prevention and antiviral regimens",
                      "Unique histopathologyHepatocytic swelling due to cholestasisCanalicular and bile ductal cholestasisMarked bile ductular reactionExtensive fibrosis extending from portal tracts, pericellular pattern",
                      "Hepatocytic swelling due to cholestasis",
                      "Canalicular and bile ductal cholestasis",
                      "Marked bile ductular reaction",
                      "Extensive fibrosis extending from portal tracts, pericellular pattern"
                    ]
                  },
                  {
                    "text": "Immunohistochemistry for HBcAg and HBsAg may be useful but not invariably positive"
                  }
                ],
                "Semiquantitative Grading and Staging": [
                  {
                    "text": "Grading denotes inflammatory activity, whereas staging indicates degree of fibrosis"
                  },
                  {
                    "text": "Stage of fibrosis indicates disease progression and is important therapeutic and prognostic indicator"
                  },
                  {
                    "text": "Ishak, Batts/Ludwig, and Metavir systems most commonly used"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatitis A": [
                  {
                    "text": "Positive hepatitis A serology (anti-HAV IgM)"
                  },
                  {
                    "text": "Often history of travel or food poisoning"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Positive autoimmune serology (ANA, anti-SMA, LKM, SLA)"
                  },
                  {
                    "text": "More prominent plasma cells"
                  },
                  {
                    "text": "Responds to steroids"
                  }
                ],
                "Chronic Hepatitis C": [
                  {
                    "text": "Positive anti-HCV antibody and HCV RNA in serum"
                  },
                  {
                    "text": "Portal lymphoid aggregates, Poulsen (bile duct) lesion, and steatosis more common in hepatitis C"
                  }
                ],
                "Drug-Associated Hepatitis": [
                  {
                    "text": "Medication history that corresponds to onset of liver diseaseSymptoms ideally resolve after drug withdrawal",
                    "sub_points": [
                      "Symptoms ideally resolve after drug withdrawal"
                    ]
                  },
                  {
                    "text": "Negative HBV serologies"
                  },
                  {
                    "text": "Eosinophils may be prominent"
                  }
                ],
                "Hepatitis E": [
                  {
                    "text": "Positive travel history, anti-hepatitis E virus (HEV) serology, or HEV RNA"
                  }
                ],
                "Other Viral Hepatitides": [
                  {
                    "text": "EBV hepatitisAtypical lymphocytes in lobules, especially in sinusoidal spaces in bead-like appearance",
                    "sub_points": [
                      "Atypical lymphocytes in lobules, especially in sinusoidal spaces in bead-like appearance"
                    ]
                  },
                  {
                    "text": "Yellow feverPositive travel history and virologic studies",
                    "sub_points": [
                      "Positive travel history and virologic studies"
                    ]
                  },
                  {
                    "text": "Dengue feverPositive travel history and virologic studies",
                    "sub_points": [
                      "Positive travel history and virologic studies"
                    ]
                  },
                  {
                    "text": "Syphilitic hepatitisPositive serologyOrganisms onTreponema pallidumimmunostain",
                    "sub_points": [
                      "Positive serology",
                      "Organisms onTreponema pallidumimmunostain"
                    ]
                  }
                ],
                "Other Causes of Ground-Glass Hepatocytes": [
                  {
                    "text": "Lafora disease"
                  },
                  {
                    "text": "Cyanamide toxicity"
                  },
                  {
                    "text": "Fibrinogen storage disease"
                  },
                  {
                    "text": "Glycogen pseudo-ground-glass cell changeCommonly seen in immunosuppressed individuals and post liver transplant, those on numerous medications",
                    "sub_points": [
                      "Commonly seen in immunosuppressed individuals and post liver transplant, those on numerous medications"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Purpose of liver biopsy is to grade and stage HBV-induced liver disease and exclude concomitant liver diseasesBiopsy showing moderate to severe inflammation (activity score ≥ A3) and advanced fibrosis (fibrosis score ≥ F2) → eligible for antiviral treatmentPersistently increased ALT + persistently low HBV DNA → biopsy done to exclude other causes of liver disease",
                    "sub_points": [
                      "Biopsy showing moderate to severe inflammation (activity score ≥ A3) and advanced fibrosis (fibrosis score ≥ F2) → eligible for antiviral treatment",
                      "Persistently increased ALT + persistently low HBV DNA → biopsy done to exclude other causes of liver disease"
                    ]
                  },
                  {
                    "text": "HBV coinfection with other viruses, such as HCV, HDV, and HIV, is commonCorrelation with clinical history and serology is important",
                    "sub_points": [
                      "Correlation with clinical history and serology is important"
                    ]
                  },
                  {
                    "text": "Unlike hepatitis C, recurrent hepatitis B after liver transplantation is rare due to advent of antiviral prophylaxisBe cautious not to overdiagnose recurrent hepatitis B in posttransplant biopsy",
                    "sub_points": [
                      "Be cautious not to overdiagnose recurrent hepatitis B in posttransplant biopsy"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatitis C": {
            "name": "Hepatitis C",
            "url": "https://app.pathprimer.com/document/dce7cf0c-e2d6-4cac-b6c7-1b88454b6772/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hepatitis, usually chronic, secondary to hepatitis C virus (HCV) infection"
                  },
                  {
                    "text": "Worldwide seroprevalence of HCV antibodies (anti-HCV) estimated at 3%Estimated 3-4 million persons infected in United States",
                    "sub_points": [
                      "Estimated 3-4 million persons infected in United States"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Common modes of transmission include blood transfusion, needle stick"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Presenting symptoms nonspecific (fatigue, anorexia, nausea)Many patients asymptomatic",
                    "sub_points": [
                      "Many patients asymptomatic"
                    ]
                  },
                  {
                    "text": "Liver biopsy no longer widely performedGrade indicates degree of necroinflammatory activityStage indicates extent of fibrosisBiopsy mostly used for confirming degree of fibrosis to place patient in hepatocellular carcinoma surveillance or exclude additional liver diseases",
                    "sub_points": [
                      "Grade indicates degree of necroinflammatory activity",
                      "Stage indicates extent of fibrosis",
                      "Biopsy mostly used for confirming degree of fibrosis to place patient in hepatocellular carcinoma surveillance or exclude additional liver diseases"
                    ]
                  },
                  {
                    "text": "Usually progressive disease, leading to cirrhosis, liver failure, risk of hepatocellular carcinoma"
                  },
                  {
                    "text": "TreatmentDirect acting antivirals are highly effective with fewer side effects",
                    "sub_points": [
                      "Direct acting antivirals are highly effective with fewer side effects"
                    ]
                  },
                  {
                    "text": "Laboratory testsAnti-HCV antibodies, HCV RNA by PCR",
                    "sub_points": [
                      "Anti-HCV antibodies, HCV RNA by PCR"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Variably dense portal lymphocytic infiltratesPortal lymphoid aggregates, periportal interface activityPatchy steatosis",
                    "sub_points": [
                      "Portal lymphoid aggregates, periportal interface activity",
                      "Patchy steatosis"
                    ]
                  },
                  {
                    "text": "Scattered lobular collections of inflammatory cells ± acidophil bodies"
                  },
                  {
                    "text": "Histologic features may still be present, even in patients with sustained virologic response"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatitis C virus (HCV)"
                  },
                  {
                    "text": "Sustained virologic response (SVR)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hepatitis, usually chronic, secondary to HCV infection"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Enveloped, single-stranded RNA virus of Flaviviridae family"
                  },
                  {
                    "text": "Inherent high mutation rate generates viral heterogeneity6 viral genotypes and > 50 subtypesVary in geography, mode of transmission, and response to treatment",
                    "sub_points": [
                      "6 viral genotypes and > 50 subtypesVary in geography, mode of transmission, and response to treatment",
                      "Vary in geography, mode of transmission, and response to treatment"
                    ]
                  },
                  {
                    "text": "Virus is directly cytopathic and induces immune-mediated cellular injury"
                  }
                ],
                "Modes of Transmission": [
                  {
                    "text": "Blood transfusion, needlestick inoculation"
                  },
                  {
                    "text": "Perinatal exposure, probably occurs with low efficiency"
                  },
                  {
                    "text": "Efficiency of sexual transmission is controversial but probably low"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Worldwide seroprevalence of HCV antibodies (anti-HCV) estimated at 3%Estimated 3-4 million persons infected in United States",
                    "sub_points": [
                      "Estimated 3-4 million persons infected in United States"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fatigue, nausea, anorexia, depression"
                  },
                  {
                    "text": "May be asymptomatic"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Antibodies (anti-HCV) indicate exposure"
                  },
                  {
                    "text": "Detection of HCV RNA indicates virus persistence"
                  },
                  {
                    "text": "Liver biopsy no longer widely performedUsed to confirm fibrosis result of noninvasive testsCirrhosis, even after SVR, places patient on recurrent hepatocellular carcinoma surveillanceIn contrast to patients who achieve SVR and do not have advanced fibrosis; do not need specific follow-upUsed to exclude additional liver disease",
                    "sub_points": [
                      "Used to confirm fibrosis result of noninvasive testsCirrhosis, even after SVR, places patient on recurrent hepatocellular carcinoma surveillanceIn contrast to patients who achieve SVR and do not have advanced fibrosis; do not need specific follow-up",
                      "Cirrhosis, even after SVR, places patient on recurrent hepatocellular carcinoma surveillance",
                      "In contrast to patients who achieve SVR and do not have advanced fibrosis; do not need specific follow-up",
                      "Used to exclude additional liver disease"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Acute infection is often subclinical; fulminant hepatitis rare"
                  },
                  {
                    "text": "Persistent (chronic) infection occurs in 85% of infected personsDefined as failure to clear virus in 6 monthsRemaining 15% have self-limited infection",
                    "sub_points": [
                      "Defined as failure to clear virus in 6 months",
                      "Remaining 15% have self-limited infection"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Historically, standard therapy has been pegylated interferon-α in combination with ribavirin"
                  },
                  {
                    "text": "Direct acting antivirals highly effective with few side effectsUniversal treatment offered to all adultsProtease inhibitors (e.g., simeprevir)Nucleoside/nucleotide inhibitors (e.g., sofosbuvir) and nonnucleotide inhibitorsGoal is SVR: Absence of HCV RNA 24 weeks after therapy",
                    "sub_points": [
                      "Universal treatment offered to all adults",
                      "Protease inhibitors (e.g., simeprevir)",
                      "Nucleoside/nucleotide inhibitors (e.g., sofosbuvir) and nonnucleotide inhibitors",
                      "Goal is SVR: Absence of HCV RNA 24 weeks after therapy"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Progressive disease, usually slow (over decades) and clinically silent; may lead to cirrhosis and liver failure"
                  },
                  {
                    "text": "Risk of hepatocellular carcinoma, usually in background of cirrhosis, regardless of SVR status"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variably dense portal-based predominant infiltratesPeriportal interface activityLymphocytes disrupt limiting plate and surround nearby hepatocytes, causing hepatocyte injury and necrosis",
                    "sub_points": [
                      "Periportal interface activityLymphocytes disrupt limiting plate and surround nearby hepatocytes, causing hepatocyte injury and necrosis",
                      "Lymphocytes disrupt limiting plate and surround nearby hepatocytes, causing hepatocyte injury and necrosis"
                    ]
                  },
                  {
                    "text": "Scattered lobular collections of inflammatory cells ± acidophil bodies"
                  },
                  {
                    "text": "Mild bile duct injury ± lymphocytic infiltrate (Poulsen lesions)"
                  },
                  {
                    "text": "Mild, patchy steatosisGreater degree of steatosis associated with genotype 3b",
                    "sub_points": [
                      "Greater degree of steatosis associated with genotype 3b"
                    ]
                  },
                  {
                    "text": "Histologic features are scored; several grading/staging schemes availableGrade: Extent and severity of interface activity and lobular inflammation and injuryStage: Extent of fibrosisProgressive fibrosis begins in portal areas and extends outward in stellate fashion",
                    "sub_points": [
                      "Grade: Extent and severity of interface activity and lobular inflammation and injury",
                      "Stage: Extent of fibrosisProgressive fibrosis begins in portal areas and extends outward in stellate fashion",
                      "Progressive fibrosis begins in portal areas and extends outward in stellate fashion"
                    ]
                  },
                  {
                    "text": "Acute infection rarely recognized clinically and rarely biopsiedUsually relatively mild lobular hepatitis",
                    "sub_points": [
                      "Usually relatively mild lobular hepatitis"
                    ]
                  },
                  {
                    "text": "Fibrosing cholestatic hepatitis C: Rare, severe variant in immunosuppressed patients"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatitis B Virus Infection": [
                  {
                    "text": "Distinguished by serologic testing"
                  },
                  {
                    "text": "± ground-glass hepatocytes"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Usually more severe hepatitis with more extensive interface activity and hepatocyte injury; prominent plasma cells"
                  },
                  {
                    "text": "Distinguished by serologic testing for autoantibodiesFalse-positive anti-HCV can occur in autoimmune hepatitis, and autoantibodies may be expressed in HCV",
                    "sub_points": [
                      "False-positive anti-HCV can occur in autoimmune hepatitis, and autoantibodies may be expressed in HCV"
                    ]
                  }
                ],
                "Drug-Induced Hepatitis": [
                  {
                    "text": "Exclusion of HCV and identification of causative agent"
                  }
                ],
                "Nonalcoholic Steatohepatitis": [
                  {
                    "text": "Inflammation typically lobular rather than portal based"
                  },
                  {
                    "text": "Fat usually zone 3 predominant rather than randomly distributed"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Epstein-Barr Virus": {
            "name": "Epstein-Barr Virus",
            "url": "https://app.pathprimer.com/document/09465c25-f4b5-4bb9-83e9-69e9e2078701/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "In liver, Epstein-Barr virus (EBV) may cause either hepatitis, smooth muscle tumors, or posttransplant lymphoproliferative disorder (PTLD)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Member of herpesvirus family (human herpesvirus-4)"
                  },
                  {
                    "text": "Transmission via saliva from infected person"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "EBV hepatitisUsually represents liver involvement by infectious mononucleosisElevated serum transaminase, alkaline phosphatase, and bilirubin levelsSelf-limited in majority of cases",
                    "sub_points": [
                      "Usually represents liver involvement by infectious mononucleosis",
                      "Elevated serum transaminase, alkaline phosphatase, and bilirubin levels",
                      "Self-limited in majority of cases"
                    ]
                  },
                  {
                    "text": "EBV-associated lymphoproliferative disordersIn immunocompromised individuals due to uncontrolled EBV replicationOccurs in 1.0-2.8% of liver transplants",
                    "sub_points": [
                      "In immunocompromised individuals due to uncontrolled EBV replication",
                      "Occurs in 1.0-2.8% of liver transplants"
                    ]
                  },
                  {
                    "text": "Smooth muscle tumorAlmost exclusively in viscera of immunocompromised patients",
                    "sub_points": [
                      "Almost exclusively in viscera of immunocompromised patients"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "EBV hepatitisDiffuse sinusoidal lymphocytic infiltration in single file or string of beads patternMixed inflammatory cell infiltrates in portal tracts, consisting predominantly of lymphocytesScattered large and irregular (atypical) lymphocytes in sinusoids and portal tracts",
                    "sub_points": [
                      "Diffuse sinusoidal lymphocytic infiltration in single file or string of beads pattern",
                      "Mixed inflammatory cell infiltrates in portal tracts, consisting predominantly of lymphocytes",
                      "Scattered large and irregular (atypical) lymphocytes in sinusoids and portal tracts"
                    ]
                  },
                  {
                    "text": "Hepatic PTLD: Morphology ranges from hepatitis-like to lymphoma"
                  },
                  {
                    "text": "Smooth muscle tumor: Low-grade morphology, actin (+)"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Detection of EBV early RNA (EBER) in tissue sections by in situ hybridization"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Epstein-Barr virus (EBV)"
                  },
                  {
                    "text": "Posttransplant lymphoproliferative disorder (PTLD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection by EBVCan cause hepatitis, smooth muscle tumors, or PTLD",
                    "sub_points": [
                      "Can cause hepatitis, smooth muscle tumors, or PTLD"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Double-stranded DNA virus, member of herpesvirus family (human herpesvirus-4)"
                  },
                  {
                    "text": "Person-to-person transmission, frequently by salivaInfection begins in oropharyngeal lymphoid tissues, particularly tonsilsViral envelope glycoprotein binds to CD21 (CR2) on B lymphocytes",
                    "sub_points": [
                      "Infection begins in oropharyngeal lymphoid tissues, particularly tonsils",
                      "Viral envelope glycoprotein binds to CD21 (CR2) on B lymphocytes"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Primary infection is common in young children and often asymptomatic"
                  },
                  {
                    "text": "Symptomatic infection more common in adolescents and young adultsClinical syndrome of mononucleosisFever, fatigue, malaise, sore throat, arthralgiaSelf-limited, usually resolves in 1-2 monthsLiver involvement present in > 90% of patients, but it is usually subclinical or self-limited",
                    "sub_points": [
                      "Clinical syndrome of mononucleosisFever, fatigue, malaise, sore throat, arthralgiaSelf-limited, usually resolves in 1-2 monthsLiver involvement present in > 90% of patients, but it is usually subclinical or self-limited",
                      "Fever, fatigue, malaise, sore throat, arthralgia",
                      "Self-limited, usually resolves in 1-2 months",
                      "Liver involvement present in > 90% of patients, but it is usually subclinical or self-limited"
                    ]
                  },
                  {
                    "text": "> 90% of worldwide adult population is seropositive"
                  },
                  {
                    "text": "Virus remains dormant or latent in memory B lymphocytes and can be reactivated"
                  }
                ],
                "Presentation": [
                  {
                    "text": "EBV hepatitisUsually represents liver involvement by infectious mononucleosisHepatic involvement can occur without symptoms of mononucleosis, howeverSeen in immunocompetent and immunocompromised individualsHepatomegaly in 10-15% of patientsJaundice in ~ 5% of patientsElevated serum transaminase, alkaline phosphatase, and bilirubin",
                    "sub_points": [
                      "Usually represents liver involvement by infectious mononucleosisHepatic involvement can occur without symptoms of mononucleosis, however",
                      "Hepatic involvement can occur without symptoms of mononucleosis, however",
                      "Seen in immunocompetent and immunocompromised individuals",
                      "Hepatomegaly in 10-15% of patients",
                      "Jaundice in ~ 5% of patients",
                      "Elevated serum transaminase, alkaline phosphatase, and bilirubin"
                    ]
                  },
                  {
                    "text": "EBV-associated lymphoproliferative disordersIn immunocompromised individuals due to uncontrolled EBV replicationOccurs in 1.0-2.8% of liver transplants> 80% of cases within 1st 2 years post transplantAccounts for > 50% of tumors in children and ~ 15% of tumors in adults following liver transplantationHost origin in majority of cases, rarely donor originNegative EBV status at transplantation and heavy immunosuppression for treatment of rejection are major risk factors",
                    "sub_points": [
                      "In immunocompromised individuals due to uncontrolled EBV replicationOccurs in 1.0-2.8% of liver transplants> 80% of cases within 1st 2 years post transplantAccounts for > 50% of tumors in children and ~ 15% of tumors in adults following liver transplantationHost origin in majority of cases, rarely donor originNegative EBV status at transplantation and heavy immunosuppression for treatment of rejection are major risk factors",
                      "Occurs in 1.0-2.8% of liver transplants> 80% of cases within 1st 2 years post transplantAccounts for > 50% of tumors in children and ~ 15% of tumors in adults following liver transplantation",
                      "> 80% of cases within 1st 2 years post transplant",
                      "Accounts for > 50% of tumors in children and ~ 15% of tumors in adults following liver transplantation",
                      "Host origin in majority of cases, rarely donor origin",
                      "Negative EBV status at transplantation and heavy immunosuppression for treatment of rejection are major risk factors"
                    ]
                  },
                  {
                    "text": "EBV-associated smooth muscle tumorsAlmost exclusively in immunocompromised patientsOften multiple and present in several viscera",
                    "sub_points": [
                      "Almost exclusively in immunocompromised patients",
                      "Often multiple and present in several viscera"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "EBV hepatitisPeripheral lymphocytosis with > 10% atypical lymphocytesSerologic studiesPositive monospot test for heterophile antibodyViral titersElevated early antigen (EBEA), viral capsid antigen (VCA) IgM, and rising VCA IgG indicate primary infectionDetection of viral DNA in peripheral blood by PCROccasionally autoimmune markers are positive, leading to confusion with autoimmune hepatitis",
                    "sub_points": [
                      "Peripheral lymphocytosis with > 10% atypical lymphocytes",
                      "Serologic studiesPositive monospot test for heterophile antibodyViral titersElevated early antigen (EBEA), viral capsid antigen (VCA) IgM, and rising VCA IgG indicate primary infection",
                      "Positive monospot test for heterophile antibody",
                      "Viral titersElevated early antigen (EBEA), viral capsid antigen (VCA) IgM, and rising VCA IgG indicate primary infection",
                      "Elevated early antigen (EBEA), viral capsid antigen (VCA) IgM, and rising VCA IgG indicate primary infection",
                      "Detection of viral DNA in peripheral blood by PCR",
                      "Occasionally autoimmune markers are positive, leading to confusion with autoimmune hepatitis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "EBV hepatitisSymptomatic &/or supportive treatmentUse of corticosteroids and antiviral agents remains controversial",
                    "sub_points": [
                      "Symptomatic &/or supportive treatment",
                      "Use of corticosteroids and antiviral agents remains controversial"
                    ]
                  },
                  {
                    "text": "PTLD lacks general treatment paradigm due to disease heterogeneityReduction of immunosuppression, chemotherapy, surgery/radiation, antiviral therapy",
                    "sub_points": [
                      "Reduction of immunosuppression, chemotherapy, surgery/radiation, antiviral therapy"
                    ]
                  },
                  {
                    "text": "Smooth muscle tumorsAntiviral treatment, chemotherapy, reduction in immunosuppression, surgery",
                    "sub_points": [
                      "Antiviral treatment, chemotherapy, reduction in immunosuppression, surgery"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Self-limited in majority of EBV hepatitis cases"
                  },
                  {
                    "text": "Serious complications occur in < 5% of casesFulminant hepatic failureSplenic ruptureHemolytic anemiaHemophagocytic syndromeGuillain-Barré syndromeMalignancies",
                    "sub_points": [
                      "Fulminant hepatic failure",
                      "Splenic rupture",
                      "Hemolytic anemia",
                      "Hemophagocytic syndrome",
                      "Guillain-Barré syndrome",
                      "Malignancies"
                    ]
                  },
                  {
                    "text": "PTLDVaries from benign lymphoproliferative lesion to aggressive lymphomaPediatric patients tend to have better survival rate in comparison with adults",
                    "sub_points": [
                      "Varies from benign lymphoproliferative lesion to aggressive lymphoma",
                      "Pediatric patients tend to have better survival rate in comparison with adults"
                    ]
                  },
                  {
                    "text": "Smooth muscle tumorsTypically do not behave aggressively",
                    "sub_points": [
                      "Typically do not behave aggressively"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Liver mass in patients with PTLD and smooth muscle tumors"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "EBV hepatitisDiffuse sinusoidal lymphocytic infiltration in single file or string of beads patternModerate to marked mixed inflammatory cell infiltrates in portal tracts, consisting predominantly of lymphocytesScattered large and irregular (atypical) lymphocytes in sinusoids and portal tracts may be presentScattered foci of interface activityFocal lobular disarray with hepatocyte ballooning and scattered acidophil bodiesSmall noncaseating epithelioid granulomas (microgranulomas) or fibrin-ring granulomas in lobulesVarying degree of steatosis with no particular zonal distributionCholestasis not prominentMild bile duct damageNo significant ductular reactionFocal venulitisNo fibrosis",
                    "sub_points": [
                      "Diffuse sinusoidal lymphocytic infiltration in single file or string of beads pattern",
                      "Moderate to marked mixed inflammatory cell infiltrates in portal tracts, consisting predominantly of lymphocytesScattered large and irregular (atypical) lymphocytes in sinusoids and portal tracts may be presentScattered foci of interface activity",
                      "Scattered large and irregular (atypical) lymphocytes in sinusoids and portal tracts may be present",
                      "Scattered foci of interface activity",
                      "Focal lobular disarray with hepatocyte ballooning and scattered acidophil bodies",
                      "Small noncaseating epithelioid granulomas (microgranulomas) or fibrin-ring granulomas in lobules",
                      "Varying degree of steatosis with no particular zonal distribution",
                      "Cholestasis not prominent",
                      "Mild bile duct damageNo significant ductular reaction",
                      "No significant ductular reaction",
                      "Focal venulitis",
                      "No fibrosis"
                    ]
                  },
                  {
                    "text": "Hepatic PTLDEarly lesions characterized by mixed mononuclear cell infiltrates in portal tracts or infectious mononucleosis-like lesionsPortal infiltrates contain small- and medium-sized lymphocytes, atypical lymphocytes, immunoblasts, and plasma cellsSinusoidal lymphocytic infiltration similar to that seen in EBV hepatitisInfiltrative lymphocytes are predominantly B cells, in contrast to predominantly T cells in EBV hepatitisPolymorphic PTLD characterized by mixed lymphoplasmacytic proliferationMore frequent atypical lymphoid cells (blast forms)Either polyclonal or monoclonalMonomorphic PTLD is classified according to standard lymphoma classification> 80% are B-cell lymphomas; most common subtype is diffuse large B-cell lymphomaRare subtypes include Burkitt or Burkitt-like lymphoma, plasma cell myeloma, peripheral T-cell lymphoma, γ/δ T-cell lymphoma, T-/NK-cell lymphoma, Hodgkin lymphoma, and Hodgkin lymphoma-like PTLDProliferation of neoplastic lymphoid cells form solitary mass or multiple massesDiffuse infiltration of portal tracts &/or sinusoids by neoplastic lymphoid cells less commonDestruction of normal hepatic architecture",
                    "sub_points": [
                      "Early lesions characterized by mixed mononuclear cell infiltrates in portal tracts or infectious mononucleosis-like lesionsPortal infiltrates contain small- and medium-sized lymphocytes, atypical lymphocytes, immunoblasts, and plasma cellsSinusoidal lymphocytic infiltration similar to that seen in EBV hepatitisInfiltrative lymphocytes are predominantly B cells, in contrast to predominantly T cells in EBV hepatitis",
                      "Portal infiltrates contain small- and medium-sized lymphocytes, atypical lymphocytes, immunoblasts, and plasma cells",
                      "Sinusoidal lymphocytic infiltration similar to that seen in EBV hepatitis",
                      "Infiltrative lymphocytes are predominantly B cells, in contrast to predominantly T cells in EBV hepatitis",
                      "Polymorphic PTLD characterized by mixed lymphoplasmacytic proliferationMore frequent atypical lymphoid cells (blast forms)Either polyclonal or monoclonal",
                      "More frequent atypical lymphoid cells (blast forms)",
                      "Either polyclonal or monoclonal",
                      "Monomorphic PTLD is classified according to standard lymphoma classification> 80% are B-cell lymphomas; most common subtype is diffuse large B-cell lymphomaRare subtypes include Burkitt or Burkitt-like lymphoma, plasma cell myeloma, peripheral T-cell lymphoma, γ/δ T-cell lymphoma, T-/NK-cell lymphoma, Hodgkin lymphoma, and Hodgkin lymphoma-like PTLDProliferation of neoplastic lymphoid cells form solitary mass or multiple massesDiffuse infiltration of portal tracts &/or sinusoids by neoplastic lymphoid cells less commonDestruction of normal hepatic architecture",
                      "> 80% are B-cell lymphomas; most common subtype is diffuse large B-cell lymphoma",
                      "Rare subtypes include Burkitt or Burkitt-like lymphoma, plasma cell myeloma, peripheral T-cell lymphoma, γ/δ T-cell lymphoma, T-/NK-cell lymphoma, Hodgkin lymphoma, and Hodgkin lymphoma-like PTLD",
                      "Proliferation of neoplastic lymphoid cells form solitary mass or multiple masses",
                      "Diffuse infiltration of portal tracts &/or sinusoids by neoplastic lymphoid cells less common",
                      "Destruction of normal hepatic architecture"
                    ]
                  },
                  {
                    "text": "Smooth muscle tumorsTypically low grade with little nuclear atypia and rare mitosesOccasional round cell areas, necrosis, and myxoid changeFrequent tumor-infiltrating lymphocytes",
                    "sub_points": [
                      "Typically low grade with little nuclear atypia and rare mitoses",
                      "Occasional round cell areas, necrosis, and myxoid change",
                      "Frequent tumor-infiltrating lymphocytes"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "EBV-latent membrane protein (LMP)Not useful in EBV hepatitis; may be useful in PTLD",
                    "sub_points": [
                      "Not useful in EBV hepatitis; may be useful in PTLD"
                    ]
                  },
                  {
                    "text": "B- and T-cell markers, κ and λ light chains may be useful for PTLD diagnosis"
                  },
                  {
                    "text": "EBV-associated smooth muscle tumors are positive for actin, less often desmin"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Hepatitis: Detection of EBV early RNA (EBER) by ISHPositive in lymphocytes, not hepatocytesMay be very focal, so negative ISH does not exclude EBV hepatitis",
                    "sub_points": [
                      "Positive in lymphocytes, not hepatocytes",
                      "May be very focal, so negative ISH does not exclude EBV hepatitis"
                    ]
                  },
                  {
                    "text": "PTLD and EBV-associated smooth muscle tumors: EBER is typically positive"
                  }
                ],
                "Gene Rearrangements": [
                  {
                    "text": "Gene rearrangement for immunoglobulins and T-cell receptors may be helpful for PTLD diagnosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatic Involvement by Leukemia": [
                  {
                    "text": "Sinusoidal and portal infiltration by monotonous lymphoid or myeloid cells"
                  },
                  {
                    "text": "Flow cytometry and immunohistochemistry are helpful"
                  }
                ],
                "Hepatosplenic T-Cell Lymphoma": [
                  {
                    "text": "Sinusoidal infiltration by monotonous, medium-sized cytotoxic T cells"
                  },
                  {
                    "text": "Characteristic CD3(+), CD4(-), and CD8(-) immunophenotype"
                  },
                  {
                    "text": "Clonal γ/δ T-cell receptor rearrangement frequently present"
                  },
                  {
                    "text": "Clonal α/β T-cell receptor rearrangement seen in occasional cases"
                  },
                  {
                    "text": "Presence of isochromosome 7q"
                  }
                ],
                "Acute Cellular Rejection": [
                  {
                    "text": "More pronounced bile duct damage &/or endophlebitis"
                  },
                  {
                    "text": "Less prominent sinusoidal lymphocytic infiltrates"
                  },
                  {
                    "text": "Negative EBER ISH, EBV serologies, and PCR"
                  }
                ],
                "Recurrent Hepatitis C Post Transplant": [
                  {
                    "text": "Less prominent sinusoidal lymphocytic infiltrates"
                  },
                  {
                    "text": "More prominent portal lymphoid aggregates"
                  },
                  {
                    "text": "Portal and periportal fibrosis"
                  },
                  {
                    "text": "Negative EBER ISH, EBV serologies, and PCR"
                  }
                ],
                "CMV Hepatitis": [
                  {
                    "text": "Occasionally produces mononucleosis-like pattern"
                  },
                  {
                    "text": "Viral inclusions are absent in this context"
                  },
                  {
                    "text": "CMV PCR, serologies are helpful"
                  }
                ],
                "Drug-Induced Hepatitis": [
                  {
                    "text": "May produce mononucleosis-like pattern"
                  },
                  {
                    "text": "History of drug use (phenytoin, sulfonamides, dapsone, minocycline, etc.)"
                  },
                  {
                    "text": "Variably present lobular necrosis, eosinophils, cholestasis"
                  },
                  {
                    "text": "Negative EBER ISH, EBV serologies, and PCR"
                  }
                ],
                "Other Spindle Cell Tumors": [
                  {
                    "text": "Metastatic leiomyosarcoma: Significant nuclear atypia and more mitoses; EBER(-)"
                  },
                  {
                    "text": "Metastatic gastrointestinal stromal tumor: C-kit, DOG1 (+); EBER(-)"
                  },
                  {
                    "text": "Mycobacteria-associated spindle cell pseudotumor: EBER and smooth muscle marker negative; positive for AFB stains"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Elevated liver function tests in patients with symptoms and signs of infectious mononucleosis"
                  },
                  {
                    "text": "Spindle cell tumor in immunosuppressed patients"
                  },
                  {
                    "text": "Hematolymphoid lesions in solid organ transplant recipients"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cytomegalovirus": {
            "name": "Cytomegalovirus",
            "url": "https://app.pathprimer.com/document/c6caddc3-6071-4b5a-bcde-fd3b9a436bb7/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "At least 60% of adults in USA have serologic evidence of past infectionMost clinically significant infections are seen in setting of immunosuppression",
                    "sub_points": [
                      "Most clinically significant infections are seen in setting of immunosuppression"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Infection can be acquired before birth, at birth, or later in lifeFollowing active infection, latent infection may persist for years",
                    "sub_points": [
                      "Following active infection, latent infection may persist for years"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Clinical (and histologic) presentation of CMV hepatitis depends on age and immune status of patientMost infections in immunocompetent patients are clinically silentImmunocompromised patients have highly variable presentationHighest risk of infection in transplant patients is seronegative recipient/seropositive donorCongenital infection ranges from asymptomatic to severe",
                    "sub_points": [
                      "Most infections in immunocompetent patients are clinically silent",
                      "Immunocompromised patients have highly variable presentationHighest risk of infection in transplant patients is seronegative recipient/seropositive donor",
                      "Highest risk of infection in transplant patients is seronegative recipient/seropositive donor",
                      "Congenital infection ranges from asymptomatic to severe"
                    ]
                  },
                  {
                    "text": "Helpful laboratory tests include serologies and PCR from blood"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Characteristic cytoplasmic and nuclear enlargement with intranuclear and intracytoplasmic inclusionsInclusions can be seen within hepatocytes, biliary epithelium, endothelial cells, and Kupffer cells",
                    "sub_points": [
                      "Inclusions can be seen within hepatocytes, biliary epithelium, endothelial cells, and Kupffer cells"
                    ]
                  },
                  {
                    "text": "Immunocompetent patients can have mononucleosis-like pattern with sinusoidal lymphocytic infiltrate and absence of viral inclusions"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Epstein-Barr-associated hepatitis"
                  },
                  {
                    "text": "Other viral infections such as HSV, adenovirus"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Cytomegalovirus (CMV)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "HHV-5"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection of liver by CMVMember ofHerpesviridaefamily, capable of infecting many cell types",
                    "sub_points": [
                      "Member ofHerpesviridaefamily, capable of infecting many cell types"
                    ]
                  },
                  {
                    "text": "At least 60% of adults in USA have serologic evidence of past infectionHigher rates in developing countries and in HIV-positive patients",
                    "sub_points": [
                      "Higher rates in developing countries and in HIV-positive patients"
                    ]
                  },
                  {
                    "text": "Most clinically significant infections are seen in setting of immunosuppressionOrgan transplantation, AIDS, congenital infection, pregnancy",
                    "sub_points": [
                      "Organ transplantation, AIDS, congenital infection, pregnancy"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infection": [
                  {
                    "text": "Can be acquired before birth, at birth, or later in life"
                  },
                  {
                    "text": "Following active infection, latent infection may persist for yearsReactivation typically occurs when normal immunity is lost or impaired",
                    "sub_points": [
                      "Reactivation typically occurs when normal immunity is lost or impaired"
                    ]
                  },
                  {
                    "text": "Pathogenesis of CMV hepatitis is unclearDirect viral damage &/or host inflammatory response may play roles in producing functional liver abnormalities",
                    "sub_points": [
                      "Direct viral damage &/or host inflammatory response may play roles in producing functional liver abnormalities"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Most infections in immunocompetent patients are clinically silentRare immunocompetent patients manifest mononucleosis-like illness",
                    "sub_points": [
                      "Rare immunocompetent patients manifest mononucleosis-like illness"
                    ]
                  },
                  {
                    "text": "Immunocompromised patients have highly variable presentationFever, malaise, myalgias, arthralgias, nausea, abdominal painAllograft recipients' symptoms usually develop between 2 weeks and 4 months post transplantHighest risk of infection is seronegative recipient/seropositive donorReactivation of latent infection may also occurAssociated with increased risk of rejection in transplant patients",
                    "sub_points": [
                      "Fever, malaise, myalgias, arthralgias, nausea, abdominal pain",
                      "Allograft recipients' symptoms usually develop between 2 weeks and 4 months post transplantHighest risk of infection is seronegative recipient/seropositive donorReactivation of latent infection may also occurAssociated with increased risk of rejection in transplant patients",
                      "Highest risk of infection is seronegative recipient/seropositive donor",
                      "Reactivation of latent infection may also occur",
                      "Associated with increased risk of rejection in transplant patients"
                    ]
                  },
                  {
                    "text": "Congenital infection: Variable presentation ranging from asymptomatic to severe infection with jaundice, hepatosplenomegaly, encephalitis, chorioretinitis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "PCR from bloodUsed for diagnosis as well as monitoring in transplant patientsDoes not necessarily correlate with organ-specific disease",
                    "sub_points": [
                      "Used for diagnosis as well as monitoring in transplant patients",
                      "Does not necessarily correlate with organ-specific disease"
                    ]
                  },
                  {
                    "text": "SerologiesLess useful in immunocompromised patients",
                    "sub_points": [
                      "Less useful in immunocompromised patients"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antiviral therapy (ganciclovir, valganciclovir) &/or reduce immunosuppression"
                  },
                  {
                    "text": "Prophylaxis and vigilant monitoring for infection in transplant patients"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on host immune statusResolves spontaneously in immunocompetent peopleMononucleosis-like pattern usually resolves within several weeksChronic liver disease very rare",
                    "sub_points": [
                      "Resolves spontaneously in immunocompetent people",
                      "Mononucleosis-like pattern usually resolves within several weeks",
                      "Chronic liver disease very rare"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "CMV cytopathic effectCytoplasmic and nuclear enlargement (2-4x normal)Inclusions within hepatocytes, biliary epithelium, endothelial cells, and Kupffer cellsIntranuclear: Large glassy round to oval inclusions with surrounding halo (\"owl's eye\")Intracytoplasmic: Basophilic or amphophilic granulesPositive on immunohistochemical stain for CMV",
                    "sub_points": [
                      "Cytoplasmic and nuclear enlargement (2-4x normal)",
                      "Inclusions within hepatocytes, biliary epithelium, endothelial cells, and Kupffer cellsIntranuclear: Large glassy round to oval inclusions with surrounding halo (\"owl's eye\")Intracytoplasmic: Basophilic or amphophilic granules",
                      "Intranuclear: Large glassy round to oval inclusions with surrounding halo (\"owl's eye\")",
                      "Intracytoplasmic: Basophilic or amphophilic granules",
                      "Positive on immunohistochemical stain for CMV"
                    ]
                  },
                  {
                    "text": "Immunosuppressed patientsCMV inclusions along with mild lobular hepatitis, hepatocellular necrosis, patchy mononuclear portal inflammation, &/or neutrophilic microabscessesInflammation may be absent in severely immunocompromised patients",
                    "sub_points": [
                      "CMV inclusions along with mild lobular hepatitis, hepatocellular necrosis, patchy mononuclear portal inflammation, &/or neutrophilic microabscesses",
                      "Inflammation may be absent in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Congenital infectionsResemble those of immunosuppressed patients (including presence of viral cytopathic effects)Some have neonatal hepatitis-like pattern (cholestasis, hepatocyte necrosis) or features that simulate biliary atresia (bile ductular proliferation and portal fibrosis)Extramedullary hematopoiesis is common finding",
                    "sub_points": [
                      "Resemble those of immunosuppressed patients (including presence of viral cytopathic effects)",
                      "Some have neonatal hepatitis-like pattern (cholestasis, hepatocyte necrosis) or features that simulate biliary atresia (bile ductular proliferation and portal fibrosis)",
                      "Extramedullary hematopoiesis is common finding"
                    ]
                  },
                  {
                    "text": "Mononucleosis-like pattern of infection in immunocompetent patientsProminent mononuclear infiltrate within portal tracts and sinusoids (string of beads pattern)Viral inclusions typically absentOccasional granulomas",
                    "sub_points": [
                      "Prominent mononuclear infiltrate within portal tracts and sinusoids (string of beads pattern)",
                      "Viral inclusions typically absent",
                      "Occasional granulomas"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Epstein-Barr-Associated Hepatitis": [
                  {
                    "text": "Epstein-Barr (+) serologies; lack of CMV inclusions"
                  }
                ],
                "Other Viral Infections": [
                  {
                    "text": "Herpes simplex virus, adenovirus, varicella-zoster"
                  },
                  {
                    "text": "Immunohistochemical stains, serologies, and clinical context are helpful"
                  },
                  {
                    "text": "HSV causes ground glass inclusions with margination of chromatin; adenovirus causes nuclear inclusions known as \"smudge cells\"; both cause zonal necrosis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "In transplant patients, look especially carefully for CMV in biopsy within 3 months of transplant (highest immunosuppression)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Herpes Simplex Virus": {
            "name": "Herpes Simplex Virus",
            "url": "https://app.pathprimer.com/document/e67aeaa2-b5cd-432b-937c-28a2abffea88/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Hepatitis is result of disseminated infection and can occur with both herpes simplex virus 1 and 2 (HSV1 and HSV2)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Anicteric hepatitis with marked elevation of transaminases"
                  },
                  {
                    "text": "Antiviral therapy with acyclovir"
                  },
                  {
                    "text": "Risk factors: Immunosuppression, neonates, pregnancy"
                  },
                  {
                    "text": "Oropharyngeal or genital manifestations in 30-50% of cases"
                  },
                  {
                    "text": "Acute decompensation 3-21 days after nonspecific symptoms"
                  },
                  {
                    "text": "PCR for viral DNA from plasma, body fluids, tissue for diagnosis"
                  },
                  {
                    "text": "Neonatal HSV typically presents 5-7 days after birth"
                  },
                  {
                    "text": "Liver transplant can be used as treatment of last resort"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Extensive nonzonal coagulative necrosis with negligible inflammation"
                  },
                  {
                    "text": "Viral inclusions in hepatocyte nuclei at interface of necrotic and viable areasCharacterized by ground-glass or smudged nuclei with margination of chromatin",
                    "sub_points": [
                      "Characterized by ground-glass or smudged nuclei with margination of chromatin"
                    ]
                  },
                  {
                    "text": "Multinucleated cells with nuclear molding are less common compared with mucocutaneous HSV infections"
                  },
                  {
                    "text": "Immunohistochemistry with antibodies directed against HSV1/HSV2 confirms diagnosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acetaminophen toxicityPerivenular necrosis",
                    "sub_points": [
                      "Perivenular necrosis"
                    ]
                  },
                  {
                    "text": "Adenovirus hepatitisCan look similar to HSV hepatitisImmunohistochemistry can help distinguish",
                    "sub_points": [
                      "Can look similar to HSV hepatitis",
                      "Immunohistochemistry can help distinguish"
                    ]
                  },
                  {
                    "text": "Wilson diseaseElevated hepatic copper, urinary copper, low ceruloplasmin",
                    "sub_points": [
                      "Elevated hepatic copper, urinary copper, low ceruloplasmin"
                    ]
                  },
                  {
                    "text": "Acute vascular injuryHemorrhagic necrosis around central vein",
                    "sub_points": [
                      "Hemorrhagic necrosis around central vein"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Herpes simplex virus (HSV) hepatitis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Hepatitis is result of disseminated infection and can occur with both HSV1 and HSV2"
                  },
                  {
                    "text": "Dissemination may occur due to immunosuppression, large initial inoculum, enhanced virulence at reactivation, or hepatovirulence of certain strains"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Risk factorsImmunosuppressionNeonates3rd trimester of pregnancy",
                    "sub_points": [
                      "Immunosuppression",
                      "Neonates",
                      "3rd trimester of pregnancy"
                    ]
                  },
                  {
                    "text": "Fulminant infections rare in immunocompetent individuals"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific flu-like symptomsFever, headache, abdominal/muscle pain",
                    "sub_points": [
                      "Fever, headache, abdominal/muscle pain"
                    ]
                  },
                  {
                    "text": "Oropharyngeal or genital manifestations in 30-50% of cases"
                  },
                  {
                    "text": "Acute decompensation 3-21 days after nonspecific symptomsAnictericNo hepatomegalyMarked elevation of transaminases (AST > ALT)Leukopenia, thrombocytopeniaEncephalitis, renal failure, and disseminated intravascular coagulation can occur",
                    "sub_points": [
                      "Anicteric",
                      "No hepatomegaly",
                      "Marked elevation of transaminases (AST > ALT)",
                      "Leukopenia, thrombocytopenia",
                      "Encephalitis, renal failure, and disseminated intravascular coagulation can occur"
                    ]
                  },
                  {
                    "text": "Neonatal HSV typically presents 5-7 days after birth and mimics bacterial sepsis (poor feeding, lethargy, fever)"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Viral culture: Mucocutaneous lesions, urine, stool, blood"
                  },
                  {
                    "text": "PCR for viral DNA using plasma, body fluids, tissueMore sensitive for diagnosis than IgM antibodies",
                    "sub_points": [
                      "More sensitive for diagnosis than IgM antibodies"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antiviral drugs: Acyclovir and adenine arabinoside"
                  },
                  {
                    "text": "Early treatment is crucial, as disease can follow rapidly progressive course"
                  },
                  {
                    "text": "Liver transplant is used as last resortSurvival rate of ~ 40%May need lifelong prophylactic treatment with acyclovir due to risk for recurrent HSV infection",
                    "sub_points": [
                      "Survival rate of ~ 40%",
                      "May need lifelong prophylactic treatment with acyclovir due to risk for recurrent HSV infection"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "High mortality (80-90%) in untreated cases"
                  },
                  {
                    "text": "Survival is better in pregnant patients"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Extensive nonzonal coagulative hemorrhagic necrosis"
                  },
                  {
                    "text": "Inflammatory response is inconspicuous"
                  },
                  {
                    "text": "Viral inclusions at interface of necrotic and viable areasGround-glass or smudged nuclei with margination of chromatinEosinophilic intranuclear inclusions surrounded by halo (Cowdry type A) can be presentMultinucleated cells with nuclear molding are less common compared with mucocutaneous HSV infections",
                    "sub_points": [
                      "Ground-glass or smudged nuclei with margination of chromatin",
                      "Eosinophilic intranuclear inclusions surrounded by halo (Cowdry type A) can be present",
                      "Multinucleated cells with nuclear molding are less common compared with mucocutaneous HSV infections"
                    ]
                  },
                  {
                    "text": "Immunohistochemistry with antibodies directed against HSV1/HSV2 should be used"
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Necrosis"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Hepatocyte"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acetaminophen Toxicity": [
                  {
                    "text": "Necrosis, often perivenular, without significant inflammation"
                  },
                  {
                    "text": "History of drug intake, elevated blood levels of drug, and absence of viral inclusions"
                  }
                ],
                "Toxin-Induced Liver Injury": [
                  {
                    "text": "Mushroom poisoning, cocaine, herbal medications, carbon tetrachloride"
                  },
                  {
                    "text": "Necrosis without significant inflammation"
                  },
                  {
                    "text": "History of exposure and absence of viral inclusions"
                  }
                ],
                "Adenovirus Hepatitis": [
                  {
                    "text": "Usually affects immunosuppressed patients"
                  },
                  {
                    "text": "Immunohistochemistry necessary to distinguish from HSV; inclusions very similar"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Rarely presents as fulminant hepatitis with necrosis and no significant inflammation"
                  },
                  {
                    "text": "Elevated hepatic copper, urinary copper, low ceruloplasmin"
                  },
                  {
                    "text": "No viral inclusions"
                  }
                ],
                "Acute Vascular Injury": [
                  {
                    "text": "Acute ischemia (circulatory shock) or venous outflow obstruction (Budd-Chiari syndrome)"
                  },
                  {
                    "text": "Hemorrhagic necrosis around central vein"
                  },
                  {
                    "text": "Sinusoidal dilatation in venous outflow obstruction"
                  },
                  {
                    "text": "No viral inclusions"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Look for inclusions at interface between necrotic zones and viable parenchyma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adenovirus": {
            "name": "Adenovirus",
            "url": "https://app.pathprimer.com/document/cbd78b90-b516-4e03-b50a-588dfe0e697e/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Nonenveloped, double-stranded DNA viruses that include > 50 serotypes known to infect humans"
                  },
                  {
                    "text": "Serotypes 1, 2, and 5 are most common hepatic isolates"
                  },
                  {
                    "text": "Incubation time of 2-14 days for new infection"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Mild, self-limited illnesses in immunocompetent individuals"
                  },
                  {
                    "text": "Fulminant hepatitis occurring in setting of severe immunosuppression, usually fatal with > 50% mortality rate"
                  },
                  {
                    "text": "No virus-specific therapy; successful treatment with cidofovir, ribavirin, or serum immunoglobulin containing high titers of neutralizing antibody to adenovirus has been reported"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Hypodense lesions in liver on CT"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Hepatomegaly with mottled foci of necrosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Random small or large foci of coagulative necrosis of hepatocytes"
                  },
                  {
                    "text": "No or minimal inflammatory response around necrotic foci"
                  },
                  {
                    "text": "Intranuclear viral inclusions with characteristic smudgy nuclear appearance and chromatin margination in infected hepatocytes commonly seen at periphery of necrotic foci"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Immunohistochemistry"
                  },
                  {
                    "text": "Polymerase chain reaction"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Herpes simplex virus hepatitisInfected hepatocytes may be slightly enlarged and multinucleatedMay show hemorrhagic appearance in areas of necrosis",
                    "sub_points": [
                      "Infected hepatocytes may be slightly enlarged and multinucleated",
                      "May show hemorrhagic appearance in areas of necrosis"
                    ]
                  },
                  {
                    "text": "Varicella-zoster virus hepatitis"
                  },
                  {
                    "text": "CMV hepatitis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Adenovirus = ADV"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hepatitis caused by adenoviruses"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Nonenveloped, double-stranded DNA virus, includes > 50 serotypes known to infect humans"
                  },
                  {
                    "text": "Serotypes 1, 2, and 5 are most common hepatic isolates"
                  },
                  {
                    "text": "Primary infection or reactivation of latent infection"
                  },
                  {
                    "text": "Spread by aerosolized droplets, water, fomites, and donor organs as well as fecal-oral, ocular, and nosocomial routes"
                  },
                  {
                    "text": "Incubation time of 2-14 days for new infection"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Mild, self-limited illnesses in immunocompetent individualsRespiratory infection, keratoconjunctivitis, hemorrhagic cystitis, and gastroenteritis",
                    "sub_points": [
                      "Respiratory infection, keratoconjunctivitis, hemorrhagic cystitis, and gastroenteritis"
                    ]
                  },
                  {
                    "text": "Severe diseases in immunocompromised patientsHepatitis, pancreatitis, pneumonia, nephritis, encephalitis, or disseminated diseaseDisseminated ADV disease definition: multi-organ involvement in the presence of 2 or more positive PCR assays of blood and other body fluids",
                    "sub_points": [
                      "Hepatitis, pancreatitis, pneumonia, nephritis, encephalitis, or disseminated disease",
                      "Disseminated ADV disease definition: multi-organ involvement in the presence of 2 or more positive PCR assays of blood and other body fluids"
                    ]
                  },
                  {
                    "text": "Fulminant hepatitis typically occurs in immunocompromised or transplant patientsHigh fever, jaundiceMarked elevation of serum transaminase levels",
                    "sub_points": [
                      "High fever, jaundice",
                      "Marked elevation of serum transaminase levels"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Detection of viral DNA by polymerase chain reaction on specimens such as blood or bronchoalveolar lavage"
                  },
                  {
                    "text": "Direct viral antigen detection"
                  },
                  {
                    "text": "Viral isolation by culture"
                  },
                  {
                    "text": "Serology"
                  }
                ],
                "Treatment": [
                  {
                    "text": "No virus-specific therapySuccessful treatment with cidofovir, ribavirin, or serum immunoglobulin containing high titers of neutralizing antibody to adenovirus has been reported",
                    "sub_points": [
                      "Successful treatment with cidofovir, ribavirin, or serum immunoglobulin containing high titers of neutralizing antibody to adenovirus has been reported"
                    ]
                  },
                  {
                    "text": "Supportive care"
                  },
                  {
                    "text": "Reduction of immunosuppression"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Fulminant hepatitis is usually fatal with > 50% mortality rate"
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Hypodense lesions in liver; lesions can be subtle"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hepatomegaly with mottled foci of necrosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Random, variably sized foci of coagulative necrosis of hepatocytesMinimal or no inflammatory response around necrotic foci",
                    "sub_points": [
                      "Minimal or no inflammatory response around necrotic foci"
                    ]
                  },
                  {
                    "text": "Mild, nonspecific lobular and portal inflammatory cell infiltrates consisting of lymphocytes, neutrophils, and eosinophils may be present"
                  },
                  {
                    "text": "Small, poorly formed granulomas and microabscesses may be seen with inclusions in necrotic centers"
                  },
                  {
                    "text": "Intranuclear viral inclusions with characteristic smudgy nuclear appearance and chromatin margination in infected hepatocytesCommonly seen at periphery of necrotic fociInfected hepatocytes do not exhibit cytomegaly or multinucleation",
                    "sub_points": [
                      "Commonly seen at periphery of necrotic foci",
                      "Infected hepatocytes do not exhibit cytomegaly or multinucleation"
                    ]
                  },
                  {
                    "text": "Rarely, viral inclusions noted in biliary epithelium, causing necrotizing cholangitis and bile duct loss"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Monoclonal antiadenovirus (blend) antibodies stain for infected cells (nuclear positivity)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Herpes Simplex Virus Hepatitis": [
                  {
                    "text": "Infected hepatocytes may be slightly enlarged and multinucleated"
                  },
                  {
                    "text": "May show hemorrhagic appearance in areas of necrosis"
                  },
                  {
                    "text": "Immunohistochemical stain is helpful"
                  }
                ],
                "Varicella-Zoster Virus Hepatitis": [
                  {
                    "text": "Histologically indistinguishable from herpes simplex virus hepatitis"
                  },
                  {
                    "text": "Presence of typical skin lesions"
                  },
                  {
                    "text": "Immunohistochemical stain and polymerase chain reaction are helpful"
                  }
                ],
                "Cytomegalovirus Hepatitis": [
                  {
                    "text": "Large eosinophilic nuclear viral inclusions typically surrounded by clear halo"
                  },
                  {
                    "text": "Presence of cytoplasmic viral inclusions"
                  },
                  {
                    "text": "Typically lack large foci of coagulative necrosis"
                  },
                  {
                    "text": "Microabscesses may be present"
                  },
                  {
                    "text": "Immunohistochemical stain is helpful"
                  }
                ],
                "Drug-Induced Hepatitis": [
                  {
                    "text": "May show more pronounced cholestasis &/or steatosis"
                  },
                  {
                    "text": "Acidophil bodies' pyknotic nuclei can mimic virus but lack true smudgy nuclear inclusions"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Jaundice and hepatic failure in setting of severe immunosuppression"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Foci of coagulative necrosis"
                  },
                  {
                    "text": "Characteristic nuclear viral inclusions"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pyogenic Abscess": {
            "name": "Pyogenic Abscess",
            "url": "https://app.pathprimer.com/document/b7e6dd70-1fa7-4144-b7d1-bf7dbbb64dee/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Localized accumulation of pus with surrounding inflammation and fibrosis, secondary to infectionOccurs via portal vein, arterial system, or bile ducts",
                    "sub_points": [
                      "Occurs via portal vein, arterial system, or bile ducts"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Bacterial pathogens most common in Western countriesKlebsiella pneumoniaeis now most common pathogen, followed byEscherichia coliAnaerobes are isolated in up to 25% of casesSignificant number are cryptogenic",
                    "sub_points": [
                      "Klebsiella pneumoniaeis now most common pathogen, followed byEscherichia coli",
                      "Anaerobes are isolated in up to 25% of cases",
                      "Significant number are cryptogenic"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Diabetes is major risk factorOther associated conditions include intraabdominal infections, biliary disease, malignancy, cirrhosis",
                    "sub_points": [
                      "Other associated conditions include intraabdominal infections, biliary disease, malignancy, cirrhosis"
                    ]
                  },
                  {
                    "text": "Presentation includes fever, chills, right upper quadrant painElevated WBC count, ESR, CRP, bilirubin, alkaline phosphatase, transaminases",
                    "sub_points": [
                      "Elevated WBC count, ESR, CRP, bilirubin, alkaline phosphatase, transaminases"
                    ]
                  },
                  {
                    "text": "Percutaneous drainage and antibiotics are mainstay of therapy"
                  },
                  {
                    "text": "Major complication is spread of infection"
                  },
                  {
                    "text": "Mortality ~ 15% overall"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Most abscesses are solitary; multiple abscesses occur in 25-45% of casesRight lobe most frequent site",
                    "sub_points": [
                      "Right lobe most frequent site"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Abundant neutrophils with surrounding fibrosis"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Culture of abscess contents is critical to diagnosis and management"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection featuring localized accumulation of pus with surrounding inflammation and fibrosisInfection seeded via portal vein, arterial system, or bile ducts",
                    "sub_points": [
                      "Infection seeded via portal vein, arterial system, or bile ducts"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Diabetes, malignancy, alcohol abuse, cirrhosis, immunosuppressionAbscesses secondary toYersiniaspp. are often associated with underlying hemochromatosis",
                    "sub_points": [
                      "Abscesses secondary toYersiniaspp. are often associated with underlying hemochromatosis"
                    ]
                  },
                  {
                    "text": "Biliary diseaseIncluding biliary ischemia secondary to surgery or ablative procedures",
                    "sub_points": [
                      "Including biliary ischemia secondary to surgery or ablative procedures"
                    ]
                  },
                  {
                    "text": "Trauma or hepatobiliary surgery"
                  },
                  {
                    "text": "Secondary to intraabdominal infections or sepsis"
                  },
                  {
                    "text": "Many are cryptogenic"
                  }
                ],
                "Epidemiology": [
                  {
                    "text": "Bacterial abscesses are most common in Western countriesKlebsiella pneumoniaeis now most common pathogen, followed byEscherichia coliBoth produce formic hydrogenlyase, which can convert acids in abscess into carbon dioxide and hydrogen gasGas-forming pyogenic abscess carries higher risk of septic shock, bacteremia, and deathOther commonly isolated organisms includeEnterococcusspp.,Streptococcusspp., andPseudomonasspp.Anaerobes are isolated in up to 25% of casesMicroaerophilicStreptococci,Bacteroidesfragilis,Fusobacteriumnecrophorum, andClostridiaspp.Actinomycesspp. can be associated with formation of sinus tracts and solitary masses that mimic malignancyRare isolates includeFrancisella tularensis,Burkholderia pseudomallei(melioidosis),Brucellaspp. (particularlyB. suis), andListeria monocytogenesFungi (i.e.,CandidaandAspergillus )are found in 15% of casesAt least 1/3 of cases are polymicrobial",
                    "sub_points": [
                      "Klebsiella pneumoniaeis now most common pathogen, followed byEscherichia coliBoth produce formic hydrogenlyase, which can convert acids in abscess into carbon dioxide and hydrogen gasGas-forming pyogenic abscess carries higher risk of septic shock, bacteremia, and death",
                      "Both produce formic hydrogenlyase, which can convert acids in abscess into carbon dioxide and hydrogen gas",
                      "Gas-forming pyogenic abscess carries higher risk of septic shock, bacteremia, and death",
                      "Other commonly isolated organisms includeEnterococcusspp.,Streptococcusspp., andPseudomonasspp.",
                      "Anaerobes are isolated in up to 25% of casesMicroaerophilicStreptococci,Bacteroidesfragilis,Fusobacteriumnecrophorum, andClostridiaspp.Actinomycesspp. can be associated with formation of sinus tracts and solitary masses that mimic malignancy",
                      "MicroaerophilicStreptococci,Bacteroidesfragilis,Fusobacteriumnecrophorum, andClostridiaspp.",
                      "Actinomycesspp. can be associated with formation of sinus tracts and solitary masses that mimic malignancy",
                      "Rare isolates includeFrancisella tularensis,Burkholderia pseudomallei(melioidosis),Brucellaspp. (particularlyB. suis), andListeria monocytogenes",
                      "Fungi (i.e.,CandidaandAspergillus )are found in 15% of cases",
                      "At least 1/3 of cases are polymicrobial"
                    ]
                  },
                  {
                    "text": "Peak incidence in patients 55-60 years old; male predominance"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Fever, chills, right upper quadrant painNonspecific signs/symptoms such as diarrhea, nausea, vomiting, jaundice, right pleural effusion also common",
                    "sub_points": [
                      "Nonspecific signs/symptoms such as diarrhea, nausea, vomiting, jaundice, right pleural effusion also common"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated WBC count, ESR, CRP, bilirubin, alkaline phosphatase, transaminases"
                  },
                  {
                    "text": "Hypoalbuminemia and anemia also common"
                  },
                  {
                    "text": "Blood culturesPositive yield in ~ 50-60% of cases",
                    "sub_points": [
                      "Positive yield in ~ 50-60% of cases"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Antibiotic therapy"
                  },
                  {
                    "text": "Drainage, surgery occasionally necessary"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality ~ 15%"
                  },
                  {
                    "text": "Complications include spread of infection (endophthalmitis, meningitis, osteomyelitis, pyelonephritis, and pneumonia)Main risk factors for spread infection are diabetes and infection withK. pneumonia",
                    "sub_points": [
                      "Main risk factors for spread infection are diabetes and infection withK. pneumonia"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Primary Method of Diagnosis": [
                  {
                    "text": "Ultrasound &/or CTConfirmatory needle aspiration useful for both diagnosis and culture",
                    "sub_points": [
                      "Confirmatory needle aspiration useful for both diagnosis and culture"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Most are solitary; multiple in 25-45% of cases"
                  },
                  {
                    "text": "Most common in right lobe (70%); left lobe or bilateral disease less frequent"
                  },
                  {
                    "text": "Appear as irregular area of softening with central liquefactive necrosis and green discoloration with variable surrounding fibrosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Collection of neutrophils with fibrin, bile, or necrotic debris"
                  },
                  {
                    "text": "Variably present fibrosis surrounding abscess"
                  },
                  {
                    "text": "Additional findings may be seen depending on causative organism, such as sulfur granules inActinomycesinfection"
                  }
                ],
                "Ancillary Studies": [
                  {
                    "text": "Histochemical stains for organisms (Gram, GMS, acid-fast, PAS, and Steiner stains)"
                  },
                  {
                    "text": "Culture of abscess contents"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Causes of Hepatic Abscess": [
                  {
                    "text": "Tuberculosis, amebiasis, ascariasisCulture, special stains, PCR, presence of organisms may help differentiate",
                    "sub_points": [
                      "Culture, special stains, PCR, presence of organisms may help differentiate"
                    ]
                  }
                ],
                "Recurrent Pyogenic Cholangitis": [
                  {
                    "text": "Patients from Far East or Asian immigrants"
                  },
                  {
                    "text": "Recurrent attacks of suppurative cholangitis with hepatic stones"
                  },
                  {
                    "text": "Associated with biliary flukes"
                  }
                ],
                "Tumor": [
                  {
                    "text": "Symptoms, imaging can mimic malignancy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Sepsis in the Liver": {
            "name": "Sepsis in the Liver",
            "url": "https://app.pathprimer.com/document/c4569d3d-a3bf-4c1e-9dd4-f12846a64e64/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Spectrum of hepatic injury in patients with sepsis or bacteremia"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Usually caused by sepsis from underlying bacterial pneumonia or intraabdominal infectionMost often gram-negative infection",
                    "sub_points": [
                      "Most often gram-negative infection"
                    ]
                  },
                  {
                    "text": "Mechanisms uncertain but probably involve decreased activity and expression of canalicular and sinusoidal transporters"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Patients are systemically ill and typically jaundiced"
                  },
                  {
                    "text": "Enzyme elevations may be hepatocellular, cholestatic, or mixed"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Ductular cholestasis pattern strongly associated with sepsisDuctular reaction at perimeter of portal tracts with dilated profile, flattened epithelium, inspissated bile",
                    "sub_points": [
                      "Ductular reaction at perimeter of portal tracts with dilated profile, flattened epithelium, inspissated bile"
                    ]
                  },
                  {
                    "text": "Variably present neutrophilic inflammation"
                  },
                  {
                    "text": "Canalicular cholestasis also commonMay lack significant attendant inflammation, especially in infants and children",
                    "sub_points": [
                      "May lack significant attendant inflammation, especially in infants and children"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Large bile duct obstruction"
                  },
                  {
                    "text": "Total parenteral nutrition"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Many entities in differential diagnosis can coexist along with sepsis and may confound histologic pictureBlood cultures should be drawn in severely ill patients with these findings on biopsy",
                    "sub_points": [
                      "Blood cultures should be drawn in severely ill patients with these findings on biopsy"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Spectrum of hepatic injury in patients with sepsis or bacteremiaUsually due to gram-negative sepsis",
                    "sub_points": [
                      "Usually due to gram-negative sepsis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanism Uncertain": [
                  {
                    "text": "Presumably bacterial endotoxins interfere with normal bile flow and canalicular functionDecreased activity and expression of both canalicular and sinusoidal transporters of bile acids and organic anionsLoss of contractile activity in actin and myosin microfilaments around canaliculi and bile ducts, which normally help transport bile acids through canalicular route",
                    "sub_points": [
                      "Decreased activity and expression of both canalicular and sinusoidal transporters of bile acids and organic anions",
                      "Loss of contractile activity in actin and myosin microfilaments around canaliculi and bile ducts, which normally help transport bile acids through canalicular route"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Patients are systemically ill from sepsis/bacteremiaMay be in shock",
                    "sub_points": [
                      "May be in shock"
                    ]
                  },
                  {
                    "text": "Jaundice is commonSepsis is 2nd leading cause of cholestasis in clinically jaundiced patientsTypically resolves with control of underlying infection",
                    "sub_points": [
                      "Sepsis is 2nd leading cause of cholestasis in clinically jaundiced patients",
                      "Typically resolves with control of underlying infection"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Hyperbilirubinemia and elevated alkaline phosphataseMay precede positive blood cultures",
                    "sub_points": [
                      "May precede positive blood cultures"
                    ]
                  },
                  {
                    "text": "Variably elevated transaminases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treatment of underlying infection"
                  },
                  {
                    "text": "Supportive care"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on severity of underlying infection"
                  },
                  {
                    "text": "Patients are often severely ill with poor prognosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Variably present hepatomegaly"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Ductular cholestasis (cholangitis lenta) most common patternDuctular reaction at perimeter of portal tracts with inspissated bileDuctules may be dilated with atrophic and flattened epitheliumPeriductular neutrophilic infiltrateInterlobular bile ducts typically spared",
                    "sub_points": [
                      "Ductular reaction at perimeter of portal tracts with inspissated bile",
                      "Ductules may be dilated with atrophic and flattened epithelium",
                      "Periductular neutrophilic infiltrate",
                      "Interlobular bile ducts typically spared"
                    ]
                  },
                  {
                    "text": "Centrilobular canalicular cholestasis may be present\"Pure\" cholestasis with no significant inflammation is fairly common in sepsis, especially in infants and childrenHepatocellular cholestasis may be present as well",
                    "sub_points": [
                      "\"Pure\" cholestasis with no significant inflammation is fairly common in sepsis, especially in infants and children",
                      "Hepatocellular cholestasis may be present as well"
                    ]
                  },
                  {
                    "text": "Neutrophilic inflammationPortal &/or lobularVariably present microabscesses",
                    "sub_points": [
                      "Portal &/or lobular",
                      "Variably present microabscesses"
                    ]
                  },
                  {
                    "text": "Additional findingsFocal hepatocyte necrosisCentrilobular &/or midzonal fatty change, usually microvesicularKupffer cell hyperplasiaHepatocellular reactive changes",
                    "sub_points": [
                      "Focal hepatocyte necrosis",
                      "Centrilobular &/or midzonal fatty change, usually microvesicular",
                      "Kupffer cell hyperplasia",
                      "Hepatocellular reactive changes"
                    ]
                  },
                  {
                    "text": "Many cases have mixed pattern combining several features above"
                  },
                  {
                    "text": "Patients in septic shock may have ischemic necrosis, particularly in perivenular distribution"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Large Bile Duct Obstruction": [
                  {
                    "text": "Histologic features may be very similarImportant to recognize histologic features of sepsis so that patients are not subjected to unnecessary invasive procedures to rule out obstruction",
                    "sub_points": [
                      "Important to recognize histologic features of sepsis so that patients are not subjected to unnecessary invasive procedures to rule out obstruction"
                    ]
                  },
                  {
                    "text": "Obstruction generally does not feature ductular cholestasis"
                  },
                  {
                    "text": "May need clinical history and imaging studies to differentiate"
                  }
                ],
                "Adverse Drug Reaction": [
                  {
                    "text": "May show ductular cholestasis or \"pure\" cholestasis, both of which can mimic sepsis"
                  },
                  {
                    "text": "Clinical history (particularly medication history) necessary to resolve"
                  }
                ],
                "Total Parenteral Nutrition": [
                  {
                    "text": "May show ductular cholestasis"
                  },
                  {
                    "text": "Patients have history of total parenteral nutrition"
                  }
                ],
                "Biliary Atresia in Newborns": [
                  {
                    "text": "May show ductular cholestasis"
                  },
                  {
                    "text": "Clinical history/imaging necessary to resolve"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Inspissated bile in ductules (not ducts) near portal tracts"
                  },
                  {
                    "text": "Bilirubin pigment without any other features of cholestasis (pure/bland cholestasis)"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Sepsis produces several different histologic patterns in liver"
                  },
                  {
                    "text": "Many entities in differential diagnosis can coexist along with sepsis and may confound histologic picture"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mycobacterium tuberculosis": {
            "name": "Mycobacterium tuberculosis",
            "url": "https://app.pathprimer.com/document/b573994f-4ebe-4454-afd6-b55df0ffdc8e/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection byMycobacterium tuberculosis(MTB)Hepatic tuberculosis (TB) seen in ~ 1% of patients with active TBMore common in HIV-positive patients",
                    "sub_points": [
                      "Hepatic tuberculosis (TB) seen in ~ 1% of patients with active TB",
                      "More common in HIV-positive patients"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Transmission typically by inhalationCan reach liver by hematogenous spread or direct spread from GI tract",
                    "sub_points": [
                      "Can reach liver by hematogenous spread or direct spread from GI tract"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Liver is usually involved as part of disseminated TB"
                  },
                  {
                    "text": "Most common symptoms overall are hepatomegaly, fever, abdominal pain, weight loss"
                  },
                  {
                    "text": "Tuberculoma/localized disease can mimic neoplasm and compress biliary tract, vessels"
                  },
                  {
                    "text": "Mortality ranges 10-40%Worse prognosis with immune compromise, drug-resistant organisms",
                    "sub_points": [
                      "Worse prognosis with immune compromise, drug-resistant organisms"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Numerous granulomas ± central necrosisCoalescence of granulomas can produce tuberculoma",
                    "sub_points": [
                      "Coalescence of granulomas can produce tuberculoma"
                    ]
                  },
                  {
                    "text": "Immunocompromised patients may have poorly developed granulomas or abscesses"
                  },
                  {
                    "text": "Acid-fast stains positive in 20-60% of cases"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Culture is more likely to be positive in cases with caseating necrosisMay take weeks to grow",
                    "sub_points": [
                      "May take weeks to grow"
                    ]
                  },
                  {
                    "text": "Immunohistochemistry becoming more widely available but less sensitive for MTB than for nontuberculous mycobacteria"
                  },
                  {
                    "text": "PCR and nucleic acid probes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Mycobacterium tuberculosis(MTB)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Tuberculosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection by MTBM. tuberculosiscomplex includes several species with > 99.9% identity, such asM. africanumandM. bovisHumans are only natural reservoir for MTB",
                    "sub_points": [
                      "M. tuberculosiscomplex includes several species with > 99.9% identity, such asM. africanumandM. bovisHumans are only natural reservoir for MTB",
                      "Humans are only natural reservoir for MTB"
                    ]
                  },
                  {
                    "text": "Tuberculoma: Hepatic mass caused by confluence of multiple granulomas"
                  },
                  {
                    "text": "Miliary disease: Widely disseminated infection"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Transmission typically by inhalation of dropletsCan reach liver by lymphatic/hematogenous spread or direct spread from GI tract",
                    "sub_points": [
                      "Can reach liver by lymphatic/hematogenous spread or direct spread from GI tract"
                    ]
                  },
                  {
                    "text": "Hepatic tuberculosis may also be part of presentation of congenital tuberculosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "~ 8.5-10 million people develop TB annually worldwideExtrapulmonary MTB is increasing in frequencyHepatic MTB seen in ~ 1% of patients with active TBExtrapulmonary disease more common in HIV-positive patients> 1/2 of HIV-positive patients with active MTB have extrapulmonary involvement",
                    "sub_points": [
                      "Extrapulmonary MTB is increasing in frequencyHepatic MTB seen in ~ 1% of patients with active TB",
                      "Hepatic MTB seen in ~ 1% of patients with active TB",
                      "Extrapulmonary disease more common in HIV-positive patients> 1/2 of HIV-positive patients with active MTB have extrapulmonary involvement",
                      "> 1/2 of HIV-positive patients with active MTB have extrapulmonary involvement"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific clinical features often lead to diagnostic delay"
                  },
                  {
                    "text": "Most common presenting signs/symptomsHepatomegaly, ± splenomegalyFeverPulmonary symptomsAbdominal painWeight loss",
                    "sub_points": [
                      "Hepatomegaly, ± splenomegaly",
                      "Fever",
                      "Pulmonary symptoms",
                      "Abdominal pain",
                      "Weight loss"
                    ]
                  },
                  {
                    "text": "Miliary diseaseLiver involvement present in 80% of patientsPatients more likely to have evidence of pulmonary infection",
                    "sub_points": [
                      "Liver involvement present in 80% of patients",
                      "Patients more likely to have evidence of pulmonary infection"
                    ]
                  },
                  {
                    "text": "Localized hepatic disease/tuberculomaPatients more likely to have abdominal painCan cause obstructive jaundice from compression of bile ductsCan cause portal hypertension from compression of portal vein",
                    "sub_points": [
                      "Patients more likely to have abdominal pain",
                      "Can cause obstructive jaundice from compression of bile ducts",
                      "Can cause portal hypertension from compression of portal vein"
                    ]
                  },
                  {
                    "text": "Tuberculous cholangitisPresents with biliary strictures and obstructive jaundice",
                    "sub_points": [
                      "Presents with biliary strictures and obstructive jaundice"
                    ]
                  },
                  {
                    "text": "Elevated alkaline phosphatase most common lab abnormalityTransaminases can be elevated, usually mild to moderateJaundice less frequently seen",
                    "sub_points": [
                      "Transaminases can be elevated, usually mild to moderate",
                      "Jaundice less frequently seen"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Tuberculin skin test"
                  },
                  {
                    "text": "Interferon release assays"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Multidrug antituberculous regimensSimilar to those used to treat MTB infecting other sitesDrug resistance is increasingly common problem",
                    "sub_points": [
                      "Similar to those used to treat MTB infecting other sites",
                      "Drug resistance is increasingly common problem"
                    ]
                  },
                  {
                    "text": "May need surgical drainage/excision of localized lesions"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent in immune competent patients with drug-susceptible infections"
                  },
                  {
                    "text": "Estimates of mortality for hepatic MTB limited by small sample sizeEstimated at 10-40%Risk factors for poor prognosis include:Age < 20 yearsImmune compromise or comorbid conditionDisseminated diseaseDrug resistance",
                    "sub_points": [
                      "Estimated at 10-40%",
                      "Risk factors for poor prognosis include:Age < 20 yearsImmune compromise or comorbid conditionDisseminated diseaseDrug resistance",
                      "Age < 20 years",
                      "Immune compromise or comorbid condition",
                      "Disseminated disease",
                      "Drug resistance"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "CT scanLocalized disease shows hypodense lesions with poorly enhancing rim and calcificationMultiple small, low-density nodules in miliary diseaseBiliary involvement may cause strictures",
                    "sub_points": [
                      "Localized disease shows hypodense lesions with poorly enhancing rim and calcification",
                      "Multiple small, low-density nodules in miliary disease",
                      "Biliary involvement may cause strictures"
                    ]
                  },
                  {
                    "text": "Plain films may show hepatic calcifications"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Miliary diseaseMultiple small focal lesions, often not grossly visible0.6-2.0 cm in size",
                    "sub_points": [
                      "Multiple small focal lesions, often not grossly visible",
                      "0.6-2.0 cm in size"
                    ]
                  },
                  {
                    "text": "Localized hepatic diseasea.k.a. tuberculomaCheesy or chalky white, irregular nodules",
                    "sub_points": [
                      "a.k.a. tuberculoma",
                      "Cheesy or chalky white, irregular nodules"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Epithelioid granuloma is most characteristic featureInflammatory process often effaces normal liver architectureGranulomas may be focal or numerousCaseating necrosisVariably present lymphocytes and giant cellsSome cases have more loosely formed lymphohistiocytic lesions without necrosis",
                    "sub_points": [
                      "Inflammatory process often effaces normal liver architecture",
                      "Granulomas may be focal or numerous",
                      "Caseating necrosis",
                      "Variably present lymphocytes and giant cells",
                      "Some cases have more loosely formed lymphohistiocytic lesions without necrosis"
                    ]
                  },
                  {
                    "text": "Immunocompromised patients may have different histologyPoorly formed granulomas or collections of foamy histiocytes with innumerable organisms",
                    "sub_points": [
                      "Poorly formed granulomas or collections of foamy histiocytes with innumerable organisms"
                    ]
                  },
                  {
                    "text": "Tuberculomas may result from numerous confluent granulomas"
                  },
                  {
                    "text": "Hilar lymph nodes may show findings similar to liver parenchyma"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Acid-fast stains positive in 20-60% of casesAcid-fast staining due to cell wall rich in lipomannan, lipoarabinomannan, and mycolic acidMycobacteria detected on AFB stain cannot be confirmed as MTB on morphology aloneCulture or PCR required for definite diagnosis",
                    "sub_points": [
                      "Acid-fast staining due to cell wall rich in lipomannan, lipoarabinomannan, and mycolic acid",
                      "Mycobacteria detected on AFB stain cannot be confirmed as MTB on morphology aloneCulture or PCR required for definite diagnosis",
                      "Culture or PCR required for definite diagnosis"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Becoming more widely available but less sensitive for MTB than nontuberculous mycobacteria"
                  }
                ],
                "Culture": [
                  {
                    "text": "More likely to be positive in cases with caseating necrosis"
                  },
                  {
                    "text": "Very slow growingTime to detection ranges from 2-8 weeks",
                    "sub_points": [
                      "Time to detection ranges from 2-8 weeks"
                    ]
                  }
                ],
                "Molecular Testing": [
                  {
                    "text": "Nucleic acid probes most commonly used for identificationUsed on colonies from solid media or positive liquid broth culturesSensitivity and specificity approach 100%",
                    "sub_points": [
                      "Used on colonies from solid media or positive liquid broth cultures",
                      "Sensitivity and specificity approach 100%"
                    ]
                  },
                  {
                    "text": "Many types of PCR assaysSensitivity and specificity vary with technology and specimen typeIncreasing number of assays available for formalin-fixed, paraffin-embedded tissue",
                    "sub_points": [
                      "Sensitivity and specificity vary with technology and specimen type",
                      "Increasing number of assays available for formalin-fixed, paraffin-embedded tissue"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sarcoidosis": [
                  {
                    "text": "Typically nonnecrotizingOccasionally have focal fibrinoid necrosis",
                    "sub_points": [
                      "Occasionally have focal fibrinoid necrosis"
                    ]
                  },
                  {
                    "text": "More prominent fibrosis"
                  },
                  {
                    "text": "Infectious work-up negative"
                  },
                  {
                    "text": "Increased serum angiotensin-converting enzyme"
                  }
                ],
                "Cat-Scratch Disease": [
                  {
                    "text": "Granulomas are stellate or geographic"
                  },
                  {
                    "text": "Granulomas have distinct layered appearance with outer rim of fibrosis"
                  },
                  {
                    "text": "History of cat bite or scratch"
                  },
                  {
                    "text": "PCR very useful to differentiate"
                  }
                ],
                "Fungal Infection": [
                  {
                    "text": "GMS stain positive"
                  },
                  {
                    "text": "Cultures useful but may take weeks"
                  },
                  {
                    "text": "Molecular tests and laboratory serum assays that target fungal antigens can be useful"
                  }
                ],
                "Granulomatous Bacterial Infections": [
                  {
                    "text": "Tularemia, listeriosis, brucellosis"
                  },
                  {
                    "text": "Bacterial cultures may be helpful"
                  },
                  {
                    "text": "Molecular tests, serologic studies, clinical history may be invaluable"
                  },
                  {
                    "text": "Special stains not useful"
                  }
                ],
                "Other Mycobacterial Species": [
                  {
                    "text": "LeprosyGranulomatous response may be similarKinyoun stain, molecular tests, culture, clinical features may help to resolve",
                    "sub_points": [
                      "Granulomatous response may be similar",
                      "Kinyoun stain, molecular tests, culture, clinical features may help to resolve"
                    ]
                  },
                  {
                    "text": "Mycobacterium avium-intracellulareTypically foamy histiocyte infiltrate rather than well-formed granulomasMolecular tests, culture may help to resolve",
                    "sub_points": [
                      "Typically foamy histiocyte infiltrate rather than well-formed granulomas",
                      "Molecular tests, culture may help to resolve"
                    ]
                  },
                  {
                    "text": "M. chimaeraSmall, ill-formed sinusoidal histiocyte clusters with rare multinucleated giant cells and background liver displaying venous outflow obstruction findingsAcid-fast stain usually noncontributoryCulture, molecular tests may help differentiateAssociated with contaminated heater-cooler water units used during cardiovascular surgery",
                    "sub_points": [
                      "Small, ill-formed sinusoidal histiocyte clusters with rare multinucleated giant cells and background liver displaying venous outflow obstruction findings",
                      "Acid-fast stain usually noncontributory",
                      "Culture, molecular tests may help differentiate",
                      "Associated with contaminated heater-cooler water units used during cardiovascular surgery"
                    ]
                  }
                ],
                "Neoplasm": [
                  {
                    "text": "Tuberculoma may mimic neoplasm both clinically and radiographically"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "High index of suspicion in patients with hepatomegaly, fever, respiratory symptoms, and elevated liver tests, especially if patient is from endemic area or HIV positive"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Epithelioid granulomas with caseating necrosis and giant cells"
                  },
                  {
                    "text": "Mycobacteria may be difficult to detect on special stain; culture and PCR may be required to establish diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Atypical Mycobacteria": {
            "name": "Atypical Mycobacteria",
            "url": "https://app.pathprimer.com/document/81550e12-4622-4fd0-8527-c9cefca75baf/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection by any number of species of nontubercular mycobacteriaMycobacteriumavium-intracellularecomplex (MAC) most commonly causes hepatic disease> 50% of disseminated MAC infection cases have liver involvement",
                    "sub_points": [
                      "Mycobacteriumavium-intracellularecomplex (MAC) most commonly causes hepatic disease> 50% of disseminated MAC infection cases have liver involvement",
                      "> 50% of disseminated MAC infection cases have liver involvement"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Widely present in environment; worldwide distributionTransmission typically by inhalation or ingestion",
                    "sub_points": [
                      "Transmission typically by inhalation or ingestion"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Common opportunistic infection in AIDS patients, particularly those that have CD4 counts < 50 cells/μLFever, hepatomegaly, elevated alkaline phosphatase are common presentationMore common in males, mirroring HIV prevalence",
                    "sub_points": [
                      "Fever, hepatomegaly, elevated alkaline phosphatase are common presentation",
                      "More common in males, mirroring HIV prevalence"
                    ]
                  },
                  {
                    "text": "Treatment is multidrug regimen for many monthsDrug resistance is problematic",
                    "sub_points": [
                      "Drug resistance is problematic"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Wide range of histologic features depending on immune status of patientPoorly formed granulomas, loose aggregates of foamy histiocytesFibrin ring granulomasSpindle cell pseudotumor",
                    "sub_points": [
                      "Poorly formed granulomas, loose aggregates of foamy histiocytes",
                      "Fibrin ring granulomas",
                      "Spindle cell pseudotumor"
                    ]
                  },
                  {
                    "text": "AFB stains often show large numbers of organisms in immunocompromised patients"
                  },
                  {
                    "text": "Well-formed granulomas in patients with preserved T-cell function"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "IHC is highly sensitive for nontubercular mycobacteria"
                  },
                  {
                    "text": "Helpful laboratory tests include blood culture and PCR"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Aggregates of foamy histiocytes in liver biopsy from patients with AIDS warrants stains for acid-fast bacteria"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection by any number of nontubercular mycobacteria speciesClassified according to growth rate, presence, or absence and type of pigmentIncludesMycobacteriumavium,M. intracellulare,M. kansasii,M. marinum,M. gordonae,M. chelonae,M. scrofulaceum,M. szulgai,M. malmoense,M. xenopi,M. abscessus,M. fortuitum,andM. chimaera",
                    "sub_points": [
                      "Classified according to growth rate, presence, or absence and type of pigment",
                      "IncludesMycobacteriumavium,M. intracellulare,M. kansasii,M. marinum,M. gordonae,M. chelonae,M. scrofulaceum,M. szulgai,M. malmoense,M. xenopi,M. abscessus,M. fortuitum,andM. chimaera"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "Widely present in environment; worldwide distributionMycobacteriumaviumandM.intracellulare, known together asM. avium-intracellularecomplex (MAC), most commonly cause hepatic diseaseNext to MAC,M.kansasiiis most common cause of nontuberculous mycobacterial infection in HIV patientsTransmission typically by inhalation or ingestionReports ofM. chimaerainfections in open heart surgery patients due to contamination of heater-cooler water units associated with heart-lung machines",
                    "sub_points": [
                      "MycobacteriumaviumandM.intracellulare, known together asM. avium-intracellularecomplex (MAC), most commonly cause hepatic disease",
                      "Next to MAC,M.kansasiiis most common cause of nontuberculous mycobacterial infection in HIV patients",
                      "Transmission typically by inhalation or ingestionReports ofM. chimaerainfections in open heart surgery patients due to contamination of heater-cooler water units associated with heart-lung machines",
                      "Reports ofM. chimaerainfections in open heart surgery patients due to contamination of heater-cooler water units associated with heart-lung machines"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Up to 35% of all AIDS patients develop disseminated MAC eventually1-year incidence is 3% among patients with CD4 counts between 100-199 cells/μL and 39% for patients with CD4 counts < 10 cells/μL> 50% of disseminated MAC infection cases have liver involvementFrequency is decreasing with widespread use of highly active antiretroviral therapy (HAART)",
                    "sub_points": [
                      "1-year incidence is 3% among patients with CD4 counts between 100-199 cells/μL and 39% for patients with CD4 counts < 10 cells/μL",
                      "> 50% of disseminated MAC infection cases have liver involvement",
                      "Frequency is decreasing with widespread use of highly active antiretroviral therapy (HAART)"
                    ]
                  },
                  {
                    "text": "More common in males, mirroring HIV prevalence"
                  },
                  {
                    "text": "Risk factors include AIDS, malignancy, chronic renal or pulmonary disease, cystic fibrosis, alcoholism"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fever, hepatomegaly, elevated alkaline phosphatase"
                  },
                  {
                    "text": "Patients treated with HAART may develop clinical manifestations of disseminated MAC due to immune reconstitution syndromeMAC most common pathogen associated with immune reconstitution syndrome",
                    "sub_points": [
                      "MAC most common pathogen associated with immune reconstitution syndrome"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Mycobacterial blood or tissue cultureSlow growing (2-3 weeks for MAC)Blood must be collected in special media separate from standard blood culture",
                    "sub_points": [
                      "Slow growing (2-3 weeks for MAC)",
                      "Blood must be collected in special media separate from standard blood culture"
                    ]
                  },
                  {
                    "text": "Molecular identificationCan be performed on fresh or routinely processed tissueCan distinguishM.tuberculosisfrom nontubercular species",
                    "sub_points": [
                      "Can be performed on fresh or routinely processed tissue",
                      "Can distinguishM.tuberculosisfrom nontubercular species"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Multidrug regimen for many months"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Median survival: 6 months, with only 24% of patients surviving for 1 yearPoor survival is often function of advanced AIDS rather than disseminated MAC infection",
                    "sub_points": [
                      "Poor survival is often function of advanced AIDS rather than disseminated MAC infection"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Hepatomegaly, uniform attenuation of lymph nodes, and clustered pattern of lymph nodes"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Wide range of histologic features depending on immune status of patientFoamy macrophages infiltrate and poorly formed granulomas more common in immunosuppressed patientsTypically minimal attendant inflammationFibrin ring granulomas have been describedNecrotic areas filled with inflammatory cells and nuclear debris or liver abscess may be seen",
                    "sub_points": [
                      "Foamy macrophages infiltrate and poorly formed granulomas more common in immunosuppressed patientsTypically minimal attendant inflammationFibrin ring granulomas have been described",
                      "Typically minimal attendant inflammation",
                      "Fibrin ring granulomas have been described",
                      "Necrotic areas filled with inflammatory cells and nuclear debris or liver abscess may be seen"
                    ]
                  },
                  {
                    "text": "MAC infection can cause mass-forming nodules of spindled histiocytes in immunocompromised patients as well (mycobacterial spindle cell pseudotumor)"
                  },
                  {
                    "text": "In patients with preserved T-cell function, granulomas can be well formed, similar to tuberculosis"
                  },
                  {
                    "text": "InM. chimaeracases, sinusoidal histiocyte collections with background of venous outflow obstruction"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Acid-fast bacterial stains (Ziehl-Neelsen, Kinyoun, Fite)Immunocompromised patients typically have numerous acid-fast organisms in macrophagesOrganisms may be extremely rare in immunocompetent patients",
                    "sub_points": [
                      "Immunocompromised patients typically have numerous acid-fast organisms in macrophages",
                      "Organisms may be extremely rare in immunocompetent patients"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Recently developed antibody is highly sensitive for nontubercular mycobacteria"
                  }
                ],
                "PCR": [
                  {
                    "text": "PCR for nontuberculous mycobacteria is possible on fresh and formalin-fixed tissue but not readily available in all laboratories"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Tuberculosis": [
                  {
                    "text": "Granulomas typically well formed with caseating necrosis and fewer organisms"
                  },
                  {
                    "text": "Clinical setting, culture, PCR are helpful"
                  }
                ],
                "Histoplasmosis": [
                  {
                    "text": "Can also cause aggregates of foamy histiocytes in immunocompromised patients"
                  },
                  {
                    "text": "GMS stain demonstrates yeast in histiocytesCaveat: Will also stain rapidly dividing atypical mycobacteria",
                    "sub_points": [
                      "Caveat: Will also stain rapidly dividing atypical mycobacteria"
                    ]
                  },
                  {
                    "text": "Fungal culture, PCR helpful"
                  }
                ],
                "Q Fever": [
                  {
                    "text": "Prototypical disease associated with fibrin ring granulomas"
                  },
                  {
                    "text": "Rickettsial disease that usually manifests as pneumonitis or endocarditis"
                  },
                  {
                    "text": "Serologies forCoxiella burnetiimay be helpful, but may be false-negative in severely immunocompromised patients"
                  }
                ],
                "Leprosy": [
                  {
                    "text": "Lepromatous leprosy shows aggregates of foamy histiocytes"
                  },
                  {
                    "text": "Clinical setting, culture, PCR are helpful"
                  }
                ],
                "Whipple Disease (Tropheryma whipplei)": [
                  {
                    "text": "Liver involvement can be seen in multiorgan disease"
                  },
                  {
                    "text": "PAS(+) material within portal and sinusoidal macrophages"
                  },
                  {
                    "text": "Clinical setting of middle-aged white male with chronic diarrhea and weight loss"
                  },
                  {
                    "text": "AFB(-); PCR helps make diagnosis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Aggregates of foamy histiocytes in liver biopsy from patient with AIDS warrants stains for acid-fast organisms"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Histoplasmosis": {
            "name": "Histoplasmosis",
            "url": "https://app.pathprimer.com/document/6c9a17ba-0af1-483b-a6cf-e96f9e8266ed/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection byHistoplasma capsulatumfungus"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Dimorphic fungus found in soil contaminated with bird or bat droppingsFound in soil, particularly when contaminated with bird or bat droppings",
                    "sub_points": [
                      "Found in soil, particularly when contaminated with bird or bat droppings"
                    ]
                  },
                  {
                    "text": "Infection acquired through inhalation of airborne microconidiaSpread through reticuloendothelial systemMost patients with systemic/disseminated disease are immunocompromised",
                    "sub_points": [
                      "Spread through reticuloendothelial system",
                      "Most patients with systemic/disseminated disease are immunocompromised"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Endemic in many parts of world, including Ohio and Mississippi River valleys, as well as parts of Central and South America, Southern Europe, Africa, Southeast AsiaMost common endemic mycosis in United States",
                    "sub_points": [
                      "Most common endemic mycosis in United States"
                    ]
                  },
                  {
                    "text": "Liver involvement is almost always part of systemic/disseminated infection"
                  },
                  {
                    "text": "With treatment, mortality rate is < 10%"
                  },
                  {
                    "text": "Most infections in immunocompetent persons are self-limited and often clinically unrecognized"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Portal and lobular lymphohistiocytic inflammation is typicalMay have little or no inflammatory response in severely immunocompromised patients",
                    "sub_points": [
                      "May have little or no inflammatory response in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Discrete granulomas variably present; more common in immune competent patients"
                  },
                  {
                    "text": "Large numbers of yeast are present in portal and sinusoidal macrophages"
                  },
                  {
                    "text": "Yeast are uniformly small (2-4 μm), oval, with narrow-based buddingGMS and PAS-D positive",
                    "sub_points": [
                      "GMS and PAS-D positive"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection byHistoplasma capsulatumfungusH. capsulatumvar.capsulatumis most common cause of histoplasmosisH. capsulatumvar.duboisiiis found in Africa",
                    "sub_points": [
                      "H. capsulatumvar.capsulatumis most common cause of histoplasmosis",
                      "H. capsulatumvar.duboisiiis found in Africa"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Dimorphic, saprophytic fungus with near-worldwide distributionNear-worldwide distributionFound in soil, particularly when contaminated with bird or bat droppingsExists as mold/mycelial form in environment and as yeast form at body temperature",
                    "sub_points": [
                      "Near-worldwide distribution",
                      "Found in soil, particularly when contaminated with bird or bat droppings",
                      "Exists as mold/mycelial form in environment and as yeast form at body temperature"
                    ]
                  },
                  {
                    "text": "Infection acquired through inhalation of airborne microconidiaTypically results in primary pulmonary infectionSpread through reticuloendothelial systemMost patients with systemic/disseminated disease are immunocompromisedRare occurrence in immunocompetent individualsConditions associated with infection/outbreaksMoving soil contaminated with bird or bat droppingsUprooting trees where birds roostDemolition of buildingsSpelunking in caves where bats live",
                    "sub_points": [
                      "Typically results in primary pulmonary infection",
                      "Spread through reticuloendothelial system",
                      "Most patients with systemic/disseminated disease are immunocompromisedRare occurrence in immunocompetent individuals",
                      "Rare occurrence in immunocompetent individuals",
                      "Conditions associated with infection/outbreaksMoving soil contaminated with bird or bat droppingsUprooting trees where birds roostDemolition of buildingsSpelunking in caves where bats live",
                      "Moving soil contaminated with bird or bat droppings",
                      "Uprooting trees where birds roost",
                      "Demolition of buildings",
                      "Spelunking in caves where bats live"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Geographic distributionVariety of endemic areas around globeOhio, Missouri, and Mississippi River valleys and parts of eastern United StatesMost common endemic mycosis in United StatesCentral and South America: Mexico, Guatemala, Peru, VenezuelaParts of southern Europe, Africa, and Southeast Asia",
                    "sub_points": [
                      "Variety of endemic areas around globeOhio, Missouri, and Mississippi River valleys and parts of eastern United StatesMost common endemic mycosis in United StatesCentral and South America: Mexico, Guatemala, Peru, VenezuelaParts of southern Europe, Africa, and Southeast Asia",
                      "Ohio, Missouri, and Mississippi River valleys and parts of eastern United StatesMost common endemic mycosis in United States",
                      "Most common endemic mycosis in United States",
                      "Central and South America: Mexico, Guatemala, Peru, Venezuela",
                      "Parts of southern Europe, Africa, and Southeast Asia"
                    ]
                  },
                  {
                    "text": "Cases can also be found in nonendemic areas"
                  },
                  {
                    "text": "Risk factors for systemic/disseminated diseaseExposure in infancy/early childhoodCell-mediated immunity not fully developedHIV/AIDSParticularly if CD4 cell count < 150 cells per μLMost common endemic mycosis in patient with AIDSImmunosuppressive drugsCorticosteroidsChemotherapyTumor necrosis factor antagonists: Etanercept, infliximab, and adalimumabHematologic malignanciesSolid organ or bone marrow transplant patients",
                    "sub_points": [
                      "Exposure in infancy/early childhoodCell-mediated immunity not fully developed",
                      "Cell-mediated immunity not fully developed",
                      "HIV/AIDSParticularly if CD4 cell count < 150 cells per μLMost common endemic mycosis in patient with AIDS",
                      "Particularly if CD4 cell count < 150 cells per μL",
                      "Most common endemic mycosis in patient with AIDS",
                      "Immunosuppressive drugsCorticosteroidsChemotherapyTumor necrosis factor antagonists: Etanercept, infliximab, and adalimumab",
                      "Corticosteroids",
                      "Chemotherapy",
                      "Tumor necrosis factor antagonists: Etanercept, infliximab, and adalimumab",
                      "Hematologic malignancies",
                      "Solid organ or bone marrow transplant patients"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute systemic/disseminated infectionUsually occurs in immunosuppressed patientsLiver is involved in up to 90% of cases of systemic/disseminated diseasePatients occasionally present with signs of liver/gastrointestinal involvement rather than pulmonary involvementPatients with acute disseminated infection are usually symptomaticChills/feverAnorexia/weight lossMucous membrane ulcersSkin lesionsHepatosplenomegalyElevated liver enzymesMost commonly alkaline phosphataseTransaminases, bilirubin often elevated as well",
                    "sub_points": [
                      "Usually occurs in immunosuppressed patientsLiver is involved in up to 90% of cases of systemic/disseminated diseasePatients occasionally present with signs of liver/gastrointestinal involvement rather than pulmonary involvement",
                      "Liver is involved in up to 90% of cases of systemic/disseminated disease",
                      "Patients occasionally present with signs of liver/gastrointestinal involvement rather than pulmonary involvement",
                      "Patients with acute disseminated infection are usually symptomaticChills/feverAnorexia/weight lossMucous membrane ulcersSkin lesionsHepatosplenomegalyElevated liver enzymesMost commonly alkaline phosphataseTransaminases, bilirubin often elevated as well",
                      "Chills/fever",
                      "Anorexia/weight loss",
                      "Mucous membrane ulcers",
                      "Skin lesions",
                      "Hepatosplenomegaly",
                      "Elevated liver enzymesMost commonly alkaline phosphataseTransaminases, bilirubin often elevated as well",
                      "Most commonly alkaline phosphatase",
                      "Transaminases, bilirubin often elevated as well"
                    ]
                  },
                  {
                    "text": "Chronic progressive systemic/disseminated infectionAlso common in immunocompromised patientsSometimes occurs in patients without other obvious causes of immunosuppressionSometimes due to large inoculumMay indicate undiagnosed immune compromisePresentationFeverNight sweatsWeight lossFatigueOral ulcersAdrenal insufficiencyDevelops as adrenal glands are destroyed by infection",
                    "sub_points": [
                      "Also common in immunocompromised patients",
                      "Sometimes occurs in patients without other obvious causes of immunosuppressionSometimes due to large inoculumMay indicate undiagnosed immune compromise",
                      "Sometimes due to large inoculum",
                      "May indicate undiagnosed immune compromise",
                      "PresentationFeverNight sweatsWeight lossFatigueOral ulcersAdrenal insufficiencyDevelops as adrenal glands are destroyed by infection",
                      "Fever",
                      "Night sweats",
                      "Weight loss",
                      "Fatigue",
                      "Oral ulcers",
                      "Adrenal insufficiencyDevelops as adrenal glands are destroyed by infection",
                      "Develops as adrenal glands are destroyed by infection"
                    ]
                  },
                  {
                    "text": "Reactivated infectionInfection can present as reactivation years after initial exposure if cell-mediated immunity is compromisedMay occur outside of endemic area",
                    "sub_points": [
                      "Infection can present as reactivation years after initial exposure if cell-mediated immunity is compromised",
                      "May occur outside of endemic area"
                    ]
                  },
                  {
                    "text": "Most infections in immunocompetent persons are self-limited and often clinically unrecognized"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Fungal culture of tissue or blood"
                  },
                  {
                    "text": "Serologic antibody assaysComplement fixation testsImmunodiffusion assaysNot useful in some circumstancesPatients with acute disseminated infection who might not have developed antibody yetImmunocompromised patients, older adult patients, and very young children who may not be able to make antibody effectively",
                    "sub_points": [
                      "Complement fixation tests",
                      "Immunodiffusion assays",
                      "Not useful in some circumstancesPatients with acute disseminated infection who might not have developed antibody yetImmunocompromised patients, older adult patients, and very young children who may not be able to make antibody effectively",
                      "Patients with acute disseminated infection who might not have developed antibody yet",
                      "Immunocompromised patients, older adult patients, and very young children who may not be able to make antibody effectively"
                    ]
                  },
                  {
                    "text": "Antigen detection assaysEnzyme immunoassayHigh sensitivity (80-90%)Urine, serum, or other body fluid samples can be tested",
                    "sub_points": [
                      "Enzyme immunoassayHigh sensitivity (80-90%)Urine, serum, or other body fluid samples can be tested",
                      "High sensitivity (80-90%)",
                      "Urine, serum, or other body fluid samples can be tested"
                    ]
                  },
                  {
                    "text": "Molecular assaysCan be performed on fresh samples as well as formalin fixed, paraffin-embedded tissue",
                    "sub_points": [
                      "Can be performed on fresh samples as well as formalin fixed, paraffin-embedded tissue"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Antifungal agents: Itraconazole, amphotericin B"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "With treatment, mortality rate is < 10%"
                  },
                  {
                    "text": "Immunocompromised patients have worse prognosis than immunocompetent patients"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Enlarged liver appears congested or mottled"
                  },
                  {
                    "text": "Infection may produce nodules up to 1 cm in diameter"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Portal and lobular lymphohistiocytic inflammationInflammatory response may be limited or virtually absent in severely immunocompromised patients",
                    "sub_points": [
                      "Inflammatory response may be limited or virtually absent in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Discrete granulomasIn portal &/or lobular areasCan be seen regardless of immune status but often absent in immunocompromised patients",
                    "sub_points": [
                      "In portal &/or lobular areas",
                      "Can be seen regardless of immune status but often absent in immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Kupffer cell hyperplasia"
                  },
                  {
                    "text": "Large numbers of fungi often present in portal and sinusoidal macrophages"
                  },
                  {
                    "text": "Infection may produce discrete nodules containing caseous necrotic material with histocytic or fibroblastic rimAs nodules age, may become entirely fibrotic with calcification",
                    "sub_points": [
                      "As nodules age, may become entirely fibrotic with calcification"
                    ]
                  },
                  {
                    "text": "Characteristics of organismUniformly small (2-4 µm)Oval with narrow-based bud at more pointed poleMay have surrounding pale halo on H&E and PAS stainsTypically intracellular (within macrophages)",
                    "sub_points": [
                      "Uniformly small (2-4 µm)",
                      "Oval with narrow-based bud at more pointed pole",
                      "May have surrounding pale halo on H&E and PAS stains",
                      "Typically intracellular (within macrophages)"
                    ]
                  },
                  {
                    "text": "Hemophagocytic lymphohistiocytosis may occur in association with histoplasmosis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "GMS"
                  },
                  {
                    "text": "PAS-D"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pneumocystosis (Pneumocystis jirovecii)": [
                  {
                    "text": "Similar in size"
                  },
                  {
                    "text": "Extracellular"
                  },
                  {
                    "text": "Lack of budding"
                  },
                  {
                    "text": "Characteristic internal structure"
                  },
                  {
                    "text": "Foamy cast appearance of inflammatory reaction"
                  }
                ],
                "Candidaglabrata": [
                  {
                    "text": "Slightly larger"
                  },
                  {
                    "text": "More often extracellular"
                  },
                  {
                    "text": "More frequent budding; fungal yeast, hyphal, and pseudohyphal forms can be seen"
                  }
                ],
                "Cryptococcosis (Cryptococcus neoformansorC. gattii)": [
                  {
                    "text": "Pleomorphic in size rather than uniformly small"
                  },
                  {
                    "text": "Capsule is often mucicarmine positive"
                  },
                  {
                    "text": "Positive with Fontana-Masson stain"
                  }
                ],
                "Leishmaniasis": [
                  {
                    "text": "Presence of kinetoplast"
                  },
                  {
                    "text": "Negative for GMS"
                  }
                ],
                "Penicilliosis (Talaromyces marneffei)": [
                  {
                    "text": "Similar in size"
                  },
                  {
                    "text": "Different endemic area (Southeast Asia)"
                  },
                  {
                    "text": "Elongated and septate (pill capsule) forms"
                  },
                  {
                    "text": "No budding"
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "May be indistinguishable from histoplasmosis by morphology alone"
                  },
                  {
                    "text": "Infectious work-up negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Liver is involved in up to 90% of cases of disseminated disease"
                  },
                  {
                    "text": "Patients may present with symptoms/signs of liver involvement rather than pulmonary involvement"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Liver biopsies may show little inflammation in immunocompromised patients, so liberal use of special stains is warranted"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cryptococcosis": {
            "name": "Cryptococcosis",
            "url": "https://app.pathprimer.com/document/2d2adf32-ff45-42b7-92bb-9e211e8d29ad/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection by fungiCryptococcus neoformansorCryptococcusgattii"
                  },
                  {
                    "text": "Most common cause of systemic mycosis in patients with AIDSLiver involvement is usually feature of disseminated diseaseMost common in, but not limited to, immunocompromised patients",
                    "sub_points": [
                      "Liver involvement is usually feature of disseminated disease",
                      "Most common in, but not limited to, immunocompromised patients"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Worldwide distribution and widespread in nature"
                  },
                  {
                    "text": "Ubiquitous soil saprophyte; acquired by inhalation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Liver involvement often presents as hepatomegaly, abdominal pain, elevated liver tests"
                  },
                  {
                    "text": "Helpful laboratory tests include culture, cryptococcal antigen testing, and PCR assays"
                  },
                  {
                    "text": "Prognosis depends on clinical features of disease, patient's immune statusUntreated disease is almost always fatal",
                    "sub_points": [
                      "Untreated disease is almost always fatal"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Round to oval yeast with narrow-based budding"
                  },
                  {
                    "text": "Considerable variation in size 2-20 μm in diameter"
                  },
                  {
                    "text": "Halo around organisms representing mucopolysaccharide capsule"
                  },
                  {
                    "text": "Variable inflammatory responseRanges from suppurative &/or granulomatous inflammation to essentially no tissue reaction in severely immunocompromised patients",
                    "sub_points": [
                      "Ranges from suppurative &/or granulomatous inflammation to essentially no tissue reaction in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Fungi stain with GMS, Alcian blue, mucicarmine, colloidal iron, and Fontana-Masson"
                  },
                  {
                    "text": "Capsule-deficient organisms are mucicarmine (-) or only weakly (+)Fontana-Masson is useful in these cases",
                    "sub_points": [
                      "Fontana-Masson is useful in these cases"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cryptococcosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection by fungiCryptococcus neoformansorC.gattiiC. gattiimore common in immunocompetent persons",
                    "sub_points": [
                      "C. gattiimore common in immunocompetent persons"
                    ]
                  },
                  {
                    "text": "Most common cause of systemic mycosis in patients with AIDS"
                  },
                  {
                    "text": "Liver involvement is usually part of disseminated disease, often with concomitant cryptococcal meningoencephalitis"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Worldwide distribution and widespread in natureUbiquitous soil saprophyte; acquired by inhalationMost abundant in avian habitats, especially those with pigeon or chicken excreta",
                    "sub_points": [
                      "Ubiquitous soil saprophyte; acquired by inhalation",
                      "Most abundant in avian habitats, especially those with pigeon or chicken excreta"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Most often encountered as opportunistic infection in immunosuppressed patients (AIDS, transplant, malignancy, corticosteroid therapy, etc.)Hepatomegaly, abdominal pain, elevated liver tests",
                    "sub_points": [
                      "Hepatomegaly, abdominal pain, elevated liver tests"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Culture"
                  },
                  {
                    "text": "Cryptococcal antigen testing on serum or CSFPatients with low fungus burden or capsule-deficient infection may have false-negative result",
                    "sub_points": [
                      "Patients with low fungus burden or capsule-deficient infection may have false-negative result"
                    ]
                  },
                  {
                    "text": "PCR"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Antifungal drugs are mainstay of therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on clinical features of disease and patient's immune status"
                  },
                  {
                    "text": "Untreated disease is almost always fatal"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually unremarkableRarely there are foci of necrosis or mass-forming lesions that can mimic neoplasia radiographically",
                    "sub_points": [
                      "Rarely there are foci of necrosis or mass-forming lesions that can mimic neoplasia radiographically"
                    ]
                  },
                  {
                    "text": "Extrahepatic biliary tree may be involved, mimicking sclerosing cholangitis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Fungal morphologyRound to oval yeastNarrow-based budsConsiderable variation in size, ranging 2-20 μm in diameterHalo around organisms representing mucopolysaccharide capsuleSoap bubble appearance at low magnificationCapsule may have diameter up to 5x that of fungal cells it surroundsOccasionally may produce hyphae and pseudohyphae",
                    "sub_points": [
                      "Round to oval yeast",
                      "Narrow-based buds",
                      "Considerable variation in size, ranging 2-20 μm in diameter",
                      "Halo around organisms representing mucopolysaccharide capsuleSoap bubble appearance at low magnificationCapsule may have diameter up to 5x that of fungal cells it surrounds",
                      "Soap bubble appearance at low magnification",
                      "Capsule may have diameter up to 5x that of fungal cells it surrounds",
                      "Occasionally may produce hyphae and pseudohyphae"
                    ]
                  },
                  {
                    "text": "Variable inflammatory responseUsually minimal accompanying inflammation, especially in immunocompromised patientsKupffer cells or portal macrophages contain engulfed yeastMay have suppurative, granulomatous, or mixed tissue reactionOccasionally large, multinucleated giant cells containing yeast are present",
                    "sub_points": [
                      "Usually minimal accompanying inflammation, especially in immunocompromised patientsKupffer cells or portal macrophages contain engulfed yeast",
                      "Kupffer cells or portal macrophages contain engulfed yeast",
                      "May have suppurative, granulomatous, or mixed tissue reaction",
                      "Occasionally large, multinucleated giant cells containing yeast are present"
                    ]
                  },
                  {
                    "text": "Histochemical stainsGMS(+)Capsule will stain with Alcian blue, mucicarmine, colloidal iron, and Fontana-MassonCapsule-deficient organisms are mucicarmine (-) or only weakly (+)Fontana-Masson is useful in these cases",
                    "sub_points": [
                      "GMS(+)",
                      "Capsule will stain with Alcian blue, mucicarmine, colloidal iron, and Fontana-MassonCapsule-deficient organisms are mucicarmine (-) or only weakly (+)Fontana-Masson is useful in these cases",
                      "Capsule-deficient organisms are mucicarmine (-) or only weakly (+)Fontana-Masson is useful in these cases",
                      "Fontana-Masson is useful in these cases"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Fungal Infections": [
                  {
                    "text": "Blastomyces dermatitidisLarger and more uniform in size thanCryptococcusBroad-based budsOccasionally mucicarmine(+) but Fontana-Masson (-)",
                    "sub_points": [
                      "Larger and more uniform in size thanCryptococcus",
                      "Broad-based buds",
                      "Occasionally mucicarmine(+) but Fontana-Masson (-)"
                    ]
                  },
                  {
                    "text": "Histoplasma capsulatumSmaller and more uniform in size thanCryptococcusMucicarmine and Fontana-Masson (-)",
                    "sub_points": [
                      "Smaller and more uniform in size thanCryptococcus",
                      "Mucicarmine and Fontana-Masson (-)"
                    ]
                  }
                ],
                "Other Suppurative and Granulomatous Processes": [
                  {
                    "text": "Bacterial and mycobacterial infections"
                  },
                  {
                    "text": "Noninfectious causes of hepatic granulomas"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Often represents part of disseminated infection"
                  },
                  {
                    "text": "Patients are usually immunocompromised"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Mucin-positive capsule is highly suggestive ofCryptococcusspeciesNegative mucicarmine stain does not exclude cryptococcosis",
                    "sub_points": [
                      "Negative mucicarmine stain does not exclude cryptococcosis"
                    ]
                  },
                  {
                    "text": "Capsule-deficientCryptococcusoften has at least some weakly positive cells when mucin stains are examined carefully"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Candidiasis": {
            "name": "Candidiasis",
            "url": "https://app.pathprimer.com/document/5ee29bb0-8d98-4844-b826-0f7059811744/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Candidiasisis most common disseminated fungal infection in immunocompromised hostsLiver involvement is commonRare in immunocompetent patients",
                    "sub_points": [
                      "Liver involvement is common",
                      "Rare in immunocompetent patients"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "C. albicansmost commonEndogenous commensal that is part of normal flora of GI tract, mouth, respiratory tract, vagina",
                    "sub_points": [
                      "Endogenous commensal that is part of normal flora of GI tract, mouth, respiratory tract, vagina"
                    ]
                  },
                  {
                    "text": "Risk factors include disruption of mucosal or cutaneous barriers, immunosuppression, use of broad-spectrum antibiotics"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Presentation may be very nonspecific (fever, hepatomegaly, abdominal pain)"
                  },
                  {
                    "text": "Prognosis depends on underlying immune status of patient"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Yellow-white nodulesUsually multiple, 1-2 cm",
                    "sub_points": [
                      "Usually multiple, 1-2 cm"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Typical inflammatory reaction is granulomatousFrequently with suppurative/necrotic centerMay have minimal inflammation in severely immunocompromised patients",
                    "sub_points": [
                      "Frequently with suppurative/necrotic center",
                      "May have minimal inflammation in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Mixture of budding yeast, hyphae, and pseudohyphaeGMS, PAS (+)",
                    "sub_points": [
                      "GMS, PAS (+)"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PCR"
                  },
                  {
                    "text": "Culture"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Fungi can sometimes be speciated by morphology, but one needs confirmatory test"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection of liver by fungusCandidaMost common disseminated fungal infection in immunocompromised hostsRare in immunocompetent patientsLiver involvement is common in disseminated infectionIn liver transplant patients, may be associated with ischemic/necrotic bile ducts, hepatic artery thrombosis",
                    "sub_points": [
                      "Most common disseminated fungal infection in immunocompromised hostsRare in immunocompetent patients",
                      "Rare in immunocompetent patients",
                      "Liver involvement is common in disseminated infection",
                      "In liver transplant patients, may be associated with ischemic/necrotic bile ducts, hepatic artery thrombosis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "C. albicansmost commonEndogenous commensal that is part of normal flora of GI tract, mouth, respiratory tract, vagina",
                    "sub_points": [
                      "Endogenous commensal that is part of normal flora of GI tract, mouth, respiratory tract, vagina"
                    ]
                  },
                  {
                    "text": "Other pathogenicCandidaincludeC. tropicalis,C. parapsilosis, C. kruseiSaprophytic yeasts present in both humans and environment",
                    "sub_points": [
                      "Saprophytic yeasts present in both humans and environment"
                    ]
                  },
                  {
                    "text": "C.(Torulopsis)glabrataNormal flora of skin, GI tract, GU tract, respiratory tract",
                    "sub_points": [
                      "Normal flora of skin, GI tract, GU tract, respiratory tract"
                    ]
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "Disruption of mucosal or cutaneous barriers, indwelling catheters/vascular devices"
                  },
                  {
                    "text": "Broad-spectrum antibiotics"
                  },
                  {
                    "text": "Metabolic abnormalities"
                  },
                  {
                    "text": "Neonates"
                  },
                  {
                    "text": "Neutropenia, immunosuppression, steroids, hematologic malignancies"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Exact pathogenesis unknown:Candidamay colonize bowel, invade following bowel mucosal injury, and seed portal circulation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Hepatomegaly, abdominal pain, fever"
                  },
                  {
                    "text": "Nonspecific presentation may delay diagnosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases and bilirubin"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Antifungals"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on underlying immune status of patientDifficult to eliminate fungusIn one study of hematologic malignancy patients with chronic disseminated candidiasis, ~ 70% continue to have residual abscesses even after 3 months of treatmentPersistent lesions may produce scarring",
                    "sub_points": [
                      "Difficult to eliminate fungusIn one study of hematologic malignancy patients with chronic disseminated candidiasis, ~ 70% continue to have residual abscesses even after 3 months of treatment",
                      "In one study of hematologic malignancy patients with chronic disseminated candidiasis, ~ 70% continue to have residual abscesses even after 3 months of treatment",
                      "Persistent lesions may produce scarring"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Multiple yellow-white, 1- to 2-cm nodules"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Typical inflammatory reaction is granulomatousGiant cells, palisading histiocytes, peripheral scarring are variably presentMay have only minimal inflammatory reaction in severely immunocompromised patients",
                    "sub_points": [
                      "Giant cells, palisading histiocytes, peripheral scarring are variably present",
                      "May have only minimal inflammatory reaction in severely immunocompromised patients"
                    ]
                  },
                  {
                    "text": "Usually suppurative center ± necrosis"
                  },
                  {
                    "text": "Nonspecific reactive findings, usually near fungal lesionCholestasisMixed portal inflammation and ductular reactionSinusoidal dilatation",
                    "sub_points": [
                      "Cholestasis",
                      "Mixed portal inflammation and ductular reaction",
                      "Sinusoidal dilatation"
                    ]
                  },
                  {
                    "text": "Morphologic features of fungusMixture of budding yeast, hyphae, and pseudohyphaeC. albicans,C. tropicalisBudding yeast onlyC.(Torulopsis)glabrataAll are GMS, PAS (+)",
                    "sub_points": [
                      "Mixture of budding yeast, hyphae, and pseudohyphaeC. albicans,C. tropicalis",
                      "C. albicans,C. tropicalis",
                      "Budding yeast onlyC.(Torulopsis)glabrata",
                      "C.(Torulopsis)glabrata",
                      "All are GMS, PAS (+)"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Laboratory Tests": [
                  {
                    "text": "PCRCan often be performed from formalin-fixed, paraffin-embedded block",
                    "sub_points": [
                      "Can often be performed from formalin-fixed, paraffin-embedded block"
                    ]
                  },
                  {
                    "text": "Culture"
                  },
                  {
                    "text": "β-D-glucan in serumMarker of disseminated infection/fungemia; not specific forCandida",
                    "sub_points": [
                      "Marker of disseminated infection/fungemia; not specific forCandida"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cat-Scratch Disease": [
                  {
                    "text": "Similar palisading histiocytes, peripheral fibrosis, and central stellate suppuration"
                  },
                  {
                    "text": "GMS stain, laboratory tests negative for fungi"
                  },
                  {
                    "text": "PCR, immunohistochemistry, silver impregnation stains to confirmBartonella"
                  }
                ],
                "Other Fungi": [
                  {
                    "text": "AspergillusTrue hyphae that branch at acute angles, usually vasocentric",
                    "sub_points": [
                      "True hyphae that branch at acute angles, usually vasocentric"
                    ]
                  },
                  {
                    "text": "MucorBroad, pauciseptate, ribbon-like hyphae; usually vasocentric",
                    "sub_points": [
                      "Broad, pauciseptate, ribbon-like hyphae; usually vasocentric"
                    ]
                  },
                  {
                    "text": "HistoplasmosisMore uniform size thanC. (Torulopsis) glabrata\"Halo\" effect around organism in tissue",
                    "sub_points": [
                      "More uniform size thanC. (Torulopsis) glabrata",
                      "\"Halo\" effect around organism in tissue"
                    ]
                  }
                ],
                "Necrotic Tumor": [
                  {
                    "text": "No evidence of fungi"
                  }
                ],
                "Bacterial Abscess": [
                  {
                    "text": "GMS(-) for fungi"
                  },
                  {
                    "text": "Usually lacks granulomatous features"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Granulomatous inflammation with necrotic centers, GMS or PAS (+) organisms with budding yeasts or pseudohyphal forms"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Schistosomiasis": {
            "name": "Schistosomiasis",
            "url": "https://app.pathprimer.com/document/8c757ced-7a06-4a7a-954b-13ab914d7429/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Parasitic infection caused by trematodes (blood flukes) of genusSchistosomaS. mansoniandS. japonicummost frequently cause hepatosplenic disease",
                    "sub_points": [
                      "S. mansoniandS. japonicummost frequently cause hepatosplenic disease"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Infection occurs when cercariae (infectious larvae) leave intermediate host snail and penetrate skin of vertebrate host (in contaminated water)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "EachSchistosomaspecies is associated with specific snail species, which determines geographic distribution85% of infections are in sub-Saharan Africa",
                    "sub_points": [
                      "85% of infections are in sub-Saharan Africa"
                    ]
                  },
                  {
                    "text": "Acute presentation (Katayama fever) is hypersensitivity reaction to schistosome antigens"
                  },
                  {
                    "text": "Chronic disease is secondary to tissue damage from inflammatory response to ova, not worms themselves"
                  },
                  {
                    "text": "10% of patients progress to severe hepatic fibrosisHepatic function preserved until late in disease course",
                    "sub_points": [
                      "Hepatic function preserved until late in disease course"
                    ]
                  },
                  {
                    "text": "Laboratory testsStool or urine examination for ovaSerology to detect antischistosomal antibodies",
                    "sub_points": [
                      "Stool or urine examination for ova",
                      "Serology to detect antischistosomal antibodies"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Portal fibrosis with partial or complete destruction of main branches of portal vein and sparing of arteries and ducts"
                  },
                  {
                    "text": "Granulomatous reaction to ova with variably present foreign body giant cells, eosinophils, mononuclear cells"
                  },
                  {
                    "text": "Ova have refractile shell and lateral spine"
                  },
                  {
                    "text": "Hematin pigment in portal and sinusoidal macrophages"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Granulomatous hepatitis in patient from endemic area warrants search for ova"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Bilharziasis, snail fever, Katayama fever"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Parasitic infection caused by trematodes (blood flukes) of genusSchistosoma3 major species cause infection in humans:S. mansoni,S. haematobium,S. japonicumS. mansoniandS. japonicummore likely to cause disease in liver and bowel",
                    "sub_points": [
                      "3 major species cause infection in humans:S. mansoni,S. haematobium,S. japonicumS. mansoniandS. japonicummore likely to cause disease in liver and bowel",
                      "S. mansoniandS. japonicummore likely to cause disease in liver and bowel"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Life Cycle and Infection": [
                  {
                    "text": "Infected humans/animals contaminate fresh water with eggs by urine or feces"
                  },
                  {
                    "text": "Eggs release miracidia, which penetrate snails"
                  },
                  {
                    "text": "Infection occurs when cercariae (infectious larvae) exit snail and penetrate skin of vertebrate host (in contaminated water)"
                  },
                  {
                    "text": "Cercaria transform into migrating schistosomulum and gain access to venous system"
                  },
                  {
                    "text": "After maturing, travel to mesenteric venous plexus, where male occupies gynecophoric canal of femaleAdult flukes live 3-5 years on average, during which they feed on host blood and release eggs",
                    "sub_points": [
                      "Adult flukes live 3-5 years on average, during which they feed on host blood and release eggs"
                    ]
                  },
                  {
                    "text": "Eggs released into environment through intestine or GU tract hatch into miracidia, which again infect freshwater snails"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Geographic distributionEachSchistosomaspecies is associated with specific snail species, which determines geographic distributionTropical countries in Africa, Caribbean, eastern South America, Southeast Asia, Middle East85% of infections are in sub-Saharan Africa",
                    "sub_points": [
                      "EachSchistosomaspecies is associated with specific snail species, which determines geographic distributionTropical countries in Africa, Caribbean, eastern South America, Southeast Asia, Middle East85% of infections are in sub-Saharan Africa",
                      "Tropical countries in Africa, Caribbean, eastern South America, Southeast Asia, Middle East",
                      "85% of infections are in sub-Saharan Africa"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Children are infected as soon as they begin to have contact with fresh water; prevalence peaks in older, school-age children"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute presentation (Katayama fever)Hypersensitivity reaction to schistosome antigensAbdominal pain, cough, diarrhea, eosinophilia, fever, hepatosplenomegaly, rash",
                    "sub_points": [
                      "Hypersensitivity reaction to schistosome antigensAbdominal pain, cough, diarrhea, eosinophilia, fever, hepatosplenomegaly, rash",
                      "Abdominal pain, cough, diarrhea, eosinophilia, fever, hepatosplenomegaly, rash"
                    ]
                  },
                  {
                    "text": "Chronic presentationDue to cumulative deposition of eggs in tissuePortal hypertension with esophageal varices, splenomegaly, and thrombocytopeniaExtrahepatic manifestations include colonic polyposis with bloody diarrhea, cystitis with hematuria, and pulmonary hypertensionTissue damage is related to inflammatory response to ova trapped in host tissue, not worms themselvesSchistosomiasis potentiates HBV and HCV infection in liver",
                    "sub_points": [
                      "Due to cumulative deposition of eggs in tissuePortal hypertension with esophageal varices, splenomegaly, and thrombocytopeniaExtrahepatic manifestations include colonic polyposis with bloody diarrhea, cystitis with hematuria, and pulmonary hypertensionTissue damage is related to inflammatory response to ova trapped in host tissue, not worms themselvesSchistosomiasis potentiates HBV and HCV infection in liver",
                      "Portal hypertension with esophageal varices, splenomegaly, and thrombocytopeniaExtrahepatic manifestations include colonic polyposis with bloody diarrhea, cystitis with hematuria, and pulmonary hypertension",
                      "Extrahepatic manifestations include colonic polyposis with bloody diarrhea, cystitis with hematuria, and pulmonary hypertension",
                      "Tissue damage is related to inflammatory response to ova trapped in host tissue, not worms themselves",
                      "Schistosomiasis potentiates HBV and HCV infection in liver"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Stool or urine examination for ovaMay require multiple specimens, as shedding of eggs varies widely",
                    "sub_points": [
                      "May require multiple specimens, as shedding of eggs varies widely"
                    ]
                  },
                  {
                    "text": "Serology to detect antischistosomal antibodiesSeveral commercially available techniques; sensitivity/specificity depend on technique usedSerologies do not distinguish between prior and current infection",
                    "sub_points": [
                      "Several commercially available techniques; sensitivity/specificity depend on technique used",
                      "Serologies do not distinguish between prior and current infection"
                    ]
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Praziquantel"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "10% of patients progress to severe hepatic fibrosisLiver function typically preserved until late-stage disease",
                    "sub_points": [
                      "Liver function typically preserved until late-stage disease"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Portal Fibrosis and Inflammation": [
                  {
                    "text": "Partial or complete destruction of main branches of portal veinInflammation induced by eggs leads to pyelophlebitis, periportal fibrosisSymmers pipestem fibrosis characterized by marked portal fibrosis but preserved lobular architecture",
                    "sub_points": [
                      "Inflammation induced by eggs leads to pyelophlebitis, periportal fibrosis",
                      "Symmers pipestem fibrosis characterized by marked portal fibrosis but preserved lobular architecture"
                    ]
                  },
                  {
                    "text": "Arteries and ducts are spared"
                  }
                ],
                "Granulomatous Reaction to Ova": [
                  {
                    "text": "Variably present foreign body giant cells, eosinophils, mononuclear cells"
                  },
                  {
                    "text": "Ova have refractile shell and lateral spine (S. mansoniandS. japonicum)"
                  },
                  {
                    "text": "Sometimes only degenerated parts of eggs are present"
                  },
                  {
                    "text": "Remote infections often feature calcified eggs without active inflammation"
                  }
                ],
                "Pigment": [
                  {
                    "text": "In sinusoidal and portal macrophages; caused by adult worms metabolizing hemoglobin and regurgitating hematin pigment"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sarcoidosis": [
                  {
                    "text": "Numerous granulomas without ova; eosinophils not feature"
                  }
                ],
                "Other Parasitic &/or Granulomatous Infections": [
                  {
                    "text": "Ascaris,Enterobius, fungal infections, tuberculosis; schistosome eggs help to distinguish"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Granulomatous hepatitis in patient from endemic area warrants search for ova"
                  },
                  {
                    "text": "Important cause of presinusoidal portal hypertension in patients from endemic areasLiver function is maintained, so patients lack stigmata of liver insufficiency",
                    "sub_points": [
                      "Liver function is maintained, so patients lack stigmata of liver insufficiency"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Echinococcosis": {
            "name": "Echinococcosis",
            "url": "https://app.pathprimer.com/document/b981b143-a4f5-49a4-bb79-45ac7109b308/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Zoonotic infection caused byEchinococcusspeciesCestode (tapeworm) with wide geographic distribution",
                    "sub_points": [
                      "Cestode (tapeworm) with wide geographic distribution"
                    ]
                  },
                  {
                    "text": "Echinococcusgranulosus(cystic form) andEchinococcusmultilocularis(alveolar form) most commonly infect humans"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Humans infected by exposure to contaminated feces of primary or intermediate host"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Right lobe of liver is most common site"
                  },
                  {
                    "text": "Often asymptomatic, given slow-growing nature of cysts (1 mm per month)"
                  },
                  {
                    "text": "Symptoms usually due to space-occupying compression of other structures or ruptureBile duct obstruction, infection, portal hypertension",
                    "sub_points": [
                      "Bile duct obstruction, infection, portal hypertension"
                    ]
                  },
                  {
                    "text": "Puncture with radiologic guidance, aspiration, infusion of protoscolicidal agent, reaspiration (PAIR) is preferred treatmentPatients with ruptured cystic disease may require lifelong antiparasitic therapy to prevent recurrence",
                    "sub_points": [
                      "Patients with ruptured cystic disease may require lifelong antiparasitic therapy to prevent recurrence"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "E. granulosusproduces unilocular cysts with fibrous rim, filled with milky material and smaller daughter cysts"
                  },
                  {
                    "text": "E. multilocularisis more likely to present as inflammatory or fibrotic masses with scattered cystic spaces"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Viable cysts ofE. granulosusare composed of 3 layersInnermost: Germinal membrane with protoscolicesMiddle: Hyalinized, laminated, acellular materialOuter: Granulation tissue and fibrosis (host response)Daughter cysts are structurally identical to primary cyst",
                    "sub_points": [
                      "Innermost: Germinal membrane with protoscolices",
                      "Middle: Hyalinized, laminated, acellular material",
                      "Outer: Granulation tissue and fibrosis (host response)",
                      "Daughter cysts are structurally identical to primary cyst"
                    ]
                  },
                  {
                    "text": "E. multiloculariscauses fibrotic mass with variably present daughter cysts and necrosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Hydatid disease"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Zoonotic infection caused byEchinococcusspeciesCestode (tapeworm) with wide geographic distribution",
                    "sub_points": [
                      "Cestode (tapeworm) with wide geographic distribution"
                    ]
                  },
                  {
                    "text": "Echinococcusgranulosus(cystic form) andEchinococcusmultilocularis(alveolar form) most commonly infect humans"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Tapeworm attaches to small intestinal mucosa in definitive hosts (dogs or other carnivores)"
                  },
                  {
                    "text": "Humans infected by exposure to contaminated feces containing eggsAfter ingestion, eggs hatch and release larval oncospheres, which travel to liver via portal veinOncospheres develop into cysts, which enlarge slowly (~ 1 mm per month), producing protoscolices and daughter cysts that fill interior of cyst",
                    "sub_points": [
                      "After ingestion, eggs hatch and release larval oncospheres, which travel to liver via portal vein",
                      "Oncospheres develop into cysts, which enlarge slowly (~ 1 mm per month), producing protoscolices and daughter cysts that fill interior of cyst"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Site": [
                  {
                    "text": "Right lobe of liver is most common site"
                  },
                  {
                    "text": "May involve any site in body"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often asymptomatic, given slow-growing nature of cysts"
                  },
                  {
                    "text": "Symptoms usually due to space-occupying compression of other structures or ruptureBile duct compression, bacterial infection, cholangitis, rupture into peritoneal or pleural cavitiesRarely, portal vein compression causes portal hypertension",
                    "sub_points": [
                      "Bile duct compression, bacterial infection, cholangitis, rupture into peritoneal or pleural cavities",
                      "Rarely, portal vein compression causes portal hypertension"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serologic studiesCross reactivity with other cestodesIntact (unruptured) cysts may not elicit antibody response",
                    "sub_points": [
                      "Cross reactivity with other cestodes",
                      "Intact (unruptured) cysts may not elicit antibody response"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Complete surgical resection of cysts(s)If ruptured, cyst fluid is highly antigenic, and leakage can result in urticaria or anaphylaxis as well as recurrence of infection",
                    "sub_points": [
                      "If ruptured, cyst fluid is highly antigenic, and leakage can result in urticaria or anaphylaxis as well as recurrence of infection"
                    ]
                  },
                  {
                    "text": "Puncture, aspiration, injection, reaspiration (PAIR)Puncture with radiologic guidance, aspiration, infusion of protoscolicidal agent, reaspirationPreferred method, as it decreases risk of anaphylaxis and recurrence",
                    "sub_points": [
                      "Puncture with radiologic guidance, aspiration, infusion of protoscolicidal agent, reaspiration",
                      "Preferred method, as it decreases risk of anaphylaxis and recurrence"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Ruptured cystic disease may require lifelong antiparasitic therapy to prevent recurrence"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Ultrasound, CT scan show cysts with internal septations"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "E. granulosusUsually unilocular, filled with milky material and smaller daughter cystsFibrous rim; measure up to 35 cmCauses expansile growth in liver",
                    "sub_points": [
                      "Usually unilocular, filled with milky material and smaller daughter cysts",
                      "Fibrous rim; measure up to 35 cm",
                      "Causes expansile growth in liver"
                    ]
                  },
                  {
                    "text": "E. multilocularislesions are more likely to present as inflammatory or fibrotic masses with scattered cystic spacesInvasive, tissue-destructive growth, can cause distant spreadMore likely to have smaller cysts (< 2.5 cm) and more cysts (> 10 cm) thanE.granulosus",
                    "sub_points": [
                      "Invasive, tissue-destructive growth, can cause distant spread",
                      "More likely to have smaller cysts (< 2.5 cm) and more cysts (> 10 cm) thanE.granulosus"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Viable cysts ofE. granulosushave 3 layersInnermost layer: Delicate germinal membraneThin lining of nucleated cells from which brood capsules and their enclosed protoscolices developOvoid protoscolices represent incipient heads of adult tapeworms; contain 2 circles of hooklets and suckerMiddle layer: Hyalinized, white membrane of laminated, acellular material secreted by parasiteOuter peripheral layer: Granulation tissue and fibrosis",
                    "sub_points": [
                      "Innermost layer: Delicate germinal membraneThin lining of nucleated cells from which brood capsules and their enclosed protoscolices developOvoid protoscolices represent incipient heads of adult tapeworms; contain 2 circles of hooklets and sucker",
                      "Thin lining of nucleated cells from which brood capsules and their enclosed protoscolices develop",
                      "Ovoid protoscolices represent incipient heads of adult tapeworms; contain 2 circles of hooklets and sucker",
                      "Middle layer: Hyalinized, white membrane of laminated, acellular material secreted by parasite",
                      "Outer peripheral layer: Granulation tissue and fibrosis"
                    ]
                  },
                  {
                    "text": "Larger lesions may have daughter cysts that are structurally identical to primary cystProduced by protoscolices released from germinal membrane or ruptured brood capsules",
                    "sub_points": [
                      "Produced by protoscolices released from germinal membrane or ruptured brood capsules"
                    ]
                  },
                  {
                    "text": "Ruptured cysts may contain only fibroinflammatory debris with shed hooklets and calcification"
                  },
                  {
                    "text": "Eosinophils are not conspicuous unless cyst has degenerated or ruptured"
                  },
                  {
                    "text": "E. multiloculariscauses fibrotic mass with variably present daughter cysts and necrosis"
                  },
                  {
                    "text": "Hooklets are partially acid-fast with Ziehl-Neelsen stain, stain with GMS, and are birefringent"
                  },
                  {
                    "text": "Polarization may also highlight hooklets"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Fine-needle aspiration fluid can be spun down and evaluated for protoscolices or hooklets"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Immunostains exist that can reportedly detect echinococcosis in liver cysts and distinguish betweenE.granulosus and E. multilocularis"
                  }
                ],
                "PCR": [
                  {
                    "text": "PCR, or sequencing performed on tissue, can also distinguish betweenE.granulosus and E. multilocularis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Tapeworm Infections": [
                  {
                    "text": "Cysticercosis (Taenia solium); coenurosis (several species of tapeworm)"
                  }
                ],
                "Fibropolycystic Liver Disease": [
                  {
                    "text": "Lack trilayered cyst, protoscolices"
                  }
                ],
                "Amebic or Pyogenic Abscess": [
                  {
                    "text": "Lack trilayered cyst, protoscolices"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Amebiasis": {
            "name": "Amebiasis",
            "url": "https://app.pathprimer.com/document/70d31470-b98f-4fbb-94e1-0ee5f570505d/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection of liver by protozoaEntamoeba histolytica"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Risk factors for infectionPoor sanitation, exposure to contaminated waterSexual or fecal/oral transmissionMen having sex with men have higher incidence than general population",
                    "sub_points": [
                      "Poor sanitation, exposure to contaminated water",
                      "Sexual or fecal/oral transmissionMen having sex with men have higher incidence than general population",
                      "Men having sex with men have higher incidence than general population"
                    ]
                  },
                  {
                    "text": "Liver abscess is most frequent complication of invasive amebiasis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Fever, sweats, and right upper quadrant pain"
                  },
                  {
                    "text": "Hepatomegaly, abdominal tenderness"
                  },
                  {
                    "text": "Elevated alkaline phosphatase, leukocytosis common"
                  },
                  {
                    "text": "Lab testsSerologic studies, PCR, stool examinationStool exam cannot distinguish betweenE. histolyticaand nonpathogenic amebae",
                    "sub_points": [
                      "Serologic studies, PCR, stool examinationStool exam cannot distinguish betweenE. histolyticaand nonpathogenic amebae",
                      "Stool exam cannot distinguish betweenE. histolyticaand nonpathogenic amebae"
                    ]
                  },
                  {
                    "text": "TreatmentAmebicidesGuided percutaneous drainage may be required for liver abscess",
                    "sub_points": [
                      "Amebicides",
                      "Guided percutaneous drainage may be required for liver abscess"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary or multiple lesions, often irregularly shaped, ranging from barely visible to > 20 cmUsually right lobeOften contain necrosis resembling anchovy paste",
                    "sub_points": [
                      "Usually right lobe",
                      "Often contain necrosis resembling anchovy paste"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Abundant nuclear debris but few intact inflammatory cells"
                  },
                  {
                    "text": "Organisms have foamy cytoplasm; round, eccentric nucleiIngested red blood cells essentially pathognomonic ofE. histolytica",
                    "sub_points": [
                      "Ingested red blood cells essentially pathognomonic ofE. histolytica"
                    ]
                  },
                  {
                    "text": "Trophozoites may mimic macrophages"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Entamebiasis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Infection of liver byEntamoeba histolyticaMany species ofEntamoeba are morphologically similar but nonpathogenicHumans are only known reservoir",
                    "sub_points": [
                      "Many species ofEntamoeba are morphologically similar but nonpathogenic",
                      "Humans are only known reservoir"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Exposure to contaminated waterMost common in poor communities with inadequate sanitationTropical and subtropical countries most commonly affected but exists in every countryIn industrialized countries, infection often acquired from travel to or immigration from endemic area",
                    "sub_points": [
                      "Most common in poor communities with inadequate sanitation",
                      "Tropical and subtropical countries most commonly affected but exists in every country",
                      "In industrialized countries, infection often acquired from travel to or immigration from endemic area"
                    ]
                  },
                  {
                    "text": "Sexual or fecal/oral transmissionMen who have sex with men have higher incidence than general population",
                    "sub_points": [
                      "Men who have sex with men have higher incidence than general population"
                    ]
                  },
                  {
                    "text": "Transmitted by ingestion of cystic formOnce inside body, cyst degenerates in GI tract, and resultant trophozoites can be seen in tissue",
                    "sub_points": [
                      "Once inside body, cyst degenerates in GI tract, and resultant trophozoites can be seen in tissue"
                    ]
                  },
                  {
                    "text": "Liver abscess is most frequent extraintestinal manifestation of invasive gastrointestinal amebiasisImmune compromise increases incidence of liver abscessPortal vein is major route by which amebae get from intestine to liverInvasive lesion in large bowel is prerequisite for passage into portal veinMany patients with amebic liver abscess do not have history of gastrointestinal symptoms, however",
                    "sub_points": [
                      "Immune compromise increases incidence of liver abscess",
                      "Portal vein is major route by which amebae get from intestine to liver",
                      "Invasive lesion in large bowel is prerequisite for passage into portal veinMany patients with amebic liver abscess do not have history of gastrointestinal symptoms, however",
                      "Many patients with amebic liver abscess do not have history of gastrointestinal symptoms, however"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "~ 50 million cases of amebiasis per year occur worldwide~ 4% prevalence in United StatesOnly minority of those infected develop symptomatic disease",
                    "sub_points": [
                      "~ 4% prevalence in United States",
                      "Only minority of those infected develop symptomatic disease"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Peak incidence around age 40"
                  }
                ],
                "Sex": [
                  {
                    "text": "> 80% of patients are maleReason(s) why unclear",
                    "sub_points": [
                      "Reason(s) why unclear"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Fever with afternoon and night sweats"
                  },
                  {
                    "text": "Malaise"
                  },
                  {
                    "text": "Right upper quadrant painMay radiate to scapular region or shoulder",
                    "sub_points": [
                      "May radiate to scapular region or shoulder"
                    ]
                  },
                  {
                    "text": "Hepatomegaly, abdominal tenderness"
                  },
                  {
                    "text": "Weight loss and anorexia"
                  },
                  {
                    "text": "Jaundice5-50% of casesMore common if hepatic ducts are compressed by abscess",
                    "sub_points": [
                      "5-50% of cases",
                      "More common if hepatic ducts are compressed by abscess"
                    ]
                  },
                  {
                    "text": "ComplicationsRuptureLiver abscess may rupture through liver capsule into peritoneal cavity, pleural space, or pericardial spaceBacterial superinfectionFistula formationWidespread dissemination",
                    "sub_points": [
                      "RuptureLiver abscess may rupture through liver capsule into peritoneal cavity, pleural space, or pericardial space",
                      "Liver abscess may rupture through liver capsule into peritoneal cavity, pleural space, or pericardial space",
                      "Bacterial superinfection",
                      "Fistula formation",
                      "Widespread dissemination"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated alkaline phosphatase in > 50% of patients"
                  },
                  {
                    "text": "Transaminases rarely elevated"
                  },
                  {
                    "text": "Leukocytosis in > 90% of patientsEosinophilia usually absent",
                    "sub_points": [
                      "Eosinophilia usually absent"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "AmebicidesMost often metronidazole",
                    "sub_points": [
                      "Most often metronidazole"
                    ]
                  },
                  {
                    "text": "Guided percutaneous drainageNot 1st-line therapyPerformed if response to drugs is inadequate, there is bacterial superinfection, or concern for rupture",
                    "sub_points": [
                      "Not 1st-line therapy",
                      "Performed if response to drugs is inadequate, there is bacterial superinfection, or concern for rupture"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent (< 1%) with modern amebicidal therapyRisk factors associated with increased mortalityLack of treatmentDisseminationBilirubin > 3.5 mg/dLAlbumin < 2.0 g/dLMultiple abscessesEncephalopathy",
                    "sub_points": [
                      "Risk factors associated with increased mortalityLack of treatmentDisseminationBilirubin > 3.5 mg/dLAlbumin < 2.0 g/dLMultiple abscessesEncephalopathy",
                      "Lack of treatment",
                      "Dissemination",
                      "Bilirubin > 3.5 mg/dL",
                      "Albumin < 2.0 g/dL",
                      "Multiple abscesses",
                      "Encephalopathy"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Ultrasound is commonly used imaging modalityRound, hypoechoic lesion with hyperechoic wallMay be difficult to distinguish from other types of hepatic abscess",
                    "sub_points": [
                      "Round, hypoechoic lesion with hyperechoic wall",
                      "May be difficult to distinguish from other types of hepatic abscess"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary or multiple lesionsOften irregularly shapedUsually right lobe, reflecting greater portal venous drainageSize ranges from barely visible to > 20 cm",
                    "sub_points": [
                      "Often irregularly shaped",
                      "Usually right lobe, reflecting greater portal venous drainage",
                      "Size ranges from barely visible to > 20 cm"
                    ]
                  },
                  {
                    "text": "May have prominent fibrous capsule, which gets thicker with age of lesion"
                  },
                  {
                    "text": "Frequently contain necrotic debrisThick, green-brown necrotic material known as \"anchovy paste\"",
                    "sub_points": [
                      "Thick, green-brown necrotic material known as \"anchovy paste\""
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Early lesionTrophozoites within sinusoidsFocal necrosisNeutrophilic infiltrateEdema",
                    "sub_points": [
                      "Trophozoites within sinusoids",
                      "Focal necrosis",
                      "Neutrophilic infiltrate",
                      "Edema"
                    ]
                  },
                  {
                    "text": "Later lesionNecrotic materialAbundant nuclear debris but few intact inflammatory cellsOrganisms most often at advancing edge of abscessMay be hard to findLess frequently seen at center of lesionMononuclear cells at advancing edge, along with edemaEventually develop fibrosis and granulation tissue",
                    "sub_points": [
                      "Necrotic materialAbundant nuclear debris but few intact inflammatory cells",
                      "Abundant nuclear debris but few intact inflammatory cells",
                      "Organisms most often at advancing edge of abscessMay be hard to findLess frequently seen at center of lesion",
                      "May be hard to find",
                      "Less frequently seen at center of lesion",
                      "Mononuclear cells at advancing edge, along with edema",
                      "Eventually develop fibrosis and granulation tissue"
                    ]
                  },
                  {
                    "text": "Morphologic features of organismFoamy cytoplasm and distinct cell membraneEccentric round nucleusPeripheral margination of chromatin, central karyosomeIngested red blood cells essentially pathognomonic ofE. histolyticaTrophozoites are PAS, trichrome positiveImmunohistochemical stains exist but are not widely available",
                    "sub_points": [
                      "Foamy cytoplasm and distinct cell membrane",
                      "Eccentric round nucleusPeripheral margination of chromatin, central karyosome",
                      "Peripheral margination of chromatin, central karyosome",
                      "Ingested red blood cells essentially pathognomonic ofE. histolytica",
                      "Trophozoites are PAS, trichrome positive",
                      "Immunohistochemical stains exist but are not widely available"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Serologic Testing": [
                  {
                    "text": "Highly sensitive and specific"
                  },
                  {
                    "text": "~ 99% of patients develop detectable antibodySerologic studies may be negative within first 7-10 days of infectionIn endemic areas, positive serologies do not necessarily indicate active infection",
                    "sub_points": [
                      "Serologic studies may be negative within first 7-10 days of infection",
                      "In endemic areas, positive serologies do not necessarily indicate active infection"
                    ]
                  }
                ],
                "Molecular Testing": [
                  {
                    "text": "PCR on liver abscess fluid samples or fecal samples may be positive even when histology is negative for amebae"
                  }
                ],
                "Stool Studies": [
                  {
                    "text": "Do not distinguish pathogenic from nonpathogenic amebae"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Neoplasms": [
                  {
                    "text": "Hepatocellular carcinoma, metastases with cystic degeneration may mimic amebic abscess radiographically"
                  }
                ],
                "Pyogenic Liver Abscess": [
                  {
                    "text": "Usually has more neutrophils, lacks parasites"
                  },
                  {
                    "text": "Patients typically older"
                  },
                  {
                    "text": "Often associated clinical factors such as diabetes or previous biliary or liver surgery"
                  },
                  {
                    "text": "Aspiration with culture may help resolve"
                  },
                  {
                    "text": "E. histolyticaserologies may be useful to exclude amebiasis"
                  }
                ],
                "Entamoeba dispar": [
                  {
                    "text": "Morphologically identical"
                  },
                  {
                    "text": "Noninvasive and does not cause disease even in severely immunocompromised individuals"
                  }
                ],
                "Balantidium coli": [
                  {
                    "text": "Large ciliate organisms with kidney bean-shaped nucleus"
                  },
                  {
                    "text": "Liver abscess due toB. coliis extremely rare"
                  }
                ],
                "Echinococcal Cyst": [
                  {
                    "text": "Patients from regions whereEchinococcusis endemic"
                  },
                  {
                    "text": "Eosinophilia is common"
                  },
                  {
                    "text": "Imaging, serologies, histology can help differentiate"
                  }
                ],
                "Macrophages": [
                  {
                    "text": "Mark by immunohistochemistry (e.g., CD68, CD163)"
                  },
                  {
                    "text": "Amebic nuclei rounder, more open chromatin pattern than macrophages"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Look for protozoa in amorphous necrotic material with few intact inflammatory cells"
                  },
                  {
                    "text": "Amebae may closely resemble macrophages"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cat-Scratch Disease": {
            "name": "Cat-Scratch Disease",
            "url": "https://app.pathprimer.com/document/0a2050d7-9221-425a-96aa-148380e93062/lesson/c7461652-12c5-4d24-8f51-e330a858b66c",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection byBartonellaspecies after inoculation by catMost cases are attributed toBartonellahenselae",
                    "sub_points": [
                      "Most cases are attributed toBartonellahenselae"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most cases are children and young adults with history of cat exposureUsually not immunocompromised",
                    "sub_points": [
                      "Usually not immunocompromised"
                    ]
                  },
                  {
                    "text": "~ 1-2% of patients develop visceral involvement (liver, spleen, bone, central nervous system, or lung)Cutaneous inoculation site often absent in patients with visceral disease",
                    "sub_points": [
                      "Cutaneous inoculation site often absent in patients with visceral disease"
                    ]
                  },
                  {
                    "text": "Multiple hepatic lesions, sometimes accompanied by splenic lesions and lymphadenopathy, may raise concern for neoplasia"
                  },
                  {
                    "text": "Serologies useful in some casesLimited sensitivity/specificityCross reactivity with other bacteria",
                    "sub_points": [
                      "Limited sensitivity/specificity",
                      "Cross reactivity with other bacteria"
                    ]
                  },
                  {
                    "text": "Excellent prognosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Irregular, stellate microabscesses with central necrosisSurrounding layers of palisading histiocytes, mononuclear cells, and rim of fibrous tissueFibrosis may be particularly prominent in liver",
                    "sub_points": [
                      "Surrounding layers of palisading histiocytes, mononuclear cells, and rim of fibrous tissue",
                      "Fibrosis may be particularly prominent in liver"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Silver impregnation stains: Warthin-Starry, Dieterle"
                  },
                  {
                    "text": "PCR from tissue block, blood, node aspirate, fresh tissue"
                  },
                  {
                    "text": "Immunohistochemistry"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Layered stellate microabscess with prominent fibrotic rim is highly characteristic"
                  },
                  {
                    "text": "Needle biopsy may only sample fibrosis, thus wedge biopsy may be required for diagnosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Cat-scratch disease (CSD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Zoonotic infection caused byBartonellaspp.Small, weakly gram-negative coccobacillusMost cases are attributed toBartonellahenselae, butBartonellaquintanaand other species have been implicated as wellInfection usually occurs after inoculation by catB. henselaehas been isolated from blood of both cats and their fleas",
                    "sub_points": [
                      "Small, weakly gram-negative coccobacillusMost cases are attributed toBartonellahenselae, butBartonellaquintanaand other species have been implicated as wellInfection usually occurs after inoculation by catB. henselaehas been isolated from blood of both cats and their fleas",
                      "Most cases are attributed toBartonellahenselae, butBartonellaquintanaand other species have been implicated as well",
                      "Infection usually occurs after inoculation by catB. henselaehas been isolated from blood of both cats and their fleas",
                      "B. henselaehas been isolated from blood of both cats and their fleas"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Majority of patients are children and young adultsTypically not immunocompromisedCases have been reported in solid organ transplant patients and other immunocompromised individuals",
                    "sub_points": [
                      "Typically not immunocompromised",
                      "Cases have been reported in solid organ transplant patients and other immunocompromised individuals"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most patients present with cutaneous inoculation site and regional lymphadenopathy~ 1-2% of patients develop visceral involvement (liver, spleen, bone, central nervous system, or lung)~ 25% of patients with hepatic CSD have lymphadenopathy, but skin papule is often absent in visceral disease",
                    "sub_points": [
                      "~ 1-2% of patients develop visceral involvement (liver, spleen, bone, central nervous system, or lung)~ 25% of patients with hepatic CSD have lymphadenopathy, but skin papule is often absent in visceral disease",
                      "~ 25% of patients with hepatic CSD have lymphadenopathy, but skin papule is often absent in visceral disease"
                    ]
                  },
                  {
                    "text": "Atypical presentations can be seen in older patients (> 60 years) or immunocompromised patients with disseminated diseaseNonspecific symptoms, including fever, abdominal pain, chills, headache, malaise, and weight loss",
                    "sub_points": [
                      "Nonspecific symptoms, including fever, abdominal pain, chills, headache, malaise, and weight loss"
                    ]
                  },
                  {
                    "text": "AIDS patients and other immunocompromised persons may get bacillary peliosis hepatis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "SerologiesSensitivity: 80-100%; specificity: 89-99%Problem of cross reactivity with other bacteriaMay get false-negatives in very young children, older adult patients, and immunocompromised patients",
                    "sub_points": [
                      "Sensitivity: 80-100%; specificity: 89-99%",
                      "Problem of cross reactivity with other bacteria",
                      "May get false-negatives in very young children, older adult patients, and immunocompromised patients"
                    ]
                  },
                  {
                    "text": "PCR of tissue, blood, or lymph node aspirate"
                  },
                  {
                    "text": "Very difficult to culture"
                  },
                  {
                    "text": "Skin test used historically, but no longer"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Antibiotics typically not recommended for immune-competent patientsSeveral antibiotics are effective (rifampin, erythromycin, ciprofloxacin, doxycycline)",
                    "sub_points": [
                      "Several antibiotics are effective (rifampin, erythromycin, ciprofloxacin, doxycycline)"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent; typically no long-term hepatic dysfunction"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Liver may be studded with hard nodules of varying sizes"
                  },
                  {
                    "text": "Bacillary peliosis hepatis: Blood-filled spaces in liver"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Irregular, stellate microabscessesSurrounded by distinct layers of palisading histiocytes, lymphocytes, and outer rim of fibrous tissue",
                    "sub_points": [
                      "Surrounded by distinct layers of palisading histiocytes, lymphocytes, and outer rim of fibrous tissue"
                    ]
                  },
                  {
                    "text": "Temporal heterogeneityYounger lesions may show more necrosis with less organization of inflammatory granulomatous responseOlder lesions may show confluent granulomas with scarring and scant residual necrosis",
                    "sub_points": [
                      "Younger lesions may show more necrosis with less organization of inflammatory granulomatous response",
                      "Older lesions may show confluent granulomas with scarring and scant residual necrosis"
                    ]
                  },
                  {
                    "text": "Occasional small, rounded granulomas with giant cells and small foci of central necrosis that can mimic caseating granulomas in mycobacterial or fungal infections"
                  },
                  {
                    "text": "Peliosis hepatis: Cystic blood-filled spaces with ruptured sinusoidal walls and foci of necrosis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Silver impregnation stains (Warthin-Starry, Dieterle)Organisms often cluster around vessels or in areas of necrosisDifficult to distinguish between organisms and nonspecific silver precipitate",
                    "sub_points": [
                      "Organisms often cluster around vessels or in areas of necrosis",
                      "Difficult to distinguish between organisms and nonspecific silver precipitate"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Recently developed IHC antibodyAvailable, not widely used; less sensitive than PCR",
                    "sub_points": [
                      "Available, not widely used; less sensitive than PCR"
                    ]
                  }
                ],
                "PCR": [
                  {
                    "text": "PCR from formalin-fixed, paraffin-embedded tissue, fresh tissue, or aspirated pus"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Infections": [
                  {
                    "text": "Mycobacteria,Candida, andActinomycesmay produce similar lesionsCulture, histochemical stains, molecular studies may be necessary to differentiateDistinct layers of CSD lesions are not typically seen in these other infections",
                    "sub_points": [
                      "Culture, histochemical stains, molecular studies may be necessary to differentiate",
                      "Distinct layers of CSD lesions are not typically seen in these other infections"
                    ]
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Nonnecrotizing granulomas without distinct layers"
                  },
                  {
                    "text": "Typically doesn't occur in children"
                  }
                ],
                "Hepatic Malignancy": [
                  {
                    "text": "Presence of hepatic nodules lymphadenopathy raises concern for neoplasia on imaging"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Layered stellate microabscess with prominent fibrotic rim is highly characteristic"
                  },
                  {
                    "text": "Needle biopsy may only sample fibrosis, thus wedge biopsy may be required for diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Nonneoplastic Lesions: Drug-Related Injury": {
        "name": "Liver Nonneoplastic Lesions: Drug-Related Injury",
        "url": "https://app.pathprimer.com/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
        "topics": {
          "Drug-Induced Acute Hepatitis": {
            "name": "Drug-Induced Acute Hepatitis",
            "url": "https://app.pathprimer.com/document/2dcf851f-e234-4ae3-beca-f6caea75e434/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "2 chief mechanisms: Intrinsic and idiosyncratic"
                  },
                  {
                    "text": "Herbal and dietary supplements are important but often overlooked cause of hepatotoxicity"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Classified into hepatitic, cholestatic, or mixed-based pattern of enzyme elevation"
                  },
                  {
                    "text": "Drug-induced liver injury (DILI) with autoimmune markers can be indistinguishable from de novo autoimmune hepatitis"
                  },
                  {
                    "text": "Symptomatic and biochemical improvement in most cases on withdrawal of drugMinority of cases progress to chronic hepatitis and rarely cirrhosisJaundice, high AST levels, and preexisting chronic liver disease are adverse prognostic factorsExtent of necrosis and prominent ductular reaction on biopsy associated with worse outcome, while eosinophils and granulomas are favorable prognostic features",
                    "sub_points": [
                      "Minority of cases progress to chronic hepatitis and rarely cirrhosis",
                      "Jaundice, high AST levels, and preexisting chronic liver disease are adverse prognostic factors",
                      "Extent of necrosis and prominent ductular reaction on biopsy associated with worse outcome, while eosinophils and granulomas are favorable prognostic features"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Most medications produce inflammation-predominant pattern"
                  },
                  {
                    "text": "Most toxins & a few medications like acetaminophen produce necrosis-predominant pattern"
                  },
                  {
                    "text": "Concomitant bile duct injury, eosinophils, granulomas, perivenular necrosis, and cholestasis out of proportion to hepatocellular injury suggest DILI, but none of these are specific"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Inflammation-predominant pattern: Acute viral hepatitis, autoimmune hepatitis, Wilson disease"
                  },
                  {
                    "text": "Necrosis-predominant pattern: Herpes/adenoviral hepatitis, ischemic necrosis, acute venous outflow obstruction"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Drug-induced liver injury (DILI)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "2 Chief Mechanisms": [
                  {
                    "text": "Intrinsic hepatotoxicityPredictable, dose-dependent hepatocellular damageIndustrial, household, or environmental toxinsTypically shows necrosis with negligible inflammation",
                    "sub_points": [
                      "Predictable, dose-dependent hepatocellular damageIndustrial, household, or environmental toxins",
                      "Industrial, household, or environmental toxins",
                      "Typically shows necrosis with negligible inflammation"
                    ]
                  },
                  {
                    "text": "Idiosyncratic hepatotoxicityMajority of adverse drug reactions fall in this categoryMetabolic and immunological categoriesMetabolic: Drug is metabolized into toxic metabolite in predisposed individualsImmunological: Drug allergy or hypersensitivity following sensitization to drugTypically shows inflammation-predominant liver injury",
                    "sub_points": [
                      "Majority of adverse drug reactions fall in this category",
                      "Metabolic and immunological categoriesMetabolic: Drug is metabolized into toxic metabolite in predisposed individualsImmunological: Drug allergy or hypersensitivity following sensitization to drug",
                      "Metabolic: Drug is metabolized into toxic metabolite in predisposed individuals",
                      "Immunological: Drug allergy or hypersensitivity following sensitization to drug",
                      "Typically shows inflammation-predominant liver injury"
                    ]
                  }
                ],
                "Herbal and Dietary Supplements": [
                  {
                    "text": "Important but often overlooked cause of hepatotoxicity"
                  },
                  {
                    "text": "Not regulated by USA Food and Drug Administration and hence not subject to rigorous testing"
                  },
                  {
                    "text": "HDS-related liver injury increased from 12% to 21% over 10-year period"
                  },
                  {
                    "text": "Nearly 20% of American adults have used herbal remedies, and > 5 billion dollars are spent on these annually"
                  },
                  {
                    "text": "Heavy metal contaminants in these agents (arsenic, cadmium, lead, mercury) can also lead to liver toxicity"
                  },
                  {
                    "text": "Offending agent may be difficult to identify as many products contain mixture of multiple substancesWeight loss products like OxyELITE Pro, HydroxyCutPolygonum, an ingredient of multiple herbal preparationsExtracts from green tea (Camellia sinensis)Green tea not hepatotoxic, but extracts used in supplements may lead to liver injury due to high amount of catechins",
                    "sub_points": [
                      "Weight loss products like OxyELITE Pro, HydroxyCut",
                      "Polygonum, an ingredient of multiple herbal preparations",
                      "Extracts from green tea (Camellia sinensis)Green tea not hepatotoxic, but extracts used in supplements may lead to liver injury due to high amount of catechins",
                      "Green tea not hepatotoxic, but extracts used in supplements may lead to liver injury due to high amount of catechins"
                    ]
                  }
                ],
                "Genetic Factors": [
                  {
                    "text": "Implicated in idiosyncratic DILI"
                  },
                  {
                    "text": "HLA-B27 and HLA-B13 associated with hypersensitivity responses to antiretroviral drug abavicir and antileprosy drug dapsone"
                  },
                  {
                    "text": "HLA-5701 predicts adverse reaction to ofloxacillin"
                  },
                  {
                    "text": "Genotypic variations in liver enzymes involved in metabolizing drugs predispose to DILI (12)Cytochrome P450 proteins catalyze many reactions involved in drug metabolismVariations such as CYP2E1 genotype increase susceptibility to antituberculosis drugs; CYP2B6 predisposes to ticlopidine-induced liver injuryUridine 5'-diphospho-glucuronosyltransferase (UGT) catalyzes glucuronidation reactions; important for drug detoxificationIsoforms like UGT1A1 predispose to liver injury with irinotecan; UGTB7 predisposes to diclofenac injury",
                    "sub_points": [
                      "Cytochrome P450 proteins catalyze many reactions involved in drug metabolismVariations such as CYP2E1 genotype increase susceptibility to antituberculosis drugs; CYP2B6 predisposes to ticlopidine-induced liver injury",
                      "Variations such as CYP2E1 genotype increase susceptibility to antituberculosis drugs; CYP2B6 predisposes to ticlopidine-induced liver injury",
                      "Uridine 5'-diphospho-glucuronosyltransferase (UGT) catalyzes glucuronidation reactions; important for drug detoxificationIsoforms like UGT1A1 predispose to liver injury with irinotecan; UGTB7 predisposes to diclofenac injury",
                      "Isoforms like UGT1A1 predispose to liver injury with irinotecan; UGTB7 predisposes to diclofenac injury"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "DILI manifests as wide spectrum of histologic patternsHepatitic pattern of injury is one of most commonAcute hepatitis with autoimmune markers may mimic autoimmune hepatitis (AIH)Commonly implicated drugs: Methyldopa (antihypertensive), diclofenac (NSAID), statins (lipid-lowering), hydralazine (antihypertensive), rifampin (antibiotic), propylthiouracil (antithyroid), infliximab (TNF-1α antagonist)Herbal agentsEchinacea(common cold) and valerian (insomnia)AIH-like disease can develop within days but can be delayedANA common in minocycline-induced AIH; both ANA and SMA common with nitrofurantoin useMost cases resolve with drug cessation but can progress despite drug withdrawal, especially with nitrofurantoinWith long-term use, chronic hepatitis mimicking AIH can also occurSystemic features of hypersensitivity like rash, arthralgia, and peripheral eosinophilia can be present in 20-30% of casesFeverRashArthralgiaPeripheral eosinophiliaSevere skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis can occurAmoxicillinAllopurinolCarbamazepineLymphadenopathy, splenomegaly, and atypical lymphocytosisPhenytoinDapsoneSulfonamidesDrug reaction with eosinophilia and systemic symptoms (DRESS): Eosinophilia with skin reactions and systemic symptomsAnticonvulsantsMinocyclineAllopurinolAbacavir",
                    "sub_points": [
                      "Hepatitic pattern of injury is one of most commonAcute hepatitis with autoimmune markers may mimic autoimmune hepatitis (AIH)Commonly implicated drugs: Methyldopa (antihypertensive), diclofenac (NSAID), statins (lipid-lowering), hydralazine (antihypertensive), rifampin (antibiotic), propylthiouracil (antithyroid), infliximab (TNF-1α antagonist)Herbal agentsEchinacea(common cold) and valerian (insomnia)AIH-like disease can develop within days but can be delayedANA common in minocycline-induced AIH; both ANA and SMA common with nitrofurantoin useMost cases resolve with drug cessation but can progress despite drug withdrawal, especially with nitrofurantoinWith long-term use, chronic hepatitis mimicking AIH can also occurSystemic features of hypersensitivity like rash, arthralgia, and peripheral eosinophilia can be present in 20-30% of casesFeverRashArthralgiaPeripheral eosinophiliaSevere skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis can occurAmoxicillinAllopurinolCarbamazepineLymphadenopathy, splenomegaly, and atypical lymphocytosisPhenytoinDapsoneSulfonamidesDrug reaction with eosinophilia and systemic symptoms (DRESS): Eosinophilia with skin reactions and systemic symptomsAnticonvulsantsMinocyclineAllopurinolAbacavir",
                      "Acute hepatitis with autoimmune markers may mimic autoimmune hepatitis (AIH)Commonly implicated drugs: Methyldopa (antihypertensive), diclofenac (NSAID), statins (lipid-lowering), hydralazine (antihypertensive), rifampin (antibiotic), propylthiouracil (antithyroid), infliximab (TNF-1α antagonist)Herbal agentsEchinacea(common cold) and valerian (insomnia)AIH-like disease can develop within days but can be delayedANA common in minocycline-induced AIH; both ANA and SMA common with nitrofurantoin useMost cases resolve with drug cessation but can progress despite drug withdrawal, especially with nitrofurantoinWith long-term use, chronic hepatitis mimicking AIH can also occur",
                      "Commonly implicated drugs: Methyldopa (antihypertensive), diclofenac (NSAID), statins (lipid-lowering), hydralazine (antihypertensive), rifampin (antibiotic), propylthiouracil (antithyroid), infliximab (TNF-1α antagonist)",
                      "Herbal agentsEchinacea(common cold) and valerian (insomnia)",
                      "AIH-like disease can develop within days but can be delayed",
                      "ANA common in minocycline-induced AIH; both ANA and SMA common with nitrofurantoin use",
                      "Most cases resolve with drug cessation but can progress despite drug withdrawal, especially with nitrofurantoin",
                      "With long-term use, chronic hepatitis mimicking AIH can also occur",
                      "Systemic features of hypersensitivity like rash, arthralgia, and peripheral eosinophilia can be present in 20-30% of casesFeverRashArthralgiaPeripheral eosinophilia",
                      "Fever",
                      "Rash",
                      "Arthralgia",
                      "Peripheral eosinophilia",
                      "Severe skin reactions such as Stevens-Johnson syndrome and toxic epidermal necrolysis can occurAmoxicillinAllopurinolCarbamazepine",
                      "Amoxicillin",
                      "Allopurinol",
                      "Carbamazepine",
                      "Lymphadenopathy, splenomegaly, and atypical lymphocytosisPhenytoinDapsoneSulfonamides",
                      "Phenytoin",
                      "Dapsone",
                      "Sulfonamides",
                      "Drug reaction with eosinophilia and systemic symptoms (DRESS): Eosinophilia with skin reactions and systemic symptomsAnticonvulsantsMinocyclineAllopurinolAbacavir",
                      "Anticonvulsants",
                      "Minocycline",
                      "Allopurinol",
                      "Abacavir"
                    ]
                  },
                  {
                    "text": "Classified into acute or chronic based on duration of injury"
                  },
                  {
                    "text": "Establishing drug as causative agent is keyTemporal profile of onset of liver dysfunction is crucialLiver toxicity may manifest weeks or months after drug ingestion and even after drug has been stoppedSystematic literature search is necessary; NIH site is a useful resource (https://www.ncbi.nlm.nih.gov/books/NBK547852/)If observed pattern has been reported, case for DILI is strengthenedRechallenge can confirm drug etiology but is rarely done",
                    "sub_points": [
                      "Temporal profile of onset of liver dysfunction is crucial",
                      "Liver toxicity may manifest weeks or months after drug ingestion and even after drug has been stopped",
                      "Systematic literature search is necessary; NIH site is a useful resource (https://www.ncbi.nlm.nih.gov/books/NBK547852/)",
                      "If observed pattern has been reported, case for DILI is strengthened",
                      "Rechallenge can confirm drug etiology but is rarely done"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Measurement of serum levels of drug or its metabolite can be helpful in diagnosis (e.g., acetaminophen toxicity)"
                  },
                  {
                    "text": "ANA &/or antiSMA"
                  },
                  {
                    "text": "Transaminase elevations may be marked"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Drug withdrawal"
                  },
                  {
                    "text": "Steroids may be necessary"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Improvement in most cases on drug withdrawal"
                  },
                  {
                    "text": "Liver enzymes can remain elevated for up to several months after discontinuation of drug"
                  },
                  {
                    "text": "Minority of cases progress to chronic hepatitis, and rarely, cirrhosis (despite drug withdrawal)"
                  },
                  {
                    "text": "Adverse prognostic factorsJaundice, high AST levels, and preexisting chronic liver diseaseHost factors like diabetesPresentation with acute liver failureHistologic featuresExtent of necrosis and prominent ductular reaction associated with worse outcomeEosinophils and granulomas are favorable prognostic features",
                    "sub_points": [
                      "Jaundice, high AST levels, and preexisting chronic liver disease",
                      "Host factors like diabetes",
                      "Presentation with acute liver failure",
                      "Histologic featuresExtent of necrosis and prominent ductular reaction associated with worse outcomeEosinophils and granulomas are favorable prognostic features",
                      "Extent of necrosis and prominent ductular reaction associated with worse outcome",
                      "Eosinophils and granulomas are favorable prognostic features"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Acute hepatitis: Inflammation-predominant patternPortal and parenchymal inflammation with hepatocellular injuryNecrosis can affect single hepatocyte (spotty necrosis) or groups of hepatocytes (confluent necrosis)By definition, fibrosis is absentRegenerative features like binucleate hepatocytes and thick cell platesProminent Kupffer cells often are presentCholestasis can be presentTerm \"cholestatic hepatitis\" should be used with caution as it is defined by liver enzyme pattern and not by histologic cholestasisFeatures suggestive but not specific for DILIConcomitant bile duct injuryProminent eosinophilsGranulomasPerivenular necrosisCholestasis out of proportion to hepatocellular injury",
                    "sub_points": [
                      "Portal and parenchymal inflammation with hepatocellular injury",
                      "Necrosis can affect single hepatocyte (spotty necrosis) or groups of hepatocytes (confluent necrosis)",
                      "By definition, fibrosis is absent",
                      "Regenerative features like binucleate hepatocytes and thick cell plates",
                      "Prominent Kupffer cells often are present",
                      "Cholestasis can be presentTerm \"cholestatic hepatitis\" should be used with caution as it is defined by liver enzyme pattern and not by histologic cholestasis",
                      "Term \"cholestatic hepatitis\" should be used with caution as it is defined by liver enzyme pattern and not by histologic cholestasis",
                      "Features suggestive but not specific for DILIConcomitant bile duct injuryProminent eosinophilsGranulomasPerivenular necrosisCholestasis out of proportion to hepatocellular injury",
                      "Concomitant bile duct injury",
                      "Prominent eosinophils",
                      "Granulomas",
                      "Perivenular necrosis",
                      "Cholestasis out of proportion to hepatocellular injury"
                    ]
                  },
                  {
                    "text": "Acute hepatitis: Inflammation-predominant pattern with autoantibodiesHistology can be indistinguishable from AIHProminent neuroinflammatory activity and numerous plasma cells",
                    "sub_points": [
                      "Histology can be indistinguishable from AIH",
                      "Prominent neuroinflammatory activity and numerous plasma cells"
                    ]
                  },
                  {
                    "text": "Acute hepatitis: Necrosis-predominant patternNecrosis with minimal inflammationPeriportal (zone 1): Cocaine, ferrous sulphateMidzonal (zone 2): BerylliumCentrizonal (zone 3): Acetaminophen, halothane, carbon tetrachlorideAcute hepatic failure with extensive necrosis",
                    "sub_points": [
                      "Necrosis with minimal inflammation",
                      "Periportal (zone 1): Cocaine, ferrous sulphate",
                      "Midzonal (zone 2): Beryllium",
                      "Centrizonal (zone 3): Acetaminophen, halothane, carbon tetrachloride",
                      "Acute hepatic failure with extensive necrosis"
                    ]
                  },
                  {
                    "text": "Resolving hepatitis patternMinimal to mild hepatocellular injury & inflammationNumerous macrophages highlighted by PAS-D stain",
                    "sub_points": [
                      "Minimal to mild hepatocellular injury & inflammation",
                      "Numerous macrophages highlighted by PAS-D stain"
                    ]
                  },
                  {
                    "text": "Syncytial giant cell hepatitis patternUncommon pattern of hepatic DILISeverity can range from mild to fulminant",
                    "sub_points": [
                      "Uncommon pattern of hepatic DILI",
                      "Severity can range from mild to fulminant"
                    ]
                  }
                ],
                "Predominant Pattern/Injury Type": [
                  {
                    "text": "Inflammatory"
                  }
                ],
                "Predominant Cell/Compartment Type": [
                  {
                    "text": "Hepatocyte"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acute Hepatitis: Inflammation-Predominant Pattern": [
                  {
                    "text": "Acute viral hepatitis, AIH, Wilson disease"
                  },
                  {
                    "text": "Clinical and serological information necessary for final diagnosisAIHAutoantibodiesElevated serum IgGProminent plasma cellsViral hepatitisSerologic testsPCRWilson diseaseLow serum ceruloplasminElevated 24-hour urinary copperElevated liver copper (quantitative analysis from paraffin block)Kayser-Fleischer ring on ophthalmic exam",
                    "sub_points": [
                      "AIHAutoantibodiesElevated serum IgGProminent plasma cells",
                      "Autoantibodies",
                      "Elevated serum IgG",
                      "Prominent plasma cells",
                      "Viral hepatitisSerologic testsPCR",
                      "Serologic tests",
                      "PCR",
                      "Wilson diseaseLow serum ceruloplasminElevated 24-hour urinary copperElevated liver copper (quantitative analysis from paraffin block)Kayser-Fleischer ring on ophthalmic exam",
                      "Low serum ceruloplasmin",
                      "Elevated 24-hour urinary copper",
                      "Elevated liver copper (quantitative analysis from paraffin block)",
                      "Kayser-Fleischer ring on ophthalmic exam"
                    ]
                  }
                ],
                "Acute Hepatitis: Necrosis-Predominant Pattern": [
                  {
                    "text": "Herpes and adenoviral hepatitisViral inclusions, immunohistochemistry-confirmed diagnosis",
                    "sub_points": [
                      "Viral inclusions, immunohistochemistry-confirmed diagnosis"
                    ]
                  },
                  {
                    "text": "Vascular etiologiesAcute venous outflow obstructionIschemic necrosisClinical information necessary to distinguish DILI from necrosis due to vascular etiologies",
                    "sub_points": [
                      "Acute venous outflow obstruction",
                      "Ischemic necrosis",
                      "Clinical information necessary to distinguish DILI from necrosis due to vascular etiologies"
                    ]
                  }
                ],
                "Resolving Hepatitis Pattern": [
                  {
                    "text": "Nonspecific reactive hepatitis in systemic diseasesSystemic diseases (SLE, rheumatoid arthritis, celiac disease)Systemic infections/abdominal inflammatory states (cholecystitis, appendicitis)",
                    "sub_points": [
                      "Systemic diseases (SLE, rheumatoid arthritis, celiac disease)",
                      "Systemic infections/abdominal inflammatory states (cholecystitis, appendicitis)"
                    ]
                  },
                  {
                    "text": "Resolving phase of any hepatitis, including viral hepatitis"
                  }
                ],
                "Syncytial Hepatitis Pattern": [
                  {
                    "text": "AIH, paramyxovirus, hepatitis C, HIV hepatitis"
                  },
                  {
                    "text": "Distinction based on clinical and serological features"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Elevated liver enzymes in variety of patterns temporally associated with drug"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Multiple patterns of enzyme elevation and liver injury"
                  },
                  {
                    "text": "Medication history, including herbal/botanical drugs"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Induced Acute Hepatic Failure": {
            "name": "Drug-Induced Acute Hepatic Failure",
            "url": "https://app.pathprimer.com/document/dcfc50fb-4c6b-466d-b066-3d2e5350d57f/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Onset of hepatic encephalopathy within 8-26 weeks of onset of symptomsINR is > 1.5, and there is no evidence of chronic liver disease",
                    "sub_points": [
                      "INR is > 1.5, and there is no evidence of chronic liver disease"
                    ]
                  },
                  {
                    "text": "Corresponding pathologic terms: Massive/submassive necrosis, fulminant hepatitis"
                  },
                  {
                    "text": "Acute or chronic liver failure can result in setting of preexisting chronic liver disease"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Acetaminophen is most common cause of acute liver failure (ALF) in USA, accounting for 40-50% of cases"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Massive/submassive necrosis with little or no inflammation: Acetaminophen, most toxins"
                  },
                  {
                    "text": "Massive/submassive necrosis with prominent inflammation: Most idiosyncratic drug reactions"
                  },
                  {
                    "text": "Microvesicular steatosis: Tetracycline, zidovudine"
                  },
                  {
                    "text": "Regenerative nodules can be seen later in course of disease and can be mistaken for cirrhosis"
                  },
                  {
                    "text": "Unlike fibrous septa of cirrhosis, necrotic areas show pale staining with trichrome stain and lack elastic fibers on elastic stain"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Necrosis with inflammation: Acute viral hepatitis A and B, autoimmune hepatitis, Wilson disease"
                  },
                  {
                    "text": "Necrosis with minimal inflammation: Herpes simplex and adenoviral hepatitis, acute ischemia, acute Budd-Chiari syndrome"
                  },
                  {
                    "text": "Microvesicular steatosis: Alcoholic foamy degeneration, acute fatty liver of pregnancy, Reye syndrome, Jamaican vomiting sickness, rare metabolic disorders, such as carnitine deficiency"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Acute liver failure (ALF)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hepatic encephalopathy and reduced synthetic function evidenced by INR > 1.5"
                  },
                  {
                    "text": "Duration of disease < 26 weeks"
                  },
                  {
                    "text": "Absence of chronic liver diseaseCorresponding pathologic term is massive/submassive necrosis or fulminant hepatitis",
                    "sub_points": [
                      "Corresponding pathologic term is massive/submassive necrosis or fulminant hepatitis"
                    ]
                  },
                  {
                    "text": "Acute or chronic liver failure can result in setting of preexisting chronic liver disease"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanisms of Injury": [
                  {
                    "text": "Massive/submassive necrosis due to intrinsic hepatotoxinsMost toxins fall in this categoryCarbon tetrachloride, mushroom poisoning, recreational drugs, such as cocaine and MDMA (ecstasy)Very few drugs cause this pattern of injuryAcetaminophen, halothaneHerbal medications: Pennyroyal, glue thistle, germander",
                    "sub_points": [
                      "Most toxins fall in this categoryCarbon tetrachloride, mushroom poisoning, recreational drugs, such as cocaine and MDMA (ecstasy)",
                      "Carbon tetrachloride, mushroom poisoning, recreational drugs, such as cocaine and MDMA (ecstasy)",
                      "Very few drugs cause this pattern of injuryAcetaminophen, halothaneHerbal medications: Pennyroyal, glue thistle, germander",
                      "Acetaminophen, halothane",
                      "Herbal medications: Pennyroyal, glue thistle, germander"
                    ]
                  },
                  {
                    "text": "Massive/submassive necrosis due to idiosyncratic injuryMost drugs fall in this categoryDrugs used for treatment of tuberculosis, such as isoniazid are 1 of leading culprits of ALF in resource-poor worldOther implicated drugs: Monoamine oxidase inhibitors, anticonvulsants (valproate, phenytoin), antimicrobial agents (sulfonamides, co-trimoxazole, ketoconazole)",
                    "sub_points": [
                      "Most drugs fall in this categoryDrugs used for treatment of tuberculosis, such as isoniazid are 1 of leading culprits of ALF in resource-poor worldOther implicated drugs: Monoamine oxidase inhibitors, anticonvulsants (valproate, phenytoin), antimicrobial agents (sulfonamides, co-trimoxazole, ketoconazole)",
                      "Drugs used for treatment of tuberculosis, such as isoniazid are 1 of leading culprits of ALF in resource-poor world",
                      "Other implicated drugs: Monoamine oxidase inhibitors, anticonvulsants (valproate, phenytoin), antimicrobial agents (sulfonamides, co-trimoxazole, ketoconazole)"
                    ]
                  },
                  {
                    "text": "Diffuse microvesicular steatosis due to acute mitochondrial injuryPresents as ALF without histologic necrosisCommonly implicated drugs: Tetracycline, zidovudine, valproic acid, amineptine",
                    "sub_points": [
                      "Presents as ALF without histologic necrosis",
                      "Commonly implicated drugs: Tetracycline, zidovudine, valproic acid, amineptine"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Depends on specific drug or toxin"
                  },
                  {
                    "text": "Acetaminophen is most common cause of ALF in USA, accounting for 40-50% of casesDose-dependent toxicity occurs with accidental (1/3 of cases) or suicidal (2/3 of cases) overdoseMinimum toxic dose in adults is 7.5-10 g, but severe liver damage occurs with ingestion of 15-25 gChronic alcohol consumption, obesity, and drugs that induce P450 cytochrome system can lower toxic threshold of acetaminophenGastrointestinal symptoms for first 12-24 hours and latent phase of 24-48 hours is followed by ALF 72-96 hours after drug ingestion",
                    "sub_points": [
                      "Dose-dependent toxicity occurs with accidental (1/3 of cases) or suicidal (2/3 of cases) overdose",
                      "Minimum toxic dose in adults is 7.5-10 g, but severe liver damage occurs with ingestion of 15-25 g",
                      "Chronic alcohol consumption, obesity, and drugs that induce P450 cytochrome system can lower toxic threshold of acetaminophen",
                      "Gastrointestinal symptoms for first 12-24 hours and latent phase of 24-48 hours is followed by ALF 72-96 hours after drug ingestion"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Drug withdrawal, supportive care, and liver resuscitation (hypothermia, albumin dialysis, artificial liver support)"
                  },
                  {
                    "text": "Liver transplantation is often necessary"
                  },
                  {
                    "text": "Acetaminophen hepatotoxicity can be prevented with acetylcysteine therapy within 12 hours of drug ingestion"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Severe encephalopathy and older age are adverse prognostic factors for spontaneous recovery"
                  },
                  {
                    "text": "For acetaminophen toxicity, blood levels 4-16 hours after ingestion are best predictor of outcome; highest mortality is encountered in late presenters"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "4 histologic patterns of injury"
                  },
                  {
                    "text": "Massive/submassive necrosis with little or no inflammationExtensive confluent hepatocellular necrosisNecrosis may be nonzonal, centrizonal (acetaminophen, halothane, carbon tetrachloride), midzonal (beryllium), or periportal (cocaine, ferrous sulphate)Concomitant steatosis, often microvesicular, can be present (carbon tetrachloride poisoning, cocaine)Mild or absent inflammation",
                    "sub_points": [
                      "Extensive confluent hepatocellular necrosis",
                      "Necrosis may be nonzonal, centrizonal (acetaminophen, halothane, carbon tetrachloride), midzonal (beryllium), or periportal (cocaine, ferrous sulphate)",
                      "Concomitant steatosis, often microvesicular, can be present (carbon tetrachloride poisoning, cocaine)",
                      "Mild or absent inflammation"
                    ]
                  },
                  {
                    "text": "Massive/submassive necrosis with prominent inflammationPortal and panacinar lymphocytic inflammation, variable eosinophils and plasma cellsConfluent necrosis common",
                    "sub_points": [
                      "Portal and panacinar lymphocytic inflammation, variable eosinophils and plasma cells",
                      "Confluent necrosis common"
                    ]
                  },
                  {
                    "text": "Extensive microvesicular steatosisHepatocyte cytoplasm diffusely filled with small fat dropletsInconspicuous inflammation and necrosis",
                    "sub_points": [
                      "Hepatocyte cytoplasm diffusely filled with small fat droplets",
                      "Inconspicuous inflammation and necrosis"
                    ]
                  },
                  {
                    "text": "Massive/submassive necrosis with regenerative nodulesRegenerative nodules can be seen later in course of disease and mistaken for cirrhosisArea between nodules is not fibrous septa of cirrhosis but bridging necrosis with collapse of liver parenchymaTrichrome stain: Pale staining in necrotic areas unlike coarse, dense staining in fibrous septa of cirrhosisElastic stain: Lack of elastic fibers in necrotic areas unlike fibrous septa of cirrhosis, which are richly endowed with elastic fibersTrichrome stain is more reliable than elastic stain to distinguish necrosis and fibrosis",
                    "sub_points": [
                      "Regenerative nodules can be seen later in course of disease and mistaken for cirrhosis",
                      "Area between nodules is not fibrous septa of cirrhosis but bridging necrosis with collapse of liver parenchyma",
                      "Trichrome stain: Pale staining in necrotic areas unlike coarse, dense staining in fibrous septa of cirrhosis",
                      "Elastic stain: Lack of elastic fibers in necrotic areas unlike fibrous septa of cirrhosis, which are richly endowed with elastic fibersTrichrome stain is more reliable than elastic stain to distinguish necrosis and fibrosis",
                      "Trichrome stain is more reliable than elastic stain to distinguish necrosis and fibrosis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acute Viral Hepatitis": [
                  {
                    "text": "Hepatotropic virusesIn USA and Europe, only accounts for 10-15% of cases (5-10% each by hepatitis A and B)Hepatitis C has been reported to cause ALF in Asia but rarely in Western worldCoinfection or superinfection with hepatitis D can lead to ALFHepatitis E has been associated with ALF in Indian subcontinent, especially in pregnant women",
                    "sub_points": [
                      "In USA and Europe, only accounts for 10-15% of cases (5-10% each by hepatitis A and B)",
                      "Hepatitis C has been reported to cause ALF in Asia but rarely in Western world",
                      "Coinfection or superinfection with hepatitis D can lead to ALF",
                      "Hepatitis E has been associated with ALF in Indian subcontinent, especially in pregnant women"
                    ]
                  },
                  {
                    "text": "Nonhepatotropic virusesHerpes simplex and adenovirus infection can lead to ALF with necrosis-predominant pattern of injuryLess common infections: CMV, Epstein-Barr virus, yellow fever, dengue fever, Ebola feverParvovirus B19 can cause fulminant hepatitis in children",
                    "sub_points": [
                      "Herpes simplex and adenovirus infection can lead to ALF with necrosis-predominant pattern of injury",
                      "Less common infections: CMV, Epstein-Barr virus, yellow fever, dengue fever, Ebola fever",
                      "Parvovirus B19 can cause fulminant hepatitis in children"
                    ]
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Rapid deterioration of liver function can lead to ALF"
                  },
                  {
                    "text": "Extensive necroinflammatory activity with plasma cell-rich infiltrate"
                  },
                  {
                    "text": "Histologically indistinguishable from idiosyncratic drug reaction"
                  },
                  {
                    "text": "Autoantibodies, elevated serum IgG, and presence of fibrosis on biopsy favor autoimmune hepatitis"
                  }
                ],
                "Ischemic Liver Injury": [
                  {
                    "text": "CausesCardiogenic or septic shockVariceal hemorrhage",
                    "sub_points": [
                      "Cardiogenic or septic shock",
                      "Variceal hemorrhage"
                    ]
                  },
                  {
                    "text": "Inflammation is typically mild or absent, mimicking toxic pattern of drug-induced injury"
                  },
                  {
                    "text": "Histologic features favoring ischemiaCentrizonal or panacinar necrosis with congestion and pooling of blood in zone 3 sinusoidsPeriportal cholangiolar bile plugs in cholangioles (cholangitis lenta) in absence of demonstrable biliary obstruction",
                    "sub_points": [
                      "Centrizonal or panacinar necrosis with congestion and pooling of blood in zone 3 sinusoids",
                      "Periportal cholangiolar bile plugs in cholangioles (cholangitis lenta) in absence of demonstrable biliary obstruction"
                    ]
                  }
                ],
                "Acute Budd-Chiari Syndrome": [
                  {
                    "text": "Acute presentation is rare, can mimic ischemia or toxic pattern of drug injury"
                  },
                  {
                    "text": "Centrizonal or panacinar necrosis with hemorrhage, congestion, and sinusoidal dilatation"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Rare but important cause of ALF in young patients (presentation after 50 years is rare)Recovery of hepatic function is rare in fulminant Wilson disease, and transplantation is only viable option",
                    "sub_points": [
                      "Recovery of hepatic function is rare in fulminant Wilson disease, and transplantation is only viable option"
                    ]
                  },
                  {
                    "text": "Can mimic toxic as well as idiosyncratic drug reactionHemolytic anemia, if present, favors Wilson diseaseAST:ALT > 2.2, high bilirubin (> 20 mg/dL), and low alkaline phosphatase has high specificity for Wilson diseaseSerum ceruloplasmin, urinary copper, or quantitative determination of hepatic copper from paraffin block helps in establishing diagnosis",
                    "sub_points": [
                      "Hemolytic anemia, if present, favors Wilson disease",
                      "AST:ALT > 2.2, high bilirubin (> 20 mg/dL), and low alkaline phosphatase has high specificity for Wilson disease",
                      "Serum ceruloplasmin, urinary copper, or quantitative determination of hepatic copper from paraffin block helps in establishing diagnosis"
                    ]
                  }
                ],
                "Malignant Neoplasms": [
                  {
                    "text": "Infiltration of liver by malignant neoplasms rarely leads to ALFImplicated tumors include leukemia/lymphoma, metastatic carcinoma, and melanoma",
                    "sub_points": [
                      "Implicated tumors include leukemia/lymphoma, metastatic carcinoma, and melanoma"
                    ]
                  },
                  {
                    "text": "Identification of tumor as underlying etiology is important to avoid transplantation, as prognosis is poor"
                  }
                ],
                "Pregnancy-Related Acute Liver Failure": [
                  {
                    "text": "HELLP syndromeHemolysis,elevatedliver enzymes, andlowplateletsSerious complication of preeclampsia, occurs in 3rd trimesterALF is rare complicationHistologically shows focal necrosis, periportal hemorrhage, and fibrin deposits",
                    "sub_points": [
                      "Hemolysis,elevatedliver enzymes, andlowplatelets",
                      "Serious complication of preeclampsia, occurs in 3rd trimester",
                      "ALF is rare complication",
                      "Histologically shows focal necrosis, periportal hemorrhage, and fibrin deposits"
                    ]
                  },
                  {
                    "text": "Acute fatty liver of pregnancyOccurs in 3rd trimester, often associated with preeclampsiaHyperbilirubinemia and elevations of ALT and AST are modest compared to other causes of ALFIncrease in blood pressure, hyperuricemia, and intense thirst favor this diagnosisLiver biopsy is often not done due to risk of bleedingHistologically shows microvesicular steatosis, hepatocellular swelling, inconspicuous necrosis",
                    "sub_points": [
                      "Occurs in 3rd trimester, often associated with preeclampsia",
                      "Hyperbilirubinemia and elevations of ALT and AST are modest compared to other causes of ALF",
                      "Increase in blood pressure, hyperuricemia, and intense thirst favor this diagnosis",
                      "Liver biopsy is often not done due to risk of bleeding",
                      "Histologically shows microvesicular steatosis, hepatocellular swelling, inconspicuous necrosis"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "ALF in patient who has been exposed to drug or toxin"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Necrosis that may be significantly out of proportion to inflammation"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Induced Cholestatic Liver Injury": {
            "name": "Drug-Induced Cholestatic Liver Injury",
            "url": "https://app.pathprimer.com/document/7d29401c-60f2-4f1a-b853-651e6ad5550d/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most common histologic pattern of drug-induced liver injury"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Pure cholestasis: Cholestasis with minimal inflammation or hepatocellular damageCommonly implicated drugs: Anabolic steroids, oral contraceptives, prochlorperazine, thiabendazole, warfarin",
                    "sub_points": [
                      "Commonly implicated drugs: Anabolic steroids, oral contraceptives, prochlorperazine, thiabendazole, warfarin"
                    ]
                  },
                  {
                    "text": "Cholestatic hepatitis: Cholestasis with inflammation and hepatocellular damageMacrolide antibiotics (erythromycin), antipsychotics (chlorpromazine), numerous other drugs",
                    "sub_points": [
                      "Macrolide antibiotics (erythromycin), antipsychotics (chlorpromazine), numerous other drugs"
                    ]
                  },
                  {
                    "text": "Prolonged cholestasis/ductopenia: Cholestasis > 3 months, bile duct lossAntibiotics, antifungals, anticonvulsants, antipsychotics, NSAIDs; rarely, oral contraceptives, amiodarone",
                    "sub_points": [
                      "Antibiotics, antifungals, anticonvulsants, antipsychotics, NSAIDs; rarely, oral contraceptives, amiodarone"
                    ]
                  },
                  {
                    "text": "Sclerosing duct injury: Fibrosis affecting large bile ducts similar to primary sclerosing cholangitis (PSC)5-fluorodeoxyuridine (intraarterial infusion for metastatic colorectal carcinoma), formaldehyde, and sodium chloride (injected into hydatid cysts)",
                    "sub_points": [
                      "5-fluorodeoxyuridine (intraarterial infusion for metastatic colorectal carcinoma), formaldehyde, and sodium chloride (injected into hydatid cysts)"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pure cholestasis: Sepsis, shock, benign recurrent intrahepatic cholestasis"
                  },
                  {
                    "text": "Cholestatic hepatitis: Other causes of hepatitisViral hepatitisAutoimmune hepatitisWilson disease",
                    "sub_points": [
                      "Viral hepatitis",
                      "Autoimmune hepatitis",
                      "Wilson disease"
                    ]
                  },
                  {
                    "text": "Obstructive biliary disease"
                  },
                  {
                    "text": "Prolonged cholestasis/ductopeniaPrimary biliary cholangitisPSC",
                    "sub_points": [
                      "Primary biliary cholangitis",
                      "PSC"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Drug-induced liver injury (DILI)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "4 General Categories": [
                  {
                    "text": "Based on symptom duration and histologic pattern of injury"
                  }
                ],
                "Pure Cholestasis": [
                  {
                    "text": "Cholestasis with minimal hepatocellular injury"
                  },
                  {
                    "text": "Commonly implicated drugs: Anabolic steroids, oral contraceptives, prochlorperazine, thiabendazole, warfarin"
                  }
                ],
                "Cholestatic Hepatitis": [
                  {
                    "text": "Most common pattern of DILI"
                  },
                  {
                    "text": "Cholestasis with hepatocellular injury"
                  },
                  {
                    "text": "Macrolide antibiotics (erythromycin), antipsychotics (chlorpromazine), numerous other drugs"
                  },
                  {
                    "text": "Clinically defined by liver enzymes (R > 2 and < 5)"
                  }
                ],
                "Chronic Cholestatic Injury ± Ductopenia": [
                  {
                    "text": "Antibiotics, antifungals, anticonvulsants, antipsychotics, NSAIDs; rarely, oral contraceptives, amiodarone"
                  }
                ],
                "Sclerosing Bile Duct Injury": [
                  {
                    "text": "5-fluorodeoxyuridine (intraarterial infusion for metastatic colorectal carcinoma), formaldehyde, and sodium chloride (injected into hydatid cysts)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Jaundice, pruritus, dark urine, pale stools"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated alkaline phosphatase (by definition R < 2)"
                  },
                  {
                    "text": "Transaminases minimally elevated in pure cholestasis; modest to marked elevation in cholestatic hepatitis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Most cases resolve with cessation of offending drug"
                  },
                  {
                    "text": "Prolonged cholestasis (> 3 months) and ductopenia can occur; can account for nearly 20% of DILIs"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Pure (bland) cholestasisBile plugs in hepatocytes &/or canaliculiMost prominent in centrizonal regionPortal/lobular inflammation, bile ductular reaction, and hepatocellular injury are minimal or absentNo bile duct damage",
                    "sub_points": [
                      "Bile plugs in hepatocytes &/or canaliculiMost prominent in centrizonal region",
                      "Most prominent in centrizonal region",
                      "Portal/lobular inflammation, bile ductular reaction, and hepatocellular injury are minimal or absent",
                      "No bile duct damage"
                    ]
                  },
                  {
                    "text": "Cholestatic hepatitis (cholangiolitic or hypersensitivity cholestasis)Bile plugs in hepatocytes &/or canaliculiPortal &/or lobular inflammation, predominantly lymphocytic, with variable plasma cells and eosinophilsBile ductular reaction with associated neutrophilic infiltrate may be presentBile duct epithelial injury and lymphocytic cholangitis may be presentNo ductopeniaVariable degree of hepatocellular injury ranging from isolated hepatocellular dropout to confluent necrosis",
                    "sub_points": [
                      "Bile plugs in hepatocytes &/or canaliculi",
                      "Portal &/or lobular inflammation, predominantly lymphocytic, with variable plasma cells and eosinophils",
                      "Bile ductular reaction with associated neutrophilic infiltrate may be present",
                      "Bile duct epithelial injury and lymphocytic cholangitis may be presentNo ductopenia",
                      "No ductopenia",
                      "Variable degree of hepatocellular injury ranging from isolated hepatocellular dropout to confluent necrosis"
                    ]
                  },
                  {
                    "text": "Prolonged cholestasis (> 3 months) and ductopeniaVariable inflammation, bile duct injury, ductular reaction, and hepatocellular damageSome cases progress to loss of bile ducts and overt ductopenia (vanishing bile duct syndrome)Rare cases progress to cirrhosis",
                    "sub_points": [
                      "Variable inflammation, bile duct injury, ductular reaction, and hepatocellular damage",
                      "Some cases progress to loss of bile ducts and overt ductopenia (vanishing bile duct syndrome)",
                      "Rare cases progress to cirrhosis"
                    ]
                  },
                  {
                    "text": "Sclerosing bile duct injuryFibrosis and strictures affecting extrahepatic and intrahepatic bile ducts similar to PSC",
                    "sub_points": [
                      "Fibrosis and strictures affecting extrahepatic and intrahepatic bile ducts similar to PSC"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pure Cholestasis": [
                  {
                    "text": "Systemic disorders (sepsis, cardiac failure, shock)"
                  },
                  {
                    "text": "Postoperative cholestasis, intrahepatic cholestasis of pregnancy, benign recurrent intrahepatic cholestasis, paraneoplastic cholestasis (most often with lymphomas)"
                  },
                  {
                    "text": "Clinical information is necessary to exclude these etiologies"
                  },
                  {
                    "text": "Early biliary obstruction can lack portal edema, ductular reaction, and inflammation, mimicking pure cholestasis"
                  }
                ],
                "Cholestatic Hepatitis": [
                  {
                    "text": "Autoimmune hepatitis, acute viral hepatitis, Wilson diseaseSerological tests for hepatitis viruses, autoantibodies, and work-up for Wilson disease",
                    "sub_points": [
                      "Serological tests for hepatitis viruses, autoantibodies, and work-up for Wilson disease"
                    ]
                  },
                  {
                    "text": "Obstructive biliary diseaseDuctular reaction, bile duct injury, and cholestasis similar to cholestatic DILIImaging necessary to evaluate bile ducts",
                    "sub_points": [
                      "Ductular reaction, bile duct injury, and cholestasis similar to cholestatic DILI",
                      "Imaging necessary to evaluate bile ducts"
                    ]
                  },
                  {
                    "text": "Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC)Hepatocellular injury minimal or absent, transaminases modestly elevated (typically < 300 U/L)Histological cholestasis in early disease (without fibrosis) does not occur in PBC and PSCAntimitochondrial antibodies (AMA) in PBCCharacteristic abnormalities in large ducts on cholangiography in PSC",
                    "sub_points": [
                      "Hepatocellular injury minimal or absent, transaminases modestly elevated (typically < 300 U/L)",
                      "Histological cholestasis in early disease (without fibrosis) does not occur in PBC and PSC",
                      "Antimitochondrial antibodies (AMA) in PBC",
                      "Characteristic abnormalities in large ducts on cholangiography in PSC"
                    ]
                  }
                ],
                "Prolonged Cholestasis and Vanishing Bile Duct Syndrome": [
                  {
                    "text": "PBC and PSC: AMA and cholangiography"
                  },
                  {
                    "text": "Rare causes of ductopenia: Ischemic bile duct injury, Hodgkin lymphoma"
                  }
                ],
                "Sclerosing Bile Duct Injury": [
                  {
                    "text": "Indistinguishable from PSC or secondary sclerosing cholangitis"
                  },
                  {
                    "text": "Cholangiography, drug history"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Induced Granulomatous Hepatitis": {
            "name": "Drug-Induced Granulomatous Hepatitis",
            "url": "https://app.pathprimer.com/document/5dedf8fd-a993-43f7-ae38-2c45d002db20/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Granulomatous inflammation caused by drug or toxinDrugs reportedly responsible for up to 30% of hepatic granulomas",
                    "sub_points": [
                      "Drugs reportedly responsible for up to 30% of hepatic granulomas"
                    ]
                  },
                  {
                    "text": "Drug-induced hepatic injury can mimic any other form of liver disease"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Many types of offending drugs, including over-the-counter and herbal preparationsAntimicrobialsAnticonvulsantsCardiac drugs (calcium channel blockers, antiarrhythmics)AllopurinolImmune checkpoint inhibitors",
                    "sub_points": [
                      "Antimicrobials",
                      "Anticonvulsants",
                      "Cardiac drugs (calcium channel blockers, antiarrhythmics)",
                      "Allopurinol",
                      "Immune checkpoint inhibitors"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Presentation varies with offending drug± signs and symptoms of hypersensitivity reactionElevated transaminases, sometimes markedly so",
                    "sub_points": [
                      "± signs and symptoms of hypersensitivity reaction",
                      "Elevated transaminases, sometimes markedly so"
                    ]
                  },
                  {
                    "text": "Histology usually improves with cessation of offending drug"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Noncaseating granulomasOften associated with lymphocytes, plasma cells, and (most notably) eosinophilsPresence of eosinophils does not prove drug-related etiology, howeverHepatocyte reactive changes, apoptotic hepatocytes, cholestasis, cytoplasmic ballooning/feathery degeneration may be presentCombination of microgranulomas and hepatocyte injury is very suggestive of granulomatous drug reaction",
                    "sub_points": [
                      "Often associated with lymphocytes, plasma cells, and (most notably) eosinophilsPresence of eosinophils does not prove drug-related etiology, however",
                      "Presence of eosinophils does not prove drug-related etiology, however",
                      "Hepatocyte reactive changes, apoptotic hepatocytes, cholestasis, cytoplasmic ballooning/feathery degeneration may be presentCombination of microgranulomas and hepatocyte injury is very suggestive of granulomatous drug reaction",
                      "Combination of microgranulomas and hepatocyte injury is very suggestive of granulomatous drug reaction"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Careful drug history and temporal correlation between drug administration and liver disease are essential"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Granulomatous inflammation caused by drug or toxinImportant mechanism of drug-related hepatotoxicityDrugs reportedly responsible for up to 30% of hepatic granulomasMany implicated drugs, including over-the-counter and herbal preparations",
                    "sub_points": [
                      "Important mechanism of drug-related hepatotoxicity",
                      "Drugs reportedly responsible for up to 30% of hepatic granulomas",
                      "Many implicated drugs, including over-the-counter and herbal preparations"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Probable Hypersensitivity Reaction": [
                  {
                    "text": "Common offendersAntimicrobialsAntibiotics: Penicillins, sulfa drugs, cephalexinAntimalarials: Sulfadoxine and dapsoneIsoniazidAnticonvulsants: Carbamazepine and phenytoinCardiac drugsDiltiazem (calcium channel blocker)Procainamide (antiarrhythmic)Trichlormethiazide (diuretic)OtherAllopurinol (antihyperuricemic)Diazepam (benzodiazepine)Glyburide (hypoglycemic)Gold (antiarthritic)InterferonProcarbazine (antineoplastic)Propylthiouracil (antithyroidal)Immune checkpoint inhibitors",
                    "sub_points": [
                      "AntimicrobialsAntibiotics: Penicillins, sulfa drugs, cephalexinAntimalarials: Sulfadoxine and dapsoneIsoniazid",
                      "Antibiotics: Penicillins, sulfa drugs, cephalexin",
                      "Antimalarials: Sulfadoxine and dapsone",
                      "Isoniazid",
                      "Anticonvulsants: Carbamazepine and phenytoin",
                      "Cardiac drugsDiltiazem (calcium channel blocker)Procainamide (antiarrhythmic)Trichlormethiazide (diuretic)",
                      "Diltiazem (calcium channel blocker)",
                      "Procainamide (antiarrhythmic)",
                      "Trichlormethiazide (diuretic)",
                      "OtherAllopurinol (antihyperuricemic)Diazepam (benzodiazepine)Glyburide (hypoglycemic)Gold (antiarthritic)InterferonProcarbazine (antineoplastic)Propylthiouracil (antithyroidal)Immune checkpoint inhibitors",
                      "Allopurinol (antihyperuricemic)",
                      "Diazepam (benzodiazepine)",
                      "Glyburide (hypoglycemic)",
                      "Gold (antiarthritic)",
                      "Interferon",
                      "Procarbazine (antineoplastic)",
                      "Propylthiouracil (antithyroidal)",
                      "Immune checkpoint inhibitors"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Drug-induced hepatic injury can mimic any other form of liver disease"
                  },
                  {
                    "text": "Varies with offending drugFever, hepatomegalyClinical signs of hypersensitivity (e.g., rash)",
                    "sub_points": [
                      "Fever, hepatomegaly",
                      "Clinical signs of hypersensitivity (e.g., rash)"
                    ]
                  },
                  {
                    "text": "Some patients are asymptomatic"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases, sometimes markedly so"
                  },
                  {
                    "text": "Elevated alkaline phosphatase"
                  },
                  {
                    "text": "± elevated bilirubin"
                  },
                  {
                    "text": "± peripheral eosinophilia"
                  },
                  {
                    "text": "± hypergammaglobulinemia"
                  },
                  {
                    "text": "± autoantibodies"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Remove offending drug"
                  },
                  {
                    "text": "Steroids may be necessary"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Varies with drug, but, typically, there is improvement with cessation of offending drugDoes not usually result in progressive liver disease or fibrosis if drug is stopped",
                    "sub_points": [
                      "Does not usually result in progressive liver disease or fibrosis if drug is stopped"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Vary with implicated drugNoncaseating granulomasVary in number and size; either portal &/or lobularEpithelioid or looseFibrin ring granulomas (e.g., allopurinol, checkpoint inhibitors)Multinucleated giant cells may be presentAssociated lymphocytes, plasma cells, and (most notably) eosinophilsUnless eosinophils are present, very difficult to distinguish drug-induced granulomas from granulomas of other causesHowever, presence of eosinophils does not prove drug-related etiologyOther variably present changesHepatocyte reactive changesApoptotic hepatocytesSteatosisCholestasisCytoplasmic ballooningCholangitis (usually associated with portal granulomas)Vasculitis",
                    "sub_points": [
                      "Noncaseating granulomasVary in number and size; either portal &/or lobularEpithelioid or looseFibrin ring granulomas (e.g., allopurinol, checkpoint inhibitors)Multinucleated giant cells may be presentAssociated lymphocytes, plasma cells, and (most notably) eosinophilsUnless eosinophils are present, very difficult to distinguish drug-induced granulomas from granulomas of other causesHowever, presence of eosinophils does not prove drug-related etiology",
                      "Vary in number and size; either portal &/or lobular",
                      "Epithelioid or loose",
                      "Fibrin ring granulomas (e.g., allopurinol, checkpoint inhibitors)",
                      "Multinucleated giant cells may be present",
                      "Associated lymphocytes, plasma cells, and (most notably) eosinophilsUnless eosinophils are present, very difficult to distinguish drug-induced granulomas from granulomas of other causesHowever, presence of eosinophils does not prove drug-related etiology",
                      "Unless eosinophils are present, very difficult to distinguish drug-induced granulomas from granulomas of other causes",
                      "However, presence of eosinophils does not prove drug-related etiology",
                      "Other variably present changesHepatocyte reactive changesApoptotic hepatocytesSteatosisCholestasisCytoplasmic ballooningCholangitis (usually associated with portal granulomas)Vasculitis",
                      "Hepatocyte reactive changes",
                      "Apoptotic hepatocytes",
                      "Steatosis",
                      "Cholestasis",
                      "Cytoplasmic ballooning",
                      "Cholangitis (usually associated with portal granulomas)",
                      "Vasculitis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sarcoidosis": [
                  {
                    "text": "Abnormal chest x-ray, elevated serum angiotensin-converting enzyme (ACE) favor sarcoidosis"
                  }
                ],
                "Infection": [
                  {
                    "text": "Special stains, immunohistochemistry, PCR, microbiologic cultures useful to exclude infection"
                  }
                ],
                "Primary Biliary Cholangitis": [
                  {
                    "text": "AMA(+), bile duct damage, lymphocytic cholangitis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Diagnosis requires high level of suspicion"
                  },
                  {
                    "text": "Need careful drug history and temporal correlation between drug administration and liver disease"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Combination of microgranulomas and hepatocyte injury is very suggestive of granulomatous drug reaction"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Induced Steatohepatitis/Phospholipidosis": {
            "name": "Drug-Induced Steatohepatitis/Phospholipidosis",
            "url": "https://app.pathprimer.com/document/f5563699-2966-4ee4-b4ab-2bbf2343007d/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Drug-induced steatohepatitis or phospholipidosis (intracellular accumulation of phospholipids)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Commonly implicated drugsAmiodaroneMethotrexateAntiretroviral drugsNifedipineTamoxifen",
                    "sub_points": [
                      "Amiodarone",
                      "Methotrexate",
                      "Antiretroviral drugs",
                      "Nifedipine",
                      "Tamoxifen"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Symptoms may present after months to years of therapyPatients may be asymptomatic despite liver injury",
                    "sub_points": [
                      "Patients may be asymptomatic despite liver injury"
                    ]
                  },
                  {
                    "text": "Due to long half-life of amiodarone, may take months to see improvement"
                  },
                  {
                    "text": "Risk of liver damage with methotrexate depends on duration of therapy, dose"
                  },
                  {
                    "text": "Patients with drug-induced steatosis/phospholipidosis may have history of alcohol use or risk factors for nonalcoholic steatohepatitis, confounding clinical picture"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "AmiodaroneMallory hyaline, often with associated neutrophils (satellitosis)SteatosisPhospholipidosis (granular, foamy appearance of hepatocytes corresponding to lamellar lysosomal inclusions by EM)",
                    "sub_points": [
                      "Mallory hyaline, often with associated neutrophils (satellitosis)",
                      "Steatosis",
                      "Phospholipidosis (granular, foamy appearance of hepatocytes corresponding to lamellar lysosomal inclusions by EM)"
                    ]
                  },
                  {
                    "text": "MethotrexateSteatosis and reactive changes (anisocytosis)FibrosisGrading scheme exists for purposes of clinical decision makingGrades 1-4; drug usually stopped at 3B-4",
                    "sub_points": [
                      "Steatosis and reactive changes (anisocytosis)",
                      "Fibrosis",
                      "Grading scheme exists for purposes of clinical decision makingGrades 1-4; drug usually stopped at 3B-4",
                      "Grades 1-4; drug usually stopped at 3B-4"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Drug-induced steatohepatitis &/or phospholipidosis (intracellular accumulation of phospholipids)Phospholipidosis likely from impaired phospholipid metabolism, although exact mechanism unknown",
                    "sub_points": [
                      "Phospholipidosis likely from impaired phospholipid metabolism, although exact mechanism unknown"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Commonly Implicated Drugs": [
                  {
                    "text": "Amiodarone (antiarrhythmic): Strongly tissue bound; becomes concentrated in liver"
                  },
                  {
                    "text": "Nifedipine (calcium channel blocker)"
                  },
                  {
                    "text": "Perhexiline maleate (calcium channel blocker)"
                  },
                  {
                    "text": "Methotrexate (immunosuppressant/antineoplastic): Hepatic injury usually occurs after long-term use"
                  },
                  {
                    "text": "Tamoxifen (estrogen antagonist)"
                  },
                  {
                    "text": "Steroids"
                  },
                  {
                    "text": "Naproxen (NSAID)"
                  },
                  {
                    "text": "Trimethoprim-sulfa (antibiotic)"
                  },
                  {
                    "text": "Total parenteral nutrition"
                  },
                  {
                    "text": "Anti-HIV drugsInduce syndrome of dyslipidemia, fat maldistribution, insulin resistanceKnown as HIV-associated lipodystrophy syndrome or HIV-associated metabolic and morphologic abnormality syndrome (HAMMAS)",
                    "sub_points": [
                      "Induce syndrome of dyslipidemia, fat maldistribution, insulin resistanceKnown as HIV-associated lipodystrophy syndrome or HIV-associated metabolic and morphologic abnormality syndrome (HAMMAS)",
                      "Known as HIV-associated lipodystrophy syndrome or HIV-associated metabolic and morphologic abnormality syndrome (HAMMAS)"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Variably present constitutional complaints, hepatomegaly, jaundice; may be asymptomatic"
                  },
                  {
                    "text": "Symptoms may present after months to years of therapy"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Transaminases usually elevatedOccasionally normal despite hepatic injury",
                    "sub_points": [
                      "Occasionally normal despite hepatic injury"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "AmiodaroneCessation of therapy should lead to regression of injuryDue to long half-life of drug, may take months to see improvementOccasionally progresses to cirrhosis, hepatic failure",
                    "sub_points": [
                      "Cessation of therapy should lead to regression of injuryDue to long half-life of drug, may take months to see improvementOccasionally progresses to cirrhosis, hepatic failure",
                      "Due to long half-life of drug, may take months to see improvement",
                      "Occasionally progresses to cirrhosis, hepatic failure"
                    ]
                  },
                  {
                    "text": "MethotrexateRisk of liver damage depends on duration of therapy and doseMay progress to fibrosis or cirrhosisExacerbated by concomitant obesity, alcohol useBecause of this, true ability of methotrexate to cause fatty liver disease has recently been questionedPeriodic liver biopsy may be recommended for surveillance",
                    "sub_points": [
                      "Risk of liver damage depends on duration of therapy and doseMay progress to fibrosis or cirrhosis",
                      "May progress to fibrosis or cirrhosis",
                      "Exacerbated by concomitant obesity, alcohol useBecause of this, true ability of methotrexate to cause fatty liver disease has recently been questioned",
                      "Because of this, true ability of methotrexate to cause fatty liver disease has recently been questioned",
                      "Periodic liver biopsy may be recommended for surveillance"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Amiodarone and other drugs causing phospholipidosisPhospholipidosis: Granular, foamy appearance of hepatocytes corresponding to lamellar lysosomal inclusions by EMCorresponds to entrapment of amiodarone in lysosomes with subsequent binding of phospholipidsHepatocyte swellingAbundant Mallory hyalineOften with associated neutrophils (satellitosis)Occasionally, abundant Mallory hyaline, but fatty changes absentSteatosisFibrosis/cirrhosis with progressive disease",
                    "sub_points": [
                      "Phospholipidosis: Granular, foamy appearance of hepatocytes corresponding to lamellar lysosomal inclusions by EMCorresponds to entrapment of amiodarone in lysosomes with subsequent binding of phospholipids",
                      "Corresponds to entrapment of amiodarone in lysosomes with subsequent binding of phospholipids",
                      "Hepatocyte swelling",
                      "Abundant Mallory hyalineOften with associated neutrophils (satellitosis)Occasionally, abundant Mallory hyaline, but fatty changes absent",
                      "Often with associated neutrophils (satellitosis)",
                      "Occasionally, abundant Mallory hyaline, but fatty changes absent",
                      "Steatosis",
                      "Fibrosis/cirrhosis with progressive disease"
                    ]
                  },
                  {
                    "text": "MethotrexateSteatosisUsually macrovesicular, but occasionally microvesicularVariably present hypertrophic Ito cellsNonspecific reactive changesHyperchromasia and anisocytosis of hepatocyte nucleiSpotty hepatocyte necrosis with associated Kupffer cellsPortal inflammationFibrosisBegins as irregular periportal spurs and progresses to portal/portal and portal/central bridgingPericellular fibrosis may also be presentGrading scheme exists for purposes of clinical decision makingGrade 1: Normal or only mild fatty or reactive changesGrade 2: Moderate to severe fatty or reactive changesGrade 3: Mild periportal fibrosis (3A) or moderate to marked fibrosis (3B)Grade 4: CirrhosisMethotrexate should be stopped in 3B or 4 cases; cautiously continued with rebiopsy in 6 months in 3A biopsies",
                    "sub_points": [
                      "SteatosisUsually macrovesicular, but occasionally microvesicularVariably present hypertrophic Ito cells",
                      "Usually macrovesicular, but occasionally microvesicular",
                      "Variably present hypertrophic Ito cells",
                      "Nonspecific reactive changesHyperchromasia and anisocytosis of hepatocyte nucleiSpotty hepatocyte necrosis with associated Kupffer cells",
                      "Hyperchromasia and anisocytosis of hepatocyte nuclei",
                      "Spotty hepatocyte necrosis with associated Kupffer cells",
                      "Portal inflammation",
                      "FibrosisBegins as irregular periportal spurs and progresses to portal/portal and portal/central bridgingPericellular fibrosis may also be present",
                      "Begins as irregular periportal spurs and progresses to portal/portal and portal/central bridging",
                      "Pericellular fibrosis may also be present",
                      "Grading scheme exists for purposes of clinical decision makingGrade 1: Normal or only mild fatty or reactive changesGrade 2: Moderate to severe fatty or reactive changesGrade 3: Mild periportal fibrosis (3A) or moderate to marked fibrosis (3B)Grade 4: Cirrhosis",
                      "Grade 1: Normal or only mild fatty or reactive changes",
                      "Grade 2: Moderate to severe fatty or reactive changes",
                      "Grade 3: Mild periportal fibrosis (3A) or moderate to marked fibrosis (3B)",
                      "Grade 4: Cirrhosis",
                      "Methotrexate should be stopped in 3B or 4 cases; cautiously continued with rebiopsy in 6 months in 3A biopsies"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Alcoholic Hepatitis": [
                  {
                    "text": "History of alcohol use vs. history of offending drug"
                  }
                ],
                "Nonalcoholic Steatohepatitis": [
                  {
                    "text": "Often lacks abundant Mallory bodies"
                  },
                  {
                    "text": "Risk factors for nonalcoholic steatohepatitis vs. history of offending drug"
                  }
                ],
                "Niemann-Pick Disease": [
                  {
                    "text": "Hereditary disorder of lipid metabolism (diminished sphingomyelinase activity)"
                  },
                  {
                    "text": "May mimic amiodarone-induced phospholipidosis"
                  }
                ],
                "Preexisting Hepatitis Treated With Steroids": [
                  {
                    "text": "Most commonly seen in treated autoimmune hepatitisAutoimmune serologies, medication history help to distinguish from drug-related steatohepatitis",
                    "sub_points": [
                      "Autoimmune serologies, medication history help to distinguish from drug-related steatohepatitis"
                    ]
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Abnormal ceruloplasmin, copper studies; lacks Mallory hyaline"
                  }
                ],
                "Malabsorption/Malnutrition": [
                  {
                    "text": "History of malnutrition vs. history of offending drug; lacks Mallory hyaline"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Appropriate history of exposure to offending drug is necessary for diagnosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Reye Syndrome": {
            "name": "Reye Syndrome",
            "url": "https://app.pathprimer.com/document/eb665f57-43c5-43fb-be05-5bc39a4a42a3/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute, life-threatening disorder characterized by diffuse hepatic microvesicular steatosis and noninflammatory encephalopathyClassic syndrome: Combination of resolving viral illness (usually influenza, varicella) and salicylate therapyReye-like syndrome: Metabolic disorders, toxins, other drugs, other infections",
                    "sub_points": [
                      "Classic syndrome: Combination of resolving viral illness (usually influenza, varicella) and salicylate therapy",
                      "Reye-like syndrome: Metabolic disorders, toxins, other drugs, other infections"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Disrupted mitochondrial metabolic pathways"
                  },
                  {
                    "text": "Inhibition of β oxidation of long chain fatty acids"
                  },
                  {
                    "text": "Uncoupling of oxidative phosphorylation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most often seen in childrenRare cases in adults",
                    "sub_points": [
                      "Rare cases in adults"
                    ]
                  },
                  {
                    "text": "Clinical picture dominated by neurologic rather than hepatic manifestationsClinical evidence of hepatic disease may be very subtle",
                    "sub_points": [
                      "Clinical evidence of hepatic disease may be very subtle"
                    ]
                  },
                  {
                    "text": "Biphasic patternViral prodrome followed by neurologic manifestationsProdromal febrile illnessVomiting and neurologic alterations 3-5 days later",
                    "sub_points": [
                      "Viral prodrome followed by neurologic manifestations",
                      "Prodromal febrile illness",
                      "Vomiting and neurologic alterations 3-5 days later"
                    ]
                  },
                  {
                    "text": "Mortality ~ 30%, usually due to cerebral edemaThose who survive acute illness usually recover completely",
                    "sub_points": [
                      "Those who survive acute illness usually recover completely"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse microvesicular steatosis"
                  },
                  {
                    "text": "No inflammation or cholestasis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Congenital metabolic conditions"
                  },
                  {
                    "text": "Acute fatty liver of pregnancy"
                  },
                  {
                    "text": "Alcoholic foamy degeneration"
                  },
                  {
                    "text": "Drug/toxin-mediated injury"
                  },
                  {
                    "text": "Sepsis"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Presumptive diagnosis can be made based on clinical and laboratory findings"
                  },
                  {
                    "text": "Microvesicular fatty change in context of neurologic alterations/encephalopathy"
                  },
                  {
                    "text": "Necessity of liver biopsy for diagnosis is controversial"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute, life-threatening disorder characterized by diffuse hepatic microvesicular steatosis and noninflammatory encephalopathyClassic or idiopathic syndrome: Combination of resolving flu-like illness and salicylate therapyReye-like syndrome: Patients that do not fit above paradigm",
                    "sub_points": [
                      "Classic or idiopathic syndrome: Combination of resolving flu-like illness and salicylate therapyReye-like syndrome: Patients that do not fit above paradigm",
                      "Reye-like syndrome: Patients that do not fit above paradigm"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Pathogenesis Unknown": [
                  {
                    "text": "Classic, or idiopathic Reye syndromeInitial descriptions linked syndrome to viral infections (mainly influenza and varicella) and salicylate therapyAssociation with salicylates not unanimously accepted; however, dramatic decrease in incidence following decrease in aspirin use",
                    "sub_points": [
                      "Initial descriptions linked syndrome to viral infections (mainly influenza and varicella) and salicylate therapy",
                      "Association with salicylates not unanimously accepted; however, dramatic decrease in incidence following decrease in aspirin use"
                    ]
                  },
                  {
                    "text": "Reye-like syndrome: Associations elucidated since initial descriptionDisorders of fatty acid oxidation, ketogenesis, ureagenesis, carbohydrate metabolism; organic aciduriasToxins: Hypoglycin (in ackee fruit, causing Jamaican vomiting sickness), margosa toxin, aflatoxin, paint thinnerOther drugs: Antiemetics, phenothiazines, valproic acid, paracetamol, zidovudine, didanosineOther infections: Parainfluenza, adenovirus, Coxsackie virus, CMV, herpes",
                    "sub_points": [
                      "Disorders of fatty acid oxidation, ketogenesis, ureagenesis, carbohydrate metabolism; organic acidurias",
                      "Toxins: Hypoglycin (in ackee fruit, causing Jamaican vomiting sickness), margosa toxin, aflatoxin, paint thinner",
                      "Other drugs: Antiemetics, phenothiazines, valproic acid, paracetamol, zidovudine, didanosine",
                      "Other infections: Parainfluenza, adenovirus, Coxsackie virus, CMV, herpes"
                    ]
                  },
                  {
                    "text": "Mitochondrial injury is main featureCytokines released during viral infections inhibit β oxidation of long chain fatty acidsSalicylates uncouple oxidative phosphorylationToxins and inherited disorders disrupt mitochondrial metabolic pathways",
                    "sub_points": [
                      "Cytokines released during viral infections inhibit β oxidation of long chain fatty acids",
                      "Salicylates uncouple oxidative phosphorylation",
                      "Toxins and inherited disorders disrupt mitochondrial metabolic pathways"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Most common in infants and childrenRare cases in adults",
                    "sub_points": [
                      "Rare cases in adults"
                    ]
                  },
                  {
                    "text": "Biphasic patternProdromal febrile illness, often influenza or varicellaVomiting and neurologic alterations 3-5 days laterLethargy and irritability initially; can progress to delirium, obtundation, seizures, coma",
                    "sub_points": [
                      "Prodromal febrile illness, often influenza or varicella",
                      "Vomiting and neurologic alterations 3-5 days laterLethargy and irritability initially; can progress to delirium, obtundation, seizures, coma",
                      "Lethargy and irritability initially; can progress to delirium, obtundation, seizures, coma"
                    ]
                  },
                  {
                    "text": "Clinical evidence of liver disease, jaundice often absent"
                  },
                  {
                    "text": "Metabolic acidosis, respiratory alkalosis may be present"
                  },
                  {
                    "text": "Recurrence reported with rechallenge in children and adults, although not universal"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "CSF has normal glucose and protein; minimal leukocytosis"
                  },
                  {
                    "text": "Increased transaminases, often marked; normal bilirubin"
                  },
                  {
                    "text": "Increased serum ammonia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive care"
                  },
                  {
                    "text": "Controlling increased intracranial pressure"
                  },
                  {
                    "text": "Correcting metabolic abnormalities"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dominated by neurologic rather than hepatic manifestations"
                  },
                  {
                    "text": "Mortality ~ 30%, usually due to cerebral edemaSurvivors of acute illness usually recover completelySmall percentage have long-term neurologic sequelaeCritical to diagnose before irreversible brain damage occurs",
                    "sub_points": [
                      "Survivors of acute illness usually recover completely",
                      "Small percentage have long-term neurologic sequelae",
                      "Critical to diagnose before irreversible brain damage occurs"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Mild hepatomegaly with yellow discoloration"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diffuse, panlobular microvesicular steatosisMost evident during first 3-4 days of illnessSmall, intrahepatocytic fat droplets that do not displace nucleusDroplets may be so small as to be missed",
                    "sub_points": [
                      "Most evident during first 3-4 days of illness",
                      "Small, intrahepatocytic fat droplets that do not displace nucleusDroplets may be so small as to be missed",
                      "Droplets may be so small as to be missed"
                    ]
                  },
                  {
                    "text": "Depleted glycogen"
                  },
                  {
                    "text": "Absent or minimal inflammation"
                  },
                  {
                    "text": "Necrosis, cholestasis rare"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "Enlarged, swollen, pleomorphic mitochondria with disrupted, fragmented cristaLucent matrix and loss of matrical dense bodies",
                    "sub_points": [
                      "Lucent matrix and loss of matrical dense bodies"
                    ]
                  },
                  {
                    "text": "Mitochondria may decrease in number as disease progresses"
                  }
                ],
                "Oil red O or Sudan black B stains": [
                  {
                    "text": "Lipid can be demonstrated using oil red O or Sudan black B stains in frozen sections"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Congenital Metabolic Conditions": [
                  {
                    "text": "Urea cycle disorders, fatty acid metabolism defects, lysosomal acid lipase deficiencyDonor liver with diffuse microvesicular steatosis may indicate above disordersNot suitable for transplantation",
                    "sub_points": [
                      "Donor liver with diffuse microvesicular steatosis may indicate above disordersNot suitable for transplantation",
                      "Not suitable for transplantation"
                    ]
                  },
                  {
                    "text": "Electron microscopy and extensive metabolic work-up needed to distinguish from Reye syndrome"
                  }
                ],
                "Drug/Toxin-Mediated Injury": [
                  {
                    "text": "Valproic acid, IV tetracycline, salicylates"
                  }
                ],
                "Wolman Disease": [
                  {
                    "text": "Infantile form of lysosomal acid lipase deficiencyAutosomal recessive disease, mutations in acid lipase geneFailure to thrive, vomiting, severe diarrhea, steatorrheaHepatosplenomegaly, ascites, lymphadenopathyEnlarged adrenals with calcifications characteristicMicrovesicular steatosisFoamy macrophages containing cholesterol and cholesteryl esters in liver, spleen, adrenals, bone marrowVacuolated lymphocytes on peripheral smear",
                    "sub_points": [
                      "Autosomal recessive disease, mutations in acid lipase gene",
                      "Failure to thrive, vomiting, severe diarrhea, steatorrhea",
                      "Hepatosplenomegaly, ascites, lymphadenopathy",
                      "Enlarged adrenals with calcifications characteristic",
                      "Microvesicular steatosis",
                      "Foamy macrophages containing cholesterol and cholesteryl esters in liver, spleen, adrenals, bone marrow",
                      "Vacuolated lymphocytes on peripheral smear"
                    ]
                  }
                ],
                "Acute Fatty Liver of Pregnancy": [
                  {
                    "text": "Distinct clinical scenario"
                  }
                ],
                "Alcoholic Foamy Degeneration": [
                  {
                    "text": "Clinical history of ethanol use"
                  },
                  {
                    "text": "Elevated bilirubin"
                  },
                  {
                    "text": "Other changes of alcoholic liver disease often present"
                  }
                ],
                "Sepsis": [
                  {
                    "text": "e.g., toxic shock syndrome"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Presumptive diagnosis can be made based on clinical and laboratory findingsNecessity of liver biopsy for diagnosis is controversial",
                    "sub_points": [
                      "Necessity of liver biopsy for diagnosis is controversial"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Microvesicular fatty change in context of neurologic alterations/encephalopathy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Drug-Induced Cholangitis/Ductopenia": {
            "name": "Drug-Induced Cholangitis/Ductopenia",
            "url": "https://app.pathprimer.com/document/00720a5a-5f97-44fa-9fae-4236457d1f67/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Bile duct injury, cholangitis, &/or duct loss due to adverse drug reactionsOften accompanied by cholestasis",
                    "sub_points": [
                      "Often accompanied by cholestasis"
                    ]
                  },
                  {
                    "text": "Vanishing bile duct syndromeUsed to describe ductopenia secondary to multiple etiologies, drug being 1 of them",
                    "sub_points": [
                      "Used to describe ductopenia secondary to multiple etiologies, drug being 1 of them"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Many medication classes implicatedAntiinflammatory, antibiotics, antiepileptics, psychiatric drugs, tranquilizers, hypoglycemics, and othersAmoxicillin/clavulanate, azithromycin, fluoroquinolones particularly associated with bile duct loss",
                    "sub_points": [
                      "Antiinflammatory, antibiotics, antiepileptics, psychiatric drugs, tranquilizers, hypoglycemics, and others",
                      "Amoxicillin/clavulanate, azithromycin, fluoroquinolones particularly associated with bile duct loss"
                    ]
                  },
                  {
                    "text": "Also occurs with herbal or toxin exposure or genetic disposition"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "JaundiceTemporal relationship between drug administration and onset of signs and symptomsMost patients recover fully with discontinuation of drugFew cases develop chronic cholestatic injury",
                    "sub_points": [
                      "Temporal relationship between drug administration and onset of signs and symptoms",
                      "Most patients recover fully with discontinuation of drug",
                      "Few cases develop chronic cholestatic injury"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Generally, no specific features indicating injury is drug relatedCholestasis, usually zone 3Bile duct epithelial cell injuryCytoplasmic eosinophilia &/or vacuolizationNuclear pleomorphism and uneven nuclear spacingApoptosis and atrophy of ductal epitheliumBile ductular proliferationLymphocytic or mixed cell cholangitis",
                    "sub_points": [
                      "Cholestasis, usually zone 3",
                      "Bile duct epithelial cell injuryCytoplasmic eosinophilia &/or vacuolizationNuclear pleomorphism and uneven nuclear spacingApoptosis and atrophy of ductal epithelium",
                      "Cytoplasmic eosinophilia &/or vacuolization",
                      "Nuclear pleomorphism and uneven nuclear spacing",
                      "Apoptosis and atrophy of ductal epithelium",
                      "Bile ductular proliferation",
                      "Lymphocytic or mixed cell cholangitis"
                    ]
                  },
                  {
                    "text": "Some cases show changes of progression/chronicityProgressive ductopeniaPeriportal hepatocyte swelling and copper accumulation",
                    "sub_points": [
                      "Progressive ductopenia",
                      "Periportal hepatocyte swelling and copper accumulation"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cholangiodestructive cholestasis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Bile duct injury, cholangitis, &/or ductopenia related to adverse drug reactions"
                  },
                  {
                    "text": "DuctopeniaAbsence of bile ducts in > 50% of portal tractsMinimum 10 portal tracts should be present for evaluation in biopsy",
                    "sub_points": [
                      "Absence of bile ducts in > 50% of portal tracts",
                      "Minimum 10 portal tracts should be present for evaluation in biopsy"
                    ]
                  },
                  {
                    "text": "Vanishing bile duct syndromeDuct loss or ductopenia secondary to multiple etiologies, drug being 1 of themOther causesImmune mediated graft-vs.-host [(GVHD), chronic allograft rejection)]SepsisIschemia",
                    "sub_points": [
                      "Duct loss or ductopenia secondary to multiple etiologies, drug being 1 of them",
                      "Other causesImmune mediated graft-vs.-host [(GVHD), chronic allograft rejection)]SepsisIschemia",
                      "Immune mediated graft-vs.-host [(GVHD), chronic allograft rejection)]",
                      "Sepsis",
                      "Ischemia"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "2 Categories of Injury": [
                  {
                    "text": "PredictableDose related, reproducible, and related to intrinsic toxicity of drug or its metabolites",
                    "sub_points": [
                      "Dose related, reproducible, and related to intrinsic toxicity of drug or its metabolites"
                    ]
                  },
                  {
                    "text": "IdiosyncraticUnpredictable, unrelated to dose, not reproducible in animal modelsAllergic or autoimmune responses to drug or its metabolite may be involved",
                    "sub_points": [
                      "Unpredictable, unrelated to dose, not reproducible in animal models",
                      "Allergic or autoimmune responses to drug or its metabolite may be involved"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Many medication classes implicatedDuct loss seen in 7% of drug-induced liver injury casesAntiinflammatoryAcetaminophen, ibuprofen, phenylbutazoneAntibioticsAmoxicillin-clavulanic acid, ampicillin, clindamycin, erythromycin, tetracycline, trimethoprim/sulfamethoxazoleAntiepilepticsCarbamazepine, phenytoinPsychiatric drugsAmitriptyline, imipramine, HaldolTranquilizersChlorpromazine, prochlorperazine, phenothiazineHypoglycemicsTolbutamide, chlorpropamideImmune checkpoint inhibitorsParticularly PD-1 inhibitors (pembrolizumab, nivolumab)OthersCromolyn sodium (antiasthmatic), cyproheptadine (antihistamine), methyltestosterone, thiabendazole (antihelminthic)Anabolic steroids, known to cause drug-induced cholestasis, arenotassociated with duct loss",
                    "sub_points": [
                      "Duct loss seen in 7% of drug-induced liver injury casesAntiinflammatoryAcetaminophen, ibuprofen, phenylbutazoneAntibioticsAmoxicillin-clavulanic acid, ampicillin, clindamycin, erythromycin, tetracycline, trimethoprim/sulfamethoxazoleAntiepilepticsCarbamazepine, phenytoinPsychiatric drugsAmitriptyline, imipramine, HaldolTranquilizersChlorpromazine, prochlorperazine, phenothiazineHypoglycemicsTolbutamide, chlorpropamideImmune checkpoint inhibitorsParticularly PD-1 inhibitors (pembrolizumab, nivolumab)OthersCromolyn sodium (antiasthmatic), cyproheptadine (antihistamine), methyltestosterone, thiabendazole (antihelminthic)Anabolic steroids, known to cause drug-induced cholestasis, arenotassociated with duct loss",
                      "AntiinflammatoryAcetaminophen, ibuprofen, phenylbutazone",
                      "Acetaminophen, ibuprofen, phenylbutazone",
                      "AntibioticsAmoxicillin-clavulanic acid, ampicillin, clindamycin, erythromycin, tetracycline, trimethoprim/sulfamethoxazole",
                      "Amoxicillin-clavulanic acid, ampicillin, clindamycin, erythromycin, tetracycline, trimethoprim/sulfamethoxazole",
                      "AntiepilepticsCarbamazepine, phenytoin",
                      "Carbamazepine, phenytoin",
                      "Psychiatric drugsAmitriptyline, imipramine, Haldol",
                      "Amitriptyline, imipramine, Haldol",
                      "TranquilizersChlorpromazine, prochlorperazine, phenothiazine",
                      "Chlorpromazine, prochlorperazine, phenothiazine",
                      "HypoglycemicsTolbutamide, chlorpropamide",
                      "Tolbutamide, chlorpropamide",
                      "Immune checkpoint inhibitorsParticularly PD-1 inhibitors (pembrolizumab, nivolumab)",
                      "Particularly PD-1 inhibitors (pembrolizumab, nivolumab)",
                      "OthersCromolyn sodium (antiasthmatic), cyproheptadine (antihistamine), methyltestosterone, thiabendazole (antihelminthic)",
                      "Cromolyn sodium (antiasthmatic), cyproheptadine (antihistamine), methyltestosterone, thiabendazole (antihelminthic)",
                      "Anabolic steroids, known to cause drug-induced cholestasis, arenotassociated with duct loss"
                    ]
                  }
                ],
                "Herbal Preparations": [
                  {
                    "text": "May not be reported by patients as part of medication and exposure history"
                  }
                ],
                "Toxins": [
                  {
                    "text": "Paraquat, rapeseed oil"
                  }
                ],
                "Genetic Predisposition": [
                  {
                    "text": "Mutations inABCB4encoding MDR3 (phospholipid export pump involved in bile secretion) predispose to drug-related cholestasisBile acids combine with phosphatidylcholine to form micelles that help with fat digestionMDR3 allows phosphatidylcholine to be present and available to bile on hepatocyte canalicular membraneIn adults harboring heterozygousABCB4mutation, MDR3 protein levels already reducedDrugs can competitively inhibit remainder of already decreased MDR3, unmasking cholestatic propensityABCB4mutations associated with bile duct injury, duct loss, periductal fibrosis",
                    "sub_points": [
                      "Bile acids combine with phosphatidylcholine to form micelles that help with fat digestion",
                      "MDR3 allows phosphatidylcholine to be present and available to bile on hepatocyte canalicular membrane",
                      "In adults harboring heterozygousABCB4mutation, MDR3 protein levels already reduced",
                      "Drugs can competitively inhibit remainder of already decreased MDR3, unmasking cholestatic propensity",
                      "ABCB4mutations associated with bile duct injury, duct loss, periductal fibrosis"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "JaundiceTemporal relationship between drug administration and onset of signs and symptomsUsually presents within weeks of taking drug but may be delayed past 1 yearFor duct loss, median 1 month for onset of presentationVanishing bile duct syndrome from drug can have temporal heterogeneityIf rapid-onset bile duct loss, more acute cholestatic manifestationsIf progressive, slow bile duct destruction over months and years: Pruritis and other symptoms of chronic and progressive cholestasis with fibrosisEven after stopping offending agent and clinical recovery, partial bile duct loss and laboratory abnormalities may remainLaboratory valuesElevated alkaline phosphataseTotal bilirubin can be > 2.5 mg/dLMild to moderate elevations in ALT, AST",
                    "sub_points": [
                      "Temporal relationship between drug administration and onset of signs and symptoms",
                      "Usually presents within weeks of taking drug but may be delayed past 1 yearFor duct loss, median 1 month for onset of presentation",
                      "For duct loss, median 1 month for onset of presentation",
                      "Vanishing bile duct syndrome from drug can have temporal heterogeneityIf rapid-onset bile duct loss, more acute cholestatic manifestationsIf progressive, slow bile duct destruction over months and years: Pruritis and other symptoms of chronic and progressive cholestasis with fibrosisEven after stopping offending agent and clinical recovery, partial bile duct loss and laboratory abnormalities may remain",
                      "If rapid-onset bile duct loss, more acute cholestatic manifestations",
                      "If progressive, slow bile duct destruction over months and years: Pruritis and other symptoms of chronic and progressive cholestasis with fibrosisEven after stopping offending agent and clinical recovery, partial bile duct loss and laboratory abnormalities may remain",
                      "Even after stopping offending agent and clinical recovery, partial bile duct loss and laboratory abnormalities may remain",
                      "Laboratory valuesElevated alkaline phosphataseTotal bilirubin can be > 2.5 mg/dLMild to moderate elevations in ALT, AST",
                      "Elevated alkaline phosphatase",
                      "Total bilirubin can be > 2.5 mg/dL",
                      "Mild to moderate elevations in ALT, AST"
                    ]
                  },
                  {
                    "text": "OtherItching, nausea, fatigue, abdominal painRash and fever also more likely with duct loss",
                    "sub_points": [
                      "Itching, nausea, fatigue, abdominal pain",
                      "Rash and fever also more likely with duct loss"
                    ]
                  },
                  {
                    "text": "Stevens-Johnson syndromeMucocutaneous reaction to drug with extensive necrosis and detachment of skinCan be accompanied by vanishing bile duct syndromeShare immunologic mechanisms targeting skin and bile duct epithelium",
                    "sub_points": [
                      "Mucocutaneous reaction to drug with extensive necrosis and detachment of skinCan be accompanied by vanishing bile duct syndromeShare immunologic mechanisms targeting skin and bile duct epithelium",
                      "Can be accompanied by vanishing bile duct syndrome",
                      "Share immunologic mechanisms targeting skin and bile duct epithelium"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Initial bile duct injury may be followed by ductopenia and prolonged cholestasis"
                  },
                  {
                    "text": "Effects may persist for months"
                  },
                  {
                    "text": "May see reduced bile duct numbers on biopsy even after clinical recovery"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Discontinue offending drug"
                  },
                  {
                    "text": "Ursodeoxycholic acid may improve cholestasis in some"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Most patients recover fully with discontinuation of drug"
                  },
                  {
                    "text": "Patients with duct loss more likely to progress to chronic liver injuryBiliary cirrhosis or sclerosing cholangitis-like pictureDegree of duct loss most predictive of poor outcomeModerate to severe duct loss associated with outcomes of death, transplantation, persistent liver injuryPresence of copper, fibrosis, duct injurynotpredictive of poor outcome",
                    "sub_points": [
                      "Biliary cirrhosis or sclerosing cholangitis-like picture",
                      "Degree of duct loss most predictive of poor outcomeModerate to severe duct loss associated with outcomes of death, transplantation, persistent liver injuryPresence of copper, fibrosis, duct injurynotpredictive of poor outcome",
                      "Moderate to severe duct loss associated with outcomes of death, transplantation, persistent liver injury",
                      "Presence of copper, fibrosis, duct injurynotpredictive of poor outcome"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Portal tract findingsBile duct epithelial cell injuryCytoplasmic vacuolization and attenuationPyknotic nuclei, overlapping nucleiLymphocyte infiltration of epithelium, other cell types can also be seenBile ductular reaction, large bile duct obstruction changes may be seenACE inhibitorsDuct injury, extravasated bile, ductular reactionImmune checkpoint inhibitor toxicity (particularly PD-1 inhibitors)Duct injury can be uncommon manifestation (hepatitic injury most common)Periductal fibrosis, lymphocytic/granulomatous inflammation around and involving bile ductEosinophils are not commonly seen featureLarge bile duct biopsies showing fibrotic duct wallPeriductal fibrosis, portal edema may be seene.g., intraarterial chemotherapy-induced sclerosing cholangitisVariable degree of portal inflammation, may include prominence of eosinophils &/or neutrophils",
                    "sub_points": [
                      "Bile duct epithelial cell injuryCytoplasmic vacuolization and attenuationPyknotic nuclei, overlapping nucleiLymphocyte infiltration of epithelium, other cell types can also be seen",
                      "Cytoplasmic vacuolization and attenuation",
                      "Pyknotic nuclei, overlapping nuclei",
                      "Lymphocyte infiltration of epithelium, other cell types can also be seen",
                      "Bile ductular reaction, large bile duct obstruction changes may be seenACE inhibitorsDuct injury, extravasated bile, ductular reactionImmune checkpoint inhibitor toxicity (particularly PD-1 inhibitors)Duct injury can be uncommon manifestation (hepatitic injury most common)Periductal fibrosis, lymphocytic/granulomatous inflammation around and involving bile ductEosinophils are not commonly seen featureLarge bile duct biopsies showing fibrotic duct wall",
                      "ACE inhibitorsDuct injury, extravasated bile, ductular reaction",
                      "Duct injury, extravasated bile, ductular reaction",
                      "Immune checkpoint inhibitor toxicity (particularly PD-1 inhibitors)Duct injury can be uncommon manifestation (hepatitic injury most common)Periductal fibrosis, lymphocytic/granulomatous inflammation around and involving bile ductEosinophils are not commonly seen featureLarge bile duct biopsies showing fibrotic duct wall",
                      "Duct injury can be uncommon manifestation (hepatitic injury most common)",
                      "Periductal fibrosis, lymphocytic/granulomatous inflammation around and involving bile duct",
                      "Eosinophils are not commonly seen feature",
                      "Large bile duct biopsies showing fibrotic duct wall",
                      "Periductal fibrosis, portal edema may be seene.g., intraarterial chemotherapy-induced sclerosing cholangitis",
                      "e.g., intraarterial chemotherapy-induced sclerosing cholangitis",
                      "Variable degree of portal inflammation, may include prominence of eosinophils &/or neutrophils"
                    ]
                  },
                  {
                    "text": "Lobular findingsVariable hepatocyte damage and lobular inflammationZone 3 canalicular bile pluggingIntrahepatocytic bile pigment",
                    "sub_points": [
                      "Variable hepatocyte damage and lobular inflammation",
                      "Zone 3 canalicular bile plugging",
                      "Intrahepatocytic bile pigment"
                    ]
                  },
                  {
                    "text": "Changes of progression/chronicityProgressive duct loss may occurHepatic artery branches or portal tracts lacking companion bile ductsCholate stasisPeriportal hepatocyte swelling and copper accumulationFibrosis",
                    "sub_points": [
                      "Progressive duct loss may occurHepatic artery branches or portal tracts lacking companion bile ducts",
                      "Hepatic artery branches or portal tracts lacking companion bile ducts",
                      "Cholate stasisPeriportal hepatocyte swelling and copper accumulation",
                      "Periportal hepatocyte swelling and copper accumulation",
                      "Fibrosis"
                    ]
                  },
                  {
                    "text": "Vanishing bile duct syndromeDuct lossChronic cholestasis if long term",
                    "sub_points": [
                      "Duct loss",
                      "Chronic cholestasis if long term"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Biliary Cholangitis": [
                  {
                    "text": "Positive AMA"
                  }
                ],
                "Sclerosing Cholangitis": [
                  {
                    "text": "Primary sclerosing cholangitisCharacteristic ERCP findingsHistory of inflammatory bowel disease",
                    "sub_points": [
                      "Characteristic ERCP findings",
                      "History of inflammatory bowel disease"
                    ]
                  },
                  {
                    "text": "Secondary sclerosing cholangitisOperative trauma, ischemia, cystic fibrosis",
                    "sub_points": [
                      "Operative trauma, ischemia, cystic fibrosis"
                    ]
                  }
                ],
                "Graft-vs.-Host Disease": [
                  {
                    "text": "Clinical context of transplantation"
                  }
                ],
                "Allograft Rejection": [
                  {
                    "text": "Clinical context of liver transplantation, presence of endothelialitis"
                  }
                ],
                "Hodgkin-Related Ductopenia": [
                  {
                    "text": "Ductopenia can occur with Hodgkin lymphoma"
                  },
                  {
                    "text": "Bile duct loss preceding diagnosis of Hodgkin lymphoma has been reported"
                  },
                  {
                    "text": "Ameliorated by treating lymphoma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Histologic features usually cannot provide definite diagnosis of drug-related injury but can assist in excluding other etiologies"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatic Stellate Cell Hyperplasia": {
            "name": "Hepatic Stellate Cell Hyperplasia",
            "url": "https://app.pathprimer.com/document/7d86a471-8b34-4c43-9f82-ba54ac8e94f4/lesson/febf01be-bf2d-41b5-9b39-a69a19d5ef2b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hyperplasia and hypertrophy of stellate cells as result of activation, most commonly due to vitamin A toxicity (hypervitaminosis A)"
                  },
                  {
                    "text": "Severity of liver disease depends on duration and dose of vitamin A"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Overingestion of vitamin A most common"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Hepatomegaly often presentVarices, ascites if portal hypertension presentJaundice variably present",
                    "sub_points": [
                      "Varices, ascites if portal hypertension present",
                      "Jaundice variably present"
                    ]
                  },
                  {
                    "text": "Cutaneous, gastrointestinal, neuroophthalmic, musculoskeletal, renal, hematologic manifestations also common"
                  },
                  {
                    "text": "Nonspecific elevations in transaminases, alkaline phosphatase"
                  },
                  {
                    "text": "Plasma vitamin A levels may be normal"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "HSC hyperplasia and hypertrophyDistinguish from steatotic hepatocyteHSC is perisinusoidal and has indented, triangular-shaped nucleus; lipid droplet is not within hepatocyte",
                    "sub_points": [
                      "Distinguish from steatotic hepatocyteHSC is perisinusoidal and has indented, triangular-shaped nucleus; lipid droplet is not within hepatocyte",
                      "HSC is perisinusoidal and has indented, triangular-shaped nucleus; lipid droplet is not within hepatocyte"
                    ]
                  },
                  {
                    "text": "Hepatocellular injury, inflammation minor"
                  },
                  {
                    "text": "Fibrosis begins in perisinusoidal pattern, may progress to cirrhosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Methotrexate therapy"
                  },
                  {
                    "text": "Steroid use"
                  },
                  {
                    "text": "IV fat emulsion administration"
                  },
                  {
                    "text": "Stellate cell activation has been reported in chronic viral hepatitis following transplantation"
                  },
                  {
                    "text": "May be marker of early fibrogenesis following transplantation"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatic stellate cells (HSC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "For HSCs: Ito cell, fat-storage cell, perisinusoidal cell"
                  },
                  {
                    "text": "HSC hypertrophy, stellate cell lipidosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "HSC: Specialized pericyte residing in space of Disse, normally inconspicuous on light microscopyContain cytoplasmic lipid droplets rich in vitamin A; main site of vitamin A storageHave long, cytoplasmic processes in contact with endothelial cells and hepatocytesRegulate sinusoidal blood flow, produce extracellular matrixPlay role in hepatic regeneration and fibrosis when activated",
                    "sub_points": [
                      "Contain cytoplasmic lipid droplets rich in vitamin A; main site of vitamin A storage",
                      "Have long, cytoplasmic processes in contact with endothelial cells and hepatocytes",
                      "Regulate sinusoidal blood flow, produce extracellular matrix",
                      "Play role in hepatic regeneration and fibrosis when activated"
                    ]
                  },
                  {
                    "text": "HSC hyperplasiaIncreased number of HSCs and accumulation of lipid droplets due to activationVisibility of otherwise inconspicuous cell on H&E by light microscopy",
                    "sub_points": [
                      "Increased number of HSCs and accumulation of lipid droplets due to activation",
                      "Visibility of otherwise inconspicuous cell on H&E by light microscopy"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Prolonged overingestion of high levels of vitamin A with cirrhosis occurring over 7 years on averageHepatotoxicity from overdose of vitamin A activates HSCHSC hypertrophy and hyperplasia obstructs sinusoids, increases collagen synthesis",
                    "sub_points": [
                      "Hepatotoxicity from overdose of vitamin A activates HSC",
                      "HSC hypertrophy and hyperplasia obstructs sinusoids, increases collagen synthesis"
                    ]
                  }
                ],
                "Other Associated Diseases Besides Vitamin A Overingestion": [
                  {
                    "text": "Drug induced: Niacin, methotrexate, valproate, steroids, topical tretinoinChronic hepatitis C, autoimmune hepatitisIn contrast, some chronic liver diseases are associated with vitamin A deficiencyViral hepatitis, NAFLD, primary biliary cholangitis, primary sclerosing cholangitis, alcoholic hepatitis",
                    "sub_points": [
                      "Chronic hepatitis C, autoimmune hepatitis",
                      "In contrast, some chronic liver diseases are associated with vitamin A deficiencyViral hepatitis, NAFLD, primary biliary cholangitis, primary sclerosing cholangitis, alcoholic hepatitis",
                      "Viral hepatitis, NAFLD, primary biliary cholangitis, primary sclerosing cholangitis, alcoholic hepatitis"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Variable; many organ systems may be involvedHepatomegalyVarices, ascites if portal hypertension presentJaundice variably presentCutaneous, gastrointestinal, neuroophthalmic, musculoskeletal, renal, hematologic manifestations also common",
                    "sub_points": [
                      "HepatomegalyVarices, ascites if portal hypertension presentJaundice variably present",
                      "Varices, ascites if portal hypertension present",
                      "Jaundice variably present",
                      "Cutaneous, gastrointestinal, neuroophthalmic, musculoskeletal, renal, hematologic manifestations also common"
                    ]
                  },
                  {
                    "text": "Some patients asymptomatic"
                  },
                  {
                    "text": "Alcohol may potentiate toxic effects of vitamin A"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Nonspecific elevations in transaminases, alkaline phosphatase"
                  },
                  {
                    "text": "Plasma vitamin A levels may be normal"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Discontinue vitamin A ingestion"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Severity of liver disease depends on duration and dose of vitamin A"
                  },
                  {
                    "text": "Cirrhosis or noncirrhotic portal hypertension due to sinusoidal fibrosis may developFibrosis can continue even after cessation of vitamin A overingestion due to long half-life and slow release from liver",
                    "sub_points": [
                      "Fibrosis can continue even after cessation of vitamin A overingestion due to long half-life and slow release from liver"
                    ]
                  },
                  {
                    "text": "Liver failure, cirrhosis at time of diagnosis portend worse prognosis"
                  },
                  {
                    "text": "In less severe cases, liver chemistries can normalize gradually after vitamin A cessation"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "In normal circumstances, HSCs store vitamin A in small cytoplasmic lipid droplets inconspicuous by light microscopy"
                  },
                  {
                    "text": "Stellate cell hyperplasia and hypertrophyPerisinusoidal cells with prominent amount of clear cytoplasm and triangular-shaped nucleusCan have multivacuolated appearance: Several lipid droplets separated by fine cytoplasmic strandsDistinguish from steatotic hepatocyte: Can look similar but 1) lipid droplet isnotwithin hepatocyte and 2) there is triangular-shaped, dark nucleus in HSC",
                    "sub_points": [
                      "Perisinusoidal cells with prominent amount of clear cytoplasm and triangular-shaped nucleus",
                      "Can have multivacuolated appearance: Several lipid droplets separated by fine cytoplasmic strandsDistinguish from steatotic hepatocyte: Can look similar but 1) lipid droplet isnotwithin hepatocyte and 2) there is triangular-shaped, dark nucleus in HSC",
                      "Distinguish from steatotic hepatocyte: Can look similar but 1) lipid droplet isnotwithin hepatocyte and 2) there is triangular-shaped, dark nucleus in HSC"
                    ]
                  },
                  {
                    "text": "Minimal hepatocellular injury, inflammation"
                  },
                  {
                    "text": "Microvesicular steatosis may be present"
                  },
                  {
                    "text": "FibrosisBegins as perisinusoidal fibrosisUsually panlobularCentral vein sclerosis has been describedMay progress to cirrhosis",
                    "sub_points": [
                      "Begins as perisinusoidal fibrosis",
                      "Usually panlobular",
                      "Central vein sclerosis has been described",
                      "May progress to cirrhosis"
                    ]
                  },
                  {
                    "text": "Peliosis hepatis, periportal sinusoidal dilatation have been described"
                  },
                  {
                    "text": "Nodular regenerative hyperplasia can be present"
                  },
                  {
                    "text": "Immunohistochemical markersVimentinDesminSMAGFAPCD56Synaptophysin",
                    "sub_points": [
                      "Vimentin",
                      "Desmin",
                      "SMA",
                      "GFAP",
                      "CD56",
                      "Synaptophysin"
                    ]
                  },
                  {
                    "text": "HSC have transient green fluorescence under ultraviolet light, particularly on frozen section"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Methotrexate Therapy": [
                  {
                    "text": "Should not have history of excessive vitamin A ingestion"
                  }
                ],
                "Other Drugs": [
                  {
                    "text": "Steroid useShould not have history of excessive vitamin A ingestion",
                    "sub_points": [
                      "Should not have history of excessive vitamin A ingestion"
                    ]
                  },
                  {
                    "text": "IV fat emulsion administration"
                  }
                ],
                "Posttransplant Biopsies": [
                  {
                    "text": "Stellate cell activation has been reported in chronic viral hepatitis following transplantation"
                  },
                  {
                    "text": "May be marker of early fibrogenesis"
                  },
                  {
                    "text": "Should not have history of excessive vitamin A ingestion"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Histologic findings are subtle and easily missed"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Nonneoplastic Lesions: Fatty Liver Diseases": {
        "name": "Liver Nonneoplastic Lesions: Fatty Liver Diseases",
        "url": "https://app.pathprimer.com/lesson/3369c90f-d827-430d-a60b-1ab587bdb9f3",
        "topics": {
          "Alcoholic Liver Disease": {
            "name": "Alcoholic Liver Disease",
            "url": "https://app.pathprimer.com/document/63fdbfc5-05a5-4ffc-99dc-cf67f032b417/lesson/3369c90f-d827-430d-a60b-1ab587bdb9f3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hepatocyte injury and inflammation from chronic alcohol consumption"
                  },
                  {
                    "text": "Wide spectrum of diseaseRanges from subclinical to end-stage liver disease",
                    "sub_points": [
                      "Ranges from subclinical to end-stage liver disease"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Variable presentation"
                  },
                  {
                    "text": "Moderately elevated transaminases (AST/ALT ratio > 1.5) in clinical alcoholic hepatitis"
                  },
                  {
                    "text": "Cause of almost 1/2 of cirrhosis-related deaths in USA"
                  },
                  {
                    "text": "Liver biopsy indicationsTo diagnose steatohepatitisExclude another disease etiology",
                    "sub_points": [
                      "To diagnose steatohepatitis",
                      "Exclude another disease etiology"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Combination of hepatocyte injury, inflammation, steatosis, and fibrosisSteatosisHepatocyte ballooningLobular inflammation with neutrophil predominanceMallory-Denk bodiesMegamitochondriaFibrosisBegins zone 3, pericellular \"chicken wire\"",
                    "sub_points": [
                      "Steatosis",
                      "Hepatocyte ballooning",
                      "Lobular inflammation with neutrophil predominance",
                      "Mallory-Denk bodies",
                      "Megamitochondria",
                      "FibrosisBegins zone 3, pericellular \"chicken wire\"",
                      "Begins zone 3, pericellular \"chicken wire\""
                    ]
                  },
                  {
                    "text": "Cholestatic features may be seen"
                  },
                  {
                    "text": "Iron deposition in hepatocytes and Kupffer cells is common"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Nonalcoholic steatohepatitis (NASH)Histology of ALD and NASH virtually identicalFavor ALD when satellitosis, sclerosing hyaline necrosis, prominent cholestatic features are present",
                    "sub_points": [
                      "Histology of ALD and NASH virtually identical",
                      "Favor ALD when satellitosis, sclerosing hyaline necrosis, prominent cholestatic features are present"
                    ]
                  },
                  {
                    "text": "Chronic hepatitis CMany patients have both ALD and hepatitis C infection",
                    "sub_points": [
                      "Many patients have both ALD and hepatitis C infection"
                    ]
                  },
                  {
                    "text": "Amiodarone toxicityHistory of arrhythmia, medication use",
                    "sub_points": [
                      "History of arrhythmia, medication use"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Alcoholic liver disease (ALD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "ALDWide spectrum of clinical and pathologic diseaseRanges from mild/subclinical to end-stage cirrhosis and death",
                    "sub_points": [
                      "Wide spectrum of clinical and pathologic diseaseRanges from mild/subclinical to end-stage cirrhosis and death",
                      "Ranges from mild/subclinical to end-stage cirrhosis and death"
                    ]
                  },
                  {
                    "text": "Alcoholic steatohepatitisHepatocyte injury and inflammation from chronic alcohol consumption",
                    "sub_points": [
                      "Hepatocyte injury and inflammation from chronic alcohol consumption"
                    ]
                  },
                  {
                    "text": "Alcohol use disorder> 3 drinks/day for male> 2 drinks/day for female",
                    "sub_points": [
                      "> 3 drinks/day for male",
                      "> 2 drinks/day for female"
                    ]
                  },
                  {
                    "text": "Binge drink> 5 drinks for male, > 4 drinks for female, consumed over 2-hour period",
                    "sub_points": [
                      "> 5 drinks for male, > 4 drinks for female, consumed over 2-hour period"
                    ]
                  },
                  {
                    "text": "1 drink = 14 g alcohol = 12-oz beer (5%/volume) = 5-oz wine (8%/volume) = 1.5-oz hard liquor (45%/volume)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Alcohol Consumption": [
                  {
                    "text": "Alcohol is direct hepatotoxin"
                  },
                  {
                    "text": "Both genetic and environmental factors determine susceptibility to liver injury"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Cause of almost 1/2 of cirrhosis-related deaths in USA"
                  },
                  {
                    "text": "~ 20-40% of chronic alcoholics who undergo biopsy have histologic evidence of ALD"
                  },
                  {
                    "text": "~ 50% of \"early\" compensated ALD may already have advanced fibrosis or cirrhosis on biopsy by time of presentation"
                  }
                ],
                "Presentation": [
                  {
                    "text": "VariableAnorexia, nausea, vomiting, abdominal pain/tenderness, hepatomegalyMay present with jaundice",
                    "sub_points": [
                      "Anorexia, nausea, vomiting, abdominal pain/tenderness, hepatomegaly",
                      "May present with jaundice"
                    ]
                  },
                  {
                    "text": "Some patients are asymptomatic"
                  },
                  {
                    "text": "End-stage patients may have encephalopathy, ascites, coagulopathy, varices"
                  },
                  {
                    "text": "Liver biopsy indicationsTo diagnose steatohepatitisExclude another disease etiologyIf there is uncertainty regarding patient's history of alcohol consumption",
                    "sub_points": [
                      "To diagnose steatohepatitis",
                      "Exclude another disease etiology",
                      "If there is uncertainty regarding patient's history of alcohol consumption"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Moderately elevated transaminases (AST/ALT ratio > 1.5) in clinical alcoholic hepatitis"
                  },
                  {
                    "text": "Variably elevated alkaline phosphatase, bilirubin > 3 mg/dL"
                  },
                  {
                    "text": "Hypoalbuminemia, prolonged PTT in end-stage disease"
                  },
                  {
                    "text": "Steatohepatitis can only be diagnosed by biopsy"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Long-term abstinence to prevent progression60% transplant-free 5-year survival in decompensated ALD patients if abstinent30% transplant-free 5-year survival in nonabstinent, decompensated ALD patients",
                    "sub_points": [
                      "60% transplant-free 5-year survival in decompensated ALD patients if abstinent",
                      "30% transplant-free 5-year survival in nonabstinent, decompensated ALD patients"
                    ]
                  },
                  {
                    "text": "Liver transplant"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Widely variable course of disease"
                  },
                  {
                    "text": "Fibrosis stage is prognostic determinant of survival in early/compensated ALD patients"
                  },
                  {
                    "text": "Pericellular fibrosis, sex, bilirubin, INR level associated with mortality in decompensated ALD patients"
                  },
                  {
                    "text": "Histologic scoring index predicting 90-day mortality exists, but interobserver agreement may need further assessment before use"
                  },
                  {
                    "text": "Risk of hepatocellular is 5-15% once cirrhosis present"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Classically micronodular cirrhosis"
                  },
                  {
                    "text": "After abstinence, micronodules coalesce to macronodules"
                  },
                  {
                    "text": "Native livers at time of explant may show mixed micro- and macronodular cirrhosis or macronodular only"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Combination of hepatocyte injury, inflammation, steatosis, and fibrosis"
                  },
                  {
                    "text": "SteatosisAlmost always present but can be absent depending on timing of biopsy and abstinenceSimple steatosis present in 90% of heavy drinkersWithin 2 weeks of heavy, steady drinkingQuickly disappears after abstinenceSmall lipogranulomas may be seen in portal tracts and parenchyma after steatosis resolvesMay not be seen in explant due to abstinenceUsually macrovesicular, can be mixed with microvesicular, or rarely pure microvesicular (foamy degeneration)Often begins in zone 3Hepatocyte ballooning degenerationEnlarged, swollen hepatocyte with pale, wispy cytoplasm",
                    "sub_points": [
                      "Almost always present but can be absent depending on timing of biopsy and abstinenceSimple steatosis present in 90% of heavy drinkersWithin 2 weeks of heavy, steady drinkingQuickly disappears after abstinenceSmall lipogranulomas may be seen in portal tracts and parenchyma after steatosis resolvesMay not be seen in explant due to abstinence",
                      "Simple steatosis present in 90% of heavy drinkers",
                      "Within 2 weeks of heavy, steady drinking",
                      "Quickly disappears after abstinenceSmall lipogranulomas may be seen in portal tracts and parenchyma after steatosis resolves",
                      "Small lipogranulomas may be seen in portal tracts and parenchyma after steatosis resolves",
                      "May not be seen in explant due to abstinence",
                      "Usually macrovesicular, can be mixed with microvesicular, or rarely pure microvesicular (foamy degeneration)",
                      "Often begins in zone 3Hepatocyte ballooning degenerationEnlarged, swollen hepatocyte with pale, wispy cytoplasm",
                      "Hepatocyte ballooning degenerationEnlarged, swollen hepatocyte with pale, wispy cytoplasm",
                      "Enlarged, swollen hepatocyte with pale, wispy cytoplasm"
                    ]
                  },
                  {
                    "text": "Alcoholic steatohepatitisInflammation, damage, fibrosis in addition to steatosisDevelops in 1/3 of patients with steatosis, if they continue to drink20-40% develop fibrosis, 8-20% develop cirrhosisIndividual hepatocyte necrosisShrunken hepatocyte, pyknotic nucleus, eosinophilic cytoplasmMallory-Denk bodiesDiscrete, intracytoplasmic aggregates of ropey eosinophilic materialAlmost always within ballooned hepatocyteNot always present in or specific for ALDInflammationLobular inflammation usually > portal inflammationNeutrophils are principal inflammatory cellEncircle Mallory-Denk body-bearing cells (satellitosis)FibrosisPericellular/perisinusoidal fibrosis: Chicken-wire pattern of fibrosis that surrounds hepatocytesPerivenular fibrosis around central veinsEventual progression to bridging fibrosis and cirrhosisGlycogenated nucleiCholestasis and cholangiolitis may be seenIron deposition frequent, especially in cirrhosis",
                    "sub_points": [
                      "Inflammation, damage, fibrosis in addition to steatosis",
                      "Develops in 1/3 of patients with steatosis, if they continue to drink",
                      "20-40% develop fibrosis, 8-20% develop cirrhosisIndividual hepatocyte necrosisShrunken hepatocyte, pyknotic nucleus, eosinophilic cytoplasmMallory-Denk bodiesDiscrete, intracytoplasmic aggregates of ropey eosinophilic materialAlmost always within ballooned hepatocyteNot always present in or specific for ALDInflammationLobular inflammation usually > portal inflammationNeutrophils are principal inflammatory cellEncircle Mallory-Denk body-bearing cells (satellitosis)FibrosisPericellular/perisinusoidal fibrosis: Chicken-wire pattern of fibrosis that surrounds hepatocytesPerivenular fibrosis around central veinsEventual progression to bridging fibrosis and cirrhosisGlycogenated nucleiCholestasis and cholangiolitis may be seenIron deposition frequent, especially in cirrhosis",
                      "Individual hepatocyte necrosisShrunken hepatocyte, pyknotic nucleus, eosinophilic cytoplasm",
                      "Shrunken hepatocyte, pyknotic nucleus, eosinophilic cytoplasm",
                      "Mallory-Denk bodiesDiscrete, intracytoplasmic aggregates of ropey eosinophilic materialAlmost always within ballooned hepatocyteNot always present in or specific for ALD",
                      "Discrete, intracytoplasmic aggregates of ropey eosinophilic material",
                      "Almost always within ballooned hepatocyte",
                      "Not always present in or specific for ALD",
                      "InflammationLobular inflammation usually > portal inflammationNeutrophils are principal inflammatory cellEncircle Mallory-Denk body-bearing cells (satellitosis)",
                      "Lobular inflammation usually > portal inflammation",
                      "Neutrophils are principal inflammatory cell",
                      "Encircle Mallory-Denk body-bearing cells (satellitosis)",
                      "FibrosisPericellular/perisinusoidal fibrosis: Chicken-wire pattern of fibrosis that surrounds hepatocytesPerivenular fibrosis around central veinsEventual progression to bridging fibrosis and cirrhosis",
                      "Pericellular/perisinusoidal fibrosis: Chicken-wire pattern of fibrosis that surrounds hepatocytes",
                      "Perivenular fibrosis around central veins",
                      "Eventual progression to bridging fibrosis and cirrhosis",
                      "Glycogenated nuclei",
                      "Cholestasis and cholangiolitis may be seen",
                      "Iron deposition frequent, especially in cirrhosis"
                    ]
                  },
                  {
                    "text": "Sclerosing hyaline necrosisSevere form of alcoholic steatohepatitisHepatocytic necrosis, dense perivenular/perisinusoidal fibrosisObliterative fibrosis of terminal hepatic venuleMay be associated with noncirrhotic portal hypertension",
                    "sub_points": [
                      "Severe form of alcoholic steatohepatitis",
                      "Hepatocytic necrosis, dense perivenular/perisinusoidal fibrosis",
                      "Obliterative fibrosis of terminal hepatic venule",
                      "May be associated with noncirrhotic portal hypertension"
                    ]
                  },
                  {
                    "text": "Cholestatic ALDFeatures mimicking large bile duct obstruction both histologically and clinicallyRecognition of this known phenomenon of cholestatic ALD can spare patient of high-risk procedureLarge bile duct obstruction features + steatohepatitis",
                    "sub_points": [
                      "Features mimicking large bile duct obstruction both histologically and clinically",
                      "Recognition of this known phenomenon of cholestatic ALD can spare patient of high-risk procedure",
                      "Large bile duct obstruction features + steatohepatitis"
                    ]
                  },
                  {
                    "text": "Megamitochondria"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Nonalcoholic Steatohepatitis": [
                  {
                    "text": "Metabolic syndrome, such as diabetes, obesity, hyperlipidemiaNo history of alcohol use",
                    "sub_points": [
                      "No history of alcohol use"
                    ]
                  },
                  {
                    "text": "Also has macrovesicular, microvesicular steatosis, Mallory-Denk bodies, ballooned hepatocytes, pericellular fibrosis"
                  },
                  {
                    "text": "Cholestatic features, sclerosing hyaline necrosis, lymphocytic phlebitis uncommon"
                  },
                  {
                    "text": "Glycogenated nuclei uncommon in ALD"
                  }
                ],
                "Chronic Hepatitis C": [
                  {
                    "text": "Both ALD and hepatitis C virus (HCV) show steatosis, but distribution is more random rather than zonal in HCV"
                  },
                  {
                    "text": "HCV usually has dense portal inflammation, fewer neutrophils"
                  },
                  {
                    "text": "ALD has at most mild portal inflammation in comparison"
                  },
                  {
                    "text": "ALD and chronic HCV may coexist in many patients"
                  }
                ],
                "Drug Toxicity": [
                  {
                    "text": "History of drug use temporally corresponding to onset of disease"
                  },
                  {
                    "text": "Eosinophils may be prominent"
                  },
                  {
                    "text": "Amiodarone in particular may closely mimic ALDCan also have Mallory-Denk bodies in pericentral distribution, steatohepatitisHistory of cardiac arrhythmia, medication use",
                    "sub_points": [
                      "Can also have Mallory-Denk bodies in pericentral distribution, steatohepatitis",
                      "History of cardiac arrhythmia, medication use"
                    ]
                  }
                ],
                "Biliary Obstruction": [
                  {
                    "text": "Bile ductular reaction with associated neutrophilic infiltrate is common"
                  },
                  {
                    "text": "Mallory-Denk bodies in periportal distribution in chronic cholestatic conditions"
                  },
                  {
                    "text": "Abnormal ERCP or image studies"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Macrovesicular steatosis, zone 3"
                  },
                  {
                    "text": "Ballooned hepatocytes with Mallory-Denk bodies"
                  },
                  {
                    "text": "Satellitosis"
                  },
                  {
                    "text": "Perivenular sinusoidal fibrosis"
                  },
                  {
                    "text": "Micronodular cirrhosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Nonalcoholic Steatohepatitis": {
            "name": "Nonalcoholic Steatohepatitis",
            "url": "https://app.pathprimer.com/document/f155e01b-a0a8-44ad-8e37-b62922e5b2bf/lesson/3369c90f-d827-430d-a60b-1ab587bdb9f3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Steatosis, inflammation, and liver cell injury in absence of history of alcohol use"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Abnormal accumulation of lipids in hepatocytes provides source of oxidative stress and leads to injury/inflammation"
                  },
                  {
                    "text": "Associated conditions: Metabolic syndrome, drugs, malabsorption, malnutrition, genetic variants inPNPLA3andTM6SF2"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Metabolic syndrome, including central obesity, type 2 diabetes, dyslipidemia, hypertension"
                  },
                  {
                    "text": "Laboratory tests: Elevated transaminases"
                  },
                  {
                    "text": "Imaging: Transient elastography, MR elastography"
                  },
                  {
                    "text": "Mainstay of treatment: Management of metabolic conditions"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Steatosis, predominantly macrovesicular"
                  },
                  {
                    "text": "Lobular inflammation (lymphocytes and Kupffer cells predominate)"
                  },
                  {
                    "text": "Ballooned hepatocytesBoth steatosis and ballooning are most prominent in zone 3",
                    "sub_points": [
                      "Both steatosis and ballooning are most prominent in zone 3"
                    ]
                  },
                  {
                    "text": "Mallory-Denk bodies, megamitochondria, glycogenated nuclei"
                  },
                  {
                    "text": "Fibrosis begins as zone 3 perivenular/pericellular (chicken-wire) fibrosis (with exception of pediatric patients); may progress to bridging fibrosis, cirrhosis"
                  },
                  {
                    "text": "If portal inflammation is accentuated, think of advanced disease or concomitant chronic liver disease"
                  },
                  {
                    "text": "Nonalcoholic steatohepatitis in pediatric population may have different injury pattern (type 2)Inflammation, fibrosis accentuated in portal regionBallooning degeneration and perisinusoidal fibrosis may not be seen",
                    "sub_points": [
                      "Inflammation, fibrosis accentuated in portal region",
                      "Ballooning degeneration and perisinusoidal fibrosis may not be seen"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Nonalcoholic fatty liver disease (NAFLD)Metabolic-associated fatty liver disease (MAFLD) nomenclature currently being considered",
                    "sub_points": [
                      "Metabolic-associated fatty liver disease (MAFLD) nomenclature currently being considered"
                    ]
                  },
                  {
                    "text": "Nonalcoholic steatohepatitis (NASH)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Steatosis, inflammation, and ballooned hepatocytes in absence of history of alcohol use"
                  },
                  {
                    "text": "Lean NASH: \"Metabolically unhealthy, lean\" phenotype resulting in NAFLD and NASH in patients without high BMI"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanism": [
                  {
                    "text": "Hepatic accumulation of lipids provides source of oxidative stress and leads to injury/inflammation"
                  },
                  {
                    "text": "Subsequent activation of TGF-β and hepatic stellate cells results in fibrosis"
                  },
                  {
                    "text": "Bile acid signaling, metabolism, and homeostasis are disrupted in NAFLDHas implications on NASH treatment (targeting farnesoid X receptor-fibroblast growth factor 19 axis or bile acid conjugates)",
                    "sub_points": [
                      "Has implications on NASH treatment (targeting farnesoid X receptor-fibroblast growth factor 19 axis or bile acid conjugates)"
                    ]
                  }
                ],
                "Associated Conditions": [
                  {
                    "text": "Metabolic syndrome, drugs, malabsorption, malnutrition"
                  },
                  {
                    "text": "Genetic variants in patatin-like phospholipase domain containing 3 (PNPLA3), transmembrane 6-superfamily member 2 (TM6SF2)Cause increased lipid accumulation in liver",
                    "sub_points": [
                      "Cause increased lipid accumulation in liver"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Metabolic syndrome, including central obesity, type 2 diabetes, dyslipidemia, hypertension"
                  },
                  {
                    "text": "Infrequently, NASH can present as subacute, severe illness with new-onset jaundice with progression to liver failureReported in patients with uncontrolled metabolic syndrome or rapid, sudden weight loss",
                    "sub_points": [
                      "Reported in patients with uncontrolled metabolic syndrome or rapid, sudden weight loss"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated transaminases"
                  },
                  {
                    "text": "Serum biomarkers to triage patients suspected of having NAFLD into low risk vs. intermediate or high risk for having advanced fibrosisFIB-4 or NAFLD fibrosis score (NFS)",
                    "sub_points": [
                      "FIB-4 or NAFLD fibrosis score (NFS)"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Management of associated metabolic syndrome; dietary modification, weight reduction"
                  },
                  {
                    "text": "Insulin sensitizers, such as pioglitazone, vitamin E (for nondiabetics), option of bariatric surgery"
                  },
                  {
                    "text": "Several drugs also undergoing investigationREGENERATE trial based on obeticholic acid (selective farnesoid X receptor agonist)Farnesoid X receptor pathway, when activated, converts cholesterol into bile acids, glucose into storage, decreases storage of fatFibrosis improved in up to 23% with treatment but causes pruritus, and patients require statin",
                    "sub_points": [
                      "REGENERATE trial based on obeticholic acid (selective farnesoid X receptor agonist)Farnesoid X receptor pathway, when activated, converts cholesterol into bile acids, glucose into storage, decreases storage of fatFibrosis improved in up to 23% with treatment but causes pruritus, and patients require statin",
                      "Farnesoid X receptor pathway, when activated, converts cholesterol into bile acids, glucose into storage, decreases storage of fat",
                      "Fibrosis improved in up to 23% with treatment but causes pruritus, and patients require statin"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "May progress to fibrosis, cirrhosis, and hepatocellular carcinoma"
                  },
                  {
                    "text": "Fibrosis is major driver of patient outcome"
                  },
                  {
                    "text": "Models employing imaging findings and laboratory studies (i.e., FAST score) found to be predictive of patients at highest risk for disease progression"
                  }
                ]
              },
              "IMAGING": {
                "Transient Elastography": [
                  {
                    "text": "Patients suspected of having advanced fibrosis by laboratory values (FIB-4 or NFS) recommended to get liver stiffness measurement (surrogate marker of fibrosis)Those considered intermediate or high risk for advanced fibrosis based on transient elastography should be considered for biopsyConfounders that can falsely raise suspicion for fibrosis include cholestasis, ALT > 100, and congestionFalsely elevate liver stiffness measurementCan be operator dependent; variable probe placement on patient body can cause discrepanciesObesity can cause false measurement",
                    "sub_points": [
                      "Those considered intermediate or high risk for advanced fibrosis based on transient elastography should be considered for biopsy",
                      "Confounders that can falsely raise suspicion for fibrosis include cholestasis, ALT > 100, and congestionFalsely elevate liver stiffness measurement",
                      "Falsely elevate liver stiffness measurement",
                      "Can be operator dependent; variable probe placement on patient body can cause discrepancies",
                      "Obesity can cause false measurement"
                    ]
                  }
                ],
                "MR Elastography": [
                  {
                    "text": "Requires radiologist trained in technique"
                  },
                  {
                    "text": "High diagnostic accuracy for advanced fibrosis"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Steatosis, predominantly macrovesicular"
                  },
                  {
                    "text": "Lobular inflammation (lymphocytes and Kupffer cells predominate)"
                  },
                  {
                    "text": "Liver cell injury: Ballooning of hepatocytes, apoptotic bodiesCriteria for ballooning: 1.5-2.0x size of normal hepatocyte, clear cytoplasm, clumped aggregates of cytoplasmic elements into eosinophilic aggregates",
                    "sub_points": [
                      "Criteria for ballooning: 1.5-2.0x size of normal hepatocyte, clear cytoplasm, clumped aggregates of cytoplasmic elements into eosinophilic aggregates"
                    ]
                  },
                  {
                    "text": "Both fat and ballooning are most prominent in zone 3"
                  },
                  {
                    "text": "Mallory-Denk bodies, megamitochondria, glycogenated nuclei"
                  },
                  {
                    "text": "FibrosisTypically begins as zone 3 pericentral (chicken-wire) fibrosisMay progress to bridging, cirrhosis",
                    "sub_points": [
                      "Typically begins as zone 3 pericentral (chicken-wire) fibrosis",
                      "May progress to bridging, cirrhosis"
                    ]
                  },
                  {
                    "text": "If portal inflammation is accentuated, think of advanced disease or concomitant chronic liver disease"
                  },
                  {
                    "text": "Steatohepatitis without typical features(1) Steatosis + pericentral fibrosis but no ballooned hepatocytesIn absence of other causes of centrizonal fibrosis, this can be diagnosed as steatohepatitis(2) Ballooned hepatocytes ± fibrosisThis may also be seen in alcohol-induced liver disease, when alcohol has not been consumed for several weeks(3) In end-stage cirrhosis, active lesions of NASH may be challenging to findRely on previous biopsy findings of NASH as evidence of disease and report \"burned-out NASH\"Residual ballooned hepatocytes and steatosis can often still be seen even in cryptogenic cirrhosis caused by NASHEnough to suggest NASH in appropriate clinical setting",
                    "sub_points": [
                      "(1) Steatosis + pericentral fibrosis but no ballooned hepatocytesIn absence of other causes of centrizonal fibrosis, this can be diagnosed as steatohepatitis",
                      "In absence of other causes of centrizonal fibrosis, this can be diagnosed as steatohepatitis",
                      "(2) Ballooned hepatocytes ± fibrosisThis may also be seen in alcohol-induced liver disease, when alcohol has not been consumed for several weeks",
                      "This may also be seen in alcohol-induced liver disease, when alcohol has not been consumed for several weeks",
                      "(3) In end-stage cirrhosis, active lesions of NASH may be challenging to findRely on previous biopsy findings of NASH as evidence of disease and report \"burned-out NASH\"Residual ballooned hepatocytes and steatosis can often still be seen even in cryptogenic cirrhosis caused by NASHEnough to suggest NASH in appropriate clinical setting",
                      "Rely on previous biopsy findings of NASH as evidence of disease and report \"burned-out NASH\"",
                      "Residual ballooned hepatocytes and steatosis can often still be seen even in cryptogenic cirrhosis caused by NASHEnough to suggest NASH in appropriate clinical setting",
                      "Enough to suggest NASH in appropriate clinical setting"
                    ]
                  },
                  {
                    "text": "In subacute liver failure presentation (rare)Cirrhotic liver with severe steatohepatitis: Marked neutrophilic inflammation in parenchyma, ballooned hepatocytes, Mallory-Denk bodies, macro- and microvesicular steatosis",
                    "sub_points": [
                      "Cirrhotic liver with severe steatohepatitis: Marked neutrophilic inflammation in parenchyma, ballooned hepatocytes, Mallory-Denk bodies, macro- and microvesicular steatosis"
                    ]
                  }
                ],
                "Variants": [
                  {
                    "text": "Pediatric patients: May have \"type 2\" featuresInflammation and fibrosis accentuated in portal (not centrilobular) regionBallooning and pericentral fibrosis typically much less obvious",
                    "sub_points": [
                      "Inflammation and fibrosis accentuated in portal (not centrilobular) region",
                      "Ballooning and pericentral fibrosis typically much less obvious"
                    ]
                  }
                ],
                "Grading and Staging": [
                  {
                    "text": "NAFLD activity and fibrosis scoring from NASH Clinical Research Network"
                  },
                  {
                    "text": "Brunt system: Semiquantitative, based on steatosis, ballooned hepatocytes, and inflammationGrade 1 = mild steatohepatitis(A) Up to 66% steatosis(B) Minimal ballooning(C) Lobular inflammation 1-2, no or mild portal inflammationGrade 2 = moderate steatohepatitis(A) Steatosis > 33%, may be > 66%(B) Ballooned hepatocytes present(C) Lobular inflammation 2; portal inflammation 1-2Grade 3 = severe steatohepatitis(A) Steatosis > 33%, may be > 66%(B) Marked presence of ballooned hepatocytes(C) Lobular inflammation 3; portal inflammation 1-2Lobular (0-3)0: None1: < 2 foci/20x field2: 2-4 foci/20x field3: > 4/20x fieldPortal (0-3)0: None1: Mild2: Moderate3: Marked",
                    "sub_points": [
                      "Grade 1 = mild steatohepatitis(A) Up to 66% steatosis(B) Minimal ballooning(C) Lobular inflammation 1-2, no or mild portal inflammation",
                      "(A) Up to 66% steatosis",
                      "(B) Minimal ballooning",
                      "(C) Lobular inflammation 1-2, no or mild portal inflammation",
                      "Grade 2 = moderate steatohepatitis(A) Steatosis > 33%, may be > 66%(B) Ballooned hepatocytes present(C) Lobular inflammation 2; portal inflammation 1-2",
                      "(A) Steatosis > 33%, may be > 66%",
                      "(B) Ballooned hepatocytes present",
                      "(C) Lobular inflammation 2; portal inflammation 1-2",
                      "Grade 3 = severe steatohepatitis(A) Steatosis > 33%, may be > 66%(B) Marked presence of ballooned hepatocytes(C) Lobular inflammation 3; portal inflammation 1-2Lobular (0-3)0: None1: < 2 foci/20x field2: 2-4 foci/20x field3: > 4/20x fieldPortal (0-3)0: None1: Mild2: Moderate3: Marked",
                      "(A) Steatosis > 33%, may be > 66%",
                      "(B) Marked presence of ballooned hepatocytes",
                      "(C) Lobular inflammation 3; portal inflammation 1-2",
                      "Lobular (0-3)0: None1: < 2 foci/20x field2: 2-4 foci/20x field3: > 4/20x field",
                      "0: None",
                      "1: < 2 foci/20x field",
                      "2: 2-4 foci/20x field",
                      "3: > 4/20x field",
                      "Portal (0-3)0: None1: Mild2: Moderate3: Marked",
                      "0: None",
                      "1: Mild",
                      "2: Moderate",
                      "3: Marked"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Steatosis (Without Specific Liver Injury)": [
                  {
                    "text": "Lack of ballooned hepatocytes and fibrosis"
                  }
                ],
                "Alcoholic Hepatitis": [
                  {
                    "text": "Almost impossible to distinguish histologically; clinical history critical"
                  },
                  {
                    "text": "More abundant Mallory-Denk bodies, neutrophilic aggregates in lobules"
                  },
                  {
                    "text": "May have cholestasis in severe cases, broad centrizonal scars (central hyaline sclerosis), often with obliteration of central vein"
                  }
                ],
                "Chronic Hepatitis C": [
                  {
                    "text": "HCV(+) antibody and RNA"
                  },
                  {
                    "text": "Portal-based inflammation and fibrosis; steatosis generally nonzonal"
                  }
                ],
                "Glycogenic Hepatopathy": [
                  {
                    "text": "Swollen hepatocytes may mimic ballooned hepatocytes"
                  }
                ],
                "Microvesicular Steatosis": [
                  {
                    "text": "May mimic ballooning; nuclei centrally located"
                  }
                ],
                "Wilson Disease": [
                  {
                    "text": "Steatosis; ballooning may be seen"
                  },
                  {
                    "text": "Copper accumulation demonstrated by quantitative analysis"
                  },
                  {
                    "text": "Screening test (serum ceruloplasmin, 24-hour urinary copper assessment)"
                  },
                  {
                    "text": "Treatment differs from NASH: Copper-chelating agents, zinc acetate"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Amiodarone, irinotecan, and other drugs can cause steatohepatitis-like disease"
                  },
                  {
                    "text": "Tamoxifen, methotrexate exacerbate steatohepatitis"
                  },
                  {
                    "text": "Medication list, clinical information of patient's risk factors and history"
                  }
                ],
                "Gut-Related Issues": [
                  {
                    "text": "Malnutrition, malabsorption, small intestinal bacterial overgrowth, increased intestinal permeability, gut microbiome changes can predispose to steatosis"
                  },
                  {
                    "text": "Steatosis due to small intestine failure (history of radiation enteritis, short bowel syndrome, refractory sprue) can progress in fibrosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Glycogenic Hepatopathy": {
            "name": "Glycogenic Hepatopathy",
            "url": "https://app.pathprimer.com/document/c72ee9ff-a520-45b4-ac06-3564d2cff99d/lesson/3369c90f-d827-430d-a60b-1ab587bdb9f3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Hepatomegaly and elevated liver enzymes associated with poorly controlled diabetes mellitus and abundant glycogen in hepatocytes"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Chronic hyperglycemia due to poorly controlled insulin-dependent diabetes mellitus"
                  },
                  {
                    "text": "Longstanding high blood sugar levels lead to glycogen accumulation in hepatocytes"
                  },
                  {
                    "text": "Hepatomegaly and transaminase elevations attributed to this excess glycogen accumulation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Elevated transaminases"
                  },
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Occurs in patients with history of poorly controlled insulin-dependent diabetes mellitus"
                  },
                  {
                    "text": "Liver histology improves and transaminases normalize with optimization of glycemic control"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse, pale-staining hepatocytes"
                  },
                  {
                    "text": "Excessive glycogen storage in hepatocytes demonstrated by PAS stain"
                  },
                  {
                    "text": "Absence of inflammation or evidence of other liver disease"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal liverPale, enlarged hepatocytes may be mistaken for normal or interpreted as fixation artifact",
                    "sub_points": [
                      "Pale, enlarged hepatocytes may be mistaken for normal or interpreted as fixation artifact"
                    ]
                  },
                  {
                    "text": "Microvesicular steatosisLipid droplets very small and do not displace nucleusPAS shows decreased staining",
                    "sub_points": [
                      "Lipid droplets very small and do not displace nucleus",
                      "PAS shows decreased staining"
                    ]
                  },
                  {
                    "text": "Fatty liver diseasePale, enlarged hepatocytes may be misinterpreted as ballooning hepatocyte degenerationGlycogenic hepatopathy has distinctly abnormal, diffuse involvement by swollen hepatocytesPAS shows decreased staining",
                    "sub_points": [
                      "Pale, enlarged hepatocytes may be misinterpreted as ballooning hepatocyte degeneration",
                      "Glycogenic hepatopathy has distinctly abnormal, diffuse involvement by swollen hepatocytes",
                      "PAS shows decreased staining"
                    ]
                  },
                  {
                    "text": "Glycogen storage diseaseNo history of diabetes mellitus",
                    "sub_points": [
                      "No history of diabetes mellitus"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Hepatic glycogenosis"
                  },
                  {
                    "text": "Liver glycogenosis"
                  },
                  {
                    "text": "Glycogen hepatopathy"
                  },
                  {
                    "text": "Diabetes mellitus-associated glycogen storage hepatomegaly"
                  },
                  {
                    "text": "Mauriac syndromeLiver changes classically accompanied by growth retardation, delayed puberty, hypercholesterolemia, and cushingoid features",
                    "sub_points": [
                      "Liver changes classically accompanied by growth retardation, delayed puberty, hypercholesterolemia, and cushingoid features"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Excessive glycogen storage in hepatocytes secondary to poorly controlled insulin-dependent diabetes mellitus"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Metabolic Factors": [
                  {
                    "text": "Chronic hyperglycemia due to poorly controlled insulin-dependent diabetes mellitus"
                  },
                  {
                    "text": "Longstanding high blood sugar levels lead to glycogen accumulation in hepatocytes"
                  },
                  {
                    "text": "Hepatomegaly and transaminase elevations due to excess glycogen accumulation"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Occurs in both children and adults"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Nausea, vomiting"
                  },
                  {
                    "text": "History of ketoacidosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Hyperglycemia"
                  },
                  {
                    "text": "Elevated transaminases"
                  },
                  {
                    "text": "Alkaline phosphatase may also be elevated"
                  },
                  {
                    "text": "Elevated hemoglobin A1c (HbA1c) indicates history of poor glycemic control"
                  }
                ],
                "Treatment": [],
                "Options, risks, complications": [
                  {
                    "text": "Mainstay treatment is improved management of diabetes mellitusOptimization of glycemic control with insulin and diet",
                    "sub_points": [
                      "Optimization of glycemic control with insulin and diet"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Resolution after pancreas transplantation has been reported"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent outcome with medical management"
                  },
                  {
                    "text": "Liver histology improves and transaminases normalize with optimization of glycemic control"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Hyperdense liver on CT scan without administration of contrast material"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Hepatomegaly"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diffuse hepatocyte swelling due to glycogen, pale-staining cytoplasm"
                  },
                  {
                    "text": "Nuclei still centrally placed, glycogenated hepatocyte nuclei"
                  },
                  {
                    "text": "PAS stain confirms excessive glycogen accumulation in hepatocytes"
                  },
                  {
                    "text": "Rare acidophil bodies may be seen"
                  },
                  {
                    "text": "Notable absence of inflammation or other features of hepatic injury"
                  },
                  {
                    "text": "Fibrosis is rare"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "Marked glycogen accumulation in hepatocyte cytoplasm and nuclei"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Liver": [
                  {
                    "text": "Pale, enlarged hepatocytes may be mistaken for normal or interpreted as fixation artifact"
                  }
                ],
                "Microvesicular Steatosis": [
                  {
                    "text": "Lipid droplets very small and do not displace nucleus"
                  },
                  {
                    "text": "Usually in very ill patients with underlying disorder of mitochondrial fatty β-oxidation"
                  },
                  {
                    "text": "Drug induced: Valproic acid, salicylates, IV tetracycline, HIV therapy: Nucleoside reverse transcriptase inhibitors (e.g., zidovudine, stavudine didanosine, fialuridine"
                  },
                  {
                    "text": "PAS shows decreased staining"
                  }
                ],
                "Fatty Liver Disease": [
                  {
                    "text": "Pale, enlarged hepatocytes may be misinterpreted as ballooning hepatocyte degeneration"
                  },
                  {
                    "text": "Most cases of glycogenic hepatopathy show little or no steatosis"
                  }
                ],
                "Glycogen Storage Disease": [
                  {
                    "text": "Typically presents at younger age and without history of diabetes mellitus"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Marked transaminase elevation attributed to excessive glycogen accumulation in hepatocytes"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diffuse involvement by swollen hepatocytes with pale cytoplasm, prominent cell membranesMay be mistaken for normal hepatocytes, glycogen storage disease, or fixation artifact",
                    "sub_points": [
                      "May be mistaken for normal hepatocytes, glycogen storage disease, or fixation artifact"
                    ]
                  },
                  {
                    "text": "Consider in patients with poorly controlled diabetes mellitus and unexplained hepatomegaly &/or transaminase elevations"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Fatty Liver of Pregnancy": {
            "name": "Fatty Liver of Pregnancy",
            "url": "https://app.pathprimer.com/document/1b38596b-73a4-472e-8c4e-a26313d4a607/lesson/3369c90f-d827-430d-a60b-1ab587bdb9f3",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute liver failure during 2nd half of pregnancy associated with severe fatty infiltration of liver"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Etiology unknown but associated with mitochondrial fatty acid oxidation defectsSome affected mothers and infants have inherited long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiencyCarnitine palmitoyltransferase I deficiency also associated with fatty liver of pregnancy",
                    "sub_points": [
                      "Some affected mothers and infants have inherited long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency",
                      "Carnitine palmitoyltransferase I deficiency also associated with fatty liver of pregnancy"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most commonly occurs in last 10 weeks and usually in last 4 weeks of pregnancy"
                  },
                  {
                    "text": "Rapidly progressive acute liver failure"
                  },
                  {
                    "text": "Early diagnosis and delivery are criticalCan be fatal for mother and fetus if not diagnosed and treated early",
                    "sub_points": [
                      "Can be fatal for mother and fetus if not diagnosed and treated early"
                    ]
                  },
                  {
                    "text": "TreatmentSupportive care and urgent delivery of infant",
                    "sub_points": [
                      "Supportive care and urgent delivery of infant"
                    ]
                  },
                  {
                    "text": "Early diagnosis and delivery associated with excellent outcome"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Severe microvesicular steatosis, predominantly centrilobular or diffuseMay show small rim of periportal sparing",
                    "sub_points": [
                      "May show small rim of periportal sparing"
                    ]
                  },
                  {
                    "text": "Zone 3 perivenular canalicular cholestasis and hepatocellular cholestasis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acute hepatic failure unrelated to pregnancy"
                  },
                  {
                    "text": "Preeclampsia/eclampsia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Acute fatty liver of pregnancy (AFLP)"
                  },
                  {
                    "text": "Hepatic lipidosis of pregnancy"
                  },
                  {
                    "text": "Sheehan syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Acute liver failure during 2nd half of pregnancy with severe fatty infiltration of liver"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Etiology Unknown": [
                  {
                    "text": "Attributed to mitochondrial fatty acid oxidation defectSome affected mothers and infants have inherited fatty acid oxidation defectsLong-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiencyInfant and parents should be evaluated for LCHAD deficiencyCarnitine palmitoyltransferase I deficiency also associated with fatty liver of pregnancy",
                    "sub_points": [
                      "Some affected mothers and infants have inherited fatty acid oxidation defectsLong-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiencyInfant and parents should be evaluated for LCHAD deficiency",
                      "Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency",
                      "Infant and parents should be evaluated for LCHAD deficiency",
                      "Carnitine palmitoyltransferase I deficiency also associated with fatty liver of pregnancy"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Diagnosed in 1/6,659 deliveries, although subclinical cases also exist"
                  },
                  {
                    "text": "Usually occurs in late 3rd trimester but can be seen in 2nd trimester"
                  },
                  {
                    "text": "More common in women who are primigravidae and have multiple gestations"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Mild prodromal illness"
                  },
                  {
                    "text": "Nausea, vomiting, and abdominal pain"
                  },
                  {
                    "text": "Jaundice, cholestatic"
                  },
                  {
                    "text": "Confusion"
                  },
                  {
                    "text": "Rapidly progressive acute liver failure"
                  },
                  {
                    "text": "May also have hypertension and proteinuria"
                  },
                  {
                    "text": "Acute pancreatitis, renal failure may also occur"
                  },
                  {
                    "text": "Disseminated intravascular coagulation"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Increased prothrombin time"
                  },
                  {
                    "text": "Low serum fibrinogen level"
                  },
                  {
                    "text": "Moderate hyperbilirubinemia and transaminase elevation"
                  },
                  {
                    "text": "Hypoglycemia"
                  },
                  {
                    "text": "Serum lipase and amylase elevated if acute pancreatitis also present"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Does not progress to chronic liver disease"
                  },
                  {
                    "text": "Subsequent pregnancies may be unaffected or complicated by recurrent disease"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Urgent delivery of infant"
                  },
                  {
                    "text": "Supportive therapy"
                  },
                  {
                    "text": "Transplantation in selected cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Can be fatal for mother and fetus if not diagnosed and treated early"
                  },
                  {
                    "text": "Early diagnosis and delivery associated with excellent outcomeUp to 100% maternal survival rateInfant mortality 6-7% or less",
                    "sub_points": [
                      "Up to 100% maternal survival rate",
                      "Infant mortality 6-7% or less"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Ultrasound and CT demonstrate fatty infiltration of liver"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Liver grossly small and pale yellow"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Severe microvesicular steatosis, predominantly centrilobular or diffuseMay show small rim of periportal hepatocyte sparingSmall steatosis vacuoles may require special stains (oil red O or Sudan black) or electron microscopy to demonstrate",
                    "sub_points": [
                      "May show small rim of periportal hepatocyte sparing",
                      "Small steatosis vacuoles may require special stains (oil red O or Sudan black) or electron microscopy to demonstrate"
                    ]
                  },
                  {
                    "text": "Zone 3 perivenular canalicular cholestasis and hepatocellular cholestasis"
                  },
                  {
                    "text": "Hepatocyte injury and Kupffer cell hyperplasia"
                  },
                  {
                    "text": "Mild mononuclear infiltrates of lobules and portal tracts"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acute Hepatic Failure Unrelated to Pregnancy": [
                  {
                    "text": "Acute viral hepatitis (hepatitis E particularly severe)"
                  },
                  {
                    "text": "Drug-induced liver injury"
                  },
                  {
                    "text": "Flares of autoimmune hepatitis may occur in pregnancy"
                  }
                ],
                "Preeclampsia/Eclampsia": [
                  {
                    "text": "Commonly also present in patients with AFLP"
                  },
                  {
                    "text": "Hypertension and proteinuria"
                  },
                  {
                    "text": "Periportal necrosisIn HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, also periportal hemorrhage and fibrin deposition",
                    "sub_points": [
                      "In HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome, also periportal hemorrhage and fibrin deposition"
                    ]
                  },
                  {
                    "text": "Both disorders treated by delivery"
                  }
                ],
                "Intrahepatic Cholestasis of Pregnancy": [
                  {
                    "text": "Associated withMRD3mutation"
                  },
                  {
                    "text": "Marked cholestasis on biopsy, pauciinflammatory"
                  },
                  {
                    "text": "Higher hyperbilirubinemia"
                  }
                ],
                "Large Duct Obstruction": [
                  {
                    "text": "Choledocholithiasis from increased cholesterol and decreased motility"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Microvesicular steatosis in pregnant woman with acute liver failure"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Nonneoplastic Lesions: Vascular Disorders": {
        "name": "Liver Nonneoplastic Lesions: Vascular Disorders",
        "url": "https://app.pathprimer.com/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
        "topics": {
          "Portal Venous Obstruction": {
            "name": "Portal Venous Obstruction",
            "url": "https://app.pathprimer.com/document/1065d52b-0c09-48db-8ac8-abd96ddce2a7/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Can occur at any level of portal venous system"
                  },
                  {
                    "text": "ExtrahepaticPortal vein thrombosisInherited or acquired prothrombotic statesReduced portal flow velocity (stasis)Vascular injuryTumor thrombosisExtrinsic compression by mass or fibrogenic lesionsCongenital vascular anomalies",
                    "sub_points": [
                      "Portal vein thrombosisInherited or acquired prothrombotic statesReduced portal flow velocity (stasis)Vascular injury",
                      "Inherited or acquired prothrombotic states",
                      "Reduced portal flow velocity (stasis)",
                      "Vascular injury",
                      "Tumor thrombosis",
                      "Extrinsic compression by mass or fibrogenic lesions",
                      "Congenital vascular anomalies"
                    ]
                  },
                  {
                    "text": "IntrahepaticPropagation of large portal vein thrombosis or emboliDiseases that affect small portal veinsSpecific etiology may not be identifiable",
                    "sub_points": [
                      "Propagation of large portal vein thrombosis or emboli",
                      "Diseases that affect small portal veins",
                      "Specific etiology may not be identifiable"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Portal vein thrombosis occurs in 1% of population5-10% in patients with portal hypertension, ↑ to 26% in those with cirrhosis< 2% in adult liver transplant recipients, but ↑ to 6% in living related transplants, ↑ to 10% in pediatric recipients",
                    "sub_points": [
                      "5-10% in patients with portal hypertension, ↑ to 26% in those with cirrhosis",
                      "< 2% in adult liver transplant recipients, but ↑ to 6% in living related transplants, ↑ to 10% in pediatric recipients"
                    ]
                  },
                  {
                    "text": "Sequelae depend on location, cause, time course, and extent of blockage"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Often inconsistent or irregularly distributed, may be missed in liver biopsy"
                  },
                  {
                    "text": "Alterations of portal venulesDilated portal venulesNarrowing, obliteration, or muscularization of portal venulesHerniation of portal venules into parenchymaParaportal shunt vessels",
                    "sub_points": [
                      "Dilated portal venules",
                      "Narrowing, obliteration, or muscularization of portal venules",
                      "Herniation of portal venules into parenchyma",
                      "Paraportal shunt vessels"
                    ]
                  },
                  {
                    "text": "Arterial buffer response due to compensatory increase in hepatic artery flowLarge, thick-walled, or dilated, thin-walled, arterioles",
                    "sub_points": [
                      "Large, thick-walled, or dilated, thin-walled, arterioles"
                    ]
                  },
                  {
                    "text": "Infarcts of ZahnZones of hepatocyte atrophy with sinusoidal dilatationPersistent occlusion can lead to atrophy of entire segments of liver (segmental atrophy)True infarcts rarely develop",
                    "sub_points": [
                      "Zones of hepatocyte atrophy with sinusoidal dilatation",
                      "Persistent occlusion can lead to atrophy of entire segments of liver (segmental atrophy)",
                      "True infarcts rarely develop"
                    ]
                  },
                  {
                    "text": "Nodular regenerative hyperplasia may be seen"
                  },
                  {
                    "text": "Ductular reaction due to portal biliopathy"
                  },
                  {
                    "text": "Findings suggestive of underlying etiologies"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatoportal sclerosis"
                  },
                  {
                    "text": "Normal liver"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Idiopathic portal hypertensionMany cases of idiopathic portal hypertension probably represent undetected portal vein thrombosis",
                    "sub_points": [
                      "Many cases of idiopathic portal hypertension probably represent undetected portal vein thrombosis"
                    ]
                  },
                  {
                    "text": "Noncirrhotic portal hypertension"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Mechanical obstruction of portal venous system"
                  },
                  {
                    "text": "ExtrahepaticObstruction of portal vein trunk or its main tributaries",
                    "sub_points": [
                      "Obstruction of portal vein trunk or its main tributaries"
                    ]
                  },
                  {
                    "text": "IntrahepaticObstruction of portal venules within liver",
                    "sub_points": [
                      "Obstruction of portal venules within liver"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Extrahepatic": [
                  {
                    "text": "Portal vein thrombosisInherited or acquired prothrombotic statesInheritedProtein C or S deficiency, antithrombin III deficiency, factor V Leiden, etc.AcquiredMyeloproliferative diseases, oral contraceptive use, pregnancy, antiphospholipid syndrome, etc.Reduced portal flow velocity (stasis)Cirrhosis, venous outflow obstruction, etc.Vascular injuryIntraabdominal procedures or inflammation",
                    "sub_points": [
                      "Inherited or acquired prothrombotic statesInheritedProtein C or S deficiency, antithrombin III deficiency, factor V Leiden, etc.AcquiredMyeloproliferative diseases, oral contraceptive use, pregnancy, antiphospholipid syndrome, etc.",
                      "InheritedProtein C or S deficiency, antithrombin III deficiency, factor V Leiden, etc.",
                      "Protein C or S deficiency, antithrombin III deficiency, factor V Leiden, etc.",
                      "AcquiredMyeloproliferative diseases, oral contraceptive use, pregnancy, antiphospholipid syndrome, etc.",
                      "Myeloproliferative diseases, oral contraceptive use, pregnancy, antiphospholipid syndrome, etc.",
                      "Reduced portal flow velocity (stasis)Cirrhosis, venous outflow obstruction, etc.",
                      "Cirrhosis, venous outflow obstruction, etc.",
                      "Vascular injuryIntraabdominal procedures or inflammation",
                      "Intraabdominal procedures or inflammation"
                    ]
                  },
                  {
                    "text": "Tumor thrombosis"
                  },
                  {
                    "text": "Extrinsic compression by mass or fibrogenic lesions"
                  },
                  {
                    "text": "Congenital vascular anomalies"
                  }
                ],
                "Intrahepatic": [
                  {
                    "text": "Propagation of large portal vein thrombosis or emboli"
                  },
                  {
                    "text": "Diseases that affect small portal veinsSarcoidosis, schistosomiasis, congenital hepatic fibrosis, cirrhosis, vasculotoxic chemicals, etc.",
                    "sub_points": [
                      "Sarcoidosis, schistosomiasis, congenital hepatic fibrosis, cirrhosis, vasculotoxic chemicals, etc."
                    ]
                  },
                  {
                    "text": "Specific etiology may not be identifiable"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Portal vein thrombosis occurs in 1% of population5-10% in patients with portal hypertension, ↑ to 26% in those with cirrhosis< 2% in adult liver transplant recipients, but up to 6% in living related transplants, up to 10% in pediatric recipients",
                    "sub_points": [
                      "5-10% in patients with portal hypertension, ↑ to 26% in those with cirrhosis",
                      "< 2% in adult liver transplant recipients, but up to 6% in living related transplants, up to 10% in pediatric recipients"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Both children and adults can be affected"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Signs/symptoms of portal hypertensionAbdominal pain/tenderness/distention, splenomegaly, varices, ascites",
                    "sub_points": [
                      "Abdominal pain/tenderness/distention, splenomegaly, varices, ascites"
                    ]
                  },
                  {
                    "text": "ComplicationsVariceal bleeding, liver failure, ischemic bowelPortal biliopathy (portal cavernoma cholangiopathy)Extrahepatic biliary obstruction due to either compression by portal cavernoma, distortion by scar, or stricture due to ischemic injury",
                    "sub_points": [
                      "Variceal bleeding, liver failure, ischemic bowel",
                      "Portal biliopathy (portal cavernoma cholangiopathy)Extrahepatic biliary obstruction due to either compression by portal cavernoma, distortion by scar, or stricture due to ischemic injury",
                      "Extrahepatic biliary obstruction due to either compression by portal cavernoma, distortion by scar, or stricture due to ischemic injury"
                    ]
                  },
                  {
                    "text": "May be asymptomaticMay be well tolerated because of liver dual blood supply and development of collaterals",
                    "sub_points": [
                      "May be well tolerated because of liver dual blood supply and development of collaterals"
                    ]
                  },
                  {
                    "text": "Sequelae depend on location, cause, time course, and extent of blockage"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Managing sequelae of portal hypertension"
                  },
                  {
                    "text": "Treating underlying cause of obstruction if possible"
                  },
                  {
                    "text": "Thrombolysis"
                  },
                  {
                    "text": "Thrombectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Determined by underlying cause as well as location, time course, extent of obstruction"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Absence of blood flow in portal vein by Doppler ultrasound"
                  },
                  {
                    "text": "Direct visualization of obstruction by CT, MR, or angiography"
                  },
                  {
                    "text": "Nodular liver contour, segmental atrophy or hypertrophy"
                  },
                  {
                    "text": "Intrahepatic obstruction may not be apparent"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Large Vessel Findings": [
                  {
                    "text": "Fresh, organizing or organized thrombi ± mural calcifications"
                  },
                  {
                    "text": "Cavernous transformation or portal cavernoma (mass formation by recanalized and collateral vessels)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Often inconsistent or irregularly distributed, may be missed in liver biopsyMay show no histopathologic abnormality",
                    "sub_points": [
                      "May show no histopathologic abnormality"
                    ]
                  },
                  {
                    "text": "Alterations of portal venulesDilated portal venulesHerniation of portal venules into parenchymaNarrowing, obliteration, or muscularization of portal venulesParaportal shunt vessels",
                    "sub_points": [
                      "Dilated portal venules",
                      "Herniation of portal venules into parenchyma",
                      "Narrowing, obliteration, or muscularization of portal venules",
                      "Paraportal shunt vessels"
                    ]
                  },
                  {
                    "text": "Arterial buffer response due to compensatory increase in hepatic artery flowLarge, thick-walled, or dilated, thin-walled, arterioles",
                    "sub_points": [
                      "Large, thick-walled, or dilated, thin-walled, arterioles"
                    ]
                  },
                  {
                    "text": "Infarcts of ZahnNot really infarcts but rather zones of hepatocyte atrophy with sinusoidal dilatation and congestionPersistent occlusion can lead to atrophy of entire segments of liver (segmental atrophy)True infarcts rarely develop",
                    "sub_points": [
                      "Not really infarcts but rather zones of hepatocyte atrophy with sinusoidal dilatation and congestion",
                      "Persistent occlusion can lead to atrophy of entire segments of liver (segmental atrophy)",
                      "True infarcts rarely develop"
                    ]
                  },
                  {
                    "text": "Nodular regenerative hyperplasia may be seen"
                  },
                  {
                    "text": "Ductular reaction due to portal biliopathy"
                  },
                  {
                    "text": "Findings suggestive of underlying etiologiesGranulomas,Schistosomaeggs, etc.",
                    "sub_points": [
                      "Granulomas,Schistosomaeggs, etc."
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatoportal Sclerosis": [
                  {
                    "text": "Abnormal hepatic architecture"
                  },
                  {
                    "text": "No extrahepatic portal vein obstruction by imaging"
                  }
                ],
                "Normal Liver": [
                  {
                    "text": "Obliteration of small number of intrahepatic portal venules is normal finding in older adults"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatoportal Sclerosis": {
            "name": "Hepatoportal Sclerosis",
            "url": "https://app.pathprimer.com/document/c7e406be-4f52-47f1-a9b9-dc07494e866b/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Portal hypertension secondary to portal fibrosis and portal vein sclerosis in absence of cirrhosisForm of noncirrhotic portal hypertension",
                    "sub_points": [
                      "Form of noncirrhotic portal hypertension"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Associated with conditions that cause increased vascular resistance at presinusoidal or perisinusoidal levelGenetic predispositionChronic exposure to toxins and medicationsProthrombotic statesImmunologic disordersChronic antibody-mediated rejection in liver transplantsMany cases idiopathic",
                    "sub_points": [
                      "Genetic predisposition",
                      "Chronic exposure to toxins and medications",
                      "Prothrombotic states",
                      "Immunologic disorders",
                      "Chronic antibody-mediated rejection in liver transplants",
                      "Many cases idiopathic"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Up to 40% of patients with portal hypertension in India and JapanIncreasingly recognized in Western countries",
                    "sub_points": [
                      "Increasingly recognized in Western countries"
                    ]
                  },
                  {
                    "text": "Most common in young and middle-aged adults"
                  },
                  {
                    "text": "Better prognosis than cirrhotic portal hypertension because of preserved liver function"
                  },
                  {
                    "text": "Typically presents with signs of portal hypertensionUsually normal or near-normal liver function tests",
                    "sub_points": [
                      "Usually normal or near-normal liver function tests"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Normal, enlarged, or shrunken liver with irregular, wrinkled capsular surface"
                  },
                  {
                    "text": "Dilatation and mural thickening of large portal veins"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Abnormal hepatic architecture with lack of consistent relationship between portal tracts and central veins"
                  },
                  {
                    "text": "Portal fibrosis"
                  },
                  {
                    "text": "Narrowing or obliteration of portal veins, often associated with thickened or arterialized walls (phlebosclerosis)"
                  },
                  {
                    "text": "Portal vein herniation and paraportal shunt formation"
                  },
                  {
                    "text": "Concomitant nodular regenerative hyperplasia may be present"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatoportal sclerosis (HPS)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Obliterative portal venopathy"
                  },
                  {
                    "text": "Idiopathic noncirrhotic portal hypertension"
                  },
                  {
                    "text": "Noncirrhotic portal fibrosis"
                  },
                  {
                    "text": "Portosinusoidal vascular disease"
                  },
                  {
                    "text": "Banti disease or Banti syndrome"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Portal hypertension secondary to portal fibrosis and portal vein sclerosis in absence of cirrhosisForm of noncirrhotic portal hypertension",
                    "sub_points": [
                      "Form of noncirrhotic portal hypertension"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Multifactorial": [
                  {
                    "text": "Associated with conditions that cause increased vascular resistance at presinusoidal or perisinusoidal levelGenetic predisposition (e.g., Turner syndrome, Abernethy syndrome, Adams-Oliver syndrome)Chronic exposure to toxins or medications (e.g., arsenic compounds, vinyl chloride, antiretroviral therapy, contraceptive steroids, azathioprine, 6-thioguanine)Intestinal and intraabdominal bacterial infectionsProthrombotic statesImmunologic disorders (e.g., common variable immunodeficiency, primary biliary cholangitis, celiac disease, connective tissue diseases)Chronic antibody-mediated rejection in liver transplantsMany cases are idiopathic",
                    "sub_points": [
                      "Genetic predisposition (e.g., Turner syndrome, Abernethy syndrome, Adams-Oliver syndrome)",
                      "Chronic exposure to toxins or medications (e.g., arsenic compounds, vinyl chloride, antiretroviral therapy, contraceptive steroids, azathioprine, 6-thioguanine)",
                      "Intestinal and intraabdominal bacterial infections",
                      "Prothrombotic states",
                      "Immunologic disorders (e.g., common variable immunodeficiency, primary biliary cholangitis, celiac disease, connective tissue diseases)",
                      "Chronic antibody-mediated rejection in liver transplants",
                      "Many cases are idiopathic"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Up to 40% of patients with portal hypertension in India and Japan"
                  },
                  {
                    "text": "3-5% in Western countries but increasingly recognized in recent years"
                  }
                ],
                "Age": [
                  {
                    "text": "Most common in young and middle-aged adults (25-56 years) but can occur in children"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Variceal bleeding, splenomegalyDue to elevated portal venous pressure",
                    "sub_points": [
                      "Due to elevated portal venous pressure"
                    ]
                  },
                  {
                    "text": "Jaundice, ascites, and encephalopathy in advanced disease"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Usually normal or near-normal liver function tests"
                  },
                  {
                    "text": "Anemia and thrombocytopenia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Transjugular intrahepatic portosystemic shunt (TIPS)"
                  },
                  {
                    "text": "Splenectomy"
                  },
                  {
                    "text": "Anticoagulant"
                  },
                  {
                    "text": "Liver transplantation for advanced disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Better than cirrhosis because of preserved liver function"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Sudden narrowing or paucity of intrahepatic portal vein branches (withered tree appearance)"
                  },
                  {
                    "text": "Irregular undulation of hepatic surface"
                  },
                  {
                    "text": "Patent extrahepatic portal and hepatic veins, but portal vein thrombosis may be seen"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Normal, enlarged, or shrunken liver"
                  },
                  {
                    "text": "Irregular, nodular, or wrinkled capsular surface"
                  },
                  {
                    "text": "Dilatation and mural thickening of large portal veins"
                  },
                  {
                    "text": "Thrombi may be seen in portal vein branches"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Abnormal hepatic architectureDistorted portal-central vein relationships (approximation or wide separation)Eccentric location of central veins in lobules, or multiple ectatic veins in single lobule",
                    "sub_points": [
                      "Distorted portal-central vein relationships (approximation or wide separation)",
                      "Eccentric location of central veins in lobules, or multiple ectatic veins in single lobule"
                    ]
                  },
                  {
                    "text": "Portal vein changesNarrowing or obliteration of portal veins, often associated with thickened or arterialized walls (phlebosclerosis)Herniation of normal-caliber or dilated portal veins into lobule, without intervening connective tissuePresence of numerous thin-walled vascular channels in portal tracts (angiomatoid malformation)",
                    "sub_points": [
                      "Narrowing or obliteration of portal veins, often associated with thickened or arterialized walls (phlebosclerosis)",
                      "Herniation of normal-caliber or dilated portal veins into lobule, without intervening connective tissue",
                      "Presence of numerous thin-walled vascular channels in portal tracts (angiomatoid malformation)"
                    ]
                  },
                  {
                    "text": "Portal fibrosisPeriportal and perisinusoidal fibrosis as well as slender portal-portal fibrous septa may be seen",
                    "sub_points": [
                      "Periportal and perisinusoidal fibrosis as well as slender portal-portal fibrous septa may be seen"
                    ]
                  },
                  {
                    "text": "Formation of paraportal shunt vessels"
                  },
                  {
                    "text": "Marked sinusoidal dilatation (megasinusoids)"
                  },
                  {
                    "text": "Minimal portal inflammation"
                  },
                  {
                    "text": "Diffuse or localized nodular regenerative hyperplasia"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Portal Venopathy Without Portal Hypertension": [
                  {
                    "text": "Unclear clinical significance, but may represent early stage of disease (subclinical) in some cases"
                  },
                  {
                    "text": "Absence of portal hypertension must be clinically documented"
                  }
                ],
                "Portal Vein Thrombosis": [
                  {
                    "text": "Demonstration of thrombus in extrahepatic portal vein on imaging"
                  }
                ],
                "Nodular Regenerative Hyperplasia": [
                  {
                    "text": "May occur concomitantly with or independently of HPS"
                  },
                  {
                    "text": "Normal-appearing portal tracts and portal veins"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Rule out other possible etiologies of portal hypertension, especially cirrhosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatic Venous Outflow Obstruction": {
            "name": "Hepatic Venous Outflow Obstruction",
            "url": "https://app.pathprimer.com/document/21cc446c-db2a-4e45-ae93-d29bb1a71afb/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Sinusoids or small hepatic veins: Sinusoidal obstruction syndrome (formerly venoocclusive disease)"
                  },
                  {
                    "text": "Large hepatic veins or inferior vena cava (Budd-Chiari syndrome)"
                  },
                  {
                    "text": "Right heart or pericardial disease"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Subacute presentation (< 6 months): Most common with painful hepatomegaly, mild jaundice, and ascites"
                  },
                  {
                    "text": "Less common: Disease presents as chronic liver disease or cirrhosis"
                  },
                  {
                    "text": "Rare cases: Fulminant presentation with acute liver failure"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Centrizonal-based changesSinusoidal dilatation and congestionHepatic plate atrophyRBC extravasation in space of DisseNecrosis",
                    "sub_points": [
                      "Sinusoidal dilatation and congestion",
                      "Hepatic plate atrophy",
                      "RBC extravasation in space of Disse",
                      "Necrosis"
                    ]
                  },
                  {
                    "text": "Portal-based changesDuctular reactionFocal bile duct damageLess commonly periportal fibrosis",
                    "sub_points": [
                      "Ductular reaction",
                      "Focal bile duct damage",
                      "Less commonly periportal fibrosis"
                    ]
                  },
                  {
                    "text": "Central vein-based fibrosis in chronic cases"
                  },
                  {
                    "text": "Nodular regenerative hyperplasia can occur"
                  },
                  {
                    "text": "Large regenerative nodules can resemble focal nodular hyperplasia or hepatocellular adenoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Biliary disease"
                  },
                  {
                    "text": "Other diseases that can cause sinusoidal dilatationPortal vein thrombosis, systemic inflammatory conditions, some neoplasms, such as renal cell carcinoma or lymphoma, artifactual sinusoidal dilatation",
                    "sub_points": [
                      "Portal vein thrombosis, systemic inflammatory conditions, some neoplasms, such as renal cell carcinoma or lymphoma, artifactual sinusoidal dilatation"
                    ]
                  },
                  {
                    "text": "Other causes of parenchymal necrosis/hemorrhageAcetaminophen toxicity, ischemic liver injury",
                    "sub_points": [
                      "Acetaminophen toxicity, ischemic liver injury"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatic venous outflow obstruction (HVOO)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Venous Obstruction": [
                  {
                    "text": "Can occur at different levels of hepatic venous outflowSinusoids or small hepatic veins: Sinusoidal obstruction syndrome (SOS; formerly venoocclusive disease)Large hepatic veins or inferior vena cava [Budd-Chiari syndrome (BCS)]Right heart or pericardial diseaseRight heart failure (either isolated or result of left heart failure)Tricuspid valve diseaseCardiac amyloidosisConstrictive pericarditis",
                    "sub_points": [
                      "Sinusoids or small hepatic veins: Sinusoidal obstruction syndrome (SOS; formerly venoocclusive disease)",
                      "Large hepatic veins or inferior vena cava [Budd-Chiari syndrome (BCS)]",
                      "Right heart or pericardial diseaseRight heart failure (either isolated or result of left heart failure)Tricuspid valve diseaseCardiac amyloidosisConstrictive pericarditis",
                      "Right heart failure (either isolated or result of left heart failure)",
                      "Tricuspid valve disease",
                      "Cardiac amyloidosis",
                      "Constrictive pericarditis"
                    ]
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Liver changes result from hepatic venous congestion, increased hepatic and sinusoidal pressure, and necrosis"
                  },
                  {
                    "text": "Secondary sinusoidal thrombosis extending into hepatic and portal veins may contribute to parenchymal damage and fibrosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Subacute presentation (< 6 months) is most common with painful hepatomegaly, mild jaundice, and ascites"
                  },
                  {
                    "text": "Less commonly, presents as chronic liver disease or cirrhosis"
                  },
                  {
                    "text": "Rare cases have fulminant presentation with acute liver failure"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Mild elevation of transaminases; marked in acute cases"
                  },
                  {
                    "text": "Alkaline phosphatase elevation is common"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Decompression procedures in BCSNonsurgical decompression by percutaneous transluminal angioplasty with stent: Suitable for webs or limited stenosisTransjugular intrahepatic portosystemic shuntSurgical decompression with portosystemic shunt",
                    "sub_points": [
                      "Nonsurgical decompression by percutaneous transluminal angioplasty with stent: Suitable for webs or limited stenosis",
                      "Transjugular intrahepatic portosystemic shunt",
                      "Surgical decompression with portosystemic shunt"
                    ]
                  },
                  {
                    "text": "For cardiac etiologies, treat underlying disease"
                  },
                  {
                    "text": "Liver transplant necessary in cases with advanced fibrosis"
                  },
                  {
                    "text": "Excellent outcome after liver transplant in fulminant cases"
                  },
                  {
                    "text": "Hematologic work-up to identify cause of thrombosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "BCS5-year survival after portosystemic shunt is 75-90%5-year survival after liver transplantation is 60%",
                    "sub_points": [
                      "5-year survival after portosystemic shunt is 75-90%",
                      "5-year survival after liver transplantation is 60%"
                    ]
                  },
                  {
                    "text": "Cardiac diseaseDepends on type and severity of underlying illness",
                    "sub_points": [
                      "Depends on type and severity of underlying illness"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Ultrasound with Doppler flow studies for BCS"
                  },
                  {
                    "text": "Hepatic scintigraphy, CT, and MR can be helpful"
                  },
                  {
                    "text": "Hepatic venography was considered gold standard in BCS, but it is now restricted to diagnostically challenging casesNormal hepatic vein flow is not seenCollaterals attempt to decompress obstruction, leading to spider web appearanceReverse flow can be seen in portal vein",
                    "sub_points": [
                      "Normal hepatic vein flow is not seen",
                      "Collaterals attempt to decompress obstruction, leading to spider web appearance",
                      "Reverse flow can be seen in portal vein"
                    ]
                  },
                  {
                    "text": "For cardiac causes, findings depend on underlying disease"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "\"Nutmeg\" liver: Alternating areas of hemorrhagic area and pale parenchyma"
                  },
                  {
                    "text": "Hemorrhagic areas correspond to centrizonal areas; pale areas are relatively unaffected periportal parenchyma"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Role of liver biopsy: Confirm diagnosis and determine degree of hepatocellular damageCentrizonal-based changesSinusoidal dilatation and congestion, hepatic plate atrophyIncreased sinusoidal pressure leads to RBC extravasation in space of DisseHepatocellular necrosis in acute and subacute casesCopper deposition can occur, often in centrizonal areas and regenerative nodulesPericentral and sinusoidal fibrosis in chronic cases that can progress to bridging fibrosis and cirrhosisFibrosis can be highly variable in distribution, especially in patients with heart failureExtent of fibrosis may determine choice of heart vs. combined heart-liver transplantationNo well-established staging schemeSemiquantitative assessment can be provided along with comment on whether fibrosis is patchy or diffuseHeterogeneity of fibrosis should be emphasized in reportPortal-based changesPortal expansion with bile ductular reaction with mild lymphoplasmacytic infiltrateDuctular reaction, mild inflammation, focal bile duct injuryPortal and periportal fibrosis can occur",
                    "sub_points": [
                      "Centrizonal-based changesSinusoidal dilatation and congestion, hepatic plate atrophyIncreased sinusoidal pressure leads to RBC extravasation in space of DisseHepatocellular necrosis in acute and subacute casesCopper deposition can occur, often in centrizonal areas and regenerative nodulesPericentral and sinusoidal fibrosis in chronic cases that can progress to bridging fibrosis and cirrhosisFibrosis can be highly variable in distribution, especially in patients with heart failureExtent of fibrosis may determine choice of heart vs. combined heart-liver transplantationNo well-established staging schemeSemiquantitative assessment can be provided along with comment on whether fibrosis is patchy or diffuseHeterogeneity of fibrosis should be emphasized in report",
                      "Sinusoidal dilatation and congestion, hepatic plate atrophy",
                      "Increased sinusoidal pressure leads to RBC extravasation in space of Disse",
                      "Hepatocellular necrosis in acute and subacute cases",
                      "Copper deposition can occur, often in centrizonal areas and regenerative nodules",
                      "Pericentral and sinusoidal fibrosis in chronic cases that can progress to bridging fibrosis and cirrhosis",
                      "Fibrosis can be highly variable in distribution, especially in patients with heart failureExtent of fibrosis may determine choice of heart vs. combined heart-liver transplantationNo well-established staging schemeSemiquantitative assessment can be provided along with comment on whether fibrosis is patchy or diffuseHeterogeneity of fibrosis should be emphasized in report",
                      "Extent of fibrosis may determine choice of heart vs. combined heart-liver transplantation",
                      "No well-established staging scheme",
                      "Semiquantitative assessment can be provided along with comment on whether fibrosis is patchy or diffuse",
                      "Heterogeneity of fibrosis should be emphasized in report",
                      "Portal-based changesPortal expansion with bile ductular reaction with mild lymphoplasmacytic infiltrateDuctular reaction, mild inflammation, focal bile duct injuryPortal and periportal fibrosis can occur",
                      "Portal expansion with bile ductular reaction with mild lymphoplasmacytic infiltrate",
                      "Ductular reaction, mild inflammation, focal bile duct injury",
                      "Portal and periportal fibrosis can occur"
                    ]
                  },
                  {
                    "text": "Features in certain clinical settingsHyaline deposits in sinusoids &/or vessel walls in amyloidosisNodular regenerative hyperplasia can be seenLarge regenerative nodules in BCSCan be multiplePresumably result from localized increase in arterial blood flowResemble focal nodular hyperplasia when associated with ductular reactionResemble hepatocellular adenoma if bile ducts and ductular reaction are absent (can be inflammatory, HNFA-inactivated or β-catenin activated)",
                    "sub_points": [
                      "Hyaline deposits in sinusoids &/or vessel walls in amyloidosis",
                      "Nodular regenerative hyperplasia can be seen",
                      "Large regenerative nodules in BCSCan be multiplePresumably result from localized increase in arterial blood flowResemble focal nodular hyperplasia when associated with ductular reactionResemble hepatocellular adenoma if bile ducts and ductular reaction are absent (can be inflammatory, HNFA-inactivated or β-catenin activated)",
                      "Can be multiple",
                      "Presumably result from localized increase in arterial blood flow",
                      "Resemble focal nodular hyperplasia when associated with ductular reaction",
                      "Resemble hepatocellular adenoma if bile ducts and ductular reaction are absent (can be inflammatory, HNFA-inactivated or β-catenin activated)"
                    ]
                  },
                  {
                    "text": "Biopsy features can determine choice of therapyCongestion without significant necrosis or fibrosisConservative management with possible repeat biopsy in 3-6 monthsCongestion with necrosis but no significant fibrosisSurgical decompressionSevere fibrosis or cirrhosisLiver transplant",
                    "sub_points": [
                      "Congestion without significant necrosis or fibrosisConservative management with possible repeat biopsy in 3-6 months",
                      "Conservative management with possible repeat biopsy in 3-6 months",
                      "Congestion with necrosis but no significant fibrosisSurgical decompression",
                      "Surgical decompression",
                      "Severe fibrosis or cirrhosisLiver transplant",
                      "Liver transplant"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Causes of Sinusoidal Dilatation": [
                  {
                    "text": "Vascular causesPortal vein thrombosisObstruction of portal vein blood flow leads to hepatocyte atrophyHepatic atrophy gives appearance of dilated sinusoidsNodular regenerative hyperplasiaMultiple 0.1- to 0.2-cm nodules without fibrosisOccurs in variety of clinical settings, including vascular disorders, myeloproliferative diseases, primary biliary cholangitisNodules compress hepatic microvasculature, leading to hepatocyte atrophy and resultant sinusoidal dilatation",
                    "sub_points": [
                      "Portal vein thrombosisObstruction of portal vein blood flow leads to hepatocyte atrophyHepatic atrophy gives appearance of dilated sinusoids",
                      "Obstruction of portal vein blood flow leads to hepatocyte atrophy",
                      "Hepatic atrophy gives appearance of dilated sinusoids",
                      "Nodular regenerative hyperplasiaMultiple 0.1- to 0.2-cm nodules without fibrosisOccurs in variety of clinical settings, including vascular disorders, myeloproliferative diseases, primary biliary cholangitisNodules compress hepatic microvasculature, leading to hepatocyte atrophy and resultant sinusoidal dilatation",
                      "Multiple 0.1- to 0.2-cm nodules without fibrosis",
                      "Occurs in variety of clinical settings, including vascular disorders, myeloproliferative diseases, primary biliary cholangitis",
                      "Nodules compress hepatic microvasculature, leading to hepatocyte atrophy and resultant sinusoidal dilatation"
                    ]
                  },
                  {
                    "text": "Systemic inflammatory conditionsCastleman disease, Crohn disease, rheumatoid arthritis, Still disease, polymyalgia rheumaticaGranulomatous conditions, such as sarcoidosisEtiology of sinusoidal dilatation in inflammatory disorders is not clear",
                    "sub_points": [
                      "Castleman disease, Crohn disease, rheumatoid arthritis, Still disease, polymyalgia rheumatica",
                      "Granulomatous conditions, such as sarcoidosis",
                      "Etiology of sinusoidal dilatation in inflammatory disorders is not clear"
                    ]
                  },
                  {
                    "text": "Extrahepatic neoplasms without liver involvementSinusoidal dilatation is most commonly associated with renal cell carcinoma and Hodgkin lymphomaOther tumors: Carcinomas of stomach, uterus, and colon",
                    "sub_points": [
                      "Sinusoidal dilatation is most commonly associated with renal cell carcinoma and Hodgkin lymphoma",
                      "Other tumors: Carcinomas of stomach, uterus, and colon"
                    ]
                  },
                  {
                    "text": "Nonspecific sinusoidal dilatation in different clinical settingsArtifactual sinusoidal dilatationMechanical reasons, such as rough handling or tearing of biopsyOften more pronounced at biopsy edgesHepatic plate atrophy or extravasation of RBC into space of Disse is not seenTransplant liver biopsiesCommonly show sinusoidal dilatation in absence of venous outflow obstructionMay be related to hemodynamic changes related to vascular anastomosisRegenerative nodules in cirrhosis or adjacent to mass lesionsCan lead to adjacent sinusoidal dilatation due to localized venous outflow obstructionIntraoperative biopsiesSinusoidal dilatation is common in biopsies obtained during abdominal surgeriesMay be due to alterations in portal blood flow during abdominal surgery",
                    "sub_points": [
                      "Artifactual sinusoidal dilatationMechanical reasons, such as rough handling or tearing of biopsyOften more pronounced at biopsy edgesHepatic plate atrophy or extravasation of RBC into space of Disse is not seen",
                      "Mechanical reasons, such as rough handling or tearing of biopsy",
                      "Often more pronounced at biopsy edges",
                      "Hepatic plate atrophy or extravasation of RBC into space of Disse is not seen",
                      "Transplant liver biopsiesCommonly show sinusoidal dilatation in absence of venous outflow obstructionMay be related to hemodynamic changes related to vascular anastomosis",
                      "Commonly show sinusoidal dilatation in absence of venous outflow obstruction",
                      "May be related to hemodynamic changes related to vascular anastomosis",
                      "Regenerative nodules in cirrhosis or adjacent to mass lesionsCan lead to adjacent sinusoidal dilatation due to localized venous outflow obstruction",
                      "Can lead to adjacent sinusoidal dilatation due to localized venous outflow obstruction",
                      "Intraoperative biopsiesSinusoidal dilatation is common in biopsies obtained during abdominal surgeriesMay be due to alterations in portal blood flow during abdominal surgery",
                      "Sinusoidal dilatation is common in biopsies obtained during abdominal surgeries",
                      "May be due to alterations in portal blood flow during abdominal surgery"
                    ]
                  }
                ],
                "Biliary Disease": [
                  {
                    "text": "Portal changes, such as ductular reaction and lymphocytic inflammation, can occur in HVOO"
                  },
                  {
                    "text": "Elevation of alkaline phosphatase is also common"
                  },
                  {
                    "text": "Both of these features can lead to additional suspicion of biliary disease, such as bile duct obstruction or primary biliary cholangitis"
                  },
                  {
                    "text": "Normal bile ducts on imaging and negative antimitochondrial antibodies do not support biliary disease"
                  }
                ],
                "Other Causes of Parenchymal Necrosis/Hemorrhage": [
                  {
                    "text": "Acetaminophen toxicityCentrizonal necrosis and absence of inflammation mimic venous outflow obstructionSinusoidal dilatation may be focal but is not markedDrug history and acetaminophen levels point toward correct diagnosis",
                    "sub_points": [
                      "Centrizonal necrosis and absence of inflammation mimic venous outflow obstruction",
                      "Sinusoidal dilatation may be focal but is not marked",
                      "Drug history and acetaminophen levels point toward correct diagnosis"
                    ]
                  },
                  {
                    "text": "Ischemic liver injuryCentrizonal hemorrhage, necrosis, and absence of inflammation mimic venous outflow obstructionProminent sinusoidal dilatation is usually not presentHistory of cardiogenic or noncardiogenic (septic, hypovolemic) shock, heatstroke is key to diagnosis",
                    "sub_points": [
                      "Centrizonal hemorrhage, necrosis, and absence of inflammation mimic venous outflow obstruction",
                      "Prominent sinusoidal dilatation is usually not present",
                      "History of cardiogenic or noncardiogenic (septic, hypovolemic) shock, heatstroke is key to diagnosis"
                    ]
                  },
                  {
                    "text": "Wilson diseaseNecrosis without prominent inflammation can be seenTypical features of venous outflow obstruction, such as sinusoidal dilatation and congestion, are not seenCopper studies will lead to correct diagnosis",
                    "sub_points": [
                      "Necrosis without prominent inflammation can be seen",
                      "Typical features of venous outflow obstruction, such as sinusoidal dilatation and congestion, are not seen",
                      "Copper studies will lead to correct diagnosis"
                    ]
                  },
                  {
                    "text": "Viral hepatitisHerpes simplex and adenoviral hepatitis can lead to hemorrhagic necrosis without significant inflammationViral inclusions confirmed by immunohistochemistry establish diagnosis",
                    "sub_points": [
                      "Herpes simplex and adenoviral hepatitis can lead to hemorrhagic necrosis without significant inflammation",
                      "Viral inclusions confirmed by immunohistochemistry establish diagnosis"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Venoocclusive Disease": {
            "name": "Venoocclusive Disease",
            "url": "https://app.pathprimer.com/document/5190b924-d4a7-48e7-b479-452e41323b25/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Term sinusoidal obstruction syndrome has been advocated"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Stem cell transplantation and high-dose chemotherapy"
                  },
                  {
                    "text": "Sinusoidal endothelial cell injury is important initial event"
                  },
                  {
                    "text": "Herbal medicines containing pyrrolizidine alkaloids"
                  },
                  {
                    "text": "Rarely, liver transplant"
                  },
                  {
                    "text": "Rare causes of sinusoidal obstruction: Sickle cell crisis,Plasmodium falciparummalaria, extensive infiltration by neoplastic cells"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Hyperbilirubinemia, weight gain, and painful hepatomegaly"
                  },
                  {
                    "text": "Attenuated or reverse flow in portal vein on Doppler ultrasound"
                  },
                  {
                    "text": "Outcome depends on disease severity with high mortality in severe disease"
                  },
                  {
                    "text": "Adverse prognostic factors: Ascites, multiorgan failure, WHVPG > 20 mm Hg"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Subendothelial edema, red cell extravasation, fibrin deposition in sinusoids and central vein"
                  },
                  {
                    "text": "Zone 3 sinusoidal dilatation and hepatocellular necrosis"
                  },
                  {
                    "text": "Venular obliteration and widespread fibrosis"
                  },
                  {
                    "text": "Changes can be patchy in early disease, leading to false-negative results"
                  },
                  {
                    "text": "Fibrosis develops in sinusoids and venular wall"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acute graft-vs.-host disease"
                  },
                  {
                    "text": "Other etiologies of hepatic venous outflow obstructionBudd-Chiari syndromePericardial or right heart disease",
                    "sub_points": [
                      "Budd-Chiari syndrome",
                      "Pericardial or right heart disease"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Venoocclusive disease (VOD)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Sinusoidal obstruction syndrome (SOS)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Etiology": [
                  {
                    "text": "Stem cell transplantation and high-dose chemotherapy"
                  },
                  {
                    "text": "Herbal medicines, such asGynura segetumand those containing pyrrolizidine alkaloids"
                  },
                  {
                    "text": "Rare complication of liver transplantation"
                  },
                  {
                    "text": "Rare causes of sinusoidal obstruction: Sickle cell crisis,Plasmodium falciparummalaria, extensive infiltration by neoplastic cells"
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "Older age and poor performance status"
                  },
                  {
                    "text": "HLA disparity in allogeneic stem cell transplant"
                  },
                  {
                    "text": "Preexisting liver dysfunction"
                  },
                  {
                    "text": "Prior abdominal radiation"
                  },
                  {
                    "text": "Pretransplant use of acyclovir or vancomycin"
                  },
                  {
                    "text": "High-dose busulphan and cyclophosphamide therapy"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Injury to sinusoidal endothelial cells is important initial event; hence, preferred term is SOS"
                  },
                  {
                    "text": "Major damage occurs in zone 3, which has high concentration of cytochrome P450 enzymes that metabolize many chemotherapeutic agents"
                  },
                  {
                    "text": "Depletion of glutathione, also predominantly present in centrizonal location, plays role in hepatocyte necrosis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "SOS in stem cell transplantationTypically occurs in first 3 weeksTriad of hyperbilirubinemia, weight gain, and painful hepatomegalyPlasma levels of plasminogen activator inhibitor-1 are often elevatedAttenuated or reverse flow in portal vein on Doppler ultrasoundWedged hepatic venous pressure gradient (WHVPG) > 10 mm Hg has specificity and sensitivity of ~ 90% and 50%, respectivelyDiagnosis often based on clinical criteria, biopsy reserved for unclear casesAcute renal dysfunction, platelet refractoriness, and elevated or abnormal tacrolimus levels can occur before typical features and can help raise the possibility of imminent disease",
                    "sub_points": [
                      "Typically occurs in first 3 weeks",
                      "Triad of hyperbilirubinemia, weight gain, and painful hepatomegaly",
                      "Plasma levels of plasminogen activator inhibitor-1 are often elevated",
                      "Attenuated or reverse flow in portal vein on Doppler ultrasound",
                      "Wedged hepatic venous pressure gradient (WHVPG) > 10 mm Hg has specificity and sensitivity of ~ 90% and 50%, respectively",
                      "Diagnosis often based on clinical criteria, biopsy reserved for unclear cases",
                      "Acute renal dysfunction, platelet refractoriness, and elevated or abnormal tacrolimus levels can occur before typical features and can help raise the possibility of imminent disease"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Use of pharmacokinetics to monitor drug levels with intent of minimizing hepatic injury"
                  },
                  {
                    "text": "Fibrinolytic agents, such as recombinant tissue plasminogen activator and anticoagulants, like heparin"
                  },
                  {
                    "text": "Antiinflammatory agents, such as ursodiol and pentoxifylline"
                  },
                  {
                    "text": "Endothelial protective agents, such as prostaglandin E1 and defibrotide"
                  },
                  {
                    "text": "Glutathione and N-acetyl cysteine supplementation"
                  },
                  {
                    "text": "Transjugular intrahepatic portosystemic shunt (TIPS) to reduce portal hypertension"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mild disease: No significant adverse effect from liver dysfunction with complete resolution"
                  },
                  {
                    "text": "Moderate disease: Requiring therapy but with eventual complete resolution"
                  },
                  {
                    "text": "Severe: Dismal outcome, mortality approaching 100%"
                  },
                  {
                    "text": "Adverse prognostic factors: Ascites, multiorgan failure, WHVPG > 20 mm Hg"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Liver biopsy is done through transjugular route; percutaneous biopsy is contraindicated given high risk for bleeding"
                  },
                  {
                    "text": "Changes can be patchy in early disease leading to false-negative results"
                  },
                  {
                    "text": "Subendothelial edema, red cell extravasation, fibrin deposition in central vein and sinusoids"
                  },
                  {
                    "text": "Narrowing of venular lumen leads to sinusoidal dilatation and hepatocyte necrosis"
                  },
                  {
                    "text": "Fibrosis develops in sinusoids and venular wall"
                  },
                  {
                    "text": "Eventually leads to venular obliteration, extensive hepatocellular necrosis, and widespread fibrosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acute Graft-vs.-Host Disease": [
                  {
                    "text": "Also causes acute liver dysfunction after stem cell transplant"
                  },
                  {
                    "text": "Bile duct damage and apoptosis are not seen in VOD"
                  },
                  {
                    "text": "Centrizonal hepatocellular damage is not characteristic of graft-vs.-host disease"
                  }
                ],
                "Hepatic Venous Outflow Obstruction Related to Budd-Chiari Syndrome, Right Heart Disease": [
                  {
                    "text": "Luminal compromise &/or obliteration of small hepatic veins typically absent"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Amyloidosis": {
            "name": "Amyloidosis",
            "url": "https://app.pathprimer.com/document/58e8abb3-a0eb-413e-9fc2-714bb4e9ab17/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Liver involvement most common in AL and LECT2 amyloidosis"
                  },
                  {
                    "text": "AA and hereditary amyloidosis can also involve liver"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Treatment or AL amyloidosis: Chemotherapy, proteasome inhibitors, stem cell transplantation"
                  },
                  {
                    "text": "Liver transplant for some hereditary cases"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Sinusoidal pattern is more common in AL amyloidosis and vascular pattern in AA amyloidosis"
                  },
                  {
                    "text": "Distribution patterns show overlap and are not reliable for definite distinction between AL and AA amyloidosis"
                  },
                  {
                    "text": "Globular deposits are typical of LECT2 amyloid"
                  },
                  {
                    "text": "Congo red stainAmyloid deposits are congophilic and show apple green birefringence under polarized lightBirefringence is best demonstrated by turning light to maximum and pulling color filters out",
                    "sub_points": [
                      "Amyloid deposits are congophilic and show apple green birefringence under polarized light",
                      "Birefringence is best demonstrated by turning light to maximum and pulling color filters out"
                    ]
                  },
                  {
                    "text": "ImmunohistochemistryP glycoprotein: Present in all cases, can help in diagnosisLight chains, SAA, and LECT2: Help in further classification",
                    "sub_points": [
                      "P glycoprotein: Present in all cases, can help in diagnosis",
                      "Light chains, SAA, and LECT2: Help in further classification"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Electron microscopyCentral electron-lucent core and nonbranching fibrils of indefinite length with mean diameter of 10 nm",
                    "sub_points": [
                      "Central electron-lucent core and nonbranching fibrils of indefinite length with mean diameter of 10 nm"
                    ]
                  },
                  {
                    "text": "Laser microdissection and mass spectrometryMost accurate method for identification of amyloid subtypeParaffin-embedded tissue or cytology material can be used",
                    "sub_points": [
                      "Most accurate method for identification of amyloid subtype",
                      "Paraffin-embedded tissue or cytology material can be used"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Monoclonal immunoglobulin deposit disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Heterogeneous disease characterized by deposition of glycoprotein fibrils in extracellular matrix and vessel wallsDeposits composed of low molecular weight subunits (5-25 KDa) derived from normal serum proteins",
                    "sub_points": [
                      "Deposits composed of low molecular weight subunits (5-25 KDa) derived from normal serum proteins"
                    ]
                  },
                  {
                    "text": "Liver involvement may be seen in different typesPrimary (or AL) amyloidosisDeposition of monoclonal light chainsOccurs alone or associated with other hematologic diseases (plasmacytoma, multiple myeloma, Waldenstrom macroglobulinemia)Liver involved in up to 70% of casesHepatic involvement reflects advanced disease and denotes poor prognosisCytogenetic changes like t(11;14), monosomies, and trisomies can occur, often associated with worse prognosisSecondary (or AA) amyloidosisDeposits are composed of fragments of SAA protein (acute phase reactant)Often secondary to chronic infections, systemic diseases, such as rheumatoid arthritisHereditary amyloidosisHereditary AApoAI amyloidosis: Some mutations in apolipoprotein A1 can lead to hepatic amyloidosisLECT2 amyloidosisDeposition of LECT2 proteinAccounts for 25% of hepatic cases",
                    "sub_points": [
                      "Primary (or AL) amyloidosisDeposition of monoclonal light chainsOccurs alone or associated with other hematologic diseases (plasmacytoma, multiple myeloma, Waldenstrom macroglobulinemia)Liver involved in up to 70% of casesHepatic involvement reflects advanced disease and denotes poor prognosisCytogenetic changes like t(11;14), monosomies, and trisomies can occur, often associated with worse prognosis",
                      "Deposition of monoclonal light chains",
                      "Occurs alone or associated with other hematologic diseases (plasmacytoma, multiple myeloma, Waldenstrom macroglobulinemia)",
                      "Liver involved in up to 70% of cases",
                      "Hepatic involvement reflects advanced disease and denotes poor prognosis",
                      "Cytogenetic changes like t(11;14), monosomies, and trisomies can occur, often associated with worse prognosis",
                      "Secondary (or AA) amyloidosisDeposits are composed of fragments of SAA protein (acute phase reactant)Often secondary to chronic infections, systemic diseases, such as rheumatoid arthritis",
                      "Deposits are composed of fragments of SAA protein (acute phase reactant)",
                      "Often secondary to chronic infections, systemic diseases, such as rheumatoid arthritis",
                      "Hereditary amyloidosisHereditary AApoAI amyloidosis: Some mutations in apolipoprotein A1 can lead to hepatic amyloidosis",
                      "Hereditary AApoAI amyloidosis: Some mutations in apolipoprotein A1 can lead to hepatic amyloidosis",
                      "LECT2 amyloidosisDeposition of LECT2 proteinAccounts for 25% of hepatic cases",
                      "Deposition of LECT2 protein",
                      "Accounts for 25% of hepatic cases"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "May be asymptomatic"
                  },
                  {
                    "text": "More common in men; mean age: 60 years"
                  },
                  {
                    "text": "Common symptoms: Weight loss, fatigue, abdominal pain, anorexia, early satiety, nausea, dysgeusia"
                  },
                  {
                    "text": "Physical exam: Hepatomegaly, ascites, edema, purpura, splenomegaly"
                  },
                  {
                    "text": "Hepatic rupture can occur (rare)"
                  },
                  {
                    "text": "Extrahepatic manifestations often present"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated alkaline phosphatase (often > 500 IU/L)"
                  },
                  {
                    "text": "Mild elevation of liver transaminases occurs in 1/3 of cases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "High-dose chemotherapy, proteasome inhibitors (like bortezomib), autologous stem cell transplantation for AL amyloidosis"
                  },
                  {
                    "text": "Liver transplant for some hereditary cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally poor"
                  },
                  {
                    "text": "Elevated bilirubin and congestive heart failure are adverse prognostic factors"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Amyloid deposition in sinusoids &/or vessel wallsSinusoidal pattern more common in AL amyloidosis, vascular pattern in AADistribution patterns overlap and are not reliable for definite distinction between AL and AA amyloidosis",
                    "sub_points": [
                      "Sinusoidal pattern more common in AL amyloidosis, vascular pattern in AA",
                      "Distribution patterns overlap and are not reliable for definite distinction between AL and AA amyloidosis"
                    ]
                  },
                  {
                    "text": "Globular deposits in sinusoids typical of LECT2 amyloidosis"
                  },
                  {
                    "text": "Macrophages, multinucleated giant cells around amyloid deposits"
                  },
                  {
                    "text": "Mild portal fibrosis can occur, no advanced fibrosis"
                  },
                  {
                    "text": "Congo red stain is gold standard for diagnosisCongophilic deposits with apple green birefringence under polarized lightColor varies from yellow-green to blue-green, changes with rotation of polarizer/analyzerDifferent areas can demonstrate different colorsBirefringence is best demonstrated by turning light to maximum and pulling color filters outThick sections (10 μm) can increase sensitivityCongophilia can be reduced after prolonged fixationFluorescence microscopy using fluorescein isothiocyanate filter yields yellow fluorescence with Congo red but is not specific for amyloid",
                    "sub_points": [
                      "Congophilic deposits with apple green birefringence under polarized lightColor varies from yellow-green to blue-green, changes with rotation of polarizer/analyzerDifferent areas can demonstrate different colorsBirefringence is best demonstrated by turning light to maximum and pulling color filters outThick sections (10 μm) can increase sensitivityCongophilia can be reduced after prolonged fixation",
                      "Color varies from yellow-green to blue-green, changes with rotation of polarizer/analyzer",
                      "Different areas can demonstrate different colors",
                      "Birefringence is best demonstrated by turning light to maximum and pulling color filters out",
                      "Thick sections (10 μm) can increase sensitivity",
                      "Congophilia can be reduced after prolonged fixation",
                      "Fluorescence microscopy using fluorescein isothiocyanate filter yields yellow fluorescence with Congo red but is not specific for amyloid"
                    ]
                  },
                  {
                    "text": "ImmunohistochemistryGlycoprotein P component can help in diagnosis, present in all amyloid depositsLight chains (AL type), SAA (AA type), LECT2 can help to subtype amyloid depositsBackground staining can make interpretation difficult",
                    "sub_points": [
                      "Glycoprotein P component can help in diagnosis, present in all amyloid deposits",
                      "Light chains (AL type), SAA (AA type), LECT2 can help to subtype amyloid deposits",
                      "Background staining can make interpretation difficult"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Electron Microscopy": [
                  {
                    "text": "Central electron-lucent core and nonbranching fibrils of indefinite length with mean diameter of 10 nm"
                  }
                ],
                "Laser Microdissection and Mass Spectrometry": [
                  {
                    "text": "Most accurate method for identification of amyloid subtype"
                  },
                  {
                    "text": "Paraffin-embedded tissue or cytology material can be used"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Monoclonal Immunoglobulin Deposit Disease": [
                  {
                    "text": "Deposition of monoclonal protein (M protein) in tissue"
                  },
                  {
                    "text": "AL amyloidosis is form of monoclonal immunoglobulin deposit disease (distinguished from other forms by Congo red staining)"
                  },
                  {
                    "text": "Other forms: Light chain deposition disease, heavy chain deposition disease, light and heavy chain deposition disease"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Diagnosis should be suspected in setting of involuntary weight loss, hepatomegaly, unexplained elevated serum alkaline phosphatase level, proteinuria, or evidence for hyposplenism"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ischemia": {
            "name": "Ischemia",
            "url": "https://app.pathprimer.com/document/494207a8-7fcd-4e83-acd1-8ef4fa89530a/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Ischemic hepatitis, hepatic infarction, and shock liver"
                  },
                  {
                    "text": "Liver injury due to reduced blood flow"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Cardiac failure"
                  },
                  {
                    "text": "Circulatory shock due to sepsis, hypovolemia, severe trauma, burns, and other causes"
                  },
                  {
                    "text": "Vascular thromboses due to stasis, endothelial injury, and hypercoagulable state"
                  },
                  {
                    "text": "In transplant patients, anastomotic complications"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Often asymptomatic"
                  },
                  {
                    "text": "Characterized by rapid and extreme rise in serum aminotransferases"
                  },
                  {
                    "text": "Patients may develop acute liver failure"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Range of findings, depending on location and extent of ischemic insult"
                  },
                  {
                    "text": "Sharply demarcated zones of coagulative hepatocyte necrosis"
                  },
                  {
                    "text": "Minimal inflammation"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "InfectionNonzonal or \"geographic\" necrosis",
                    "sub_points": [
                      "Nonzonal or \"geographic\" necrosis"
                    ]
                  },
                  {
                    "text": "Drug-induced liver injury"
                  },
                  {
                    "text": "Chronic passive congestion"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Consider in systemically ill patients or those at risk for thrombosis with rapid, extreme rise in aminotransferases"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Ischemic hepatitis or hypoxic hepatitis"
                  },
                  {
                    "text": "Shock liver"
                  },
                  {
                    "text": "Hepatic infarction"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Liver injury due to reduced blood flow"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Systemic Hypotension &/or Hypoxemia": [
                  {
                    "text": "Cardiac failure or circulatory shock of any cause"
                  }
                ],
                "Vascular Obstruction": [
                  {
                    "text": "Caused by stasis, endothelial injury, and hypercoagulable state≥ 1 vessels may be involved",
                    "sub_points": [
                      "≥ 1 vessels may be involved"
                    ]
                  },
                  {
                    "text": "In transplant patients, anastomotic complications lead to vascular thromboses"
                  },
                  {
                    "text": "In native livers, usually requires obstruction of 2 vessels to result in clinically significant ischemiaGreater collateralization present in native livers, but allografts subject to injury with single vessel obstruction",
                    "sub_points": [
                      "Greater collateralization present in native livers, but allografts subject to injury with single vessel obstruction"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Often asymptomatic"
                  },
                  {
                    "text": "May exhibit mild jaundice"
                  },
                  {
                    "text": "Severely affected patients may present with acute liver failure"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Rapid and extreme rise in serum aminotransferases (often > 10 upper limit of normal), usually identified by screening laboratory testsMay be followed by liver failureIf patient survives, enzymes then normalize rapidlyAlkaline phosphatase and bilirubin are typically minimally affected in nontransplant setting",
                    "sub_points": [
                      "May be followed by liver failure",
                      "If patient survives, enzymes then normalize rapidly",
                      "Alkaline phosphatase and bilirubin are typically minimally affected in nontransplant setting"
                    ]
                  },
                  {
                    "text": "Marked elevation of lactate dehydrogenase (LDH)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treat underlying cause of ischemia"
                  },
                  {
                    "text": "Supportive care"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on duration and extent of liver injuryIn severe cases, often accompanied by multisystem organ failure and poor prognosis",
                    "sub_points": [
                      "In severe cases, often accompanied by multisystem organ failure and poor prognosis"
                    ]
                  },
                  {
                    "text": "Most cases are brief and followed by recoveryMany cases are likely subclinical",
                    "sub_points": [
                      "Many cases are likely subclinical"
                    ]
                  },
                  {
                    "text": "Hepatic abscess may occur if necrotic tissue is colonized by organisms"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Variably present gross abnormalities"
                  },
                  {
                    "text": "Infarcts evident as hyperemic areas"
                  },
                  {
                    "text": "\"Nutmeg\" liverSerpiginous, red discoloration representing zones of necrosis and hemorrhageCommon autopsy finding",
                    "sub_points": [
                      "Serpiginous, red discoloration representing zones of necrosis and hemorrhage",
                      "Common autopsy finding"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Range of findings, depending on location and extent of ischemic insultDifferent regions of liver can be variably affectedNeedle biopsies may not be representative of extent or severity of injury",
                    "sub_points": [
                      "Different regions of liver can be variably affected",
                      "Needle biopsies may not be representative of extent or severity of injury"
                    ]
                  },
                  {
                    "text": "Sharply demarcated zones of coagulative hepatocyte necrosisCollapse of liver cell plates seen on reticulin stainSinusoidal congestionMay see cholestasis at periphery of necrotic areasWith cardiac failure or shock, zone 3/perivenular hepatocytes most often affectedMay extend into zone 2Zone 1 necrosis more typical of diseases with intravascular fibrin depositionDisseminated intravascular coagulation, toxemia of pregnancy",
                    "sub_points": [
                      "Collapse of liver cell plates seen on reticulin stain",
                      "Sinusoidal congestion",
                      "May see cholestasis at periphery of necrotic areas",
                      "With cardiac failure or shock, zone 3/perivenular hepatocytes most often affectedMay extend into zone 2",
                      "May extend into zone 2",
                      "Zone 1 necrosis more typical of diseases with intravascular fibrin depositionDisseminated intravascular coagulation, toxemia of pregnancy",
                      "Disseminated intravascular coagulation, toxemia of pregnancy"
                    ]
                  },
                  {
                    "text": "Hepatic infarct: Ischemic necrosis of ≥ 2 contiguous and complete acini"
                  },
                  {
                    "text": "Hepatocyte swelling"
                  },
                  {
                    "text": "Minimal inflammation"
                  },
                  {
                    "text": "Aggregates of ceroid pigment-laden macrophages in hepatic lobules following resolution"
                  },
                  {
                    "text": "Dystrophic calcification may eventually develop"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Infection": [
                  {
                    "text": "Necrotic areas are nonzonal (\"geographic\" necrosis)"
                  },
                  {
                    "text": "Herpes simplex and adenovirus hepatitis cause nonzonal confluent necrosisViral inclusions can usually be found on H&E &/or immunohistochemistry",
                    "sub_points": [
                      "Viral inclusions can usually be found on H&E &/or immunohistochemistry"
                    ]
                  }
                ],
                "Drug-Induced Liver Injury": [
                  {
                    "text": "Acetaminophen and cocaine also cause zone 3 hepatocyte necrosis"
                  },
                  {
                    "text": "Distinction based on history and other clinical findings"
                  }
                ],
                "Chronic Passive Congestion": [
                  {
                    "text": "Centrilobular hepatocyte atrophy and sinusoidal dilatation"
                  },
                  {
                    "text": "History and imaging can be helpful"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Consider in systemically ill patients or those at risk for thrombosis with rapid, extreme rise in aminotransferasesOften, prior history of cardiac disease, particularly right heart failure",
                    "sub_points": [
                      "Often, prior history of cardiac disease, particularly right heart failure"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Nodular Regenerative Hyperplasia": {
            "name": "Nodular Regenerative Hyperplasia",
            "url": "https://app.pathprimer.com/document/00872140-a033-414b-8452-a96a925f53b9/lesson/85b5dfc8-4317-40a0-93bc-f5740c12ad1b",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Nodular regenerative hyperplasia (NRH) results from changes in hepatic blood flow resulting from obliteration of small portal vein radicles"
                  },
                  {
                    "text": "Often occurs in setting of vascular disorders, rheumatologic diseases, hematological diseases, antineoplastic/immunosuppressive drugs, celiac disease, primary biliary cirrhosis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Symptomatic NRH clinically manifests as portal hypertension and its sequelae"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Most nodules are 1-3 mm but can be larger"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Diffuse replacement of liver parenchyma by small nodules without fibrous septa"
                  },
                  {
                    "text": "Nodules are often vague and ill definedTypically 1-3 mm",
                    "sub_points": [
                      "Typically 1-3 mm"
                    ]
                  },
                  {
                    "text": "No fibrous septa between nodulesHowever, focal sinusoidal or periportal fibrosis can be seen",
                    "sub_points": [
                      "However, focal sinusoidal or periportal fibrosis can be seen"
                    ]
                  },
                  {
                    "text": "Inflammation is absentBile ducts and hepatic arterioles are normal",
                    "sub_points": [
                      "Bile ducts and hepatic arterioles are normal"
                    ]
                  },
                  {
                    "text": "ImmunohistochemistryIncreased GS and patchy CK7 staining in hepatocytes",
                    "sub_points": [
                      "Increased GS and patchy CK7 staining in hepatocytes"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cirrhosis"
                  },
                  {
                    "text": "Focal nodular hyperplasia"
                  },
                  {
                    "text": "Hepatic adenomatosis"
                  },
                  {
                    "text": "Partial nodular transformation"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Reticulin stain should be obtained in all cases of unexplained portal hypertension"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Nodular regenerative hyperplasia (NRH)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Pattern of liver injury associated with many underlying causesFormation of nodules with minimal or no fibrosisBelieved to be related to ischemic atrophy with secondary nodular hyperplasia in areas with good blood flow",
                    "sub_points": [
                      "Formation of nodules with minimal or no fibrosis",
                      "Believed to be related to ischemic atrophy with secondary nodular hyperplasia in areas with good blood flow"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanism": [
                  {
                    "text": "Results from changes in hepatic blood flow resulting from obliteration of small portal vein radicles"
                  },
                  {
                    "text": "Obliterative changes in some portal vein radicles lead to localized areas of decreased blood flow and atrophy"
                  },
                  {
                    "text": "Portal hypertension results from obliterative portal venopathy or sinusoidal compression by nodules"
                  }
                ],
                "Clinical Associations": [
                  {
                    "text": "Vascular disordersPortal vein thrombosis, Budd-Chiari syndrome",
                    "sub_points": [
                      "Portal vein thrombosis, Budd-Chiari syndrome"
                    ]
                  },
                  {
                    "text": "Rheumatologic diseasesRheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, polyarteritis nodosa",
                    "sub_points": [
                      "Rheumatoid arthritis, systemic lupus erythematosus, antiphospholipid syndrome, polyarteritis nodosa"
                    ]
                  },
                  {
                    "text": "Hematologic diseasesLymphoma, leukemia, myeloproliferative disorders, sickle cell anemia, extramedullary hematopoiesis",
                    "sub_points": [
                      "Lymphoma, leukemia, myeloproliferative disorders, sickle cell anemia, extramedullary hematopoiesis"
                    ]
                  },
                  {
                    "text": "Antineoplastic/immunosuppressive drugsAzathioprine, 6-thioguanine, busulphan, doxorubicin, cyclophosphamide",
                    "sub_points": [
                      "Azathioprine, 6-thioguanine, busulphan, doxorubicin, cyclophosphamide"
                    ]
                  },
                  {
                    "text": "Other disordersPrimary biliary cirrhosis, cardiac failure, celiac disease, liver tumors (rare)",
                    "sub_points": [
                      "Primary biliary cirrhosis, cardiac failure, celiac disease, liver tumors (rare)"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "More prevalent in elderly but can occur in children"
                  },
                  {
                    "text": "Underlying disease is often clinically evident long before NRH becomes symptomatic"
                  },
                  {
                    "text": "Portal hypertension and its sequelae: Variceal bleeding, ascites, and splenomegaly"
                  },
                  {
                    "text": "NRH should always be considered in setting of portal hypertension without cirrhosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Liver transaminases and serum bilirubin usually normal"
                  },
                  {
                    "text": "Alkaline phosphatase elevated in 25-50% of cases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Identification and treatment of underlying etiology"
                  },
                  {
                    "text": "Portosystemic shunt for portal hypertension"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Imaging can be normal or show diffuse nodularity mimicking cirrhosis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Diffuse replacement of liver parenchyma by small nodulesMost nodules are 1-3 mm but can be larger",
                    "sub_points": [
                      "Most nodules are 1-3 mm but can be larger"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Diagnosis may be difficult in small biopsies"
                  },
                  {
                    "text": "Vague, ill-defined, diffuse parenchymal nodulesHepatocytes in nodule arranged in plates that are 1-2 cells thickHepatocytes between nodules are small and atrophic; often compressed into thin, parallel platesVariation in hepatocytes within and between nodules is best demonstrated on reticulin stainRegenerative features (large nuclei, binucleation)",
                    "sub_points": [
                      "Hepatocytes in nodule arranged in plates that are 1-2 cells thick",
                      "Hepatocytes between nodules are small and atrophic; often compressed into thin, parallel platesVariation in hepatocytes within and between nodules is best demonstrated on reticulin stain",
                      "Variation in hepatocytes within and between nodules is best demonstrated on reticulin stain",
                      "Regenerative features (large nuclei, binucleation)"
                    ]
                  },
                  {
                    "text": "Sinusoidal dilation in areas of hepatocellular atrophy"
                  },
                  {
                    "text": "No fibrous septa around nodules; focal sinusoidal or periportal fibrosis can be seen"
                  },
                  {
                    "text": "Occlusion of small portal vein radicles can occur; larger portal veins are generally normal"
                  },
                  {
                    "text": "No inflammation; normal bile ducts and hepatic arterioles"
                  },
                  {
                    "text": "Increase in glutamine synthetase staining and patchy CK7(+) in hepatocytes can be seen"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cirrhosis": [
                  {
                    "text": "Fibrous septa around nodules unlike NRH"
                  }
                ],
                "Focal Nodular Hyperplasia": [
                  {
                    "text": "Usually solitary, < 5 cm"
                  },
                  {
                    "text": "Central scar, fibrous septa, aberrant arterioles, ductular reaction"
                  }
                ],
                "Hepatic Adenomatosis": [
                  {
                    "text": "Variably sized nodules with features of hepatic adenoma"
                  },
                  {
                    "text": "Multiple lesions but generally do not involve liver diffusely and uniformly"
                  },
                  {
                    "text": "Nodules typically larger than NRH"
                  }
                ],
                "Partial Nodular Transformation": [
                  {
                    "text": "Single or multiple nodules at or close to hepatic hilum"
                  },
                  {
                    "text": "Size of nodules larger than nodules in NRH (3-5 cm)"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Reticulin stain should be obtained in all cases of unexplained portal hypertension"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Nonneoplastic Lesions: Transplant Pathology": {
        "name": "Liver Nonneoplastic Lesions: Transplant Pathology",
        "url": "https://app.pathprimer.com/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
        "topics": {
          "Preservation Injury": {
            "name": "Preservation Injury",
            "url": "https://app.pathprimer.com/document/df30526c-e222-4393-ba1f-420c26ede06b/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Tissue damage sustained during harvesting, preservation, transportation, and reperfusion"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Cold ischemiaProlonged storage in preservation solutions",
                    "sub_points": [
                      "Prolonged storage in preservation solutions"
                    ]
                  },
                  {
                    "text": "Warm ischemiaCompromised blood flow to liver at body temperature before and during harvestingResumption of blood flow after implantation",
                    "sub_points": [
                      "Compromised blood flow to liver at body temperature before and during harvesting",
                      "Resumption of blood flow after implantation"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Elevation of serum transaminases and poor bile production within 24-48 hours after revascularization"
                  },
                  {
                    "text": "Enzyme levels typically decrease progressively within several days if graft survives injury"
                  },
                  {
                    "text": "Complete resolution in most cases"
                  },
                  {
                    "text": "Graft failure in rare occasions (primary nonfunction)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hepatocyte ballooning and microvesicular/small droplet steatosis at zone 3, imparting distinct pale appearance on low-power view"
                  },
                  {
                    "text": "Hepatocyte detachment from each other, scattered acidophil bodies, and spotty necrosis"
                  },
                  {
                    "text": "Confluent zone 3 necrosis in severe cases, can also involve periportal areas"
                  },
                  {
                    "text": "Cytoplasmic and canalicular cholestasis, more pronounced at zone 3"
                  },
                  {
                    "text": "Varying degree of neutrophilic infiltrates in lobules"
                  },
                  {
                    "text": "No significant portal inflammation in general"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Antibody-mediated rejection"
                  },
                  {
                    "text": "Hepatic artery thrombosis"
                  },
                  {
                    "text": "Hepatic vein stenosis and thrombosis"
                  },
                  {
                    "text": "Biliary obstruction"
                  },
                  {
                    "text": "\"Surgical hepatitis\""
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Preservation/reperfusion injury"
                  },
                  {
                    "text": "Ischemia and reperfusion injury"
                  },
                  {
                    "text": "Harvesting injury"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Tissue damage sustained during harvesting, preservation, transportation, and reperfusion"
                  },
                  {
                    "text": "One of major causes of initial graft dysfunction"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Ischemic Injury": [
                  {
                    "text": "4 stagesPrepreservation injuryCold preservationRewarmingReperfusion injury",
                    "sub_points": [
                      "Prepreservation injury",
                      "Cold preservation",
                      "Rewarming",
                      "Reperfusion injury"
                    ]
                  },
                  {
                    "text": "2 types of ischemic injuryCold ischemiaProlonged storage in preservation solutions (< 12 hours)Preferentially targets sinusoidal endothelial cellsWarm ischemiaCompromised blood flow to liver at body temperature before and during harvestingResumption of blood flow after implantationPrimarily damages hepatocytes",
                    "sub_points": [
                      "Cold ischemiaProlonged storage in preservation solutions (< 12 hours)Preferentially targets sinusoidal endothelial cells",
                      "Prolonged storage in preservation solutions (< 12 hours)",
                      "Preferentially targets sinusoidal endothelial cells",
                      "Warm ischemiaCompromised blood flow to liver at body temperature before and during harvestingResumption of blood flow after implantationPrimarily damages hepatocytes",
                      "Compromised blood flow to liver at body temperature before and during harvesting",
                      "Resumption of blood flow after implantation",
                      "Primarily damages hepatocytes"
                    ]
                  },
                  {
                    "text": "Bile duct epithelium, Kupffer cells, and Ito cells sensitive to both cold and warm ischemia"
                  },
                  {
                    "text": "Severity of injury depends on type and duration of ischemic stress"
                  },
                  {
                    "text": "Preexisting donor risk factorsSevere large droplet macrovesicular steatosis (> 30%)Donation after cardiac deathProlonged stay in intensive care unitIncreasing donor age",
                    "sub_points": [
                      "Severe large droplet macrovesicular steatosis (> 30%)",
                      "Donation after cardiac death",
                      "Prolonged stay in intensive care unit",
                      "Increasing donor age"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Elevation of serum transaminases and poor bile production within first 24-48 hours after revascularizationEnzyme levels typically decrease progressively within several days if graft survives injuryAbnormal liver tests may persist for several months if injury is severe",
                    "sub_points": [
                      "Enzyme levels typically decrease progressively within several days if graft survives injury",
                      "Abnormal liver tests may persist for several months if injury is severe"
                    ]
                  },
                  {
                    "text": "Clinical resolution usually observed within 1-4 weeks"
                  }
                ],
                "Treatment": [
                  {
                    "text": "No specific therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Complete resolution in most casesGraft failure in rare occasions (primary nonfunction)",
                    "sub_points": [
                      "Graft failure in rare occasions (primary nonfunction)"
                    ]
                  },
                  {
                    "text": "Higher incidence of subsequent acute and chronic rejection"
                  },
                  {
                    "text": "Higher incidence of biliary complications, such as ischemic cholangiopathy"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hepatocyte injury, primarily at zone 3Hepatocyte ballooning and microvesicular/small droplet steatosisImparts distinct pale appearance on low-power viewHepatocyte detachment from each other, scattered acidophil bodies, and spotty necrosisConfluent necrosis in severe casesCan also involve periportal areasDamaged hepatocytes may release existing fat into extracellular spaces (lipopeliosis)",
                    "sub_points": [
                      "Hepatocyte ballooning and microvesicular/small droplet steatosisImparts distinct pale appearance on low-power view",
                      "Imparts distinct pale appearance on low-power view",
                      "Hepatocyte detachment from each other, scattered acidophil bodies, and spotty necrosis",
                      "Confluent necrosis in severe casesCan also involve periportal areas",
                      "Can also involve periportal areas",
                      "Damaged hepatocytes may release existing fat into extracellular spaces (lipopeliosis)"
                    ]
                  },
                  {
                    "text": "Varying degree of neutrophilic infiltrates in lobulesNo significant portal inflammation, in general",
                    "sub_points": [
                      "No significant portal inflammation, in general"
                    ]
                  },
                  {
                    "text": "Biliary/cholestatic changesCytoplasmic and canalicular cholestasisMore pronounced at zone 3Bile duct degeneration and detachment of duct epithelium from basement membraneDuctular reaction, sometimes with ductular cholestasis and bile plugsNo significant bile duct injury in most cases",
                    "sub_points": [
                      "Cytoplasmic and canalicular cholestasisMore pronounced at zone 3",
                      "More pronounced at zone 3",
                      "Bile duct degeneration and detachment of duct epithelium from basement membrane",
                      "Ductular reaction, sometimes with ductular cholestasis and bile plugs",
                      "No significant bile duct injury in most cases"
                    ]
                  },
                  {
                    "text": "Resolving preservation injury with regenerative changes of hepatocytesIncreased mitotic activity, nuclear enlargement, frequent binucleation, and thickened cell platesMild ballooning and cytoplasmic cholestasis may persist for several weeksZone 3 histiocytes and other inflammatory cells",
                    "sub_points": [
                      "Increased mitotic activity, nuclear enlargement, frequent binucleation, and thickened cell plates",
                      "Mild ballooning and cytoplasmic cholestasis may persist for several weeks",
                      "Zone 3 histiocytes and other inflammatory cells"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Antibody-Mediated Rejection": [
                  {
                    "text": "Preformed donor-reactive antibodies in recipient"
                  },
                  {
                    "text": "Hemorrhagic necrosis of graft with fibrin thrombi"
                  },
                  {
                    "text": "Fibrinoid necrosis of hepatic artery branches"
                  }
                ],
                "Hepatic Artery Thrombosis": [
                  {
                    "text": "Doppler ultrasound and angiography are diagnostic"
                  },
                  {
                    "text": "Massive or zone 3 coagulative necrosis"
                  },
                  {
                    "text": "Bile duct necrosis"
                  }
                ],
                "Hepatic Vein Stenosis and Thrombosis": [
                  {
                    "text": "Doppler ultrasound and venography are diagnostic"
                  },
                  {
                    "text": "Zone 3 congestion, hemorrhage, and necrosis"
                  }
                ],
                "Biliary Obstruction": [
                  {
                    "text": "Cholangiography is diagnostic"
                  },
                  {
                    "text": "Portal edema, prominent ductular reaction, and neutrophilic portal infiltrates"
                  },
                  {
                    "text": "Portal and periportal fibrosis may develop rapidly"
                  }
                ],
                "\"Surgical Hepatitis\"": [
                  {
                    "text": "Clusters of neutrophils in sinusoids, without necrosis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Zone 3 hepatocyte damage characterized by ballooning, necrosis, and cholestasis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Antibody-Mediated Rejection": {
            "name": "Antibody-Mediated Rejection",
            "url": "https://app.pathprimer.com/document/2385bdae-4e25-4c7d-bb9c-af369350035d/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Graft dysfunction mediated by antibodies directed against donor antigens; preformed antibodies or donor-specific antibodies (DSA) developed after transplantation"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hyperacute antibody-mediated rejection (AMR)Fibrin thrombi in portal and central veins and sinusoidsNeutrophilic &/or fibrinoid arteritisPatchy or massive hemorrhagic hepatocyte necrosis",
                    "sub_points": [
                      "Fibrin thrombi in portal and central veins and sinusoids",
                      "Neutrophilic &/or fibrinoid arteritis",
                      "Patchy or massive hemorrhagic hepatocyte necrosis"
                    ]
                  },
                  {
                    "text": "Acute AMR (Banff criteria 2016)Definite (requires all 4 criteria)Histologic pattern of injuryPositive serum DSADiffuse (> 50%) C4d depositionReasonable exclusion of competing etiologiesSuspicious (requires both criteria)Positive serum DSAC4d-score + H-score = 3 or 4Indeterminate (requires 1st 2 criteria + 3 or 4)C4d-score + H-score ≥ 2DSA is not available, equivocal, or negativeC4d is not available, equivocal, negativeCoexisting insult might be contributing to injury",
                    "sub_points": [
                      "Definite (requires all 4 criteria)Histologic pattern of injuryPositive serum DSADiffuse (> 50%) C4d depositionReasonable exclusion of competing etiologies",
                      "Histologic pattern of injury",
                      "Positive serum DSA",
                      "Diffuse (> 50%) C4d deposition",
                      "Reasonable exclusion of competing etiologies",
                      "Suspicious (requires both criteria)Positive serum DSAC4d-score + H-score = 3 or 4",
                      "Positive serum DSA",
                      "C4d-score + H-score = 3 or 4",
                      "Indeterminate (requires 1st 2 criteria + 3 or 4)C4d-score + H-score ≥ 2DSA is not available, equivocal, or negativeC4d is not available, equivocal, negativeCoexisting insult might be contributing to injury",
                      "C4d-score + H-score ≥ 2",
                      "DSA is not available, equivocal, or negative",
                      "C4d is not available, equivocal, negative",
                      "Coexisting insult might be contributing to injury"
                    ]
                  },
                  {
                    "text": "Chronic AMR (Banff criteria 2016)Probable (requires all 4 criteria)Histologic pattern of injuryRecent (< 3 months) positive serum DSAAt least focal (> 10%) C4d deposition in portal microvasculatureReasonable exclusion of other competing etiologiesPossible; as above, but C4d is minimal (< 10%) or absent",
                    "sub_points": [
                      "Probable (requires all 4 criteria)Histologic pattern of injuryRecent (< 3 months) positive serum DSAAt least focal (> 10%) C4d deposition in portal microvasculatureReasonable exclusion of other competing etiologies",
                      "Histologic pattern of injury",
                      "Recent (< 3 months) positive serum DSA",
                      "At least focal (> 10%) C4d deposition in portal microvasculature",
                      "Reasonable exclusion of other competing etiologies",
                      "Possible; as above, but C4d is minimal (< 10%) or absent"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Vascular thrombosis"
                  },
                  {
                    "text": "Biliary obstruction"
                  },
                  {
                    "text": "Preservation injury"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Antibody-mediated rejection (AMR)"
                  },
                  {
                    "text": "Donor-specific antibodies (DSA)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Humoral rejection"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Graft dysfunction mediated by antibodies directed against donor antigens"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Preformed Antibodies": [
                  {
                    "text": "Major ABO blood group isoagglutinins"
                  },
                  {
                    "text": "Lymphocytotoxic antibodies against major histocompatibility complex (MHC) antigens"
                  }
                ],
                "De Novo DSA Formed After Transplantation": [
                  {
                    "text": "Seen in 8-15% of liver transplant recipients"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "AMR mediated by preformed antibodiesUp to 35% in ABO-incompatible transplants< 1% in ABO-compatible transplants",
                    "sub_points": [
                      "Up to 35% in ABO-incompatible transplants",
                      "< 1% in ABO-compatible transplants"
                    ]
                  },
                  {
                    "text": "AMR mediated by DSA developed after transplantationUnknown",
                    "sub_points": [
                      "Unknown"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Hyperacute AMRSevere graft dysfunction over period of hours to days following initial short period of normal reperfusion and bile productionSeen in ABO-incompatible transplants",
                    "sub_points": [
                      "Severe graft dysfunction over period of hours to days following initial short period of normal reperfusion and bile production",
                      "Seen in ABO-incompatible transplants"
                    ]
                  },
                  {
                    "text": "Acute AMRVarying degrees of graft dysfunction in 1st several weeks after transplantationLate onset (> 6 months) may occurSeen in ABO-compatible transplantsAlso seen in ABO-incompatible transplants treated with B-cell-directed immunosuppression",
                    "sub_points": [
                      "Varying degrees of graft dysfunction in 1st several weeks after transplantation",
                      "Late onset (> 6 months) may occur",
                      "Seen in ABO-compatible transplants",
                      "Also seen in ABO-incompatible transplants treated with B-cell-directed immunosuppression"
                    ]
                  },
                  {
                    "text": "Chronic AMRPoorly defined",
                    "sub_points": [
                      "Poorly defined"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Immunosuppression"
                  },
                  {
                    "text": "Anti-CD20 antibody (rituximab) therapy"
                  },
                  {
                    "text": "Plasmapheresis"
                  },
                  {
                    "text": "Retransplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Graft failure"
                  },
                  {
                    "text": "Increased incidence of graft complications, such as ischemic cholangiopathy and hepatic artery stenosis"
                  }
                ]
              },
              "IMAGING": {
                "Hepatic Artery Angiogram": [
                  {
                    "text": "Segmental or diffuse luminal narrowing with poor peripheral filling, indicative of vasospasm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hyperacute AMRFibrin thrombi in portal and central veins and sinusoidsNeutrophilic &/or fibrinoid arteritisPatchy or massive hemorrhagic hepatocyte necrosisPortal edema, hemorrhage, ductular reaction, and cholangitis",
                    "sub_points": [
                      "Fibrin thrombi in portal and central veins and sinusoids",
                      "Neutrophilic &/or fibrinoid arteritis",
                      "Patchy or massive hemorrhagic hepatocyte necrosis",
                      "Portal edema, hemorrhage, ductular reaction, and cholangitis"
                    ]
                  },
                  {
                    "text": "Acute AMR (Banff criteria 2016)Definite (requires all 4 criteria)Histologic pattern of injuryDilation of portal veins and capillaries with endothelial hypertrophyMonocytic, eosinophilic, or neutrophilic microvasculitis (H-score 1: 3-4 marginated or intraluminal cells; 2: 5-10 cells; 3: > 10 cells)Portal edema, ductular reactionCholestasis is usually present, but variablePeriportal hepatocyte necrosis may be prominent in ABO-incompatible graftsVariable lymphocytic &/or necrotizing arteritisPositive serum DSADiffuse C4d deposition (C4d-score 3: > 50%)Staining portal stroma in ABO-incompatible graftsStrong linear/granular staining of endothelial cellsC4d-score 0: negative; 1: minimal (< 10% portal tracts); 2: focal (10-50%); 3: diffuse (> 50%)Reasonable exclusion of competing etiologiesSuspicious (requires both criteria)Positive serum DSAC4d-score + H-score = 3 or 4Indeterminate (requires 1st 2 criteria + 3 or 4)C4d-score + H-score ≥ 2DSA is not available, equivocal, or negativeC4d is not available, equivocal, negativeCoexisting insult might be contributing to injury",
                    "sub_points": [
                      "Definite (requires all 4 criteria)Histologic pattern of injuryDilation of portal veins and capillaries with endothelial hypertrophyMonocytic, eosinophilic, or neutrophilic microvasculitis (H-score 1: 3-4 marginated or intraluminal cells; 2: 5-10 cells; 3: > 10 cells)Portal edema, ductular reactionCholestasis is usually present, but variablePeriportal hepatocyte necrosis may be prominent in ABO-incompatible graftsVariable lymphocytic &/or necrotizing arteritisPositive serum DSADiffuse C4d deposition (C4d-score 3: > 50%)Staining portal stroma in ABO-incompatible graftsStrong linear/granular staining of endothelial cellsC4d-score 0: negative; 1: minimal (< 10% portal tracts); 2: focal (10-50%); 3: diffuse (> 50%)Reasonable exclusion of competing etiologies",
                      "Histologic pattern of injuryDilation of portal veins and capillaries with endothelial hypertrophyMonocytic, eosinophilic, or neutrophilic microvasculitis (H-score 1: 3-4 marginated or intraluminal cells; 2: 5-10 cells; 3: > 10 cells)Portal edema, ductular reactionCholestasis is usually present, but variablePeriportal hepatocyte necrosis may be prominent in ABO-incompatible graftsVariable lymphocytic &/or necrotizing arteritis",
                      "Dilation of portal veins and capillaries with endothelial hypertrophy",
                      "Monocytic, eosinophilic, or neutrophilic microvasculitis (H-score 1: 3-4 marginated or intraluminal cells; 2: 5-10 cells; 3: > 10 cells)",
                      "Portal edema, ductular reaction",
                      "Cholestasis is usually present, but variable",
                      "Periportal hepatocyte necrosis may be prominent in ABO-incompatible grafts",
                      "Variable lymphocytic &/or necrotizing arteritis",
                      "Positive serum DSA",
                      "Diffuse C4d deposition (C4d-score 3: > 50%)Staining portal stroma in ABO-incompatible graftsStrong linear/granular staining of endothelial cellsC4d-score 0: negative; 1: minimal (< 10% portal tracts); 2: focal (10-50%); 3: diffuse (> 50%)",
                      "Staining portal stroma in ABO-incompatible grafts",
                      "Strong linear/granular staining of endothelial cells",
                      "C4d-score 0: negative; 1: minimal (< 10% portal tracts); 2: focal (10-50%); 3: diffuse (> 50%)",
                      "Reasonable exclusion of competing etiologies",
                      "Suspicious (requires both criteria)Positive serum DSAC4d-score + H-score = 3 or 4",
                      "Positive serum DSA",
                      "C4d-score + H-score = 3 or 4",
                      "Indeterminate (requires 1st 2 criteria + 3 or 4)C4d-score + H-score ≥ 2DSA is not available, equivocal, or negativeC4d is not available, equivocal, negativeCoexisting insult might be contributing to injury",
                      "C4d-score + H-score ≥ 2",
                      "DSA is not available, equivocal, or negative",
                      "C4d is not available, equivocal, negative",
                      "Coexisting insult might be contributing to injury"
                    ]
                  },
                  {
                    "text": "Chronic AMR (Banff criteria 2016)Probable (requires all 4 criteria)Histologic pattern of injuryUnexplained, at least mild portal &/or perivenular mononuclear cell inflammation with interface &/or perivenular activityAt least moderate portal/periportal, sinusoidal, &/or perivenular fibrosisRecent (< 3 months) positive serum DSAAt least focal C4d deposition in portal microvasculatureReasonable exclusion of competing etiologiesPossible; as above, but C4d is minimal or absent",
                    "sub_points": [
                      "Probable (requires all 4 criteria)Histologic pattern of injuryUnexplained, at least mild portal &/or perivenular mononuclear cell inflammation with interface &/or perivenular activityAt least moderate portal/periportal, sinusoidal, &/or perivenular fibrosisRecent (< 3 months) positive serum DSAAt least focal C4d deposition in portal microvasculatureReasonable exclusion of competing etiologies",
                      "Histologic pattern of injuryUnexplained, at least mild portal &/or perivenular mononuclear cell inflammation with interface &/or perivenular activityAt least moderate portal/periportal, sinusoidal, &/or perivenular fibrosis",
                      "Unexplained, at least mild portal &/or perivenular mononuclear cell inflammation with interface &/or perivenular activity",
                      "At least moderate portal/periportal, sinusoidal, &/or perivenular fibrosis",
                      "Recent (< 3 months) positive serum DSA",
                      "At least focal C4d deposition in portal microvasculature",
                      "Reasonable exclusion of competing etiologies",
                      "Possible; as above, but C4d is minimal or absent"
                    ]
                  },
                  {
                    "text": "Frequent overlap with T-cell-mediated rejection"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "C4d Immunohistochemistry": [
                  {
                    "text": "May or may not correlate with DSA"
                  },
                  {
                    "text": "Can be difficult to interpret due to high background"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Vascular Thrombosis": [
                  {
                    "text": "Zone 3 hepatocyte damage"
                  }
                ],
                "Biliary Obstruction": [
                  {
                    "text": "Cholangiography is diagnostic"
                  },
                  {
                    "text": "More pronounced ductular reaction and fibrosis"
                  }
                ],
                "Preservation Injury": [
                  {
                    "text": "Zone 3 hepatocyte damage"
                  },
                  {
                    "text": "Progressive resolution"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Severe graft dysfunction immediately or during 1st week following revascularization"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Massive hemorrhagic necrosis and thrombosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "T-Cell-Mediated Rejection (Acute Cellular Rejection)": {
            "name": "T-Cell-Mediated Rejection (Acute Cellular Rejection)",
            "url": "https://app.pathprimer.com/document/b856f9a0-9496-4b37-8ec3-1d10e4ad61f7/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "T-cell-mediated immune reaction to \"foreign\" donor HLA class I and II antigens present on allograft"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Activated donor dendritic cells from allograft migrate to recipient lymph nodes and present donor alloantigens, recipient mounts CD4 and CD8 T-cell immune response"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "May occur few days to years after transplantation"
                  },
                  {
                    "text": "Early onset/acute: May be asymptomatic, abnormal liver tests, fever, hepatomegaly, ascites, abdominal painPreferential elevation of alkaline phosphataseResponds well to steroid bolus, leads to chronic rejection if untreated or refractory",
                    "sub_points": [
                      "Preferential elevation of alkaline phosphatase",
                      "Responds well to steroid bolus, leads to chronic rejection if untreated or refractory"
                    ]
                  },
                  {
                    "text": "Late-onset/atypical forms: May be asymptomatic, abnormal liver tests, jaundice, abdominal pain, malaise, feverElevated transaminases, bilirubin, alkaline phosphataseLess responsive to steroid bolus, 2nd-line drugs needed, more likely to progress to chronic rejection",
                    "sub_points": [
                      "Elevated transaminases, bilirubin, alkaline phosphatase",
                      "Less responsive to steroid bolus, 2nd-line drugs needed, more likely to progress to chronic rejection"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Classic T-cell-mediated rejection (TCMR): Triad of mixed portal inflammation, bile duct damage, and endotheliitis"
                  },
                  {
                    "text": "Late-onset TCMR: Same features as classic but \"muted\""
                  },
                  {
                    "text": "Central perivenulitis: Endotheliitis of central veins, perivenular inflammation, and hepatocyte dropout"
                  },
                  {
                    "text": "Plasma cell-rich rejection: Portal &/or perivenular inflammation with > 30% plasma cells"
                  },
                  {
                    "text": "Hepatitic rejection: Lobular necroinflammation not restricted to interface or perivenular areas"
                  },
                  {
                    "text": "Idiopathic posttransplant hepatitis: Chronic hepatitis with no identifiable cause"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Recurrent chronic viral hepatitis B/C, autoimmune hepatitis"
                  },
                  {
                    "text": "Biliary complications"
                  },
                  {
                    "text": "Nonhepatotropic viral infections (CMV, EBV)"
                  },
                  {
                    "text": "Posttransplant lymphoproliferative disorders"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "T-cell-mediated rejection (TCMR)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Acute cellular rejection early-onset TCMR (within 6 months)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "T-cell-mediated immune reaction to \"foreign\" donor HLA class I and II antigens present on allograft"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "": [
                  {
                    "text": "Activated donor dendritic cells from allograft migrate to recipient lymph nodes and present donor alloantigens, recipient mounts T-cell-mediated immune response with CD4 and CD8 T cells, which damage allograft"
                  },
                  {
                    "text": "Damage to hepatocytes and sinusoidal cells during ischemia-reperfusion creates proinflammatory microenvironment for TCMR to occurUpregulation of MHC antigens, release of proinflammatory cytokines, recruitment of lymphocytes",
                    "sub_points": [
                      "Upregulation of MHC antigens, release of proinflammatory cytokines, recruitment of lymphocytes"
                    ]
                  },
                  {
                    "text": "Plasma cell-rich rejection: Donor-specific antibodies to glutathione S-transferase T1"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Affects ~ 20-40% of liver allograft recipientsAll liver transplant recipients are susceptibleMore frequent in younger, healthier recipients; recipients with immune dysregulation; older donors; long cold ischemia time",
                    "sub_points": [
                      "All liver transplant recipients are susceptible",
                      "More frequent in younger, healthier recipients; recipients with immune dysregulation; older donors; long cold ischemia time"
                    ]
                  },
                  {
                    "text": "Few days to years after transplantation"
                  },
                  {
                    "text": "Early onset/acute: May be asymptomatic, abnormal liver tests on follow-up; may present with fever, hepatomegaly, ascites, abdominal pain"
                  },
                  {
                    "text": "Late-onset/atypical forms: May be asymptomatic, abnormal liver tests, jaundice, abdominal pain, malaise, fever"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Early onset/acute: Preferential elevation of alkaline phosphatase followed by transaminases and bilirubin"
                  },
                  {
                    "text": "Late-onset/atypical forms: Elevated transaminases, bilirubin, alkaline phosphatase"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Early onset/acute: Responds well to steroid bolus, leads to chronic rejection if untreated or refractory"
                  },
                  {
                    "text": "Late-onset/atypical forms: Less responsive to immunosuppression, 2nd-line drugs needed, more likely to progress to chronic rejection"
                  },
                  {
                    "text": "Central perivenulitis (parenchymal rejection): Higher risk of recurrence and progression to chronic rejection"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Corticosteroids, usually as bolus, is standard therapy"
                  },
                  {
                    "text": "2nd-line drugs: OKT3, tacrolimus, mycophenolate"
                  },
                  {
                    "text": "May be managed by adjusting baseline immunosuppression"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Early onset/acute: Very good if recognized and treated"
                  },
                  {
                    "text": "Late-onset/atypical forms: Variable, may respond to increased immunosuppression, may progress to chronic rejection or graft failure at variable rate"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Classic TCMR: Triad of mixed portal inflammation, bile duct damage, and endotheliitisPortal inflammation composed of enlarged, activated lymphocytes, eosinophils, neutrophils, and macrophagesBile duct damage with intraepithelial lymphocytes; nuclear overlapping, enlargement, pleomorphism; cytoplasmic vacuolation and eosinophiliaEndotheliitis with subendothelial lymphocytes, lymphocytes attached to endothelium; endothelium damaged, swollen, detached",
                    "sub_points": [
                      "Portal inflammation composed of enlarged, activated lymphocytes, eosinophils, neutrophils, and macrophages",
                      "Bile duct damage with intraepithelial lymphocytes; nuclear overlapping, enlargement, pleomorphism; cytoplasmic vacuolation and eosinophilia",
                      "Endotheliitis with subendothelial lymphocytes, lymphocytes attached to endothelium; endothelium damaged, swollen, detached"
                    ]
                  },
                  {
                    "text": "Late-onset TCMR: Same features as classic but \"muted\""
                  },
                  {
                    "text": "Central perivenulitis (parenchymal rejection): Endotheliitis of central veins, perivenular inflammation, and hepatocyte dropoutMay occur without typical portal features (isolated central perivenulitis)",
                    "sub_points": [
                      "May occur without typical portal features (isolated central perivenulitis)"
                    ]
                  },
                  {
                    "text": "Plasma cell-rich rejection: Portal &/or perivenular inflammation with > 30% plasma cells"
                  },
                  {
                    "text": "Hepatitic rejection: Lobular necroinflammation not restricted to interface or perivenular areas"
                  },
                  {
                    "text": "Idiopathic posttransplant hepatitis: Chronic hepatitis with no identifiable cause, variable interface or lobular activity, no ductopenia, bile duct damage, endotheliitis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "": [
                  {
                    "text": "Search on for blood-based marker based on -omics and genetic testing"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Recurrent Chronic Viral Hepatitis B or C": [
                  {
                    "text": "Patient transplanted for chronic viral hepatitis"
                  },
                  {
                    "text": "Both TCMR and chronic viral hepatitis exhibit portal inflammation and can show endotheliitis"
                  },
                  {
                    "text": "Interface activity and lobular inflammation favor chronic viral hepatitisLate TCMR shows fewer blastic lymphocytes, less endotheliitis, and more lobular inflammation",
                    "sub_points": [
                      "Late TCMR shows fewer blastic lymphocytes, less endotheliitis, and more lobular inflammation"
                    ]
                  }
                ],
                "Biliary Complications": [
                  {
                    "text": "Neutrophil-rich portal inflammatory cell infiltrates, bile ductular reaction, portal edema ±"
                  },
                  {
                    "text": "Acute cholangitis shows collections of neutrophils within bile duct lumina"
                  }
                ],
                "Recurrent Autoimmune Hepatitis": [
                  {
                    "text": "Numerous plasma cells, perivenular inflammation, and interface hepatitisIf patient not transplanted for autoimmune hepatitis (AIH), above changes may represent plasma cell-rich TCMR",
                    "sub_points": [
                      "If patient not transplanted for autoimmune hepatitis (AIH), above changes may represent plasma cell-rich TCMR"
                    ]
                  }
                ],
                "Posttransplant Lymphoproliferative Disorders": [
                  {
                    "text": "B-cell proliferation (TCMR is T-cell process), EBV positive"
                  }
                ],
                "Nonhepatotropic Viral Infections": [
                  {
                    "text": "EBV: Sinusoidal lymphocytosis, atypical cells, stains for EBER, LMP"
                  },
                  {
                    "text": "CMV: Tiny microabscesses, punched-out areas of necrosis, prominent eosinophilic nuclear inclusions"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Rejection": {
            "name": "Chronic Rejection",
            "url": "https://app.pathprimer.com/document/f844e0e0-37cf-4765-8d87-9b9718416248/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Obliterative (foam cell) arteriopathySubintimal ± mural deposition of foam cell",
                    "sub_points": [
                      "Subintimal ± mural deposition of foam cell"
                    ]
                  },
                  {
                    "text": "Ductopenic rejectionLoss of bile ducts in > 50% of portal tracts",
                    "sub_points": [
                      "Loss of bile ducts in > 50% of portal tracts"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Evolves from severe, recurring, persistent, or intractable episodes of T-cell-mediated rejectionProgressive; eventually irreversible damage to bile ducts and vascular structures",
                    "sub_points": [
                      "Progressive; eventually irreversible damage to bile ducts and vascular structures"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Progressive jaundice, cholestatic biochemical profile"
                  },
                  {
                    "text": "Early chronic rejection may respond to potent immunosuppressants, such as tacrolimus, OKT3, mycophenolate, or rapamycin"
                  },
                  {
                    "text": "Late stages: Unresponsive to immunosuppression"
                  },
                  {
                    "text": "Progressive graft damage, retransplantation needed"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Early chronic rejectionLymphocytic cholangitis, biliary epithelial damageCholestasis, typically no prominent ductular reactionFoam cell arteriopathyIschemic perivenular hepatocyte drop-outMild to moderate lymphocytic portal inflammation",
                    "sub_points": [
                      "Lymphocytic cholangitis, biliary epithelial damageCholestasis, typically no prominent ductular reaction",
                      "Cholestasis, typically no prominent ductular reaction",
                      "Foam cell arteriopathyIschemic perivenular hepatocyte drop-out",
                      "Ischemic perivenular hepatocyte drop-out",
                      "Mild to moderate lymphocytic portal inflammation"
                    ]
                  },
                  {
                    "text": "Late chronic rejection: Above issues and also includesLoss of small bile ductsLuminal narrowing, loss of hepatic arteriesMinimal to no portal inflammationModerate to severe perivenular fibrosis",
                    "sub_points": [
                      "Loss of small bile ducts",
                      "Luminal narrowing, loss of hepatic arteries",
                      "Minimal to no portal inflammation",
                      "Moderate to severe perivenular fibrosis"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Ischemic cholangiopathy"
                  },
                  {
                    "text": "Recurrent primary biliary cholangitis"
                  },
                  {
                    "text": "Recurrent primary sclerosing cholangitis"
                  },
                  {
                    "text": "Vanishing bile duct syndrome induced by drugs/medications"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Ductopenic rejection"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Obliterative (foam cell) arteriopathySubintimal ± mural deposition of foam cellsAffects large- and medium-sized arteries, therefore not seen in needle biopsies",
                    "sub_points": [
                      "Subintimal ± mural deposition of foam cells",
                      "Affects large- and medium-sized arteries, therefore not seen in needle biopsies"
                    ]
                  },
                  {
                    "text": "Ductopenic rejectionLoss of bile ducts in > 50% of portal tractsAffects small bile ducts, visualized in needle biopsies",
                    "sub_points": [
                      "Loss of bile ducts in > 50% of portal tracts",
                      "Affects small bile ducts, visualized in needle biopsies"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Immune-Mediated Damage to Allograft": [
                  {
                    "text": "Evolves from severe, recurring, persistent or intractable episodes of T-cell-mediated rejectionProgressive; eventually irreversible graft damage",
                    "sub_points": [
                      "Progressive; eventually irreversible graft damage"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Usually occurs after 6 monthsRare documented cases of presentation < 6 months",
                    "sub_points": [
                      "Rare documented cases of presentation < 6 months"
                    ]
                  },
                  {
                    "text": "Progressive jaundice and elevated cholestatic enzymes"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Early chronic rejection may respond to potent immunosuppressants, such as tacrolimus, OKT3, mycophenolate, or rapamycin"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Unresponsive to immunosuppression, especially in late stages"
                  },
                  {
                    "text": "Progressive graft damage, retransplantation needed"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Early chronic rejectionLymphocytic cholangitis, biliary epithelial damageIschemic perivenular hepatocyte drop-out",
                    "sub_points": [
                      "Lymphocytic cholangitis, biliary epithelial damage",
                      "Ischemic perivenular hepatocyte drop-out"
                    ]
                  },
                  {
                    "text": "Late chronic rejectionLoss of small bile ducts\"Ductopenic\" when duct loss in > 50% of portal tractsTypically, ductular reaction not prominentSevere cholestasisFoam cell arteriopathy, arterial luminal narrowingLoss of hepatic arteriesIschemic perivenular necrosisMinimal to no portal inflammationModerate to severe perivenular fibrosis",
                    "sub_points": [
                      "Loss of small bile ducts\"Ductopenic\" when duct loss in > 50% of portal tractsTypically, ductular reaction not prominentSevere cholestasis",
                      "\"Ductopenic\" when duct loss in > 50% of portal tracts",
                      "Typically, ductular reaction not prominent",
                      "Severe cholestasis",
                      "Foam cell arteriopathy, arterial luminal narrowingLoss of hepatic arteriesIschemic perivenular necrosis",
                      "Loss of hepatic arteries",
                      "Ischemic perivenular necrosis",
                      "Minimal to no portal inflammation",
                      "Moderate to severe perivenular fibrosis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Ischemic Cholangiopathy": [
                  {
                    "text": "Imaging studies"
                  },
                  {
                    "text": "Chronic rejection often lacks prominent ductular reaction"
                  }
                ],
                "Recurrent Primary Biliary Cholangitis": [
                  {
                    "text": "Florid duct lesions, bile ductular reaction"
                  },
                  {
                    "text": "Positive antimitochondrial antibody (AMA)"
                  }
                ],
                "Recurrent Primary Sclerosing Cholangitis": [
                  {
                    "text": "Characteristic ERCP findings"
                  },
                  {
                    "text": "Portal inflammation with bile ductular reaction"
                  }
                ],
                "Drug-Induced Vanishing Bile Duct Syndrome": [
                  {
                    "text": "Temporal association with drugs known to cause ductopeniaAugmentin, Flucloxacillin",
                    "sub_points": [
                      "Augmentin, Flucloxacillin"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Previous episodes of severe, persistent, recurring, or intractable T-cell-mediated rejection"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Centrilobular necrosis &/or cholestasis in repeated biopsy specimens are clues to evolving chronic rejection"
                  },
                  {
                    "text": "Foam cell arteriopathy occurs in medium- or large-sized arteries and may not be seen in allograft biopsy specimens"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatic Artery Thrombosis": {
            "name": "Hepatic Artery Thrombosis",
            "url": "https://app.pathprimer.com/document/e72267e0-99dd-4467-92bb-07b8b4228516/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Thrombotic occlusion of hepatic artery &/or its branches"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Secondary to atherosclerosis, hypercoagulable state, complication after liver transplantation, or infusion of chemotherapeutic agentsResults in bile duct ischemia, hepatic parenchymal infarctionBile ducts depend on arterial flow and therefore suffer ischemic injury",
                    "sub_points": [
                      "Results in bile duct ischemia, hepatic parenchymal infarctionBile ducts depend on arterial flow and therefore suffer ischemic injury",
                      "Bile ducts depend on arterial flow and therefore suffer ischemic injury"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Relatively well tolerated in native liversAnastomosing blood supply with good collateralization protects against ischemic injury",
                    "sub_points": [
                      "Anastomosing blood supply with good collateralization protects against ischemic injury"
                    ]
                  },
                  {
                    "text": "Transplanted livers much more susceptible, especially early post transplant"
                  },
                  {
                    "text": "Symptoms related to acuity and ensuing complications"
                  },
                  {
                    "text": "Cholestatic liver function abnormalities are common"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Zone 3 hemorrhage and hepatocyte dropout in early posttransplant period"
                  },
                  {
                    "text": "Ischemic bile duct injuryDenuded, necrotic bile duct epithelium sloughs into lumen, forming eosinophilic bile castsBile leakage into periductal connective tissueIn time, chronic ischemia can lead to biliary strictures, fibrosis, and duct loss",
                    "sub_points": [
                      "Denuded, necrotic bile duct epithelium sloughs into lumen, forming eosinophilic bile casts",
                      "Bile leakage into periductal connective tissue",
                      "In time, chronic ischemia can lead to biliary strictures, fibrosis, and duct loss"
                    ]
                  },
                  {
                    "text": "Hepatic infarctionNecrosis of hepatocytes and portal connective tissue",
                    "sub_points": [
                      "Necrosis of hepatocytes and portal connective tissue"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Needle biopsy may not be representative, as ischemic features may be patchy"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatic artery thrombosis (HAT)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Thrombotic occlusion of hepatic artery &/or its branches"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Causes of Thrombosis": [
                  {
                    "text": "Atherosclerosis"
                  },
                  {
                    "text": "Hypercoagulable state"
                  },
                  {
                    "text": "Anastomotic complication after liver transplantationGreatest risk with non-heart-beating donors",
                    "sub_points": [
                      "Greatest risk with non-heart-beating donors"
                    ]
                  },
                  {
                    "text": "Hepatic artery infusion of chemotherapeutic agents"
                  }
                ],
                "Sequelae": [
                  {
                    "text": "Bile duct ischemiaBile ducts dependent on hepatic artery flowAcute ischemia leads to biliary ulcers, duct necrosis, and bile leaksChronic ischemia leads to scarring, strictures, and duct loss",
                    "sub_points": [
                      "Bile ducts dependent on hepatic artery flowAcute ischemia leads to biliary ulcers, duct necrosis, and bile leaksChronic ischemia leads to scarring, strictures, and duct loss",
                      "Acute ischemia leads to biliary ulcers, duct necrosis, and bile leaks",
                      "Chronic ischemia leads to scarring, strictures, and duct loss"
                    ]
                  },
                  {
                    "text": "Hepatic infarction"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Relatively well tolerated in native liversAnastomosing blood supply with good collateralization is protective against ischemic injury",
                    "sub_points": [
                      "Anastomosing blood supply with good collateralization is protective against ischemic injury"
                    ]
                  },
                  {
                    "text": "Transplanted livers much more susceptible, especially in early posttransplant periodMost common cause of posttransplant vascular complicationsLiver grafts lack anastomosing blood supply and are more dependent on arterial inflowPediatric and split-liver grafts at greatest risk due to smaller vessels and greater technical difficulty",
                    "sub_points": [
                      "Most common cause of posttransplant vascular complications",
                      "Liver grafts lack anastomosing blood supply and are more dependent on arterial inflow",
                      "Pediatric and split-liver grafts at greatest risk due to smaller vessels and greater technical difficulty"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms related to acuity and ensuing complicationsFever, abdominal pain, bile peritonitis in some casesJaundiceFulminant hepatic failure",
                    "sub_points": [
                      "Fever, abdominal pain, bile peritonitis in some cases",
                      "Jaundice",
                      "Fulminant hepatic failure"
                    ]
                  },
                  {
                    "text": "Cholestatic liver function abnormalitiesElevated bilirubin, alkaline phosphatase, γ-glutamyl transferase",
                    "sub_points": [
                      "Elevated bilirubin, alkaline phosphatase, γ-glutamyl transferase"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Arterial thrombectomy or revascularization"
                  },
                  {
                    "text": "Liver transplantation/retransplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Long-term complications include ischemic cholangiopathy with stricture and duct loss"
                  },
                  {
                    "text": "Can lead to sepsis, fulminant hepatic failure, and multisystem organ failure"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "May appear grossly normal, especially on surface"
                  },
                  {
                    "text": "Mottled liver parenchyma with foci of parenchymal necrosis and bile leak"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Nonspecific zone 3 hemorrhage, inflammation, and hepatocyte dropoutOccurs very early in posttransplant period and mimics reperfusion injury",
                    "sub_points": [
                      "Occurs very early in posttransplant period and mimics reperfusion injury"
                    ]
                  },
                  {
                    "text": "Ischemic bile duct epithelial cell injuryBile duct necrosis with flattening of epithelium and cytoplasmic eosinophiliaEosinophilic bile casts composed of sloughed, necrotic biliary epithelial cellsBile leakage into periductal connective tissue",
                    "sub_points": [
                      "Bile duct necrosis with flattening of epithelium and cytoplasmic eosinophilia",
                      "Eosinophilic bile casts composed of sloughed, necrotic biliary epithelial cells",
                      "Bile leakage into periductal connective tissue"
                    ]
                  },
                  {
                    "text": "Necrosis of hepatocytes and portal connective tissue seen in hepatic infarctsMay develop secondary infection and abscesses",
                    "sub_points": [
                      "May develop secondary infection and abscesses"
                    ]
                  },
                  {
                    "text": "In time, ongoing ischemic injury can lead to biliary strictures, fibrosis, and duct loss"
                  },
                  {
                    "text": "Pattern of concurrent increase in hepatocyte mitosis and apoptosis without significant lobular inflammation has been strongly associated with hepatic arterial insufficiency"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "May be indistinguishable from chronic ischemia based on histologic features alone"
                  },
                  {
                    "text": "Distinct clinical pictureTypically young male patients with history of inflammatory bowel disease",
                    "sub_points": [
                      "Typically young male patients with history of inflammatory bowel disease"
                    ]
                  }
                ],
                "Acute or Chronic Allograft Rejection": [
                  {
                    "text": "Acute rejection shows typical rejection-type infiltrates and endotheliitis"
                  },
                  {
                    "text": "Chronic rejection shows senescent duct changes; associated with refractory or untreated acute rejection"
                  }
                ],
                "Other Biliary Complications": [
                  {
                    "text": "Biliary obstruction"
                  }
                ],
                "Ischemic Hepatitis": [
                  {
                    "text": "More diffuse process with zone 3 hepatocyte injury"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Ischemic features may be patchy, and large ducts are often not sampledNeedle biopsy may not be representative",
                    "sub_points": [
                      "Needle biopsy may not be representative"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Graft-vs.-Host Disease": {
            "name": "Graft-vs.-Host Disease",
            "url": "https://app.pathprimer.com/document/8b5bc75e-a6b7-4370-be00-d60106dc3975/lesson/8d5090e6-44dd-4394-bc83-f6711f040ebf",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Syndrome characterized by attack of immunocompetent, donor-derived cells against recipient tissues"
                  },
                  {
                    "text": "Acute graft-vs.-host disease (GVHD) classically diagnosed < 100 days post transplant"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Donor-derived T-lymphocyte response against immunocompromised host epitheliumImmunosuppressed recipient cannot destroy donor cells",
                    "sub_points": [
                      "Immunosuppressed recipient cannot destroy donor cells"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Represents major hepatic complication after stem cell transplant"
                  },
                  {
                    "text": "Common presenting signs are jaundice and hepatomegaly"
                  },
                  {
                    "text": "Elevated serum alkaline phosphatase and bilirubin"
                  },
                  {
                    "text": "Variably elevated transaminases"
                  },
                  {
                    "text": "Acute and chronic GVHD defined clinically but no clear histologic dichotomy; if untreated, may progress to bile duct loss and progressive fibrosis"
                  },
                  {
                    "text": "Increase immunosuppression; corticosteroids are 1st-line therapy"
                  },
                  {
                    "text": "Acute GVHD fatal in < 5% of patients"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Bile duct epithelial cell damage is key distinguishing featureEpithelial cell vacuolization, withering, sloughing, and attenuationLymphocytic infiltration",
                    "sub_points": [
                      "Epithelial cell vacuolization, withering, sloughing, and attenuation",
                      "Lymphocytic infiltration"
                    ]
                  },
                  {
                    "text": "Mild portal inflammation, endotheliitis; cholestasis, lobular inflammation, and hepatocyte swelling can occur"
                  },
                  {
                    "text": "Acute hepatitis pattern also described"
                  },
                  {
                    "text": "Chronic GVHD features ductopenia, fibrosis"
                  },
                  {
                    "text": "Histologic findings may be focal; diagnosis of possible GVHD is reasonable if overall findings are mild"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Graft-vs.-host disease (GVHD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Syndrome characterized by attack of immunocompetent, donor-derived cells against recipient tissuesUsually occurs in bone marrow transplant or hematopoietic stem cell transplant recipientsOccurs infrequently after solid organ transplant and, rarely, after blood transfusionDiagnostic criteria include clinical, laboratory, and histologic findings",
                    "sub_points": [
                      "Usually occurs in bone marrow transplant or hematopoietic stem cell transplant recipients",
                      "Occurs infrequently after solid organ transplant and, rarely, after blood transfusion",
                      "Diagnostic criteria include clinical, laboratory, and histologic findings"
                    ]
                  },
                  {
                    "text": "Acute GVHD occurs ≤ 100 days post transplant classicallyPersistent/recurrent acute GVHD has identical features of classic acute GVHD but usually develops with reduction of immunosuppression",
                    "sub_points": [
                      "Persistent/recurrent acute GVHD has identical features of classic acute GVHD but usually develops with reduction of immunosuppression"
                    ]
                  },
                  {
                    "text": "Chronic GVHD occurs > 100 days post transplant classicallyMay show overlap with acute GVHD",
                    "sub_points": [
                      "May show overlap with acute GVHD"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Immune Mediated": [
                  {
                    "text": "Donor-derived T-lymphocyte response against immunocompromised host epitheliumUsually due to graft major histocompatibility complex incompatibilityImmunosuppressed recipient cannot destroy donor cellsCan also occur with autologous and syngeneic grafts",
                    "sub_points": [
                      "Usually due to graft major histocompatibility complex incompatibility",
                      "Immunosuppressed recipient cannot destroy donor cells",
                      "Can also occur with autologous and syngeneic grafts"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Represents major hepatic complication after stem cell transplant"
                  },
                  {
                    "text": "Affects most hematopoietic stem cell recipients at some point in their course"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice, hepatomegaly"
                  },
                  {
                    "text": "Hepatomegaly"
                  },
                  {
                    "text": "Elevated liver function testsElevated serum alkaline phosphatase and bilirubinTransaminases mildly elevated; marked increase in hepatitis pattern of GVHDTransaminases can be markedly elevated in acute hepatitis pattern of GVHD",
                    "sub_points": [
                      "Elevated serum alkaline phosphatase and bilirubin",
                      "Transaminases mildly elevated; marked increase in hepatitis pattern of GVHD",
                      "Transaminases can be markedly elevated in acute hepatitis pattern of GVHD"
                    ]
                  },
                  {
                    "text": "Acute GVHD often accompanied by skin or gastrointestinal tract involvementRash, diarrhea, weight loss",
                    "sub_points": [
                      "Rash, diarrhea, weight loss"
                    ]
                  },
                  {
                    "text": "Chronic GVHD often presents with widespread diseaseWasting disease with salivary gland, oral, ocular, and musculoskeletal involvement",
                    "sub_points": [
                      "Wasting disease with salivary gland, oral, ocular, and musculoskeletal involvement"
                    ]
                  },
                  {
                    "text": "Hepatic failure and coagulopathy with advanced disease"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Acute and chronic GVHD defined clinically but no clear histologic dichotomy; if untreated, may progress to bile duct loss and progressive fibrosis"
                  }
                ],
                "Treatment": [],
                "Drugs": [
                  {
                    "text": "Increase immunosuppression; corticosteroids are 1st-line therapy"
                  },
                  {
                    "text": "Ursodeoxycholic acid used for prophylaxis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Acute GVHD fatal in < 5% of patients"
                  },
                  {
                    "text": "Persistent jaundice is poor prognostic sign"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Bile duct epithelial cell damageKey feature that distinguishes GVHD from other forms of hepatic injuryFindings may be focal and not present in every portal tractDamage of > 50% of ducts with minimal inflammation or duct loss (< 80% of portal tracts contain duct) is highly suggestive of GVHDLymphocytic infiltration of bile ductsEpithelial cell vacuolization and attenuationWithering, sloughing, and necrosis of biliary epithelial cellsUsually limited ductular reaction relative to biliary epithelial injuryDuctopenia with progression to chronic disease",
                    "sub_points": [
                      "Key feature that distinguishes GVHD from other forms of hepatic injuryFindings may be focal and not present in every portal tractDamage of > 50% of ducts with minimal inflammation or duct loss (< 80% of portal tracts contain duct) is highly suggestive of GVHD",
                      "Findings may be focal and not present in every portal tractDamage of > 50% of ducts with minimal inflammation or duct loss (< 80% of portal tracts contain duct) is highly suggestive of GVHD",
                      "Damage of > 50% of ducts with minimal inflammation or duct loss (< 80% of portal tracts contain duct) is highly suggestive of GVHD",
                      "Lymphocytic infiltration of bile ducts",
                      "Epithelial cell vacuolization and attenuation",
                      "Withering, sloughing, and necrosis of biliary epithelial cells",
                      "Usually limited ductular reaction relative to biliary epithelial injury",
                      "Ductopenia with progression to chronic disease"
                    ]
                  },
                  {
                    "text": "Endotheliitis may be seen (and, if present with bile duct injury, strongly suggests GVHD)"
                  },
                  {
                    "text": "Other nonspecific changesPortal inflammation, typically mildCholestasisHepatocyte swelling or apoptosis or lobular inflammationFibrosis with progression to chronic disease",
                    "sub_points": [
                      "Portal inflammation, typically mild",
                      "Cholestasis",
                      "Hepatocyte swelling or apoptosis or lobular inflammation",
                      "Fibrosis with progression to chronic disease"
                    ]
                  },
                  {
                    "text": "Acute hepatitis pattern also well describedMay have prominent portal plasmacytic infiltrate and numerous apoptotic bodiesMay have mixed typical and hepatitis pattern and can eventually progress to typical histologic pattern",
                    "sub_points": [
                      "May have prominent portal plasmacytic infiltrate and numerous apoptotic bodies",
                      "May have mixed typical and hepatitis pattern and can eventually progress to typical histologic pattern"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Drug-Induced Liver Injury": [
                  {
                    "text": "Wide variety of drugs can cause bile duct damage/ductopenia"
                  },
                  {
                    "text": "Cyclosporine causes mild hyperbilirubinemia by inhibiting canalicular bile transport"
                  }
                ],
                "Acute Hepatitis": [
                  {
                    "text": "Acute hepatitis pattern of GVHD can mimic other causes of acute hepatitis; specifically, herpes simplex virus (HSV), CMV, and adenovirus infection should be excluded"
                  }
                ],
                "Sepsis": [
                  {
                    "text": "Cholestasis, ductular reaction, cholangiolar bile plugs"
                  }
                ],
                "Posttransplant Lymphoproliferative Disorder": [
                  {
                    "text": "Mass-forming or diffuse sinusoidal infiltration with portal aggregates; B cells are predominant"
                  },
                  {
                    "text": "Epstein-Barr virus (EBV) ISH positive"
                  }
                ],
                "Recurrence of Primary Disease (Leukemia/Lymphoma)": [
                  {
                    "text": "Usually cytologic atypia; may form nodules or diffusely infiltrate liver; ancillary studies required"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Liver Tumors": {
        "name": "Liver Tumors",
        "url": "https://app.pathprimer.com/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
        "topics": {
          "Hepatocellular Adenoma": {
            "name": "Hepatocellular Adenoma",
            "url": "https://app.pathprimer.com/document/ace456f1-313a-473e-8afc-ef19e1730791/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Classification": [
                  {
                    "text": "HNF1Ainactivated"
                  },
                  {
                    "text": "β-catenin activatedExon 3 mutations (high or intermediate level activation): Best considered as atypical hepatocellular neoplasm (AHN) rather than hepatocellular adenoma (HCA) due to high risk of hepatocellular carcinoma (HCC)Exon 7 or 8 mutations (low-level activation): Often categorized as unclassified based on currently used immunohistochemistry for HCA",
                    "sub_points": [
                      "Exon 3 mutations (high or intermediate level activation): Best considered as atypical hepatocellular neoplasm (AHN) rather than hepatocellular adenoma (HCA) due to high risk of hepatocellular carcinoma (HCC)",
                      "Exon 7 or 8 mutations (low-level activation): Often categorized as unclassified based on currently used immunohistochemistry for HCA"
                    ]
                  },
                  {
                    "text": "Inflammatory"
                  },
                  {
                    "text": "UnclassifiedSonic hedgehog activated (shHCA) is new subtype",
                    "sub_points": [
                      "Sonic hedgehog activated (shHCA) is new subtype"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Associated with oral contraceptives or long-term steroids"
                  },
                  {
                    "text": "Associated with obesity and metabolic syndrome"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Typically in women of reproductive ageNoncirrhotic background liver",
                    "sub_points": [
                      "Noncirrhotic background liver"
                    ]
                  },
                  {
                    "text": "SymptomsAbdominal pain; acute, intermittent, or chronic",
                    "sub_points": [
                      "Abdominal pain; acute, intermittent, or chronic"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Benign hepatocytes, unpaired arterioles, intact reticulin"
                  },
                  {
                    "text": "HNF1A-inactivated HCA (HHCA): Often show prominent fatLoss of liver fatty acid binding protein (LFABP)",
                    "sub_points": [
                      "Loss of liver fatty acid binding protein (LFABP)"
                    ]
                  },
                  {
                    "text": "Inflammatory HCA (IHCA): Sinusoidal dilatation, ductular reaction, inflammationSAA &/or CRP positive",
                    "sub_points": [
                      "SAA &/or CRP positive"
                    ]
                  },
                  {
                    "text": "β-catenin activated: Cytoarchitectural atypiaDiffuse GS, nuclear β-catenin",
                    "sub_points": [
                      "Diffuse GS, nuclear β-catenin"
                    ]
                  },
                  {
                    "text": "shHCA: High risk of hemorrhage"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Well-differentiated HCC"
                  },
                  {
                    "text": "Focal nodular hyperplasia"
                  },
                  {
                    "text": "Epithelioid angiomyolipoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign liver neoplasm composed of cells with hepatocellular differentiation"
                  },
                  {
                    "text": "Adenomatosis> 10 adenomasAssociated withGlycogenosis type Ia or III, galactosemia, tyrosinemiaKlinefelter syndromeFamilial adenomatosis polyposisFaconi anemia",
                    "sub_points": [
                      "> 10 adenomas",
                      "Associated withGlycogenosis type Ia or III, galactosemia, tyrosinemiaKlinefelter syndromeFamilial adenomatosis polyposisFaconi anemia",
                      "Glycogenosis type Ia or III, galactosemia, tyrosinemia",
                      "Klinefelter syndrome",
                      "Familial adenomatosis polyposis",
                      "Faconi anemia"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Definite Mechanism Unclear": [
                  {
                    "text": "Sex hormones appear to play roleCommonly associated with oral contraceptives and anabolic steroidsNewer generation contraceptive pills with lower estrogen content are associated with lower risk",
                    "sub_points": [
                      "Commonly associated with oral contraceptives and anabolic steroidsNewer generation contraceptive pills with lower estrogen content are associated with lower risk",
                      "Newer generation contraceptive pills with lower estrogen content are associated with lower risk"
                    ]
                  },
                  {
                    "text": "Obesity, metabolic syndrome, and ethanol use"
                  },
                  {
                    "text": "Maturity-onset diabetes of young, type 3 (MODY3)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Reproductive age in women"
                  }
                ],
                "Sex": [
                  {
                    "text": "Typically women"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Liver massArises in noncirrhotic liver, typically without underlying liver diseaseMay be multiple",
                    "sub_points": [
                      "Arises in noncirrhotic liver, typically without underlying liver disease",
                      "May be multiple"
                    ]
                  },
                  {
                    "text": "SymptomsAbdominal painAcute, intermittent, or chronic",
                    "sub_points": [
                      "Abdominal painAcute, intermittent, or chronic",
                      "Acute, intermittent, or chronic"
                    ]
                  },
                  {
                    "text": "May be asymptomatic and found on imaging"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum liver tests usually normal"
                  },
                  {
                    "text": "α-fetoprotein not elevated"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cessation of oral contraceptives can lead to tumor regression"
                  },
                  {
                    "text": "Locoregional therapies, such as ablation"
                  },
                  {
                    "text": "Surgical resection is recommended for high-risk featuresSize > 5 cmIncrease in size with associated risks ofBleedingRuptureMalignant transformationMale patients",
                    "sub_points": [
                      "Size > 5 cm",
                      "Increase in size with associated risks ofBleedingRuptureMalignant transformation",
                      "Bleeding",
                      "Rupture",
                      "Malignant transformation",
                      "Male patients"
                    ]
                  },
                  {
                    "text": "Multiple tumorsResection or ablation of high-risk tumors, follow-up for othersLiver transplantation (multiple unresectable tumors with high-risk features)",
                    "sub_points": [
                      "Resection or ablation of high-risk tumors, follow-up for others",
                      "Liver transplantation (multiple unresectable tumors with high-risk features)"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Complete surgical resection usually curative"
                  },
                  {
                    "text": "Hemorrhage or rupture"
                  },
                  {
                    "text": "Malignant transformation in 4-10%Prevalence of malignancy 10x higher in affected men compared to women",
                    "sub_points": [
                      "Prevalence of malignancy 10x higher in affected men compared to women"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unencapsulated, well-demarcated, solitary or multiple masses"
                  },
                  {
                    "text": "Tan-brown, may have hemorrhage or necrosis"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide variation in sizeSmall microscopic tumors can be present (usually in cases with multiple tumors or adenomatosis)",
                    "sub_points": [
                      "Small microscopic tumors can be present (usually in cases with multiple tumors or adenomatosis)"
                    ]
                  },
                  {
                    "text": "Larger tumors can be > 20 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Background of noncirrhotic liver in vast majority of cases"
                  },
                  {
                    "text": "Cords or sheets of benign hepatocytesLow nuclear:cytoplasmic ratioRegular and uniform nuclei, lack prominent nucleoliMitoses rareFat and glycogen may be abundant in tumor cellsPseudoacinar or pseudoglandular structures typically focal or absent",
                    "sub_points": [
                      "Low nuclear:cytoplasmic ratio",
                      "Regular and uniform nuclei, lack prominent nucleoli",
                      "Mitoses rare",
                      "Fat and glycogen may be abundant in tumor cells",
                      "Pseudoacinar or pseudoglandular structures typically focal or absent"
                    ]
                  },
                  {
                    "text": "Architectural featuresNo portal tracts in tumorUnpaired arteriesInterlobular bile ducts absent; ductules may be presentIntact reticulin framework",
                    "sub_points": [
                      "No portal tracts in tumor",
                      "Unpaired arteries",
                      "Interlobular bile ducts absent; ductules may be present",
                      "Intact reticulin framework"
                    ]
                  },
                  {
                    "text": "Hemorrhage &/or infarcts may be presentHemosiderin-laden macrophages or fibrotic regions",
                    "sub_points": [
                      "Hemosiderin-laden macrophages or fibrotic regions"
                    ]
                  },
                  {
                    "text": "SubtypesHNF1A-inactivated hepatocellular adenoma (HHCA)30-40% of all hepatocellular adenomas (HCAs)Mutations inHNF1AOften associated with oral contraceptivesFamilial cases associated with germlineHNF1AmutationOften multipleAssociated with MODY3Morphologic findingsOften show prominent fatNonfatty portion is mix of eosinophilic cells and swollen cells with cleared glycogen-rich cytoplasmPseudoacinar architecture may be presentMarked sinusoidal dilatation/myxoid change in rare casesReticulin often surrounds groups of tumor cells (\"packeting\")Loss of liver fatty acid binding protein (LFABP) on immunohistochemistryLow association with hepatocellular carcinoma (HCC), likely < 2%Inflammatory hepatocellular adenoma (IHCA)40-50% of all HCAsIL6STmutation in 60% of cases, other mutations includeSTAT3orGNASAssociated with obesity, metabolic syndromeMorphologic findingsProminent sinusoidal dilatation (telangiectasia)Ductular reaction and inflammationSteatosis and steatohepatitis common in nonneoplastic liverSerum amyloid A (SAA) (80-90%) &/or C-reactive protein (CRP) (~ 100%) on immunohistochemistrySAA more specific, CRP more sensitive10% have β-catenin activationNuclear β-catenin &/or diffuse glutamine synthetase (GS) seen in these tumors in addition to SAA/CRPRare cases reported in cirrhosis, often of alcoholic etiologyMorphology typical of IHCA; SAA &/or CRP (+)Mutations typical of IHCA have been describedNatural history unclear; best considered as SAA/CRP (+) hepatocellular nodules rather than typical IHCAβ-catenin activated5-10% of all HCAs, depending on how this term is usedActivation of β-catenin by mutations in exon 3 ofCTNNB1or other Wnt genes likeAPCandAXIN130-40% occur in menMorphologic findingsCytologic atypia often present: Large nuclei, prominent nucleoliSmall cell change and pseudoacinar architecture can be presentβ-catenin nuclear staining and diffuse GS staining on immunohistochemistryGains of chromosomes 1 and 8 similar to HCC in nearly 1/2 of casesSubset showsTERTpromoter mutation similar to HCCHigh risk for concurrent or subsequent HCCIt has been advocated that this should not be considered as adenoma subtype due to high risk of HCCVariety of other terms suggested for this subtypeAtypical hepatocellular neoplasm (AHN)Borderline lesionHepatocellular neoplasm with uncertain malignant potential (HUMP)Some groups use this term for all β-catenin-activated hepatocellular tumors (without atypia, or atypia insufficient for HCC); others reserve this term only for β-catenin-activated hepatocellular tumors with atypical features insufficient for HCCUnclassified5-10% of all HCAs; cannot be classified into any of above subtypesAdditional subtypes: Some of previously unclassified subtypes can be categorized into newly recognized subtypesCTNNB1-exon 7 or 8 mutated HCA5-10% of HCAsLow-level β-catenin activation GS is not diffusePeripheral accentuation of GS staining can be seenHCC risk thought to be low but has not been well studiedSonic hedgehog-activated HCA (shHCA)4-5% of HCAsAssociated with obesity and high risk of bleedingSomatic deletions ofINHBE, leading to fusion ofINHBEandGLI1genes and activation of sonic hedgehog pathwayImmunohistochemistry with prostaglandin D synthase suggested as marker of this subtypeArginosuccinate synthase 1 (ASS1) (+)Proposed marker for shHCA but not well establishedCan be (+) in other subtypes like inflammatoryASS1(+) HCA have been associated with high risk of bleeding",
                    "sub_points": [
                      "HNF1A-inactivated hepatocellular adenoma (HHCA)30-40% of all hepatocellular adenomas (HCAs)Mutations inHNF1AOften associated with oral contraceptivesFamilial cases associated with germlineHNF1AmutationOften multipleAssociated with MODY3Morphologic findingsOften show prominent fatNonfatty portion is mix of eosinophilic cells and swollen cells with cleared glycogen-rich cytoplasmPseudoacinar architecture may be presentMarked sinusoidal dilatation/myxoid change in rare casesReticulin often surrounds groups of tumor cells (\"packeting\")Loss of liver fatty acid binding protein (LFABP) on immunohistochemistryLow association with hepatocellular carcinoma (HCC), likely < 2%",
                      "30-40% of all hepatocellular adenomas (HCAs)Mutations inHNF1AOften associated with oral contraceptives",
                      "Mutations inHNF1A",
                      "Often associated with oral contraceptives",
                      "Familial cases associated with germlineHNF1AmutationOften multipleAssociated with MODY3",
                      "Often multiple",
                      "Associated with MODY3",
                      "Morphologic findingsOften show prominent fatNonfatty portion is mix of eosinophilic cells and swollen cells with cleared glycogen-rich cytoplasmPseudoacinar architecture may be presentMarked sinusoidal dilatation/myxoid change in rare casesReticulin often surrounds groups of tumor cells (\"packeting\")Loss of liver fatty acid binding protein (LFABP) on immunohistochemistry",
                      "Often show prominent fat",
                      "Nonfatty portion is mix of eosinophilic cells and swollen cells with cleared glycogen-rich cytoplasm",
                      "Pseudoacinar architecture may be present",
                      "Marked sinusoidal dilatation/myxoid change in rare cases",
                      "Reticulin often surrounds groups of tumor cells (\"packeting\")",
                      "Loss of liver fatty acid binding protein (LFABP) on immunohistochemistry",
                      "Low association with hepatocellular carcinoma (HCC), likely < 2%",
                      "Inflammatory hepatocellular adenoma (IHCA)40-50% of all HCAsIL6STmutation in 60% of cases, other mutations includeSTAT3orGNASAssociated with obesity, metabolic syndromeMorphologic findingsProminent sinusoidal dilatation (telangiectasia)Ductular reaction and inflammationSteatosis and steatohepatitis common in nonneoplastic liverSerum amyloid A (SAA) (80-90%) &/or C-reactive protein (CRP) (~ 100%) on immunohistochemistrySAA more specific, CRP more sensitive10% have β-catenin activationNuclear β-catenin &/or diffuse glutamine synthetase (GS) seen in these tumors in addition to SAA/CRPRare cases reported in cirrhosis, often of alcoholic etiologyMorphology typical of IHCA; SAA &/or CRP (+)Mutations typical of IHCA have been describedNatural history unclear; best considered as SAA/CRP (+) hepatocellular nodules rather than typical IHCA",
                      "40-50% of all HCAsIL6STmutation in 60% of cases, other mutations includeSTAT3orGNASAssociated with obesity, metabolic syndrome",
                      "IL6STmutation in 60% of cases, other mutations includeSTAT3orGNAS",
                      "Associated with obesity, metabolic syndrome",
                      "Morphologic findingsProminent sinusoidal dilatation (telangiectasia)Ductular reaction and inflammationSteatosis and steatohepatitis common in nonneoplastic liverSerum amyloid A (SAA) (80-90%) &/or C-reactive protein (CRP) (~ 100%) on immunohistochemistrySAA more specific, CRP more sensitive",
                      "Prominent sinusoidal dilatation (telangiectasia)",
                      "Ductular reaction and inflammation",
                      "Steatosis and steatohepatitis common in nonneoplastic liver",
                      "Serum amyloid A (SAA) (80-90%) &/or C-reactive protein (CRP) (~ 100%) on immunohistochemistry",
                      "SAA more specific, CRP more sensitive",
                      "10% have β-catenin activationNuclear β-catenin &/or diffuse glutamine synthetase (GS) seen in these tumors in addition to SAA/CRP",
                      "Nuclear β-catenin &/or diffuse glutamine synthetase (GS) seen in these tumors in addition to SAA/CRP",
                      "Rare cases reported in cirrhosis, often of alcoholic etiologyMorphology typical of IHCA; SAA &/or CRP (+)Mutations typical of IHCA have been describedNatural history unclear; best considered as SAA/CRP (+) hepatocellular nodules rather than typical IHCA",
                      "Morphology typical of IHCA; SAA &/or CRP (+)",
                      "Mutations typical of IHCA have been described",
                      "Natural history unclear; best considered as SAA/CRP (+) hepatocellular nodules rather than typical IHCA",
                      "β-catenin activated5-10% of all HCAs, depending on how this term is usedActivation of β-catenin by mutations in exon 3 ofCTNNB1or other Wnt genes likeAPCandAXIN130-40% occur in menMorphologic findingsCytologic atypia often present: Large nuclei, prominent nucleoliSmall cell change and pseudoacinar architecture can be presentβ-catenin nuclear staining and diffuse GS staining on immunohistochemistryGains of chromosomes 1 and 8 similar to HCC in nearly 1/2 of casesSubset showsTERTpromoter mutation similar to HCCHigh risk for concurrent or subsequent HCCIt has been advocated that this should not be considered as adenoma subtype due to high risk of HCCVariety of other terms suggested for this subtypeAtypical hepatocellular neoplasm (AHN)Borderline lesionHepatocellular neoplasm with uncertain malignant potential (HUMP)Some groups use this term for all β-catenin-activated hepatocellular tumors (without atypia, or atypia insufficient for HCC); others reserve this term only for β-catenin-activated hepatocellular tumors with atypical features insufficient for HCC",
                      "5-10% of all HCAs, depending on how this term is usedActivation of β-catenin by mutations in exon 3 ofCTNNB1or other Wnt genes likeAPCandAXIN1",
                      "Activation of β-catenin by mutations in exon 3 ofCTNNB1or other Wnt genes likeAPCandAXIN1",
                      "30-40% occur in men",
                      "Morphologic findingsCytologic atypia often present: Large nuclei, prominent nucleoliSmall cell change and pseudoacinar architecture can be presentβ-catenin nuclear staining and diffuse GS staining on immunohistochemistry",
                      "Cytologic atypia often present: Large nuclei, prominent nucleoli",
                      "Small cell change and pseudoacinar architecture can be present",
                      "β-catenin nuclear staining and diffuse GS staining on immunohistochemistry",
                      "Gains of chromosomes 1 and 8 similar to HCC in nearly 1/2 of cases",
                      "Subset showsTERTpromoter mutation similar to HCC",
                      "High risk for concurrent or subsequent HCC",
                      "It has been advocated that this should not be considered as adenoma subtype due to high risk of HCC",
                      "Variety of other terms suggested for this subtypeAtypical hepatocellular neoplasm (AHN)Borderline lesionHepatocellular neoplasm with uncertain malignant potential (HUMP)",
                      "Atypical hepatocellular neoplasm (AHN)",
                      "Borderline lesion",
                      "Hepatocellular neoplasm with uncertain malignant potential (HUMP)",
                      "Some groups use this term for all β-catenin-activated hepatocellular tumors (without atypia, or atypia insufficient for HCC); others reserve this term only for β-catenin-activated hepatocellular tumors with atypical features insufficient for HCC",
                      "Unclassified5-10% of all HCAs; cannot be classified into any of above subtypes",
                      "5-10% of all HCAs; cannot be classified into any of above subtypes",
                      "Additional subtypes: Some of previously unclassified subtypes can be categorized into newly recognized subtypesCTNNB1-exon 7 or 8 mutated HCA5-10% of HCAsLow-level β-catenin activation GS is not diffusePeripheral accentuation of GS staining can be seenHCC risk thought to be low but has not been well studiedSonic hedgehog-activated HCA (shHCA)4-5% of HCAsAssociated with obesity and high risk of bleedingSomatic deletions ofINHBE, leading to fusion ofINHBEandGLI1genes and activation of sonic hedgehog pathwayImmunohistochemistry with prostaglandin D synthase suggested as marker of this subtypeArginosuccinate synthase 1 (ASS1) (+)Proposed marker for shHCA but not well establishedCan be (+) in other subtypes like inflammatoryASS1(+) HCA have been associated with high risk of bleeding",
                      "CTNNB1-exon 7 or 8 mutated HCA5-10% of HCAsLow-level β-catenin activation GS is not diffusePeripheral accentuation of GS staining can be seenHCC risk thought to be low but has not been well studied",
                      "5-10% of HCAs",
                      "Low-level β-catenin activation GS is not diffuse",
                      "Peripheral accentuation of GS staining can be seen",
                      "HCC risk thought to be low but has not been well studied",
                      "Sonic hedgehog-activated HCA (shHCA)4-5% of HCAsAssociated with obesity and high risk of bleedingSomatic deletions ofINHBE, leading to fusion ofINHBEandGLI1genes and activation of sonic hedgehog pathwayImmunohistochemistry with prostaglandin D synthase suggested as marker of this subtype",
                      "4-5% of HCAs",
                      "Associated with obesity and high risk of bleeding",
                      "Somatic deletions ofINHBE, leading to fusion ofINHBEandGLI1genes and activation of sonic hedgehog pathway",
                      "Immunohistochemistry with prostaglandin D synthase suggested as marker of this subtype",
                      "Arginosuccinate synthase 1 (ASS1) (+)Proposed marker for shHCA but not well establishedCan be (+) in other subtypes like inflammatoryASS1(+) HCA have been associated with high risk of bleeding",
                      "Proposed marker for shHCA but not well established",
                      "Can be (+) in other subtypes like inflammatory",
                      "ASS1(+) HCA have been associated with high risk of bleeding"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "GS staining patternsDiffuse: Moderate to strong cytoplasmic staining in > 50% of tumor cellsDiffuse homogeneous: Moderate to strong cytoplasmic staining in > 90% of tumor cellsHigh-level β-catenin activation (exon 3 deletions, certain mutations)Diffuse heterogeneous: Moderate to strong cytoplasmic staining in 50-90% of tumor cellsIntermediate-level β-catenin activation (exon 3 S45 mutation), may show starry-sky patternPatchy: Moderate to strong cytoplasmic staining in < 50% of tumor cellsWeak or no β-catenin activationMay be seen inCTNNB1exon 7 or 8 mutation that leads to weak β-catenin activationIndeterminateDistinction between diffuse heterogeneous and patchy patterns can be difficult if GS staining is (+) in close to 50% of tumor cellsMolecular analysis for β-catenin activation may help in these cases for guiding management",
                    "sub_points": [
                      "Diffuse: Moderate to strong cytoplasmic staining in > 50% of tumor cellsDiffuse homogeneous: Moderate to strong cytoplasmic staining in > 90% of tumor cellsHigh-level β-catenin activation (exon 3 deletions, certain mutations)Diffuse heterogeneous: Moderate to strong cytoplasmic staining in 50-90% of tumor cellsIntermediate-level β-catenin activation (exon 3 S45 mutation), may show starry-sky patternPatchy: Moderate to strong cytoplasmic staining in < 50% of tumor cellsWeak or no β-catenin activationMay be seen inCTNNB1exon 7 or 8 mutation that leads to weak β-catenin activationIndeterminateDistinction between diffuse heterogeneous and patchy patterns can be difficult if GS staining is (+) in close to 50% of tumor cellsMolecular analysis for β-catenin activation may help in these cases for guiding management",
                      "Diffuse homogeneous: Moderate to strong cytoplasmic staining in > 90% of tumor cellsHigh-level β-catenin activation (exon 3 deletions, certain mutations)",
                      "High-level β-catenin activation (exon 3 deletions, certain mutations)",
                      "Diffuse heterogeneous: Moderate to strong cytoplasmic staining in 50-90% of tumor cellsIntermediate-level β-catenin activation (exon 3 S45 mutation), may show starry-sky pattern",
                      "Intermediate-level β-catenin activation (exon 3 S45 mutation), may show starry-sky pattern",
                      "Patchy: Moderate to strong cytoplasmic staining in < 50% of tumor cellsWeak or no β-catenin activationMay be seen inCTNNB1exon 7 or 8 mutation that leads to weak β-catenin activation",
                      "Weak or no β-catenin activation",
                      "May be seen inCTNNB1exon 7 or 8 mutation that leads to weak β-catenin activation",
                      "IndeterminateDistinction between diffuse heterogeneous and patchy patterns can be difficult if GS staining is (+) in close to 50% of tumor cellsMolecular analysis for β-catenin activation may help in these cases for guiding management",
                      "Distinction between diffuse heterogeneous and patchy patterns can be difficult if GS staining is (+) in close to 50% of tumor cells",
                      "Molecular analysis for β-catenin activation may help in these cases for guiding management"
                    ]
                  },
                  {
                    "text": "Glypican-3 is (-) in HCA; CD34 shows increase in sinusoidal stainingPeripheral rim of tumor can be CD34(-) and GS(+) withCTNNB1exon 7 or 8 and S45 mutations",
                    "sub_points": [
                      "Peripheral rim of tumor can be CD34(-) and GS(+) withCTNNB1exon 7 or 8 and S45 mutations"
                    ]
                  },
                  {
                    "text": "Immunohistochemical stains for subtyping HCAs can be (+) in HCC cannot be used to distinguish from HCCLFABP loss can occur in small subset of HCC, some of which are very well differentiatedSAA and CRP can be (+) in HCC",
                    "sub_points": [
                      "LFABP loss can occur in small subset of HCC, some of which are very well differentiated",
                      "SAA and CRP can be (+) in HCC"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Well-Differentiated Hepatocellular Carcinoma": [
                  {
                    "text": "Cytologic atypia with increased nuclear:cytoplasmic ratio and prominent nucleoli"
                  },
                  {
                    "text": "Thick cell plates, prominent pseudoacinar architecture"
                  },
                  {
                    "text": "Reticulin stain and immunohistochemistryReticulin: Loss of reticulin suggests HCC, but reticulin may be lost in fatty area of HCAGlypican-3 (+) cytoplasmic staining supports HCCβ-catenin (+) nuclear staining favors HCCGlutamine synthase: Diffuse staining favors HCC",
                    "sub_points": [
                      "Reticulin: Loss of reticulin suggests HCC, but reticulin may be lost in fatty area of HCA",
                      "Glypican-3 (+) cytoplasmic staining supports HCC",
                      "β-catenin (+) nuclear staining favors HCC",
                      "Glutamine synthase: Diffuse staining favors HCC"
                    ]
                  },
                  {
                    "text": "Often arises in cirrhosis or chronic liver disease"
                  },
                  {
                    "text": "More common in men and older individuals of either sex"
                  }
                ],
                "Focal Nodular Hyperplasia": [
                  {
                    "text": "Central scar and fibrous septa with thick-walled arteries"
                  },
                  {
                    "text": "Prominent bile ductular reaction and inflammatory infiltrate in fibrous septa"
                  },
                  {
                    "text": "Immunohistochemical stain for GS shows map-like staining pattern"
                  },
                  {
                    "text": "SAA usually (-); patchy staining in 10-20% focal nodular hyperplasia (FNH)"
                  },
                  {
                    "text": "CRP often shows periseptal staining; diffuse staining typical of IHCA is uncommon"
                  }
                ],
                "Nodular Regenerative Hyperplasia": [
                  {
                    "text": "Diffuse nodular appearance throughout liver without advanced fibrosis or cirrhosis"
                  },
                  {
                    "text": "Occasional larger regenerative nodules can mimic HCA; distinction based on clinical setting"
                  }
                ],
                "Atypical Hepatocellular Neoplasm": [
                  {
                    "text": "Not distinct entity; this term is used for well-differentiated hepatocellular neoplasms withAtypical features that are insufficient for definite diagnosis of HCCβ-catenin activation irrespective of morphologic features",
                    "sub_points": [
                      "Atypical features that are insufficient for definite diagnosis of HCC",
                      "β-catenin activation irrespective of morphologic features"
                    ]
                  },
                  {
                    "text": "Used more often in biopsy setting when features of entire lesion have not been evaluated"
                  }
                ],
                "Hepatic Epithelioid Angiomyolipoma": [
                  {
                    "text": "Monotypic epithelioid variant can resemble HCA"
                  },
                  {
                    "text": "GS can be (+); keratin/hepatocellular markers (-), (+) for SMA/HMB-45"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Liver mass in individuals on long-term oral contraceptives/anabolic steroids"
                  },
                  {
                    "text": "Caution necessary when making this diagnosis in men or older women"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Focal Nodular Hyperplasia": {
            "name": "Focal Nodular Hyperplasia",
            "url": "https://app.pathprimer.com/document/85d78d83-a005-4a45-97df-2422bef421fa/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign, tumor-like lesion of liver caused by hyperplastic response to localized vascular abnormality"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Association with vascular lesions and chemotherapy; can occur adjacent to other tumors"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Mostly incidental finding on imaging studies; most common in women"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Unencapsulated, well-circumscribed lesion with bulging cut surfaceNoncirrhotic background liver",
                    "sub_points": [
                      "Noncirrhotic background liver"
                    ]
                  },
                  {
                    "text": "Central stellate scar with radiating septa"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Localized nodular parenchyma with fibrous septa and stellate central scarSepta contain thick-walled vessels and ductular reactionNo normal portal structures",
                    "sub_points": [
                      "Septa contain thick-walled vessels and ductular reaction",
                      "No normal portal structures"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Glutamine synthetase: Characteristic map-like pattern with sparing of areas around scar and fibrous septa"
                  },
                  {
                    "text": "Serum amyloid A is typically negative; focal staining in few cases"
                  },
                  {
                    "text": "C-reactive protein staining typically restricted to periseptal areas"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular adenoma"
                  },
                  {
                    "text": "Cirrhosis"
                  },
                  {
                    "text": "Hepatocellular carcinoma"
                  },
                  {
                    "text": "Nodular regenerative hyperplasia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Focal nodular hyperplasia (FNH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Focal cirrhosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign, nonneoplastic, tumor-like lesion caused by hyperplastic response to localized vascular abnormality"
                  },
                  {
                    "text": "Most lesions formerly labeled as telangiectatic FNH are now thought to be inflammatory hepatocellular adenomas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Localized Abnormal Blood Flow": [
                  {
                    "text": "Exact mechanism unclear"
                  },
                  {
                    "text": "Hepatocytes polyclonal, unlike hepatocellular adenomas"
                  },
                  {
                    "text": "Steroids/OCs not thought to play etiologic role"
                  },
                  {
                    "text": "Association with vascular lesions, can occur with other hepatic tumors"
                  },
                  {
                    "text": "Associated with chemotherapy, especially in children"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Mostly incidental finding on imaging studies"
                  },
                  {
                    "text": "More common in women"
                  },
                  {
                    "text": "Normal liver biochemical tests"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Reserved for large and symptomatic lesions"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign lesion; rupture and bleeding in rare cases"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Brightly, homogeneously enhancing mass in arterial phase CT or MR with delayed enhancement of central scar"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Unencapsulated, well-circumscribed lesion~ 20% are multiple; can be associated with chemotherapy or vascular lesions",
                    "sub_points": [
                      "~ 20% are multiple; can be associated with chemotherapy or vascular lesions"
                    ]
                  },
                  {
                    "text": "Firm to rubbery cut surface that bulges from surface of liver"
                  },
                  {
                    "text": "Central stellate scar with radiating septa"
                  },
                  {
                    "text": "Noncirrhotic background liver"
                  }
                ],
                "Size": [
                  {
                    "text": "Most < 5 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Nodular architecture"
                  },
                  {
                    "text": "Fibrous septa; central stellate scar in 70-80% of cases"
                  },
                  {
                    "text": "Ductular reaction in fibrous septa in most cases"
                  },
                  {
                    "text": "Dilated sinusoids and lymphocytic infiltrate may be present"
                  },
                  {
                    "text": "Periseptal hepatocytes may show positive copper staining"
                  },
                  {
                    "text": "No cytoarchitectural atypia"
                  },
                  {
                    "text": "Intact reticulin; wide plates and focal loss can be seen at periphery"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Bland hepatocytes"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Glutamine synthetase (GS): Characteristic map-like pattern with sparing of areas around scar and fibrous septa"
                  },
                  {
                    "text": "CK7: Highlights ductular reaction, typically negative in lesional hepatocytes"
                  },
                  {
                    "text": "CD34: Patchy sinusoidal staining, can be variably diffuse"
                  },
                  {
                    "text": "Serum amyloid A (SAA): Negative; focally positive in few cases"
                  },
                  {
                    "text": "C-reactive protein (CRP): Staining usually restricted to periseptal areas"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Inflammatory Hepatocellular Adenoma": [
                  {
                    "text": "Histologic features overlap with FNH"
                  },
                  {
                    "text": "Naked, unpaired arteries in parenchyma, sinusoidal dilatation, and lesional steatosis more common in adenoma"
                  },
                  {
                    "text": "Ductular reaction, fibrous septa, and thick-walled arteries are more common in FNH"
                  },
                  {
                    "text": "Diffuse immunoreactivity for SAA and CRP in most cases"
                  },
                  {
                    "text": "Map-like GS staining not seen"
                  }
                ],
                "Cirrhosis": [
                  {
                    "text": "Diffuse liver involvement"
                  },
                  {
                    "text": "Ductular reaction and inflammation may be present in fibrous septa"
                  },
                  {
                    "text": "Bile ducts present except in ductopenic biliary disease"
                  },
                  {
                    "text": "Lack of thick-walled arteries"
                  },
                  {
                    "text": "Evidence of underlying liver disease"
                  }
                ],
                "Hepatocellular Carcinoma": [
                  {
                    "text": "Thick cell plates, reticulin loss"
                  },
                  {
                    "text": "Cytologic atypia variable but often present"
                  },
                  {
                    "text": "Ductular reaction not present in tumor"
                  },
                  {
                    "text": "Diffuse GS, positive glypican-3, HSP70"
                  }
                ],
                "Nodular Regenerative Hyperplasia": [
                  {
                    "text": "Nodularity is typically diffuse"
                  },
                  {
                    "text": "By definition, fibrous septa are not present"
                  }
                ],
                "FNH-Like Lesion": [
                  {
                    "text": "Loosely defined term that has been used in 2 settingsHistologic features indistinguishable from FNH but associated with other diseasesVascular diseases: Budd-Chiari syndrome, cavernous hemangioma, Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)Adjacent to other tumors, primary or metastaticCirrhotic liverFeatures suggestive of FNH but ≥ 1 atypical features, such as portal tracts in lesion, GS pattern not map-like",
                    "sub_points": [
                      "Histologic features indistinguishable from FNH but associated with other diseasesVascular diseases: Budd-Chiari syndrome, cavernous hemangioma, Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)Adjacent to other tumors, primary or metastaticCirrhotic liver",
                      "Vascular diseases: Budd-Chiari syndrome, cavernous hemangioma, Osler-Weber-Rendu disease (hereditary hemorrhagic telangiectasia)",
                      "Adjacent to other tumors, primary or metastatic",
                      "Cirrhotic liver",
                      "Features suggestive of FNH but ≥ 1 atypical features, such as portal tracts in lesion, GS pattern not map-like"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Nodular liver parenchyma with fibrous septa containing thick-walled arteries at periphery, bile ductular reaction, and mixed mononuclear inflammation"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Regenerative and Dysplastic Nodules": {
            "name": "Regenerative and Dysplastic Nodules",
            "url": "https://app.pathprimer.com/document/6057d619-441b-4766-8de3-beed45fe61cb/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Regenerative nodule (RN)Cirrhotic nodule > 1 cm; most of these are believed to be nonneoplastic",
                    "sub_points": [
                      "Cirrhotic nodule > 1 cm; most of these are believed to be nonneoplastic"
                    ]
                  },
                  {
                    "text": "Low-grade dysplastic nodules (LGDNs) resemble RN morphologically but are clonal"
                  },
                  {
                    "text": "High-grade dysplastic nodules (HGDNs): Preneoplastic lesion; likely precursor of hepatocellular carcinoma (HCC)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "> 1 cm but usually < 3 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "RN/LGDNPlates 1-2 cells thick, portal tracts present, no architectural or cytologic atypia",
                    "sub_points": [
                      "Plates 1-2 cells thick, portal tracts present, no architectural or cytologic atypia"
                    ]
                  },
                  {
                    "text": "HGDN:Plates focally up to 3 cells thick; small cell change with increased nuclear:cytoplasmic ratioUnpaired arterioles and pseudoacinar architecture can be present",
                    "sub_points": [
                      "Plates focally up to 3 cells thick; small cell change with increased nuclear:cytoplasmic ratio",
                      "Unpaired arterioles and pseudoacinar architecture can be present"
                    ]
                  },
                  {
                    "text": "Reticulin is preservedMay be focally lost in HGDN",
                    "sub_points": [
                      "May be focally lost in HGDN"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Small cell change, high nuclear:cytoplasmic ratio, pseudoacinar architecture, and unpaired arterioles favor HGDN over LGDN"
                  },
                  {
                    "text": "Uniformly thick plates (> 3 cells) are most important feature distinguishing HCC from HGDNProminent pseudoacinar architecture, numerous unpaired arterioles, and loss or fragmentation of reticulin favor HCC",
                    "sub_points": [
                      "Prominent pseudoacinar architecture, numerous unpaired arterioles, and loss or fragmentation of reticulin favor HCC"
                    ]
                  },
                  {
                    "text": "Stromal invasion distinguishes early HCC from HGDNLack of CK7-positive ductular reaction is useful in demonstrating stromal invasion",
                    "sub_points": [
                      "Lack of CK7-positive ductular reaction is useful in demonstrating stromal invasion"
                    ]
                  },
                  {
                    "text": "Positive results with 2 out of 3 markers (GPC, GS, HSP70) favor HCC"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Regenerative nodule (RN), large RN (LRN), low-grade dysplastic nodule (LGDN), high-grade dysplastic nodule (HGDN), α-fetoprotein (AFP)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Macroregenerative nodule (MRN), adenomatous hyperplasia"
                  },
                  {
                    "text": "Borderline nodule, type II MRN, atypical adenomatous hyperplasia, atypical MRN"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Dysplasia: Abnormal histologic growth that does not fulfill criteria of malignancyDysplastic focus: Cluster of dysplastic hepatocytes < 1 cm in diameterDysplastic nodule: Cluster of dysplastic hepatocytes > 1 cm in diameter",
                    "sub_points": [
                      "Dysplastic focus: Cluster of dysplastic hepatocytes < 1 cm in diameter",
                      "Dysplastic nodule: Cluster of dysplastic hepatocytes > 1 cm in diameter"
                    ]
                  },
                  {
                    "text": "LRN: > 1 cm, usually seen in cirrhosisNo reliable gross or histologic criteria to distinguish RN and LGDNLGDN is clonal proliferation; likelihood of progression to carcinoma is unclearMost RNs are probably not preneoplastic",
                    "sub_points": [
                      "No reliable gross or histologic criteria to distinguish RN and LGDNLGDN is clonal proliferation; likelihood of progression to carcinoma is unclear",
                      "LGDN is clonal proliferation; likelihood of progression to carcinoma is unclear",
                      "Most RNs are probably not preneoplastic"
                    ]
                  },
                  {
                    "text": "HGDN: Nodule with atypical cytologic and architectural features believed to be precursor of carcinoma"
                  },
                  {
                    "text": "Large cell change (formerly large cell dysplasia)Large hepatocytes with nuclear enlargement, hyperchromasia, prominent nucleoli, often multinucleatedAbundant cytoplasm, normal nuclear:cytoplasmic ratioVery common in cirrhotic liverFormerly thought to be precursor of hepatocellular carcinoma (HCC)No longer considered preneoplastic but rather regenerative or degenerative phenomenonLow proliferation rate and absence ofTP53mutations also do not support preneoplastic process",
                    "sub_points": [
                      "Large hepatocytes with nuclear enlargement, hyperchromasia, prominent nucleoli, often multinucleatedAbundant cytoplasm, normal nuclear:cytoplasmic ratio",
                      "Abundant cytoplasm, normal nuclear:cytoplasmic ratio",
                      "Very common in cirrhotic liver",
                      "Formerly thought to be precursor of hepatocellular carcinoma (HCC)No longer considered preneoplastic but rather regenerative or degenerative phenomenonLow proliferation rate and absence ofTP53mutations also do not support preneoplastic process",
                      "No longer considered preneoplastic but rather regenerative or degenerative phenomenon",
                      "Low proliferation rate and absence ofTP53mutations also do not support preneoplastic process"
                    ]
                  },
                  {
                    "text": "Small cell change (formerly small cell dysplasia)Small hepatocytes with increased nuclear:cytoplasmic ratio and hyperchromatic nucleiHigh proliferative activity andTP53overexpression can occurLikely to be preneoplastic when occurring in expansile nodulesPoorly defined or diffuse areas of small cell change without nodular configuration may represent regenerative phenomenonSmall cell regenerative foci common in biliary disease, unlikely to be preneoplastic",
                    "sub_points": [
                      "Small hepatocytes with increased nuclear:cytoplasmic ratio and hyperchromatic nucleiHigh proliferative activity andTP53overexpression can occur",
                      "High proliferative activity andTP53overexpression can occur",
                      "Likely to be preneoplastic when occurring in expansile nodules",
                      "Poorly defined or diffuse areas of small cell change without nodular configuration may represent regenerative phenomenon",
                      "Small cell regenerative foci common in biliary disease, unlikely to be preneoplastic"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Occur in setting of cirrhosis, usually in background of hepatitis B, hepatitis C, alcoholic liver disease, hemochromatosisUncommon in chronic biliary diseasesOccasionally in chronic liver disease without fully developed cirrhosisCan occur in noncirrhotic liver in Budd-Chiari syndrome, portal vein thrombosis, or regeneration after necrosis",
                    "sub_points": [
                      "Uncommon in chronic biliary diseases",
                      "Occasionally in chronic liver disease without fully developed cirrhosis",
                      "Can occur in noncirrhotic liver in Budd-Chiari syndrome, portal vein thrombosis, or regeneration after necrosis"
                    ]
                  },
                  {
                    "text": "May be detected at autopsy, transplantation, or by imaging"
                  },
                  {
                    "text": "Serum AFP is normal or mildly elevated"
                  }
                ],
                "Treatment": [
                  {
                    "text": "RN/LGDN: Follow-up by imaging and serological markers"
                  },
                  {
                    "text": "HGDN: No well-defined guidelines; often ablated"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "RN: Most regress or remain unchanged on imaging follow-up and thus are probably not preneoplasticLGDN: Unclear but low likelihood of progressionDifficult to ascertain prognosis, as it is difficult to clearly define LGDN",
                    "sub_points": [
                      "LGDN: Unclear but low likelihood of progression",
                      "Difficult to ascertain prognosis, as it is difficult to clearly define LGDN"
                    ]
                  },
                  {
                    "text": "HGDNPreneoplastic lesion;likely precursor of HCCAllelic imbalance in > 80% compared to 15% of RNMost remain stable or regress on follow-up; progression to HCC in 10-15% based on limited studies",
                    "sub_points": [
                      "Preneoplastic lesion;likely precursor of HCC",
                      "Allelic imbalance in > 80% compared to 15% of RN",
                      "Most remain stable or regress on follow-up; progression to HCC in 10-15% based on limited studies"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "Large Regenerative Nodule RN (Including Low-Grade Dysplastic Nodule)": [
                  {
                    "text": "Larger than typical cirrhotic nodules"
                  },
                  {
                    "text": "By definition, > 1 cm but usually < 3 cm"
                  },
                  {
                    "text": "Pale yellow to tan or bile stained"
                  },
                  {
                    "text": "Sharply circumscribed and bulged on cut section"
                  }
                ],
                "High-Grade Dysplastic Nodule": [
                  {
                    "text": "Similar gross appearance as RN/LGDN"
                  },
                  {
                    "text": "Some HGDN are not well circumscribed and may show irregular border"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "RNResemble cirrhotic nodules; cell plates are 1-2 cells thickReticulin framework is intactPortal tracts are usually present within nodule, and ductular reaction may be prominentOccasional unpaired arterioles may be seen, but this is not prominent findingHepatocytes typically appear normal; mild variation in cell size and scattered large cell change can be presentFeatures for LGDN not well establishedIndistinguishable from LRN without clonality studiesMay contain Mallory-Denk bodies, bile, clear cell changes, iron, copper, and fatCD34 shows patchy sinusoidal staining at edge; occasional nodules can show more diffuse expressionNodules are negative for α-fetoprotein and glypican-3 (GPC) with rare exceptionsNo histologic criteria to distinguish RN from LGDN",
                    "sub_points": [
                      "Resemble cirrhotic nodules; cell plates are 1-2 cells thickReticulin framework is intact",
                      "Reticulin framework is intact",
                      "Portal tracts are usually present within nodule, and ductular reaction may be prominent",
                      "Occasional unpaired arterioles may be seen, but this is not prominent finding",
                      "Hepatocytes typically appear normal; mild variation in cell size and scattered large cell change can be presentFeatures for LGDN not well establishedIndistinguishable from LRN without clonality studies",
                      "Features for LGDN not well established",
                      "Indistinguishable from LRN without clonality studies",
                      "May contain Mallory-Denk bodies, bile, clear cell changes, iron, copper, and fat",
                      "CD34 shows patchy sinusoidal staining at edge; occasional nodules can show more diffuse expression",
                      "Nodules are negative for α-fetoprotein and glypican-3 (GPC) with rare exceptions",
                      "No histologic criteria to distinguish RN from LGDN"
                    ]
                  },
                  {
                    "text": "High-grade DNHG dysplastic changes may involve entire nodule or present as 1 or more dysplastic foci within noduleBy definition, atypical features do not fulfill criteria of diagnosis of HCCFocal areas with up to 3-cell-thick plates may be present (normal cell plates are typically 1-2 cells thick)Reticulin network is normal or focally decreasedPseudoacinar architecture can be present but is usually not diffusePortal tracts are present within noduleScattered unpaired arterioles are present but not as numerous as in HCCSmall cell change with increased nuclear:cytoplasmic ratio is characteristic featureResults in nuclear crowding and increased nuclear densityLarge cell change can be seen but is neither sufficient nor necessary for diagnosisMay contain Mallory-Denk bodies, fat, clear cell change, cytoplasmic basophilia, bileTend to lack iron (in contrast to MRN, in which iron deposits are more common)CD34 shows patchy sinusoidal staining, usually at edge; occasional nodules can show more diffuse expressionAFP negativeGPC expression is variable; diffuse strong expression strongly favors HCC",
                    "sub_points": [
                      "HG dysplastic changes may involve entire nodule or present as 1 or more dysplastic foci within nodule",
                      "By definition, atypical features do not fulfill criteria of diagnosis of HCC",
                      "Focal areas with up to 3-cell-thick plates may be present (normal cell plates are typically 1-2 cells thick)Reticulin network is normal or focally decreasedPseudoacinar architecture can be present but is usually not diffuse",
                      "Reticulin network is normal or focally decreased",
                      "Pseudoacinar architecture can be present but is usually not diffuse",
                      "Portal tracts are present within nodule",
                      "Scattered unpaired arterioles are present but not as numerous as in HCC",
                      "Small cell change with increased nuclear:cytoplasmic ratio is characteristic featureResults in nuclear crowding and increased nuclear densityLarge cell change can be seen but is neither sufficient nor necessary for diagnosis",
                      "Results in nuclear crowding and increased nuclear density",
                      "Large cell change can be seen but is neither sufficient nor necessary for diagnosis",
                      "May contain Mallory-Denk bodies, fat, clear cell change, cytoplasmic basophilia, bile",
                      "Tend to lack iron (in contrast to MRN, in which iron deposits are more common)",
                      "CD34 shows patchy sinusoidal staining, usually at edge; occasional nodules can show more diffuse expression",
                      "AFP negative",
                      "GPC expression is variable; diffuse strong expression strongly favors HCC"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Regenerative Nodules": [
                  {
                    "text": "By definition, size > 1 cm differentiates RN from other cirrhotic nodules"
                  }
                ],
                "Hepatic Adenoma": [
                  {
                    "text": "Rarely, RN may lack portal zones and resemble hepatic adenoma"
                  },
                  {
                    "text": "True adenomas rarely, if ever, occur in cirrhotic liver"
                  }
                ],
                "Regenerative Nodule/Low-Grade Dysplastic Nodule vs. High-Grade Dysplastic Nodule": [
                  {
                    "text": "Cytologic abnormalities, such as small cell change and nuclear atypia, favor HGDN"
                  },
                  {
                    "text": "Architectural abnormalities like pseudoacinar architecture, focal reticulin loss, and unpaired arterioles, favor HGDN"
                  }
                ],
                "High-Grade Dysplastic Nodule vs. Well-Differentiated Hepatocellular Carcinoma": [
                  {
                    "text": "Cell plates > 3 cells thick are most important feature distinguishing HCC from HGDN"
                  },
                  {
                    "text": "Prominent pseudoacinar architecture and numerous unpaired arterioles are typical of HCC"
                  },
                  {
                    "text": "Multifocal loss or fragmentation of reticulin network strongly favors HCC"
                  },
                  {
                    "text": "CD34 is typically diffuse in HCC and patchy in HGDN, but considerable overlap exists"
                  },
                  {
                    "text": "CK7-positive ductular reaction present: ~ > 50% of circumference of HGDN in most cases; this is focal or lost in most HCC"
                  },
                  {
                    "text": "GPC expression favors HCC, especially if strong and diffuseGPC expression described in 7-22% of HGDN",
                    "sub_points": [
                      "GPC expression described in 7-22% of HGDN"
                    ]
                  }
                ],
                "High-Grade Dysplastic Nodule vs. Early Hepatocellular Carcinoma (Early Well-Differentiated Hepatocellular Carcinoma or Vaguely Nodular Hepatocellular Carcinoma)": [
                  {
                    "text": "Characteristic feature of early HCC is stromal invasion leading to vaguely nodular appearanceStromal invasion can occur at nodule-parenchymal or nodule-septal interface within nodule or at peripherySince stromal invasion can be focal, distinction from HGDN on biopsy may not be possibleLack of CK7-positive ductular reaction can be useful in demonstrating stromal invasion",
                    "sub_points": [
                      "Stromal invasion can occur at nodule-parenchymal or nodule-septal interface within nodule or at periphery",
                      "Since stromal invasion can be focal, distinction from HGDN on biopsy may not be possible",
                      "Lack of CK7-positive ductular reaction can be useful in demonstrating stromal invasion"
                    ]
                  },
                  {
                    "text": "Uniformly thick plates (> 3 cells), prominent pseudoglands, and loss of reticulin are typical of progressed HCC; may not be seen in early HCC"
                  },
                  {
                    "text": "ImmunohistochemistryGPC expression is more often seen in early HCC than HGDNGlutamine synthetase (GS), which is downstream gene in β-catenin pathway, is diffusely positive in many early HCC (up to 70%)10-15% of HGDN can be positive (usually focal)Heat shock protein 70, which is cell cycle/apoptosis regulator, is overexpressed in 80% of early HCC5-10% of HGDN can be positive (usually focal)When 2 of these 3 markers are positive, specificity and sensitivity for diagnosis of HCC are 100% and 72%, respectively, in resectionsWhen 2 of these 3 markers are positive, specificity and sensitivity for diagnosis of HCC are 100% and 50%, respectively, in biopsies",
                    "sub_points": [
                      "GPC expression is more often seen in early HCC than HGDN",
                      "Glutamine synthetase (GS), which is downstream gene in β-catenin pathway, is diffusely positive in many early HCC (up to 70%)10-15% of HGDN can be positive (usually focal)",
                      "10-15% of HGDN can be positive (usually focal)",
                      "Heat shock protein 70, which is cell cycle/apoptosis regulator, is overexpressed in 80% of early HCC5-10% of HGDN can be positive (usually focal)",
                      "5-10% of HGDN can be positive (usually focal)",
                      "When 2 of these 3 markers are positive, specificity and sensitivity for diagnosis of HCC are 100% and 72%, respectively, in resections",
                      "When 2 of these 3 markers are positive, specificity and sensitivity for diagnosis of HCC are 100% and 50%, respectively, in biopsies"
                    ]
                  },
                  {
                    "text": "In practice, GS is useful but utility of GPC and HSP70 is limited due to low sensitivity in well-differentiated HCC"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "No reliable criteria other than clonality to distinguish LGDN from RNMost RN/LGDN are probably not preneoplastic",
                    "sub_points": [
                      "Most RN/LGDN are probably not preneoplastic"
                    ]
                  },
                  {
                    "text": "HGDN have significant cytologic and sometimes architectural atypia; considered precursors of HCC"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatocellular Carcinoma and Variants": {
            "name": "Hepatocellular Carcinoma and Variants",
            "url": "https://app.pathprimer.com/document/99b1f048-b74b-4505-bd1a-0d7b9c48a426/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Chronic viral hepatitis, alcohol are leading causes"
                  },
                  {
                    "text": "70-90% of hepatocellular carcinoma (HCC) arises in cirrhosis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "α-fetoprotein is elevated in 70-90% of patients"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Arterial enhancement and venous washout is typical"
                  },
                  {
                    "text": "Liver Imaging Reporting and Data System (LI-RADS)Based on arterial enhancement along with size, venous washout, presence of capsule, interval growth",
                    "sub_points": [
                      "Based on arterial enhancement along with size, venous washout, presence of capsule, interval growth"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Typically soft, bile-stained with hemorrhage and necrosis"
                  },
                  {
                    "text": "Can be solitary tumor, multiple discrete tumors, or small indistinct nodules throughout portion of liver"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Architectural patterns: Trabecular, pseudoacinar, compact, macrotrabecular"
                  },
                  {
                    "text": "Tumor cells resemble hepatocytes with polygonal shape, round, vesicular nuclei, and prominent nucleoli"
                  },
                  {
                    "text": "Bile pigment in dilated canaliculi"
                  },
                  {
                    "text": "Histologic variants: Fibrolamellar, scirrhous, steatohepatitic, sarcomatoid, lymphocyte rich, neutrophil rich, clear cell, macrotrabecular, chromophobe"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Arginase-1: Sensitive and specific marker of hepatocellular differentiation"
                  },
                  {
                    "text": "Albumin in situ hybridization: Positive in HCC and intrahepatic cholangiocarcinoma"
                  },
                  {
                    "text": "HepPar1, polyclonal CEA: Overall high sensitivity but < 50% in poorly differentiated HCC"
                  },
                  {
                    "text": "Glypican-3: Poorly differentiated and scirrhous HCC"
                  },
                  {
                    "text": "Reticulin stain: Wide cell plates, loss of reticulin frameworkNot reliable in presence of fat as nonneoplastic liver with steatosis also shows reticulin loss and fragmentation",
                    "sub_points": [
                      "Not reliable in presence of fat as nonneoplastic liver with steatosis also shows reticulin loss and fragmentation"
                    ]
                  },
                  {
                    "text": "Typical mutational profile can help in making diagnosisTERTpromoter andCTNNB1mutation favor HCCIDH1/IDH2mutation,FGFR2fusions favor intrahepatic cholangiocarcinoma",
                    "sub_points": [
                      "TERTpromoter andCTNNB1mutation favor HCC",
                      "IDH1/IDH2mutation,FGFR2fusions favor intrahepatic cholangiocarcinoma"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatocellular carcinoma (HCC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Primary malignant neoplasm of liver with hepatocytic differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Alagille syndrome, ataxia-telangiectasia, Abernethy malformation, genetic diseases, such as bile salt export pump deficiency"
                  }
                ],
                "Environmental Exposure": [
                  {
                    "text": "Aflatoxin B1 (mycotoxin produced by fungi ofAspergillusgenus that contaminates food) is major cause of HCC in China and Southern Africa"
                  },
                  {
                    "text": "Alcoholic cirrhosis is major cause of HCC in Western populations"
                  },
                  {
                    "text": "Other exposures linked to HCC include anabolic steroids, Thorotrast, oral contraceptives, and smoking"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Chronic viral hepatitis (hepatitis B and hepatitis C) is leading cause of HCC worldwide"
                  }
                ],
                "Metabolic Disorders": [
                  {
                    "text": "Hemochromatosis, tyrosinemia, hypercitrullinemia, α-1-antitrypsin deficiency, fructosemia"
                  },
                  {
                    "text": "Recent studies have implicated diabetes, obesity, and metabolic syndrome as risk factors"
                  }
                ],
                "Cirrhosis": [
                  {
                    "text": "80-90% of HCC cases arise in cirrhosis"
                  },
                  {
                    "text": "Prognosis is significantly worse compared to HCC in noncirrhotic liver"
                  },
                  {
                    "text": "Macronodular cirrhosis is more strongly associated with HCC than micronodular"
                  }
                ],
                "Progression of Benign Tumor": [
                  {
                    "text": "HCC can rarely arise from transformation of hepatocellular adenoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Varies widely depending on geography in parallel with prevalence of hepatitis B/C and aflatoxin exposureEast Asia and Southern Africa have highest incidence worldwide, up to 150 per 100,000In USA, annual incidence is 9.5 per 100,000 (2019 data)",
                    "sub_points": [
                      "East Asia and Southern Africa have highest incidence worldwide, up to 150 per 100,000",
                      "In USA, annual incidence is 9.5 per 100,000 (2019 data)"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Incidence increases with advancing age and then falls off in older adults; however, average age varies depending on geographyIn parts of world with high incidence, average age is 35 yearsIn USA, average age is 60 years",
                    "sub_points": [
                      "In parts of world with high incidence, average age is 35 years",
                      "In USA, average age is 60 years"
                    ]
                  },
                  {
                    "text": "Can occur in children, particularly in those with metabolic or genetic disorders"
                  }
                ],
                "Sex": [
                  {
                    "text": "More common in men"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain due to stretching of Glisson capsule"
                  },
                  {
                    "text": "Malaise, weight loss, hepatomegaly"
                  },
                  {
                    "text": "Decompensation of previously stable cirrhotic patient with jaundice and rapidly accumulating ascites"
                  },
                  {
                    "text": "Fever, leukocytosis, and liver mass mimicking hepatic abscess"
                  },
                  {
                    "text": "Small, asymptomatic tumors found during surveillance of cirrhosis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "α-fetoprotein (AFP) is elevated in 70-90% of patients (> 400 ng/mL in 50% of cases)"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Metastasis occurs in 40-60% of patientsMost common locations are lymph nodes in porta hepatis, around pancreas, and celiac axis",
                    "sub_points": [
                      "Most common locations are lymph nodes in porta hepatis, around pancreas, and celiac axis"
                    ]
                  },
                  {
                    "text": "HCC has tendency for intravascular spread with involvement of hepatic and portal veinsHematogenous spread most commonly occurs to lungs but also adrenal glands, bone, stomach, heart, pancreas, kidney, spleen, and ovary",
                    "sub_points": [
                      "Hematogenous spread most commonly occurs to lungs but also adrenal glands, bone, stomach, heart, pancreas, kidney, spleen, and ovary"
                    ]
                  },
                  {
                    "text": "Tumor seldom breaches Glisson capsule; hence, peritoneal dissemination is rare"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Local therapyRadiofrequency or microwave ablation, or direct percutaneous ethanol injections are options for small tumorsTransarterial embolization (TEA) and transarterial chemoembolization (TACE) can prolong survivalLow-dose brachytherapy using radioactive yttrium spheres",
                    "sub_points": [
                      "Radiofrequency or microwave ablation, or direct percutaneous ethanol injections are options for small tumors",
                      "Transarterial embolization (TEA) and transarterial chemoembolization (TACE) can prolong survival",
                      "Low-dose brachytherapy using radioactive yttrium spheres"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Resection is possible if sufficient reserve liver function"
                  },
                  {
                    "text": "Transplantation is option if patient meets Milan criteria of single tumor < 5 cm, or < 4 tumors, none > 3 cm"
                  },
                  {
                    "text": "Less stringent UCSF criteria have been proposed: Solitary tumor < 6.5 cm, or < 4 tumors, none > 4.5 cm, and total tumor diameter up to 8 cm, without gross vascular invasion"
                  },
                  {
                    "text": "Histologic differentiation as selection criterion has been implemented in certain centers, as poor differentiation has been shown to be associated with high recurrence"
                  }
                ],
                "Drugs": [
                  {
                    "text": "HCC is resistant to chemotherapeutic agents"
                  },
                  {
                    "text": "Tyrosine kinase inhibitorsSorafenib for unresectable or advanced casesRegorafenib and cabozantinib used for patients who progress on sorafenib; lenvatinib used as 1st choiceVEGF-inhibitor bevacizumab in combination with atezolizumab for unresectable or metastatic HCCNivolumab (PD-1 inhibitor) and pembrolizumab (PD-L1 inhibitor) for those who have been treated with sorafenib",
                    "sub_points": [
                      "Sorafenib for unresectable or advanced cases",
                      "Regorafenib and cabozantinib used for patients who progress on sorafenib; lenvatinib used as 1st choice",
                      "VEGF-inhibitor bevacizumab in combination with atezolizumab for unresectable or metastatic HCC",
                      "Nivolumab (PD-1 inhibitor) and pembrolizumab (PD-L1 inhibitor) for those who have been treated with sorafenib"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Favorable prognostic factorsAge < 50 years, female sexResectable tumorNoncirrhotic liverEncapsulated tumor, early HCC, well differentiatedAbsence of vascular invasionCK19 negative",
                    "sub_points": [
                      "Age < 50 years, female sex",
                      "Resectable tumor",
                      "Noncirrhotic liver",
                      "Encapsulated tumor, early HCC, well differentiated",
                      "Absence of vascular invasion",
                      "CK19 negative"
                    ]
                  },
                  {
                    "text": "In USA, 5-year survival is 30% for localized disease, 10% for regional disease, and < 5% for metastatic disease"
                  },
                  {
                    "text": "For early cancers that receive transplant, 5-year survival is 60-70%"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Characteristic features on contrast-enhanced study (dynamic CT or MR)HCC enhances more intensely than surrounding liver in arterial phaseHCC enhances less than surrounding liver in venous phase (washout)",
                    "sub_points": [
                      "HCC enhances more intensely than surrounding liver in arterial phase",
                      "HCC enhances less than surrounding liver in venous phase (washout)"
                    ]
                  },
                  {
                    "text": "Biopsy not required for diagnosis if imaging findings typical of HCC in cirrhotic liver"
                  },
                  {
                    "text": "All suspicious lesions in noncirrhotic liver as well as ones in cirrhotic liver with atypical imaging features should be biopsied"
                  },
                  {
                    "text": "Liver Imaging Reporting and Data System (LI-RADS) is now being usedCombines arterial enhancement with size, venous washout, presence of capsule, and growth compared to prior imaging to yield these diagnostic categoriesLR-1: Definitely benignLR-2: Probably benignLR-3: Intermediate probability of malignancyLR-4: Probably HCCLR-5: Definitely HCCLR-M: Probably or definitely malignant but not HCC specific",
                    "sub_points": [
                      "Combines arterial enhancement with size, venous washout, presence of capsule, and growth compared to prior imaging to yield these diagnostic categoriesLR-1: Definitely benignLR-2: Probably benignLR-3: Intermediate probability of malignancyLR-4: Probably HCCLR-5: Definitely HCCLR-M: Probably or definitely malignant but not HCC specific",
                      "LR-1: Definitely benign",
                      "LR-2: Probably benign",
                      "LR-3: Intermediate probability of malignancy",
                      "LR-4: Probably HCC",
                      "LR-5: Definitely HCC",
                      "LR-M: Probably or definitely malignant but not HCC specific"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Variable hemorrhage and necrosis, can be bile stained"
                  },
                  {
                    "text": "Solitary ± satellite nodules or multiple discrete tumors"
                  },
                  {
                    "text": "Multiple small, indistinct tumor nodules can mimic cirrhosis on imaging and gross examination (cirrhosis-like variant)Pedunculated tumors are rare, more easily resected and have better prognosisEncapsulated tumors are usually solitary tumors that arise in cirrhotic livers and have better prognosis",
                    "sub_points": [
                      "Pedunculated tumors are rare, more easily resected and have better prognosis",
                      "Encapsulated tumors are usually solitary tumors that arise in cirrhotic livers and have better prognosis"
                    ]
                  },
                  {
                    "text": "Gross venous or bile duct invasion may be seen"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Architectural patternsTrabecular pattern: Thickened plates separated by sinusoids without desmoplastic stromaPseudoglandular or acinar pattern: Gland-like or tubular architecture can be result of dilated canaliculi; no true luminaCompact/diffuse pattern: Tumor cells in sheets without distinct sinusoidal spacesSpindle cell pattern: Observed in sarcomatoid HCC",
                    "sub_points": [
                      "Trabecular pattern: Thickened plates separated by sinusoids without desmoplastic stroma",
                      "Pseudoglandular or acinar pattern: Gland-like or tubular architecture can be result of dilated canaliculi; no true lumina",
                      "Compact/diffuse pattern: Tumor cells in sheets without distinct sinusoidal spaces",
                      "Spindle cell pattern: Observed in sarcomatoid HCC"
                    ]
                  },
                  {
                    "text": "Tumor cell morphologyTumor cells resemble hepatocytes with polygonal shape, round, vesicular nuclei, and prominent nucleoliInclusions can be seen in tumor cells: Mallory hyaline, ground-glass inclusions, hyaline globules, pale bodiesClear cells may be present and even numerous due to accumulation of glycogen or fatBizarre mono- or multinucleate tumor giant cells, rare osteoclast-like giant cellsCytoplasmic fat can be present, often diffuse in small, well-differentiated tumorsBile can be present in dilated canaliculi, helpful in distinguishing HCC from its mimics",
                    "sub_points": [
                      "Tumor cells resemble hepatocytes with polygonal shape, round, vesicular nuclei, and prominent nucleoli",
                      "Inclusions can be seen in tumor cells: Mallory hyaline, ground-glass inclusions, hyaline globules, pale bodies",
                      "Clear cells may be present and even numerous due to accumulation of glycogen or fat",
                      "Bizarre mono- or multinucleate tumor giant cells, rare osteoclast-like giant cells",
                      "Cytoplasmic fat can be present, often diffuse in small, well-differentiated tumors",
                      "Bile can be present in dilated canaliculi, helpful in distinguishing HCC from its mimics"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Neoplastic cells resemble hepatocytes but with enlarged nuclei, nuclear membrane irregularity, coarse chromatin, and prominent macronucleoliMay have dispersed cell pattern with numerous stripped, atypical nuclei",
                    "sub_points": [
                      "May have dispersed cell pattern with numerous stripped, atypical nuclei"
                    ]
                  },
                  {
                    "text": "Tumor cells tend to be more monotonous with less anisonucleosis and higher nuclear:cytoplasmic ratio than benign hepatocytes"
                  },
                  {
                    "text": "Thick, disordered plates or balls of neoplastic cells, focally lined by sinusoidal endothelial cells (endothelial wrapping)"
                  },
                  {
                    "text": "Large tissue fragments traversed by blood vessels"
                  }
                ],
                "Fibrolamellar Carcinoma": [
                  {
                    "text": "5% of HCCs"
                  },
                  {
                    "text": "Arises in noncirrhotic livers"
                  },
                  {
                    "text": "Affects both sexes equally; usually < 35 years of age"
                  },
                  {
                    "text": "5-year survival rate: ~ 50%Better prognosis than conventional HCC arising in cirrhosis but overall survival similar to conventional HCC in noncirrhotic liver",
                    "sub_points": [
                      "Better prognosis than conventional HCC arising in cirrhosis but overall survival similar to conventional HCC in noncirrhotic liver"
                    ]
                  },
                  {
                    "text": "Gross examination: Lobulated appearance with fibrous septa or central stellate scar"
                  },
                  {
                    "text": "Triad of morphologic features: All 3 should be present for making diagnosisNests and sheets of large polygonal tumor cells with vesicular nuclei and single prominent nucleoliAbundant granular eosinophilic (oncocytic) cytoplasmFibrous stroma composed of parallel lamellae of collagen",
                    "sub_points": [
                      "Nests and sheets of large polygonal tumor cells with vesicular nuclei and single prominent nucleoli",
                      "Abundant granular eosinophilic (oncocytic) cytoplasm",
                      "Fibrous stroma composed of parallel lamellae of collagen"
                    ]
                  },
                  {
                    "text": "Pale bodies are present more often than conventional HCC"
                  },
                  {
                    "text": "Focal glandular differentiation and focal staining for neuroendocrine markers can be seen"
                  },
                  {
                    "text": "CK7 and CD68 are typically positive"
                  },
                  {
                    "text": "Characteristic 400 bp deletion on chromosome 19 in nearly 100% of casesLeads to novelPRKACA-DNAJB1fusion transcript that encodes chimeric protein with protein kinase A activityCan be detected in paraffin-embedded tissue by reverse transcription polymerase chain reaction (RT-PCR) or break-apart FISHNot described in other HCC or other liver tumors",
                    "sub_points": [
                      "Leads to novelPRKACA-DNAJB1fusion transcript that encodes chimeric protein with protein kinase A activity",
                      "Can be detected in paraffin-embedded tissue by reverse transcription polymerase chain reaction (RT-PCR) or break-apart FISH",
                      "Not described in other HCC or other liver tumors"
                    ]
                  }
                ],
                "Scirrhous HCC": [
                  {
                    "text": "Definition of > 50% fibrous stroma arbitrarily used to define this variant"
                  },
                  {
                    "text": "HepPar1, polyclonal CEA often negative"
                  },
                  {
                    "text": "CK7, CK19, &/or MOC31 often positive"
                  },
                  {
                    "text": "Morphology and immunoprofile can be mistaken for cholangiocarcinoma or metastatic adenocarcinoma"
                  },
                  {
                    "text": "Arginase-1 and glypican-3 have higher sensitivity compared to other hepatocellular markers"
                  },
                  {
                    "text": "Genetic alterationsAssociated withTSC1/TSC2mutationsTGF-β signaling activation",
                    "sub_points": [
                      "Associated withTSC1/TSC2mutations",
                      "TGF-β signaling activation"
                    ]
                  },
                  {
                    "text": "Poor outcome in some, but not all, studies"
                  }
                ],
                "Steatohepatitic HCC": [
                  {
                    "text": "Tumor cells show steatohepatitic changes: Steatosis, ballooning, Mallory hyaline, fibrosis, inflammationThese changes involve at least 50% of tumor",
                    "sub_points": [
                      "These changes involve at least 50% of tumor"
                    ]
                  },
                  {
                    "text": "Strongly associated with steatohepatitis and metabolic syndrome"
                  },
                  {
                    "text": "Less commonly described in other liver diseases, such as chronic hepatitis C"
                  }
                ],
                "Sarcomatoid HCC": [
                  {
                    "text": "Not recognized variant per WHO 2019"
                  },
                  {
                    "text": "Partly or completely composed of malignant spindle cells"
                  },
                  {
                    "text": "Hepatocellular markers typically negative in spindle cells; identification of typical HCC component necessary to make diagnosis"
                  },
                  {
                    "text": "Keratin usually positiveUse of multiple antibodies like AE1/AE3, CAM5.2, MNF116 increases sensitivity",
                    "sub_points": [
                      "Use of multiple antibodies like AE1/AE3, CAM5.2, MNF116 increases sensitivity"
                    ]
                  },
                  {
                    "text": "Heterologous differentiation can occur (smooth muscle, skeletal muscle, bone/cartilage, etc.)"
                  },
                  {
                    "text": "Sarcomatoid change can occur following chemotherapy or TACE"
                  },
                  {
                    "text": "More aggressive than conventional HCC"
                  }
                ],
                "Lymphocyte-Rich Carcinoma": [
                  {
                    "text": "Abundant lymphocytes that outnumber hepatocytes in most areas"
                  },
                  {
                    "text": "Rare cases have syncytial growth pattern with Epstein-Barr virus (EBV) positivity (lymphoepithelioma-like)"
                  },
                  {
                    "text": "Microsatellite stable"
                  }
                ],
                "Neutrophil-Rich HCC": [
                  {
                    "text": "Rare variant with production of G-CSF by tumor cells"
                  },
                  {
                    "text": "Leukocytosis &/or abundant neutrophilic infiltration amidst tumor cells"
                  },
                  {
                    "text": "Can be mistaken for liver abscess"
                  }
                ],
                "HCC With Stem Cell Features": [
                  {
                    "text": "Not recognized variant in WHO 2019 classification"
                  },
                  {
                    "text": "Small, uniform tumor cells at periphery of nests and trabeculae, typical of HCC, and may also form nests and trabeculae of their own"
                  },
                  {
                    "text": "Small tumor cells thought to be stem cells, may be negative for hepatocellular markers"
                  },
                  {
                    "text": "AFP and glypican-3 can be positive"
                  },
                  {
                    "text": "Variable staining with CK19, CD56, CD117, CD133, none of which are specific for stem cells"
                  },
                  {
                    "text": "Should not be classified as cholangiocarcinoma based on \"stem cell\" features alone"
                  },
                  {
                    "text": "May be more aggressive, but detailed outcome studies are not available"
                  }
                ],
                "Clear Cell": [
                  {
                    "text": "Clear cytoplasm; mimics other clear cell tumors, such as renal cell carcinoma (RCC)"
                  },
                  {
                    "text": "Positive for hepatocellular markers"
                  }
                ],
                "Macrotrabecular Massive": [
                  {
                    "text": "By definition, 10 or more cell thick plates present in > 50% of tumor (> 6 in some studies)"
                  },
                  {
                    "text": "FrequentTP53mutation,FGF19amplification"
                  },
                  {
                    "text": "Poor prognosis"
                  }
                ],
                "Chromophobe": [
                  {
                    "text": "Lightly eosinophilic to clear cytoplasm"
                  },
                  {
                    "text": "Bland cytology with focal anaplastic cells"
                  },
                  {
                    "text": "Pseudocysts"
                  },
                  {
                    "text": "Associated with alternate lengthening of telomeres (ALT)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Reticulin stainWidened cell platesLoss and fragmentation of reticulin frameworkMay be intact in very well-differentiated casesNot reliable in presence of fat as nonneoplastic liver with steatosis also shows reticulin loss and fragmentation",
                    "sub_points": [
                      "Widened cell plates",
                      "Loss and fragmentation of reticulin framework",
                      "May be intact in very well-differentiated cases",
                      "Not reliable in presence of fat as nonneoplastic liver with steatosis also shows reticulin loss and fragmentation"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Hepatocellular markersArginase-1: High sensitive and specificityHepPar1: Overall high sensitivity but < 50% in poorly differentiated HCCSome adenocarcinomas and neuroendocrine neoplasms can be positiveGlypican-3: Not specific hepatocellular markerHigh sensitivity in poorly differentiated and scirrhous HCCLow sensitivity in well-differentiated casesNegative in benign lesions like adenomaPolyclonal CEA, villin, and CD10 demonstrate canalicular patternLimited sensitivity in poorly differentiated HCCAFP has high specificity but low sensitivity (20-30%) and often shows background staining",
                    "sub_points": [
                      "Arginase-1: High sensitive and specificity",
                      "HepPar1: Overall high sensitivity but < 50% in poorly differentiated HCCSome adenocarcinomas and neuroendocrine neoplasms can be positive",
                      "Some adenocarcinomas and neuroendocrine neoplasms can be positive",
                      "Glypican-3: Not specific hepatocellular markerHigh sensitivity in poorly differentiated and scirrhous HCCLow sensitivity in well-differentiated casesNegative in benign lesions like adenoma",
                      "High sensitivity in poorly differentiated and scirrhous HCC",
                      "Low sensitivity in well-differentiated cases",
                      "Negative in benign lesions like adenoma",
                      "Polyclonal CEA, villin, and CD10 demonstrate canalicular patternLimited sensitivity in poorly differentiated HCC",
                      "Limited sensitivity in poorly differentiated HCC",
                      "AFP has high specificity but low sensitivity (20-30%) and often shows background staining"
                    ]
                  },
                  {
                    "text": "Sinusoidal capillarization demonstrated with CD34"
                  },
                  {
                    "text": "KeratinCK-PAN, CAM5.2 (keratins 8 and 18): PositiveCK7, CK19: Positive in 5-20% of cases; CK19 staining is associated with poor prognosisCK20: Negative or focal; diffuse staining in rare cases",
                    "sub_points": [
                      "CK-PAN, CAM5.2 (keratins 8 and 18): Positive",
                      "CK7, CK19: Positive in 5-20% of cases; CK19 staining is associated with poor prognosis",
                      "CK20: Negative or focal; diffuse staining in rare cases"
                    ]
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Albumin in situ hybridization has high sensitivity and specificity for primary liver carcinomaPositive in both HCC and intrahepatic cholangiocarcinomaAberrant staining in pancreatic acinar cell carcinomaFocal staining can be seen in adenocarcinomas of various sites",
                    "sub_points": [
                      "Positive in both HCC and intrahepatic cholangiocarcinoma",
                      "Aberrant staining in pancreatic acinar cell carcinoma",
                      "Focal staining can be seen in adenocarcinomas of various sites"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cholangiocarcinoma": [
                  {
                    "text": "Discrete glands and desmoplastic stroma"
                  },
                  {
                    "text": "Desmoplastic stroma"
                  },
                  {
                    "text": "Mucicarmine, CK7, CK19, &/or MOC31 often positive"
                  },
                  {
                    "text": "Hepatocyte nuclear factor-β highlights most cholangiocarcinomas while most HCCs are negative, but data is limited"
                  },
                  {
                    "text": "Hepatocellular markers negative; glypican-3 positive in 5-10%"
                  },
                  {
                    "text": "Typical mutational profile can help in making diagnosis in challenging casesTERTpromoter andCTNNB1mutation favor HCCIDH1/IDH2mutation,FGFR2fusions favor intrahepatic cholangiocarcinoma",
                    "sub_points": [
                      "TERTpromoter andCTNNB1mutation favor HCC",
                      "IDH1/IDH2mutation,FGFR2fusions favor intrahepatic cholangiocarcinoma"
                    ]
                  }
                ],
                "Metastatic Neuroendocrine Tumor": [
                  {
                    "text": "Prominent collagenous stroma"
                  },
                  {
                    "text": "Positive staining for neuroendocrine markers"
                  },
                  {
                    "text": "Hepatocellular markers negative; rare cases can show aberrant staining with HepPar1"
                  }
                ],
                "Metastatic Adenocarcinoma": [
                  {
                    "text": "Mucicarmine, MOC31 positive; keratin profile not limited to 8 and 18"
                  }
                ],
                "Angiomyolipoma": [
                  {
                    "text": "Adipose tissue and muscular arteries; may not be present in monotypic variant"
                  },
                  {
                    "text": "Myoid component can be spindle or epithelioid"
                  },
                  {
                    "text": "HMB-45, SMA positive; arginase-1, HepPar1, keratin negative"
                  },
                  {
                    "text": "Often indistinguishable from HCC on imaging"
                  }
                ],
                "Metastatic RCC": [
                  {
                    "text": "History of RCC or renal tumor, no cirrhosis"
                  },
                  {
                    "text": "Arginase-1, HepPar1 negative; PAX2, PAX8 positive"
                  }
                ],
                "Hepatocellular Adenoma": [
                  {
                    "text": "Female sex"
                  },
                  {
                    "text": "No or minimal cytologic atypia, 1- to 2-cell-thick plates"
                  },
                  {
                    "text": "Intact reticulin"
                  },
                  {
                    "text": "Glypican-3 and HSP70 typically negative"
                  }
                ],
                "Regenerative Nodule in Cirrhosis": [
                  {
                    "text": "Cytologically benign; absence of trabecular or pseudoglandular growth pattern"
                  },
                  {
                    "text": "Portal tracts present in nodule, intact reticulin"
                  }
                ],
                "Dysplastic Nodule in Cirrhosis": [
                  {
                    "text": "Small cell change &/or focally wide cell plates"
                  },
                  {
                    "text": "May have portal tracts, rare unpaired arterioles"
                  },
                  {
                    "text": "Ductular reaction at stromal interface, no invasion of intranodular portal tracts or adjacent liver"
                  },
                  {
                    "text": "Reticulin intact or only focal loss"
                  },
                  {
                    "text": "Stromal invasion and immunohistochemistry for glutamine synthetase, HSP70, and glypican-3 may help in distinction from early HCC"
                  }
                ],
                "Combined Hepatocellular-Cholangiocarcinoma": [
                  {
                    "text": "Additional cholangiocarcinoma component defined by discrete gland formation and strong staining for CK7, CK19, &/or MOC31Since these markers can be positive in HCC as well, they should not be used in absence of corresponding morphologic featuresMucin helpful to confirm cholangiocarcinoma component but is not always present",
                    "sub_points": [
                      "Since these markers can be positive in HCC as well, they should not be used in absence of corresponding morphologic features",
                      "Mucin helpful to confirm cholangiocarcinoma component but is not always present"
                    ]
                  },
                  {
                    "text": "Strict criteria for diagnosis should be used due to significant therapeutic implicationsCholangiocarcinoma component increases chances of lymph node involvement, which may require lymph node dissectionGemcitabine-based chemotherapy may be used if cholangiocarcinoma component is presentCholangiocarcinoma may exclude option of liver transplantation",
                    "sub_points": [
                      "Cholangiocarcinoma component increases chances of lymph node involvement, which may require lymph node dissection",
                      "Gemcitabine-based chemotherapy may be used if cholangiocarcinoma component is present",
                      "Cholangiocarcinoma may exclude option of liver transplantation"
                    ]
                  }
                ],
                "Metastatic Adrenocortical Carcinoma": [
                  {
                    "text": "CK-PAN weak or absent; hepatocellular markers negative"
                  },
                  {
                    "text": "Positive for SF1, inhibin, calretinin, &/or MART-1"
                  }
                ],
                "Hepatoid Carcinoma": [
                  {
                    "text": "Rare extrahepatic tumor resembling HCC on morphology and immunohistochemistryPrimary sites: Stomach, pancreas, gallbladder, colon, lung, urinary bladder",
                    "sub_points": [
                      "Primary sites: Stomach, pancreas, gallbladder, colon, lung, urinary bladder"
                    ]
                  },
                  {
                    "text": "No liver mass (except for rare cases with liver metastasis)"
                  },
                  {
                    "text": "Solid/hepatoid pattern, often with tubular component"
                  },
                  {
                    "text": "Serum AFP can be elevated"
                  },
                  {
                    "text": "Hepatocellular markers, including arginase-1, AFP, and glypican-3, can be positive"
                  },
                  {
                    "text": "CK19 and CK20 can be positive"
                  },
                  {
                    "text": "SALL4, transcription factor used in diagnosis of germ cell tumors, can be positive"
                  },
                  {
                    "text": "Aggressive tumors with poor outcome"
                  }
                ]
              },
              "GRADING": {
                "Edmondson and Steiner": [
                  {
                    "text": "Grade I: Extremely well differentiated; challenging to distinguish from adenoma or dysplastic nodule; mild nuclear enlargement; pseudoacini may be present"
                  },
                  {
                    "text": "Grade II: Resemblance to hepatocytes; nuclei larger and more hyperchromatic than normal; low nuclear:cytoplasmic ratio; pseudoacini often frequent"
                  },
                  {
                    "text": "Grade III: Nuclei larger and more hyperchromatic than grade II tumors; higher nuclear:cytoplasmic ratio; break-up or distortion of trabecular pattern; tumor giant cells can be present"
                  },
                  {
                    "text": "Grade IV: Nuclei intensely hyperchromatic; high nuclear:cytoplasmic ratio with often scanty cytoplasm; indistinct trabeculae; loosely cohesive cell nests; spindle cell areas can be present"
                  }
                ],
                "WHO 2019": [
                  {
                    "text": "Well differentiated: Resembles adenoma or dysplastic nodules; minimal to mild nuclear atypia; cytoplasm abundant eosinophilic to moderate basophilic"
                  },
                  {
                    "text": "Moderately differentiated: Clearly malignant; moderate nuclear atypia; cytoplasm abundant eosinophilic to moderate basophilic"
                  },
                  {
                    "text": "Poorly differentiated: Hepatocellular differentiation may not be evident on morphology; marked nuclear pleomorphism; cytoplasm moderate to scant basophilic"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatoblastoma": {
            "name": "Hepatoblastoma",
            "url": "https://app.pathprimer.com/document/29800c2b-5787-4f8f-b711-36d3c47dc829/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "AberrantWnt/CTNNB1(β-catenin) activation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common malignant liver neoplasm in children"
                  },
                  {
                    "text": "Most patients have increased serum α-fetoprotein"
                  },
                  {
                    "text": "Key prognostic factor of survival is tumor stage"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Most common component is epithelial subtypesPure fetal epithelial histology is associated with favorable prognosisEmbryonal and fetal epithelial patterns often seen togetherMacrotrabecular is composed of fetal or embryonal-type cells in wide trabeculaeSmall undifferentiated component is associated with poorer prognosis",
                    "sub_points": [
                      "Pure fetal epithelial histology is associated with favorable prognosis",
                      "Embryonal and fetal epithelial patterns often seen together",
                      "Macrotrabecular is composed of fetal or embryonal-type cells in wide trabeculae",
                      "Small undifferentiated component is associated with poorer prognosis"
                    ]
                  },
                  {
                    "text": "Mixed hepatoblastomas (HBs) are composed of epithelial and mesenchymal componentsMesenchymal component can range from immature spindle cells to fibrous tissueOsteoid-like and teratoid elements can occur",
                    "sub_points": [
                      "Mesenchymal component can range from immature spindle cells to fibrous tissue",
                      "Osteoid-like and teratoid elements can occur"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Nuclear β-catenin staining in epithelial and mesenchymal components (70% of cases), often membranous in fetal pattern"
                  },
                  {
                    "text": "Positive glypican-3 and HepPar1 staining in fetal and embryonal epithelial cells"
                  },
                  {
                    "text": "Positive glutamine synthetase staining in fetal and variably in embryonal cells"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal liver parenchyma; positive nuclear &/or cytoplasmic β-catenin staining in HB"
                  },
                  {
                    "text": "Hepatocellular carcinoma; presence of both fetal and embryonal patterns diagnostic of HB"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Hepatoblastoma (HB)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Predominantly pediatric liver tumor that morphologically resembles developing fetal or embryonal liver histologically"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neoplasm": [
                  {
                    "text": "Wntpathway activation; in 70-90% due toCTNNB1(β-catenin) mutation and, less commonly, due to germlineAPCmutations (familial adenomatous polyposis syndrome)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2.1% of all pediatric cancers (1-19 years)"
                  },
                  {
                    "text": "Higher in low-birth-weight infants"
                  },
                  {
                    "text": "Slight increase from 2000 to 2015 per SEER database and may be related to increasing survival of low-birth-weight infants"
                  }
                ],
                "Age": [
                  {
                    "text": "Most common malignant liver neoplasm in children88% in children ≤ 5 years and 3% > 15 yearsMean age at diagnosis: 19 months",
                    "sub_points": [
                      "88% in children ≤ 5 years and 3% > 15 years",
                      "Mean age at diagnosis: 19 months"
                    ]
                  },
                  {
                    "text": "May be congenital"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance (M:F = 3:2)"
                  }
                ],
                "Site": [
                  {
                    "text": "58% involve right lobe, 27% involve both lobes"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Painless abdominal mass, hepatomegaly"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Increased serum α-fetoprotein (AFP) in 75-96% of patientsOften ≥ 100,000 ng/mLCaveat: High AFP normal before 6 months of ageUseful marker of response to therapy and recurrence",
                    "sub_points": [
                      "Often ≥ 100,000 ng/mL",
                      "Caveat: High AFP normal before 6 months of age",
                      "Useful marker of response to therapy and recurrence"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resectionStage 1 pure fetal HB cured by surgical resection aloneOnly 1/3-1/2 have resectable disease at presentationPreoperative chemotherapy converts > 50% of inoperable tumors to resectable tumorsChildren's Oncology Group (COG) standard regimen consists of cisplatin, 5-fluorouracil, and vincristine (C5V)",
                    "sub_points": [
                      "Stage 1 pure fetal HB cured by surgical resection alone",
                      "Only 1/3-1/2 have resectable disease at presentation",
                      "Preoperative chemotherapy converts > 50% of inoperable tumors to resectable tumors",
                      "Children's Oncology Group (COG) standard regimen consists of cisplatin, 5-fluorouracil, and vincristine (C5V)"
                    ]
                  },
                  {
                    "text": "Liver transplant considered in unresectable cases"
                  }
                ],
                "COG Staging System (Pretreatment Staging)": [
                  {
                    "text": "Stage I: Completely resected tumor with negative margin"
                  },
                  {
                    "text": "Stage II: Grossly resected tumor with microscopic residual tumor (positive margin)"
                  },
                  {
                    "text": "Stage III: Unresectable tumorBiopsy diagnosis, partially resected, macroscopic residual tumor, tumor rupturePositive abdominal lymph node",
                    "sub_points": [
                      "Biopsy diagnosis, partially resected, macroscopic residual tumor, tumor rupture",
                      "Positive abdominal lymph node"
                    ]
                  },
                  {
                    "text": "Stage IV: Metastasis to lungs, other organs, or sites distant from abdomen"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tumor stage is key prognostic factor in survival90% event-free survival with complete tumor resection< 70% event-free survival with nonmetastatic, unresectable tumor",
                    "sub_points": [
                      "90% event-free survival with complete tumor resection",
                      "< 70% event-free survival with nonmetastatic, unresectable tumor"
                    ]
                  }
                ],
                "Metastasis": [
                  {
                    "text": "10-20% of patients have metastases at presentation"
                  },
                  {
                    "text": "Lung most frequent but can involve bone, brain, eye, or ovaries"
                  },
                  {
                    "text": "20-30% survival with metastatic disease at presentation"
                  }
                ],
                "Conditions Associated With Hepatoblastoma": [
                  {
                    "text": "Familial adenomatous polyposis, Beckwith-Wiedemann, Li-Fraumeni, Simpson-Golabi-Behmel, Sotos, Kabuki, and Prader-Willi syndromes"
                  },
                  {
                    "text": "Trisomy 18, glycogen storage disease types I-IV, hemihypertrophy"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Solitary or multifocal heterogeneous and hypervascular massCalcification is common",
                    "sub_points": [
                      "Calcification is common"
                    ]
                  }
                ],
                "Pretreatment Extent of Disease and Posttreatment Extent of Disease Classification": [
                  {
                    "text": "Assessment made prior to or post chemotherapy"
                  },
                  {
                    "text": "Guides surgical approach"
                  },
                  {
                    "text": "Determines number of affected liver segments and extent of venous involvement"
                  },
                  {
                    "text": "Pretreatment extent of disease (PRETEXT) guides surgical approachI: 3 contiguous sections tumor freeII: 2 contiguous sections tumor freeIII: 1 contiguous section tumor freeIV: No contiguous sections tumor freeAny group may have VPEMC component: V (ingrowth vena cava, all 3 hepatic veins), P (ingrowth portal vein, portal bifurcation), E (extrahepatic spread), M (metastasis), C (caudate lobe involvement)",
                    "sub_points": [
                      "I: 3 contiguous sections tumor free",
                      "II: 2 contiguous sections tumor free",
                      "III: 1 contiguous section tumor free",
                      "IV: No contiguous sections tumor free",
                      "Any group may have VPEMC component: V (ingrowth vena cava, all 3 hepatic veins), P (ingrowth portal vein, portal bifurcation), E (extrahepatic spread), M (metastasis), C (caudate lobe involvement)"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary or multifocal, lobulated, heterogeneous massFetal pattern areas resemble normal liverEmbryonal, small cell patterns: Softer, fleshy to gelatinous, gray-tan or pale pinkMesenchymal: Osteoid-like areas firm or calcifiedTeratoid, melanotic component: Dark brown or black",
                    "sub_points": [
                      "Fetal pattern areas resemble normal liver",
                      "Embryonal, small cell patterns: Softer, fleshy to gelatinous, gray-tan or pale pink",
                      "Mesenchymal: Osteoid-like areas firm or calcified",
                      "Teratoid, melanotic component: Dark brown or black"
                    ]
                  },
                  {
                    "text": "Carefully search for vascular invasion"
                  }
                ],
                "Size": [
                  {
                    "text": "Large; can be > 15 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Epithelial patternsFetal pattern (mitotically inactive)Uniform cells forming slender cords and trabeculaeSmaller than normal hepatocytesCentral round to oval nuclei, inconspicuous nucleolus, abundant clear to pink cytoplasm, distinct membraneAlternating light and dark areas based on cytoplasmic glycogen content; may have fatLow mitotic index (≤ 2 mitoses/10 HPF)Crowded fetal pattern (mitotically active)Similar to pure fetal but for closely packed cells and higher mitoses (> 2 mitoses/10 HPF)Slightly increased nuclear:cytoplasmic ratioIntermixed with pure fetal pattern and merges into embryonal pattern; can be difficult to differentiateEmbryonal patternMost common pattern in HBPrimitive cells in sheets, pseudorosettes, acini, tubulesSmall, angulated nuclei (larger than fetal nuclei), coarse chromatin, prominent nucleoli, scant cytoplasm, indistinct membranesMitotic figures more frequentSmall cell undifferentiated (should show SMARCB1 retention)Can be difficult to recognizeResembles cells found in small round blue cell neoplasmsGrows in sheets, infiltrative, lacks cohesionHigh nuclear:cytoplasmic ratio with almost no cytoplasm, hyperchromatic nuclei, inconspicuous nucleoliCan have rhabdoid-like cells with eccentric cytoplasmVariable mitotic rateAny percentage of this component should be reported, as it may be associated with adverse outcomeIt is now thought that cases with SMARCB1 loss are best classified as malignant rhabdoid tumorsExtramedullary hematopoiesis may occur in fetal and embryonal patternsNot useful to distinguish these epithelial patterns based on this finding aloneCholangioblasticSmall ducts lie within or around hepatocellular componentsMacrotrabecularThick trabecula composed of fetal or embryonal hepatoblasts or pleomorphic cells and measuring 5-12 cells thickMixed epithelialAny combination of above patterns",
                    "sub_points": [
                      "Fetal pattern (mitotically inactive)Uniform cells forming slender cords and trabeculaeSmaller than normal hepatocytesCentral round to oval nuclei, inconspicuous nucleolus, abundant clear to pink cytoplasm, distinct membraneAlternating light and dark areas based on cytoplasmic glycogen content; may have fatLow mitotic index (≤ 2 mitoses/10 HPF)",
                      "Uniform cells forming slender cords and trabeculae",
                      "Smaller than normal hepatocytes",
                      "Central round to oval nuclei, inconspicuous nucleolus, abundant clear to pink cytoplasm, distinct membrane",
                      "Alternating light and dark areas based on cytoplasmic glycogen content; may have fat",
                      "Low mitotic index (≤ 2 mitoses/10 HPF)",
                      "Crowded fetal pattern (mitotically active)Similar to pure fetal but for closely packed cells and higher mitoses (> 2 mitoses/10 HPF)Slightly increased nuclear:cytoplasmic ratioIntermixed with pure fetal pattern and merges into embryonal pattern; can be difficult to differentiate",
                      "Similar to pure fetal but for closely packed cells and higher mitoses (> 2 mitoses/10 HPF)",
                      "Slightly increased nuclear:cytoplasmic ratio",
                      "Intermixed with pure fetal pattern and merges into embryonal pattern; can be difficult to differentiate",
                      "Embryonal patternMost common pattern in HBPrimitive cells in sheets, pseudorosettes, acini, tubulesSmall, angulated nuclei (larger than fetal nuclei), coarse chromatin, prominent nucleoli, scant cytoplasm, indistinct membranesMitotic figures more frequent",
                      "Most common pattern in HB",
                      "Primitive cells in sheets, pseudorosettes, acini, tubules",
                      "Small, angulated nuclei (larger than fetal nuclei), coarse chromatin, prominent nucleoli, scant cytoplasm, indistinct membranes",
                      "Mitotic figures more frequent",
                      "Small cell undifferentiated (should show SMARCB1 retention)Can be difficult to recognizeResembles cells found in small round blue cell neoplasmsGrows in sheets, infiltrative, lacks cohesionHigh nuclear:cytoplasmic ratio with almost no cytoplasm, hyperchromatic nuclei, inconspicuous nucleoliCan have rhabdoid-like cells with eccentric cytoplasmVariable mitotic rateAny percentage of this component should be reported, as it may be associated with adverse outcomeIt is now thought that cases with SMARCB1 loss are best classified as malignant rhabdoid tumors",
                      "Can be difficult to recognize",
                      "Resembles cells found in small round blue cell neoplasms",
                      "Grows in sheets, infiltrative, lacks cohesion",
                      "High nuclear:cytoplasmic ratio with almost no cytoplasm, hyperchromatic nuclei, inconspicuous nucleoli",
                      "Can have rhabdoid-like cells with eccentric cytoplasm",
                      "Variable mitotic rate",
                      "Any percentage of this component should be reported, as it may be associated with adverse outcome",
                      "It is now thought that cases with SMARCB1 loss are best classified as malignant rhabdoid tumors",
                      "Extramedullary hematopoiesis may occur in fetal and embryonal patternsNot useful to distinguish these epithelial patterns based on this finding alone",
                      "Not useful to distinguish these epithelial patterns based on this finding alone",
                      "CholangioblasticSmall ducts lie within or around hepatocellular components",
                      "Small ducts lie within or around hepatocellular components",
                      "MacrotrabecularThick trabecula composed of fetal or embryonal hepatoblasts or pleomorphic cells and measuring 5-12 cells thick",
                      "Thick trabecula composed of fetal or embryonal hepatoblasts or pleomorphic cells and measuring 5-12 cells thick",
                      "Mixed epithelialAny combination of above patterns",
                      "Any combination of above patterns"
                    ]
                  },
                  {
                    "text": "Mesenchymal componentHighly cellular primitive mesenchyme (immature spindle cells), scant cytoplasm, elongated plump nucleiLoose collagenous stroma &/or mature fibrous tissueOsteoid-like areas (usually more prominent after chemotherapy)Immunoreactive for cytokeratin and EMABone, cartilage, and rhabdomyoblasts can be present",
                    "sub_points": [
                      "Highly cellular primitive mesenchyme (immature spindle cells), scant cytoplasm, elongated plump nuclei",
                      "Loose collagenous stroma &/or mature fibrous tissue",
                      "Osteoid-like areas (usually more prominent after chemotherapy)Immunoreactive for cytokeratin and EMA",
                      "Immunoreactive for cytokeratin and EMA",
                      "Bone, cartilage, and rhabdomyoblasts can be present"
                    ]
                  },
                  {
                    "text": "Mixed epithelial and mesenchymal patternsCombination of above patterns",
                    "sub_points": [
                      "Combination of above patterns"
                    ]
                  },
                  {
                    "text": "Teratoid component (may be present in mixed epithelial mesenchymal HB)Primitive neuroglia, ganglion cells, or melanin pigmentCan also show bone, cartilage, rhabdomyoblasts, squamous cells, and mucinous glands",
                    "sub_points": [
                      "Primitive neuroglia, ganglion cells, or melanin pigment",
                      "Can also show bone, cartilage, rhabdomyoblasts, squamous cells, and mucinous glands"
                    ]
                  },
                  {
                    "text": "Pleomorphic epithelial HBPresent in posttherapy resections with bizarre pleomorphic cells and tumor giant cell",
                    "sub_points": [
                      "Present in posttherapy resections with bizarre pleomorphic cells and tumor giant cell"
                    ]
                  }
                ],
                "Prognostic Factors": [
                  {
                    "text": "StageStage IV has uniform poor prognosis (39% 5-year survival)",
                    "sub_points": [
                      "Stage IV has uniform poor prognosis (39% 5-year survival)"
                    ]
                  },
                  {
                    "text": "HistologyPure fetal has excellent prognosis (100% 5-year, event-free survival)Small cell undifferentiated, macrotrabecular may be more aggressive",
                    "sub_points": [
                      "Pure fetal has excellent prognosis (100% 5-year, event-free survival)",
                      "Small cell undifferentiated, macrotrabecular may be more aggressive"
                    ]
                  },
                  {
                    "text": "Posttreatment extent of tumorPoor response to chemotherapyPositive surgical margins or unresectable tumor",
                    "sub_points": [
                      "Poor response to chemotherapy",
                      "Positive surgical margins or unresectable tumor"
                    ]
                  },
                  {
                    "text": "Indicators of poor prognosisPRETEXT category IVLarge sizeVascular invasionMetastasis at diagnosisAFP < 100 at diagnosis",
                    "sub_points": [
                      "PRETEXT category IV",
                      "Large size",
                      "Vascular invasion",
                      "Metastasis at diagnosis",
                      "AFP < 100 at diagnosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Nuclear β-catenin staining in epithelial and mesenchymal components (70-90% of HB)Nuclear staining not seen in most fetal HBPositive in small, undifferentiated component",
                    "sub_points": [
                      "Nuclear staining not seen in most fetal HB",
                      "Positive in small, undifferentiated component"
                    ]
                  },
                  {
                    "text": "Glypican-3 and HepPar1 positive in fetal and embryonal pattern"
                  },
                  {
                    "text": "Glutamine synthetase is strongly expressed particularly in fetal component and patchy in embryonal component, while it is negative in small cell undifferentiated HB"
                  },
                  {
                    "text": "INI1/BAF47/SMARCB1 usually preserved, unlike rhabdoid tumors, but INI1 loss is noted in small cell undifferentiated HB with worse prognosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Liver Parenchyma": [
                  {
                    "text": "Must distinguish fetal pattern from normal hepatocytes, particularly near marginNuclear &/or cytoplasmic β-catenin staining in HBFetal cells are smaller than normal hepatocytes",
                    "sub_points": [
                      "Nuclear &/or cytoplasmic β-catenin staining in HB",
                      "Fetal cells are smaller than normal hepatocytes"
                    ]
                  }
                ],
                "Hepatocellular Carcinoma": [
                  {
                    "text": "May be indistinguishable from macrotrabecular HBBiphasic pattern with fetal and embryonal cells in HBNuclear β-catenin, glypican-3 more often positive in HBNuclear inclusions, atypical mitoses, and α-1-antitrypsin globules favor hepatocellular carcinoma",
                    "sub_points": [
                      "Biphasic pattern with fetal and embryonal cells in HB",
                      "Nuclear β-catenin, glypican-3 more often positive in HB",
                      "Nuclear inclusions, atypical mitoses, and α-1-antitrypsin globules favor hepatocellular carcinoma"
                    ]
                  },
                  {
                    "text": "In patients who present initially over 10 years of age, hepatocellular carcinoma is much more likely diagnosis"
                  }
                ],
                "Teratoma": [
                  {
                    "text": "Mature hepatocytes, lacks embryonal and fetal patterns"
                  },
                  {
                    "text": "No nuclear staining with β-catenin"
                  }
                ],
                "Small Round Blue Cell Tumors": [
                  {
                    "text": "Small undifferentiated HB may mimic metastatic small round cell tumorsMetastatic neuroblastoma, peripheral neuroectodermal tumor, Wilms tumor",
                    "sub_points": [
                      "Metastatic neuroblastoma, peripheral neuroectodermal tumor, Wilms tumor"
                    ]
                  },
                  {
                    "text": "Clinical setting, morphology, and immunohistochemistry enable differentiation in most cases"
                  }
                ],
                "Hepatocellular Neoplasm, Not Otherwise Specified": [
                  {
                    "text": "Formerly called transitional cell tumor"
                  },
                  {
                    "text": "Features intermediate between HB and hepatocellular carcinoma"
                  },
                  {
                    "text": "Older children, typically over 8 years"
                  },
                  {
                    "text": "Aggressive tumor, often unresponsive to chemotherapy"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Stage 1 pure fetal HB cured by surgical resection alone"
                  },
                  {
                    "text": "Important to report any amount of small undifferentiated cells; confers worse prognosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Bile Duct Adenoma": {
            "name": "Bile Duct Adenoma",
            "url": "https://app.pathprimer.com/document/41b3d7ce-35e3-4b20-8ffe-1885813b2dd3/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Historically called \"bile duct adenoma\" but shown to have phenotype of peribiliary glands rather than bile ducts"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "BRAFV600E mutations in > 50% of cases"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Almost always incidental finding during surgery for another reasonOften submitted for frozen section to rule out metastasis",
                    "sub_points": [
                      "Often submitted for frozen section to rule out metastasis"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Uniformly sized tubules and acini with rounded outlines"
                  },
                  {
                    "text": "Single layer of cuboidal to columnar cells that lack atypia, hyperchromasia, mitoses"
                  },
                  {
                    "text": "Fibrous stroma either scant or dense and hyalinized"
                  },
                  {
                    "text": "Bile is not present, and ducts do not communicate with biliary tree"
                  },
                  {
                    "text": "Variant features include clear cell change, mucinous metaplasia, neuroendocrine differentiation, and α-1-antitrypsin globules"
                  },
                  {
                    "text": "Circumscribed outline and lack of cytologic atypia are most important features to distinguish from adenocarcinoma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Ki-67 typically < 10%"
                  },
                  {
                    "text": "p53 weak and patchy (wild-type pattern)"
                  },
                  {
                    "text": "DPC4 is intact in contrast to most of metastatic pancreatic ductal adenocarcinomas"
                  },
                  {
                    "text": "Albumin ISH is positive and may help to distinguish from metastatic adenocarcinoma but not from other bile duct hamartoma or intrahepatic cholangiocarcinoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Biliary microhamartoma (von Meyenburg complex)"
                  },
                  {
                    "text": "Intrahepatic cholangiocarcinoma"
                  },
                  {
                    "text": "Metastatic adenocarcinoma"
                  },
                  {
                    "text": "Neuroendocrine tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Bile duct adenoma (BDA)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Cholangioma, cholangioadenoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Small, benign epithelial tumor composed of glands that resemble bile ducts"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Molecular Changes": [
                  {
                    "text": "BRAFV600E mutations in ~ 50% of cases"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "> 40 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Equal distribution"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Almost always incidental findings during surgery for another reasonOften submitted for frozen section during intraabdominal surgery to exclude metastasis",
                    "sub_points": [
                      "Often submitted for frozen section during intraabdominal surgery to exclude metastasis"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "ExcellentMalignant transformation has not been well documented",
                    "sub_points": [
                      "Malignant transformation has not been well documented"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Typically small (< 1 cm), rarely up to 4 cm"
                  },
                  {
                    "text": "Usually single but can be multiple"
                  },
                  {
                    "text": "Well circumscribed but not encapsulated"
                  },
                  {
                    "text": "Often subcapsular"
                  },
                  {
                    "text": "Firm and gray-white"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Uniformly sized tubules and aciniSingle layer of cuboidal to columnar cellsNo cytoarchitectural atypia or mitosesSmall or inapparent lumina with rounded outlines",
                    "sub_points": [
                      "Single layer of cuboidal to columnar cells",
                      "No cytoarchitectural atypia or mitoses",
                      "Small or inapparent lumina with rounded outlines"
                    ]
                  },
                  {
                    "text": "Fibrous stroma either scant or dense and hyalinizedMore abundant centrally than peripherally",
                    "sub_points": [
                      "More abundant centrally than peripherally"
                    ]
                  },
                  {
                    "text": "Variable amount of inflammation present"
                  },
                  {
                    "text": "Normal portal tracts &/or large bile ducts often associated with BDA"
                  },
                  {
                    "text": "Bile is not presentDucts do not communicate with biliary tree",
                    "sub_points": [
                      "Ducts do not communicate with biliary tree"
                    ]
                  },
                  {
                    "text": "Acidic mucin is usually present"
                  },
                  {
                    "text": "Variant featuresMucinous metaplasiaNeuroendocrine differentiationα-1-antitrypsin globulesRare cases associated with α-1-antitrypsin deficiency also contain α-1-antitrypsin globulesRare variant with clear cells can be mistaken for primary or metastatic clear cell carcinoma",
                    "sub_points": [
                      "Mucinous metaplasia",
                      "Neuroendocrine differentiation",
                      "α-1-antitrypsin globulesRare cases associated with α-1-antitrypsin deficiency also contain α-1-antitrypsin globules",
                      "Rare cases associated with α-1-antitrypsin deficiency also contain α-1-antitrypsin globules",
                      "Rare variant with clear cells can be mistaken for primary or metastatic clear cell carcinoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Ki-67 typically < 10%, p53 weak and patchy (wild-type pattern)"
                  },
                  {
                    "text": "DPC4, a.k.a. SMAD4, is intact"
                  },
                  {
                    "text": "BRAF V600E may be positive in ~ 1/2 of cases"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Biliary Microhamartoma (von Meyenburg Complex)": [
                  {
                    "text": "Curvilinear and angular rather than round ducts"
                  },
                  {
                    "text": "More abundant stroma"
                  },
                  {
                    "text": "Often contain bile"
                  },
                  {
                    "text": "Associated with polycystic liver disease"
                  }
                ],
                "Cholangiocarcinoma/Metastatic Adenocarcinoma": [
                  {
                    "text": "Nuclear atypia"
                  },
                  {
                    "text": "Poorly circumscribedInfiltrative or destructive growth pattern",
                    "sub_points": [
                      "Infiltrative or destructive growth pattern"
                    ]
                  },
                  {
                    "text": "Lymphovascular or perineural invasion"
                  },
                  {
                    "text": "Mitoses"
                  },
                  {
                    "text": "BDAs are small (usually < 1 cm) and almost always found incidentally in asymptomatic patients"
                  },
                  {
                    "text": "Ki-67 often > 10%; DPC4 may be lost in metastatic pancreatic ductal adenocarcinoma"
                  }
                ],
                "Neuroendocrine Tumor": [
                  {
                    "text": "Endocrine cell clusters in some BDAs can be confused with metastatic neuroendocrine tumors"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Almost always incidental findings at time of surgery for another intraabdominal processThis lesion is most noteworthy for being mistaken for metastatic adenocarcinoma",
                    "sub_points": [
                      "This lesion is most noteworthy for being mistaken for metastatic adenocarcinoma"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "von Meyenburg Complex (Biliary Microhamartoma)": {
            "name": "von Meyenburg Complex (Biliary Microhamartoma)",
            "url": "https://app.pathprimer.com/document/a5f44486-d552-441b-846f-25db402ac161/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Developmental malformation resulting from aberrant construction/remodeling of embryonic bile ducts"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Majority are sporadicAlso within spectrum of numerous fibropolycystic diseases of liver, including congenital hepatic fibrosis, Caroli disease, autosomal dominant polycystic disease",
                    "sub_points": [
                      "Also within spectrum of numerous fibropolycystic diseases of liver, including congenital hepatic fibrosis, Caroli disease, autosomal dominant polycystic disease"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Reportedly occurs in ~ 3% of autopsied patients"
                  },
                  {
                    "text": "Not considered premalignant"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually multifocal"
                  },
                  {
                    "text": "Often subcapsular"
                  },
                  {
                    "text": "Typically < 0.5 cm"
                  },
                  {
                    "text": "Presence of numerous, widely scattered von Meyenburg complexes raises possibility of fibropolycystic disease or congenital hepatic fibrosis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Angulated, branching, irregular ducts embedded in dense fibrous stromaUsually within or at edge of portal tractsDucts are lined by cuboidal, often flattened, epitheliumDucts may contain eosinophilic proteinaceous debris or inspissated bile",
                    "sub_points": [
                      "Usually within or at edge of portal tracts",
                      "Ducts are lined by cuboidal, often flattened, epithelium",
                      "Ducts may contain eosinophilic proteinaceous debris or inspissated bile"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Multiple widely scattered von Meyenburg complexes raise possibility of associated fibropolycystic disease"
                  },
                  {
                    "text": "May be submitted for frozen section during abdominal surgery to exclude liver metastasis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "von Meyenburg complex (VMC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Biliary microhamartoma, ductal plate malformation"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Developmental malformation resulting from aberrant construction/remodeling of embryonic bile ducts"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Most often sporadic"
                  },
                  {
                    "text": "Also within spectrum of numerous fibropolycystic diseases of liver, including congenital hepatic fibrosis, Caroli disease, autosomal dominant polycystic diseaseBasic lesion of congenital hepatic fibrosisConsidered precursor lesion of autosomal dominant polycystic liver disease",
                    "sub_points": [
                      "Basic lesion of congenital hepatic fibrosis",
                      "Considered precursor lesion of autosomal dominant polycystic liver disease"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Not precisely known; reportedly occurs in ~ 3% of autopsied patients"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often incidental findings at surgery or autopsyMay be submitted for frozen section during abdominal surgery to exclude metastasis",
                    "sub_points": [
                      "May be submitted for frozen section during abdominal surgery to exclude metastasis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "None for sporadic lesions"
                  },
                  {
                    "text": "Treat underlying disease if part of fibropolycystic disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Not considered premalignantTransition to dysplasia and cholangiocarcinoma has been very rarely noted",
                    "sub_points": [
                      "Transition to dysplasia and cholangiocarcinoma has been very rarely noted"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Majority are small (usually < 0.5 cm), gray-white, irregular, and commonly multifocal"
                  },
                  {
                    "text": "Most often multiplePresence of numerous, widely scattered VMC raises possibility of fibropolycystic disease or congenital hepatic fibrosis",
                    "sub_points": [
                      "Presence of numerous, widely scattered VMC raises possibility of fibropolycystic disease or congenital hepatic fibrosis"
                    ]
                  },
                  {
                    "text": "Often subcapsular"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Located within and at edge of portal tracts"
                  },
                  {
                    "text": "Small- to medium-sized ducts embedded in dense fibrous stromaMany ducts are irregularly shaped, angulated, or branching and dilatedDucts are lined by cuboidal, often flattened, epitheliumNo atypiaNo mitotic activityDucts may contain eosinophilic proteinaceous debris or inspissated bileVarying degrees of dilatation that may eventually lead to cyst formationNot connected to normal biliary tree",
                    "sub_points": [
                      "Many ducts are irregularly shaped, angulated, or branching and dilatedDucts are lined by cuboidal, often flattened, epitheliumNo atypiaNo mitotic activityDucts may contain eosinophilic proteinaceous debris or inspissated bile",
                      "Ducts are lined by cuboidal, often flattened, epithelium",
                      "No atypia",
                      "No mitotic activity",
                      "Ducts may contain eosinophilic proteinaceous debris or inspissated bile",
                      "Varying degrees of dilatation that may eventually lead to cyst formation",
                      "Not connected to normal biliary tree"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "Normal DNA content by flow cytometry"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Bile Duct Adenoma (Peribiliary Hamartoma)": [
                  {
                    "text": "Glands have uniform round outlines"
                  },
                  {
                    "text": "Bile is absent"
                  },
                  {
                    "text": "No cystic changes"
                  },
                  {
                    "text": "Not associated with fibropolycystic liver diseases"
                  },
                  {
                    "text": "~ 1/2 of bile duct adenomas are positive for BRAF V600E immunohistochemistry while VMCs are negative"
                  }
                ],
                "Cholangiocarcinoma/Metastatic Adenocarcinoma": [
                  {
                    "text": "Nuclear atypia, infiltrative or destructive growth pattern, mitoses"
                  },
                  {
                    "text": "Lymphovascular or perineural invasion"
                  },
                  {
                    "text": "Variant of cholangiocarcinoma shows ductal plate malformation-like pattern,ARID1Agenetic alterations; nuclei are often monotonous but larger and more atypical than VMC"
                  }
                ],
                "Biliary Adenofibroma": [
                  {
                    "text": "Rare entity with few reported cases"
                  },
                  {
                    "text": "Cystic and tubular duct elements with prominent fibroblastic stroma"
                  },
                  {
                    "text": "Immunophenotype same as VMC"
                  },
                  {
                    "text": "Bears marked resemblance to biliary hamartoma but largerDoes not appear to be associated with fibropolycystic liver diseases",
                    "sub_points": [
                      "Does not appear to be associated with fibropolycystic liver diseases"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Multiple widely scattered VMCs raise possibility of associated congenital hepatic fibrosis or polycystic liver disease"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mucinous Cystic Neoplasm, Liver": {
            "name": "Mucinous Cystic Neoplasm, Liver",
            "url": "https://app.pathprimer.com/document/458de1ba-3f67-4ab7-9a88-e2f6ad59b65e/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Almost exclusively occurs in women"
                  },
                  {
                    "text": "CA19-9 and CEA in cyst fluid help differentiate between simple cyst and mucinous cystic neoplasm (MCN)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary, multiloculated cystic neoplasm"
                  },
                  {
                    "text": "Clear, mucinous, or opalescent cystic fluid"
                  },
                  {
                    "text": "Cyst lining may be smooth, trabeculated, or have papillary excrescences"
                  },
                  {
                    "text": "Thickened, nodular areas suggest malignancy"
                  },
                  {
                    "text": "Average size: 4.5 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Similar to MCN of pancreas"
                  },
                  {
                    "text": "MCNLined by mucinous columnar epithelium with focal cuboidal, flattened, or papillary areasMay have gastric or intestinal metaplasiaLow-grade, high-grade dysplasiaDensely cellular ovarian-like stroma positive for ER, PR, SF-1, GLI-1",
                    "sub_points": [
                      "Lined by mucinous columnar epithelium with focal cuboidal, flattened, or papillary areas",
                      "May have gastric or intestinal metaplasia",
                      "Low-grade, high-grade dysplasia",
                      "Densely cellular ovarian-like stroma positive for ER, PR, SF-1, GLI-1"
                    ]
                  },
                  {
                    "text": "MCN with associated invasive carcinomaMost arise from preexisting MCNInvasion of underlying stroma by malignant glands or single cells",
                    "sub_points": [
                      "Most arise from preexisting MCN",
                      "Invasion of underlying stroma by malignant glands or single cells"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cystic variant of biliary intraductal papillary neoplasm"
                  },
                  {
                    "text": "Solitary bile duct cysts"
                  },
                  {
                    "text": "Ciliated hepatic foregut cyst"
                  },
                  {
                    "text": "Endometrial cyst"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Multilocular cystic neoplasm lined by mucinous epithelial cells with underlying ovarian-type stroma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Mucinous cystic neoplasm (MCN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Cystic neoplasm arising within liver or in extrahepatic biliary tree"
                  },
                  {
                    "text": "Formerly known as hepatobiliary cystadenoma and cystadenocarcinoma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Ectopic Primordial Germ Cell Hypothesis": [
                  {
                    "text": "MCN may originate from few primordial gonadal precursor cells aberrantly stopped near developing liver during their descent to gonadsWeek 5 of embryogenesis: Primordial germ cells, developing liver, pancreatic, and duct system are all in close proximity to dorsal mesenteryWhile proliferating en route to gonads, few may aberrantly be stopped in area of developing liver",
                    "sub_points": [
                      "Week 5 of embryogenesis: Primordial germ cells, developing liver, pancreatic, and duct system are all in close proximity to dorsal mesentery",
                      "While proliferating en route to gonads, few may aberrantly be stopped in area of developing liver"
                    ]
                  }
                ],
                "Fetal Mesenchyme Transdifferentiation Hypothesis": [
                  {
                    "text": "Fetal mesenchyme cuffing liver and pancreatic ductal structures may transdifferentiate into ovarian-type stroma under pathologic conditions"
                  }
                ],
                "Molecular Findings": [
                  {
                    "text": "Hedgehog and Wnt pathways activated"
                  },
                  {
                    "text": "Much lower rate ofKRASmutations in hepatic MCNs vs. pancreatic MCNs"
                  },
                  {
                    "text": "Similar to ovarian stroma: UpregulatedESR2,PGR, alsoWT1Demonstration of estrogen biosynthesis and steroidogenesis on RNA levelStroma is both hormonally responsive and capable of sex hormone production",
                    "sub_points": [
                      "Demonstration of estrogen biosynthesis and steroidogenesis on RNA level",
                      "Stroma is both hormonally responsive and capable of sex hormone production"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare; < 5% of cystic lesions of liver"
                  }
                ],
                "Age": [
                  {
                    "text": "Average: 40-50 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Almost exclusively occurs in women"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Pain, mass, and occasionally jaundiceSome patients are asymptomatic",
                    "sub_points": [
                      "Some patients are asymptomatic"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "CA19-9 and CEA in cyst fluid help differentiate between simple cyst and MCN"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Complete resection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Complete surgical resection should be curativeIncompletely resected tumor may recur or undergo malignant transformation, but this is rare",
                    "sub_points": [
                      "Incompletely resected tumor may recur or undergo malignant transformation, but this is rare"
                    ]
                  },
                  {
                    "text": "3-6% malignant transformation (uncommon); much lower than pancreatic MCN"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Large, well-defined, multiloculated, anechoic mass with highly echogenic septations"
                  },
                  {
                    "text": "Mural or septal calcifications or fluid levels"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "NECTLarge, well-defined, homogeneous, hypodense, heterogeneous mass (cystic and hemorrhagic areas)MCN: Septations without nodularityMCN with associated invasive carcinoma: Septations and nodularityFine mural or septal calcificationsBiliary dilatation",
                    "sub_points": [
                      "Large, well-defined, homogeneous, hypodense, heterogeneous mass (cystic and hemorrhagic areas)",
                      "MCN: Septations without nodularity",
                      "MCN with associated invasive carcinoma: Septations and nodularity",
                      "Fine mural or septal calcifications",
                      "Biliary dilatation"
                    ]
                  },
                  {
                    "text": "CECTNonenhancing cystic spacesEnhancement of internal septa, capsule, and papillary excrescences or nodulesFine mural or septal calcifications",
                    "sub_points": [
                      "Nonenhancing cystic spaces",
                      "Enhancement of internal septa, capsule, and papillary excrescences or nodules",
                      "Fine mural or septal calcifications"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary, multiloculated cystic neoplasm; average size 4.5 cm, can be > 20 cmTypically large with variable amount of internal septationsClear, straw-colored, mucinous, or opalescent cystic fluidRarely hemorrhagic or purulentCyst lining may be smooth, trabeculated, or have papillary excrescencesThickened areas suggest malignancy, and extensive sampling is warranted",
                    "sub_points": [
                      "Typically large with variable amount of internal septations",
                      "Clear, straw-colored, mucinous, or opalescent cystic fluidRarely hemorrhagic or purulent",
                      "Rarely hemorrhagic or purulent",
                      "Cyst lining may be smooth, trabeculated, or have papillary excrescencesThickened areas suggest malignancy, and extensive sampling is warranted",
                      "Thickened areas suggest malignancy, and extensive sampling is warranted"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cyst liningMucinous columnar or cuboidal biliary epithelium, may be flattenedGastric-type or intestinal metaplasia may be presentEpithelial cells immunoreactive to CK8, CK18, CK7, CK19, and GLI-1Low-grade dysplasia or high-grade dysplasia",
                    "sub_points": [
                      "Mucinous columnar or cuboidal biliary epithelium, may be flattened",
                      "Gastric-type or intestinal metaplasia may be present",
                      "Epithelial cells immunoreactive to CK8, CK18, CK7, CK19, and GLI-1",
                      "Low-grade dysplasia or high-grade dysplasia"
                    ]
                  },
                  {
                    "text": "Ovarian-type stromaRequired for diagnosis, densely cellular spindled cellsLuteinized stromal cells and occasional steroidogenic cells with vacuolated cytoplasm can be seenAs seen in ovary, and latter also seen in adrenal cortexImmunoreactive to ER and PR; GLI-1, sex cord stromal markers SF-1 (diffuse), inhibin (focal); WT1 (focal), FOXL2 (diffuse)",
                    "sub_points": [
                      "Required for diagnosis, densely cellular spindled cellsLuteinized stromal cells and occasional steroidogenic cells with vacuolated cytoplasm can be seenAs seen in ovary, and latter also seen in adrenal cortexImmunoreactive to ER and PR; GLI-1, sex cord stromal markers SF-1 (diffuse), inhibin (focal); WT1 (focal), FOXL2 (diffuse)",
                      "Luteinized stromal cells and occasional steroidogenic cells with vacuolated cytoplasm can be seenAs seen in ovary, and latter also seen in adrenal cortex",
                      "As seen in ovary, and latter also seen in adrenal cortex",
                      "Immunoreactive to ER and PR; GLI-1, sex cord stromal markers SF-1 (diffuse), inhibin (focal); WT1 (focal), FOXL2 (diffuse)"
                    ]
                  },
                  {
                    "text": "MCN with associated invasive carcinomaCytologic atypia and mitoses in epithelial lining cellsInvasion of underlying stroma by malignant glands or single cells",
                    "sub_points": [
                      "Cytologic atypia and mitoses in epithelial lining cells",
                      "Invasion of underlying stroma by malignant glands or single cells"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Solitary Biliary Cyst": [
                  {
                    "text": "Asymptomatic; often incidental findings"
                  },
                  {
                    "text": "Usually unilocular"
                  },
                  {
                    "text": "No sex predilection"
                  },
                  {
                    "text": "Lack of ovarian-type stroma"
                  }
                ],
                "Ciliated Hepatic Foregut Cyst": [
                  {
                    "text": "Ciliated epithelium"
                  },
                  {
                    "text": "Usually small, asymptomatic, incidental findings"
                  },
                  {
                    "text": "No sex predilection"
                  },
                  {
                    "text": "Lack of ovarian-type stroma"
                  }
                ],
                "Endometrial Cyst": [
                  {
                    "text": "Positive ER and PR and negative α-inhibin staining within both epithelium and stroma"
                  },
                  {
                    "text": "ER, PR, and α-inhibin only positive in stromal cells in MCN and MCN with associated invasive carcinoma but not in cystic lining epithelium"
                  },
                  {
                    "text": "CD10 positive in stromal cells in endometrial cyst but not in MCN"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Multilocular cystic neoplasm lined by mucinous epithelial cells with underlying ovarian-type stroma"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intrahepatic Cholangiocarcinoma": {
            "name": "Intrahepatic Cholangiocarcinoma",
            "url": "https://app.pathprimer.com/document/45221ba9-abb2-41f5-8dac-bee8e75e20ca/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Primary biliary adenocarcinoma arising in liver"
                  },
                  {
                    "text": "Intrahepatic cholangiocarcinoma (iCCA)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Incidence2nd most common primary liver cancer after hepatocellular carcinomaHas been increasing around world, including USAVery prevalent in Asia, particularly in northeastern ThailandSlight male predominance",
                    "sub_points": [
                      "2nd most common primary liver cancer after hepatocellular carcinoma",
                      "Has been increasing around world, including USA",
                      "Very prevalent in Asia, particularly in northeastern Thailand",
                      "Slight male predominance"
                    ]
                  },
                  {
                    "text": "Well-known risk factors include liver fluke infection, primary sclerosing cholangitis, hepatolithiasis, Thorotrast exposure, congenital anomalies of bile ducts"
                  },
                  {
                    "text": "Serum level of CA19-9 is commonly elevated"
                  },
                  {
                    "text": "Most patients are diagnosed with advanced stages of diseaseDismal prognosis",
                    "sub_points": [
                      "Dismal prognosis"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Almost exclusively adenocarcinomaDesmoplastic stromaFrequently shows perineural invasionCK7, CK19 positive",
                    "sub_points": [
                      "Desmoplastic stroma",
                      "Frequently shows perineural invasion",
                      "CK7, CK19 positive"
                    ]
                  },
                  {
                    "text": "Neoplastic cells can form glands, solid nests, cords, or papillary structures"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular carcinoma"
                  },
                  {
                    "text": "Metastatic adenocarcinoma"
                  },
                  {
                    "text": "Epithelioid hemangioendothelioma"
                  },
                  {
                    "text": "Bile ductular reaction"
                  },
                  {
                    "text": "Bile duct adenoma"
                  },
                  {
                    "text": "Biliary adenofibroma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Distinction from metastatic adenocarcinoma from other sites like stomach and pancreas relies on clinical and imaging correlation"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Intrahepatic cholangiocarcinoma (iCCA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Primary biliary adenocarcinoma of liver"
                  }
                ],
                "Subtypes": [
                  {
                    "text": "Large duct typeProximal to hepatic hilumDevelops from biliary intraepithelial neoplasia or intraductal papillary neoplasmMucin-secreting glands arise from large bile ducts and peribiliary glandsKRASmutations",
                    "sub_points": [
                      "Proximal to hepatic hilum",
                      "Develops from biliary intraepithelial neoplasia or intraductal papillary neoplasm",
                      "Mucin-secreting glands arise from large bile ducts and peribiliary glands",
                      "KRASmutations"
                    ]
                  },
                  {
                    "text": "Small duct typePeripheral hepatic parenchymaUnknown precursor(s)Non mucin-secreting glands arise from small bile ducts and bile ductulesIDH1/IDH2mutations andFGFR2fusions",
                    "sub_points": [
                      "Peripheral hepatic parenchyma",
                      "Unknown precursor(s)",
                      "Non mucin-secreting glands arise from small bile ducts and bile ductules",
                      "IDH1/IDH2mutations andFGFR2fusions"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Multistep Carcinogenesis": [
                  {
                    "text": "Chronic inflammation may be common pathogenic pathway"
                  },
                  {
                    "text": "Wide array of genetic changes have been described, includingTP53andKRASmutations"
                  },
                  {
                    "text": "Characteristic genetic changes that are rare in other GI adenocarcinomasMutations inIDH1/IDH2: 15-30%Mutations in chromatin remodeling genes:BAP1Fusions involvingFGFR2",
                    "sub_points": [
                      "Mutations inIDH1/IDH2: 15-30%",
                      "Mutations in chromatin remodeling genes:BAP1",
                      "Fusions involvingFGFR2"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2nd most common primary liver cancer after hepatocellular carcinoma; 10-15% of primary liver cancer"
                  },
                  {
                    "text": "Varies widely worldwide; most prevalent in East AsiaVery prevalent in Asia, particularly in northeastern Thailand",
                    "sub_points": [
                      "Very prevalent in Asia, particularly in northeastern Thailand"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Average at presentation: > 50 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slight male predominance"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Very prevalent in Asia, particularly in northeastern Thailand (associated with liver fluke infestation)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most patients diagnosed with advanced disease"
                  },
                  {
                    "text": "Abdominal pain, weight loss, malaise, jaundice, or cholangitis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "CA19-9 is important tumor marker"
                  },
                  {
                    "text": "Alkaline phosphatase and bilirubin variably elevated"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection"
                  },
                  {
                    "text": "Gemcitabine-based therapy for unresectable cases or for tumors with positive resection margin"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Long-term survival is dismal"
                  },
                  {
                    "text": "Perineural invasion is associated with poor prognosis"
                  },
                  {
                    "text": "Small duct type may have better prognosis"
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "Exposure to organic solvents has been reportedRecent outbreak among printing company workers in Japan",
                    "sub_points": [
                      "Recent outbreak among printing company workers in Japan"
                    ]
                  },
                  {
                    "text": "Large duct iCCABiliary tract malformationCaroli disease, congenital hepatic fibrosis, bile duct cystsBiliary tract inflammation and infectionLiver fluke infection, primary sclerosing cholangitis, hepatolithiasis",
                    "sub_points": [
                      "Biliary tract malformationCaroli disease, congenital hepatic fibrosis, bile duct cysts",
                      "Caroli disease, congenital hepatic fibrosis, bile duct cysts",
                      "Biliary tract inflammation and infectionLiver fluke infection, primary sclerosing cholangitis, hepatolithiasis",
                      "Liver fluke infection, primary sclerosing cholangitis, hepatolithiasis"
                    ]
                  },
                  {
                    "text": "Small duct iCCAChronic viral hepatitisCirrhosis due to metabolic syndrome, alcoholic liver disease, or hemochromatosis",
                    "sub_points": [
                      "Chronic viral hepatitis",
                      "Cirrhosis due to metabolic syndrome, alcoholic liver disease, or hemochromatosis"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Single well-defined, predominantly homogeneous mass with irregular borders"
                  },
                  {
                    "text": "Satellite or daughter nodules frequent and vary in size"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Rim-like enhancement may be seen around periphery of tumor on arterial phase and as gradual centripetal enhancement on delayed phase"
                  },
                  {
                    "text": "Entire mass may be enhanced only on delayed phase images"
                  },
                  {
                    "text": "Capsular retraction is common"
                  },
                  {
                    "text": "Dilatation of bile ducts peripheral to tumor is common"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Similar to MR findings"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Firm, irregular, white-tan fibrotic single or multiple masses with infiltrative borders"
                  },
                  {
                    "text": "Classified into ductal mass forming, periductal infiltrating based on gross morphologic featuresMass formingMost common typeDefinite mass forms within liver parenchymaPeriductal infiltratingTumor grows longitudinally along large bile ductsIntraductalTumor grows toward lumina of large bile ducts with papillary pattern",
                    "sub_points": [
                      "Mass formingMost common typeDefinite mass forms within liver parenchyma",
                      "Most common type",
                      "Definite mass forms within liver parenchyma",
                      "Periductal infiltratingTumor grows longitudinally along large bile ducts",
                      "Tumor grows longitudinally along large bile ducts",
                      "IntraductalTumor grows toward lumina of large bile ducts with papillary pattern",
                      "Tumor grows toward lumina of large bile ducts with papillary pattern"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Tumor cells form glands, solid nests, cords, or papillary structuresTumor cells columnar to cuboidal with slightly eosinophilic or vacuolated cytoplasm",
                    "sub_points": [
                      "Tumor cells columnar to cuboidal with slightly eosinophilic or vacuolated cytoplasm"
                    ]
                  },
                  {
                    "text": "Desmoplastic stroma"
                  },
                  {
                    "text": "Mucin in large duct-type iCCA; often absent in small duct iCCAEither intracytoplasmic or extracellularMay be demonstrated by mucicarmine, PAS-D, or Alcian blue",
                    "sub_points": [
                      "Either intracytoplasmic or extracellularMay be demonstrated by mucicarmine, PAS-D, or Alcian blue",
                      "May be demonstrated by mucicarmine, PAS-D, or Alcian blue"
                    ]
                  },
                  {
                    "text": "Uncommon variants includeAdenosquamousSquamousMucinousClear cellDuctal plate malformation patternLymphoepithelioma-likeSarcomatoid",
                    "sub_points": [
                      "Adenosquamous",
                      "Squamous",
                      "Mucinous",
                      "Clear cell",
                      "Ductal plate malformation pattern",
                      "Lymphoepithelioma-like",
                      "Sarcomatoid"
                    ]
                  },
                  {
                    "text": "Perineural invasion is more common in large duct type iCCA"
                  }
                ],
                "Precursor Lesions": [
                  {
                    "text": "2 types of precursor lesions for large duct iCCABiliary intraepithelial neoplasia (BilIN)Flat or micropapillary proliferation of dysplastic epitheliumDivided into low-grade BilIN (formerly BilIN grade 1 and grade 2) and high-grade BilIN (formerly BilIN grade 3) based on severity of atypia, nuclear polarity and stratificationIntraductal papillary neoplasm of bile ductsNoninvasive papillary biliary proliferation in dilated intrahepatic bile duct",
                    "sub_points": [
                      "Biliary intraepithelial neoplasia (BilIN)Flat or micropapillary proliferation of dysplastic epitheliumDivided into low-grade BilIN (formerly BilIN grade 1 and grade 2) and high-grade BilIN (formerly BilIN grade 3) based on severity of atypia, nuclear polarity and stratification",
                      "Flat or micropapillary proliferation of dysplastic epitheliumDivided into low-grade BilIN (formerly BilIN grade 1 and grade 2) and high-grade BilIN (formerly BilIN grade 3) based on severity of atypia, nuclear polarity and stratification",
                      "Divided into low-grade BilIN (formerly BilIN grade 1 and grade 2) and high-grade BilIN (formerly BilIN grade 3) based on severity of atypia, nuclear polarity and stratification",
                      "Intraductal papillary neoplasm of bile ductsNoninvasive papillary biliary proliferation in dilated intrahepatic bile duct",
                      "Noninvasive papillary biliary proliferation in dilated intrahepatic bile duct"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for CK7, CK19, MOC31, CDX2 (variable), villin (variable brush border pattern)"
                  }
                ],
                "In Situ Hybridization": [
                  {
                    "text": "Positive for albumin in situ hybridization (at least 60-70%)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatocellular Carcinoma": [
                  {
                    "text": "Positive for arginase-1, HepPar1, glypican-3, pCEA/CD10 (canalicular pattern)"
                  },
                  {
                    "text": "Bile production"
                  },
                  {
                    "text": "Negative mucin staining"
                  },
                  {
                    "text": "May have fat in tumor"
                  },
                  {
                    "text": "Tumor cells may contain Mallory-Denk bodies"
                  }
                ],
                "Metastatic Adenocarcinoma": [
                  {
                    "text": "Clinical history of primary carcinoma in other sites"
                  },
                  {
                    "text": "Immunoprofile may be helpful"
                  },
                  {
                    "text": "BAP1 intact"
                  },
                  {
                    "text": "No underlying liver diseases or cirrhosis"
                  },
                  {
                    "text": "Albumin in situ hybridization focal or absent in most cases"
                  },
                  {
                    "text": "Detection ofFGFR2fusions orIDH1/IDH2mutations may support iCCA"
                  },
                  {
                    "text": "Final distinction often relies on clinical and imaging features"
                  }
                ],
                "Epithelioid Hemangioendothelioma": [
                  {
                    "text": "Intracytoplasmic lumina may contain RBCs"
                  },
                  {
                    "text": "Positive for CD31, CD34, FLI-1, ERG, CAMTA1"
                  }
                ],
                "Combined Hepatocellular/Cholangiocarcinoma": [
                  {
                    "text": "Has hepatocellular carcinoma component"
                  }
                ],
                "Bile Duct Adenoma": [
                  {
                    "text": "Smaller and well circumscribed"
                  },
                  {
                    "text": "Lack of significant cytologic or architectural atypia"
                  },
                  {
                    "text": "May have angulated bile ducts"
                  },
                  {
                    "text": "Low Ki-67 proliferation index (typically < 10%), wild-type p53 staining; may be positive forBRAFV600E by immunohistochemistry"
                  }
                ],
                "Ductular Reaction With Atypia": [
                  {
                    "text": "Presence of marked background inflammation"
                  },
                  {
                    "text": "Lobular architecture, minimal nuclear atypia"
                  },
                  {
                    "text": "Lack of lymphovascular or perineural invasion"
                  },
                  {
                    "text": "Respects normal architecture of portal tracts"
                  }
                ],
                "Biliary Adenofibroma": [
                  {
                    "text": "Complex tubulocystic proliferation lined by biliary epithelium with no or minimal atypia"
                  },
                  {
                    "text": "Abundant fibrous stroma"
                  },
                  {
                    "text": "No mucin and no infiltrative growth pattern"
                  }
                ],
                "Hyperplasia of Peribiliary Glands": [
                  {
                    "text": "Lobular proliferation"
                  },
                  {
                    "text": "Can occur in otherwise normal liver or in acquired liver diseases"
                  },
                  {
                    "text": "Alcohol-related liver disease associated with peribiliary cysts"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Immunophenotypes of cholangiocarcinoma and pancreatic adenocarcinoma are virtually identical"
                  },
                  {
                    "text": "Loss of BAP1 and albumin (+) in situ hybridization favor iCCA"
                  },
                  {
                    "text": "Final distinction from pancreatic ductal adenocarcinoma relies on clinical and imaging correlation"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hemangioma": {
            "name": "Hemangioma",
            "url": "https://app.pathprimer.com/document/1f52f481-a899-4fc8-86fb-767f644950dd/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Most common primary tumor of liverIncidence ranges from < 1-7.3% in autopsy studiesMore common in older patients and women",
                    "sub_points": [
                      "Incidence ranges from < 1-7.3% in autopsy studies",
                      "More common in older patients and women"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Majority discovered incidentallyClinically silentTumors < 4 cm are rarely symptomaticWhen symptomatic, presents with abdominal pain, hepatomegaly, palpable mass",
                    "sub_points": [
                      "Clinically silentTumors < 4 cm are rarely symptomatic",
                      "Tumors < 4 cm are rarely symptomatic",
                      "When symptomatic, presents with abdominal pain, hepatomegaly, palpable mass"
                    ]
                  },
                  {
                    "text": "Treatment is surgical resection or ablative therapy if symptomatic; otherwise, observation"
                  },
                  {
                    "text": "Complications rare but include rupture and consumptive coagulopathy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually solitary and subcapsular"
                  },
                  {
                    "text": "Cut surface shows dark red, spongy mass composed of blood-filled cavities"
                  },
                  {
                    "text": "Most are < 4 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Dilated, variably sized vascular spacesLined by flat, bland endothelial cellsFibrin thrombi may be present in vascular spaces",
                    "sub_points": [
                      "Lined by flat, bland endothelial cells",
                      "Fibrin thrombi may be present in vascular spaces"
                    ]
                  },
                  {
                    "text": "Connective tissue septa of varying widths"
                  },
                  {
                    "text": "Older lesions frequently contain involutional changes, such as fibrosis, thrombosis, calcificationCan usually detect underlying vascular architecture, even if involutional change is extensive",
                    "sub_points": [
                      "Can usually detect underlying vascular architecture, even if involutional change is extensive"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Peliosis hepatis"
                  },
                  {
                    "text": "Infantile hemangioendothelioma"
                  },
                  {
                    "text": "Angiosarcoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cavernous hemangioma, sclerosing hemangioma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign vascular tumor; most common hepatic primary tumor"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Possibly congenital"
                  },
                  {
                    "text": "Postulated but unproven role of sex hormones"
                  },
                  {
                    "text": "Some may be malformations rather than neoplastic"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "< 1- 7.3% in autopsy studies"
                  }
                ],
                "Age": [
                  {
                    "text": "All ages; more frequent in older patients"
                  }
                ],
                "Sex": [
                  {
                    "text": "More common in women"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Majority discovered incidentally on imagingTumors < 4 cm are rarely symptomatic; larger tumors may be symptomatic: Vague abdominal pain, hepatomegaly, palpable mass",
                    "sub_points": [
                      "Tumors < 4 cm are rarely symptomatic; larger tumors may be symptomatic: Vague abdominal pain, hepatomegaly, palpable mass"
                    ]
                  },
                  {
                    "text": "Complications rareSpontaneous ruptureConsumptive coagulopathy",
                    "sub_points": [
                      "Spontaneous rupture",
                      "Consumptive coagulopathy"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection or ablative therapy if symptomatic; otherwise, observation"
                  },
                  {
                    "text": "Prognosis is excellent"
                  }
                ]
              },
              "IMAGING": {
                "MR Findings": [
                  {
                    "text": "Heterogeneous appearance that is virtually diagnosticHemangiomas with extensive scarring may mimic other tumors, such as cholangiocarcinoma",
                    "sub_points": [
                      "Hemangiomas with extensive scarring may mimic other tumors, such as cholangiocarcinoma"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually solitary; ≤ 10% are multiple"
                  },
                  {
                    "text": "Usually subcapsularMay appear as red or purple capsular blotches",
                    "sub_points": [
                      "May appear as red or purple capsular blotches"
                    ]
                  },
                  {
                    "text": "Cut surface: Dark red, spongy with blood-filled cavitiesVariably scarring, calcification",
                    "sub_points": [
                      "Variably scarring, calcification"
                    ]
                  },
                  {
                    "text": "Occurs anywhere in liver"
                  },
                  {
                    "text": "Involuted lesions may consist mostly of fibrosis, calcification, &/or necrosis"
                  }
                ],
                "Size": [
                  {
                    "text": "Most < 4 cmTumors up to 30 cm have been described",
                    "sub_points": [
                      "Tumors up to 30 cm have been described"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Well demarcated from surrounding liverOccasionally irregular interface",
                    "sub_points": [
                      "Occasionally irregular interface"
                    ]
                  },
                  {
                    "text": "Dilated, variably sized vascular spacesLined by flat, bland endothelial cells without atypiaConnective tissue septaPaucicellular fibrous bands of varying widthVariably present fibrosis and myxoid changeLarger septa may show thick-walled vessels, bile ductsFibrin thrombi may be present in vascular spaces",
                    "sub_points": [
                      "Lined by flat, bland endothelial cells without atypia",
                      "Connective tissue septaPaucicellular fibrous bands of varying widthVariably present fibrosis and myxoid changeLarger septa may show thick-walled vessels, bile ducts",
                      "Paucicellular fibrous bands of varying width",
                      "Variably present fibrosis and myxoid change",
                      "Larger septa may show thick-walled vessels, bile ducts",
                      "Fibrin thrombi may be present in vascular spaces"
                    ]
                  },
                  {
                    "text": "Older lesions frequently contain involutional changesHyalinization, calcification, ossification, or necrosisThrombosis or obliteration of vascular channelsCan usually detect underlying vascular architecture, even if involutional change is extensive",
                    "sub_points": [
                      "Hyalinization, calcification, ossification, or necrosis",
                      "Thrombosis or obliteration of vascular channels",
                      "Can usually detect underlying vascular architecture, even if involutional change is extensive"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Peliosis Hepatis": [
                  {
                    "text": "No fibrous septa"
                  }
                ],
                "Hereditary Hemorrhagic Telangiectasia": [
                  {
                    "text": "Dilated vascular channels in portal and periportal zones"
                  },
                  {
                    "text": "Accompanied by aberrant portal vessels"
                  }
                ],
                "Infantile Hemangioendothelioma": [
                  {
                    "text": "Characteristic small vascular proliferation"
                  }
                ],
                "Angiosarcoma": [
                  {
                    "text": "Malignant endothelial cells"
                  }
                ],
                "Anastomosing Hemangioma": [
                  {
                    "text": "Benign vascular tumor that may mimic angiosarcomaCapillary-sized endothelial proliferation with occasional nuclear hobnailingMay have infiltrative border but does not destroy portal tractsExtramedullary hematopoiesis and fat are common; fibrin thrombi are routinely seenRare mitotic activity if any mitotic figures are seen",
                    "sub_points": [
                      "Capillary-sized endothelial proliferation with occasional nuclear hobnailing",
                      "May have infiltrative border but does not destroy portal tracts",
                      "Extramedullary hematopoiesis and fat are common; fibrin thrombi are routinely seen",
                      "Rare mitotic activity if any mitotic figures are seen"
                    ]
                  },
                  {
                    "text": "Histologically similar to lesion described as hepatic small vessel neoplasm (HSVN)HSVN described as having infiltrative border while anastomosing hemangioma is well circumscribedBoth lesions show frequentGNAQ,GNA14, andGNA11somatic mutationsAnastomosing hemangioma and HSVN may be same entity",
                    "sub_points": [
                      "HSVN described as having infiltrative border while anastomosing hemangioma is well circumscribed",
                      "Both lesions show frequentGNAQ,GNA14, andGNA11somatic mutations",
                      "Anastomosing hemangioma and HSVN may be same entity"
                    ]
                  },
                  {
                    "text": "Distinct from cavernous hemangioma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Core needle biopsy may be contraindicated due to bleeding risk; fine-needle aspiration usually safe"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Angiosarcoma": {
            "name": "Angiosarcoma",
            "url": "https://app.pathprimer.com/document/e9ba8a63-27d0-4a05-b0f1-06ce22f302b6/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Most common primary hepatic sarcoma"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "25-40% of cases associated with vinyl chloride, Thorotrast, arsenic, or steroids"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Predominantly older patients, strong male predominance"
                  },
                  {
                    "text": "Liver biopsy may result in bleeding and death"
                  },
                  {
                    "text": "Best treatment option is surgery with adjuvant therapy"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Proliferation of malignant endothelial cells in wide variety of patternsAnastomosing small vessels, mix of small or large vessels, or slit-like vascular spacesPeliotic: Dilated vascular channelsSinusoidal: Tumor cells proliferating in sinusoidal-like spaces that surround plates of hepatocytesNonvasoformative comprising epithelioid or spindle cells",
                    "sub_points": [
                      "Anastomosing small vessels, mix of small or large vessels, or slit-like vascular spaces",
                      "Peliotic: Dilated vascular channels",
                      "Sinusoidal: Tumor cells proliferating in sinusoidal-like spaces that surround plates of hepatocytes",
                      "Nonvasoformative comprising epithelioid or spindle cells"
                    ]
                  },
                  {
                    "text": "Immunopositive for vascular markers: CD31, CD34, factor VIII"
                  },
                  {
                    "text": "Nuclear staining for transcription factors FLI-1 and ERG helps in confirming endothelial differentiation"
                  },
                  {
                    "text": "Positive keratin can lead to mistaken diagnosis of carcinoma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "High Ki-67 (> 10%), diffuse p53, and diffuse MYC staining favors angiosarcoma over benign vascular tumors"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Epithelioid hemangioendothelioma"
                  },
                  {
                    "text": "Carcinoma"
                  },
                  {
                    "text": "Other sarcomas"
                  },
                  {
                    "text": "Hepatic small vessel neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Rare malignant vascular tumor of liverMost common primary hepatic sarcoma~ 2% of malignant liver tumors",
                    "sub_points": [
                      "Most common primary hepatic sarcoma",
                      "~ 2% of malignant liver tumors"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Environmental Exposure": [
                  {
                    "text": "Drugs: Androgens, contraceptive steroids, diethylstilbestrol, phenelzine"
                  },
                  {
                    "text": "Toxins: Vinyl chloride, arsenic, copper sulfate, Thorotrast"
                  },
                  {
                    "text": "~ 25-40% of cases associated with vinyl chloride, Thorotrast, arsenic, or steroidsMany of these no longer used or strictly controlledLatency period can be up to several decades",
                    "sub_points": [
                      "Many of these no longer used or strictly controlled",
                      "Latency period can be up to several decades"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Peak incidence in 6th-7th decades"
                  },
                  {
                    "text": "Rare cases in children, formerly considered to be type 2 infantile hemangioendothelioma"
                  }
                ],
                "Sex": [
                  {
                    "text": "M:F = 3:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Signs and symptoms are nonspecificAbdominal pain &/or distensionHepatomegaly or palpable massJaundice, ascites, weakness, fatigue, weight loss",
                    "sub_points": [
                      "Abdominal pain &/or distension",
                      "Hepatomegaly or palpable mass",
                      "Jaundice, ascites, weakness, fatigue, weight loss"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Mild elevation of liver enzymes and bilirubinDecreased albumin, increased PT",
                    "sub_points": [
                      "Decreased albumin, increased PT"
                    ]
                  },
                  {
                    "text": "α-fetoprotein and CEA are not elevated"
                  },
                  {
                    "text": "Anemia, leukocytosis, thrombocytopenia common"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Best treatment option is surgery with adjuvant therapy"
                  },
                  {
                    "text": "> 80% of cases may be inoperable at presentation"
                  },
                  {
                    "text": "Transarterial chemoembolization used as palliation for unresectable cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Most patients die of liver failure within 1 year"
                  },
                  {
                    "text": "5-year survival < 10% in adultsMay be better in pediatric setting with reported 50% 5-year survival",
                    "sub_points": [
                      "May be better in pediatric setting with reported 50% 5-year survival"
                    ]
                  },
                  {
                    "text": "Liver biopsy may result in bleeding and death"
                  },
                  {
                    "text": "Numerous complications related to vascular nature of tumorGI and intraabdominal bleedingVascular shunts involving tumor",
                    "sub_points": [
                      "GI and intraabdominal bleeding",
                      "Vascular shunts involving tumor"
                    ]
                  },
                  {
                    "text": "Metastases common to lung, bone, lymph nodes, spleen"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "CT and angiography: Hypervascular tumors with heterogeneous early and progressive enhancement"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Liver often markedly enlarged"
                  },
                  {
                    "text": "No distinct mass lesion in 10-20% of cases"
                  },
                  {
                    "text": "Usually multicentricBoth lobes involvedTumor nodules range from barely visible to many centimeters",
                    "sub_points": [
                      "Both lobes involved",
                      "Tumor nodules range from barely visible to many centimeters"
                    ]
                  },
                  {
                    "text": "Red-brown, spongy, hemorrhagic cut surface"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Proliferation of malignant endothelial cells with enlarged, pleomorphic, hyperchromatic nuclei and frequent mitoses"
                  },
                  {
                    "text": "Histologic patternsVasoformative with anastomosing small vessels, mix of small or large vessels, or slit-like vascular spacesPapillary cell clusters, blood, necrotic debrisNonvasoformative with epithelioid &/or spindle cellsPeliotic: Dilated vascular channelsSinusoidal: Tumor cells proliferating in sinusoidal-like spaces that surround plates of hepatocytesOften nonmass forming and can be easily overlooked",
                    "sub_points": [
                      "Vasoformative with anastomosing small vessels, mix of small or large vessels, or slit-like vascular spacesPapillary cell clusters, blood, necrotic debris",
                      "Papillary cell clusters, blood, necrotic debris",
                      "Nonvasoformative with epithelioid &/or spindle cells",
                      "Peliotic: Dilated vascular channels",
                      "Sinusoidal: Tumor cells proliferating in sinusoidal-like spaces that surround plates of hepatocytesOften nonmass forming and can be easily overlooked",
                      "Often nonmass forming and can be easily overlooked"
                    ]
                  },
                  {
                    "text": "Tumor infiltrates preexisting vascular structuresProgressive atrophy and disappearance of liver parenchymaTumor may invade and occlude central veins or portal venules",
                    "sub_points": [
                      "Progressive atrophy and disappearance of liver parenchyma",
                      "Tumor may invade and occlude central veins or portal venules"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for CD31, CD34, factor VIII, FLI-1, ERGStaining may be weak or absent in poorly differentiated tumors",
                    "sub_points": [
                      "Staining may be weak or absent in poorly differentiated tumors"
                    ]
                  },
                  {
                    "text": "High Ki-67 (> 10%), diffuse p53, and diffuse MYC staining favors angiosarcoma over benign vascular tumors"
                  },
                  {
                    "text": "CK7 and pankeratin can be positive in 50-60% of cases"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Epithelioid Hemangioendothelioma": [
                  {
                    "text": "Less nuclear atypia, prominent stroma"
                  },
                  {
                    "text": "Characteristic zonation and infiltrative growth pattern"
                  },
                  {
                    "text": "Ki-67 typically low; p53 and MYC not diffuse"
                  },
                  {
                    "text": "Positive for CAMTA1, less commonly for TFE3"
                  }
                ],
                "Carcinoma": [
                  {
                    "text": "Absence of endothelial markers"
                  },
                  {
                    "text": "Diffuse strong keratin staining favors carcinoma, but keratin can be positive in angiosarcoma"
                  }
                ],
                "Other Sarcomas": [
                  {
                    "text": "Positive staining with endothelial markers confirms angiosarcoma"
                  }
                ],
                "Bacillary Angiomatosis": [
                  {
                    "text": "Abundant inflammation, no significant cytologic atypia"
                  },
                  {
                    "text": "Associated withBartonellainfection"
                  }
                ],
                "Hepatic Small Vessel Neoplasm": [
                  {
                    "text": "Rare tumor composed of small vessels"
                  },
                  {
                    "text": "Infiltrative border can mimic angiosarcoma"
                  },
                  {
                    "text": "Absence of cytologic atypia, low Ki-67 (< 10%), lack of diffuse p53, andGNAQ/GNA14mutations helps in diagnosis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Historically, 25-40% are associated with drug/toxin exposure"
                  },
                  {
                    "text": "Liver biopsy may result in bleeding and death"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Epithelioid Hemangioendothelioma": {
            "name": "Epithelioid Hemangioendothelioma",
            "url": "https://app.pathprimer.com/document/01ca7a7e-ff57-4470-9617-3a71bd39d700/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "t(1;3) translocation resulting inWWTR1-CAMTA1fusion gene in > 80%"
                  },
                  {
                    "text": "YAP1-TFE3fusion in small subset"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare, low-grade malignant vascular neoplasm"
                  },
                  {
                    "text": "Prognosis better than angiosarcoma"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Hypoechoic nodules on ultrasound, hypodense on CT scan"
                  },
                  {
                    "text": "Multinodular epithelioid hemangioendothelial (EHE) can mimic metastatic disease"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Firm, white to yellow with ill-defined borders"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Central portion is fibrotic and paucicellular"
                  },
                  {
                    "text": "Dendritic or epithelioid tumor cells, often with intracytoplasmic vacuoles, in fibrous stroma"
                  },
                  {
                    "text": "Tumor cells express vascular markers, such as CD31, ERG, and FLI1"
                  },
                  {
                    "text": "Tumors withWWTR1-CAMTA1fusionNuclear staining with CAMTA1 immunohistochemistry",
                    "sub_points": [
                      "Nuclear staining with CAMTA1 immunohistochemistry"
                    ]
                  },
                  {
                    "text": "Tumors withYAP1-TFE3Well-formed vascular channels, tumor cells with voluminous eosinophilic cytoplasmNuclear staining with TFE3 immunohistochemistry",
                    "sub_points": [
                      "Well-formed vascular channels, tumor cells with voluminous eosinophilic cytoplasm",
                      "Nuclear staining with TFE3 immunohistochemistry"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Dense myxoid stroma and intracytoplasmic vacuoles can mimic adenocarcinoma"
                  },
                  {
                    "text": "Greater nuclear atypia, mitotic activity, and destructive growth pattern distinguish angiosarcoma from epithelioid hemangioendothelioma"
                  },
                  {
                    "text": "High Ki-67, diffuse p53, diffuse MYC favor angiosarcoma when present"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Epithelioid hemangioendothelioma (EHE)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Uncommon vascular neoplasm, considered low-grade malignancy"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Molecular Changes": [
                  {
                    "text": "t(1;3) resulting inWWTR1-CAMTA1fusion gene in > 80%"
                  },
                  {
                    "text": "YAP1-TFE3fusion in small subset"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Primarily affects adults (30-40 years); rare in children"
                  },
                  {
                    "text": "Slightly more common in women"
                  },
                  {
                    "text": "Upper abdominal mass or discomfort and elevated alkaline phosphatase may be presentOften discovered as incidental finding",
                    "sub_points": [
                      "Often discovered as incidental finding"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Primary treatment is hepatic resection"
                  },
                  {
                    "text": "Liver transplantation in unresectable casesExtrahepatic spread not contraindication for transplant",
                    "sub_points": [
                      "Extrahepatic spread not contraindication for transplant"
                    ]
                  },
                  {
                    "text": "Radiotherapy and chemotherapy generally ineffective"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Natural history is extremely variableLong survival despite no treatment or incomplete resection in some casesAdverse outcome in others despite adequate resection and adjuvant therapy",
                    "sub_points": [
                      "Long survival despite no treatment or incomplete resection in some cases",
                      "Adverse outcome in others despite adequate resection and adjuvant therapy"
                    ]
                  },
                  {
                    "text": "5- and 10-year survival ~ 90% and 50%, respectively"
                  },
                  {
                    "text": "Prognosis better than angiosarcoma, even with incomplete excision or extrahepatic metastases"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Multinodular EHE can mimic metastatic disease"
                  },
                  {
                    "text": "Hypoechoic nodules on ultrasound, hypodense on CT scan"
                  },
                  {
                    "text": "MR: Low signal intensity on T1-weighted images, high signal intensity on T2-weighted images"
                  },
                  {
                    "text": "Peripheral enhancement and hypodense rim with contrast"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Firm, white to yellow with ill-defined borders"
                  },
                  {
                    "text": "Focal calcification can cause gritty consistency"
                  },
                  {
                    "text": "Can be multifocal with involvement of both lobes"
                  },
                  {
                    "text": "2 different types, depending on distribution in liverNodular: Early stage of disease; observed in 10%Diffuse: Advanced stage due to coalescence of multiple lesions",
                    "sub_points": [
                      "Nodular: Early stage of disease; observed in 10%",
                      "Diffuse: Advanced stage due to coalescence of multiple lesions"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Infiltrates preexisting structures; leaves portal zones and central veins intactPeriphery has higher cellularityCenter of tumor is often fibrotic and paucicellular",
                    "sub_points": [
                      "Periphery has higher cellularity",
                      "Center of tumor is often fibrotic and paucicellular"
                    ]
                  },
                  {
                    "text": "Myxoid to fibrous stromaCalcification may be present in dense areas of stroma",
                    "sub_points": [
                      "Calcification may be present in dense areas of stroma"
                    ]
                  },
                  {
                    "text": "Intravascular small papillary projections or tufts can occur"
                  },
                  {
                    "text": "Tumor cells are dendritic or epithelioidDendritic: Irregular, elongated, or stellate with branching processesEpithelioid: Round with more abundant cytoplasmCytoplasmic vacuole may represent intracellular lumina and may have erythrocytesNuclear atypia and mitoses typically not prominent",
                    "sub_points": [
                      "Dendritic: Irregular, elongated, or stellate with branching processes",
                      "Epithelioid: Round with more abundant cytoplasm",
                      "Cytoplasmic vacuole may represent intracellular lumina and may have erythrocytes",
                      "Nuclear atypia and mitoses typically not prominent"
                    ]
                  },
                  {
                    "text": "Scattered inflammatory cells, such as lymphocytes and neutrophils, often present"
                  },
                  {
                    "text": "Residual hepatocytes or bile ducts can be present within tumor"
                  },
                  {
                    "text": "Invasion of portal and central veins mimics thrombosis"
                  },
                  {
                    "text": "\"Malignant\" EHERare tumors with higher nuclear grade, increased mitosis, and solid growthMore aggressive than conventional EHE",
                    "sub_points": [
                      "Rare tumors with higher nuclear grade, increased mitosis, and solid growth",
                      "More aggressive than conventional EHE"
                    ]
                  },
                  {
                    "text": "Immunohistochemical featuresVascular markers like CD31, CD34, &/or FVIIIR-Ag are usually positiveERG and FLI-1, endothelial transcription factors of ETS family, are expressed in nuclei of tumor cellsPodoplanin (recognized by antibody D2-40), which is lymphatic endothelial marker, is expressed in 70% of EHEsD2-40 is not expressed in angiosarcoma, although experience with this is limitedTumors withWWTR1-CAMTA1fusionNuclear staining with CAMTA1 immunohistochemistryHigh specificity for diagnosisTumors withYAP1-TFE3Areas with well-formed vascular channelsTumor cells with voluminous eosinophilic cytoplasmNuclear staining with TFE3 immunohistochemistry",
                    "sub_points": [
                      "Vascular markers like CD31, CD34, &/or FVIIIR-Ag are usually positive",
                      "ERG and FLI-1, endothelial transcription factors of ETS family, are expressed in nuclei of tumor cells",
                      "Podoplanin (recognized by antibody D2-40), which is lymphatic endothelial marker, is expressed in 70% of EHEsD2-40 is not expressed in angiosarcoma, although experience with this is limited",
                      "D2-40 is not expressed in angiosarcoma, although experience with this is limited",
                      "Tumors withWWTR1-CAMTA1fusionNuclear staining with CAMTA1 immunohistochemistryHigh specificity for diagnosis",
                      "Nuclear staining with CAMTA1 immunohistochemistry",
                      "High specificity for diagnosis",
                      "Tumors withYAP1-TFE3Areas with well-formed vascular channelsTumor cells with voluminous eosinophilic cytoplasmNuclear staining with TFE3 immunohistochemistry",
                      "Areas with well-formed vascular channels",
                      "Tumor cells with voluminous eosinophilic cytoplasm",
                      "Nuclear staining with TFE3 immunohistochemistry"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adenocarcinoma (Including Cholangiocarcinoma)": [
                  {
                    "text": "Intracytoplasmic lumina and dense sclerotic stroma in EHE can be mistaken for adenocarcinoma"
                  },
                  {
                    "text": "Focal keratin positivity in EHE tumor cells, as well as in entrapped hepatocytes and bile ducts, can mimic carcinoma"
                  },
                  {
                    "text": "Favor EHE: Young age, multifocal involvement, pattern of tumor infiltration at periphery, calcification"
                  },
                  {
                    "text": "Endothelial markers in tumor cells confirm EHE"
                  }
                ],
                "Angiosarcoma": [
                  {
                    "text": "Tend to be large and hemorrhagic"
                  },
                  {
                    "text": "Greater nuclear atypia, mitoses, and destructive growth pattern"
                  },
                  {
                    "text": "High Ki-67, diffuse p53, diffuse MYC favor angiosarcoma when present"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Angiomyolipoma": {
            "name": "Angiomyolipoma",
            "url": "https://app.pathprimer.com/document/fef995ed-20fd-479f-9daf-ecb200407054/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Rare, benign mesenchymal neoplasm presumed to arise from perivascular epithelioid cells (PEC), which variably resemble smooth muscle and adipose tissue, and are associated with thick-walled vessels"
                  },
                  {
                    "text": "Part of PEComa family of tumors"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Infrequently associated with tuberous sclerosis (6-10%)"
                  },
                  {
                    "text": "Benign behavior in vast majority of hepatic cases"
                  },
                  {
                    "text": "Most patients are asymptomatic and present incidentally"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tumor consists of 3 phases in varying proportions: Abnormal, thick-walled vessels, cells resembling smooth muscle and cells, resembling adipose tissueEpithelioid smooth muscle cells are typically large with round to oval nuclei and eosinophilic to fibrillar or vacuolated cytoplasm",
                    "sub_points": [
                      "Epithelioid smooth muscle cells are typically large with round to oval nuclei and eosinophilic to fibrillar or vacuolated cytoplasm"
                    ]
                  },
                  {
                    "text": "Features that predict malignant behavior are not well definedNuclear atypia and infiltrative margins can be seen in benign tumors",
                    "sub_points": [
                      "Nuclear atypia and infiltrative margins can be seen in benign tumors"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Tumor cells stain with HMB-45, Melan-A, and smooth muscle markers but not keratins or Hep-Par1"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular neoplasm, particularly hepatocellular carcinoma"
                  },
                  {
                    "text": "Malignant melanoma"
                  },
                  {
                    "text": "Lipoma"
                  },
                  {
                    "text": "Metastatic malignant neoplasm: Carcinoma or sarcoma"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Heterogeneous tumor that contains mixture of plump eosinophilic cells and fat-distended cells should raise suspicion for angiomyolipoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Angiomyolipoma (AML)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Perivascular epithelioid cell (PEComa) tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Rare, mesenchymal neoplasm composed of predominantly epithelioid cells showing variable expression of smooth muscle and melanocytic markers"
                  },
                  {
                    "text": "Tumor cells are characteristically accompanied by thick-walled, tortuous blood vessels; some tumor cells are lipid-laden and resemble adipocytes in nonneoplastic fatThought to arise from PEC; therefore, part of PEComa family of tumors",
                    "sub_points": [
                      "Thought to arise from PEC; therefore, part of PEComa family of tumors"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "": [
                  {
                    "text": "Most are sporadic; rarely associated with tuberous sclerosis"
                  },
                  {
                    "text": "Pathogenesis is unknown"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare: Overall incidence unknown but only few hundred cases reported"
                  },
                  {
                    "text": "Some cases associated with tuberous sclerosis (6-10%) but less often than renal AML (20-40%)More likely to be associated with tuberous sclerosis if multiple &/or associated with renal tumors",
                    "sub_points": [
                      "More likely to be associated with tuberous sclerosis if multiple &/or associated with renal tumors"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Adults: 17-86 years (mean: 43.5-50 years)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Marked female predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Most patients are asymptomatic and present incidentally"
                  },
                  {
                    "text": "Large tumors may cause symptoms related to mass effect or abdominal discomfort"
                  },
                  {
                    "text": "Tumor rupture is rare"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Conservative approachesIf diagnosis can be confidently established, radiologic follow-up is recommended",
                    "sub_points": [
                      "If diagnosis can be confidently established, radiologic follow-up is recommended"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "ExcisionWhen diagnosis cannot be established on biopsySymptomatic tumorsLarge lesions at risk for rupturing",
                    "sub_points": [
                      "When diagnosis cannot be established on biopsy",
                      "Symptomatic tumors",
                      "Large lesions at risk for rupturing"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "mTOR inhibitors have been successfully used in rare malignant PEComas"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign behavior in vast majority of casesTumor recurrence is uncommonMetastasis extremely rare",
                    "sub_points": [
                      "Tumor recurrence is uncommon",
                      "Metastasis extremely rare"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Most AMLs present as heterogeneous hyperechoic lesions but can be hypoechoic"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "MR is most specific imaging modality for detecting lipomatous component"
                  },
                  {
                    "text": "Most tumors are hypointense on T1WI and slightly hyperintense on T2WI"
                  },
                  {
                    "text": "Can be indistinguishable from hepatocellular carcinoma"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Usually hypodense on precontrast CT with peripheral enhancement in arterial phase"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually solitary, occasionally multiple"
                  },
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "Either not encapsulated or only partially encapsulated"
                  },
                  {
                    "text": "Cut surface is soft, fleshy, and yellow-tan, gray, or brownMay contain areas of hemorrhage and necrosis",
                    "sub_points": [
                      "May contain areas of hemorrhage and necrosis"
                    ]
                  },
                  {
                    "text": "Background liver is typically noncirrhotic"
                  }
                ],
                "Size": [
                  {
                    "text": "Wide range: 0.1-36 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Tumor consists of 3 phases in varying proportionsResembling smooth muscleResembling adipose tissueThick-walled blood vessels",
                    "sub_points": [
                      "Resembling smooth muscle",
                      "Resembling adipose tissue",
                      "Thick-walled blood vessels"
                    ]
                  },
                  {
                    "text": "AML tumor cellsCan be epithelioid, intermediate (ovoid or short spindle), or spindledEpithelioid cellsLarge, polygonal, or spheroid and may mimic hepatocytesMay be clear, reticulated, granular, vacuolated cytoplasmSpider-like cytoplasmic filaments may be visible on H&ECytoplasmic clearing is due to glycogen and, occasionally, small fat vacuoles in periphery of cellsRound to oval, eccentric nuclei that may occasionally show degenerative atypiaSingle eosinophilic nucleolusSpindled cells (often resemble smooth muscle)Round to oval pale nucleiRim of eosinophilic cytoplasmHepatic AML is often monophasic and composed of epithelioid cells with myoid phenotype",
                    "sub_points": [
                      "Can be epithelioid, intermediate (ovoid or short spindle), or spindled",
                      "Epithelioid cellsLarge, polygonal, or spheroid and may mimic hepatocytesMay be clear, reticulated, granular, vacuolated cytoplasmSpider-like cytoplasmic filaments may be visible on H&ECytoplasmic clearing is due to glycogen and, occasionally, small fat vacuoles in periphery of cellsRound to oval, eccentric nuclei that may occasionally show degenerative atypiaSingle eosinophilic nucleolus",
                      "Large, polygonal, or spheroid and may mimic hepatocytes",
                      "May be clear, reticulated, granular, vacuolated cytoplasmSpider-like cytoplasmic filaments may be visible on H&E",
                      "Spider-like cytoplasmic filaments may be visible on H&E",
                      "Cytoplasmic clearing is due to glycogen and, occasionally, small fat vacuoles in periphery of cells",
                      "Round to oval, eccentric nuclei that may occasionally show degenerative atypia",
                      "Single eosinophilic nucleolus",
                      "Spindled cells (often resemble smooth muscle)Round to oval pale nucleiRim of eosinophilic cytoplasm",
                      "Round to oval pale nuclei",
                      "Rim of eosinophilic cytoplasm",
                      "Hepatic AML is often monophasic and composed of epithelioid cells with myoid phenotype"
                    ]
                  },
                  {
                    "text": "Variable featuresIntracytoplasmic hyaline globulesExtramedullary hematopoiesis is commonly observedHemorrhage/hemosiderin, peliosisFoamy macrophages and lymphocytic infiltrates may be present and, in some cases, may obscure underlying tumorMelaninCholesterol clefts",
                    "sub_points": [
                      "Intracytoplasmic hyaline globules",
                      "Extramedullary hematopoiesis is commonly observed",
                      "Hemorrhage/hemosiderin, peliosis",
                      "Foamy macrophages and lymphocytic infiltrates may be present and, in some cases, may obscure underlying tumor",
                      "Melanin",
                      "Cholesterol clefts"
                    ]
                  },
                  {
                    "text": "Tumor may show infiltration of surrounding liver sinusoids or even \"invasion\" into adjacent liver tissueThis finding is not indicative of biologic behavior",
                    "sub_points": [
                      "This finding is not indicative of biologic behavior"
                    ]
                  },
                  {
                    "text": "No well-defined features predictive of malignant behaviorLarge size (> 10 cm)Coagulative necrosisProposed criteria for malignancy in gastrointestinal PEComas are marked nuclear atypia, diffuse pleomorphism, and mitotic activity > 2/10 HPF",
                    "sub_points": [
                      "Large size (> 10 cm)",
                      "Coagulative necrosis",
                      "Proposed criteria for malignancy in gastrointestinal PEComas are marked nuclear atypia, diffuse pleomorphism, and mitotic activity > 2/10 HPF"
                    ]
                  },
                  {
                    "text": "Tumor cells distended with lipid resemble adipose tissue"
                  },
                  {
                    "text": "Blood vessels are thick and tortuous and frequently harbor neoplastic cells within their walls"
                  },
                  {
                    "text": "Low or absent mitotic activity"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Clusters of plump, smooth muscle cells with arborizing traversing capillaries but admixed with adipocytes"
                  },
                  {
                    "text": "Smooth muscle cells show fibrillary cytoplasm, indistinct cytoplasmic borders, and spindled, elongated, or oval nuclei with nucleoli and occasional intranuclear inclusions"
                  }
                ],
                "Variants": [
                  {
                    "text": "Tumors with predominantly or purely trabecular growth patternFrequently have little or no adipose tissueMay be misdiagnosed as hepatocellular carcinoma",
                    "sub_points": [
                      "Frequently have little or no adipose tissue",
                      "May be misdiagnosed as hepatocellular carcinoma"
                    ]
                  },
                  {
                    "text": "Oncocytic AMLRelatively homogeneous cytologic featuresLittle or no adipose tissueProminent degenerative-type cytologic atypia",
                    "sub_points": [
                      "Relatively homogeneous cytologic features",
                      "Little or no adipose tissue",
                      "Prominent degenerative-type cytologic atypia"
                    ]
                  },
                  {
                    "text": "Inflammatory subtype of AMLProminent infiltrate of lymphocytes and plasma cells may obscure neoplastic cells",
                    "sub_points": [
                      "Prominent infiltrate of lymphocytes and plasma cells may obscure neoplastic cells"
                    ]
                  },
                  {
                    "text": "No known difference in clinical behavior for various subtypes of AML"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS-diastaseReactivity: PositiveStaining pattern: Hyaline globules",
                    "sub_points": [
                      "Reactivity: Positive",
                      "Staining pattern: Hyaline globules"
                    ]
                  },
                  {
                    "text": "IronReactivity: PositiveStaining pattern: Stains hemosiderin in some tumors",
                    "sub_points": [
                      "Reactivity: Positive",
                      "Staining pattern: Stains hemosiderin in some tumors"
                    ]
                  },
                  {
                    "text": "Fontana-MassonReactivity: PositiveStaining pattern: Stains melanin pigment in some tumors",
                    "sub_points": [
                      "Reactivity: Positive",
                      "Staining pattern: Stains melanin pigment in some tumors"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Positive for desmin &/or SMA (60-75% of cases) and variable extents of expression for HMB-45, Melan-A, tyrosinase, and MITFEpithelioid cells stain most intensely with HMB-45 and stain less with other melanocyte markersSpindle cells stain most intensely with SMA, myosin, desmin, and vimentin and less intensely with HMB-45Occasionally, S100 and NSE positiveKeratin negative",
                    "sub_points": [
                      "Epithelioid cells stain most intensely with HMB-45 and stain less with other melanocyte markers",
                      "Spindle cells stain most intensely with SMA, myosin, desmin, and vimentin and less intensely with HMB-45",
                      "Occasionally, S100 and NSE positive",
                      "Keratin negative"
                    ]
                  },
                  {
                    "text": "Mature adipocytes frequently stain with antibodies to S100 and vessels stain with CD34 and other vascular markers"
                  },
                  {
                    "text": "Diffuse glutamine synthetase staining can occur in ~ 40% hepatic AMLs"
                  }
                ],
                "Flow Cytometry": [
                  {
                    "text": "Diploid DNA pattern, favoring benign nature"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Cytoplasmic-bound granules consistent with premelanosomes and intracytoplasmic filaments that aggregate to produce dense bodies"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatocellular Neoplasm": [
                  {
                    "text": "Hepatocellular adenoma or hepatocellular carcinoma"
                  },
                  {
                    "text": "May see steatosis"
                  },
                  {
                    "text": "Keratins and hepatocyte markers (Hep-Par1, arginase) are positive"
                  },
                  {
                    "text": "HMB-45 and SMA are negative"
                  }
                ],
                "Malignant Melanoma": [
                  {
                    "text": "Absence of component resembling adipose tissue"
                  },
                  {
                    "text": "Vasculature is dissimilar to that described for PEComa"
                  },
                  {
                    "text": "Immunohistochemistry for SMA and desmin are negative"
                  }
                ],
                "Gastrointestinal Stromal Tumor": [
                  {
                    "text": "Absence of component resembling adipose tissue"
                  },
                  {
                    "text": "CD117 (KIT), DOG1 are positive"
                  },
                  {
                    "text": "HMB-45 negative"
                  }
                ],
                "Smooth Muscle Tumor": [
                  {
                    "text": "Leiomyoma or leiomyosarcoma"
                  },
                  {
                    "text": "Absence of component resembling adipose tissue"
                  },
                  {
                    "text": "HMB-45 negative"
                  }
                ],
                "Lipoma, Focal Fatty Change, or Myelolipoma": [
                  {
                    "text": "HMB-45 negative"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Fat component may be noted on radiologic studies"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Heterogeneous tumor that contains mixture of plump eosinophilic cells and fat should raise suspicion for AML"
                  },
                  {
                    "text": "HMB-45 immunohistochemistry advisable for unusual presumed carcinomas or sarcomas of liver"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "PEComa of Liver": {
            "name": "PEComa of Liver",
            "url": "https://app.pathprimer.com/document/bd6ebac2-f86b-4580-84b6-5c2825545fe4/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Some cases associated with tuberous sclerosis complex"
                  },
                  {
                    "text": "mTOR pathway inhibitors utilized for locally aggressive or metastatic disease"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Nests and sheets of epithelioid cells with large, thin-walled vesselsStriking perivascular growth patternMay contain adipocytic component",
                    "sub_points": [
                      "Striking perivascular growth pattern",
                      "May contain adipocytic component"
                    ]
                  },
                  {
                    "text": "Tumor cells have variably eosinophilic granular or clear cytoplasmMay have spindled morphology and mimic smooth muscle tumorsProminent nucleoli and show variable degrees of pleomorphism",
                    "sub_points": [
                      "May have spindled morphology and mimic smooth muscle tumors",
                      "Prominent nucleoli and show variable degrees of pleomorphism"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Immunohistochemistry: Myoid and melanocytic marker expressionMyoid markers: SMA, desmin, caldesmonMelanocytic markers: MART1, HMB-45, MITF",
                    "sub_points": [
                      "Myoid markers: SMA, desmin, caldesmon",
                      "Melanocytic markers: MART1, HMB-45, MITF"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular carcinoma, clear cell variant"
                  },
                  {
                    "text": "Hepatic adenoma"
                  },
                  {
                    "text": "Cholangiocarcinoma"
                  },
                  {
                    "text": "Metastatic renal cell carcinoma"
                  },
                  {
                    "text": "Malignant melanoma"
                  },
                  {
                    "text": "Gastrointestinal neuroectodermal tumor"
                  },
                  {
                    "text": "Gastrointestinal stromal tumor"
                  },
                  {
                    "text": "Metastatic adrenal cortical carcinoma"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Perivascular epithelioid cell (PEC)oma"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Angiomyolipoma"
                  },
                  {
                    "text": "Clear cell myomelanocytic tumor of falciform ligament/ligamentum teres"
                  },
                  {
                    "text": "Extrapulmonary clear cell \"sugar\" tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Considered to be family of tumors with dual myoid and melanocytic differentiationMay have adipocytic component (angiomyolipoma)No known normal tissue counterpart",
                    "sub_points": [
                      "May have adipocytic component (angiomyolipoma)",
                      "No known normal tissue counterpart"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Etiology and Molecular Genetics": [
                  {
                    "text": "May be sporadic or associated with tuberous sclerosis complexSporadic PEComas as well as those associated with tuberous sclerosis syndrome haveTSC2mutations",
                    "sub_points": [
                      "Sporadic PEComas as well as those associated with tuberous sclerosis syndrome haveTSC2mutations"
                    ]
                  },
                  {
                    "text": "Mutations in eitherTSC1orTSC2result in activation of mTOR signaling pathwaymTOR inhibitors are used for patients with locally aggressive or metastatic PEComa",
                    "sub_points": [
                      "mTOR inhibitors are used for patients with locally aggressive or metastatic PEComa"
                    ]
                  },
                  {
                    "text": "Subset of PEComas harborTFE3gene fusions"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Relatively rare and may be slightly more common in female patients"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually occurs in middle-aged adultsWide age rangeRare in children",
                    "sub_points": [
                      "Wide age range",
                      "Rare in children"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Patients generally present with vague abdominal pain or discomfortMay be asymptomaticPalpable mass may be present",
                    "sub_points": [
                      "May be asymptomatic",
                      "Palpable mass may be present"
                    ]
                  },
                  {
                    "text": "Liver enzymes are generally normal"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Resection for majority of cases"
                  },
                  {
                    "text": "Cases having morphologic features of malignancy should be treated as high-grade sarcomas"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Locally aggressive or metastatic tumors are treated with mTOR pathway inhibitors such as sirolimus or everolimus"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign clinical courseRare cases may show aggressive clinical behavior with locally aggressive or metastatic disease",
                    "sub_points": [
                      "Rare cases may show aggressive clinical behavior with locally aggressive or metastatic disease"
                    ]
                  },
                  {
                    "text": "Nuclear atypia, diffuse pleomorphism, and mitotic activity of ≥ 2 mitoses per 10 HPF has been associated with metastatic disease in cases primary to GI tract and mesentery"
                  }
                ]
              },
              "Image Findings": {
                "General Features": [
                  {
                    "text": "Well-circumscribed, mostly fatty mass in liverOnly 50% of hepatic PEComas have substantial fat component",
                    "sub_points": [
                      "Only 50% of hepatic PEComas have substantial fat component"
                    ]
                  }
                ],
                "Ultrasonographic Findings": [
                  {
                    "text": "Lesions will generally show sharply delineated, homogeneous hyperechoic appearance"
                  },
                  {
                    "text": "Contrast-enhanced ultrasound will show capillary flow similar to hemangioma"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Fatty component of tumor results in hyperintense (high signal) foci on T1WI and T2WI"
                  },
                  {
                    "text": "Hypointensity or hyperintensity on T1WIDepends on amount of fat and whether fat-suppressed technique is usedFatty component of tumor results in hyperintense (high signal) foci on T1WI",
                    "sub_points": [
                      "Depends on amount of fat and whether fat-suppressed technique is used",
                      "Fatty component of tumor results in hyperintense (high signal) foci on T1WI"
                    ]
                  },
                  {
                    "text": "High signal intensity of fatty components on T2WIHeterogeneous hyperintensity",
                    "sub_points": [
                      "Heterogeneous hyperintensity"
                    ]
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Variable amounts of large irregular fatty and dilated vesselsMay be absent in some cases",
                    "sub_points": [
                      "May be absent in some cases"
                    ]
                  },
                  {
                    "text": "Arterial phase enhancement of nonfatty portion of lesion"
                  },
                  {
                    "text": "Portal phase will show hypoattenuation throughout mass"
                  },
                  {
                    "text": "Central vessels within lesion if mass is large"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Usually well circumscribed but unencapsulated, tan-brown to pale yellow in color, with variable amounts of hemorrhage, cystic change, or necrosis"
                  },
                  {
                    "text": "Tumors are usually solitary within liver; in some cases, intrahepatic metastases may be present"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Nests and sheets of predominantly epithelioid cells surrounded by delicate capillary vasculatureLarge, thin-walled vessels are usually present with striking perivascular growth patternTumor cells closely appose endothelium; radially arranged around vessel wallsSome hepatic PEComas contain adipocytic component, which may be prominent",
                    "sub_points": [
                      "Large, thin-walled vessels are usually present with striking perivascular growth pattern",
                      "Tumor cells closely appose endothelium; radially arranged around vessel walls",
                      "Some hepatic PEComas contain adipocytic component, which may be prominent"
                    ]
                  },
                  {
                    "text": "Tumor cells have variably eosinophilic granular or clear cytoplasm, prominent nucleoli, and show variable degrees of pleomorphismMay have spindled morphology and mimic smooth muscle tumorsVariable amounts of atypia, pleomorphism, and mitotic activity",
                    "sub_points": [
                      "May have spindled morphology and mimic smooth muscle tumors",
                      "Variable amounts of atypia, pleomorphism, and mitotic activity"
                    ]
                  },
                  {
                    "text": "Subset of cases of hepatic PEComas show a prominent inflammatory component comprising lymphocytes, plasma cells, and histiocytes"
                  },
                  {
                    "text": "Extramedullary hematopoiesis may be present"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "Combined immunophenotypic expression of 1 or more myoid marker and 1 or more melanocytic markerMyoid markers: SMA, desmin, caldesmonAt least 1 marker should be positive in majority of casesMelanocytic markers: MART1, HMB-45, MITFMay lack expression of all melanocytic markersS100 protein positivity is seen in ~ 10-20%",
                    "sub_points": [
                      "Myoid markers: SMA, desmin, caldesmonAt least 1 marker should be positive in majority of cases",
                      "At least 1 marker should be positive in majority of cases",
                      "Melanocytic markers: MART1, HMB-45, MITFMay lack expression of all melanocytic markers",
                      "May lack expression of all melanocytic markers",
                      "S100 protein positivity is seen in ~ 10-20%"
                    ]
                  },
                  {
                    "text": "Subset of tumors will show TFE3 nuclear expression"
                  },
                  {
                    "text": "Cathepsin-K has been proposed as putative marker of PEComaLacks specificity",
                    "sub_points": [
                      "Lacks specificity"
                    ]
                  },
                  {
                    "text": "Extent of staining may be variable, ranging from focal or scattered positive cells to diffuse positivity"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Hepatocellular Carcinoma (HCC), Clear Cell Variant": [
                  {
                    "text": "PEComa without adipocytic differentiation can mimic hepatocellular carcinoma"
                  },
                  {
                    "text": "ImmunohistochemistryHepatocellular carcinoma expresses Hep-Par1 and Arginase-1Variable expression of glypican-3 and cytokeratinsPEComas should not be positive for any of these markers",
                    "sub_points": [
                      "Hepatocellular carcinoma expresses Hep-Par1 and Arginase-1",
                      "Variable expression of glypican-3 and cytokeratins",
                      "PEComas should not be positive for any of these markers"
                    ]
                  },
                  {
                    "text": "Background liver enzymes should be elevated in HCC"
                  }
                ],
                "Hepatic Adenoma": [
                  {
                    "text": "Typically present in young women on oral contraceptives"
                  },
                  {
                    "text": "Well defined, often surrounded by capsuleHypoattenuating mass with heterogeneous attenuation; areas of hemorrhage and fat within",
                    "sub_points": [
                      "Hypoattenuating mass with heterogeneous attenuation; areas of hemorrhage and fat within"
                    ]
                  },
                  {
                    "text": "Histologically resembles hepatocytes"
                  },
                  {
                    "text": "ImmunohistochemistryHepatocellular adenoma expresses Hep-Par1 and Arginase-1",
                    "sub_points": [
                      "Hepatocellular adenoma expresses Hep-Par1 and Arginase-1"
                    ]
                  }
                ],
                "Cholangiocarcinoma": [
                  {
                    "text": "PEComa without adipocytic differentiation can mimic cholangiocarcinoma"
                  },
                  {
                    "text": "ImmunohistochemistryMay express CK7Should be negative for all melanocytic and myoid markers",
                    "sub_points": [
                      "May express CK7",
                      "Should be negative for all melanocytic and myoid markers"
                    ]
                  },
                  {
                    "text": "Molecular genetics: 40% may show translocations involvingFGFR2"
                  },
                  {
                    "text": "Background liver enzymes should be elevated in HCC"
                  }
                ],
                "Metastatic Renal Cell Carcinoma (RCC)": [
                  {
                    "text": "Can show significant morphologic overlap with PEComa"
                  },
                  {
                    "text": "ImmunohistochemistryRCC express EMA(+), Pax-8(+)Focal to diffuse cytokeratin positivityRCC will be negative myoid markersTranslocation carcinomas expressing melanocytic markers or TFE3 may be a pitfall",
                    "sub_points": [
                      "RCC express EMA(+), Pax-8(+)",
                      "Focal to diffuse cytokeratin positivity",
                      "RCC will be negative myoid markersTranslocation carcinomas expressing melanocytic markers or TFE3 may be a pitfall",
                      "Translocation carcinomas expressing melanocytic markers or TFE3 may be a pitfall"
                    ]
                  }
                ],
                "Malignant Melanoma": [
                  {
                    "text": "Absence of adipose tissue component or abnormal vessels"
                  },
                  {
                    "text": "Immunohistochemical staining shows S100 staining in spindle or epithelioid cells"
                  }
                ],
                "Gastrointestinal Neuroectodermal Tumor": [
                  {
                    "text": "Absence of adipose tissue component or abnormal vesselsMay show areas of perivascular condensation",
                    "sub_points": [
                      "May show areas of perivascular condensation"
                    ]
                  },
                  {
                    "text": "Tumors can have clear cell morphology, but will be in the minority"
                  },
                  {
                    "text": "ImmunohistochemistryS100 protein (+), synaptophysin (+)Melanocytic marker positivity in rare cases",
                    "sub_points": [
                      "S100 protein (+), synaptophysin (+)",
                      "Melanocytic marker positivity in rare cases"
                    ]
                  },
                  {
                    "text": "Molecular genetics:EWSR1-ATF1orEWSR1-CREB1"
                  }
                ],
                "Gastrointestinal Stromal Tumor": [
                  {
                    "text": "Absence of adipose tissue"
                  },
                  {
                    "text": "Positive staining with CD117 and CD34; HMB-45(-)"
                  }
                ],
                "Metastatic Adrenal Cortical Carcinoma": [
                  {
                    "text": "Tumors are more pleomorphic"
                  },
                  {
                    "text": "ImmunohistochemistryShould express calretinin, melan-A, and inhibinExpression of melan-A may serve as diagnostic pitfallShould be negative for HMB-45 and desmin",
                    "sub_points": [
                      "Should express calretinin, melan-A, and inhibin",
                      "Expression of melan-A may serve as diagnostic pitfall",
                      "Should be negative for HMB-45 and desmin"
                    ]
                  },
                  {
                    "text": "Primary in adrenal gland itself is virtually always identified 1st (i.e., occult adrenal cell carcinoma is exceptionally rare)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Infantile Hemangioma": {
            "name": "Infantile Hemangioma",
            "url": "https://app.pathprimer.com/document/7af6a3bc-1dba-4aa6-a699-d35fa30c1eb0/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Originally described as infantile hemangioendothelioma type 1"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common hepatic neoplasm in 1st year of lifeMost present before age of 6 monthsFemale predominance",
                    "sub_points": [
                      "Most present before age of 6 months",
                      "Female predominance"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary or multifocal"
                  },
                  {
                    "text": "Nonencapsulated"
                  },
                  {
                    "text": "0.3-13.0cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Vascular proliferation resembling small capillariesSlightly dilated and irregular in shapeLined by single layer of bland endothelial cells",
                    "sub_points": [
                      "Slightly dilated and irregular in shape",
                      "Lined by single layer of bland endothelial cells"
                    ]
                  },
                  {
                    "text": "Secondary involutional changes in central portion"
                  },
                  {
                    "text": "Peripheral cellular areas show proliferation of vascular channels in loose fibrous stroma"
                  },
                  {
                    "text": "Mitoses often present in peripheral cellular area"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Positive for vascular markers: Factor VIII, CD31, CD34, FLI-1"
                  },
                  {
                    "text": "GLUT-1 is often positive, while most vascular malformations are negative"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "AngiosarcomaPreviously termed infantile hemangioendothelioma type 2Key distinguishing feature is nuclear atypia of endothelial cells",
                    "sub_points": [
                      "Previously termed infantile hemangioendothelioma type 2",
                      "Key distinguishing feature is nuclear atypia of endothelial cells"
                    ]
                  },
                  {
                    "text": "Cavernous hemangioma"
                  },
                  {
                    "text": "Lymphangioma"
                  },
                  {
                    "text": "Mesenchymal hamartoma"
                  },
                  {
                    "text": "Vascular malformation"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Originally described by Dehner and Ishak as infantile hemangioendothelioma type 1"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Hepatic vascular neoplasmMost common hepatic neoplasm during 1st year of lifeAccounts for 15% of primary liver tumors in pediatric population",
                    "sub_points": [
                      "Most common hepatic neoplasm during 1st year of life",
                      "Accounts for 15% of primary liver tumors in pediatric population"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Most present before age of 6 months; rare in adults"
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Hepatomegaly, abdominal enlargement, palpable massSmall tumors may be asymptomatic",
                    "sub_points": [
                      "Small tumors may be asymptomatic"
                    ]
                  },
                  {
                    "text": "Frequently have cutaneous hemangiomas, hypothyroidism"
                  },
                  {
                    "text": "ComplicationsHigh-output cardiac failure due to shunting through tumorKasabach-Merritt syndrome (thrombocytopenia, hypofibrinogenemia)",
                    "sub_points": [
                      "High-output cardiac failure due to shunting through tumor",
                      "Kasabach-Merritt syndrome (thrombocytopenia, hypofibrinogenemia)"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Spontaneous regression (5-10%)"
                  },
                  {
                    "text": "Malignant transformation has been reported"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Intravenous steroids, β-blockers, chemotherapy"
                  },
                  {
                    "text": "Hepatic artery ligation, embolization of feeding vessels"
                  },
                  {
                    "text": "Surgical resection"
                  },
                  {
                    "text": "Orthotopic liver transplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Survival rate of 70% with treatment"
                  },
                  {
                    "text": "Diffuse disease and cardiac failure are adverse prognostic factors"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary or multifocal, nonencapsulated; 0.3-13.0 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Peripheral cellular areas show proliferation of vascular channels in loose fibrous stromaSmall, capillary-like, and thin walledSlightly dilated and irregularSome ectatic (cavernous) vessels",
                    "sub_points": [
                      "Small, capillary-like, and thin walled",
                      "Slightly dilated and irregular",
                      "Some ectatic (cavernous) vessels"
                    ]
                  },
                  {
                    "text": "Entrapped hepatocytes and bile ducts near periphery"
                  },
                  {
                    "text": "Secondary involutional changes in central portionMyxoid change, necrosis, fibrosis, thrombosis, calcification",
                    "sub_points": [
                      "Myxoid change, necrosis, fibrosis, thrombosis, calcification"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Single layer of bland endothelial cellsElongated plump cells with scant cytoplasmRound to oval nuclei with finely granular nuclear chromatinMitoses often present in peripheral cellular area",
                    "sub_points": [
                      "Elongated plump cells with scant cytoplasm",
                      "Round to oval nuclei with finely granular nuclear chromatin",
                      "Mitoses often present in peripheral cellular area"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for vascular markers: Factor VIII, CD31, CD34, FLI-1"
                  },
                  {
                    "text": "Endothelial cells are surrounded by SMA immunoreactivityNegative for desmin",
                    "sub_points": [
                      "Negative for desmin"
                    ]
                  },
                  {
                    "text": "GLUT-1 is often positive"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Angiosarcoma": [
                  {
                    "text": "Previously termed infantile hemangioendothelioma type 2"
                  },
                  {
                    "text": "Poorly formed, irregular, branching, and budding vascular spacesLined by stratified and atypical endothelial cellsPleomorphic, large, and hyperchromatic nuclei",
                    "sub_points": [
                      "Lined by stratified and atypical endothelial cellsPleomorphic, large, and hyperchromatic nuclei",
                      "Pleomorphic, large, and hyperchromatic nuclei"
                    ]
                  },
                  {
                    "text": "Peripheral region of sinusoidal growth patternDilated sinusoids lined by enlarged atypical cells",
                    "sub_points": [
                      "Dilated sinusoids lined by enlarged atypical cells"
                    ]
                  },
                  {
                    "text": "Kaposiform spindle cell areas"
                  },
                  {
                    "text": "Absence of bile ducts within tumor"
                  }
                ],
                "Cavernous Hemangioma": [
                  {
                    "text": "Large, dilated, thin-walled, blood-filled spaces lined by flattened endothelium"
                  }
                ],
                "Lymphangioma": [
                  {
                    "text": "Large vascular spaces with attenuated endothelium, filled with proteinaceous fluid"
                  },
                  {
                    "text": "Small lymphoid aggregates in stroma"
                  },
                  {
                    "text": "Immunoreactive for D2-40"
                  }
                ],
                "Mesenchymal Hamartoma": [
                  {
                    "text": "Overlapping age and clinical presentation"
                  },
                  {
                    "text": "Contains mixture of epithelial and stromal components"
                  },
                  {
                    "text": "Cystic spaces not lined by endothelial cells"
                  },
                  {
                    "text": "Vessels are thick walled with round lumina"
                  }
                ],
                "Vascular Malformation": [
                  {
                    "text": "Often presents early in infancy"
                  },
                  {
                    "text": "Large, thick-walled vessels typical of arteriovenous malformation"
                  },
                  {
                    "text": "Can be indistinguishable from infantile hemangioma in some areas"
                  },
                  {
                    "text": "GLUT-1 often negative"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mesenchymal Hamartoma": {
            "name": "Mesenchymal Hamartoma",
            "url": "https://app.pathprimer.com/document/e369e47e-072a-4d79-95ed-286851785204/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Benign tumor that develops in utero"
                  },
                  {
                    "text": "Translocation involving 19q13.4 or 19q13.3Associated with androgenetic-biparental mosaicism during embryogenesisActivate C19MC microRNA cluster",
                    "sub_points": [
                      "Associated with androgenetic-biparental mosaicism during embryogenesisActivate C19MC microRNA cluster",
                      "Activate C19MC microRNA cluster"
                    ]
                  },
                  {
                    "text": "Some cases that lack chromosome 19 translocation haveDICER1mutations that mimic C19MC activation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "2nd most common benign liver tumor in children"
                  },
                  {
                    "text": "Male predominance"
                  },
                  {
                    "text": "Painless abdominal mass"
                  },
                  {
                    "text": "Excellent prognosis after complete excision"
                  },
                  {
                    "text": "Occasional spontaneous regression"
                  },
                  {
                    "text": "Rare transformation to embryonal sarcoma"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary, well circumscribed"
                  },
                  {
                    "text": "Solid areas: White, yellow, or tan, gelatinous texture"
                  },
                  {
                    "text": "Variably sized degenerative cysts"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Edematous myxoid or fibrous stromaBland spindled or stellate fibroblasts and myofibroblasts",
                    "sub_points": [
                      "Bland spindled or stellate fibroblasts and myofibroblasts"
                    ]
                  },
                  {
                    "text": "Bile ducts with abnormal branching"
                  },
                  {
                    "text": "Islands and clusters of hepatocytes"
                  },
                  {
                    "text": "Degenerative cysts lack epithelial lining"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Not needed for diagnosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatoblastoma"
                  },
                  {
                    "text": "Infantile hemangioma"
                  },
                  {
                    "text": "Choledochal cyst (type IV)"
                  },
                  {
                    "text": "Mucinous cystic neoplasm"
                  },
                  {
                    "text": "Foregut cyst"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Benign mesenchymal and epithelial tumor of early childhood"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Presumably Neoplastic in Nature": [
                  {
                    "text": "Balanced translocation involving same breakpoint at chromosome band 19q13.4 or 19q13.3"
                  },
                  {
                    "text": "Associated with androgenetic-biparental mosaicism during embryogenesisDiploid chromosomal complement derived entirely from father in subset of cellsAlso predisposes to placental mesenchymal dysplasia",
                    "sub_points": [
                      "Diploid chromosomal complement derived entirely from father in subset of cells",
                      "Also predisposes to placental mesenchymal dysplasia"
                    ]
                  },
                  {
                    "text": "Both abnormalities activate C19MC microRNA cluster in hepatic stroma"
                  },
                  {
                    "text": "Some cases that lack chromosome 19 translocation haveDICER1mutations that mimic C19MC activation"
                  },
                  {
                    "text": "Risk of transformation to undifferentiated embryonal sarcoma: chromosomal rearrangements involving 19q13 in both tumors"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.7/million/year"
                  },
                  {
                    "text": "Accounts for 22% of benign liver tumors in first 2 years of life"
                  },
                  {
                    "text": "2nd most common benign liver tumor in children"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually in first 2 years of life, < 5% after age 5"
                  },
                  {
                    "text": "Rarely seen in adults"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance in pediatric cases"
                  },
                  {
                    "text": "Female predominance in adult cases"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Painless abdominal mass"
                  },
                  {
                    "text": "Sudden abdominal distention due to rapid fluid accumulation in tumor"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Normal or mildly elevated liver tests"
                  },
                  {
                    "text": "Moderately elevated serum α-fetoprotein level"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection, rarely transplant"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent after complete excision"
                  },
                  {
                    "text": "Occasional spontaneous regression"
                  },
                  {
                    "text": "Rare transformation to embryonal sarcoma"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Hypodense, hypovascular, solid or multicystic lesion"
                  },
                  {
                    "text": "Can be detected prenatally by ultrasound and MR"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Well circumscribed, solitary"
                  },
                  {
                    "text": "Pedunculated in 20% of cases, 75% involve right lobeUsually attached to inferior surface of liver",
                    "sub_points": [
                      "Usually attached to inferior surface of liver"
                    ]
                  },
                  {
                    "text": "< 5 cm to > 30 cm"
                  },
                  {
                    "text": "Solid and cysticSolid areas: White, yellow, or tan, gelatinous textureVariably sized degenerative cystsClear to yellow fluid, or gelatinous material",
                    "sub_points": [
                      "Solid areas: White, yellow, or tan, gelatinous texture",
                      "Variably sized degenerative cystsClear to yellow fluid, or gelatinous material",
                      "Clear to yellow fluid, or gelatinous material"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Mesenchymal componentMyxoid or fibrous stroma with marked edemaRelatively condensed around bile ductsBland spindled or stellate fibroblasts and myofibroblastsNo pleomorphism, mitoses, or necrosis",
                    "sub_points": [
                      "Myxoid or fibrous stroma with marked edema",
                      "Relatively condensed around bile ducts",
                      "Bland spindled or stellate fibroblasts and myofibroblasts",
                      "No pleomorphism, mitoses, or necrosis"
                    ]
                  },
                  {
                    "text": "Bile ductsAbnormal (\"staghorn\") branching or ductal-plate-malformation patternNormal cuboidal or atrophic biliary epitheliumOccasional mucinous epithelium or goblet cellsNeutrophil infiltration may be seen",
                    "sub_points": [
                      "Abnormal (\"staghorn\") branching or ductal-plate-malformation pattern",
                      "Normal cuboidal or atrophic biliary epithelium",
                      "Occasional mucinous epithelium or goblet cells",
                      "Neutrophil infiltration may be seen"
                    ]
                  },
                  {
                    "text": "HepatocytesLarge islands, small clusters, or thin, compressed stripsMore abundant at periphery of tumorCytologically normal; may show reactive changesMay resemble fetal liver",
                    "sub_points": [
                      "Large islands, small clusters, or thin, compressed strips",
                      "More abundant at periphery of tumor",
                      "Cytologically normal; may show reactive changes",
                      "May resemble fetal liver"
                    ]
                  },
                  {
                    "text": "Arteries, veins, and capillaries throughoutThick-walled arterioles at periphery",
                    "sub_points": [
                      "Thick-walled arterioles at periphery"
                    ]
                  },
                  {
                    "text": "Degenerative cystsLymphangioma-like but lacking endothelial lining",
                    "sub_points": [
                      "Lymphangioma-like but lacking endothelial lining"
                    ]
                  },
                  {
                    "text": "Absence of normal portal tracts"
                  },
                  {
                    "text": "Foci of extramedullary hematopoiesis may be seen"
                  },
                  {
                    "text": "Irregular tumor border without true capsule"
                  },
                  {
                    "text": "Variant features in older children and adults: Prominent myxoid stroma, minimal ductular component, steatosis, and lack of cysts"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Not needed for diagnosis"
                  },
                  {
                    "text": "Mesenchyme: Vimentin, smooth muscle actin, and desmin"
                  },
                  {
                    "text": "Bile ducts: Cytokeratins 7 and 19"
                  },
                  {
                    "text": "Mucinous epithelium: cytokeratin 20 and CDX2 expression"
                  },
                  {
                    "text": "Hepatocytes: Hep-Par1, glypican-3, α-fetoprotein expression"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatoblastoma": [
                  {
                    "text": "Small samples simulate fetal &/or embryonal patterns"
                  }
                ],
                "Infantile Hemangioma": [
                  {
                    "text": "Shares myxoid background"
                  },
                  {
                    "text": "Features vascular proliferation with plump endothelial cells"
                  }
                ],
                "Choledochal Cyst (Type IV)": [
                  {
                    "text": "Absence of branching bile ducts"
                  }
                ],
                "Mucinous Cystic Neoplasm": [
                  {
                    "text": "Ovarian-type stroma, mucinous epithelium"
                  }
                ],
                "Foregut Cyst": [
                  {
                    "text": "Ciliated columnar epithelium, muscular wall"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Embryonal Sarcoma": {
            "name": "Embryonal Sarcoma",
            "url": "https://app.pathprimer.com/document/ee298dca-ffa4-4678-bbea-393baf026618/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Rare cases may arise in mesenchymal hamartomas"
                  },
                  {
                    "text": "TP53mutation or loss"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Usually occurring 6-10 years of age"
                  },
                  {
                    "text": "Equal sex distribution"
                  },
                  {
                    "text": "Treatment includes resection with neoadjuvant and adjuvant chemotherapy and radiotherapy"
                  },
                  {
                    "text": "5-year survival ~ 70% with multimodal therapy"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary, well circumscribed, unencapsulated; span 9-30 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Fibrous pseudocapsule contains entrapped hepatocytes and bile ducts"
                  },
                  {
                    "text": "Myxoid stroma"
                  },
                  {
                    "text": "Lesional cells are spindled, oval, or stellateNuclear pleomorphism and hyperchromasiaPAS-positive, diastase-resistant cytoplasmic eosinophilic globules",
                    "sub_points": [
                      "Nuclear pleomorphism and hyperchromasia",
                      "PAS-positive, diastase-resistant cytoplasmic eosinophilic globules"
                    ]
                  },
                  {
                    "text": "Population of bizarre multinucleated cells"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Diffusely positive for vimentin, desmin, α-1-antitrypsin, and α-1-antichymotrypsin"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Embryonal rhabdomyosarcomaExpression of skeletal muscle markers (myogenin, myoD1)",
                    "sub_points": [
                      "Expression of skeletal muscle markers (myogenin, myoD1)"
                    ]
                  },
                  {
                    "text": "Sarcomatoid hepatocellular carcinomaExpression of HepPar1, arginase",
                    "sub_points": [
                      "Expression of HepPar1, arginase"
                    ]
                  },
                  {
                    "text": "Primary and metastatic high-grade mesenchymal tumors of adult liverExceedingly rare in this populationDistinguishable by immunohistochemical stains",
                    "sub_points": [
                      "Exceedingly rare in this population",
                      "Distinguishable by immunohistochemical stains"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Undifferentiated embryonal sarcoma"
                  },
                  {
                    "text": "Malignant mesenchymoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant mesenchymal liver tumor with partial, divergent differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Sporadic": [
                  {
                    "text": "TP53mutation or loss"
                  },
                  {
                    "text": "Rare cases may arise in mesenchymal hamartomasShare same chromosome translocation involving 19q13.4Activates C19MC microRNA cluster",
                    "sub_points": [
                      "Share same chromosome translocation involving 19q13.4Activates C19MC microRNA cluster",
                      "Activates C19MC microRNA cluster"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "6-13% of all primary hepatic tumors in childhood"
                  },
                  {
                    "text": "3rd most common liver malignancy in this age group"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually occurring between 6-10 years"
                  },
                  {
                    "text": "Rarely seen in middle-aged and older adult patients"
                  }
                ],
                "Sex": [
                  {
                    "text": "Equal distribution"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal distention, pain, palpable mass, weight loss, fever"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Normal or mildly elevated transaminases and alkaline phosphatase"
                  },
                  {
                    "text": "Normal serum α-fetoprotein level"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Resection"
                  },
                  {
                    "text": "Orthotopic liver transplant for refractory disease"
                  },
                  {
                    "text": "Neoadjuvant and adjuvant chemotherapy, radiotherapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-year survival ~ 70% with multimodal therapyMedian survival < 1 year in 1980s",
                    "sub_points": [
                      "Median survival < 1 year in 1980s"
                    ]
                  },
                  {
                    "text": "Local recurrence common"
                  },
                  {
                    "text": "Distant metastasis to lungs, pleura, peritoneum uncommon"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Heterogeneous mass with solid and cystic components"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Predilection for right lobe"
                  },
                  {
                    "text": "Solitary, well circumscribed, unencapsulated; span 9-30 cm"
                  },
                  {
                    "text": "Variegated cut surface with solid and gelatinous cystic areas and foci of necrosis and hemorrhage"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Fibrous pseudocapsule contains entrapped hepatocytes and bile ducts"
                  },
                  {
                    "text": "Intratumoral necrosis and hemorrhage"
                  },
                  {
                    "text": "Myxoid stroma"
                  },
                  {
                    "text": "Foci of extramedullary hematopoiesis"
                  },
                  {
                    "text": "Lesional cellsSpindle, oval, or stellateNuclear pleomorphism and hyperchromasiaPink granular cytoplasm with ill-defined cell bordersPAS-positive, diastase-resistant cytoplasmic eosinophilic globulesFrequent mitotic figuresPopulation of bizarre multinucleated cells",
                    "sub_points": [
                      "Spindle, oval, or stellate",
                      "Nuclear pleomorphism and hyperchromasia",
                      "Pink granular cytoplasm with ill-defined cell borders",
                      "PAS-positive, diastase-resistant cytoplasmic eosinophilic globules",
                      "Frequent mitotic figures",
                      "Population of bizarre multinucleated cells"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Reflects primitive nature of tumor"
                  },
                  {
                    "text": "Diffusely positive for vimentin, desmin, α-1-antitrypsin, and α-1-antichymotrypsin"
                  },
                  {
                    "text": "Focally positive for glypican-3, smooth muscle actin, muscle-specific actin, CD34, S100, calponin, CK-PAN, CD10, CD68, Bcl-2, p53"
                  },
                  {
                    "text": "Dot-like reactivity with pancytokeratin and membrane staining with CD56 has been reported"
                  },
                  {
                    "text": "Ki-67 proliferation index: 30-95%"
                  },
                  {
                    "text": "Eosinophilic globules stain with α-1-antitrypsin, α-1-antichymotrypsin, vimentin, immunoglobulins, and albumin"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Embryonal Rhabdomyosarcoma": [
                  {
                    "text": "Occurs before age 5"
                  },
                  {
                    "text": "Usually arises in extrahepatic biliary tree"
                  },
                  {
                    "text": "Rhabdomyoblasts with cross striations"
                  },
                  {
                    "text": "Subepithelial cambium layer"
                  },
                  {
                    "text": "Expression of skeletal muscle markers (myogenin, myoD1)"
                  }
                ],
                "Sarcomatoid Hepatocellular Carcinoma": [
                  {
                    "text": "Intracellular bile, nests of polygonal cells, hyaline (Mallory) bodies"
                  },
                  {
                    "text": "Expression of HepPar1, arginase"
                  }
                ],
                "Primary and Metastatic High-Grade Mesenchymal Tumors of Adult Liver": [
                  {
                    "text": "Exceedingly rare in this population"
                  },
                  {
                    "text": "Distinguishable by immunohistochemical stains"
                  },
                  {
                    "text": "Leiomysarcoma (smooth muscle actin, desmin, myosin, H-caldesmon)"
                  },
                  {
                    "text": "Liposarcoma (MDM2)"
                  },
                  {
                    "text": "Angiosarcoma (factor VIII, CD31, CD34, ERG)"
                  },
                  {
                    "text": "Melanoma (S100, melan-A, HMB45, Sox10)"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatectomy Specimen Handling": {
            "name": "Hepatectomy Specimen Handling",
            "url": "https://app.pathprimer.com/document/65f79567-015a-4f72-a9c9-9b78be9a636c/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "TERMINOLOGY": {
                "Partial Hepatectomy": [
                  {
                    "text": "Ranges from removal of small wedge to removal of segment, lobe, or more"
                  },
                  {
                    "text": "Typically consists of lesion + variably sized rim of nonneoplastic liver parenchyma"
                  }
                ],
                "Liver Explant": [
                  {
                    "text": "Result of liver transplantationTumorsGoals of evaluation are to assess margins, evaluate tumor's pathologic features, and determine pathologic stageMedical liver diseaseGoal of evaluation is to determine or confirm cause of liver disease &/or liver failure",
                    "sub_points": [
                      "TumorsGoals of evaluation are to assess margins, evaluate tumor's pathologic features, and determine pathologic stage",
                      "Goals of evaluation are to assess margins, evaluate tumor's pathologic features, and determine pathologic stage",
                      "Medical liver diseaseGoal of evaluation is to determine or confirm cause of liver disease &/or liver failure",
                      "Goal of evaluation is to determine or confirm cause of liver disease &/or liver failure"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "Specimen Handling": [
                  {
                    "text": "Partial hepatectomyDetermine which procedure was performedInclude exactly which structures/organs are presentOrient specimenMay require surgeon's assistanceIdentify surgical margin (exposed, cauterized, cut surface of hepatic parenchyma) and ink itSpecimen dimensionsWeightMeasurementsExamine external surfaceBulges and areas of serosal retraction may indicate tumorsResection for trauma may have capsular lacerations, similar to spleenMake initial slice through center of tumor, perpendicular to resection marginContinue to serially section specimen perpendicular to margin, parallel to initial slice; make sections as thin as possible (< 1 cm)Identify closest approach of tumor(s) to margin, measure distance of tumor to margin, and take section(s) of closest approach of tumor to marginExamine all cut surfaces for additional lesionsDocument all lesionsLocationSizeCircumscriptionIf it is nodule within cirrhotic liver, determine if it appears larger and more expansile than other nodules (have growth advantage compared to other regenerative nodules)ColorDetermine if it is different color from surrounding parenchymaConsistencyDetermine if it bulges from cut surfaceNote necrosis, scarring, or hemorrhageIf patient has received preoperative ablative therapy, describe areas of necrosis vs. grossly viable tumor and estimate percentage of necrosisSections of tumor(s) should demonstrate relationship of tumor to surrounding liver and marginInterface between nonneoplastic liver and tumor is important and often less necroticPrimary tumors should be sampled more extensively than known metastasesSearch for vascular invasion (usually at interface between primary tumor and nonneoplastic liver)Document and sample if present grosslyDocument tumor thrombiExamine and describe nonneoplastic hepatic parenchyma and take sectionsNote especially if there is background of cirrhosisTake sections of nonneoplastic liver away from tumor mass (at minimum of 1 cm away from mass)Examine lymph nodes if present",
                    "sub_points": [
                      "Determine which procedure was performedInclude exactly which structures/organs are present",
                      "Include exactly which structures/organs are present",
                      "Orient specimenMay require surgeon's assistance",
                      "May require surgeon's assistance",
                      "Identify surgical margin (exposed, cauterized, cut surface of hepatic parenchyma) and ink it",
                      "Specimen dimensionsWeightMeasurements",
                      "Weight",
                      "Measurements",
                      "Examine external surfaceBulges and areas of serosal retraction may indicate tumorsResection for trauma may have capsular lacerations, similar to spleen",
                      "Bulges and areas of serosal retraction may indicate tumors",
                      "Resection for trauma may have capsular lacerations, similar to spleen",
                      "Make initial slice through center of tumor, perpendicular to resection margin",
                      "Continue to serially section specimen perpendicular to margin, parallel to initial slice; make sections as thin as possible (< 1 cm)Identify closest approach of tumor(s) to margin, measure distance of tumor to margin, and take section(s) of closest approach of tumor to marginExamine all cut surfaces for additional lesions",
                      "Identify closest approach of tumor(s) to margin, measure distance of tumor to margin, and take section(s) of closest approach of tumor to margin",
                      "Examine all cut surfaces for additional lesions",
                      "Document all lesionsLocationSizeCircumscriptionIf it is nodule within cirrhotic liver, determine if it appears larger and more expansile than other nodules (have growth advantage compared to other regenerative nodules)ColorDetermine if it is different color from surrounding parenchymaConsistencyDetermine if it bulges from cut surfaceNote necrosis, scarring, or hemorrhageIf patient has received preoperative ablative therapy, describe areas of necrosis vs. grossly viable tumor and estimate percentage of necrosisSections of tumor(s) should demonstrate relationship of tumor to surrounding liver and marginInterface between nonneoplastic liver and tumor is important and often less necroticPrimary tumors should be sampled more extensively than known metastases",
                      "Location",
                      "Size",
                      "CircumscriptionIf it is nodule within cirrhotic liver, determine if it appears larger and more expansile than other nodules (have growth advantage compared to other regenerative nodules)",
                      "If it is nodule within cirrhotic liver, determine if it appears larger and more expansile than other nodules (have growth advantage compared to other regenerative nodules)",
                      "ColorDetermine if it is different color from surrounding parenchyma",
                      "Determine if it is different color from surrounding parenchyma",
                      "ConsistencyDetermine if it bulges from cut surface",
                      "Determine if it bulges from cut surface",
                      "Note necrosis, scarring, or hemorrhageIf patient has received preoperative ablative therapy, describe areas of necrosis vs. grossly viable tumor and estimate percentage of necrosis",
                      "If patient has received preoperative ablative therapy, describe areas of necrosis vs. grossly viable tumor and estimate percentage of necrosis",
                      "Sections of tumor(s) should demonstrate relationship of tumor to surrounding liver and margin",
                      "Interface between nonneoplastic liver and tumor is important and often less necrotic",
                      "Primary tumors should be sampled more extensively than known metastases",
                      "Search for vascular invasion (usually at interface between primary tumor and nonneoplastic liver)Document and sample if present grosslyDocument tumor thrombi",
                      "Document and sample if present grossly",
                      "Document tumor thrombi",
                      "Examine and describe nonneoplastic hepatic parenchyma and take sectionsNote especially if there is background of cirrhosisTake sections of nonneoplastic liver away from tumor mass (at minimum of 1 cm away from mass)",
                      "Note especially if there is background of cirrhosis",
                      "Take sections of nonneoplastic liver away from tumor mass (at minimum of 1 cm away from mass)",
                      "Examine lymph nodes if present"
                    ]
                  },
                  {
                    "text": "Liver explantDetermine which procedure was performedNote exactly which structures/organs are presentOrient liverIdentify right and left lobes (best viewed from above)Caudate lobe is between portal vein and inferior vena cava; best viewed from belowQuadrate lobe is between gallbladder fossa and ligamentum teres, separated from caudate lobe by inferior vena cava; best viewed from belowPorta hepatis contains bile duct, hepatic artery, portal vein, nerves, lymphaticsSpecimen dimensionsWeightMeasurementsMeasure gallbladder, too, if presentExamine external surfaceDocument any abnormalities/lesionsIdentify porta hepatis 1stDocument if tumor involves structures at portal hepatis and if tumor is at margin of these structuresSpecifically document if tumor is at margin of any of these structuresLook for thrombi in vesselsSubmit complete cross section of all structuresPortal vein, bile duct, hepatic arteryIdentify hepatic veins and submit sectionIn cases of biliary disease, extrahepatic bile duct may be hard to findCan insert probe into intrahepatic duct near hilum and work backwardLook for hilar lymph nodesSubmit section of soft tissue and liver perpendicular to hilumAllows evaluation of larger bile ducts and peribiliary glandsEvaluate gallbladderDescribe and section as per routine cholecystectomySection liver perpendicular to its long axis with long, sharp knifeRecord color and consistency of liver parenchymaDescribe any focal lesions, including lesional size and locationTransplant teams will often want to compare lesions seen preoperatively by imaging with what is found at pathologic evaluationUnited Network for Organ Sharing (UNOS) requires sampling of 5 largest tumor nodules if hepatocellular carcinoma (HCC)Tumor within vascular structure should be categorized as lymphatic/vascular invasion and not satellitosisSubmit sectionsRight lobe-3Left lobe-3Caudate lobe-1Quadrate lobe-1Any focal lesionsAny other areas with distinct appearanceFor primary sclerosing cholangitis cases, take sections of entire hilar soft tissue to look for cholangiocarcinoma",
                    "sub_points": [
                      "Determine which procedure was performedNote exactly which structures/organs are present",
                      "Note exactly which structures/organs are present",
                      "Orient liverIdentify right and left lobes (best viewed from above)Caudate lobe is between portal vein and inferior vena cava; best viewed from belowQuadrate lobe is between gallbladder fossa and ligamentum teres, separated from caudate lobe by inferior vena cava; best viewed from belowPorta hepatis contains bile duct, hepatic artery, portal vein, nerves, lymphatics",
                      "Identify right and left lobes (best viewed from above)",
                      "Caudate lobe is between portal vein and inferior vena cava; best viewed from below",
                      "Quadrate lobe is between gallbladder fossa and ligamentum teres, separated from caudate lobe by inferior vena cava; best viewed from below",
                      "Porta hepatis contains bile duct, hepatic artery, portal vein, nerves, lymphatics",
                      "Specimen dimensionsWeightMeasurementsMeasure gallbladder, too, if present",
                      "Weight",
                      "MeasurementsMeasure gallbladder, too, if present",
                      "Measure gallbladder, too, if present",
                      "Examine external surfaceDocument any abnormalities/lesions",
                      "Document any abnormalities/lesions",
                      "Identify porta hepatis 1stDocument if tumor involves structures at portal hepatis and if tumor is at margin of these structuresSpecifically document if tumor is at margin of any of these structuresLook for thrombi in vesselsSubmit complete cross section of all structuresPortal vein, bile duct, hepatic arteryIdentify hepatic veins and submit sectionIn cases of biliary disease, extrahepatic bile duct may be hard to findCan insert probe into intrahepatic duct near hilum and work backwardLook for hilar lymph nodes",
                      "Document if tumor involves structures at portal hepatis and if tumor is at margin of these structuresSpecifically document if tumor is at margin of any of these structures",
                      "Specifically document if tumor is at margin of any of these structures",
                      "Look for thrombi in vessels",
                      "Submit complete cross section of all structuresPortal vein, bile duct, hepatic artery",
                      "Portal vein, bile duct, hepatic artery",
                      "Identify hepatic veins and submit section",
                      "In cases of biliary disease, extrahepatic bile duct may be hard to findCan insert probe into intrahepatic duct near hilum and work backward",
                      "Can insert probe into intrahepatic duct near hilum and work backward",
                      "Look for hilar lymph nodes",
                      "Submit section of soft tissue and liver perpendicular to hilumAllows evaluation of larger bile ducts and peribiliary glands",
                      "Allows evaluation of larger bile ducts and peribiliary glands",
                      "Evaluate gallbladderDescribe and section as per routine cholecystectomy",
                      "Describe and section as per routine cholecystectomy",
                      "Section liver perpendicular to its long axis with long, sharp knifeRecord color and consistency of liver parenchymaDescribe any focal lesions, including lesional size and locationTransplant teams will often want to compare lesions seen preoperatively by imaging with what is found at pathologic evaluationUnited Network for Organ Sharing (UNOS) requires sampling of 5 largest tumor nodules if hepatocellular carcinoma (HCC)Tumor within vascular structure should be categorized as lymphatic/vascular invasion and not satellitosisSubmit sectionsRight lobe-3Left lobe-3Caudate lobe-1Quadrate lobe-1Any focal lesionsAny other areas with distinct appearanceFor primary sclerosing cholangitis cases, take sections of entire hilar soft tissue to look for cholangiocarcinoma",
                      "Record color and consistency of liver parenchyma",
                      "Describe any focal lesions, including lesional size and locationTransplant teams will often want to compare lesions seen preoperatively by imaging with what is found at pathologic evaluationUnited Network for Organ Sharing (UNOS) requires sampling of 5 largest tumor nodules if hepatocellular carcinoma (HCC)Tumor within vascular structure should be categorized as lymphatic/vascular invasion and not satellitosis",
                      "Transplant teams will often want to compare lesions seen preoperatively by imaging with what is found at pathologic evaluation",
                      "United Network for Organ Sharing (UNOS) requires sampling of 5 largest tumor nodules if hepatocellular carcinoma (HCC)",
                      "Tumor within vascular structure should be categorized as lymphatic/vascular invasion and not satellitosis",
                      "Submit sectionsRight lobe-3Left lobe-3Caudate lobe-1Quadrate lobe-1Any focal lesionsAny other areas with distinct appearance",
                      "Right lobe-3",
                      "Left lobe-3",
                      "Caudate lobe-1",
                      "Quadrate lobe-1",
                      "Any focal lesions",
                      "Any other areas with distinct appearance",
                      "For primary sclerosing cholangitis cases, take sections of entire hilar soft tissue to look for cholangiocarcinoma"
                    ]
                  }
                ],
                "Anatomic Features": [
                  {
                    "text": "Liver has dual blood supplyPortal veinCarries blood away from intestines and pancreasEnters liver at porta hepatisHepatic arterySupplies oxygen-rich blood from celiac axisEnters liver at porta hepatis",
                    "sub_points": [
                      "Portal veinCarries blood away from intestines and pancreasEnters liver at porta hepatis",
                      "Carries blood away from intestines and pancreas",
                      "Enters liver at porta hepatis",
                      "Hepatic arterySupplies oxygen-rich blood from celiac axisEnters liver at porta hepatis",
                      "Supplies oxygen-rich blood from celiac axis",
                      "Enters liver at porta hepatis"
                    ]
                  },
                  {
                    "text": "Hepatic veinsRight, middle, and left hepatic veins drain liver and enter vena cava",
                    "sub_points": [
                      "Right, middle, and left hepatic veins drain liver and enter vena cava"
                    ]
                  },
                  {
                    "text": "Bile ductsFollow courses of hepatic artery and portal vein through liverNourished by hepatic arteries via peribiliary plexusBile is formed in hepatocytes and secreted into canaliculi and, eventually, into bile ducts",
                    "sub_points": [
                      "Follow courses of hepatic artery and portal vein through liver",
                      "Nourished by hepatic arteries via peribiliary plexus",
                      "Bile is formed in hepatocytes and secreted into canaliculi and, eventually, into bile ducts"
                    ]
                  },
                  {
                    "text": "LymphaticsCapsule and stroma of liver are rich in lymphaticsHepatic lymphatics exit at porta hepatisDrain primarily to hepatic nodes along hepatic artery and celiac nodes",
                    "sub_points": [
                      "Capsule and stroma of liver are rich in lymphatics",
                      "Hepatic lymphatics exit at porta hepatis",
                      "Drain primarily to hepatic nodes along hepatic artery and celiac nodes"
                    ]
                  },
                  {
                    "text": "Anatomic divisionsRight lobe lateral to falciform ligamentLeft lobe medial to falciform ligamentCaudate and quadrate lobes8 functional segments are served by their own vascular pedicles and branches of biliary treeMore important anatomy in terms of surgical approaches",
                    "sub_points": [
                      "Right lobe lateral to falciform ligament",
                      "Left lobe medial to falciform ligament",
                      "Caudate and quadrate lobes",
                      "8 functional segments are served by their own vascular pedicles and branches of biliary treeMore important anatomy in terms of surgical approaches",
                      "More important anatomy in terms of surgical approaches"
                    ]
                  },
                  {
                    "text": "Superior, anterior, and lateral surfaces are smooth and covered by peritoneumExcept for \"bare area\" below diaphragm",
                    "sub_points": [
                      "Except for \"bare area\" below diaphragm"
                    ]
                  },
                  {
                    "text": "Falciform and round ligaments connect liver to abdominal wall"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hepatocellular Carcinoma Cancer Protocol": {
            "name": "Hepatocellular Carcinoma Cancer Protocol",
            "url": "https://app.pathprimer.com/document/05acb220-0344-4097-939a-c64c5844ba74/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "General Predictors of Outcome": {
                "Resectability for Cure": [
                  {
                    "text": "Multiple tumors with any tumor > 5 cm associated with decreased survival"
                  },
                  {
                    "text": "Positive surgical margin associated with decreased survival"
                  }
                ],
                "Extent of Vascular Invasion": [
                  {
                    "text": "Major vessel invasion associated with decreased survival"
                  }
                ],
                "Adverse Clinical Indicators": [
                  {
                    "text": "Elevated serum AFP"
                  },
                  {
                    "text": "Cirrhosis with Child-Pugh class B or C disease"
                  }
                ]
              },
              "Primary Tumor Classification": {
                "Vascular Invasion": [
                  {
                    "text": "For pathologic staging, vascular invasion includes gross and microscopic involvement"
                  },
                  {
                    "text": "Major vascular invasion is defined as invasion of branches of main portal vein or invasion of 1 or more of the 3 branches of hepatic vein"
                  },
                  {
                    "text": "For clinical staging, vascular invasion may be assessed pathologically &/or radiographically"
                  },
                  {
                    "text": "If tumor is solitary and lacks vascular invasion, size does not affect prognosis (T1 disease)"
                  }
                ],
                "Number/Size of Tumor Nodules": [
                  {
                    "text": "Single vs. multiple"
                  },
                  {
                    "text": "Size of largest tumor nodule (< 5 cm vs. > 5 cm)"
                  },
                  {
                    "text": "\"Multiple tumors\" includes tumor satellitosis, multifocal tumor nodules, and intrahepatic metastases"
                  },
                  {
                    "text": "Invasion of adjacent structures other than gallbladder is considered T4 disease"
                  },
                  {
                    "text": "Perforation of visceral peritoneum is considered T4 disease"
                  }
                ]
              },
              "Other Histologic Variables": {
                "Grade": [
                  {
                    "text": "Edmondson and Steiner grading scheme recommendedBased on nuclear pleomorphismWell differentiatedModerately differentiatedPoorly differentiatedUndifferentiated",
                    "sub_points": [
                      "Based on nuclear pleomorphismWell differentiatedModerately differentiatedPoorly differentiatedUndifferentiated",
                      "Well differentiated",
                      "Moderately differentiated",
                      "Poorly differentiated",
                      "Undifferentiated"
                    ]
                  }
                ],
                "Status of Adjacent Liver": [
                  {
                    "text": "Presence of cirrhosis"
                  },
                  {
                    "text": "Presence of chronic liver disease"
                  }
                ]
              },
              "Regional Lymph Node Involvement": {
                "Regional Nodes": [
                  {
                    "text": "Hilar, hepatoduodenal ligament, caval, inferior phrenic comprise the regional nodesRegional node involvement is rare (approximately 5%) except in fibrolamellar HCC",
                    "sub_points": [
                      "Regional node involvement is rare (approximately 5%) except in fibrolamellar HCC"
                    ]
                  },
                  {
                    "text": "Any nodal involvement considered N1, but stage IV disease (carry same prognosis as distant metastases)"
                  }
                ]
              },
              "Metastases": {
                "Route of Dissemination": [
                  {
                    "text": "Main route of dissemination is vascular (via intrahepatic portal and hepatic veins)"
                  }
                ],
                "Common Sites": [
                  {
                    "text": "Most common sites of distant metastasis are lung, bones"
                  }
                ],
                "Intrahepatic": [
                  {
                    "text": "Intrahepatic venous dissemination considered same as satellitosis or multifocal tumors"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intrahepatic Bile Duct Cancer Protocol": {
            "name": "Intrahepatic Bile Duct Cancer Protocol",
            "url": "https://app.pathprimer.com/document/a51db094-bfdd-43fc-8cf6-d7f72516df5c/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "Intrahepatic Cholangiocarcinoma": {
                "General": [
                  {
                    "text": "15-20% of primary hepatic malignancies"
                  },
                  {
                    "text": "20% of bile duct cholangiocarcinomas are intrahepatic"
                  },
                  {
                    "text": "Currently staged differently than hepatocellular carcinomaDifferences inPrognosisClinical behaviorEpidemiologyTreatmentSize not prognostic factor for IHBDC",
                    "sub_points": [
                      "Differences inPrognosisClinical behaviorEpidemiologyTreatment",
                      "Prognosis",
                      "Clinical behavior",
                      "Epidemiology",
                      "Treatment",
                      "Size not prognostic factor for IHBDC"
                    ]
                  }
                ]
              },
              "Primary Tumor": {
                "Growth Patterns and Staging": [
                  {
                    "text": "Mass-forming lesion (60%)"
                  },
                  {
                    "text": "Periductal infiltrating pattern (20%)Defined as diffuse longitudinal growth pattern along intrahepatic bile ducts on gross &/or microscopic evaluationT4 by definitionAssociated with poor prognosis, although analysis limited",
                    "sub_points": [
                      "Defined as diffuse longitudinal growth pattern along intrahepatic bile ducts on gross &/or microscopic evaluation",
                      "T4 by definition",
                      "Associated with poor prognosis, although analysis limited"
                    ]
                  },
                  {
                    "text": "Mixed mass-forming and periductal patterns (20%)Also staged as T4 disease",
                    "sub_points": [
                      "Also staged as T4 disease"
                    ]
                  },
                  {
                    "text": "Intraductal papillary cholangiocarcinomas defined as Tis"
                  },
                  {
                    "text": "Solitary vs. multiple tumors helps determines T1 vs. T2 diseaseMultiple tumors includeSatellitosisMultifocal tumor nodulesIntrahepatic metastases",
                    "sub_points": [
                      "Multiple tumors includeSatellitosisMultifocal tumor nodulesIntrahepatic metastases",
                      "Satellitosis",
                      "Multifocal tumor nodules",
                      "Intrahepatic metastases"
                    ]
                  },
                  {
                    "text": "Perforation of visceral peritoneum &/or directly invading adjacent structures is T3 disease"
                  }
                ]
              },
              "Vascular Invasion": {
                "Location": [
                  {
                    "text": "Includes both major vessel and microscopic vessel invasion"
                  }
                ]
              },
              "Lymph Nodes": {
                "Right Liver": [
                  {
                    "text": "Regional nodes include hilar, periduodenal, peripancreatic nodes"
                  }
                ],
                "Left Liver": [
                  {
                    "text": "Regional nodes include hilar and gastrohepatic"
                  }
                ],
                "Other": [
                  {
                    "text": "Inferior phrenic nodes considered regional"
                  },
                  {
                    "text": "Spread to celiac &/or periaortic and caval nodes is considered distant metastatic disease (M1)"
                  }
                ]
              },
              "Metastases": {
                "Intrahepatic": [
                  {
                    "text": "Intrahepatic metastases classified as multiple tumors"
                  }
                ],
                "Distant": [
                  {
                    "text": "Distant metastases usually to peritoneum, lungs, pleura"
                  }
                ]
              },
              "Prognostic Features": {
                "Adverse Indicators": [
                  {
                    "text": "Elevated CA19-9"
                  },
                  {
                    "text": "Underlying liver diseaseIncluding primary sclerosing cholangitis",
                    "sub_points": [
                      "Including primary sclerosing cholangitis"
                    ]
                  },
                  {
                    "text": "Lymph node involvement"
                  },
                  {
                    "text": "Incomplete resection"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lymphoma": {
            "name": "Lymphoma",
            "url": "https://app.pathprimer.com/document/179a6234-b57b-4aa5-b7ef-73834a3474d6/lesson/82a63492-4cb6-49c4-b908-f299469d6c78",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Primary hepatic lymphoma: Extranodal lymphoma arising in the liver (a rare entity)Most common primary lymphomas in the liver are B-cell lymphomasDiffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma",
                    "sub_points": [
                      "Most common primary lymphomas in the liver are B-cell lymphomasDiffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma",
                      "Diffuse large B-cell lymphoma (DLBCL) and mucosa-associated lymphoid tissue (MALT) lymphoma"
                    ]
                  },
                  {
                    "text": "Lymphoma in the liver occurs most commonly as secondary site involvementIn low-grade B-cell lymphomas, the liver is often involved secondarily",
                    "sub_points": [
                      "In low-grade B-cell lymphomas, the liver is often involved secondarily"
                    ]
                  },
                  {
                    "text": "T-cell lymphomas of the liver include hepatosplenic T-cell lymphoma and Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Primary liver lymphomaUp to 25% of primary hepatic MALT lymphomas and 66% of primary hepatic DLBCL are associated with hepatitis C infection, with or without mixed cryoglobulinemiaMay arise in the background of hepatitis B virus, HIV, EBV (as in EBV-positive T-cell lymphoproliferative disease of childhood), or primary biliary cirrhosisHepatosplenic T-cell lymphomas have been linked to iatrogenic immune suppression, specifically in children with Crohn disease; tumor cells are most often of γδ T receptor type",
                    "sub_points": [
                      "Up to 25% of primary hepatic MALT lymphomas and 66% of primary hepatic DLBCL are associated with hepatitis C infection, with or without mixed cryoglobulinemia",
                      "May arise in the background of hepatitis B virus, HIV, EBV (as in EBV-positive T-cell lymphoproliferative disease of childhood), or primary biliary cirrhosis",
                      "Hepatosplenic T-cell lymphomas have been linked to iatrogenic immune suppression, specifically in children with Crohn disease; tumor cells are most often of γδ T receptor type"
                    ]
                  },
                  {
                    "text": "Secondary lymphomaIn 16% to 43% of non-Hodgkin lymphoma cases liver infiltration occurs, mainly in low-grade B-cell lymphomas, such as chronic lymphocytic leukemia and follicular lymphomaIn up to 14% of cases the liver is secondarily involved by Hodgkin lymphoma",
                    "sub_points": [
                      "In 16% to 43% of non-Hodgkin lymphoma cases liver infiltration occurs, mainly in low-grade B-cell lymphomas, such as chronic lymphocytic leukemia and follicular lymphoma",
                      "In up to 14% of cases the liver is secondarily involved by Hodgkin lymphoma"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Primary liver lymphomaTwo-thirds of cases affect middle-aged men, though T-cell lymphomas occur in younger populationsAssociation with viruses HBV, HCV, and EBVSymptomsRight upper abdominal/epigastric pain or discomfortAbnormal liver enzyme tests (in some cases)",
                    "sub_points": [
                      "Two-thirds of cases affect middle-aged men, though T-cell lymphomas occur in younger populations",
                      "Association with viruses HBV, HCV, and EBV",
                      "SymptomsRight upper abdominal/epigastric pain or discomfortAbnormal liver enzyme tests (in some cases)",
                      "Right upper abdominal/epigastric pain or discomfort",
                      "Abnormal liver enzyme tests (in some cases)"
                    ]
                  },
                  {
                    "text": "Secondary lymphomaSecondary hepatic involvement of a systemic lymphoma, usually low-grade B-cell lymphomasSymptoms\"B symptoms,” such as fever, night sweats, and weight lossAbdominal discomfort/pain may occur due to infiltration of the liver, resulting in hepatomegalyAbnormal liver enzyme tests may be seen",
                    "sub_points": [
                      "Secondary hepatic involvement of a systemic lymphoma, usually low-grade B-cell lymphomas",
                      "Symptoms\"B symptoms,” such as fever, night sweats, and weight lossAbdominal discomfort/pain may occur due to infiltration of the liver, resulting in hepatomegalyAbnormal liver enzyme tests may be seen",
                      "\"B symptoms,” such as fever, night sweats, and weight loss",
                      "Abdominal discomfort/pain may occur due to infiltration of the liver, resulting in hepatomegaly",
                      "Abnormal liver enzyme tests may be seen"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solitary or multiple masses within the liver"
                  },
                  {
                    "text": "Rarely, diffuse infiltration of the liver is associated with hepatomegaly"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Morphology and phenotype are specific to the entityThe majority of primary lymphomas are DLBCLs composed of monotonous large cells, which often form a mass lesion; low-grade B-cell lymphomas (i.e., MALT type) are characterized by portal tract infiltratesHepatosplenic T-cell lymphoma is characterized by a monomorphic infiltrate of medium-sized cells with round basophilic nuclei in the sinusoidsSecondary involvement by low-grade B-cell lymphoma usually involves the portal triads; systemic T-cell lymphomas predominantly involve the sinuses",
                    "sub_points": [
                      "The majority of primary lymphomas are DLBCLs composed of monotonous large cells, which often form a mass lesion; low-grade B-cell lymphomas (i.e., MALT type) are characterized by portal tract infiltrates",
                      "Hepatosplenic T-cell lymphoma is characterized by a monomorphic infiltrate of medium-sized cells with round basophilic nuclei in the sinusoids",
                      "Secondary involvement by low-grade B-cell lymphoma usually involves the portal triads; systemic T-cell lymphomas predominantly involve the sinuses"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Hepatocellular carcinoma or metastatic carcinoma (on radiology)"
                  },
                  {
                    "text": "Hepatitis C infection"
                  },
                  {
                    "text": "IgG4 associated sclerosing cholangitis"
                  },
                  {
                    "text": "Reactive/infectious processes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Primary hepatic lymphoma: Extranodal lymphoma arising in the liver"
                  }
                ],
                "Molecular": [
                  {
                    "text": "Hepatic MALT lymphoma: Associated withIGHαandMALT1translocation"
                  },
                  {
                    "text": "Hepatosplenic T-cell lymphoma: Associated with isochromosome 7q and trisomy 8"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Middle age (B-cell lymphoma)"
                  },
                  {
                    "text": "Children and young adults (T-cell lymphoma)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Typically affects men (especially B-cell lymphomas and hepatosplenic T-cell lymphoma)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Liver massSolitary or multiple massesMay present with hepatomegaly",
                    "sub_points": [
                      "Solitary or multiple masses",
                      "May present with hepatomegaly"
                    ]
                  },
                  {
                    "text": "SymptomsRight upper quadrant abdominal or epigastric painWeight lossFeverAbnormal liver enzymes",
                    "sub_points": [
                      "Right upper quadrant abdominal or epigastric pain",
                      "Weight loss",
                      "Fever",
                      "Abnormal liver enzymes"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum liver function tests are usually abnormalModerate elevation of transaminases and alkaline phosphatase",
                    "sub_points": [
                      "Moderate elevation of transaminases and alkaline phosphatase"
                    ]
                  },
                  {
                    "text": "Serum lactate dehydrogenase levels may be very high"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Depends on the type and stage of lymphoma"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on the entityDiffuse large B cell lymphoma (DLBCL): AggressiveSecondary liver involvement indicates stage IV diseaseHepatosplenic T-cell lymphomas: Aggressive, with aMean survival of approximately 1 year",
                    "sub_points": [
                      "Diffuse large B cell lymphoma (DLBCL): AggressiveSecondary liver involvement indicates stage IV disease",
                      "Secondary liver involvement indicates stage IV disease",
                      "Hepatosplenic T-cell lymphomas: Aggressive, with aMean survival of approximately 1 year",
                      "Mean survival of approximately 1 year"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Often presents with hepatomegaly, without discrete nodules, but nodes may be seen in small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Morphology and phenotype: Specific to the primary entity"
                  },
                  {
                    "text": "Primary hepatic lymphomaB-cellMajority are DLBCLsComposed of monotonous large cells that often form a mass lesionLow-grade B-cell lymphomas (i.e., MALT type) areCharacterized by portal tract infiltratesT cellHepatosplenic T-cell lymphoma is characterized by a monomorphic infiltrate of medium-sized cells with round basophilic nuclei in the sinusoids",
                    "sub_points": [
                      "B-cellMajority are DLBCLsComposed of monotonous large cells that often form a mass lesionLow-grade B-cell lymphomas (i.e., MALT type) areCharacterized by portal tract infiltrates",
                      "Majority are DLBCLsComposed of monotonous large cells that often form a mass lesion",
                      "Composed of monotonous large cells that often form a mass lesion",
                      "Low-grade B-cell lymphomas (i.e., MALT type) areCharacterized by portal tract infiltrates",
                      "Characterized by portal tract infiltrates",
                      "T cellHepatosplenic T-cell lymphoma is characterized by a monomorphic infiltrate of medium-sized cells with round basophilic nuclei in the sinusoids",
                      "Hepatosplenic T-cell lymphoma is characterized by a monomorphic infiltrate of medium-sized cells with round basophilic nuclei in the sinusoids"
                    ]
                  },
                  {
                    "text": "Secondary lymphomaInvolvement by low-grade B-cell lymphoma usually involves the portal triadsSystemic T-cell lymphomas predominantly involve the sinuses",
                    "sub_points": [
                      "Involvement by low-grade B-cell lymphoma usually involves the portal triads",
                      "Systemic T-cell lymphomas predominantly involve the sinuses"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Hepatocellular carcinoma or metastatic carcinoma (on radiology)": [],
                "Hepatitis C infection": [],
                "IgG4 associated sclerosing cholangitis": [],
                "Reactive/infectious processes": []
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Secondary liver involvement by lymphoma is more common than primary hepatic lymphoma"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Biliary Tract and Gallbladder: Nonneoplastic Lesions": {
        "name": "Biliary Tract and Gallbladder: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/ed11d970-de34-4425-8f31-580de747cab5",
        "topics": {
          "Primary Biliary Cirrhosis": {
            "name": "Primary Biliary Cirrhosis",
            "url": "https://app.pathprimer.com/document/4dd7d9aa-4465-4370-8186-e510cb6129e8/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Chronic cholestatic disease in which intrahepatic bile ducts are progressively destroyed by nonsuppurative inflammation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Middle-aged to elderly womenMore than 90% of patients are femaleMost common in individuals of North European descent",
                    "sub_points": [
                      "More than 90% of patients are female",
                      "Most common in individuals of North European descent"
                    ]
                  },
                  {
                    "text": "Insidious onset with pruritus, fatigue, jaundice; often other associated autoimmune disorders"
                  },
                  {
                    "text": "Positive antimitochondrial antibodies (AMA)Minority of cases are AMA(-)",
                    "sub_points": [
                      "Minority of cases are AMA(-)"
                    ]
                  },
                  {
                    "text": "Elevation of GGT, alkaline phosphatase out of proportion to transaminases"
                  },
                  {
                    "text": "Ursodeoxycholic acid (UDCA) is treatment of choice"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Florid duct lesion with lymphocytic cholangitis and bile duct injuryGranulomatous inflammation variably present",
                    "sub_points": [
                      "Granulomatous inflammation variably present"
                    ]
                  },
                  {
                    "text": "Bile ductular reaction"
                  },
                  {
                    "text": "Cholate stasisCopper stain highlights accumulated copper in hepatocytes",
                    "sub_points": [
                      "Copper stain highlights accumulated copper in hepatocytes"
                    ]
                  },
                  {
                    "text": "Initially portal-based fibrosus, eventually forms portal-portal bridgesCirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)",
                    "sub_points": [
                      "Cirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)"
                    ]
                  },
                  {
                    "text": "4 histologic stages ranging from portal involvement to cirrhosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Primary biliary cirrhosis (PBC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Chronic cholestatic disease in which intrahepatic bile ducts are progressively destroyed by nonsuppurative inflammation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Probable autoimmune etiology"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common in individuals of North European descentTypically 40-60 years of ageMore than 90% of patients are female",
                    "sub_points": [
                      "Typically 40-60 years of age",
                      "More than 90% of patients are female"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Insidious onset with pruritus (most common), fatigue, jaundice, associated autoimmune disorders"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Positive antimitochondrial antibodies (AMA)"
                  },
                  {
                    "text": "Elevation of GGT &/or alkaline phosphatase out of proportion to transaminases, which are typically mildly elevated or normal"
                  },
                  {
                    "text": "Elevated bilirubin, usually late in disease"
                  },
                  {
                    "text": "Elevated IgM"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Ursodeoxycholic acidNot cure but delays progression in some patients",
                    "sub_points": [
                      "Not cure but delays progression in some patients"
                    ]
                  },
                  {
                    "text": "Liver transplant for advanced or decompensated disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Chronic, progressive disease"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Florid duct lesion/destructive cholangitisPortal-based nodular inflammation composed of lymphocytes, plasma cells, eosinophils, macrophagesInterface hepatitis may be present in some cases, resembling chronic hepatitisBile duct injuryDisrupted basement membraneBiliary epithelial disarray with irregularly sized and pseudostratified nuclei and vacuolated, swollen cytoplasmEventual loss of interlobular bile ductsLymphocytic cholangitisGranulomas variably present",
                    "sub_points": [
                      "Portal-based nodular inflammation composed of lymphocytes, plasma cells, eosinophils, macrophagesInterface hepatitis may be present in some cases, resembling chronic hepatitis",
                      "Interface hepatitis may be present in some cases, resembling chronic hepatitis",
                      "Bile duct injuryDisrupted basement membraneBiliary epithelial disarray with irregularly sized and pseudostratified nuclei and vacuolated, swollen cytoplasmEventual loss of interlobular bile ducts",
                      "Disrupted basement membrane",
                      "Biliary epithelial disarray with irregularly sized and pseudostratified nuclei and vacuolated, swollen cytoplasm",
                      "Eventual loss of interlobular bile ducts",
                      "Lymphocytic cholangitisGranulomas variably present",
                      "Granulomas variably present"
                    ]
                  },
                  {
                    "text": "Bile ductular reaction"
                  },
                  {
                    "text": "FibrosisInitially portal, eventually forms portal-portal bridgesCirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)",
                    "sub_points": [
                      "Initially portal, eventually forms portal-portal bridges",
                      "Cirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)"
                    ]
                  },
                  {
                    "text": "Chronic cholestasisSwollen and rarefied hepatocytes adjacent to portal tracts (cholate stasis)Copper stain highlights copper in hepatocytes",
                    "sub_points": [
                      "Swollen and rarefied hepatocytes adjacent to portal tracts (cholate stasis)Copper stain highlights copper in hepatocytes",
                      "Copper stain highlights copper in hepatocytes"
                    ]
                  },
                  {
                    "text": "4 histologic stages ranging from portal involvement to cirrhosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis (PSC)": [
                  {
                    "text": "Predominantly men, associated with chronic idiopathic inflammatory bowel disease"
                  },
                  {
                    "text": "Negative AMA; characteristic cholangiographic findings"
                  }
                ],
                "Large Bile Duct Obstruction": [
                  {
                    "text": "AMA negative"
                  },
                  {
                    "text": "Lack florid duct lesion, progressive duct destruction, cholate stasis"
                  }
                ],
                "Drug-Induced Cholestasis/Duct Injury": [
                  {
                    "text": "Medication history"
                  }
                ],
                "Infection": [
                  {
                    "text": "Special stains necessary to exclude infection when granulomas are present"
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Systemic involvement; elevated angiotensin converting enzyme"
                  }
                ],
                "Chronic Viral Hepatitis": [
                  {
                    "text": "Bile duct damage/lymphocytic cholangitis is common, especially in hepatitis C (Poulsen lesion)"
                  },
                  {
                    "text": "AMA negative; positive viral serology or quantitative PCR"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Lack of florid duct lesion, bile duct damage/lymphocytic cholangitis"
                  },
                  {
                    "text": "More active lobular inflammation ± hepatocyte necrosis"
                  },
                  {
                    "text": "Transaminases typically significantly elevated"
                  }
                ],
                "Autoimmune Hepatitis-PBC Overlap Syndrome": [
                  {
                    "text": "< 10% of PBC patients; laboratory and histologic features of both autoimmune hepatitis and PBC"
                  },
                  {
                    "text": "Combination therapy with ursodeoxycholic acid (UDCA) and immunosuppression may be indicated"
                  }
                ],
                "Autoimmune Cholangitis/AMA-Negative PBC": [
                  {
                    "text": "Negative AMA, otherwise histology resembles PBC"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Florid duct lesion"
                  },
                  {
                    "text": "Loss of interlobular bile ducts"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Primary Biliary Cholangitis": {
            "name": "Primary Biliary Cholangitis",
            "url": "https://app.pathprimer.com/document/b9eb3bbb-1573-4b3e-a2c0-8e0073543e6d/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Chronic cholestatic disease in which intrahepatic bile ducts are progressively destroyed by nonsuppurative inflammation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Middle-aged to elderly female patients> 90% of patients are femaleMost common in individuals of North European descent",
                    "sub_points": [
                      "> 90% of patients are female",
                      "Most common in individuals of North European descent"
                    ]
                  },
                  {
                    "text": "Insidious onset with pruritus, fatigue, jaundiceOften other associated autoimmune disorders",
                    "sub_points": [
                      "Often other associated autoimmune disorders"
                    ]
                  },
                  {
                    "text": "Antimitochondrial antibodies (AMA)(+)Minority of cases are AMA(-)",
                    "sub_points": [
                      "Minority of cases are AMA(-)"
                    ]
                  },
                  {
                    "text": "Sustained elevation of alkaline phosphatase, GGT, > 6 monthsOut of proportion to transaminases",
                    "sub_points": [
                      "Out of proportion to transaminases"
                    ]
                  },
                  {
                    "text": "Ursodeoxycholic acid is 1st-line treatmentNot cure but delays progression in some patients",
                    "sub_points": [
                      "Not cure but delays progression in some patients"
                    ]
                  },
                  {
                    "text": "Obeticholic acidFor patients who cannot tolerate or do not respond to ursodeoxycholic acid",
                    "sub_points": [
                      "For patients who cannot tolerate or do not respond to ursodeoxycholic acid"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Florid duct lesion with lymphocytic cholangitis and bile duct injuryGranulomatous inflammation variably present",
                    "sub_points": [
                      "Granulomatous inflammation variably present"
                    ]
                  },
                  {
                    "text": "Biliary epithelial disarray with irregularly sized and pseudostratified nuclei and vacuolated, swollen cytoplasm"
                  },
                  {
                    "text": "Bile ductular reaction"
                  },
                  {
                    "text": "Cholate stasisCopper stain highlights accumulated copper in hepatocytes",
                    "sub_points": [
                      "Copper stain highlights accumulated copper in hepatocytes"
                    ]
                  },
                  {
                    "text": "Initially portal-based fibrosis, eventually forms portal-portal bridgesCirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)",
                    "sub_points": [
                      "Cirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)"
                    ]
                  },
                  {
                    "text": "4 histologic stages ranging from portal involvement to cirrhosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary Sclerosing Cholangitis"
                  },
                  {
                    "text": "Drug-Induced Cholestasis/Duct Injury"
                  },
                  {
                    "text": "Sarcoidosis"
                  },
                  {
                    "text": "Autoimmune Hepatitis"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Primary biliary cholangitis (PBC) diagnosis: 2 of followingAlkaline phosphatase elevationAMA or other PBC-specific autoantibody at titer > 1:40Florid duct lesion on biopsy",
                    "sub_points": [
                      "Alkaline phosphatase elevation",
                      "AMA or other PBC-specific autoantibody at titer > 1:40",
                      "Florid duct lesion on biopsy"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Primary biliary cholangitis (PBC)"
                  },
                  {
                    "text": "Antimitochondrial antibodies (AMA)"
                  },
                  {
                    "text": "Antinuclear antibodies (ANA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Chronic, immune-mediated, cholestatic disease in which intrahepatic bile ducts are progressively destroyed by granulomatous and lymphocytic inflammation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Probable autoimmune etiology, with genetic and environmental influencesInfectious, chemical triggers causing antibodies to antigen molecularly similar to mitochondrial component",
                    "sub_points": [
                      "Infectious, chemical triggers causing antibodies to antigen molecularly similar to mitochondrial component"
                    ]
                  },
                  {
                    "text": "Antimitochondrial antibody (AMA) is directed against E2 subunit of pyruvate dehydrogenase complex in inner mitochondrial membrane"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common in individuals of North European descentTypically 40-60 years of age> 90% of patients are femaleGlobally, 1 in 1000 women have primary biliary cholangitis (PBC)",
                    "sub_points": [
                      "Typically 40-60 years of age",
                      "> 90% of patients are female",
                      "Globally, 1 in 1000 women have primary biliary cholangitis (PBC)"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Insidious onset with pruritus (most common)"
                  },
                  {
                    "text": "Fatigue, jaundice, associated autoimmune disorders"
                  },
                  {
                    "text": "Some asymptomatic patients now caught early in disease because of laboratory abnormalities on routine studies"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "AMA(+) in > 90% of patientsSerum AMA(+) in cholestatic patient is highly sensitive and specific for PBCAMA positivity alone does not equate with PBCAMA is positive in 1 in 1,000 people in general populationAMA positivity only useful to diagnose PBC when in combination with abnormal liver chemistries1 of 6 patients with AMA(+) develop PBC in 5 years",
                    "sub_points": [
                      "Serum AMA(+) in cholestatic patient is highly sensitive and specific for PBCAMA positivity alone does not equate with PBCAMA is positive in 1 in 1,000 people in general populationAMA positivity only useful to diagnose PBC when in combination with abnormal liver chemistries1 of 6 patients with AMA(+) develop PBC in 5 years",
                      "AMA positivity alone does not equate with PBC",
                      "AMA is positive in 1 in 1,000 people in general population",
                      "AMA positivity only useful to diagnose PBC when in combination with abnormal liver chemistries",
                      "1 of 6 patients with AMA(+) develop PBC in 5 years"
                    ]
                  },
                  {
                    "text": "PBC-specific antinuclear antibodies (ANA ) (anti-sp100 or anti-gp210) by Western blotting or ELISAEspecially in AMA(-) PBC",
                    "sub_points": [
                      "Especially in AMA(-) PBC"
                    ]
                  },
                  {
                    "text": "Elevation of GGT &/or alkaline phosphatase out of proportion to transaminases, which are typically mildly elevated or normalAnnual screening with alkaline phosphatase levels advocated for patients who have positive AMA without elevated alkaline phosphatase",
                    "sub_points": [
                      "Annual screening with alkaline phosphatase levels advocated for patients who have positive AMA without elevated alkaline phosphatase"
                    ]
                  },
                  {
                    "text": "Elevated bilirubin, usually late in disease"
                  },
                  {
                    "text": "Elevated IgM"
                  },
                  {
                    "text": "Diagnosis of PBC can be made without biopsyIn adult patient with cholestasis and no other systemic disease, if they are AMA(+) and have elevated alkaline phosphataseIn AMA(-) patient if cholestatic patient with ANA(+) (especially sp100, gp210)",
                    "sub_points": [
                      "In adult patient with cholestasis and no other systemic disease, if they are AMA(+) and have elevated alkaline phosphatase",
                      "In AMA(-) patient if cholestatic patient with ANA(+) (especially sp100, gp210)"
                    ]
                  },
                  {
                    "text": "Biopsy indicationsFor diagnosisWhen PBC-specific antibodies absent [AMA(-)]When other competing or coexisting disease suspected [such as autoimmune hepatitis (AIH) or nonalcoholic steatohepatitis (NASH)]When treatment-refractoryTo identify presence of interface hepaitits, ductopenia, fibrosisPost transplantTo diagnose recurrent PBC",
                    "sub_points": [
                      "For diagnosisWhen PBC-specific antibodies absent [AMA(-)]When other competing or coexisting disease suspected [such as autoimmune hepatitis (AIH) or nonalcoholic steatohepatitis (NASH)]",
                      "When PBC-specific antibodies absent [AMA(-)]",
                      "When other competing or coexisting disease suspected [such as autoimmune hepatitis (AIH) or nonalcoholic steatohepatitis (NASH)]",
                      "When treatment-refractoryTo identify presence of interface hepaitits, ductopenia, fibrosis",
                      "To identify presence of interface hepaitits, ductopenia, fibrosis",
                      "Post transplantTo diagnose recurrent PBC",
                      "To diagnose recurrent PBC"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Manifestations of cholestasis, followed by ductopenia and progressive biliary fibrosis"
                  },
                  {
                    "text": "Without treatment: average survival ~10 years after presentation25% liver failure during this timeMedian time to develop advanced liver fibrosis: ~2 years",
                    "sub_points": [
                      "25% liver failure during this time",
                      "Median time to develop advanced liver fibrosis: ~2 years"
                    ]
                  },
                  {
                    "text": "With treatment, average 10-year survival is 80%"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Ursodeoxycholic (UDCA) acidNot cure but delays progression in some patients40% will have persistently elevated alkaline phosphatase levels",
                    "sub_points": [
                      "Not cure but delays progression in some patients",
                      "40% will have persistently elevated alkaline phosphatase levels"
                    ]
                  },
                  {
                    "text": "Obeticholic acid, synthetic bile acidImpacts FXR, which affects inflammation, fibrosis, and directly regulates bile acidsFDA-approved for patients who do not respond to 1 year of therapy with UDCA aloneTo be used in combination with UDCA",
                    "sub_points": [
                      "Impacts FXR, which affects inflammation, fibrosis, and directly regulates bile acids",
                      "FDA-approved for patients who do not respond to 1 year of therapy with UDCA alone",
                      "To be used in combination with UDCA"
                    ]
                  },
                  {
                    "text": "Liver transplant for advanced or decompensated disease"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Male, age younger than 45 at onset, advanced disease at baseline associated with poor outcome"
                  },
                  {
                    "text": "Chronic, progressive disease resulting in biliary fibrosis and cirrhosisPortal hypertension, varicesHepatocellular carcinoma estimated at 0.36 per 100 person years",
                    "sub_points": [
                      "Portal hypertension, varices",
                      "Hepatocellular carcinoma estimated at 0.36 per 100 person years"
                    ]
                  },
                  {
                    "text": "Osteoporosis common, due to cholestasis-related decreased bile acid secretion, which results in lipid malabsorption"
                  },
                  {
                    "text": "Liver transplantation20% recurrence of PBCAMA(+) persists after transplantation",
                    "sub_points": [
                      "20% recurrence of PBC",
                      "AMA(+) persists after transplantation"
                    ]
                  }
                ],
                "Diagnosis: 2 of Following": [
                  {
                    "text": "Alkaline phosphatase elevation"
                  },
                  {
                    "text": "AMA or other PBC-specific autoantibody at titer > 1:40"
                  },
                  {
                    "text": "Florid duct lesion on biopsy"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Early PBC: No imaging abnormalitiesNo sign of mechanical bile duct obstruction, mass, or gallbladder abnormalityThis is useful, as it helps indicate that cholestasis is due to intrahepatic cause",
                    "sub_points": [
                      "No sign of mechanical bile duct obstruction, mass, or gallbladder abnormalityThis is useful, as it helps indicate that cholestasis is due to intrahepatic cause",
                      "This is useful, as it helps indicate that cholestasis is due to intrahepatic cause"
                    ]
                  },
                  {
                    "text": "Late PBCPortal hypertension, splenomegaly, ascitesHilar lymphadenopathy",
                    "sub_points": [
                      "Portal hypertension, splenomegaly, ascites",
                      "Hilar lymphadenopathy"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Florid duct lesion/destructive cholangitis: Dense portal inflammation ± nonsuppurative granulomas, surrounding and injuring bile ductsBile duct injuryDisrupted basement membraneBiliary epithelial disarrayIrregularly sized and pseudostratified or pyknotic nucleiAttenuated, vacuolated, cytoplasmEventual loss of interlobular bile ductsLymphocytic cholangitisGranulomas variably present",
                    "sub_points": [
                      "Bile duct injuryDisrupted basement membraneBiliary epithelial disarrayIrregularly sized and pseudostratified or pyknotic nucleiAttenuated, vacuolated, cytoplasmEventual loss of interlobular bile ducts",
                      "Disrupted basement membrane",
                      "Biliary epithelial disarray",
                      "Irregularly sized and pseudostratified or pyknotic nuclei",
                      "Attenuated, vacuolated, cytoplasm",
                      "Eventual loss of interlobular bile ducts",
                      "Lymphocytic cholangitisGranulomas variably present",
                      "Granulomas variably present"
                    ]
                  },
                  {
                    "text": "Bile ductular reaction"
                  },
                  {
                    "text": "Portal-based, dense, inflammation composed of lymphocytes, plasma cells, eosinophils, macrophagesInterface activity may be present in some cases, resembling chronic hepatitisUsually does not affect every portal tract",
                    "sub_points": [
                      "Interface activity may be present in some cases, resembling chronic hepatitis",
                      "Usually does not affect every portal tract"
                    ]
                  },
                  {
                    "text": "Mild lobular inflammation can be seen, directed at canals of Hering (not directly visible on light microscopy)"
                  },
                  {
                    "text": "FibrosisInitially portal, eventually forms portal-portal bridgesCirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)",
                    "sub_points": [
                      "Initially portal, eventually forms portal-portal bridges",
                      "Cirrhosis is biliary type with irregular nodules (so-called jigsaw puzzle pattern)"
                    ]
                  },
                  {
                    "text": "Chronic cholestasisSwollen and rarefied hepatocytes adjacent to portal tracts (cholate stasis)Copper stain highlights copper in hepatocytes",
                    "sub_points": [
                      "Swollen and rarefied hepatocytes adjacent to portal tracts (cholate stasis)Copper stain highlights copper in hepatocytes",
                      "Copper stain highlights copper in hepatocytes"
                    ]
                  },
                  {
                    "text": "4 histologic stages ranging from portal involvement to cirrhosis"
                  },
                  {
                    "text": "Multiple staging schemes: Scheuer, Ludwig, Nakanuma (latter is not widely used due to its complexity)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Predominantly men, associated with chronic idiopathic inflammatory bowel disease"
                  },
                  {
                    "text": "AMA(-); characteristic cholangiographic findings"
                  }
                ],
                "Large Bile Duct Obstruction": [
                  {
                    "text": "AMA(-)"
                  },
                  {
                    "text": "Lacks florid duct lesion"
                  }
                ],
                "Drug-Induced Cholestasis/Duct Injury": [
                  {
                    "text": "Medication history, including recreational drugsKratom injury reported to have similar features to PBC including granulomatous cholangitisProminent eosinophils, less portal inflammation, male sex, AMA(-), history of Kratom use can all help distinguish from PBCAnabolic steroids/estrogen useAssociated with \"bland\" lobular cholestasis without portal biliary findingsACE inhibitorsCan have bile ductular reaction and cholestasisTotal parenteral nutritionCan have cholestatic liver biopsy findings; history of use can help diagnose",
                    "sub_points": [
                      "Kratom injury reported to have similar features to PBC including granulomatous cholangitisProminent eosinophils, less portal inflammation, male sex, AMA(-), history of Kratom use can all help distinguish from PBC",
                      "Prominent eosinophils, less portal inflammation, male sex, AMA(-), history of Kratom use can all help distinguish from PBC",
                      "Anabolic steroids/estrogen useAssociated with \"bland\" lobular cholestasis without portal biliary findings",
                      "Associated with \"bland\" lobular cholestasis without portal biliary findings",
                      "ACE inhibitorsCan have bile ductular reaction and cholestasis",
                      "Can have bile ductular reaction and cholestasis",
                      "Total parenteral nutritionCan have cholestatic liver biopsy findings; history of use can help diagnose",
                      "Can have cholestatic liver biopsy findings; history of use can help diagnose"
                    ]
                  }
                ],
                "Infection": [
                  {
                    "text": "Special stains necessary to exclude infection when granulomas are present"
                  },
                  {
                    "text": "Sepsis can also cause cholestatic liver biopsy findingsDuctular cholestasis (inspissated bile within bile ductules)",
                    "sub_points": [
                      "Ductular cholestasis (inspissated bile within bile ductules)"
                    ]
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Systemic involvement; elevated ACE"
                  }
                ],
                "Chronic Viral Hepatitis": [
                  {
                    "text": "Bile duct damage/lymphocytic cholangitis is common, especially in hepatitis C (Poulsen lesion)"
                  },
                  {
                    "text": "AMA(-); viral serology or quantitative PCR(+)"
                  }
                ],
                "Autoimmune Hepatitis": [
                  {
                    "text": "Lack of florid duct lesion, bile duct damage/lymphocytic cholangitis"
                  },
                  {
                    "text": "Intense interface activity involving most of portal tracts"
                  },
                  {
                    "text": "More active lobular inflammation ± hepatocyte necrosis"
                  },
                  {
                    "text": "Transaminases typically significantly elevated"
                  }
                ],
                "Autoimmune Hepatitis-PBC Overlap Syndrome": [
                  {
                    "text": "< 10% of PBC patients"
                  },
                  {
                    "text": "Requires liver biopsy by some guidelines"
                  },
                  {
                    "text": "Worse prognosis than PBC alone"
                  },
                  {
                    "text": "Diagnosis should be made based on overall patient featuresNo well-accepted criteria",
                    "sub_points": [
                      "No well-accepted criteria"
                    ]
                  },
                  {
                    "text": "Laboratory and histologic features of both autoimmune hepatitis and PBCParis criteria proposed: 2 of 3 features of each category belowPBC aspect: 2 of followingAlkaline phosphatase levels > 2x upper limit of normal or GGT > 5x upper limit of normalAMA titer > 1:40Florid duct lesion in biopsyAIH aspect: 2 of followingAlanine aminotransferase level > 5x upper limit of normalIgG serum levels > 2x upper limit of normal or positive smooth muscle autoantibodyModerate or severe interface hepatitis on biopsy",
                    "sub_points": [
                      "Paris criteria proposed: 2 of 3 features of each category belowPBC aspect: 2 of followingAlkaline phosphatase levels > 2x upper limit of normal or GGT > 5x upper limit of normalAMA titer > 1:40Florid duct lesion in biopsyAIH aspect: 2 of followingAlanine aminotransferase level > 5x upper limit of normalIgG serum levels > 2x upper limit of normal or positive smooth muscle autoantibodyModerate or severe interface hepatitis on biopsy",
                      "PBC aspect: 2 of followingAlkaline phosphatase levels > 2x upper limit of normal or GGT > 5x upper limit of normalAMA titer > 1:40Florid duct lesion in biopsy",
                      "Alkaline phosphatase levels > 2x upper limit of normal or GGT > 5x upper limit of normal",
                      "AMA titer > 1:40",
                      "Florid duct lesion in biopsy",
                      "AIH aspect: 2 of followingAlanine aminotransferase level > 5x upper limit of normalIgG serum levels > 2x upper limit of normal or positive smooth muscle autoantibodyModerate or severe interface hepatitis on biopsy",
                      "Alanine aminotransferase level > 5x upper limit of normal",
                      "IgG serum levels > 2x upper limit of normal or positive smooth muscle autoantibody",
                      "Moderate or severe interface hepatitis on biopsy"
                    ]
                  },
                  {
                    "text": "Combination therapy with ursodeoxycholic acid and immunosuppression may be indicated"
                  }
                ],
                "Autoimmune Cholangitis/AMA(-) PBC": [
                  {
                    "text": "AMA(-), otherwise histology resembles PBC histologically and clinically"
                  }
                ],
                "Genetic Causes for Cholestasis": [
                  {
                    "text": "Mutations inABCB4mutations can cause cholestasis, ductopenia, bile ductular reaction, progressive fibrosis"
                  },
                  {
                    "text": "To distinguish from PBCFamily history of biliary disorders, jaundice at pregnancy, AMA(-)Genetic testing forABCB4mutations",
                    "sub_points": [
                      "Family history of biliary disorders, jaundice at pregnancy, AMA(-)",
                      "Genetic testing forABCB4mutations"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Florid duct lesion"
                  },
                  {
                    "text": "Loss of interlobular bile ducts"
                  }
                ]
              },
              "REPORTING": {
                "If Florid Duct Lesion is Present": [
                  {
                    "text": "In patient with positive AMA or elevated alkaline phosphatase, this is diagnostic of PBC"
                  }
                ],
                "If Florid Duct Lesion is Absent (Possibly Sampling-Related)": [
                  {
                    "text": "If cholestatic histologic features are present in patient with +AMA or elevated alkaline phosphatase, PBC still a possibility"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Idiopathic Adulthood Ductopenia": {
            "name": "Idiopathic Adulthood Ductopenia",
            "url": "https://app.pathprimer.com/document/32b3d733-8112-4a6e-92fc-07481cf2c2f3/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Heterogeneous group of chronic cholestatic diseases of unknown etiology in adults characterized by ductopenia"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Typically seen in young or middle-aged adults"
                  },
                  {
                    "text": "Jaundice, pruritus, fatigue"
                  },
                  {
                    "text": "Can be asymptomaticBiochemical evidence of cholestasis",
                    "sub_points": [
                      "Biochemical evidence of cholestasis"
                    ]
                  },
                  {
                    "text": "Normal extrahepatic bile ducts"
                  },
                  {
                    "text": "Variable prognosis, ranging from benign clinical course to progressive disease requiring liver transplantationCan progress rapidly",
                    "sub_points": [
                      "Can progress rapidly"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Loss of interlobular bile ducts in > 50% portal tractsMild form may show duct loss in < 50% of portal tracts",
                    "sub_points": [
                      "Mild form may show duct loss in < 50% of portal tracts"
                    ]
                  },
                  {
                    "text": "Mild ductular reaction may be seen"
                  },
                  {
                    "text": "Usually minimal, if any, nonspecific portal inflammation"
                  },
                  {
                    "text": "Sequelae of ductopeniaCholestasis, cholate stasis, copper deposition in periportal hepatocytes, biliary cirrhosis",
                    "sub_points": [
                      "Cholestasis, cholate stasis, copper deposition in periportal hepatocytes, biliary cirrhosis"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Cytokeratin 7 or 19 immunostaining can help highlight bile ducts and ductules"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Primary biliary cholangitis"
                  },
                  {
                    "text": "Primary sclerosing cholangitisMay be difficult to separate from small duct variant",
                    "sub_points": [
                      "May be difficult to separate from small duct variant"
                    ]
                  },
                  {
                    "text": "Drug-induced vanishing bile duct syndrome"
                  },
                  {
                    "text": "Ischemic cholangiopathy"
                  },
                  {
                    "text": "Chronic graft-vs.-host disease"
                  },
                  {
                    "text": "Chronic allograft rejection"
                  },
                  {
                    "text": "Viral infection"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Diagnosis of exclusion"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Idiopathic adulthood ductopenia (IAD)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Heterogeneous group of chronic cholestatic diseases of unknown etiology in adults characterized by ductopenia"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Diagnosis of exclusion"
                  }
                ],
                "Potential Etiologies": [
                  {
                    "text": "Late onset of nonsyndromic paucity of intrahepatic bile ducts"
                  },
                  {
                    "text": "Familial cases may be related to mutations ofABCB11(BSEP) orABCB4(MDR3) genes"
                  },
                  {
                    "text": "Nonsuppurative viral cholangitis"
                  },
                  {
                    "text": "Small duct primary sclerosing cholangitis in absence of large duct involvement or inflammatory bowel disease"
                  },
                  {
                    "text": "Autoimmune cholangitis in absence of autoantibodies or granuloma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "< 100 cases have been published since 1st report in 1988"
                  }
                ],
                "Age": [
                  {
                    "text": "Typically seen in young or middle-aged adultsPatients > 60 years old have been reported",
                    "sub_points": [
                      "Patients > 60 years old have been reported"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice, pruritus, fatigue"
                  },
                  {
                    "text": "Can be asymptomaticBiochemical evidence of cholestasis",
                    "sub_points": [
                      "Biochemical evidence of cholestasis"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated serum alkaline phosphatase, γ-glutamyltransferase, and bilirubin levels"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Ursodeoxycholic acid"
                  },
                  {
                    "text": "Immune suppression/modulation"
                  },
                  {
                    "text": "Liver transplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Variable, ranging from benign clinical course to progressive disease requiring liver transplantationCan progress rapidly",
                    "sub_points": [
                      "Can progress rapidly"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Cholangiogram": [
                  {
                    "text": "Normal extrahepatic bile ducts"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Loss of interlobular bile ducts in > 50% portal tractsRequires at least 10 portal tracts for evaluation, but diagnosis can be suggested on fewer portal tractsMild form may show duct loss in < 50% of portal tracts",
                    "sub_points": [
                      "Requires at least 10 portal tracts for evaluation, but diagnosis can be suggested on fewer portal tracts",
                      "Mild form may show duct loss in < 50% of portal tracts"
                    ]
                  },
                  {
                    "text": "Usually minimal, if any, nonspecific portal inflammation"
                  },
                  {
                    "text": "Remaining ducts may show features of injuryNo features of granulomatous cholangiopathy, florid duct lesion, or periduct concentric fibrosis",
                    "sub_points": [
                      "No features of granulomatous cholangiopathy, florid duct lesion, or periduct concentric fibrosis"
                    ]
                  },
                  {
                    "text": "Mild ductular reaction may be seenMust be distinguished from bile ductPresent at edge of portal tracts near limiting platesDoes not travel with hepatic artery",
                    "sub_points": [
                      "Must be distinguished from bile ductPresent at edge of portal tracts near limiting platesDoes not travel with hepatic artery",
                      "Present at edge of portal tracts near limiting plates",
                      "Does not travel with hepatic artery"
                    ]
                  },
                  {
                    "text": "Sequelae of ductopeniaCholestasis, cholate stasis, copper deposition in periportal hepatocytes, biliary cirrhosis",
                    "sub_points": [
                      "Cholestasis, cholate stasis, copper deposition in periportal hepatocytes, biliary cirrhosis"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Cytokeratin 7 or 19 can help highlight bile ducts and ductules"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Biliary Cholangitis": [
                  {
                    "text": "Positive antimitochondrial &/or antinuclear antibodies"
                  },
                  {
                    "text": "Florid duct lesion, granulomatous cholangiopathy"
                  }
                ],
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Abnormal cholangiogram"
                  },
                  {
                    "text": "Association with inflammatory bowel disease"
                  },
                  {
                    "text": "\"Onion skin\" periduct concentric fibrosis"
                  },
                  {
                    "text": "May be difficult to separate from small duct variant"
                  }
                ],
                "Sarcoidosis": [
                  {
                    "text": "Large epithelioid granulomas extrahepatic sarcoidosis, elevated angiotensin converting enzyme"
                  },
                  {
                    "text": "Presence of extrahepatic disease"
                  },
                  {
                    "text": "Elevated serum angiotensin converting enzyme levels"
                  }
                ],
                "Cholestatic Drug Reaction": [
                  {
                    "text": "May cause vanishing bile duct syndromeIbuprofen, carbamazepine, chlorpromazine, antibiotics, such as amoxicillin-clavulanate, etc.",
                    "sub_points": [
                      "Ibuprofen, carbamazepine, chlorpromazine, antibiotics, such as amoxicillin-clavulanate, etc."
                    ]
                  }
                ],
                "Ischemic Cholangiopathy": [
                  {
                    "text": "History of injury to hepatic artery"
                  }
                ],
                "Chronic Graft-vs.-Host Disease": [
                  {
                    "text": "History of hematopoietic stem cell transplantation"
                  }
                ],
                "Chronic Allograft Rejection": [
                  {
                    "text": "History of liver transplantation"
                  },
                  {
                    "text": "Foam cell arteriopathy"
                  }
                ],
                "Langerhans Cell Histiocytosis": [
                  {
                    "text": "Infiltration of liver and bile ducts by Langerhans dendritic cells expressing CD1a and langerin"
                  }
                ],
                "Viral Infection": [
                  {
                    "text": "CMV, reovirus 3, hepatitis B, hepatitis C, etc."
                  }
                ],
                "Hodgkin Lymphoma": [
                  {
                    "text": "Granuloma, cholestasis, &/or ductopenia can occur whether or not liver is involved by lymphoma"
                  }
                ],
                "Cystic Fibrosis": [
                  {
                    "text": "Inspissated eosinophilic concretions in dilated ductules"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Diagnosis of exclusion"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ischemic Cholangitis": {
            "name": "Ischemic Cholangitis",
            "url": "https://app.pathprimer.com/document/23c8faa1-e547-467d-b19e-187ac35555eb/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Any impairment of hepatic artery or peribiliary vascular plexus blood flow may result in ischemic bile duct injuryManifestations vary with severity and rapidity of ischemic insultCauses include arterial thrombosis, surgical injury, hypotensionTransplant relatedBiliary epithelium more vulnerable to ischemia-reperfusion than hepatocytesBile ducts prone to ischemia from hepatic artery thrombosis",
                    "sub_points": [
                      "Manifestations vary with severity and rapidity of ischemic insult",
                      "Causes include arterial thrombosis, surgical injury, hypotension",
                      "Transplant relatedBiliary epithelium more vulnerable to ischemia-reperfusion than hepatocytesBile ducts prone to ischemia from hepatic artery thrombosis",
                      "Biliary epithelium more vulnerable to ischemia-reperfusion than hepatocytes",
                      "Bile ducts prone to ischemia from hepatic artery thrombosis"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Prognosis varies depending on rapidity and extent of ischemic insultSevere acute injury may lead to hepatic failureChronic ischemia leads to progressive obliteration of bile ducts, biliary cirrhosis, liver failure",
                    "sub_points": [
                      "Severe acute injury may lead to hepatic failure",
                      "Chronic ischemia leads to progressive obliteration of bile ducts, biliary cirrhosis, liver failure"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Acute ischemic injury results in dilated bile ducts with filling defects due to biliary casts"
                  },
                  {
                    "text": "In chronic setting, diffuse stricturing and segmental dilatation of biliary tree seen by CT, MR, MRCP, or ERCPIschemic cholangitis is 1 cause of secondary sclerosing cholangitis",
                    "sub_points": [
                      "Ischemic cholangitis is 1 cause of secondary sclerosing cholangitis"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Acute ischemiaBile duct epithelial cell necrosis and desquamation with formation of biliary castsBile leaks result in bilomas and bile abscess",
                    "sub_points": [
                      "Bile duct epithelial cell necrosis and desquamation with formation of biliary casts",
                      "Bile leaks result in bilomas and bile abscess"
                    ]
                  },
                  {
                    "text": "Chronic ischemic injuryAtrophy and erosion of large duct epitheliumPeriductal fibrosis with progressive bile duct loss, stricturing, and fibrosisSecondary features of biliary obstructionProgression to biliary fibrosis or cirrhosis",
                    "sub_points": [
                      "Atrophy and erosion of large duct epithelium",
                      "Periductal fibrosis with progressive bile duct loss, stricturing, and fibrosis",
                      "Secondary features of biliary obstruction",
                      "Progression to biliary fibrosis or cirrhosis"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Ischemic cholangiopathy"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Bile duct injury and necrosis due to impaired blood supply of any cause"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Arterial Blood Supply Dependence": [
                  {
                    "text": "Unlike hepatocytes, intrahepatic biliary tree is entirely dependent on arterial blood supplyImpairment of hepatic artery or peribiliary vascular plexus blood flow due to any cause results in ischemic bile duct injury",
                    "sub_points": [
                      "Impairment of hepatic artery or peribiliary vascular plexus blood flow due to any cause results in ischemic bile duct injury"
                    ]
                  },
                  {
                    "text": "Manifestations vary with severity and rapidity of ischemic insult"
                  }
                ],
                "Associated Conditions": [
                  {
                    "text": "Arterial thrombosis"
                  },
                  {
                    "text": "Hypotension"
                  },
                  {
                    "text": "Surgical injury to biliary tree"
                  },
                  {
                    "text": "Transplant settingBiliary epithelium more vulnerable to ischemia-reperfusion than hepatocytesPrimary ischemia during preservation (cooling of organ to reduce oxygen needs)Reperfusion of organ causes toxic radical oxygen species, and other factors cause immune system activation, apoptosis, and necrosisBile ducts prone to ischemia from hepatic artery thrombosisCold ischemia time > 12 hours associated with 35% incidence of ischemic cholangiopathy",
                    "sub_points": [
                      "Biliary epithelium more vulnerable to ischemia-reperfusion than hepatocytesPrimary ischemia during preservation (cooling of organ to reduce oxygen needs)Reperfusion of organ causes toxic radical oxygen species, and other factors cause immune system activation, apoptosis, and necrosis",
                      "Primary ischemia during preservation (cooling of organ to reduce oxygen needs)",
                      "Reperfusion of organ causes toxic radical oxygen species, and other factors cause immune system activation, apoptosis, and necrosis",
                      "Bile ducts prone to ischemia from hepatic artery thrombosis",
                      "Cold ischemia time > 12 hours associated with 35% incidence of ischemic cholangiopathy"
                    ]
                  },
                  {
                    "text": "CMV-induced endothelial cell injury"
                  },
                  {
                    "text": "Intraarterial chemotherapy infusion (fluorodeoxyuridine for colon cancer metastasis to liver)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Fever"
                  },
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Biliary sepsis"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Hyperbilirubinemia"
                  },
                  {
                    "text": "Elevated alkaline phosphatase"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Acute complications include bile duct necrosis with bile leak and secondary infection"
                  },
                  {
                    "text": "Chronic ischemic injury leads to progressive bile duct obliteration, biliary cirrhosis, liver failureCholangiocarcinoma may develop as result of chronic biliary injury and cirrhosis",
                    "sub_points": [
                      "Cholangiocarcinoma may develop as result of chronic biliary injury and cirrhosis"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical approachesRevision of hepatic artery anastomosis to improve perfusionBiliary drainage or reconstructionLiver transplantation",
                    "sub_points": [
                      "Revision of hepatic artery anastomosis to improve perfusion",
                      "Biliary drainage or reconstruction",
                      "Liver transplantation"
                    ]
                  },
                  {
                    "text": "Thrombolysis of hepatic artery thrombosis"
                  },
                  {
                    "text": "Often cannot be treated"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Varies depending on rapidity and extent of ischemic insultIn severe and rapid cases, may lead to acute hepatic failure",
                    "sub_points": [
                      "In severe and rapid cases, may lead to acute hepatic failure"
                    ]
                  },
                  {
                    "text": "Consequences lessened by presence or development of collateral circulation"
                  },
                  {
                    "text": "Liver transplant recipients with ischemic cholangitis may require retransplantation"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Cholangiography with contrast shows multifocal bile duct wall irregularities ± intraductal cast formation, leakage of contrast into liver parenchyma"
                  },
                  {
                    "text": "Acute ischemic injury results in dilated bile ducts with filling defects due to biliary casts"
                  },
                  {
                    "text": "Intrahepatic bilomas may be seen"
                  },
                  {
                    "text": "In chronic setting, diffuse stricturing and segmental dilatation of biliary tree seen by CT, MR, MRCP, or ERCPIschemic cholangitis is 1 cause of secondary sclerosing cholangitis",
                    "sub_points": [
                      "Ischemic cholangitis is 1 cause of secondary sclerosing cholangitis"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Vary with location, timing, and extent of injury"
                  },
                  {
                    "text": "AcuteBile duct injury with cytoplasmic vacuolization, pyknotic nucleus, sloughing, biliary castsBile duct contents may leak through wall of necrotic duct into adjacent portal tract or parenchyma, causing necrosis and biloma formationBiloma may become infected, resulting in bile abscess",
                    "sub_points": [
                      "Bile duct injury with cytoplasmic vacuolization, pyknotic nucleus, sloughing, biliary casts",
                      "Bile duct contents may leak through wall of necrotic duct into adjacent portal tract or parenchyma, causing necrosis and biloma formation",
                      "Biloma may become infected, resulting in bile abscess"
                    ]
                  },
                  {
                    "text": "ChronicAtrophy and erosion of large duct epitheliumPeriductal fibrosis with progressive bile duct lossBiliary strictures and cholangiectasisSecondary features of biliary obstructionCholestasis, portal edema, and bile infarctsPortal inflammation usually mildProgressive development of biliary fibrosis or cirrhosis",
                    "sub_points": [
                      "Atrophy and erosion of large duct epithelium",
                      "Periductal fibrosis with progressive bile duct loss",
                      "Biliary strictures and cholangiectasis",
                      "Secondary features of biliary obstructionCholestasis, portal edema, and bile infarcts",
                      "Cholestasis, portal edema, and bile infarcts",
                      "Portal inflammation usually mild",
                      "Progressive development of biliary fibrosis or cirrhosis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Histologically similar to chronic ischemic cholangitis"
                  },
                  {
                    "text": "Associated with inflammatory bowel disease"
                  },
                  {
                    "text": "Lacks history/risk factors for ischemic cholangitis"
                  },
                  {
                    "text": "More bile staining and leakage seen beyond bile duct wall with ischemic cholangitis"
                  }
                ],
                "Cholangiocarcinoma": [
                  {
                    "text": "Usually produces more focal bile duct narrowing than ischemic cholangitis"
                  }
                ],
                "Other Forms of Secondary Sclerosing Cholangitis": [
                  {
                    "text": "Choledocholithiasis"
                  },
                  {
                    "text": "Recurrent pyogenic cholangitis"
                  },
                  {
                    "text": "Congenital disorders (choledochal cyst, Caroli disease)"
                  },
                  {
                    "text": "Fungal infection with invasion or colonization of biliary tree"
                  },
                  {
                    "text": "Biliary parasites"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Bile duct damage, epithelial cell necrosis, and sloughing with formation of biliary casts"
                  },
                  {
                    "text": "Chronic: Periductal fibrosis, stricturing, cholestasis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Large Bile Duct Obstruction": {
            "name": "Large Bile Duct Obstruction",
            "url": "https://app.pathprimer.com/document/0d3720d0-a884-471c-959f-2fa1695ef9f5/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Mechanical blockage of extrahepatic or large intrahepatic bile ductsChanges on liver biopsy secondary to obstructive biliary processUsually clinical and radiographic diagnosisLiver biopsy often unnecessary unless clinical findings/radiographic studies equivocal or misleading",
                    "sub_points": [
                      "Changes on liver biopsy secondary to obstructive biliary process",
                      "Usually clinical and radiographic diagnosisLiver biopsy often unnecessary unless clinical findings/radiographic studies equivocal or misleading",
                      "Liver biopsy often unnecessary unless clinical findings/radiographic studies equivocal or misleading"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "MultifactorialGallstones, neoplasms/masses, strictures, sclerosing cholangitis, anatomic abnormalities, infection",
                    "sub_points": [
                      "Gallstones, neoplasms/masses, strictures, sclerosing cholangitis, anatomic abnormalities, infection"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Elevated bilirubin and alkaline phosphatase very common"
                  },
                  {
                    "text": "Patients often present with abdominal pain, jaundiceJaundice variably present depending on severity of obstruction",
                    "sub_points": [
                      "Jaundice variably present depending on severity of obstruction"
                    ]
                  },
                  {
                    "text": "Treatment and prognosis depend on underlying cause of obstruction"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Cholangiography is invasive but allows direct visualization of duct lumen, defines site, and often reveals cause of obstruction"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Histologic findings nonspecific, affected by duration, severity, and cause of large bile duct obstructionPortal edema, mixed inflammation, ductular reactionNeutrophils often prominentReactive epithelial changes in interlobular bile ducts ± neutrophilsCanalicular cholestasis typically earliest changeMay be absent if blockage is partial or intermittentCopper deposition, fibrosis, and even cirrhosis can develop if process is chronic",
                    "sub_points": [
                      "Portal edema, mixed inflammation, ductular reactionNeutrophils often prominent",
                      "Neutrophils often prominent",
                      "Reactive epithelial changes in interlobular bile ducts ± neutrophils",
                      "Canalicular cholestasis typically earliest changeMay be absent if blockage is partial or intermittent",
                      "May be absent if blockage is partial or intermittent",
                      "Copper deposition, fibrosis, and even cirrhosis can develop if process is chronic"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Large bile duct obstruction (LBDO)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Extrahepatic cholestasis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Mechanical blockage of extrahepatic or large intrahepatic bile ducts"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanical Obstruction": [
                  {
                    "text": "LBDO is extrahepatic, mechanical cause of cholestasis"
                  },
                  {
                    "text": "This is in contrast to medical/intrahepatic causes of cholestasis"
                  }
                ],
                "Multifactorial": [
                  {
                    "text": "Gallstones"
                  },
                  {
                    "text": "Neoplasms/massesExamples: Pancreatic or bile duct cancer, Langerhans cell histiocytosis",
                    "sub_points": [
                      "Examples: Pancreatic or bile duct cancer, Langerhans cell histiocytosis"
                    ]
                  },
                  {
                    "text": "Strictures, sclerosing cholangitis (primary or secondary)"
                  },
                  {
                    "text": "Biliary atresia"
                  },
                  {
                    "text": "Anatomical abnormalities of biliary tree"
                  },
                  {
                    "text": "Parasitic infection"
                  },
                  {
                    "text": "IgG4-sclerosing cholangitis"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "JaundiceMay be absent in partial or low-grade obstructionDue to excess deposition of bilirubin in skin",
                    "sub_points": [
                      "May be absent in partial or low-grade obstruction",
                      "Due to excess deposition of bilirubin in skin"
                    ]
                  },
                  {
                    "text": "Pruritus"
                  },
                  {
                    "text": "SteatorrheaStool contains excess fat, as bile cannot enter intestine to help digest lipid in food",
                    "sub_points": [
                      "Stool contains excess fat, as bile cannot enter intestine to help digest lipid in food"
                    ]
                  },
                  {
                    "text": "Light-colored stoolsBilirubin prevented from being eliminated through stool due to bile duct obstruction",
                    "sub_points": [
                      "Bilirubin prevented from being eliminated through stool due to bile duct obstruction"
                    ]
                  },
                  {
                    "text": "ComplicationsBacterial cholangitis/sepsisCirrhosisFat-soluble vitamin deficiencies",
                    "sub_points": [
                      "Bacterial cholangitis/sepsis",
                      "Cirrhosis",
                      "Fat-soluble vitamin deficiencies"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated bilirubin and alkaline phosphatase"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treat cause of obstruction"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on underlying cause of LBDO"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Ultrasound and CT can confirm dilated bile ductsDilated ducts may be absent in early or intermittent obstruction or if ducts are fibroticNeedle biopsy may be taken in this situation",
                    "sub_points": [
                      "Dilated ducts may be absent in early or intermittent obstruction or if ducts are fibrotic",
                      "Needle biopsy may be taken in this situation"
                    ]
                  },
                  {
                    "text": "Cholangiography allows direct visualization of duct lumen, defines site, and often reveals cause of obstruction"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Liver histologic findings are secondary to obstructive biliary processBiopsy occasionally provides 1st sign that patient may have LBDOEspecially useful early in disease process when ducts are not dilated on imagingHistologic findings nonspecific and affected by duration, severity, and cause of LBDO",
                    "sub_points": [
                      "Biopsy occasionally provides 1st sign that patient may have LBDOEspecially useful early in disease process when ducts are not dilated on imaging",
                      "Especially useful early in disease process when ducts are not dilated on imaging",
                      "Histologic findings nonspecific and affected by duration, severity, and cause of LBDO"
                    ]
                  },
                  {
                    "text": "Portal tract alterationsEdemaEarly finding in LBDODuctular reaction at edges of portal tractsEarly finding in LBDODuctules form to try and bypass obstructed duct with collateral formationOften with admixed neutrophils around ductulesDuctules leak bile, which is chemotactic, bringing neutrophils to areaMixed portal inflammation with prominent neutrophils and variably present eosinophilsReactive changes in interlobular bile ductsNeutrophils may infiltrate ductal epitheliumDoes not necessarily imply biliary tree infectionPeriductal fibrosis may be seenNot specific to primary sclerosing cholangitis",
                    "sub_points": [
                      "EdemaEarly finding in LBDO",
                      "Early finding in LBDO",
                      "Ductular reaction at edges of portal tractsEarly finding in LBDODuctules form to try and bypass obstructed duct with collateral formationOften with admixed neutrophils around ductulesDuctules leak bile, which is chemotactic, bringing neutrophils to area",
                      "Early finding in LBDO",
                      "Ductules form to try and bypass obstructed duct with collateral formation",
                      "Often with admixed neutrophils around ductulesDuctules leak bile, which is chemotactic, bringing neutrophils to area",
                      "Ductules leak bile, which is chemotactic, bringing neutrophils to area",
                      "Mixed portal inflammation with prominent neutrophils and variably present eosinophils",
                      "Reactive changes in interlobular bile ductsNeutrophils may infiltrate ductal epitheliumDoes not necessarily imply biliary tree infectionPeriductal fibrosis may be seenNot specific to primary sclerosing cholangitis",
                      "Neutrophils may infiltrate ductal epitheliumDoes not necessarily imply biliary tree infection",
                      "Does not necessarily imply biliary tree infection",
                      "Periductal fibrosis may be seenNot specific to primary sclerosing cholangitis",
                      "Not specific to primary sclerosing cholangitis"
                    ]
                  },
                  {
                    "text": "CholestasisCanalicular cholestasis typically earliest changeBile pigment within dilated canaliculusOften accompanied by inflammation, hepatocellular injuryMay be absent if blockage is partial or intermittentHepatocellular cholestasis (bile within hepatocyte cytoplasm) may also be presentDuctular cholestasis rarely seenDuctules at edge of portal tract that are inspissated with bileBile lakes may form from leakage of bile from ducts/ductulesBile infarctsConfluent areas of necrotic hepatocytes that have ruptured and leaked bileSurrounded by macrophagesHepatocyte death due to toxic effect of high levels of retained bile salts plus effects of biliary pressureLarge &/or periportal bile infarcts imply high-grade obstructionFeatures of chronic cholestasisPeriportal cholate stasis (swollen, vacuolated hepatocytes) ± Mallory bodiesCopper stainingUsually excreted in bile, copper is retained in longstanding bile duct obstructionCK7 stainingPeriportal hepatocyte expression of CK7 can indicate early cholestasisExpansion of portal areas by fibrosis, inflammation, ductular proliferationXanthomatous cellsCollections of foamy macrophages containing cholesterol and lipidFibrosisIrregular expansion of portal tract yields portal/portal septa in chronic LBDOEventually progresses to biliary cirrhosis if untreated\"Jigsaw puzzle\" irregular nodulesWith \"halo\" of cholate stasis &/or pale fibrosis at periphery of nodules",
                    "sub_points": [
                      "Canalicular cholestasis typically earliest changeBile pigment within dilated canaliculusOften accompanied by inflammation, hepatocellular injuryMay be absent if blockage is partial or intermittentHepatocellular cholestasis (bile within hepatocyte cytoplasm) may also be present",
                      "Bile pigment within dilated canaliculus",
                      "Often accompanied by inflammation, hepatocellular injury",
                      "May be absent if blockage is partial or intermittent",
                      "Hepatocellular cholestasis (bile within hepatocyte cytoplasm) may also be present",
                      "Ductular cholestasis rarely seenDuctules at edge of portal tract that are inspissated with bile",
                      "Ductules at edge of portal tract that are inspissated with bile",
                      "Bile lakes may form from leakage of bile from ducts/ductules",
                      "Bile infarctsConfluent areas of necrotic hepatocytes that have ruptured and leaked bileSurrounded by macrophagesHepatocyte death due to toxic effect of high levels of retained bile salts plus effects of biliary pressure",
                      "Confluent areas of necrotic hepatocytes that have ruptured and leaked bile",
                      "Surrounded by macrophages",
                      "Hepatocyte death due to toxic effect of high levels of retained bile salts plus effects of biliary pressure",
                      "Large &/or periportal bile infarcts imply high-grade obstruction",
                      "Features of chronic cholestasisPeriportal cholate stasis (swollen, vacuolated hepatocytes) ± Mallory bodiesCopper stainingUsually excreted in bile, copper is retained in longstanding bile duct obstructionCK7 stainingPeriportal hepatocyte expression of CK7 can indicate early cholestasisExpansion of portal areas by fibrosis, inflammation, ductular proliferationXanthomatous cellsCollections of foamy macrophages containing cholesterol and lipid",
                      "Periportal cholate stasis (swollen, vacuolated hepatocytes) ± Mallory bodies",
                      "Copper stainingUsually excreted in bile, copper is retained in longstanding bile duct obstruction",
                      "Usually excreted in bile, copper is retained in longstanding bile duct obstruction",
                      "CK7 stainingPeriportal hepatocyte expression of CK7 can indicate early cholestasis",
                      "Periportal hepatocyte expression of CK7 can indicate early cholestasis",
                      "Expansion of portal areas by fibrosis, inflammation, ductular proliferation",
                      "Xanthomatous cellsCollections of foamy macrophages containing cholesterol and lipid",
                      "Collections of foamy macrophages containing cholesterol and lipid",
                      "FibrosisIrregular expansion of portal tract yields portal/portal septa in chronic LBDOEventually progresses to biliary cirrhosis if untreated\"Jigsaw puzzle\" irregular nodulesWith \"halo\" of cholate stasis &/or pale fibrosis at periphery of nodules",
                      "Irregular expansion of portal tract yields portal/portal septa in chronic LBDO",
                      "Eventually progresses to biliary cirrhosis if untreated",
                      "\"Jigsaw puzzle\" irregular nodulesWith \"halo\" of cholate stasis &/or pale fibrosis at periphery of nodules",
                      "With \"halo\" of cholate stasis &/or pale fibrosis at periphery of nodules"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7Highlights native bile ducts and can be positive in periportal hepatocytesHepatocytic expression of CK7 can indicate early cholestasis",
                    "sub_points": [
                      "Highlights native bile ducts and can be positive in periportal hepatocytes",
                      "Hepatocytic expression of CK7 can indicate early cholestasis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sepsis": [
                  {
                    "text": "Ductular reaction with presence of inspissated ductular bile (\"ductular cholestasis\")"
                  },
                  {
                    "text": "Bland cholestasisBile plugs without inflammation or other LBDO portal tract findingsCan be seen in very early LBDO without other histologic findings",
                    "sub_points": [
                      "Bile plugs without inflammation or other LBDO portal tract findingsCan be seen in very early LBDO without other histologic findings",
                      "Can be seen in very early LBDO without other histologic findings"
                    ]
                  },
                  {
                    "text": "Other clinical and laboratory features of infection"
                  }
                ],
                "Drug-Induced Cholestasis": [
                  {
                    "text": "History of offending drug"
                  },
                  {
                    "text": "Absence of ductular reaction"
                  },
                  {
                    "text": "Bland cholestasis"
                  },
                  {
                    "text": "Cholestatic hepatitisCholestasis seen along with prominent component of hepatitis",
                    "sub_points": [
                      "Cholestasis seen along with prominent component of hepatitis"
                    ]
                  },
                  {
                    "text": "Drug-induced cholestatic injuryMay show bile ductular reaction, can be indistinguishable from LBDO (e.g., angiotensin-converting enzyme inhibitor)",
                    "sub_points": [
                      "May show bile ductular reaction, can be indistinguishable from LBDO (e.g., angiotensin-converting enzyme inhibitor)"
                    ]
                  }
                ],
                "Total Parenteral Nutrition": [
                  {
                    "text": "History of use; steatosis often present"
                  }
                ],
                "Acute Viral Hepatitis": [
                  {
                    "text": "May have cholestatic features"
                  },
                  {
                    "text": "Ductular reaction in addition to other parenchymal changes of viral hepatitis"
                  },
                  {
                    "text": "Transaminases elevated as well as bilirubin, alkaline phosphatase"
                  },
                  {
                    "text": "Viral serologic studies helpful"
                  }
                ],
                "Alcoholic Liver Disease": [
                  {
                    "text": "Severe disease may feature cholestasis, ductular reaction, reactive bile duct changes"
                  },
                  {
                    "text": "Look for other features of alcoholic liver diseaseSteatosis, ballooned hepatocytes near central vein, pericellular fibrosis",
                    "sub_points": [
                      "Steatosis, ballooned hepatocytes near central vein, pericellular fibrosis"
                    ]
                  }
                ],
                "Genetic Cholestatic Liver Disorders (ParticularlyABCB4Mutation)": [
                  {
                    "text": "Canalicular transporter enzyme deficiency"
                  },
                  {
                    "text": "Can also have large duct obstruction findings, such as mild ductular reaction and periductal fibrosisAdults can present with mild form of cholestatic disease caused by enzyme deficiencyParticularly if affected by heterozygous gene mutationVarious clinical and histological appearancesEarly cholesterol stone formationBland cholestasis, bile duct injury, bile duct loss, ductular reactionLBDO findings particularly inABCB4mutation",
                    "sub_points": [
                      "Adults can present with mild form of cholestatic disease caused by enzyme deficiencyParticularly if affected by heterozygous gene mutationVarious clinical and histological appearancesEarly cholesterol stone formationBland cholestasis, bile duct injury, bile duct loss, ductular reactionLBDO findings particularly inABCB4mutation",
                      "Particularly if affected by heterozygous gene mutation",
                      "Various clinical and histological appearancesEarly cholesterol stone formationBland cholestasis, bile duct injury, bile duct loss, ductular reactionLBDO findings particularly inABCB4mutation",
                      "Early cholesterol stone formation",
                      "Bland cholestasis, bile duct injury, bile duct loss, ductular reaction",
                      "LBDO findings particularly inABCB4mutation"
                    ]
                  },
                  {
                    "text": "Suspect canalicular transporter mutation in adult ifPatient has biliary injury-type histologic pattern plus clinical and family historyJaundice during pregnancy, early gallstones in mother, unexplained elevation in cholestatic laboratory values",
                    "sub_points": [
                      "Patient has biliary injury-type histologic pattern plus clinical and family historyJaundice during pregnancy, early gallstones in mother, unexplained elevation in cholestatic laboratory values",
                      "Jaundice during pregnancy, early gallstones in mother, unexplained elevation in cholestatic laboratory values"
                    ]
                  }
                ],
                "Ascending Cholangitis": [
                  {
                    "text": "Usually clinically symptomatic and biopsy not needed for diagnosis"
                  },
                  {
                    "text": "If neutrophils are seen prominentlyinduct lumen, this indicates acute cholangitis"
                  }
                ],
                "Fibrosing Cholestatic Hepatitis B/C": [
                  {
                    "text": "Severe, rapidly progressive, usually recurrent infection post transplant"
                  },
                  {
                    "text": "History of infection, periportal with striking pericellular fibrosis, immunostain for HBsAg"
                  }
                ],
                "Preservation Injury": [
                  {
                    "text": "Bile duct injury due to ischemia during organ preservation and toxic radical oxygen species formation during reperfusion"
                  },
                  {
                    "text": "Bile duct injury, bile casts, strictures, post transplant"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Usually clinical and radiographic diagnosisLiver biopsy often unnecessary unless clinical findings/radiographic studies equivocal or misleadingLBDO findings includePortal tract findingsEdemaBile ductular reactionNeutrophils surrounding bile ductulesLobular findingsCanalicular and hepatocytic bile pigment (early and can persist and get more prominent)Cholate stasisBile lakes, xanthomatous cellsLarge bile infarcts",
                    "sub_points": [
                      "Liver biopsy often unnecessary unless clinical findings/radiographic studies equivocal or misleading",
                      "LBDO findings includePortal tract findingsEdemaBile ductular reactionNeutrophils surrounding bile ductulesLobular findingsCanalicular and hepatocytic bile pigment (early and can persist and get more prominent)Cholate stasisBile lakes, xanthomatous cellsLarge bile infarcts",
                      "Portal tract findingsEdemaBile ductular reactionNeutrophils surrounding bile ductules",
                      "Edema",
                      "Bile ductular reaction",
                      "Neutrophils surrounding bile ductules",
                      "Lobular findingsCanalicular and hepatocytic bile pigment (early and can persist and get more prominent)Cholate stasisBile lakes, xanthomatous cellsLarge bile infarcts",
                      "Canalicular and hepatocytic bile pigment (early and can persist and get more prominent)",
                      "Cholate stasis",
                      "Bile lakes, xanthomatous cells",
                      "Large bile infarcts"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Biliary Atresia": {
            "name": "Biliary Atresia",
            "url": "https://app.pathprimer.com/document/35744091-c09c-48d2-8105-9e7625367f65/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Idiopathic obstructive cholangiopathy of perinatal/neonatal period and early childhood"
                  },
                  {
                    "text": "1:5,000 to 1:19,000 newbornsIncidence higher in South East Asia than West",
                    "sub_points": [
                      "Incidence higher in South East Asia than West"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Neonatal jaundice, dark urine with pale stools, hepatomegalyIsolated biliary atresia (BA) in ~ 80% of casesExtrahepatic congenital anomalies in ~ 20% of casesCMV IgM in ~10-20% of cases in West, ~ 50% in China",
                    "sub_points": [
                      "Isolated biliary atresia (BA) in ~ 80% of cases",
                      "Extrahepatic congenital anomalies in ~ 20% of cases",
                      "CMV IgM in ~10-20% of cases in West, ~ 50% in China"
                    ]
                  },
                  {
                    "text": "Conjugated hyperbilirubinemia, GGT not low"
                  },
                  {
                    "text": "Kasai procedure mainstay of therapyBest outcomes when performed < 45-60 days of ageBest outcomes when performed at specialized centers",
                    "sub_points": [
                      "Best outcomes when performed < 45-60 days of age",
                      "Best outcomes when performed at specialized centers"
                    ]
                  },
                  {
                    "text": "Liver transplantation when Kasai not possible or fails to restore bile flow"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Explanted liverWithout Kasai: Green, very firm, micronodularAfter years of functioning Kasai: Large perihilar nodules surrounded by smaller nodules, green, very firm",
                    "sub_points": [
                      "Without Kasai: Green, very firm, micronodular",
                      "After years of functioning Kasai: Large perihilar nodules surrounded by smaller nodules, green, very firm"
                    ]
                  },
                  {
                    "text": "Hypoplastic or atretic gallbladder"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Marked ductular reaction with prominent periportal fibrosis"
                  },
                  {
                    "text": "Cholestasis, giant cells, extramedullary hematopoiesis"
                  },
                  {
                    "text": "Duct remnants with variable degrees of fibrous obliteration and chronic periductal inflammation"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Neonatal hepatitis"
                  },
                  {
                    "text": "α-1-antitrypsin deficiency"
                  },
                  {
                    "text": "Total parenteral nutrition-associated cholestasis"
                  },
                  {
                    "text": "CMV infection"
                  },
                  {
                    "text": "Choledochal cyst"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Biliary atresia (BA)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Extrahepatic BAInvolves both extrahepatic and intrahepatic bile ductsBest designated simply as BA because there is no isolated intrahepatic variant",
                    "sub_points": [
                      "Involves both extrahepatic and intrahepatic bile ductsBest designated simply as BA because there is no isolated intrahepatic variant",
                      "Best designated simply as BA because there is no isolated intrahepatic variant"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Idiopathic inflammatory, obstructive cholangiopathy of perinatal/neonatal period and early childhoodRapidly progresses to biliary cirrhosis within months",
                    "sub_points": [
                      "Rapidly progresses to biliary cirrhosis within months"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Idiopathic, Multifactorial": [
                  {
                    "text": "End-stage phenotype of variable, intersecting, and interacting pathogenic pathwaysImmune dysfunction, viral infection, developmental anomalies, genetic susceptibility",
                    "sub_points": [
                      "Immune dysfunction, viral infection, developmental anomalies, genetic susceptibility"
                    ]
                  },
                  {
                    "text": "No associated findings in 80% of cases (isolated BA)"
                  },
                  {
                    "text": "Associated findings in 20% of casesDevelopmental anomalies in 10% of European/North American cases, rare in Asian patientsPolysplenia/asplenia, other laterality defectsBA-splenic malformation (BASM) syndromeNonlaterality-associated malformationsCystic BABile- or mucus-containing cysts, in addition to obliterated bile ductsVisualized in ~ 50% of cases on antenatal ultrasound, may coexist with BASMBA associated with CMVCMV IgM present in 10-20% of European cases, ~ 50% of Chinese cases",
                    "sub_points": [
                      "Developmental anomalies in 10% of European/North American cases, rare in Asian patientsPolysplenia/asplenia, other laterality defectsBA-splenic malformation (BASM) syndromeNonlaterality-associated malformations",
                      "Polysplenia/asplenia, other laterality defectsBA-splenic malformation (BASM) syndrome",
                      "BA-splenic malformation (BASM) syndrome",
                      "Nonlaterality-associated malformations",
                      "Cystic BABile- or mucus-containing cysts, in addition to obliterated bile ductsVisualized in ~ 50% of cases on antenatal ultrasound, may coexist with BASM",
                      "Bile- or mucus-containing cysts, in addition to obliterated bile ducts",
                      "Visualized in ~ 50% of cases on antenatal ultrasound, may coexist with BASM",
                      "BA associated with CMVCMV IgM present in 10-20% of European cases, ~ 50% of Chinese cases",
                      "CMV IgM present in 10-20% of European cases, ~ 50% of Chinese cases"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "High incidence in East Asia1:5,000 to 1:10,000 (Taiwan, Japan)",
                    "sub_points": [
                      "1:5,000 to 1:10,000 (Taiwan, Japan)"
                    ]
                  },
                  {
                    "text": "Lower incidence in mainland Europe, England/Wales, North America1:15,000 to 1:20,000",
                    "sub_points": [
                      "1:15,000 to 1:20,000"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Clinical triadPersistent neonatal jaundice beyond 2 weeks of lifeDark urine and acholic pale stoolsHepatomegaly",
                    "sub_points": [
                      "Persistent neonatal jaundice beyond 2 weeks of life",
                      "Dark urine and acholic pale stools",
                      "Hepatomegaly"
                    ]
                  },
                  {
                    "text": "Associated extrahepatic congenital anomalies in ~ 20% of cases"
                  },
                  {
                    "text": "2 general clinical patternsPrenatal, embryonal/fetal, congenital, or early form (15-35% of cases)Low birth weight, jaundice at birthPerinatal, postnatal, infantile, acquired, or late form (65-85% of cases)Healthy anicteric, average-weight neonatesJaundice usually presents after 2 weeks of age",
                    "sub_points": [
                      "Prenatal, embryonal/fetal, congenital, or early form (15-35% of cases)Low birth weight, jaundice at birth",
                      "Low birth weight, jaundice at birth",
                      "Perinatal, postnatal, infantile, acquired, or late form (65-85% of cases)Healthy anicteric, average-weight neonatesJaundice usually presents after 2 weeks of age",
                      "Healthy anicteric, average-weight neonates",
                      "Jaundice usually presents after 2 weeks of age"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Similar to other forms of neonatal cholestasisConjugated hyperbilirubinemiaVariably elevated alkaline phosphatase and transaminasesγ-glutamyl transpeptidase not low (typically > 200 U/L)",
                    "sub_points": [
                      "Conjugated hyperbilirubinemia",
                      "Variably elevated alkaline phosphatase and transaminases",
                      "γ-glutamyl transpeptidase not low (typically > 200 U/L)"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "SurgeryHepatoportoenterostomy (Kasai procedure)Establishes bile flow in 75-80% of patientsBest outcomes when performed before 45-60 days of ageBest outcomes when performed at specialized centersLiver transplantationBiliary atresia most frequent indication for pediatric liver transplantationFor infants not amenable to Kasai procedure, or when it fails to restore bile flowTransplant within 6 months to 2 years of ageFor children with deteriorating liver function after 10-20 years of functioning Kasai",
                    "sub_points": [
                      "Hepatoportoenterostomy (Kasai procedure)Establishes bile flow in 75-80% of patientsBest outcomes when performed before 45-60 days of ageBest outcomes when performed at specialized centers",
                      "Establishes bile flow in 75-80% of patients",
                      "Best outcomes when performed before 45-60 days of age",
                      "Best outcomes when performed at specialized centers",
                      "Liver transplantationBiliary atresia most frequent indication for pediatric liver transplantationFor infants not amenable to Kasai procedure, or when it fails to restore bile flowTransplant within 6 months to 2 years of ageFor children with deteriorating liver function after 10-20 years of functioning Kasai",
                      "Biliary atresia most frequent indication for pediatric liver transplantation",
                      "For infants not amenable to Kasai procedure, or when it fails to restore bile flowTransplant within 6 months to 2 years of age",
                      "Transplant within 6 months to 2 years of age",
                      "For children with deteriorating liver function after 10-20 years of functioning Kasai"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Fatal by age 2 if untreatedPrenatal form has worse outcome than postnatal form",
                    "sub_points": [
                      "Prenatal form has worse outcome than postnatal form"
                    ]
                  },
                  {
                    "text": "25-35% of patients with Kasai survive > 10 years without liver transplantation"
                  },
                  {
                    "text": "1/3 of patients develop complications of cirrhosis, require transplantation before age 10"
                  },
                  {
                    "text": "Good long-term survival after orthotopic liver transplantationOverall patient survival at 10 years: 82%Overall graft survival at 10 years: 71%",
                    "sub_points": [
                      "Overall patient survival at 10 years: 82%",
                      "Overall graft survival at 10 years: 71%"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "UltrasoundAbsent or atretic gallbladder\"Gallbladder ghost\" triad, \"triangular cord\" sign",
                    "sub_points": [
                      "Absent or atretic gallbladder",
                      "\"Gallbladder ghost\" triad, \"triangular cord\" sign"
                    ]
                  },
                  {
                    "text": "Hepatobiliary iminodiacetic acid (HIDA) scanIV radiotracer given, excreted into bileExcretion excludes diagnosis of BAAbsence of excretion not specific to BAHigh sensitivity (~ 100%) but specificity of 87%",
                    "sub_points": [
                      "IV radiotracer given, excreted into bileExcretion excludes diagnosis of BAAbsence of excretion not specific to BAHigh sensitivity (~ 100%) but specificity of 87%",
                      "Excretion excludes diagnosis of BA",
                      "Absence of excretion not specific to BAHigh sensitivity (~ 100%) but specificity of 87%",
                      "High sensitivity (~ 100%) but specificity of 87%"
                    ]
                  },
                  {
                    "text": "Intraoperative cholangiogram"
                  },
                  {
                    "text": "Endoscopic retrograde cholangiopancreatographyInvasive procedure, requires general anesthesiaTechnically difficult, requires specialized equipment and operator skills",
                    "sub_points": [
                      "Invasive procedure, requires general anesthesiaTechnically difficult, requires specialized equipment and operator skills",
                      "Technically difficult, requires specialized equipment and operator skills"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Biliary remnants excised at Kasai: Firm fibrotic tissue at hilum, represents obliterated bile ducts"
                  },
                  {
                    "text": "Explanted liverDark green, very firm, micronodularSeveral years after functioning Kasai: Large perihilar nodules surrounded by smaller nodulesDilated intrahepatic ducts with inspissated bile",
                    "sub_points": [
                      "Dark green, very firm, micronodular",
                      "Several years after functioning Kasai: Large perihilar nodules surrounded by smaller nodules",
                      "Dilated intrahepatic ducts with inspissated bile"
                    ]
                  }
                ],
                "Surgical Classification": [
                  {
                    "text": "Based on level of extrahepatic duct obliterationType 1 (5-10%)Within common bile ductIf gallbladder present, likely contains bileType 2 (3-5%)Within common hepatic ductIf gallbladder present, does not contain bileType 3 (> 85-90%)Within portal hepatisHypoplastic or atretic gallbladder",
                    "sub_points": [
                      "Type 1 (5-10%)Within common bile ductIf gallbladder present, likely contains bile",
                      "Within common bile duct",
                      "If gallbladder present, likely contains bile",
                      "Type 2 (3-5%)Within common hepatic ductIf gallbladder present, does not contain bile",
                      "Within common hepatic duct",
                      "If gallbladder present, does not contain bile",
                      "Type 3 (> 85-90%)Within portal hepatisHypoplastic or atretic gallbladder",
                      "Within portal hepatis",
                      "Hypoplastic or atretic gallbladder"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Liver biopsy: Features of biliary obstructionExpanded portal tracts with prominent ductular reactionEdema, proliferating ductules, mixed inflammationBile plugsProminent hepatic arteriolesProminent fibrosis: Portal, periportal, bridgingLobular featuresCanalicular cholestasis with variable pseudoacinar transformationFocal giant cell transformation of hepatocytesScattered foci of extramedullary hematopoiesis",
                    "sub_points": [
                      "Expanded portal tracts with prominent ductular reactionEdema, proliferating ductules, mixed inflammationBile plugsProminent hepatic arteriolesProminent fibrosis: Portal, periportal, bridging",
                      "Edema, proliferating ductules, mixed inflammation",
                      "Bile plugs",
                      "Prominent hepatic arterioles",
                      "Prominent fibrosis: Portal, periportal, bridging",
                      "Lobular featuresCanalicular cholestasis with variable pseudoacinar transformationFocal giant cell transformation of hepatocytesScattered foci of extramedullary hematopoiesis",
                      "Canalicular cholestasis with variable pseudoacinar transformation",
                      "Focal giant cell transformation of hepatocytes",
                      "Scattered foci of extramedullary hematopoiesis"
                    ]
                  },
                  {
                    "text": "Explanted liver years after functioning Kasai (in addition to above)Loss of intrahepatic bile ductsDucts usually present around larger regenerative perihilar nodules, absent around surrounding atrophic smaller nodules± cholangitis",
                    "sub_points": [
                      "Loss of intrahepatic bile ductsDucts usually present around larger regenerative perihilar nodules, absent around surrounding atrophic smaller nodules",
                      "Ducts usually present around larger regenerative perihilar nodules, absent around surrounding atrophic smaller nodules",
                      "± cholangitis"
                    ]
                  },
                  {
                    "text": "Biliary remnant excised at KasaiCompletely or partially obliterated ductsPeriductal chronic inflammatory infiltrate, active fibroplasia, or dense fibrosisObliterated ducts marked by scarPartially obliterated ducts lined focally by cuboidal or columnar tissueSquamous metaplasia may be presentClassification of duct remnantsBased on size and degree of duct obliterationNot very useful because remnants of variable sizes and variable degree of obliteration present simultaneously at different levels in all cases2 classification schemes1st classificationType 1: Completely atretic ductType 2: Partially destroyed duct, cleft-like lumen lined by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μType 3: Duct lined partially by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μ2nd classificationType 1: Ducts with lumina > 150 μType 2: Ducts with lumina < 150 μType 3: No epithelial-lined structures",
                    "sub_points": [
                      "Completely or partially obliterated ductsPeriductal chronic inflammatory infiltrate, active fibroplasia, or dense fibrosisObliterated ducts marked by scarPartially obliterated ducts lined focally by cuboidal or columnar tissueSquamous metaplasia may be present",
                      "Periductal chronic inflammatory infiltrate, active fibroplasia, or dense fibrosis",
                      "Obliterated ducts marked by scar",
                      "Partially obliterated ducts lined focally by cuboidal or columnar tissueSquamous metaplasia may be present",
                      "Squamous metaplasia may be present",
                      "Classification of duct remnantsBased on size and degree of duct obliterationNot very useful because remnants of variable sizes and variable degree of obliteration present simultaneously at different levels in all cases2 classification schemes",
                      "Based on size and degree of duct obliteration",
                      "Not very useful because remnants of variable sizes and variable degree of obliteration present simultaneously at different levels in all cases",
                      "2 classification schemes",
                      "1st classificationType 1: Completely atretic ductType 2: Partially destroyed duct, cleft-like lumen lined by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μType 3: Duct lined partially by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μ",
                      "Type 1: Completely atretic duct",
                      "Type 2: Partially destroyed duct, cleft-like lumen lined by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μ",
                      "Type 3: Duct lined partially by columnar or cuboidal cells, surrounding smaller ductal structures < 50 μ",
                      "2nd classificationType 1: Ducts with lumina > 150 μType 2: Ducts with lumina < 150 μType 3: No epithelial-lined structures",
                      "Type 1: Ducts with lumina > 150 μ",
                      "Type 2: Ducts with lumina < 150 μ",
                      "Type 3: No epithelial-lined structures"
                    ]
                  },
                  {
                    "text": "Histologic stages of biliary atresia in patients who have not undergone surgery; timing of stages is approximationEarly stage: 1-4 weeksNonspecific, features not diagnosticCholestasis with minimal inflammationFew lobular multinucleated hepatocytes (giant cell transformation)2nd stage: 4-7 weeksCharacteristic obstructive featuresDuctular reaction, best developed at or after 6 weeks, is most reliable criterionPortal tract edema and variable inflammationInterlobular duct epithelial damageCholestasis with bile plugs3rd stage: 7-8 weeksPortal and periportal fibrosis4th stage: 10 weeksPortal to bridging fibrosisInflammation decreasesVariable periductal fibrosisLast stage: > 12 weeksBiliary cirrhosisDuctular reaction may not be prominentVariable paucity of interlobular bile ducts",
                    "sub_points": [
                      "Early stage: 1-4 weeksNonspecific, features not diagnosticCholestasis with minimal inflammationFew lobular multinucleated hepatocytes (giant cell transformation)",
                      "Nonspecific, features not diagnostic",
                      "Cholestasis with minimal inflammation",
                      "Few lobular multinucleated hepatocytes (giant cell transformation)",
                      "2nd stage: 4-7 weeksCharacteristic obstructive featuresDuctular reaction, best developed at or after 6 weeks, is most reliable criterionPortal tract edema and variable inflammationInterlobular duct epithelial damageCholestasis with bile plugs",
                      "Characteristic obstructive features",
                      "Ductular reaction, best developed at or after 6 weeks, is most reliable criterion",
                      "Portal tract edema and variable inflammation",
                      "Interlobular duct epithelial damage",
                      "Cholestasis with bile plugs",
                      "3rd stage: 7-8 weeksPortal and periportal fibrosis",
                      "Portal and periportal fibrosis",
                      "4th stage: 10 weeksPortal to bridging fibrosisInflammation decreasesVariable periductal fibrosis",
                      "Portal to bridging fibrosis",
                      "Inflammation decreases",
                      "Variable periductal fibrosis",
                      "Last stage: > 12 weeksBiliary cirrhosisDuctular reaction may not be prominentVariable paucity of interlobular bile ducts",
                      "Biliary cirrhosis",
                      "Ductular reaction may not be prominent",
                      "Variable paucity of interlobular bile ducts"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Neonatal Hepatitis": [
                  {
                    "text": "Primarily lobular processHepatocyte disarray with giant cell transformation predominatesImaging studies helpful",
                    "sub_points": [
                      "Hepatocyte disarray with giant cell transformation predominates",
                      "Imaging studies helpful"
                    ]
                  }
                ],
                "Choledochal Cyst or Cholelithiasis": [
                  {
                    "text": "Radiographic imaging studies needed"
                  }
                ],
                "Total Parenteral Nutrition-Associated Cholestasis": [
                  {
                    "text": "History of total parenteral nutrition; not duct destructive"
                  }
                ],
                "α-1-Antitrypsin Deficiency": [
                  {
                    "text": "Decreased levels of serum α-1-antitrypsin, abnormal genotype"
                  },
                  {
                    "text": "Typical periportal PAS-D(+) cytoplasmic globules may not be evident before 12 weeks of age"
                  }
                ],
                "Cytomegalovirus Infection": [
                  {
                    "text": "CMV in endothelial cells, hepatocytes, or bile duct epithelium"
                  }
                ],
                "Alagille Syndrome": [
                  {
                    "text": "Can mimic BA histologically and radiographicallyDuctular reaction without duct loss seen in early lifePresence of interlobular ducts, especially before 6 months of age, does not exclude diagnosisCK7 useful in assessing ducts/ductules",
                    "sub_points": [
                      "Ductular reaction without duct loss seen in early lifePresence of interlobular ducts, especially before 6 months of age, does not exclude diagnosisCK7 useful in assessing ducts/ductules",
                      "Presence of interlobular ducts, especially before 6 months of age, does not exclude diagnosisCK7 useful in assessing ducts/ductules",
                      "CK7 useful in assessing ducts/ductules"
                    ]
                  },
                  {
                    "text": "Common bile duct hypoplasia without visualization of intrahepatic biliary tree on cholangiogram"
                  },
                  {
                    "text": "Associated clinical manifestations (cardiopulmonary malformations, etc.) useful in diagnosis"
                  }
                ],
                "Cholestasis-Associated Sepsis": [
                  {
                    "text": "Sepsis may cause dilated ductules with bile plugs"
                  },
                  {
                    "text": "Interlobular bile ducts usually intact and free of injury"
                  }
                ],
                "Progressive Familial Intrahepatic Cholestasis Type 3": [
                  {
                    "text": "Mutation ofMDR3, multidrug resistance protein 3, coded byABCB4gene"
                  },
                  {
                    "text": "Early in course has expanded portal tracts with ductular reaction"
                  }
                ],
                "Cystic Fibrosis": [
                  {
                    "text": "Dilated ductules with luminal amorphous pink secretion"
                  },
                  {
                    "text": "Mutation inCFTR"
                  }
                ],
                "Bile Plug (Inspissated Bile) Syndrome": [
                  {
                    "text": "Secondary to Rh and ABO group incompatibility, hemolytic disorders, sepsis, cystic fibrosis, dehydration, or total parenteral nutrition"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Ductular reaction is nonspecific and can be seen in many conditions"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Neonatal Hepatitis": {
            "name": "Neonatal Hepatitis",
            "url": "https://app.pathprimer.com/document/46ca7893-8ceb-436b-bd41-bbc4037d68f1/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Constellation of histopathologic findings in neonates with persistent jaundice (neonatal jaundice)Nonspecific response of neonatal liver to injury",
                    "sub_points": [
                      "Nonspecific response of neonatal liver to injury"
                    ]
                  },
                  {
                    "text": "Broad spectrum of causative disease processes and associations"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Biliary atresia, Alagille syndrome"
                  },
                  {
                    "text": "CMV, herpes, enterovirus, rubella, toxoplasmosis, listeria, sepsis"
                  },
                  {
                    "text": "α-1 antitrypsin deficiency, cystic fibrosis, hypopituitarism, galactosemia, tyrosinemia, fructosemia, neonatal hemochromatosis, bile acid synthetic defects"
                  },
                  {
                    "text": "Trisomy 18, Down syndrome"
                  },
                  {
                    "text": "Progressive familial intrahepatic cholestasis (PFIC)"
                  },
                  {
                    "text": "~ 10-30% of cases idiopathic; diagnosis of exclusion"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Prolonged jaundice, dark urine, pale stools"
                  },
                  {
                    "text": "Hepatomegaly ± splenomegaly"
                  },
                  {
                    "text": "Bruising/bleeding due to vitamin K deficiency"
                  },
                  {
                    "text": "Elevated serum total and conjugated bilirubin"
                  },
                  {
                    "text": "Variably elevated transaminases"
                  },
                  {
                    "text": "Prognosis depends on underlying etiology"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Variable combinations and severity of cholestasis, multinucleated giant hepatocytes, inflammation, extramedullary hemopoiesis, ductular reaction, necrosis, and fibrosis"
                  },
                  {
                    "text": "Viral inclusions ± (CMV, herpes, parvovirus)"
                  },
                  {
                    "text": "Microabscesses ± (Listeria, congenital syphilis)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Biliary atresia, which requires prompt surgical intervention"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Neonatal hepatitis (NH)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Giant cell hepatitis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Constellation of histopathologic findings in neonates with persistent jaundice (neonatal jaundice)"
                  },
                  {
                    "text": "Wide variety of etiologies and associations"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Biliary atresia, Alagille syndrome"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "CMV, herpes, enterovirus, rubella, toxoplasmosis, Listeria, sepsis"
                  }
                ],
                "Metabolic Conditions": [
                  {
                    "text": "α-1 antitrypsin deficiency, cystic fibrosis, hypopituitarism, galactosemia, tyrosinemia, fructosemia, neonatal hemochromatosis, bile acid synthetic defects"
                  }
                ],
                "Chromosomal Abnormalities": [
                  {
                    "text": "Trisomy 18, Down syndrome"
                  }
                ],
                "Bile Transporter Mutations": [
                  {
                    "text": "Progressive familial intrahepatic cholestasis (PFIC)"
                  }
                ],
                "Idiopathic": [
                  {
                    "text": "~ 10-30% of cases, diagnosis of exclusion"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Nonspecific response of neonatal liver to injuryDecompensation of bile synthetic and secretory pathwaysGiant cells may be due to mitotic inhibition of hepatocytes, dissolution of cellular membranes of adjacent hepatocytes, or accumulation of bile salts",
                    "sub_points": [
                      "Decompensation of bile synthetic and secretory pathways",
                      "Giant cells may be due to mitotic inhibition of hepatocytes, dissolution of cellular membranes of adjacent hepatocytes, or accumulation of bile salts"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "In early 1970s, 65% of cases were idiopathic"
                  },
                  {
                    "text": "By mid-2000s, only 15-30% considered idiopathic due to improved understanding of underlying etiologies"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Prolonged jaundice, dark urine, pale stools"
                  },
                  {
                    "text": "Hepatomegaly ± splenomegaly in ~ 50%"
                  },
                  {
                    "text": "Bruising or bleeding due to vitamin K deficiency"
                  },
                  {
                    "text": "Signs of infection"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated total and conjugated bilirubin, alkaline phosphatase, and γ-glutamyl transpeptidase"
                  },
                  {
                    "text": "Variably elevated transaminases"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Treat underlying cause, supportive care"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on underlying etiologySome cases resolve spontaneously",
                    "sub_points": [
                      "Some cases resolve spontaneously"
                    ]
                  },
                  {
                    "text": "Little risk of chronic liver disease in most instances"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variable degree of lobular inflammation and disarray, giant cell transformation, apoptosis, necrosis"
                  },
                  {
                    "text": "Canalicular and hepatocellular cholestasis ± pseudorosettes"
                  },
                  {
                    "text": "Extramedullary hematopoiesis"
                  },
                  {
                    "text": "Variable degrees of portal inflammation and ductular reaction"
                  },
                  {
                    "text": "Viral inclusions (CMV, herpes, parvovirus) may be seen, if that is underlying etiology"
                  },
                  {
                    "text": "Bile ducts are intact and not decreased"
                  },
                  {
                    "text": "Microabscesses can be seen with Listeria, congenital syphilis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Biliary Atresia": [
                  {
                    "text": "Early in disease course, obstructive-type pattern of injury with ductular reaction may not be evident"
                  },
                  {
                    "text": "Abnormalities of biliary tree on imaging"
                  },
                  {
                    "text": "Requires prompt surgical intervention"
                  }
                ],
                "Hypopituitarism": [
                  {
                    "text": "Histologically indistinguishable from idiopathic NH but may have small hypoplastic bile ducts"
                  },
                  {
                    "text": "Dysmorphic facial features, hypotonia, hypoglycemia, micropenis, optic nerve hypoplasia"
                  },
                  {
                    "text": "Septooptic dysplasia: Hypopituitarism and neonatal hepatitis"
                  }
                ],
                "Paucity of Intrahepatic Bile Ducts": [
                  {
                    "text": "Reduction in numbers of bile ducts"
                  },
                  {
                    "text": "Other clinical manifestations of Alagille syndrome"
                  }
                ],
                "α-1 Antitrypsin Deficiency": [
                  {
                    "text": "Low serum α-1 antitrypsin level, abnormal protease inhibitor (PiZZ or PiSZ) phenotype"
                  },
                  {
                    "text": "Cytoplasmic globules not apparent until ~ 12 weeks of age"
                  }
                ],
                "Infections": [
                  {
                    "text": "TORCH infections"
                  },
                  {
                    "text": "Serologic tests, culture, viral inclusions on histology"
                  }
                ],
                "Bile Acid Synthetic Defects": [
                  {
                    "text": "Extensive giant cell change"
                  },
                  {
                    "text": "Serum γ-glutamyl transpeptidase not elevated"
                  },
                  {
                    "text": "Low or normal levels of serum bile acids"
                  },
                  {
                    "text": "Identification of specific metabolic defect by analysis of urine, by fast atom bombardment-mass spectrometry, and gas chromatography-mass spectrometry"
                  }
                ],
                "Progressive Familial Intrahepatic Cholestasis Type 2": [
                  {
                    "text": "Extensive giant cell change"
                  },
                  {
                    "text": "Mutations inABCB11gene encoding bile salt export pumpAbsence of canalicular bile salt export pump by immunohistochemical staining",
                    "sub_points": [
                      "Absence of canalicular bile salt export pump by immunohistochemical staining"
                    ]
                  },
                  {
                    "text": "Serum γ-glutamyl transpeptidase not elevated"
                  }
                ],
                "Other Rare Conditions": [
                  {
                    "text": "Neonatal lupus erythematosus, severe combined immunodeficiency, neonatal hemochromatosis, cystic fibrosis, and Seckel syndrome"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Syndromic Paucity of Intrahepatic Bile Ducts (Alagille Syndrome)": {
            "name": "Syndromic Paucity of Intrahepatic Bile Ducts (Alagille Syndrome)",
            "url": "https://app.pathprimer.com/document/5610c099-e3fd-439b-9303-8a6ee31edc54/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Autosomal dominant multisystem disorder with variable combinations of bile duct loss, cholestasis, facial dysmorphism, as well as cardiovascular, vertebral, ocular, and renal abnormalities"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations inJAG1gene that encodes ligand for Notch receptor (90%) or mutations inNOTCH2gene (1-2%)"
                  },
                  {
                    "text": "JAG1andNOTCH2interactions involved in development of intrahepatic bile ducts"
                  },
                  {
                    "text": "JAG1andNOTCH4interactions involved in vascular remodeling, developing portal vasculature influences ductal plate remodeling"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Jaundice and cholestasis before age of 6 months"
                  },
                  {
                    "text": "Xanthomas, fat-soluble vitamin deficiency, severe and debilitating pruritus"
                  },
                  {
                    "text": "Characteristic facies: Broad forehead, deep-set eyes, straight nose, pointed chin"
                  },
                  {
                    "text": "Variable combinations and severities of multisystem defects"
                  },
                  {
                    "text": "Conjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Increased serum GGT, alkaline phosphatase, bile acids, cholesterol"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Hepatobiliary (HIDA) scan mimics biliary atresia"
                  },
                  {
                    "text": "Cholangiography may show bile duct hypoplasia"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Early in life, bile duct damage, mild inflammation, and ductular reaction, mimics biliary atresia"
                  },
                  {
                    "text": "As patient ages, evolving ductopenia and fibrosisBile ducts absent in > 50% of portal tracts",
                    "sub_points": [
                      "Bile ducts absent in > 50% of portal tracts"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Biliary atresia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Alagille syndrome"
                  },
                  {
                    "text": "Arteriohepatic dysplasia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Autosomal dominant multisystem disorder with variable combinations of bile duct loss, cholestasis, facial dysmorphism, as well as cardiovascular, vertebral, ocular, and renal abnormalities"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Genetic Disorder": [
                  {
                    "text": "Autosomal dominant disorder with highly variable phenotypic expressionMutations inJAG1gene that encodes ligand for Notch receptor (90% of patients)Mutations inNOTCH2gene (1-2%)JAG1andNOTCH2interactions involved in development of intrahepatic bile ductsJAG1andNOTCH4interactions involved in vascular remodelingDeveloping portal vasculature influences ductal plate remodeling",
                    "sub_points": [
                      "Mutations inJAG1gene that encodes ligand for Notch receptor (90% of patients)",
                      "Mutations inNOTCH2gene (1-2%)JAG1andNOTCH2interactions involved in development of intrahepatic bile ductsJAG1andNOTCH4interactions involved in vascular remodelingDeveloping portal vasculature influences ductal plate remodeling",
                      "JAG1andNOTCH2interactions involved in development of intrahepatic bile ducts",
                      "JAG1andNOTCH4interactions involved in vascular remodelingDeveloping portal vasculature influences ductal plate remodeling",
                      "Developing portal vasculature influences ductal plate remodeling"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Incidence 1 in 100,000; no ethnic or sex predilection"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Typically presents in childhood before 6 months of age"
                  },
                  {
                    "text": "Variable combinations and severities of multisystem defects"
                  },
                  {
                    "text": "Jaundice and consequences of cholestasisXanthomas, fat-soluble vitamin deficiency, pruritusPruritus severe and debilitating, skin excoriationHepatomegaly, splenomegaly",
                    "sub_points": [
                      "Xanthomas, fat-soluble vitamin deficiency, pruritusPruritus severe and debilitating, skin excoriation",
                      "Pruritus severe and debilitating, skin excoriation",
                      "Hepatomegaly, splenomegaly"
                    ]
                  },
                  {
                    "text": "Failure to thriveInsensitivity to growth hormone, malabsorption",
                    "sub_points": [
                      "Insensitivity to growth hormone, malabsorption"
                    ]
                  },
                  {
                    "text": "Characteristic faciesBroad forehead, deep-set eyes, straight nose, pointed chin",
                    "sub_points": [
                      "Broad forehead, deep-set eyes, straight nose, pointed chin"
                    ]
                  },
                  {
                    "text": "Cardiovascular abnormalitiesPeripheral pulmonary stenosis, pulmonary valve stenosis, tetralogy of Fallot, aortic stenosis, ventricular septal defects",
                    "sub_points": [
                      "Peripheral pulmonary stenosis, pulmonary valve stenosis, tetralogy of Fallot, aortic stenosis, ventricular septal defects"
                    ]
                  },
                  {
                    "text": "Skeletal abnormalitiesButterfly vertebrae, curved phalanges, short ulna",
                    "sub_points": [
                      "Butterfly vertebrae, curved phalanges, short ulna"
                    ]
                  },
                  {
                    "text": "Ocular abnormalitiesPosterior embryotoxon, optic nerve drusen",
                    "sub_points": [
                      "Posterior embryotoxon, optic nerve drusen"
                    ]
                  },
                  {
                    "text": "Renal abnormalitiesDysplasia, arterial stenosis, renal tubular acidosis",
                    "sub_points": [
                      "Dysplasia, arterial stenosis, renal tubular acidosis"
                    ]
                  },
                  {
                    "text": "Spontaneous bleedingIntracranial, during medical procedures",
                    "sub_points": [
                      "Intracranial, during medical procedures"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Conjugated hyperbilirubinemia"
                  },
                  {
                    "text": "Increased serum GGT, alkaline phosphatase, bile acids, cholesterol"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Progresses to cirrhosis in ~ 20% of patients"
                  },
                  {
                    "text": "Associated with risk of hepatocellular carcinoma"
                  },
                  {
                    "text": "Severity of extrahepatic defects influences course"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Ursodeoxycholic acid, rifampin, phenobarbitone, cholestyramine to manage cholestasis and pruritus"
                  },
                  {
                    "text": "Partial external biliary diversion"
                  },
                  {
                    "text": "Liver transplantation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "In era before liver transplantation, 75% reached age 20~ 25% of all patients require liver transplantation",
                    "sub_points": [
                      "~ 25% of all patients require liver transplantation"
                    ]
                  },
                  {
                    "text": "Presentation with neonatal cholestasis carries worse prognosis50% require liver transplantation before age 10",
                    "sub_points": [
                      "50% require liver transplantation before age 10"
                    ]
                  },
                  {
                    "text": "Cardiac disease increases mortality risk"
                  },
                  {
                    "text": "Intracranial bleeds account for 25% of deaths"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Excretion of technetium-labeled iminodiacetic dye (HIDA scan) typically absent, mimics biliary atresia"
                  },
                  {
                    "text": "May show bile duct hypoplasia"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Explanted liver firm, green, micronodular"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "< 3 months: Bile duct damage, mild portal inflammation, mild ductular reaction; mimics biliary atresia"
                  },
                  {
                    "text": "As patient ages, evolving ductopenia, may be focalBile ducts absent in > 50% of portal tracts, at least 10 portal tracts must be presentArterioles not accompanied by bile ducts (\"unpaired\" arterioles), no to minimal inflammation, severe canalicular and hepatocellular cholestasisProgressive fibrosis, leading to biliary cirrhosis",
                    "sub_points": [
                      "Bile ducts absent in > 50% of portal tracts, at least 10 portal tracts must be present",
                      "Arterioles not accompanied by bile ducts (\"unpaired\" arterioles), no to minimal inflammation, severe canalicular and hepatocellular cholestasis",
                      "Progressive fibrosis, leading to biliary cirrhosis"
                    ]
                  },
                  {
                    "text": "Canalicular CD10 is absent in Alagille patients but is also absent in children < 24 months without Alagille"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Biliary Atresia": [
                  {
                    "text": "Similar presentation to Alagille with conjugated hyperbilirubinemia, small gallbladder, and hypoplasia of common bile ductBile ductular reaction with bile plugs and portal fibrosis on liver biopsy in biliary atresia",
                    "sub_points": [
                      "Bile ductular reaction with bile plugs and portal fibrosis on liver biopsy in biliary atresia"
                    ]
                  },
                  {
                    "text": "Extrahepatic manifestations of Alagille syndrome may allow distinction"
                  }
                ],
                "Paucity of Intrahepatic Bile Ducts (Nonsyndromic)": [
                  {
                    "text": "Liver biopsy does not distinguish between syndromic and nonsyndromic paucity of intrahepatic bile ducts"
                  },
                  {
                    "text": "Stigmata of syndromic disorder favors Alagille"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Bile duct paucity in infant is indication for slit lamp examination and dorsal spine radiograph examination"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Liver biopsies in infants with neonatal cholestasis due to Alagille syndrome may be indistinguishable from biliary atresia"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Nonsyndromic Paucity of Intrahepatic Bile Ducts": {
            "name": "Nonsyndromic Paucity of Intrahepatic Bile Ducts",
            "url": "https://app.pathprimer.com/document/38e72b40-c9fa-494c-9264-f41c113f2123/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Heterogeneous group of disorders in children without extrahepatic manifestations of Alagille syndrome"
                  },
                  {
                    "text": "Absence of bile ducts in > 50% of portal tractsBiopsy must contain ≥ 10 portal tracts for evaluation",
                    "sub_points": [
                      "Biopsy must contain ≥ 10 portal tracts for evaluation"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Congenital disorders: Biliary atresia"
                  },
                  {
                    "text": "Metabolic disorders: α-1 antitrypsin deficiency, cystic fibrosis, progressive familial intrahepatic cholestasis, peroxisomal disorders, Niemann-Pick type C, arthrogryposis-renal dysfunction cholestasis"
                  },
                  {
                    "text": "Chromosomal abnormalities: Turner syndrome, monosomy X, trisomies"
                  },
                  {
                    "text": "Intrauterine infections: CMV, rubella, syphilis"
                  },
                  {
                    "text": "Idiopathic: Diagnosis of exclusion, incidence decreasing as more definitive etiologies are identified"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Prognosis varies depending on underlying cause and ranges from liver failure to complete resolution"
                  },
                  {
                    "text": "~ 45% progress to cirrhosis, requiring liver transplantation"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Interlobular bile ducts absent in > 50% of portal tracts≥ 10 portal tracts must be available for evaluation",
                    "sub_points": [
                      "≥ 10 portal tracts must be available for evaluation"
                    ]
                  },
                  {
                    "text": "Surviving ducts may show epithelial damage ± associated inflammation"
                  },
                  {
                    "text": "Canalicular and cellular cholestasis ± ductular reaction ± giant cell transformation of hepatocytes"
                  },
                  {
                    "text": "Variable fibrosis, from mild portal fibrosis to cirrhosis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Syndromic paucity of intrahepatic bile ducts (Alagille)"
                  },
                  {
                    "text": "α-1 antitrypsin deficiency"
                  },
                  {
                    "text": "Cystic fibrosis"
                  },
                  {
                    "text": "Progressive familial intrahepatic cholestasis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Ductopenia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Heterogeneous group of disorders that cause ductopenia in children without extrahepatic manifestations of Alagille syndrome"
                  },
                  {
                    "text": "Absence of bile ducts in > 50% of portal tracts in biopsy that contains ≥ 10 portal tracts for evaluationNormal ratio of bile ducts:portal tracts: 0.8:1.9",
                    "sub_points": [
                      "Normal ratio of bile ducts:portal tracts: 0.8:1.9"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Congenital disorders: Biliary atresia"
                  },
                  {
                    "text": "Metabolic disorders: α-1 antitrypsin deficiency, cystic fibrosis, progressive familial intrahepatic cholestasis, peroxisomal disorders, Niemann-Pick type C, arthrogryposis-renal dysfunction cholestasis syndrome"
                  },
                  {
                    "text": "Chromosomal abnormalities: Turner syndrome, monosomy X, trisomies"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Intrauterine infections: CMV, rubella, syphilis"
                  }
                ],
                "Idiopathic": [
                  {
                    "text": "Diagnosis of exclusion; incidence decreasing as more etiologies are identified"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Varies in population studied but increased in regions where consanguineous marriages are common"
                  }
                ],
                "Age": [
                  {
                    "text": "Generally considered disease of childhood as adults with ductopenia are classified in different categories"
                  },
                  {
                    "text": "Some patients with idiopathic adulthood ductopenia may represent late manifestation of same disorder"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice, pruritus, and acholic stools"
                  },
                  {
                    "text": "Hepatomegaly"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Increased serum bilirubin, alkaline phosphatase, γ-glutamyl transpeptidase"
                  },
                  {
                    "text": "Variably increased serum cholesterol"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Complications of fat malabsorption and deficiency of fat-soluble vitaminsProlonged prothrombin time, rickets, vitamin E-responsive hemolytic anemia, corneal ulcers",
                    "sub_points": [
                      "Prolonged prothrombin time, rickets, vitamin E-responsive hemolytic anemia, corneal ulcers"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Liver transplantation for severe refractory symptoms, cirrhosis, or liver failure"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Ursodeoxycholic acid, cholestyramine, phenobarbital"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depending on underlying cause, ranges from complete spontaneous resolution to liver failure requiring transplantationProgression to cirrhosis seen in ~ 45% of patientsProgressive liver failure and death without transplantation",
                    "sub_points": [
                      "Progression to cirrhosis seen in ~ 45% of patientsProgressive liver failure and death without transplantation",
                      "Progressive liver failure and death without transplantation"
                    ]
                  },
                  {
                    "text": "Prognosis worse than for patients with Alagille syndrome"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Interlobular bile ducts absent in > 50% of portal tractsAt least 10 portal tracts must be available for evaluation",
                    "sub_points": [
                      "At least 10 portal tracts must be available for evaluation"
                    ]
                  },
                  {
                    "text": "Surviving ducts may show epithelial damage ± associated inflammation"
                  },
                  {
                    "text": "Ductular reaction may be present"
                  },
                  {
                    "text": "Canalicular and cellular cholestasis ± giant cell transformation of hepatocytes"
                  },
                  {
                    "text": "Variable fibrosis, ranging from mild portal fibrosis to cirrhosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Syndromic Paucity of Intrahepatic Bile Ducts (Alagille Syndrome)": [
                  {
                    "text": "Presence of extrahepatic manifestations of Alagille syndromeSkeletal, ocular, cardiac abnormalities; facial dysmorphism, spontaneous bleeding",
                    "sub_points": [
                      "Skeletal, ocular, cardiac abnormalities; facial dysmorphism, spontaneous bleeding"
                    ]
                  },
                  {
                    "text": "JAG1orNOTCH2mutations"
                  }
                ],
                "Biliary Atresia": [
                  {
                    "text": "Failure of excretion into bile duct on HIDA scan"
                  },
                  {
                    "text": "Ultrasound shows absent or small gallbladder"
                  },
                  {
                    "text": "Liver biopsy shows ductular reaction with bile plugs in ductules"
                  }
                ],
                "α-1 Antitrypsin Deficiency": [
                  {
                    "text": "PAS-diastase globules in hepatocytes (may be absent in patients < 12 weeks old)"
                  },
                  {
                    "text": "Proteinase inhibitor phenotyping, measurement of serum α-1 antitrypsin"
                  }
                ],
                "Cystic Fibrosis": [
                  {
                    "text": "Ductular reaction with PAS(+) inspissated proteinaceous secretions"
                  }
                ],
                "Progressive Familial Intrahepatic Cholestasis": [
                  {
                    "text": "Identification of genetic mutation, immunohistochemistry (if available) for suspected bile canalicular protein"
                  }
                ],
                "Adulthood Idiopathic Ductopenia": [
                  {
                    "text": "Ductopenia in adult without known underlying cause"
                  },
                  {
                    "text": "May be same disorder as childhood nonsyndromic paucity of intrahepatic bile ducts"
                  }
                ],
                "Peroxisomal Disorder (Zellweger Syndrome)": [
                  {
                    "text": "Reduced or absent peroxisomes on ultrastructural examination"
                  },
                  {
                    "text": "Accumulation of very long chain fatty acids, phytanic acid, L-pipecolic acid, bile acid intermediates"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "As peripheral bile ducts are last to undergo remodeling, biopsies from premature infants, or even superficial biopsies from near-term infants, can give false impression of paucity"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cholelithiasis": {
            "name": "Cholelithiasis",
            "url": "https://app.pathprimer.com/document/233cba70-effb-4831-9048-a0cfc14ee215/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Formation of stones in gallbladderOne of most common gastrointestinal diseases worldwideParticularly common in Scandinavia, ChileIn United States, estimated 10-20% of population have gallstones",
                    "sub_points": [
                      "One of most common gastrointestinal diseases worldwideParticularly common in Scandinavia, ChileIn United States, estimated 10-20% of population have gallstones",
                      "Particularly common in Scandinavia, Chile",
                      "In United States, estimated 10-20% of population have gallstones"
                    ]
                  },
                  {
                    "text": "2 main types: Cholesterol stones and pigment stonesCholesterol stones> 80% of stones in developed nationsPigment stonesBlack: Associated with hemolytic disorders, cirrhosis, total parenteral nutritionBrown: Associated with ascending cholangitis and biliary inflammation",
                    "sub_points": [
                      "Cholesterol stones> 80% of stones in developed nations",
                      "> 80% of stones in developed nations",
                      "Pigment stonesBlack: Associated with hemolytic disorders, cirrhosis, total parenteral nutritionBrown: Associated with ascending cholangitis and biliary inflammation",
                      "Black: Associated with hemolytic disorders, cirrhosis, total parenteral nutrition",
                      "Brown: Associated with ascending cholangitis and biliary inflammation"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most gallstones are clinically silentMay present with right upper quadrant pain, intolerance of fatty food",
                    "sub_points": [
                      "May present with right upper quadrant pain, intolerance of fatty food"
                    ]
                  },
                  {
                    "text": "2-4x more common in women than men"
                  },
                  {
                    "text": "Laparoscopic cholecystectomy is standard therapy"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Ultrasound (diagnostic modality of choice) can detect stones > 3 mm in diameter"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Cholesterol stones usually < 2 cm, multiple, and round or faceted"
                  },
                  {
                    "text": "Black pigment stones are 2-5 mm, shiny, irregular, multifaceted"
                  },
                  {
                    "text": "Brown pigment stones have softer texture and flaky appearance, often larger than black stones"
                  },
                  {
                    "text": "Stones are often associated with inflammation (cholecystitis)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Formation of stones in gallbladder"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Cholesterol Stone Formation": [
                  {
                    "text": "> 80% of stones in developed nations are mixed cholesterol stonesFormed by bile supersaturation, destabilization + gallbladder hypermotilityCholesterol crystals form, which grow and aggregate with mucin proteins to form stonesAlso contain variable amounts of calcium bilirubinate and calcium carbonateCrystals and particles, such as calcium carbonate, induce extrusion of neutrophil DNA (neutrophil extracellular traps); this is intended to capture particulate matter but induces further neutrophil recruitment and neutrophil extracellular trap formation, forming \"glue\" that allows assembly of gallstones",
                    "sub_points": [
                      "Formed by bile supersaturation, destabilization + gallbladder hypermotility",
                      "Cholesterol crystals form, which grow and aggregate with mucin proteins to form stones",
                      "Also contain variable amounts of calcium bilirubinate and calcium carbonateCrystals and particles, such as calcium carbonate, induce extrusion of neutrophil DNA (neutrophil extracellular traps); this is intended to capture particulate matter but induces further neutrophil recruitment and neutrophil extracellular trap formation, forming \"glue\" that allows assembly of gallstones",
                      "Crystals and particles, such as calcium carbonate, induce extrusion of neutrophil DNA (neutrophil extracellular traps); this is intended to capture particulate matter but induces further neutrophil recruitment and neutrophil extracellular trap formation, forming \"glue\" that allows assembly of gallstones"
                    ]
                  },
                  {
                    "text": "Numerous risk factorsObesity, multiparity, rapid weight loss, estrogen replacement therapy, oral contraceptive use, hypertriglyceridemia, many medicationsHigher rates in Latin American women (Hispanic Americans) and Native Americans in both North and South America",
                    "sub_points": [
                      "Obesity, multiparity, rapid weight loss, estrogen replacement therapy, oral contraceptive use, hypertriglyceridemia, many medications",
                      "Higher rates in Latin American women (Hispanic Americans) and Native Americans in both North and South America"
                    ]
                  }
                ],
                "Black Pigment Stones": [
                  {
                    "text": "Contain calcium bilirubinate, calcium phosphate, and calcium carbonate"
                  },
                  {
                    "text": "Associated with hemolytic disorders, cirrhosis, malaria, total parenteral nutrition, Crohn disease"
                  }
                ],
                "Brown Pigment Stones": [
                  {
                    "text": "Calcium salts of bilirubin and palmitate, more cholesterol than black stones"
                  },
                  {
                    "text": "Strongly associated with ascending cholangitis and biliary inflammation, especially due toEscherichia coliand flukes"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "One of most common gastrointestinal diseases worldwideVariably common in different parts of worldParticularly common in Scandinavia, ChileIn United States, estimated 10-20% of population have gallstonesPigment stones are much more common in Asian and African populations",
                    "sub_points": [
                      "Variably common in different parts of worldParticularly common in Scandinavia, ChileIn United States, estimated 10-20% of population have gallstonesPigment stones are much more common in Asian and African populations",
                      "Particularly common in Scandinavia, Chile",
                      "In United States, estimated 10-20% of population have gallstones",
                      "Pigment stones are much more common in Asian and African populations"
                    ]
                  },
                  {
                    "text": "Age: Overall, increased incidence with age; quite uncommon in children"
                  },
                  {
                    "text": "Sex: 2-4x more common in women than men"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Majority of gallstones are clinically silent"
                  },
                  {
                    "text": "Symptoms usually consist of right upper quadrant pain, flatulence, and intolerance of fatty food"
                  },
                  {
                    "text": "Complications include acute and chronic cholecystitis, choledocholithiasis, fistulas, acute pancreatitis, and gallbladder cancer"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Laparoscopic cholecystectomy most common treatmentApproach to asymptomatic gallstones remains controversialIncidence of carcinoma is < 1%, so cholecystectomy not routinely recommended",
                    "sub_points": [
                      "Approach to asymptomatic gallstones remains controversial",
                      "Incidence of carcinoma is < 1%, so cholecystectomy not routinely recommended"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "70-90% of gallstones are radiolucent; at least 80% of these are cholesterol stones"
                  },
                  {
                    "text": "Black stones may be radiopaque"
                  },
                  {
                    "text": "Ultrasound (diagnostic modality of choice) can detect stones > 3 mm in diameter"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Cholesterol Stones": [
                  {
                    "text": "Usually < 2 cm, multiple, and round or faceted"
                  },
                  {
                    "text": "Cut surface is laminated with alternating layers having variegated appearance depending on how much pigment is present"
                  },
                  {
                    "text": "Stones with > 90% cholesterol are referred to as pure cholesterol stonesRound or ovoid, single, usually 2-4 cm in diameterCut surface shows radial arrangement of crystals; pigment is either absent or present only in scant amounts",
                    "sub_points": [
                      "Round or ovoid, single, usually 2-4 cm in diameter",
                      "Cut surface shows radial arrangement of crystals; pigment is either absent or present only in scant amounts"
                    ]
                  }
                ],
                "Pigment Stones": [
                  {
                    "text": "Black pigment stones2-5 mm, shiny, irregular, multifaceted",
                    "sub_points": [
                      "2-5 mm, shiny, irregular, multifaceted"
                    ]
                  },
                  {
                    "text": "Brown pigment stonesSofter texture and flaky appearance, often larger than black stones",
                    "sub_points": [
                      "Softer texture and flaky appearance, often larger than black stones"
                    ]
                  }
                ],
                "Unusual Types of Gallstones": [
                  {
                    "text": "Disappearing gallstones3 possible mechanisms: Spontaneous passage via common bile duct, passage through cholecystenteric fistula, and spontaneous dissolution",
                    "sub_points": [
                      "3 possible mechanisms: Spontaneous passage via common bile duct, passage through cholecystenteric fistula, and spontaneous dissolution"
                    ]
                  },
                  {
                    "text": "Intramural gallstonesStones become adherent to wall, leading to ulceration and erosion into muscularisMay form within Rokitansky-Aschoff sinuses",
                    "sub_points": [
                      "Stones become adherent to wall, leading to ulceration and erosion into muscularis",
                      "May form within Rokitansky-Aschoff sinuses"
                    ]
                  },
                  {
                    "text": "Gas-containing gallstonesNitrogen, smaller amounts of carbon dioxide and oxygen",
                    "sub_points": [
                      "Nitrogen, smaller amounts of carbon dioxide and oxygen"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Cholecystitis": {
            "name": "Acute Cholecystitis",
            "url": "https://app.pathprimer.com/document/6054f4fd-c9f1-4247-9ba4-289e87cdb23e/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Acutecalculouscholecystitis: 95% of casesObstruction of cystic duct by pigment or cholesterol stones",
                    "sub_points": [
                      "Obstruction of cystic duct by pigment or cholesterol stones"
                    ]
                  },
                  {
                    "text": "Acuteacalculouscholecystitis: 5% of casesRisk factors include critical illness, burns, trauma, major surgical procedures, diabetes, immunosuppression",
                    "sub_points": [
                      "Risk factors include critical illness, burns, trauma, major surgical procedures, diabetes, immunosuppression"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Right upper quadrant pain, tenderness, and guarding"
                  },
                  {
                    "text": "Fever, leukocytosis"
                  },
                  {
                    "text": "Laparoscopic cholecystectomy is procedure of choice"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Mural thickening, congestion, purulent exudate, adhesions"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Changes depend on duration of diseaseInflammation may be sparse in early diseaseEdema and congestion seen in early disease",
                    "sub_points": [
                      "Inflammation may be sparse in early disease",
                      "Edema and congestion seen in early disease"
                    ]
                  },
                  {
                    "text": "Inflammation dominated by neutrophils and variable necrosis in later stages of disease"
                  },
                  {
                    "text": "Widespread fibroblastic proliferation can occur"
                  },
                  {
                    "text": "Transmural fibrosis and Rokitansky-Aschoff (RA) sinuses, stigmata of chronic cholecystitis, may be present"
                  },
                  {
                    "text": "Variant formsXanthogranulomatous: Foamy macrophages as result of response to bile from ruptured RA sinusesEmphysematous: Necrotic wall with gas bubbles and often contains Gram(+) bacilliEosinophilic: Eosinophils comprise > 90% of infiltrate; may be associated with parasites, hypereosinophilic syndrome",
                    "sub_points": [
                      "Xanthogranulomatous: Foamy macrophages as result of response to bile from ruptured RA sinuses",
                      "Emphysematous: Necrotic wall with gas bubbles and often contains Gram(+) bacilli",
                      "Eosinophilic: Eosinophils comprise > 90% of infiltrate; may be associated with parasites, hypereosinophilic syndrome"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chronic cholecystitis"
                  },
                  {
                    "text": "Dysplasia or carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute inflammation of gallbladder"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Acute Calculous Cholecystitis": [
                  {
                    "text": "Key elements are cystic duct obstruction by stones"
                  },
                  {
                    "text": "Trauma to mucosa releases phospholipase from lysosomesPhospholipase converts lecithin in bile to lysolecithin, which damages gallbladder epithelium",
                    "sub_points": [
                      "Phospholipase converts lecithin in bile to lysolecithin, which damages gallbladder epithelium"
                    ]
                  },
                  {
                    "text": "Secondary bacterial infection with enteric organisms occurs in 20% of cases"
                  },
                  {
                    "text": "Overgrowth by gas-producing organisms leads to emphysematous cholecystitis"
                  }
                ],
                "Acute Acalculous Cholecystitis": [
                  {
                    "text": "Accounts for 5% of cases"
                  },
                  {
                    "text": "Risk factorsCritical illness, burns, trauma, major surgical procedures, diabetes, immunosuppression, vasculitisCommon elements in this group of disorders are biliary sludge formation and mucosal ischemiaPediatric cases can result from systemic viral infections and immune-related disorders",
                    "sub_points": [
                      "Critical illness, burns, trauma, major surgical procedures, diabetes, immunosuppression, vasculitisCommon elements in this group of disorders are biliary sludge formation and mucosal ischemia",
                      "Common elements in this group of disorders are biliary sludge formation and mucosal ischemia",
                      "Pediatric cases can result from systemic viral infections and immune-related disorders"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Commonly seen between 40-80 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "F > M"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Right upper quadrant pain, tenderness, and guarding"
                  },
                  {
                    "text": "Fever, leukocytosis"
                  },
                  {
                    "text": "Murphy sign: Arrest of inspiration while palpating gallbladder during deep inspiration"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Early laparoscopic cholecystectomy is treatment of choice"
                  },
                  {
                    "text": "Conservative measures reserved for poor surgical candidatesPercutaneous cholecystostomy may be performed",
                    "sub_points": [
                      "Percutaneous cholecystostomy may be performed"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Acute acalculous cholecystitis, unlike acute calculous cholecystitis, is associated with high mortality"
                  }
                ],
                "Complications": [
                  {
                    "text": "Gangrenous cholecystitis"
                  },
                  {
                    "text": "Perforation"
                  },
                  {
                    "text": "Emphysematous cholecystitisCaused by overgrowth by gas-producing organisms",
                    "sub_points": [
                      "Caused by overgrowth by gas-producing organisms"
                    ]
                  },
                  {
                    "text": "Empyema of gallbladder"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Gallstones in 95% of cases"
                  },
                  {
                    "text": "Thickening of gallbladder (> 5 mm), pericholecystic fluid, ultrasonographic Murphy sign"
                  }
                ],
                "Hepatobiliary Scintigraphy": [
                  {
                    "text": "Absence of gallbladder filling within 60 minutes after tracer administration indicates acute cholecystitis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Thickened congested wall, may appear necrotic"
                  },
                  {
                    "text": "Serosa dull, occasionally with fibrinopurulent exudates"
                  },
                  {
                    "text": "Mucosal edema and ulceration; pus may be present"
                  },
                  {
                    "text": "95% have stones"
                  },
                  {
                    "text": "Serosal adhesions"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Changes depend on duration of diseaseEdema, congestion, and hemorrhage in early diseaseMay lack inflammation altogether",
                    "sub_points": [
                      "Edema, congestion, and hemorrhage in early diseaseMay lack inflammation altogether",
                      "May lack inflammation altogether"
                    ]
                  },
                  {
                    "text": "Inflammatory infiltrateAcute inflammation with neutrophil predominanceEosinophils, macrophages, and lymphocytes appear laterEventually transmural inflammation, secondary vasculitis, and mural necrosis develop",
                    "sub_points": [
                      "Acute inflammation with neutrophil predominance",
                      "Eosinophils, macrophages, and lymphocytes appear later",
                      "Eventually transmural inflammation, secondary vasculitis, and mural necrosis develop"
                    ]
                  },
                  {
                    "text": "Fibroblastic proliferation with tissue culture-like look"
                  },
                  {
                    "text": "Mucosal ulceration"
                  },
                  {
                    "text": "Transmural fibrosis and Rokitansky-Aschoff (RA) sinuses, stigmata of chronic cholecystitis, may be present"
                  },
                  {
                    "text": "Calculous and noncalculous forms are histologically similar"
                  },
                  {
                    "text": "Variant formsXanthogranulomatous: Foamy macrophages as result of response to bile from ruptured RA sinusesEmphysematous: Necrotic wall with gas bubbles and often contains Gram(+) bacilliEosinophilic: > 90% of infiltrate is eosinophils; may be associated with parasites, hypereosinophilic syndrome",
                    "sub_points": [
                      "Xanthogranulomatous: Foamy macrophages as result of response to bile from ruptured RA sinuses",
                      "Emphysematous: Necrotic wall with gas bubbles and often contains Gram(+) bacilli",
                      "Eosinophilic: > 90% of infiltrate is eosinophils; may be associated with parasites, hypereosinophilic syndrome"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Cholecystitis": [
                  {
                    "text": "Lacks acute inflammation"
                  }
                ],
                "Gallbladder Dysplasia and Carcinoma": [
                  {
                    "text": "Cytoarchitectural atypia separates neoplasia from regenerative changes"
                  },
                  {
                    "text": "Ulceration and inflammation can be seen on both neoplastic and reactive settings"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Cholecystitis": {
            "name": "Chronic Cholecystitis",
            "url": "https://app.pathprimer.com/document/a481ecf7-a9ae-4dfd-8f0d-86f526ab586e/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Almost always associated with gallstonesRadiolucent cholesterol stonesRisk factors: Old age, female sex, obesity, hyperlipidemia, bile transport defects, such as MDR3 deficiency (low-phospholipid-associated cholelithiasis syndrome)Radiopaque pigment stonesRisk factors: Chronic hemolysis, biliary infection, and gastrointestinal diseases affecting bile salt reabsorption",
                    "sub_points": [
                      "Radiolucent cholesterol stones",
                      "Risk factors: Old age, female sex, obesity, hyperlipidemia, bile transport defects, such as MDR3 deficiency (low-phospholipid-associated cholelithiasis syndrome)",
                      "Radiopaque pigment stones",
                      "Risk factors: Chronic hemolysis, biliary infection, and gastrointestinal diseases affecting bile salt reabsorption"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "More common in women: ~ 3:1"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Predominantly mononuclear inflammatory infiltrate with lymphocytes dominating over plasma cells and histiocytes"
                  },
                  {
                    "text": "Minor component of eosinophils and neutrophils may be present"
                  },
                  {
                    "text": "Wall thickening secondary to muscular hypertrophy and fibrosis"
                  },
                  {
                    "text": "Metaplastic changes; most common is antral type"
                  },
                  {
                    "text": "Rokitansky-Aschoff sinuses"
                  },
                  {
                    "text": "Histologic variantsFollicular cholecystitis: Prominent lymphoid folliclesLymphoplasmacytic sclerosing cholecystitis (IgG4 related): Often associated with autoimmune pancreatitisEosinophilic cholecystitis: > 90% of infiltrate composed of eosinophils",
                    "sub_points": [
                      "Follicular cholecystitis: Prominent lymphoid follicles",
                      "Lymphoplasmacytic sclerosing cholecystitis (IgG4 related): Often associated with autoimmune pancreatitis",
                      "Eosinophilic cholecystitis: > 90% of infiltrate composed of eosinophils"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal gallbladder"
                  },
                  {
                    "text": "Acute cholecystitis"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Presence of gallstones is neither necessary nor sufficient for diagnosis of chronic cholecystitis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Chronic inflammation of gallbladder"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Pathogenesis": [
                  {
                    "text": "Almost always associated with gallstonesCholesterol stones (80% in West): Supersaturation of bile with cholesterolRisk factors: Old age, female sex, obesity, hyperlipidemia, bile transport defects, such as MDR3 deficiency (low-phospholipid-associated cholelithiasis syndrome)Pigment stones composed of bilirubin calcium saltsRisk factors: Chronic hemolysis, biliary infection, gastrointestinal diseases affecting bile salt reabsorptionPure cholesterol stones are radiolucent, whereas pigment stones are radiopaque",
                    "sub_points": [
                      "Cholesterol stones (80% in West): Supersaturation of bile with cholesterolRisk factors: Old age, female sex, obesity, hyperlipidemia, bile transport defects, such as MDR3 deficiency (low-phospholipid-associated cholelithiasis syndrome)",
                      "Risk factors: Old age, female sex, obesity, hyperlipidemia, bile transport defects, such as MDR3 deficiency (low-phospholipid-associated cholelithiasis syndrome)",
                      "Pigment stones composed of bilirubin calcium saltsRisk factors: Chronic hemolysis, biliary infection, gastrointestinal diseases affecting bile salt reabsorption",
                      "Risk factors: Chronic hemolysis, biliary infection, gastrointestinal diseases affecting bile salt reabsorption",
                      "Pure cholesterol stones are radiolucent, whereas pigment stones are radiopaque"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "40s or 50s"
                  }
                ],
                "Sex": [
                  {
                    "text": "More common in women (3:1)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Episodic, steady, abdominal pain (\"biliary colic\")Usually located in epigastrium or right upper quadrantMay be precipitated by ingestion of food",
                    "sub_points": [
                      "Usually located in epigastrium or right upper quadrant",
                      "May be precipitated by ingestion of food"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cholecystectomy is curative"
                  }
                ],
                "Complications": [
                  {
                    "text": "Perforation, choledocholithiasis, gallstone pancreatitis, Mirizzi syndrome (impaction of gallstone in cystic duct)"
                  },
                  {
                    "text": "Risk factor for adenocarcinoma"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Demonstrate stones and abnormalities in gallbladder wall"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Variable, depending on degree of inflammation and fibrosisNormal or mild wall thickening and serosal adhesionsShrunken with marked wall thickening and scarring",
                    "sub_points": [
                      "Normal or mild wall thickening and serosal adhesions",
                      "Shrunken with marked wall thickening and scarring"
                    ]
                  },
                  {
                    "text": "Mucosa may be flattened, granular, ulcerated, or polypoid"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "InflammationPredominantly lymphocytic infiltrateFocal or diffuse in lamina propria, may extend into muscularis and pericholecystic tissuesMinor component of eosinophils and neutrophils",
                    "sub_points": [
                      "Predominantly lymphocytic infiltrate",
                      "Focal or diffuse in lamina propria, may extend into muscularis and pericholecystic tissues",
                      "Minor component of eosinophils and neutrophils"
                    ]
                  },
                  {
                    "text": "Wall thickeningSecondary to muscular hypertrophy and fibrosisAdventitia is frequently thickened with diffuse scarring",
                    "sub_points": [
                      "Secondary to muscular hypertrophy and fibrosis",
                      "Adventitia is frequently thickened with diffuse scarring"
                    ]
                  },
                  {
                    "text": "Metaplastic changesGastric (pyloric/antral or foveolar type)Intestinal metaplasia, rarely squamous",
                    "sub_points": [
                      "Gastric (pyloric/antral or foveolar type)",
                      "Intestinal metaplasia, rarely squamous"
                    ]
                  },
                  {
                    "text": "Rokitansky-Aschoff sinusesHerniation of mucosa into or through muscularisIndicative of increased intraluminal pressure or outflow obstructionCommonly associated with hypertrophic muscularisNot sufficient for diagnosis by itself",
                    "sub_points": [
                      "Herniation of mucosa into or through muscularis",
                      "Indicative of increased intraluminal pressure or outflow obstruction",
                      "Commonly associated with hypertrophic muscularis",
                      "Not sufficient for diagnosis by itself"
                    ]
                  },
                  {
                    "text": "VariantsFollicular cholecystitisNumerous lymphoid follicles with germinal centersLarge follicles can appear as polypsMay occur with infections [especially gram(-)] and primary sclerosing cholangitisChronic acalculous cholecystitisNo gallstonesVariant with diffuse lymphoplasmacytic infiltrate confined to lamina propria may be associated with extrahepatic bile duct obstructionPorcelain gallbladderDystrophic calcification resembling eggshellAssociated with higher risk of carcinomaLymphoplasmacytic sclerosing cholecystitis (IgG4 related)Often associated with autoimmune pancreatitisDense lymphoplasmacytic infiltrate, often with eosinophils and prominent extramural involvementPhlebitis and inflammatory pseudotumor-like nodulesIncreased IgG4(+) plasma cells on immunohistochemistry (typically > 10 per HPF)Increased IgG4:IgG (+) plasma cells with ratio of ≥ 0.4Eosinophilic cholecystitisRare entity with eosinophils comprising > 90% of inflammatory cellsOften idiopathic but has been associated with hypereosinophilic syndrome, adverse drug reaction, allergies, systemic vasculitides, and parasitic infestationShould be distinguished from Langerhans cell histiocytosis",
                    "sub_points": [
                      "Follicular cholecystitisNumerous lymphoid follicles with germinal centersLarge follicles can appear as polypsMay occur with infections [especially gram(-)] and primary sclerosing cholangitis",
                      "Numerous lymphoid follicles with germinal centers",
                      "Large follicles can appear as polyps",
                      "May occur with infections [especially gram(-)] and primary sclerosing cholangitis",
                      "Chronic acalculous cholecystitisNo gallstonesVariant with diffuse lymphoplasmacytic infiltrate confined to lamina propria may be associated with extrahepatic bile duct obstruction",
                      "No gallstones",
                      "Variant with diffuse lymphoplasmacytic infiltrate confined to lamina propria may be associated with extrahepatic bile duct obstruction",
                      "Porcelain gallbladderDystrophic calcification resembling eggshellAssociated with higher risk of carcinoma",
                      "Dystrophic calcification resembling eggshell",
                      "Associated with higher risk of carcinoma",
                      "Lymphoplasmacytic sclerosing cholecystitis (IgG4 related)Often associated with autoimmune pancreatitisDense lymphoplasmacytic infiltrate, often with eosinophils and prominent extramural involvementPhlebitis and inflammatory pseudotumor-like nodulesIncreased IgG4(+) plasma cells on immunohistochemistry (typically > 10 per HPF)Increased IgG4:IgG (+) plasma cells with ratio of ≥ 0.4",
                      "Often associated with autoimmune pancreatitis",
                      "Dense lymphoplasmacytic infiltrate, often with eosinophils and prominent extramural involvement",
                      "Phlebitis and inflammatory pseudotumor-like nodules",
                      "Increased IgG4(+) plasma cells on immunohistochemistry (typically > 10 per HPF)",
                      "Increased IgG4:IgG (+) plasma cells with ratio of ≥ 0.4",
                      "Eosinophilic cholecystitisRare entity with eosinophils comprising > 90% of inflammatory cellsOften idiopathic but has been associated with hypereosinophilic syndrome, adverse drug reaction, allergies, systemic vasculitides, and parasitic infestationShould be distinguished from Langerhans cell histiocytosis",
                      "Rare entity with eosinophils comprising > 90% of inflammatory cells",
                      "Often idiopathic but has been associated with hypereosinophilic syndrome, adverse drug reaction, allergies, systemic vasculitides, and parasitic infestation",
                      "Should be distinguished from Langerhans cell histiocytosis"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Gallbladder": [
                  {
                    "text": "Sparse, focally distributed lymphoid cells"
                  },
                  {
                    "text": "Lacks fibrosis, Rokitansky-Aschoff sinuses"
                  }
                ],
                "Acute Cholecystitis": [
                  {
                    "text": "Acute inflammation, edema, hemorrhage"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Gallstones are not necessary nor sufficient for diagnosis"
                  },
                  {
                    "text": "Normal gallbladder contains some chronic inflammatory cells"
                  },
                  {
                    "text": "Histology can be normal even with symptomatic lithiasis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Xanthogranulomatous Cholecystitis": {
            "name": "Xanthogranulomatous Cholecystitis",
            "url": "https://app.pathprimer.com/document/d97dff72-97df-402d-a270-e9a22fa3b11f/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Variant of chronic cholecystitis featuring florid proliferation of foamy macrophages and granulomatous reaction to bile"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Usually preceded by rupture of Rokitansky-Aschoff sinusProduces granulomatous reaction to extruded bile and lipid",
                    "sub_points": [
                      "Produces granulomatous reaction to extruded bile and lipid"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "2-9% of cholecystectomy specimensMajority of cases associated with gallstones",
                    "sub_points": [
                      "Majority of cases associated with gallstones"
                    ]
                  },
                  {
                    "text": "Can mimic malignancy radiographically and grossly"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Cream to brown tumor-like masses, nodules, or plaquesUsually intramural, typically multipleRange from few millimeters up to 3 cm",
                    "sub_points": [
                      "Usually intramural, typically multiple",
                      "Range from few millimeters up to 3 cm"
                    ]
                  },
                  {
                    "text": "Gallbladder wall often markedly thickened (up to 2 cm)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Spectrum of granulomatous lesions centered on ruptured Rokitansky-Aschoff sinusesRange of lesions from loose aggregates of foamy histiocytes to granulomasAssociated ceroid pigment, bile, cholesterol clefts",
                    "sub_points": [
                      "Range of lesions from loose aggregates of foamy histiocytes to granulomas",
                      "Associated ceroid pigment, bile, cholesterol clefts"
                    ]
                  },
                  {
                    "text": "Pools of extravasated bile may be present in wall of gallbladder"
                  },
                  {
                    "text": "Occasionally histiocytes are spindled, mimicking mesenchymal neoplasm"
                  },
                  {
                    "text": "Over time, organization occurs, and fibrosis may predominate"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Carcinoma of gallbladder"
                  },
                  {
                    "text": "IgG4-related disease"
                  },
                  {
                    "text": "Malakoplakia"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Cholegranulomas, cholecystic granulomas, ceroid granulomas"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Variant of chronic cholecystitis featuring florid proliferation of foamy macrophages and granulomatous reaction to bileNamed due to histologic similarity to xanthogranulomatous pyelonephritis",
                    "sub_points": [
                      "Named due to histologic similarity to xanthogranulomatous pyelonephritis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Reaction to Bile": [
                  {
                    "text": "Usually preceded by rupture of Rokitansky-Aschoff sinusBile and lipid extruded into gallbladder wall, producing granulomatous reaction",
                    "sub_points": [
                      "Bile and lipid extruded into gallbladder wall, producing granulomatous reaction"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2-9% of cholecystectomy specimens"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to chronic cholecystitis"
                  },
                  {
                    "text": "May be clinically and radiologically mistaken as gallbladder cancer"
                  },
                  {
                    "text": "Majority of cases associated with gallstones"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cholecystectomy"
                  },
                  {
                    "text": "~ 15% of xanthogranulomatous cholecystitis cases have to be converted from laparoscopic to open surgeryInflammation extends from gallbladder to other organs to form adhesions or fistulas",
                    "sub_points": [
                      "Inflammation extends from gallbladder to other organs to form adhesions or fistulas"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Surgery is generally curative"
                  },
                  {
                    "text": "No established association with cholangiocarcinomaRare reports of elevated CA19-9 associated with xanthogranulomatous cholecystitis",
                    "sub_points": [
                      "Rare reports of elevated CA19-9 associated with xanthogranulomatous cholecystitis"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Thickened wall with echogenic, isoechoic, or hyperechoic nodules"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Tumor-like masses, nodules, or plaquesOften multipleUsually intramuralCan produce mucosal masses as well, with overlying mucosal ulcerationPoorly circumscribed, soft, cream to brown color, ranging from few millimeters up to 3.0 cm",
                    "sub_points": [
                      "Often multiple",
                      "Usually intramuralCan produce mucosal masses as well, with overlying mucosal ulceration",
                      "Can produce mucosal masses as well, with overlying mucosal ulceration",
                      "Poorly circumscribed, soft, cream to brown color, ranging from few millimeters up to 3.0 cm"
                    ]
                  },
                  {
                    "text": "Gallbladder wall often markedly thickened (up to 2.0 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Spectrum of granulomatous lesionsUsually centered on ruptured Rokitansky-Aschoff sinusesOften produces mural nodules that may ulcerate mucosa as they expandFoamy histiocyte infiltrate or loosely formed granulomasHistiocytes may contain light brown ceroid granules, fat, or cholesterol cleftsBile may be present in center of granulomaMultinucleate giant cells are commonOccasionally histiocytes are spindledMixture of other inflammatory cells, especially lymphocytes, with occasional neutrophils",
                    "sub_points": [
                      "Usually centered on ruptured Rokitansky-Aschoff sinuses",
                      "Often produces mural nodules that may ulcerate mucosa as they expand",
                      "Foamy histiocyte infiltrate or loosely formed granulomasHistiocytes may contain light brown ceroid granules, fat, or cholesterol cleftsBile may be present in center of granulomaMultinucleate giant cells are commonOccasionally histiocytes are spindled",
                      "Histiocytes may contain light brown ceroid granules, fat, or cholesterol clefts",
                      "Bile may be present in center of granuloma",
                      "Multinucleate giant cells are common",
                      "Occasionally histiocytes are spindled",
                      "Mixture of other inflammatory cells, especially lymphocytes, with occasional neutrophils"
                    ]
                  },
                  {
                    "text": "Pools of extravasated bile may be present in wall of gallbladder"
                  },
                  {
                    "text": "Over time, organization occurs, and fibrosis may predominateCalcifications also seen in older lesions",
                    "sub_points": [
                      "Calcifications also seen in older lesions"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Carcinoma": [
                  {
                    "text": "Nodules and markedly thickened wall of xanthogranulomatous cholecystitis can mimic malignancy both grossly and radiographicallySurgeons may submit frozen section of xanthogranulomatous cholecystitis to rule out malignancyIf spindled, macrophages can mimic mesenchymal neoplasmMacrophages mark with CD68, CD163",
                    "sub_points": [
                      "Surgeons may submit frozen section of xanthogranulomatous cholecystitis to rule out malignancy",
                      "If spindled, macrophages can mimic mesenchymal neoplasmMacrophages mark with CD68, CD163",
                      "Macrophages mark with CD68, CD163"
                    ]
                  }
                ],
                "Malakoplakia": [
                  {
                    "text": "Has Michaelis-Gutmann bodies"
                  },
                  {
                    "text": "Lacks ceroid-laden histiocytes, cholesterol clefts, and bile"
                  }
                ],
                "IgG4-Related Disease": [
                  {
                    "text": "Dense lymphoplasmocytic infiltration with high numbers of IgG4(+) plasma cells, storiform fibrosis, obliterative phlebitis"
                  },
                  {
                    "text": "Obliterative phlebitis and storiform fibrosis are not typical features of xanthogranulomatous cholecystitis"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Markedly thickened gallbladder wall may mimic malignancy grossly and radiographically"
                  },
                  {
                    "text": "Spindled variant of xanthogranulomatous cholecystitis may mimic mesenchymal neoplasm"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Eosinophilic Cholecystitis": {
            "name": "Eosinophilic Cholecystitis",
            "url": "https://app.pathprimer.com/document/7838c1be-2d6e-4f15-b516-13de23416598/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Inflammatory disease of gallbladder in which inflammatory infiltrate is composed predominantly of eosinophilsProbably not distinct entity, but rather descriptive designation with associated clinical correlates",
                    "sub_points": [
                      "Probably not distinct entity, but rather descriptive designation with associated clinical correlates"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Majority of cases have no known cause or disease association"
                  },
                  {
                    "text": "Some associated with hypersensitivity reactions, parasitic infection, other eosinophilic diseasesHypersensitivity reaction to bile and bile stones has been hypothesized but never proven",
                    "sub_points": [
                      "Hypersensitivity reaction to bile and bile stones has been hypothesized but never proven"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Presenting signs are similar to other forms of cholecystitis"
                  },
                  {
                    "text": "Peripheral eosinophilia may be present"
                  },
                  {
                    "text": "Gallstones often present"
                  },
                  {
                    "text": "Diagnosis virtually always made following resection of gallbladder for symptomatic disease"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Thickened gallbladder wall"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Dense eosinophilic infiltrate of gallbladderTypically > 50% of inflammatory infiltrate is composed of eosinophilsSo-called lymphoeosinophilic cholecystitis shows significant component of lymphocytes as wellIn \"true\" or \"pure\" eosinophilic cholecystitis, close to 100% of inflammatory component is composed of eosinophils",
                    "sub_points": [
                      "Typically > 50% of inflammatory infiltrate is composed of eosinophils",
                      "So-called lymphoeosinophilic cholecystitis shows significant component of lymphocytes as well",
                      "In \"true\" or \"pure\" eosinophilic cholecystitis, close to 100% of inflammatory component is composed of eosinophils"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chronic cholecystitis"
                  },
                  {
                    "text": "Acute and subacute cholecystitis with cholelithiasis"
                  },
                  {
                    "text": "Churg-Strauss syndrome"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Eosinophilic cholecystitis (EC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Inflammatory disease of gallbladder in which inflammatory infiltrate is composed predominantly of eosinophilsSome reserve this term for cases in which infiltrate is purely eosinophilicProbably not distinct entity, but rather histologic patternRare, < 1-2% of cholecystectomies",
                    "sub_points": [
                      "Some reserve this term for cases in which infiltrate is purely eosinophilic",
                      "Probably not distinct entity, but rather histologic pattern",
                      "Rare, < 1-2% of cholecystectomies"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Majority of cases have no specific underlying cause or disease association"
                  },
                  {
                    "text": "Some cases associated with hypersensitivity reaction to drugs or with infections (Echinococcus,Clonorchis sinensis)"
                  },
                  {
                    "text": "Some cases associated with other eosinophilic diseasesEosinophilic gastroenteritis, eosinophilic cholangitis, hypereosinophilic syndrome",
                    "sub_points": [
                      "Eosinophilic gastroenteritis, eosinophilic cholangitis, hypereosinophilic syndrome"
                    ]
                  },
                  {
                    "text": "Hypersensitivity reaction to bile and bile stones has been hypothesized but never proven"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Presenting signs are similar to other forms of acute and chronic cholecystitisRight upper quadrant pain, biliary colic",
                    "sub_points": [
                      "Right upper quadrant pain, biliary colic"
                    ]
                  },
                  {
                    "text": "Variably present peripheral eosinophilia"
                  },
                  {
                    "text": "Originally thought that stones are less commonly seen in EC than in other forms of acute and chronic cholecystitisMore current reports show frequent occurrence of gallstones with EC",
                    "sub_points": [
                      "More current reports show frequent occurrence of gallstones with EC"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "CholecystectomyDiagnosis is invariably made following evaluation of gallbladder specimen",
                    "sub_points": [
                      "Diagnosis is invariably made following evaluation of gallbladder specimen"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Cholecystectomy is curative, and disease does not recur"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Thickened gallbladder wall; bile ducts may also be thickened"
                  },
                  {
                    "text": "Gallstones are often present"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Thickened and inflamed gallbladder wallPredominantly eosinophilic infiltrateTypically > 50% of inflammatory infiltrate is composed of eosinophilsSheets and clusters of eosinophils infiltrate mucosa, muscularis propria, and subserosaInflammation may preferentially involve 1 layer of gallbladder wall or may be transmural",
                    "sub_points": [
                      "Predominantly eosinophilic infiltrateTypically > 50% of inflammatory infiltrate is composed of eosinophilsSheets and clusters of eosinophils infiltrate mucosa, muscularis propria, and subserosaInflammation may preferentially involve 1 layer of gallbladder wall or may be transmural",
                      "Typically > 50% of inflammatory infiltrate is composed of eosinophils",
                      "Sheets and clusters of eosinophils infiltrate mucosa, muscularis propria, and subserosa",
                      "Inflammation may preferentially involve 1 layer of gallbladder wall or may be transmural"
                    ]
                  },
                  {
                    "text": "VariationsIn \"true\" or \"pure\" EC, close to 100% of inflammatory component is composed of eosinophilsMore rare than lymphoeosinophilic formSo-called lymphoeosinophilic cholecystitis shows significant component of lymphocytes as well",
                    "sub_points": [
                      "In \"true\" or \"pure\" EC, close to 100% of inflammatory component is composed of eosinophilsMore rare than lymphoeosinophilic form",
                      "More rare than lymphoeosinophilic form",
                      "So-called lymphoeosinophilic cholecystitis shows significant component of lymphocytes as well"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Cholecystitis": [
                  {
                    "text": "Subacute phase of acute cholecystitis may show significant tissue eosinophilia"
                  },
                  {
                    "text": "Dense sheets and significant clustering of eosinophils are not seen in chronic calculous cholecystitis"
                  }
                ],
                "Acute and Subacute Cholecystitis With Cholelithiasis": [
                  {
                    "text": "Frequent admixture of neutrophils and eosinophils, particularly in instances of acute cholecystitis in which cholecystectomy is delayed"
                  },
                  {
                    "text": "However, eosinophils do not typically dominate infiltrate"
                  }
                ],
                "Autoimmune Pancreatitis-Associated Cholecystitis": [
                  {
                    "text": "Gallbladder inflammation associated with autoimmune pancreatitis is dominated by lymphocytes and plasma cellsCan show significant numbers of eosinophils",
                    "sub_points": [
                      "Can show significant numbers of eosinophils"
                    ]
                  },
                  {
                    "text": "Elevated numbers of IgG4(+) plasma cells help distinguish this entity from EC"
                  }
                ],
                "Churg-Strauss Syndrome": [
                  {
                    "text": "EC lacks significant vascular infiltration by eosinophils and should not have vascular damage"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Predominance of eosinophils in inflamed gallbladder"
                  },
                  {
                    "text": "May be associated with other eosinophilic diseases or peripheral eosinophiliaMost cases have no specific disease association",
                    "sub_points": [
                      "Most cases have no specific disease association"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Polyarteritis Nodosa and Other Vasculitides": {
            "name": "Polyarteritis Nodosa and Other Vasculitides",
            "url": "https://app.pathprimer.com/document/fb68e41f-1e4c-43bf-91c6-b973fcf909cc/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Vasculitis: Group of disorders with variable etiology and presentations that produce inflammation and destruction of blood vessels"
                  },
                  {
                    "text": "Polyarteritis nodosa (PAN): Necrotizing systemic vasculitis that frequently affects skin, kidneys, peripheral nervous system, and gastrointestinal tract"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Immune-mediated or sequela of certain infections"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Liver involved in > 40% of cases of PAN"
                  },
                  {
                    "text": "Gallbladder involvement in PAN most often part of systemic diseaseIsolated form rarely progresses to systemic form, but systemic form may develop up to 1 year later",
                    "sub_points": [
                      "Isolated form rarely progresses to systemic form, but systemic form may develop up to 1 year later"
                    ]
                  },
                  {
                    "text": "Common presenting complaints include fever, abdominal painSigns/symptoms can mimic acute acalculous cholecystitis",
                    "sub_points": [
                      "Signs/symptoms can mimic acute acalculous cholecystitis"
                    ]
                  },
                  {
                    "text": "Laboratory findings usually reflect severe systemic inflammationElevated ESR, CRP, WBC count",
                    "sub_points": [
                      "Elevated ESR, CRP, WBC count"
                    ]
                  },
                  {
                    "text": "Treatment includes combination of steroids and immunosuppressive agents"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Hallmark lesion of PAN is fibrinoid necrosis and destructive inflammation involving medium-sized arteries"
                  },
                  {
                    "text": "As healing occurs, bead-like nodular aneurysm (nodose) may form"
                  },
                  {
                    "text": "Admixture of early and late lesions is common"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cholecystitis: May show perivascular inflammation, lacks fibrinoid necrosis"
                  },
                  {
                    "text": "Other vasculitides that infrequently involve biliary tree: Cryoglobulinemia, rheumatoid arthritis, systemic lupus erythematosus, microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis, IgA vasculitis, giant cell arteritis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Polyarteritis nodosa (PAN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Vasculitis: Group of disorders with variable etiology and presentations that produce inflammation, destruction of blood vessels"
                  },
                  {
                    "text": "PAN: Necrotizing systemic vasculitis that frequently affects skin, kidneys, peripheral nervous system, and gastrointestinal tract"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Idiopathic": [
                  {
                    "text": "PAN: Idiopathic, but frequently associated with chronic hepatitis B infection"
                  },
                  {
                    "text": "Other vasculitides are immune mediated or sequela of infections"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Liver involved in > 40% of cases of PAN, frequently associated with hepatitis B"
                  },
                  {
                    "text": "PAN may be isolated to gallbladder (rare)Systemic form may develop for up to 1 year after presentation",
                    "sub_points": [
                      "Systemic form may develop for up to 1 year after presentation"
                    ]
                  },
                  {
                    "text": "Gallbladder involvement more often part of systemic disease in up to 40% of cases"
                  },
                  {
                    "text": "Signs and symptoms similar to acute acalculous cholecystitis"
                  },
                  {
                    "text": "Liver/gallbladder involvement may be clinically silentLesions discovered incidentally in tissue sections",
                    "sub_points": [
                      "Lesions discovered incidentally in tissue sections"
                    ]
                  },
                  {
                    "text": "Sequelae: Hepatic infarction, arterial rupture with intraabdominal hemorrhage, nodular regenerative hyperplasia"
                  },
                  {
                    "text": "Liver and gallbladder rarely involved in vasculitides other than PAN"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated ESR, CRP, WBC count, serum immunoglobulins"
                  },
                  {
                    "text": "Anemia may be present, secondary to blood loss or renal failure"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Combination of steroids and immunosuppressive agentsOngoing therapy may be required to maintain remission",
                    "sub_points": [
                      "Ongoing therapy may be required to maintain remission"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Angiography": [
                  {
                    "text": "May reveal aneurysms, evidence of vasculitis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Liver": [
                  {
                    "text": "Gross evidence of infarction"
                  },
                  {
                    "text": "May be normal"
                  }
                ],
                "Gallbladder": [
                  {
                    "text": "Thickened, edematous wall"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Hallmark lesion of PAN is fibrinoid necrosis involving medium-sized arteriesInitially involves media with destruction of elastic laminae and smooth muscleOnly segment of wall may be affectedAcute phase endothelial damage may cause thrombosisAs healing occurs, bead-like nodular aneurysm (nodose) may formRecanalized thrombi may be seenUsually, temporal mixture of lesions is present, ranging from early to completely scarred",
                    "sub_points": [
                      "Initially involves media with destruction of elastic laminae and smooth muscle",
                      "Only segment of wall may be affected",
                      "Acute phase endothelial damage may cause thrombosis",
                      "As healing occurs, bead-like nodular aneurysm (nodose) may form",
                      "Recanalized thrombi may be seen",
                      "Usually, temporal mixture of lesions is present, ranging from early to completely scarred"
                    ]
                  },
                  {
                    "text": "Often accompanied by mixed inflammatory infiltrateEosinophils may be prominent",
                    "sub_points": [
                      "Eosinophils may be prominent"
                    ]
                  },
                  {
                    "text": "Infarction, mucosal ulceration (gallbladder) may be present"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cholecystitis": [
                  {
                    "text": "Acute, chronic, and eosinophilic cholecystitis may show perivascular inflammation; lacks fibrinoid necrosis"
                  }
                ],
                "Vasculitides That Rarely Involve Biliary Tree": [
                  {
                    "text": "CryoglobulinemiaAssociated with hepatitis CLeukocytoclastic vasculitis: Fibrinoid vessel wall necrosis with neutrophil-rich infiltrates involving capillaries, arterioles",
                    "sub_points": [
                      "Associated with hepatitis C",
                      "Leukocytoclastic vasculitis: Fibrinoid vessel wall necrosis with neutrophil-rich infiltrates involving capillaries, arterioles"
                    ]
                  },
                  {
                    "text": "Rheumatoid arthritis-associated vasculitisNecrotizing inflammation of small-to-medium-sized arteries",
                    "sub_points": [
                      "Necrotizing inflammation of small-to-medium-sized arteries"
                    ]
                  },
                  {
                    "text": "Systemic lupus erythematosusMultiorgan diseaseFibrinoid necrosis of venules and arterioles, immune complex deposits on immunofluorescence",
                    "sub_points": [
                      "Multiorgan disease",
                      "Fibrinoid necrosis of venules and arterioles, immune complex deposits on immunofluorescence"
                    ]
                  },
                  {
                    "text": "Microscopic polyangiitisRapidly progressive glomerulonephritisNecrotizing vasculitis of arterioles, capillaries, venules",
                    "sub_points": [
                      "Rapidly progressive glomerulonephritis",
                      "Necrotizing vasculitis of arterioles, capillaries, venules"
                    ]
                  },
                  {
                    "text": "Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)Asthma, sinusitis, neuropathy, peripheral eosinophiliaNecrotizing vasculitis with eosinophil-rich inflammation and extravascular granulomas",
                    "sub_points": [
                      "Asthma, sinusitis, neuropathy, peripheral eosinophilia",
                      "Necrotizing vasculitis with eosinophil-rich inflammation and extravascular granulomas"
                    ]
                  },
                  {
                    "text": "IgA vasculitis (Henoch-Schönlein purpura)Most common vasculitis in children; sequela of streptococcal pharyngitis, nonblanching purpura, arthralgias, nephritis, diarrheaLeukocytoclastic vasculitis, IgA deposits in vessel walls on immunofluorescence",
                    "sub_points": [
                      "Most common vasculitis in children; sequela of streptococcal pharyngitis, nonblanching purpura, arthralgias, nephritis, diarrhea",
                      "Leukocytoclastic vasculitis, IgA deposits in vessel walls on immunofluorescence"
                    ]
                  },
                  {
                    "text": "Giant cell arteritisHeadaches, visual disturbance, claudicationLymphohistiocytic infiltrates with giant cells, necrosis, intimal thickening of arteries, disrupted elastic lamina",
                    "sub_points": [
                      "Headaches, visual disturbance, claudication",
                      "Lymphohistiocytic infiltrates with giant cells, necrosis, intimal thickening of arteries, disrupted elastic lamina"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Parasitic Infection": {
            "name": "Parasitic Infection",
            "url": "https://app.pathprimer.com/document/a1f76515-228f-4f77-8848-1ce488bb011f/lesson/ed11d970-de34-4425-8f31-580de747cab5",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Infection of bile ducts by parasiteUsually protozoan (Cryptosporidia, Cystoisospora) or helminth (liver fluke, schistosomiasis, ascariasis)",
                    "sub_points": [
                      "Usually protozoan (Cryptosporidia, Cystoisospora) or helminth (liver fluke, schistosomiasis, ascariasis)"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Protozoal infection usually seen in context of AIDS (AIDS cholangiopathy)Can mimic primary sclerosing cholangitis radiographicallyCryptosporidiumis most common pathogen associated with AIDS cholangiopathy",
                    "sub_points": [
                      "Can mimic primary sclerosing cholangitis radiographically",
                      "Cryptosporidiumis most common pathogen associated with AIDS cholangiopathy"
                    ]
                  },
                  {
                    "text": "Helminths often present with fever, right upper quadrant pain, signs of biliary obstruction, hepatomegaly"
                  },
                  {
                    "text": "Prognosis depends on specific infection and status of hostSequelae ofClonorchis,Opisthorchisinfection include cholangiocarcinoma, recurrent pyogenic cholangiohepatitis",
                    "sub_points": [
                      "Sequelae ofClonorchis,Opisthorchisinfection include cholangiocarcinoma, recurrent pyogenic cholangiohepatitis"
                    ]
                  },
                  {
                    "text": "Variably elevated liver tests"
                  },
                  {
                    "text": "Ancillary testsSerologies forFasciola, SchistosomaspeciesExamination of stool or bile for eggsStool examination with special stains forCryptosporidium, Cystoisospora, Microsporidia",
                    "sub_points": [
                      "Serologies forFasciola, Schistosomaspecies",
                      "Examination of stool or bile for eggs",
                      "Stool examination with special stains forCryptosporidium, Cystoisospora, Microsporidia"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Clonorchis,Opisthorchis,FasciolaWorms often visible to naked eyeVariably present dilation of intrahepatic ducts with mural thickening",
                    "sub_points": [
                      "Worms often visible to naked eye",
                      "Variably present dilation of intrahepatic ducts with mural thickening"
                    ]
                  },
                  {
                    "text": "Ascaris: Large worms easily visible to naked eye"
                  },
                  {
                    "text": "Schistosoma: Fibrosis of bile ducts"
                  },
                  {
                    "text": "Protozoa: Stricture/dilatation of common bile duct"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Protozoa: Epithelial disarray, lymphocytic inflammation, organisms in epithelium"
                  },
                  {
                    "text": "Flukes: Inflammation of ducts with fibrosis, reactive epithelial changes"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Infection of bile ducts by parasite"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Protozoans": [
                  {
                    "text": "Spread by ingestion of contaminated water (swimming pools) or food"
                  },
                  {
                    "text": "CryptosporidiumNotorious for resistance to chlorine water treatment",
                    "sub_points": [
                      "Notorious for resistance to chlorine water treatment"
                    ]
                  },
                  {
                    "text": "MicrosporidiaNow molecularly classified as fungus but discussed with other coccidians due to clinicopathologic similarities",
                    "sub_points": [
                      "Now molecularly classified as fungus but discussed with other coccidians due to clinicopathologic similarities"
                    ]
                  },
                  {
                    "text": "Cystoisospora"
                  }
                ],
                "Helminths": [
                  {
                    "text": "TrematodesLiver flukesClonorchis sinensis(Chinese or Oriental liver fluke)Opisthorchisspecies (Southeast Asian liver fluke or cat liver fluke)O. felineus, O. viverriniFasciolaspeciesF. hepatica, F. giganticaSchistosomaspecies (blood flukes)",
                    "sub_points": [
                      "Liver flukesClonorchis sinensis(Chinese or Oriental liver fluke)Opisthorchisspecies (Southeast Asian liver fluke or cat liver fluke)O. felineus, O. viverriniFasciolaspeciesF. hepatica, F. gigantica",
                      "Clonorchis sinensis(Chinese or Oriental liver fluke)",
                      "Opisthorchisspecies (Southeast Asian liver fluke or cat liver fluke)O. felineus, O. viverrini",
                      "O. felineus, O. viverrini",
                      "FasciolaspeciesF. hepatica, F. gigantica",
                      "F. hepatica, F. gigantica",
                      "Schistosomaspecies (blood flukes)"
                    ]
                  },
                  {
                    "text": "NematodesAscarisspecies",
                    "sub_points": [
                      "Ascarisspecies"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "ProtozoansInfection usually seen in context of AIDSAlso known as AIDS cholangiopathyCD4 T-lymphocyte counts typically < 100Cryptosporidiumis most common pathogen associated with AIDS cholangiopathyCan be seen in transplant patientsRarely seen in immunocompetent patients",
                    "sub_points": [
                      "Infection usually seen in context of AIDS",
                      "Also known as AIDS cholangiopathyCD4 T-lymphocyte counts typically < 100Cryptosporidiumis most common pathogen associated with AIDS cholangiopathy",
                      "CD4 T-lymphocyte counts typically < 100",
                      "Cryptosporidiumis most common pathogen associated with AIDS cholangiopathy",
                      "Can be seen in transplant patients",
                      "Rarely seen in immunocompetent patients"
                    ]
                  },
                  {
                    "text": "ClonorchisandOpisthorchisEndemic in many parts of Asia (ClonorchisandO. viverrini), Russia, and Eastern Europe (O. felineus)Infection acquired from eating raw or undercooked fish and crawfish",
                    "sub_points": [
                      "Endemic in many parts of Asia (ClonorchisandO. viverrini), Russia, and Eastern Europe (O. felineus)Infection acquired from eating raw or undercooked fish and crawfish",
                      "Infection acquired from eating raw or undercooked fish and crawfish"
                    ]
                  },
                  {
                    "text": "FasciolaWorldwide distributionPrimarily disease of sheep and cattleHumans acquire from eating contaminated watercress",
                    "sub_points": [
                      "Worldwide distribution",
                      "Primarily disease of sheep and cattle",
                      "Humans acquire from eating contaminated watercress"
                    ]
                  },
                  {
                    "text": "Schistosomaspecies85% of disease found in sub-Saharan AfricaDepending on species, also found in South America, Middle East, East Asia, other parts of AfricaHumans infected by contaminated water",
                    "sub_points": [
                      "85% of disease found in sub-Saharan Africa",
                      "Depending on species, also found in South America, Middle East, East Asia, other parts of Africa",
                      "Humans infected by contaminated water"
                    ]
                  },
                  {
                    "text": "AscarisspeciesWorldwide distributionEggs present in contaminated soil",
                    "sub_points": [
                      "Worldwide distribution",
                      "Eggs present in contaminated soil"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "ProtozoansStenosis of common bile duct, often distalDilatation &/or stricture of intrahepatic bile ductsSome patients have ERCP abnormalities that mimic primary sclerosing cholangitis (PSC)Symptoms include abdominal pain, occasionally low-grade feverJaundice is rare",
                    "sub_points": [
                      "Stenosis of common bile duct, often distalDilatation &/or stricture of intrahepatic bile ductsSome patients have ERCP abnormalities that mimic primary sclerosing cholangitis (PSC)",
                      "Dilatation &/or stricture of intrahepatic bile ductsSome patients have ERCP abnormalities that mimic primary sclerosing cholangitis (PSC)",
                      "Some patients have ERCP abnormalities that mimic primary sclerosing cholangitis (PSC)",
                      "Symptoms include abdominal pain, occasionally low-grade feverJaundice is rare",
                      "Jaundice is rare"
                    ]
                  },
                  {
                    "text": "ClonorchisandOpisthorchisRight upper quadrant (RUQ) painFatigueAnorexiaDiarrheaHepatomegalyGrowth restriction in childrenLight infectious burden often asymptomatic",
                    "sub_points": [
                      "Right upper quadrant (RUQ) pain",
                      "Fatigue",
                      "Anorexia",
                      "Diarrhea",
                      "Hepatomegaly",
                      "Growth restriction in children",
                      "Light infectious burden often asymptomatic"
                    ]
                  },
                  {
                    "text": "FasciolaAcute fascioliasisFeverHepatomegalyPeripheral eosinophiliaChronic infection presents as biliary colic",
                    "sub_points": [
                      "Acute fascioliasisFeverHepatomegalyPeripheral eosinophilia",
                      "Fever",
                      "Hepatomegaly",
                      "Peripheral eosinophilia",
                      "Chronic infection presents as biliary colic"
                    ]
                  },
                  {
                    "text": "Schistosomaspecies (schistosomiasis)May involve both intra- and extrahepatic bile ductsSigns and symptoms of portal hypertension late in disease courseMRCP findings can mimic PSC",
                    "sub_points": [
                      "May involve both intra- and extrahepatic bile ducts",
                      "Signs and symptoms of portal hypertension late in disease course",
                      "MRCP findings can mimic PSC"
                    ]
                  },
                  {
                    "text": "AscarisWorms in duodenum pass through ampulla of Vater to enter common bile duct, may become trapped in liverSudden onset of severe RUQ pain when worm enters ductVariably present cholestasisMay cause inflammatory masses",
                    "sub_points": [
                      "Worms in duodenum pass through ampulla of Vater to enter common bile duct, may become trapped in liverSudden onset of severe RUQ pain when worm enters ductVariably present cholestasis",
                      "Sudden onset of severe RUQ pain when worm enters duct",
                      "Variably present cholestasis",
                      "May cause inflammatory masses"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Variably elevated liver testsTransaminasesBilirubin, alkaline phosphatase, GGT",
                    "sub_points": [
                      "Transaminases",
                      "Bilirubin, alkaline phosphatase, GGT"
                    ]
                  },
                  {
                    "text": "SerologiesAvailable forFasciola, Schistosomaspecies",
                    "sub_points": [
                      "Available forFasciola, Schistosomaspecies"
                    ]
                  },
                  {
                    "text": "Examination of stool or bile for eggs"
                  },
                  {
                    "text": "Ascarisworms may be passed in stool"
                  },
                  {
                    "text": "Stool examination with special stains forCryptosporidium, Cystoisospora, Microsporidia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cholangiopathy due to protozoal infectionSphincterotomy to relieve obstruction and correct stenosisRestoration of immune function with antiretroviral therapyUrsodeoxycholic acid for symptomatic improvementNo effective antimicrobial regimen forCryptosporidiaCystoisosporamay respond to oral trimethoprim-sulfa + ivermectinMicrosporidiamay respond to albendazole",
                    "sub_points": [
                      "Sphincterotomy to relieve obstruction and correct stenosis",
                      "Restoration of immune function with antiretroviral therapy",
                      "Ursodeoxycholic acid for symptomatic improvement",
                      "No effective antimicrobial regimen forCryptosporidiaCystoisosporamay respond to oral trimethoprim-sulfa + ivermectinMicrosporidiamay respond to albendazole",
                      "Cystoisosporamay respond to oral trimethoprim-sulfa + ivermectin",
                      "Microsporidiamay respond to albendazole"
                    ]
                  },
                  {
                    "text": "Helminths usually treated with medical therapyAscarismay require surgical removal/draining of abscess if worm is trapped in liver",
                    "sub_points": [
                      "Ascarismay require surgical removal/draining of abscess if worm is trapped in liver"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on specific infection and immune status of host"
                  },
                  {
                    "text": "Sequelae ofClonorchis,Opisthorchisinfection include cholangiocarcinoma, recurrent pyogenic cholangiohepatitisFasciolanot associated with malignancy",
                    "sub_points": [
                      "Fasciolanot associated with malignancy"
                    ]
                  },
                  {
                    "text": "AIDS cholangiopathy mortality has decreased due to improved access to antiretroviral therapyStill associated with development of cholangiocarcinoma, sclerosing cholangitis",
                    "sub_points": [
                      "Still associated with development of cholangiocarcinoma, sclerosing cholangitis"
                    ]
                  },
                  {
                    "text": "Mortality associated with schistosomiasis is lowMorbidity correlates with parasite burden, duration, and site of infection",
                    "sub_points": [
                      "Morbidity correlates with parasite burden, duration, and site of infection"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "ProtozoansStricture and dilatation of common bile duct &/or intrahepatic biliary tree",
                    "sub_points": [
                      "Stricture and dilatation of common bile duct &/or intrahepatic biliary tree"
                    ]
                  },
                  {
                    "text": "Clonorchis,Opisthorchis,FasciolaWorms are visible to naked eyeVariably present dilation of intrahepatic ducts with mural thickening",
                    "sub_points": [
                      "Worms are visible to naked eye",
                      "Variably present dilation of intrahepatic ducts with mural thickening"
                    ]
                  },
                  {
                    "text": "SchistosomaspeciesPeriductal fibrosis",
                    "sub_points": [
                      "Periductal fibrosis"
                    ]
                  },
                  {
                    "text": "AscarisLarge worms easily visible to naked eye",
                    "sub_points": [
                      "Large worms easily visible to naked eye"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "ProtozoansSurface epithelial disarray, lymphocytic inflammation; organisms present within epitheliumInflammatory reaction may be minimalIncreased intraepithelial lymphocytesOrganisms present within epitheliumCystoisospora belliEosinophilic, oval, or banana-shaped intraepithelial parasites within perinuclear parasitophorous vacuolesEosinophils may be presentCryptosporidiumRound basophilic inclusions (\"blue beads\") at luminal surfaceMicrosporidiaspeciesSubtle vacuolization in supranuclear cytoplasmDifficult to see on H&EVariably stain with Gram stain, Warthin-Starry, Giemsa, modified trichrome stains",
                    "sub_points": [
                      "Surface epithelial disarray, lymphocytic inflammation; organisms present within epitheliumInflammatory reaction may be minimal",
                      "Inflammatory reaction may be minimal",
                      "Increased intraepithelial lymphocytes",
                      "Organisms present within epitheliumCystoisospora belliEosinophilic, oval, or banana-shaped intraepithelial parasites within perinuclear parasitophorous vacuolesEosinophils may be presentCryptosporidiumRound basophilic inclusions (\"blue beads\") at luminal surfaceMicrosporidiaspeciesSubtle vacuolization in supranuclear cytoplasmDifficult to see on H&EVariably stain with Gram stain, Warthin-Starry, Giemsa, modified trichrome stains",
                      "Cystoisospora belliEosinophilic, oval, or banana-shaped intraepithelial parasites within perinuclear parasitophorous vacuolesEosinophils may be present",
                      "Eosinophilic, oval, or banana-shaped intraepithelial parasites within perinuclear parasitophorous vacuoles",
                      "Eosinophils may be present",
                      "CryptosporidiumRound basophilic inclusions (\"blue beads\") at luminal surface",
                      "Round basophilic inclusions (\"blue beads\") at luminal surface",
                      "MicrosporidiaspeciesSubtle vacuolization in supranuclear cytoplasmDifficult to see on H&EVariably stain with Gram stain, Warthin-Starry, Giemsa, modified trichrome stains",
                      "Subtle vacuolization in supranuclear cytoplasm",
                      "Difficult to see on H&E",
                      "Variably stain with Gram stain, Warthin-Starry, Giemsa, modified trichrome stains"
                    ]
                  },
                  {
                    "text": "OpisthorchisandClonorchisEpithelial desquamation followed by hyperplasia of epithelium and periductal mucus glandsPeriductal fibrosis",
                    "sub_points": [
                      "Epithelial desquamation followed by hyperplasia of epithelium and periductal mucus glands",
                      "Periductal fibrosis"
                    ]
                  },
                  {
                    "text": "FasciolaNecrosis and hemorrhage of ducts with abscess formationUltimately leads to fibrosis",
                    "sub_points": [
                      "Necrosis and hemorrhage of ducts with abscess formation",
                      "Ultimately leads to fibrosis"
                    ]
                  },
                  {
                    "text": "SchistosomaVigorous fibroinflammatory response to eggs, not wormsViable and nonviable eggs rarely seen in fibrous tissue adjacent to ductsGranulomas, eosinophils variably present",
                    "sub_points": [
                      "Vigorous fibroinflammatory response to eggs, not worms",
                      "Viable and nonviable eggs rarely seen in fibrous tissue adjacent to ducts",
                      "Granulomas, eosinophils variably present"
                    ]
                  },
                  {
                    "text": "AscarisWorms and eggs may be present in ducts with associated inflammation and abscess formation",
                    "sub_points": [
                      "Worms and eggs may be present in ducts with associated inflammation and abscess formation"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Primary Sclerosing Cholangitis": [
                  {
                    "text": "Protozoal infection of biliary tree can mimic PSC radiographically"
                  }
                ],
                "Other Causes of Large Bile Duct Obstruction": [
                  {
                    "text": "Gallstones"
                  },
                  {
                    "text": "Neoplasms"
                  }
                ],
                "Other Causes of Cholangitis": [
                  {
                    "text": "Bacterial infection"
                  },
                  {
                    "text": "CMVAlso frequent cause of AIDS cholangiopathy",
                    "sub_points": [
                      "Also frequent cause of AIDS cholangiopathy"
                    ]
                  },
                  {
                    "text": "Histoplasma capsulatum"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Biliary Tract and Gallbladder: Tumors": {
        "name": "Biliary Tract and Gallbladder: Tumors",
        "url": "https://app.pathprimer.com/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
        "topics": {
          "Pyloric Gland Adenoma": {
            "name": "Pyloric Gland Adenoma",
            "url": "https://app.pathprimer.com/document/c7524529-a468-47f1-a36d-3b5544d92394/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Neoplasm composed of glandular epithelium showing pyloric gland differentiation"
                  },
                  {
                    "text": "Most common type of gallbladder adenoma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Often discovered incidentally at cholecystectomy"
                  },
                  {
                    "text": "Majority associated with cholelithiasis"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually solitary sessile lesions measuring < 2 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Well-demarcated nodules composed of closely packed pyloric-type glandsLittle intervening stromaGlands composed of single layer of cuboidal or low columnar mucinous cellsPale to eosinophilic cytoplasm lacking apical mucin capNuclei are small, round or ovoid, and basally locatedSquamoid morules are occasionally seen",
                    "sub_points": [
                      "Little intervening stroma",
                      "Glands composed of single layer of cuboidal or low columnar mucinous cellsPale to eosinophilic cytoplasm lacking apical mucin capNuclei are small, round or ovoid, and basally locatedSquamoid morules are occasionally seen",
                      "Pale to eosinophilic cytoplasm lacking apical mucin cap",
                      "Nuclei are small, round or ovoid, and basally located",
                      "Squamoid morules are occasionally seen"
                    ]
                  },
                  {
                    "text": "High-grade dysplasia/carcinoma are uncommon in gallbladder PGA"
                  },
                  {
                    "text": "Adjacent gallbladder mucosa often shows pseudopyloric metaplasia"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PGAs are positive for MUC6 and negative for MUC2"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Intestinal-type adenoma"
                  },
                  {
                    "text": "Nodular hyperplasia of pseudopyloric glands"
                  },
                  {
                    "text": "Ectopic gastric mucosa"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pyloric gland adenoma (PGA)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Neoplasm composed of glandular epithelium showing pyloric gland differentiation"
                  },
                  {
                    "text": "Most common type of gallbladder adenomaAlso reported in other sites including stomach, duodenum, pancreas, common bile duct",
                    "sub_points": [
                      "Also reported in other sites including stomach, duodenum, pancreas, common bile duct"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Etiology Remains Speculative": [
                  {
                    "text": "Also reported in other sitesStomachDuodenumPancreasCommon bile ductUterine cervix",
                    "sub_points": [
                      "Stomach",
                      "Duodenum",
                      "Pancreas",
                      "Common bile duct",
                      "Uterine cervix"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Sex": [
                  {
                    "text": "Predominantly occurs in adult women"
                  }
                ],
                "Presentation": [
                  {
                    "text": "AsymptomaticUsually discovered incidentally at cholecystectomyMost PGAs associated with cholelithiasis",
                    "sub_points": [
                      "Usually discovered incidentally at cholecystectomy",
                      "Most PGAs associated with cholelithiasis"
                    ]
                  },
                  {
                    "text": "When multiple and filling lumen or at neck of gallbladder, can mimic chronic cholecystitis"
                  },
                  {
                    "text": "Occasional PGAs have been reported in association with polyposis syndromes"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Surgical resection is curative"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "ExcellentCurrent data suggest that PGAs are not a common pathway for development of gallbladder carcinoma",
                    "sub_points": [
                      "Current data suggest that PGAs are not a common pathway for development of gallbladder carcinoma"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually solitary sessile lesions"
                  }
                ],
                "Size": [
                  {
                    "text": "Typically measures a few millimeters but can be as large as 2 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Well-demarcated nodules composed of closely packed pyloric-type glands with little intervening stromaGlands composed of single layer of cuboidal or low columnar mucinous cellsMajority of glands are small and typically round, but occasional dilated glands are seenCytoplasm is pale to eosinophilic, often vacuolatedApical mucin caps are absent in cells of PGANuclei are small, round or ovoid, basally located, and often hyperchromaticMild nuclear atypia is commonNucleoli usually inconspicuous",
                    "sub_points": [
                      "Glands composed of single layer of cuboidal or low columnar mucinous cellsMajority of glands are small and typically round, but occasional dilated glands are seenCytoplasm is pale to eosinophilic, often vacuolatedApical mucin caps are absent in cells of PGANuclei are small, round or ovoid, basally located, and often hyperchromaticMild nuclear atypia is commonNucleoli usually inconspicuous",
                      "Majority of glands are small and typically round, but occasional dilated glands are seen",
                      "Cytoplasm is pale to eosinophilic, often vacuolatedApical mucin caps are absent in cells of PGA",
                      "Apical mucin caps are absent in cells of PGA",
                      "Nuclei are small, round or ovoid, basally located, and often hyperchromaticMild nuclear atypia is commonNucleoli usually inconspicuous",
                      "Mild nuclear atypia is common",
                      "Nucleoli usually inconspicuous"
                    ]
                  },
                  {
                    "text": "Histologically, cells resemble gastric pyloric gland epithelium and Brunner glands"
                  },
                  {
                    "text": "Squamoid morules composed of spindle-shaped squamous cells are occasionally seen; overt keratinization is infrequent"
                  },
                  {
                    "text": "Occasional goblet and Paneth cells may be present"
                  },
                  {
                    "text": "High-grade dysplasia/intramucosal carcinoma are seen in only a minority of cases in gallbladder"
                  },
                  {
                    "text": "Adjacent gallbladder mucosa often shows pseudopyloric metaplasia"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "PGA tumor cells are positive for MUC6 and negative for MUC2"
                  },
                  {
                    "text": "Intestinal-type adenomas are negative for MUC6 and positive for MUC2"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Gallbladder PGAs frequently haveβ-cateninmutations and are negative forKRASmutationsIn contrast, gallbladder carcinomas lack β-catenin mutations and frequently show KRAS mutations",
                    "sub_points": [
                      "In contrast, gallbladder carcinomas lack β-catenin mutations and frequently show KRAS mutations"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Nodular Hyperplasia of Pseudopyloric Glands": [
                  {
                    "text": "Pseudopyloric metaplasia is commonly seen in association with chronic cholecystitis"
                  },
                  {
                    "text": "Pseudopyloric glands may coalesce and produce elevations of gallbladder mucosa, mimicking PGA"
                  },
                  {
                    "text": "Continuity with adjacent pseudopyloric metaplasia and poor demarcation help distinguish pseudopyloric metaplasia from PGA"
                  }
                ],
                "Ectopic Gastric Mucosa": [
                  {
                    "text": "Parietal and oxyntic cells are invariably present"
                  }
                ],
                "Intestinal-Type Adenoma": [
                  {
                    "text": "Lining epithelium resembles colonic adenoma and shows numerous goblet cells"
                  },
                  {
                    "text": "MUC6 staining is negative"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intestinal-Type Adenoma": {
            "name": "Intestinal-Type Adenoma",
            "url": "https://app.pathprimer.com/document/91135eb7-9cea-4b06-92e7-bc2bc073d6b7/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Exophytic, noninvasive neoplastic epithelial lesion of gallbladder and biliary treeIncludes neoplastic lesions previously classified as adenomas (both intestinal and pyloric types), papillary carcinoma in situ, papillomatosis",
                    "sub_points": [
                      "Includes neoplastic lesions previously classified as adenomas (both intestinal and pyloric types), papillary carcinoma in situ, papillomatosis"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Many patients asymptomatic, and ICPN discovered incidentally at cholecystectomy"
                  },
                  {
                    "text": "Associated with invasive carcinoma in 50% of cases at diagnosis"
                  },
                  {
                    "text": "5-year survival of 60% for cases with associated invasive carcinoma, 78% for noninvasive lesions"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Most cases are solitary; 1/3 multiple"
                  },
                  {
                    "text": "May become detached from lumen and grossly mimic gallstones or biliary sludge"
                  },
                  {
                    "text": "Average size: ~ 2 cm; reported as large as 7 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Classified as tubular (> 75%), papillary (> 75%), or tubulopapillary (25-75% each pattern)"
                  },
                  {
                    "text": "Cell types: Gastric (pyloric, foveolar), intestinal, biliary, oncocyticPyloric type has lowest association with high-grade dysplasia and carcinoma (~ 15%)Intestinal type resembles colonic adenomasBiliary type accounts for ~ 50% of ICPN, frequently associated with high-grade dysplasia and carcinoma",
                    "sub_points": [
                      "Pyloric type has lowest association with high-grade dysplasia and carcinoma (~ 15%)",
                      "Intestinal type resembles colonic adenomas",
                      "Biliary type accounts for ~ 50% of ICPN, frequently associated with high-grade dysplasia and carcinoma"
                    ]
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Entire lesion should be submitted for microscopic examination to rule out associated invasive carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Intracholecystic papillary-tubular neoplasms (ICPN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Tumoral intraepithelial neoplasms"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Exophytic or polypoid neoplastic epithelial proliferation in gallbladderIncludes neoplastic lesions previously classified as adenomas (both intestinal and pyloric types), papillary carcinoma in situ, papillomatosis≥ 1 cm\"Incipient ICPN\" has been suggested for adenomas that have dysplasia but are < 1 cmBiliary, foveolar, pyloric, intestinal, and oncocytic cell typesNoninvasive by definitionDistinct from adjacent mucosa",
                    "sub_points": [
                      "Includes neoplastic lesions previously classified as adenomas (both intestinal and pyloric types), papillary carcinoma in situ, papillomatosis",
                      "≥ 1 cm\"Incipient ICPN\" has been suggested for adenomas that have dysplasia but are < 1 cm",
                      "\"Incipient ICPN\" has been suggested for adenomas that have dysplasia but are < 1 cm",
                      "Biliary, foveolar, pyloric, intestinal, and oncocytic cell types",
                      "Noninvasive by definition",
                      "Distinct from adjacent mucosa"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Mean: 61 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance (F:M = 2:1)"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "More common in Asia"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often discovered incidentally at cholecystectomy"
                  },
                  {
                    "text": "When symptomatic, patients typically present with right upper quadrant painJaundice, biliary obstruction can occur with multiple lesions or location near neck of gallbladder",
                    "sub_points": [
                      "Jaundice, biliary obstruction can occur with multiple lesions or location near neck of gallbladder"
                    ]
                  },
                  {
                    "text": "Only ~ 20% of cases associated with gallstones"
                  },
                  {
                    "text": "~ 20% of patients have other neoplasms at time of diagnosisMost commonly GI tract and pancreatic tumors",
                    "sub_points": [
                      "Most commonly GI tract and pancreatic tumors"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Cholecystectomy is curative in most cases with noninvasive lesions"
                  },
                  {
                    "text": "New primary lesions may subsequently develop in biliary tree"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Invasive carcinoma present in > 50% of cases at diagnosisHigh-risk featuresExtent of high-grade dysplasiaExtent of papillary componentSize of lesionIntestinal or pancreatobiliary phenotypeMost commonly pancreaticobiliary type adenocarcinomas5-year survival 60% in ICPN with invasive componentOnly minority of gallbladder adenocarcinomas associated with precursor ICPN, however",
                    "sub_points": [
                      "High-risk featuresExtent of high-grade dysplasiaExtent of papillary componentSize of lesionIntestinal or pancreatobiliary phenotype",
                      "Extent of high-grade dysplasia",
                      "Extent of papillary component",
                      "Size of lesion",
                      "Intestinal or pancreatobiliary phenotype",
                      "Most commonly pancreaticobiliary type adenocarcinomas",
                      "5-year survival 60% in ICPN with invasive component",
                      "Only minority of gallbladder adenocarcinomas associated with precursor ICPN, however"
                    ]
                  },
                  {
                    "text": "5-year survival 78% for ICPN without invasionSome of these patients die from invasive carcinoma, which may arise from new lesion, or may have been missed at time of resection",
                    "sub_points": [
                      "Some of these patients die from invasive carcinoma, which may arise from new lesion, or may have been missed at time of resection"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Larger lesions may be seen as mucosal irregularities or filling defectsOften radiographically interpreted as carcinoma~ 10% mistaken for sludge or stones and not recognized radiographically",
                    "sub_points": [
                      "Often radiographically interpreted as carcinoma",
                      "~ 10% mistaken for sludge or stones and not recognized radiographically"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Prominent exophytic growth or friable soft excrescencesMost cases are solitaryMultiple lesions can occur in ~ 30% of casesSessile and broad based or pedunculatedMay become detached from lumen and grossly mimic gallstones or biliary sludgeVariably present hemorrhage or necrosis",
                    "sub_points": [
                      "Most cases are solitaryMultiple lesions can occur in ~ 30% of cases",
                      "Multiple lesions can occur in ~ 30% of cases",
                      "Sessile and broad based or pedunculated",
                      "May become detached from lumen and grossly mimic gallstones or biliary sludge",
                      "Variably present hemorrhage or necrosis"
                    ]
                  },
                  {
                    "text": "Most commonly found in fundus and body"
                  },
                  {
                    "text": "Average size: ~ 2 cm; reported as large as 7 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Designated as tubular (> 75%), papillary (> 75%), or tubulopapillary (25-75% each pattern)"
                  },
                  {
                    "text": "4 cell typesBiliaryPredominantly papillary growth patternAccounts for ~ 50% of ICPNFrequent association with high-grade dysplasia and adenocarcinoma (~ 70%)Cuboidal, biliary-type epithelial cellsNeutrophilic infiltrates commonGastric~ 36% of casesPredominantly tubular patternFoveolar typeHigher association with adenocarcinoma (similar to biliary type)Tall, columnar cells with basal nuclei and apical mucin cap, resembling foveolar gastric mucosaPyloric type (2 histologic forms)Lowest association with adenocarcinoma (~ 15%)Simple mucinous: Tightly packed, evenly sized, small, and bland pyloric-type glandsComplex nonmucinous: Pedunculated multinodular polyps with small, nonmucinous complex variably dilated glands, high N:C ratio, squamoid morulesEndocrine cells, Paneth cells, amyloid-like stroma seen in some cases of complex nonmucinous pyloric ICPNPreviously designated as pyloric gland adenomasIntestinal type< 10% of casesResemble colonic adenoma histologicallyAssociation with adenocarcinoma in 60%Oncocytic typeRarest cell typeComplex papillary architecture with oncocytic featuresMost closely resemble biliary typeMixed histologic subtypes observed in vast majority of cases",
                    "sub_points": [
                      "BiliaryPredominantly papillary growth patternAccounts for ~ 50% of ICPNFrequent association with high-grade dysplasia and adenocarcinoma (~ 70%)Cuboidal, biliary-type epithelial cellsNeutrophilic infiltrates common",
                      "Predominantly papillary growth pattern",
                      "Accounts for ~ 50% of ICPN",
                      "Frequent association with high-grade dysplasia and adenocarcinoma (~ 70%)",
                      "Cuboidal, biliary-type epithelial cells",
                      "Neutrophilic infiltrates common",
                      "Gastric~ 36% of casesPredominantly tubular patternFoveolar typeHigher association with adenocarcinoma (similar to biliary type)Tall, columnar cells with basal nuclei and apical mucin cap, resembling foveolar gastric mucosaPyloric type (2 histologic forms)Lowest association with adenocarcinoma (~ 15%)Simple mucinous: Tightly packed, evenly sized, small, and bland pyloric-type glandsComplex nonmucinous: Pedunculated multinodular polyps with small, nonmucinous complex variably dilated glands, high N:C ratio, squamoid morulesEndocrine cells, Paneth cells, amyloid-like stroma seen in some cases of complex nonmucinous pyloric ICPNPreviously designated as pyloric gland adenomas",
                      "~ 36% of cases",
                      "Predominantly tubular pattern",
                      "Foveolar typeHigher association with adenocarcinoma (similar to biliary type)Tall, columnar cells with basal nuclei and apical mucin cap, resembling foveolar gastric mucosa",
                      "Higher association with adenocarcinoma (similar to biliary type)",
                      "Tall, columnar cells with basal nuclei and apical mucin cap, resembling foveolar gastric mucosa",
                      "Pyloric type (2 histologic forms)Lowest association with adenocarcinoma (~ 15%)Simple mucinous: Tightly packed, evenly sized, small, and bland pyloric-type glandsComplex nonmucinous: Pedunculated multinodular polyps with small, nonmucinous complex variably dilated glands, high N:C ratio, squamoid morulesEndocrine cells, Paneth cells, amyloid-like stroma seen in some cases of complex nonmucinous pyloric ICPNPreviously designated as pyloric gland adenomas",
                      "Lowest association with adenocarcinoma (~ 15%)",
                      "Simple mucinous: Tightly packed, evenly sized, small, and bland pyloric-type glands",
                      "Complex nonmucinous: Pedunculated multinodular polyps with small, nonmucinous complex variably dilated glands, high N:C ratio, squamoid morules",
                      "Endocrine cells, Paneth cells, amyloid-like stroma seen in some cases of complex nonmucinous pyloric ICPN",
                      "Previously designated as pyloric gland adenomas",
                      "Intestinal type< 10% of casesResemble colonic adenoma histologicallyAssociation with adenocarcinoma in 60%",
                      "< 10% of cases",
                      "Resemble colonic adenoma histologically",
                      "Association with adenocarcinoma in 60%",
                      "Oncocytic typeRarest cell typeComplex papillary architecture with oncocytic featuresMost closely resemble biliary type",
                      "Rarest cell type",
                      "Complex papillary architecture with oncocytic features",
                      "Most closely resemble biliary type",
                      "Mixed histologic subtypes observed in vast majority of cases"
                    ]
                  },
                  {
                    "text": "DysplasiaClassified as low or high gradeTubulopapillary and papillary patterns show greater extent of high-grade dysplasiaRange of dysplasia common within same lesion",
                    "sub_points": [
                      "Classified as low or high grade",
                      "Tubulopapillary and papillary patterns show greater extent of high-grade dysplasia",
                      "Range of dysplasia common within same lesion"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Intestinal typePositive: MUC2 (50%), CDX-2, CK20Negative: MUC6, CK7 (variable)",
                    "sub_points": [
                      "Positive: MUC2 (50%), CDX-2, CK20",
                      "Negative: MUC6, CK7 (variable)"
                    ]
                  },
                  {
                    "text": "Pyloric typePositive: CK7 ,MUC6, MUC5AC (40%), MUC1 (50-60%)Negative: MUC2",
                    "sub_points": [
                      "Positive: CK7 ,MUC6, MUC5AC (40%), MUC1 (50-60%)",
                      "Negative: MUC2"
                    ]
                  },
                  {
                    "text": "Foveolar typePositive: MUC5AC, MUC6 (some cases)Negative: MUC1, MUC2MUC1 may be positive in areas of high-grade dysplasia",
                    "sub_points": [
                      "Positive: MUC5AC, MUC6 (some cases)",
                      "Negative: MUC1, MUC2MUC1 may be positive in areas of high-grade dysplasia",
                      "MUC1 may be positive in areas of high-grade dysplasia"
                    ]
                  },
                  {
                    "text": "Biliary typePositive: CK7, MUC1 (majority but not all), MUC5AC (variable)Negative: MUC6, CK20, CDX-2",
                    "sub_points": [
                      "Positive: CK7, MUC1 (majority but not all), MUC5AC (variable)",
                      "Negative: MUC6, CK20, CDX-2"
                    ]
                  },
                  {
                    "text": "Oncocytic typeSimilar to biliary",
                    "sub_points": [
                      "Similar to biliary"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "TP53,KRAS,p16mutations virtually absentThese mutations common in gallbladder adenocarcinoma and flat dysplasia~ 30% of biliary-type ICPN with high-grade dysplasia showTP53mutations",
                    "sub_points": [
                      "These mutations common in gallbladder adenocarcinoma and flat dysplasia",
                      "~ 30% of biliary-type ICPN with high-grade dysplasia showTP53mutations"
                    ]
                  },
                  {
                    "text": "Complex pyloric gland phenotype associated with mutations in ß-catenin"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Intestinal Metaplasia": [
                  {
                    "text": "May form small nodule but no discrete polypoid lesion"
                  }
                ],
                "Papillary Hyperplasia": [
                  {
                    "text": "Diffuse mucosal papillary proliferation lined by biliary-type epithelium"
                  },
                  {
                    "text": "No discrete polypoid lesion"
                  }
                ],
                "Invasive Carcinoma Arising in ICPN": [
                  {
                    "text": "Extension of dysplastic epithelium along Rokitansky-Aschoff sinuses may mimic invasive adenocarcinoma"
                  },
                  {
                    "text": "Invasive carcinomas show irregularly shaped glands, small infiltrative glands, and high-grade cellular atypia"
                  }
                ],
                "Nodular Hyperplasia of Pseudopyloric Glands": [
                  {
                    "text": "Pseudopyloric metaplasia commonly seen in association with chronic cholecystitis"
                  },
                  {
                    "text": "Pseudopyloric glands may coalesce and produce elevations of gallbladder mucosa, mimicking pyloric type ICPN"
                  },
                  {
                    "text": "Continuity with adjacent pseudopyloric metaplasia and poor demarcation help distinguish pseudopyloric metaplasia from ICPN"
                  }
                ],
                "Ectopic Gastric Mucosa": [
                  {
                    "text": "Parietal and oxyntic cells are invariably present"
                  }
                ],
                "Flat Dysplasia (Intraepithelial Neoplasia)": [
                  {
                    "text": "Histologic features may overlap with ICPN"
                  },
                  {
                    "text": "Does not form mass lesion"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Entire lesion must be submitted for microscopic examination to rule out associated invasive carcinoma"
                  },
                  {
                    "text": "Submit any detached fragments in lumen as well"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Inflammatory Polyps": {
            "name": "Inflammatory Polyps",
            "url": "https://app.pathprimer.com/document/e30c670d-d4d0-4388-860f-4b94a9dcbd33/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Nonneoplastic gallbladder mucosal projections characterized by granulation tissue, chronic inflammation, and edema"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Associated with chronic cholecystitis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Usually asymptomatic"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Usually solitary, sessile, red-gray or brown mucosal projections"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Composed of inflamed, edematous, granulation tissue-type stroma and benign epithelium"
                  },
                  {
                    "text": "Single layer of epithelial cells may cover or comprise elements set within  fibrous stroma"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Fibroinflammatory polyp"
                  },
                  {
                    "text": "Fibroepithelial polyp"
                  },
                  {
                    "text": "Granulation tissue polyp"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nonneoplastic gallbladder mucosal projections characterized byGranulation tissueChronic inflammationEdema",
                    "sub_points": [
                      "Granulation tissue",
                      "Chronic inflammation",
                      "Edema"
                    ]
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Mucosal Inflammation": [
                  {
                    "text": "Associated with chronic cholecystitis"
                  },
                  {
                    "text": "Likely develop as result of mucosal injury"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Represent 15% of all benign gallbladder polyps"
                  }
                ],
                "Gender": [
                  {
                    "text": "Affect females and males"
                  }
                ],
                "Presentation": [],
                "Abnormal imaging finding": [
                  {
                    "text": "Often incidental"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Cholecystectomy recommended for symptomatic or large (> 10 millimeters) lesions identified on imagingFor larger polyps, surgery performed to exclude possibility of malignancy",
                    "sub_points": [
                      "For larger polyps, surgery performed to exclude possibility of malignancy"
                    ]
                  },
                  {
                    "text": "Cholecystectomy is curative"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign lesions with no malignant potential"
                  },
                  {
                    "text": "Prognosis is excellent"
                  }
                ]
              },
              "Image Findings": {
                "General Features": [
                  {
                    "text": "Polypoid lesion may be seen on ultrasound or computed-tomography (CT) scan"
                  },
                  {
                    "text": "May be difficult to distinguish from gallstones"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Red-gray or brown mucosal projections"
                  },
                  {
                    "text": "Usually sessile"
                  },
                  {
                    "text": "Often solitary"
                  }
                ],
                "Size": [
                  {
                    "text": "Typically range from 3-15 mm"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Composed of inflamed, edematous, granulation tissue-type stroma and benign epitheliumContains chronic inflammatory cells",
                    "sub_points": [
                      "Contains chronic inflammatory cells"
                    ]
                  },
                  {
                    "text": "Single layer of epithelial cells may cover &/or form invaginations set within fibrous stromaTypical columnar gallbladder-type epitheliumEpithelium may show reactive changes",
                    "sub_points": [
                      "Typical columnar gallbladder-type epithelium",
                      "Epithelium may show reactive changes"
                    ]
                  },
                  {
                    "text": "Clusters of pyloric-type glands may be present"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Pyloric Gland Adenoma": [
                  {
                    "text": "Lesion composed of pyloric-type glands"
                  }
                ],
                "Cholesterol Polyp": [
                  {
                    "text": "Localized form of cholesterolosis"
                  },
                  {
                    "text": "Collection of lipid-laden macrophages form polypoid mucosal lesion"
                  },
                  {
                    "text": "Appears yellow at gross examination"
                  },
                  {
                    "text": "Stroma filled with lipid-laden macrophages"
                  },
                  {
                    "text": "Lacks chronic inflammation and granulation tissue-type stroma of inflammatory polyp"
                  }
                ],
                "Villous Papilloma": [
                  {
                    "text": "Papillary epithelial hyperplasia"
                  },
                  {
                    "text": "Can occur in association with metachromatic leukodystrophyLamina propria expansion by macrophages containing abnormal metachromatic material",
                    "sub_points": [
                      "Lamina propria expansion by macrophages containing abnormal metachromatic material"
                    ]
                  }
                ],
                "Intestinal-type Adenoma": [
                  {
                    "text": "Exhibits at least low-grade epithelial dysplasia"
                  },
                  {
                    "text": "Epithelium resembles that of typical colonic adenomas with enlarged, hyperchromatic nuclei showing pseudostratification"
                  }
                ],
                "Adenomyoma": [
                  {
                    "text": "Characterized by gallbladder wall thickening and irregular, ectatic invagination of mucosal lining into smooth muscle of gallbladder wall"
                  }
                ],
                "Hyperplastic Polyp": [
                  {
                    "text": "Thickened gallbladder mucosa lined by normal-appearing epithelial cells"
                  }
                ],
                "Biliary-type Adenoma": [
                  {
                    "text": "Also lined by biliary-type epitheliumLacks inflamed, edematous, granulation-type stroma",
                    "sub_points": [
                      "Lacks inflamed, edematous, granulation-type stroma"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Hyperplastic Polyps": {
            "name": "Hyperplastic Polyps",
            "url": "https://app.pathprimer.com/document/e934349f-9339-49ad-adad-2d54be363a88/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "2nd most common type of gallbladder polyp"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Most occur secondary to cholecystitis or cholelithiasis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Usually incidental finding"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Small polyps, usually < 5 mm in diameter"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Prominent hyperplastic mucosal folds and papillae"
                  },
                  {
                    "text": "Mucosa on surface resembles normal gallbladder epithelium"
                  },
                  {
                    "text": "Metaplastic changes are common"
                  },
                  {
                    "text": "May show focal inflammation, especially at surface"
                  },
                  {
                    "text": "May be associated with reactive epithelial changes that may be confused with dysplasia"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Hyperplastic polyp (HP)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Metaplastic polyp"
                  },
                  {
                    "text": "Localized papillary hyperplasia"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Polypoid growth of hyperplastic gallbladder mucosa"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Reactive/Inflammatory": [
                  {
                    "text": "Most occur in setting of cholecystitis or cholelithiasis"
                  },
                  {
                    "text": "Rarely occur in association with chronic ulcerative colitis or metachromatic leukodystrophy"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "2nd most common type of gallbladder polyp"
                  },
                  {
                    "text": "Accounts for approximately 20% of cases"
                  }
                ],
                "Age": [
                  {
                    "text": "No age predilectionDocumented in both children and adults",
                    "sub_points": [
                      "Documented in both children and adults"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually incidental finding at time of cholecystectomyMay present with symptoms secondary to background cholecystitis &/or cholelithiasis",
                    "sub_points": [
                      "May present with symptoms secondary to background cholecystitis &/or cholelithiasis"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Cholecystectomy recommended if patient is symptomatic or if polyp  is ≥ 1 cm in diameter on imaging"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Currently regarded as benign lesion with no risk of progression to dysplasia or malignancy"
                  },
                  {
                    "text": "Cholecystectomy is curative"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Larger lesions may be detected radiographically with ultrasound or computed-tomography (CT) scan"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Small polypoid mucosal lesionsUsually < 0.5 cm in diameter",
                    "sub_points": [
                      "Usually < 0.5 cm in diameter"
                    ]
                  },
                  {
                    "text": "May be multiple"
                  },
                  {
                    "text": "May be either sessile or pedunculated"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Prominent hyperplastic mucosal folds and papillae"
                  },
                  {
                    "text": "Mucosa consists of typical columnar-type gallbladder epithelium"
                  },
                  {
                    "text": "Metaplastic changes are commonGastric-type foveolar mucosaGastric pyloric-type mucus-secreting glandsIntestinal-type mucosa with goblet cells, possible Paneth cells, and endocrine cells",
                    "sub_points": [
                      "Gastric-type foveolar mucosa",
                      "Gastric pyloric-type mucus-secreting glands",
                      "Intestinal-type mucosa with goblet cells, possible Paneth cells, and endocrine cells"
                    ]
                  },
                  {
                    "text": "May show focal inflammation, especially at surfaceUsually nonspecific chronic inflammationConsists predominantly of lymphocytes with smaller numbers of plasma cells, histiocytes, eosinophils, and neutrophilsMay be associated with reactive epithelial changesMay be confused with dysplasiaReactive changes should be focal and accompanied by inflammationNuclei are enlarged and vesicularOccasionally, nuclei may be focally pseudostratified or crowded",
                    "sub_points": [
                      "Usually nonspecific chronic inflammationConsists predominantly of lymphocytes with smaller numbers of plasma cells, histiocytes, eosinophils, and neutrophils",
                      "Consists predominantly of lymphocytes with smaller numbers of plasma cells, histiocytes, eosinophils, and neutrophils",
                      "May be associated with reactive epithelial changesMay be confused with dysplasiaReactive changes should be focal and accompanied by inflammationNuclei are enlarged and vesicularOccasionally, nuclei may be focally pseudostratified or crowded",
                      "May be confused with dysplasia",
                      "Reactive changes should be focal and accompanied by inflammation",
                      "Nuclei are enlarged and vesicular",
                      "Occasionally, nuclei may be focally pseudostratified or crowded"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Adenoma, Intestinal Type": [
                  {
                    "text": "Entire polyp composed of dysplastic intestinal-type epitheliumSimilar to colonic adenomas",
                    "sub_points": [
                      "Similar to colonic adenomas"
                    ]
                  },
                  {
                    "text": "Absent or minimal inflammation"
                  },
                  {
                    "text": "Nuclei are hyperchromatic, cigar-shaped, pseudostratified, and show loss of polarity"
                  }
                ],
                "Adenoma, Pyloric Gland Type": [
                  {
                    "text": "Discrete lesion"
                  },
                  {
                    "text": "> 0.5 cm"
                  },
                  {
                    "text": "Composed of tightly packed, pyloric-type glands"
                  },
                  {
                    "text": "Minimal cytologic atypia"
                  }
                ],
                "Cholesterol Polyp": [
                  {
                    "text": "Formed by multiple lipid-laden foamy macrophages within stroma"
                  }
                ],
                "Mucus Gland Polyp": [
                  {
                    "text": "Predominantly in neck region"
                  },
                  {
                    "text": "Usually < 0.5 cm"
                  },
                  {
                    "text": "Consists of hyperplastic mucinous glands, not hyperplastic surface epithelium"
                  }
                ],
                "Diffuse Mucosal Hyperplasia": [
                  {
                    "text": "Widespread nonpolypoid hyperplasia; not a discrete lesion"
                  }
                ],
                "Adenomyoma": [
                  {
                    "text": "Irregular invaginations of mucosa into smooth muscle of gallbladder wall"
                  }
                ],
                "Gastric Heterotopia": [
                  {
                    "text": "Composed of pyloric-type glands with parietal and chief cells"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cholesterol Polyps and Cholesterolosis": {
            "name": "Cholesterol Polyps and Cholesterolosis",
            "url": "https://app.pathprimer.com/document/a08c8ae8-10b4-41e4-bb5e-407253cde082/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Accumulation of neutral lipid within macrophages of lamina propria of gallbladder"
                  }
                ],
                "Macroscopic Features": [
                  {
                    "text": "Lipid droplets appear as yellow flecks or streaks against green or red background (\"strawberry\" gallbladder)"
                  },
                  {
                    "text": "Lipid droplets may form polypoid excrescences, called cholesterol polyps, that project into lumen"
                  },
                  {
                    "text": "May contain cholesterol gallstones"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Foamy macrophages with small dark nuclei within lamina propria of gallbladder mucosa"
                  },
                  {
                    "text": "Cholesterol polyps have vascular stalk and villous projectionsLamina propria of polyp is filled with foamy lipid containing macrophages",
                    "sub_points": [
                      "Lamina propria of polyp is filled with foamy lipid containing macrophages"
                    ]
                  }
                ]
              },
              "Terminology": {
                "Definitions": [
                  {
                    "text": "Accumulation of neutral lipid within macrophages of lamina propria of gallbladder"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Pathogenesis": [
                  {
                    "text": "Poorly understood"
                  },
                  {
                    "text": "May reflect increased hepatic synthesis of lipids or increased absorption and esterification by gallbladder"
                  },
                  {
                    "text": "Frequently occurs with cholesterol gallstones in setting of supersaturated bile"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Cholesterol polyps account for 50-60% of all gallbladder polyps"
                  },
                  {
                    "text": "Prevalence rate of 12% in autopsy studies and from 9-26% in surgical studiesMore prevalent in patients with morbid obesity",
                    "sub_points": [
                      "More prevalent in patients with morbid obesity"
                    ]
                  },
                  {
                    "text": "Reports of possible association with acute pancreatitis"
                  }
                ],
                "Age": [
                  {
                    "text": "Usually patients between ages of 20 and 70"
                  },
                  {
                    "text": "Peak in 5th and 6th decades of life"
                  }
                ],
                "Presentation": [
                  {
                    "text": "May be asymptomatic and discovered incidentally"
                  },
                  {
                    "text": "Also associated with abdominal pain and postprandial symptoms"
                  },
                  {
                    "text": "Occasional reports of cholesterol polyps becoming detached and impacted in distal bile duct, resulting in jaundice"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Cholecystectomy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Cholecystectomy is curative"
                  }
                ]
              },
              "Image Findings": {
                "Radiographic Findings": [
                  {
                    "text": "Cholesterol polyps may be diagnosed, but diffuse form of cholesterolosis is infrequently recognized"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Cholesterolosis: Yellow flecks or streaks against green or red backgroundFlecks composed of lipid droplets, usually < 1 mm in diameterAppearance has been compared with that of a strawberry",
                    "sub_points": [
                      "Flecks composed of lipid droplets, usually < 1 mm in diameter",
                      "Appearance has been compared with that of a strawberry"
                    ]
                  },
                  {
                    "text": "Cholesterol polyps: Polypoid excrescences composed of lipid droplets that project into lumenSmall pedunculated lesions measuring 0.4-1.0 cmConnected to mucosa by a fine stalk, which can be easily disrupted",
                    "sub_points": [
                      "Small pedunculated lesions measuring 0.4-1.0 cm",
                      "Connected to mucosa by a fine stalk, which can be easily disrupted"
                    ]
                  },
                  {
                    "text": "4 different patterns may be seenDiffuse type (majority of cases, up to 80%)Polypoid pattern with 1 or more small mucosal polypsPolyps in absence of diffuse pattern in approximately 10% of casesMixed pattern with cholesterol polyps present within background of diffuse cholesterolosis (about 10% of cases)Focal type: Cholesterolosis is limited to small area of gallbladder mucosa only",
                    "sub_points": [
                      "Diffuse type (majority of cases, up to 80%)",
                      "Polypoid pattern with 1 or more small mucosal polypsPolyps in absence of diffuse pattern in approximately 10% of cases",
                      "Polyps in absence of diffuse pattern in approximately 10% of cases",
                      "Mixed pattern with cholesterol polyps present within background of diffuse cholesterolosis (about 10% of cases)",
                      "Focal type: Cholesterolosis is limited to small area of gallbladder mucosa only"
                    ]
                  },
                  {
                    "text": "Associated with cholesterol gallstones"
                  },
                  {
                    "text": "Cholesterolosis usually ends at start of cystic duct, but involvement of cystic or common ducts has been reported"
                  },
                  {
                    "text": "Bile may be thick and tarry with detached yellow flecks consisting of masses of foam cells (lipoidic corpuscles)"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Foamy macrophages with small dark nuclei within lamina propriaMay result in thickened folds &/or polypsAdjacent mucosa may be normal or inflamedInflammation almost exclusively occurs in patients with gallstonesExtracellular deposits of lipid are rareClear spaces in histiocytes are PAS(-), consistent with absence of mucus",
                    "sub_points": [
                      "May result in thickened folds &/or polyps",
                      "Adjacent mucosa may be normal or inflamedInflammation almost exclusively occurs in patients with gallstones",
                      "Inflammation almost exclusively occurs in patients with gallstones",
                      "Extracellular deposits of lipid are rare",
                      "Clear spaces in histiocytes are PAS(-), consistent with absence of mucus"
                    ]
                  },
                  {
                    "text": "Cholesterol polypsVascular connective tissue stalkVariable number of branching villous projectionsPacked with numerous foamy macrophages of type seen in diffuse form of cholesterolosisCovered by histologically unremarkable biliary epithelium",
                    "sub_points": [
                      "Vascular connective tissue stalk",
                      "Variable number of branching villous projections",
                      "Packed with numerous foamy macrophages of type seen in diffuse form of cholesterolosis",
                      "Covered by histologically unremarkable biliary epithelium"
                    ]
                  },
                  {
                    "text": "Lipofuscin pigment may be present in small number of patientsCan be within histiocytes as well as adjacent gallbladder epitheliumBrownish, granular pigment that is weakly PAS(+)Most likely related to leakage of bile into mucosa",
                    "sub_points": [
                      "Can be within histiocytes as well as adjacent gallbladder epithelium",
                      "Brownish, granular pigment that is weakly PAS(+)",
                      "Most likely related to leakage of bile into mucosa"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "Metachromic Leukodystrophy": [
                  {
                    "text": "Macrophages contain brown-tan material, not cholesterol"
                  }
                ],
                "Hyperplastic or Inflammatory Polyp": [
                  {
                    "text": "Do not contain lipid-filled macrophages"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Biliary Papillomatosis": {
            "name": "Biliary Papillomatosis",
            "url": "https://app.pathprimer.com/document/f51bc3c0-abbb-494a-96c2-27c052dde0e7/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Multiple, often numerous adenomas of bile ducts"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Very rare; some cases associated with familial adenomatous polyposis"
                  },
                  {
                    "text": "Peak incidence in 6th-7th decade of lifePatients typically present with jaundice, signs/symptoms of biliary obstruction",
                    "sub_points": [
                      "Patients typically present with jaundice, signs/symptoms of biliary obstruction"
                    ]
                  },
                  {
                    "text": "Complications include development of adenocarcinoma, cholangitis"
                  },
                  {
                    "text": "Surgical excision is treatment of choiceResection often not possible given multicentricity",
                    "sub_points": [
                      "Resection often not possible given multicentricity"
                    ]
                  },
                  {
                    "text": "Poor prognosisMean survival after diagnosis is approximately 3 years",
                    "sub_points": [
                      "Mean survival after diagnosis is approximately 3 years"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "ERCP may be useful confirmatory test"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Soft, friable, often villiform polypoid massesMost are located throughout biliary tract; rarely confined to intrahepatic bile ducts",
                    "sub_points": [
                      "Most are located throughout biliary tract; rarely confined to intrahepatic bile ducts"
                    ]
                  },
                  {
                    "text": "Often grow circumferentially"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Multiple complex papillary lesionsColumnar or cuboidal epitheliumCytoplasmic mucin may be presentMay resemble intestinal-type adenomas",
                    "sub_points": [
                      "Columnar or cuboidal epithelium",
                      "Cytoplasmic mucin may be present",
                      "May resemble intestinal-type adenomas"
                    ]
                  },
                  {
                    "text": "May resemble intestinal-type villous or tubulovillous adenomas"
                  },
                  {
                    "text": "Associated with noninvasive papillary carcinoma as well as frankly invasive malignancy"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Multiple biliary papillomatosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Multiple, often numerous adenomas of bile ducts"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Extremely rare; minority associated with other diseases, such asUlcerative colitisFamilial adenomatous polyposisCholedochal cyst",
                    "sub_points": [
                      "Ulcerative colitis",
                      "Familial adenomatous polyposis",
                      "Choledochal cyst"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Peak incidence in 6th-7th decade of life"
                  }
                ],
                "Sex": [
                  {
                    "text": "No significant gender predominanceSome sources report slight male predominance",
                    "sub_points": [
                      "Some sources report slight male predominance"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Signs and symptoms of biliary obstruction"
                  },
                  {
                    "text": "Abdominal pain"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical excision if possibleOften not possible given multicentricity",
                    "sub_points": [
                      "Often not possible given multicentricity"
                    ]
                  },
                  {
                    "text": "Laser treatment or local excision may be options in some cases"
                  },
                  {
                    "text": "Even resected lesions are prone to recurrence"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Approximately 50% mortality rateSerious complicationsAdenocarcinomaBiliary obstructionCholangitisVery difficult to treat if lesions are multiple and widespreadMean survival after diagnosis is approximately 3 years",
                    "sub_points": [
                      "Serious complicationsAdenocarcinomaBiliary obstructionCholangitis",
                      "Adenocarcinoma",
                      "Biliary obstruction",
                      "Cholangitis",
                      "Very difficult to treat if lesions are multiple and widespread",
                      "Mean survival after diagnosis is approximately 3 years"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "ERCP may be useful confirmatory testMultiple filling defects within biliary treeMucosal irregularities within biliary tree",
                    "sub_points": [
                      "Multiple filling defects within biliary tree",
                      "Mucosal irregularities within biliary tree"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Soft, friable, often villiform polypoid massesRed-brown to gray-white in colorPedunculated or sessileMay have cauliflower-like appearance",
                    "sub_points": [
                      "Red-brown to gray-white in color",
                      "Pedunculated or sessile",
                      "May have cauliflower-like appearance"
                    ]
                  },
                  {
                    "text": "0.2-2.0 cm in size"
                  },
                  {
                    "text": "Often grow circumferentially"
                  },
                  {
                    "text": "Detached fragments of tumor tissue and associated thrombus may be found in duct lumen"
                  }
                ],
                "Location": [
                  {
                    "text": "Most are multicentric throughout biliary tract"
                  },
                  {
                    "text": "Rarely, lesions are confined to intrahepatic bile ducts"
                  },
                  {
                    "text": "Occasional involvement of proximal pancreatic duct and gallbladder"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Multiple complex papillary lesionsArchitecture may be tubular as wellMay resemble intestinal-type villous or tubulovillous adenomasDelicate fibrovascular coresEpithelium can be cuboidal or columnarCytoplasmic mucin may be presentNuclei are often basally located and uniform",
                    "sub_points": [
                      "Architecture may be tubular as wellMay resemble intestinal-type villous or tubulovillous adenomas",
                      "May resemble intestinal-type villous or tubulovillous adenomas",
                      "Delicate fibrovascular cores",
                      "Epithelium can be cuboidal or columnar",
                      "Cytoplasmic mucin may be present",
                      "Nuclei are often basally located and uniform"
                    ]
                  },
                  {
                    "text": "Associated with noninvasive papillary carcinoma as well as frankly invasive malignancyMalignancy may be multifocal as wellEven low-grade, noninvasive lesions have been reported to metastasize",
                    "sub_points": [
                      "Malignancy may be multifocal as well",
                      "Even low-grade, noninvasive lesions have been reported to metastasize"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Isolated Adenomatous Polyp": [
                  {
                    "text": "Histologic features often identical"
                  },
                  {
                    "text": "Given difficulty of surveillance and likelihood of recurrence, it is important to note if multiple adenomas are present"
                  }
                ],
                "Pyloric Gland Adenoma": [
                  {
                    "text": "Composed of closely packed tubular glands that resemble pyloric epithelium"
                  },
                  {
                    "text": "Lack papillary architecture"
                  },
                  {
                    "text": "Lack intestinal-type epithelium"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Important to recognize this rare entity given serious complications and difficulties with treatment and surveillance"
                  },
                  {
                    "text": "Minority of cases associated with familial adenomatous polyposis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adenocarcinoma of Gallbladder": {
            "name": "Adenocarcinoma of Gallbladder",
            "url": "https://app.pathprimer.com/document/d67a698a-8080-418c-b445-ebc4b8debd42/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm of gallbladder"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Risk factorsChronic inflammationChronic cholecystitis, cholelithiasis, chronic biliary infectionsPorcelain gallbladderPrimary sclerosing cholangitisGastrointestinal polyposis",
                    "sub_points": [
                      "Chronic inflammationChronic cholecystitis, cholelithiasis, chronic biliary infections",
                      "Chronic cholecystitis, cholelithiasis, chronic biliary infections",
                      "Porcelain gallbladder",
                      "Primary sclerosing cholangitis",
                      "Gastrointestinal polyposis"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most often occurs in India, Chile, Pakistan, and EcuadorFemales more often affected",
                    "sub_points": [
                      "Females more often affected"
                    ]
                  },
                  {
                    "text": "Symptoms often vague, nonspecificOften incidental finding at cholecystectomy for cholecystitis or cholelithiasis",
                    "sub_points": [
                      "Often incidental finding at cholecystectomy for cholecystitis or cholelithiasis"
                    ]
                  },
                  {
                    "text": "Surgery is most effective and only potentially curative treatmentTumor stage probably most important prognostic factor",
                    "sub_points": [
                      "Tumor stage probably most important prognostic factor"
                    ]
                  },
                  {
                    "text": "Overall 5-year survival ~ 10%"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Area of thickening and induration of gallbladder wallTumor may be difficult to appreciate grossly",
                    "sub_points": [
                      "Tumor may be difficult to appreciate grossly"
                    ]
                  },
                  {
                    "text": "Exophytic or polypoid mucosal mass"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Malignant glands, clusters, or individual cells invading gallbladder wallSome extremely well-differentiated tumors are deceptively bland and difficult to recognizeMultiple histologic variants recognized by WHO",
                    "sub_points": [
                      "Some extremely well-differentiated tumors are deceptively bland and difficult to recognize",
                      "Multiple histologic variants recognized by WHO"
                    ]
                  },
                  {
                    "text": "Majority of cases associated with epithelial dysplasia &/or carcinoma in situ"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant glandular epithelial neoplasm of gallbladder"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Chronic inflammationChronic cholecystitis and cholelithiasis> 80% of gallbladder adenocarcinomas are associated with gallstonesChronic biliary infectionsOpisthorchis viverriniSalmonella typhiPancreatobiliary reflux",
                    "sub_points": [
                      "Chronic cholecystitis and cholelithiasis> 80% of gallbladder adenocarcinomas are associated with gallstones",
                      "> 80% of gallbladder adenocarcinomas are associated with gallstones",
                      "Chronic biliary infectionsOpisthorchis viverriniSalmonella typhi",
                      "Opisthorchis viverrini",
                      "Salmonella typhi",
                      "Pancreatobiliary reflux"
                    ]
                  },
                  {
                    "text": "Porcelain gallbladder> 10% of affected patients have or will develop adenocarcinoma",
                    "sub_points": [
                      "> 10% of affected patients have or will develop adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Primary sclerosing cholangitis (PSC)Gallbladder adenocarcinoma reported in ~ 14% of patients undergoing liver transplantation for PSC",
                    "sub_points": [
                      "Gallbladder adenocarcinoma reported in ~ 14% of patients undergoing liver transplantation for PSC"
                    ]
                  },
                  {
                    "text": "Gastrointestinal polyposisFamilial adenomatous polyposis coliGardner syndromePeutz-Jeghers syndrome",
                    "sub_points": [
                      "Familial adenomatous polyposis coli",
                      "Gardner syndrome",
                      "Peutz-Jeghers syndrome"
                    ]
                  }
                ],
                "Molecular Alterations": [
                  {
                    "text": "ReportedKRASmutation rates vary from 0-50%"
                  },
                  {
                    "text": "TP53mutations common in late-stage disease"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Reported 1.43 cases per 100,000 persons at risk"
                  },
                  {
                    "text": "Rates of incidental diagnosis at time of laparoscopic cholecystectomy range from 0.28-2.10%"
                  }
                ],
                "Age": [
                  {
                    "text": "Predominantly affects elderly patients"
                  },
                  {
                    "text": "Mean: 65 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Females more often affected (F:M = 3:1)"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "Most often occurs in India, Chile, Pakistan, and Ecuador"
                  },
                  {
                    "text": "In western countries, Latin American and Native American individuals at greatest risk"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms often vague, nonspecificUpper abdominal painWeight lossFeverJaundice",
                    "sub_points": [
                      "Upper abdominal pain",
                      "Weight loss",
                      "Fever",
                      "Jaundice"
                    ]
                  },
                  {
                    "text": "Many patients asymptomaticTumor found incidentally at time of cholecystectomy",
                    "sub_points": [
                      "Tumor found incidentally at time of cholecystectomy"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated alkaline phosphatase"
                  }
                ],
                "Treatment": [
                  {
                    "text": "SurgeryMost effective and only potentially curative treatmentNot effective for advanced diseaseLow-stage tumorsOften identified incidentally at time of cholecystectomy for cholelithiasis or cholecystitisSimple cholecystectomy may be adequate therapyReexcision of bed of gallbladder may be considered laterAdvanced tumorsRadical cholecystectomy with lymphadenectomy and right hepatic lobectomy",
                    "sub_points": [
                      "Most effective and only potentially curative treatmentNot effective for advanced disease",
                      "Not effective for advanced disease",
                      "Low-stage tumorsOften identified incidentally at time of cholecystectomy for cholelithiasis or cholecystitisSimple cholecystectomy may be adequate therapyReexcision of bed of gallbladder may be considered later",
                      "Often identified incidentally at time of cholecystectomy for cholelithiasis or cholecystitis",
                      "Simple cholecystectomy may be adequate therapyReexcision of bed of gallbladder may be considered later",
                      "Reexcision of bed of gallbladder may be considered later",
                      "Advanced tumorsRadical cholecystectomy with lymphadenectomy and right hepatic lobectomy",
                      "Radical cholecystectomy with lymphadenectomy and right hepatic lobectomy"
                    ]
                  },
                  {
                    "text": "Adjuvant chemotherapyGemcitabine and gemcitabine-based regimens appear to be most effective to date",
                    "sub_points": [
                      "Gemcitabine and gemcitabine-based regimens appear to be most effective to date"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "~ 10% overall 5-year survival42% 5-year survival for patients with resectable tumors",
                    "sub_points": [
                      "42% 5-year survival for patients with resectable tumors"
                    ]
                  },
                  {
                    "text": "Tumor stage probably most important prognostic factor"
                  },
                  {
                    "text": "Other prognostic factorsTumor gradePoorly differentiated tumors associated with poor survivalLymph node metastasesCompleteness of resection",
                    "sub_points": [
                      "Tumor gradePoorly differentiated tumors associated with poor survival",
                      "Poorly differentiated tumors associated with poor survival",
                      "Lymph node metastases",
                      "Completeness of resection"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Various appearances may be seen on imagingTumor mass occupying or replacing gallbladder lumen40-65% of tumorsLocalized or diffuse wall thickeningPolypoid lesion in gallbladder lumenLiver invasion may be seen",
                    "sub_points": [
                      "Tumor mass occupying or replacing gallbladder lumen40-65% of tumors",
                      "40-65% of tumors",
                      "Localized or diffuse wall thickening",
                      "Polypoid lesion in gallbladder lumen",
                      "Liver invasion may be seen"
                    ]
                  },
                  {
                    "text": "US is common 1st-line test for suspected gallbladder diseaseHigh sensitivity for advanced tumorsUnreliable for staging and diagnosis or early tumors",
                    "sub_points": [
                      "High sensitivity for advanced tumors",
                      "Unreliable for staging and diagnosis or early tumors"
                    ]
                  },
                  {
                    "text": "CT and MR provide more detailed informationTumor stagingEvaluate for metastases",
                    "sub_points": [
                      "Tumor staging",
                      "Evaluate for metastases"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "LocationFundus (60%), body (30%), or neck (10%) of gallbladder",
                    "sub_points": [
                      "Fundus (60%), body (30%), or neck (10%) of gallbladder"
                    ]
                  },
                  {
                    "text": "Variable gross appearancesArea of thickening and induration of gallbladder wallExophytic or polypoid mucosal mass",
                    "sub_points": [
                      "Area of thickening and induration of gallbladder wall",
                      "Exophytic or polypoid mucosal mass"
                    ]
                  },
                  {
                    "text": "Tumor may not be grossly evident"
                  },
                  {
                    "text": "Tumors often firm, white, and gritty on cut section"
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "Cystic duct marginTumors are often incidental and more often located near gallbladder neckEvaluate margin for carcinoma or dysplasia",
                    "sub_points": [
                      "Tumors are often incidental and more often located near gallbladder neck",
                      "Evaluate margin for carcinoma or dysplasia"
                    ]
                  },
                  {
                    "text": "Hepatic resection margin"
                  },
                  {
                    "text": "Gallbladder dysplasiaIf identified, extensive sampling warranted to exclude occult carcinomaDysplasia can cause granular mucosal patches but may not be grossly recognizable",
                    "sub_points": [
                      "If identified, extensive sampling warranted to exclude occult carcinoma",
                      "Dysplasia can cause granular mucosal patches but may not be grossly recognizable"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Malignant glands, clusters, or individual cells invading gallbladder wallComplex and irregular glands can also be seen",
                    "sub_points": [
                      "Complex and irregular glands can also be seen"
                    ]
                  },
                  {
                    "text": "Wide spectrum of histologic appearancesMay be extremely well differentiatedSome tumors are deceptively blandMay exhibit well-formed glands and only minimal cytologic abnormalitiesInfiltrative growth pattern, nuclear grooves and anisocytosis, and mitotic activity are helpful cluesMalignant glands/cells may be rare and widely spaced in abundant desmoplastic stromaMultiple histologic variants recognized by WHOPapillary adenocarcinomaIntestinal-type or gastric foveolar-type adenocarcinomaMucinous adenocarcinomaClear cell adenocarcinomaSignet ring cell carcinomaAdenosquamous carcinomaMicropapillaryAdenosquamous carcinoma or squamous cell carcinomaSmall cell or large cell neuroendocrine carcinomaUndifferentiated carcinomaBiliary cystadenocarcinoma",
                    "sub_points": [
                      "May be extremely well differentiatedSome tumors are deceptively blandMay exhibit well-formed glands and only minimal cytologic abnormalitiesInfiltrative growth pattern, nuclear grooves and anisocytosis, and mitotic activity are helpful clues",
                      "Some tumors are deceptively bland",
                      "May exhibit well-formed glands and only minimal cytologic abnormalities",
                      "Infiltrative growth pattern, nuclear grooves and anisocytosis, and mitotic activity are helpful clues",
                      "Malignant glands/cells may be rare and widely spaced in abundant desmoplastic stroma",
                      "Multiple histologic variants recognized by WHOPapillary adenocarcinomaIntestinal-type or gastric foveolar-type adenocarcinomaMucinous adenocarcinomaClear cell adenocarcinomaSignet ring cell carcinomaAdenosquamous carcinomaMicropapillaryAdenosquamous carcinoma or squamous cell carcinomaSmall cell or large cell neuroendocrine carcinomaUndifferentiated carcinomaBiliary cystadenocarcinoma",
                      "Papillary adenocarcinoma",
                      "Intestinal-type or gastric foveolar-type adenocarcinoma",
                      "Mucinous adenocarcinoma",
                      "Clear cell adenocarcinoma",
                      "Signet ring cell carcinoma",
                      "Adenosquamous carcinoma",
                      "Micropapillary",
                      "Adenosquamous carcinoma or squamous cell carcinoma",
                      "Small cell or large cell neuroendocrine carcinoma",
                      "Undifferentiated carcinoma",
                      "Biliary cystadenocarcinoma"
                    ]
                  },
                  {
                    "text": "Majority of cases associated with epithelial dysplasia &/or carcinoma in situDysplasia or carcinoma in situ are usually incidental findings in cholecystectomy",
                    "sub_points": [
                      "Dysplasia or carcinoma in situ are usually incidental findings in cholecystectomy"
                    ]
                  },
                  {
                    "text": "Perineural invasion is common"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Peritoneal cytology most helpful in patients with advanced tumors"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Similar to other adenocarcinomas arising in pancreaticobiliary tree"
                  },
                  {
                    "text": "Most tumors CK7 and CK19 (+) with variable expression of CK20"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Cholecystitis": [
                  {
                    "text": "Rokitansky-Aschoff sinuses (RAS) can mimic invasive adenocarcinomaUsually RAS consist of larger glandular structures that are contiguous with surface epitheliumCan extend deeply into and even through gallbladder wall (similar to diverticula)May be surrounded by fibrotic stroma that mimics desmoplastic stromaEven more problematic if epithelial dysplasia or carcinoma in situ involves RASAdenocarcinoma arising in RAS reported but extremely rare",
                    "sub_points": [
                      "Usually RAS consist of larger glandular structures that are contiguous with surface epitheliumCan extend deeply into and even through gallbladder wall (similar to diverticula)May be surrounded by fibrotic stroma that mimics desmoplastic stroma",
                      "Can extend deeply into and even through gallbladder wall (similar to diverticula)",
                      "May be surrounded by fibrotic stroma that mimics desmoplastic stroma",
                      "Even more problematic if epithelial dysplasia or carcinoma in situ involves RASAdenocarcinoma arising in RAS reported but extremely rare",
                      "Adenocarcinoma arising in RAS reported but extremely rare"
                    ]
                  },
                  {
                    "text": "Adenocarcinoma usually comprised of smaller glands with more cytologic atypia than RAS"
                  },
                  {
                    "text": "Neoplastic glands are usually smaller and more crowded than RAS"
                  }
                ],
                "Adenomyoma": [
                  {
                    "text": "Irregular, dilated cystic structures set in hypertrophic smooth muscle"
                  },
                  {
                    "text": "Bland epithelium and lobular configuration distinguishes adenomyoma from adenocarcinoma"
                  }
                ],
                "Acute Cholecystitis": [
                  {
                    "text": "Reactive epithelial alterations may be mistaken for dysplasia or carcinoma"
                  },
                  {
                    "text": "Use caution when making diagnosis in setting of marked inflammation"
                  }
                ],
                "Ducts of Luschka": [
                  {
                    "text": "Groups of small, round, benign ducts often seen at hepatic surface of gallbladder"
                  },
                  {
                    "text": "Lack invasive growth pattern or cytologic features of malignancy"
                  },
                  {
                    "text": "May be very challenging to distinguish from adenocarcinoma on frozen section"
                  }
                ],
                "Metastatic Adenocarcinoma to Gallbladder": [
                  {
                    "text": "Extremely rare; diagnosis based on clinical history &/or immunohistochemistry"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adenocarcinoma of Extrahepatic Bile Ducts": {
            "name": "Adenocarcinoma of Extrahepatic Bile Ducts",
            "url": "https://app.pathprimer.com/document/dbedd893-5e67-4661-abef-3baaa6aa2944/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant biliary epithelial neoplasm arising from extrahepatic bile ducts (right and left hepatic ducts, common hepatic duct, and common bile duct)3 forms: Perihilar, distal, and diffuse",
                    "sub_points": [
                      "3 forms: Perihilar, distal, and diffuse"
                    ]
                  },
                  {
                    "text": "Klatskin tumor: Perihilar tumor occurring at confluence of right and left hepatic ducts"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Numerous risk factors, including developmental anomalies, flukes, primary sclerosing cholangitis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Poor prognosis with 10% overall 5-year survivalSurgical resection is only hope for long-term survival",
                    "sub_points": [
                      "Surgical resection is only hope for long-term survival"
                    ]
                  },
                  {
                    "text": "Rare (incidence is 0.53-2.00 per 100,000)"
                  },
                  {
                    "text": "Primarily 6th and 7th decades of life"
                  },
                  {
                    "text": "Nonspecific symptoms, signs of biliary obstruction"
                  },
                  {
                    "text": "Elevated serum CA19-9, CEA-M, CA125"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Wide spectrum of histologic appearances"
                  },
                  {
                    "text": "Malignant glands are arranged in haphazard pattern, infiltrating duct wall"
                  },
                  {
                    "text": "Often associated with desmoplastic stroma"
                  },
                  {
                    "text": "Nuclear pleomorphism with increased N:C ratio, nuclear grooves, and brisk mitotic activityCytologic features may be deceptively bland",
                    "sub_points": [
                      "Cytologic features may be deceptively bland"
                    ]
                  },
                  {
                    "text": "Frequent lymphovascular &/or perineural invasion"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Positive: CK-PAN, CK7, CK19, CEA-M, CA19-9, MUC1, and MUC5ACCK20, CDX-2 positive in < 50% of cases",
                    "sub_points": [
                      "CK20, CDX-2 positive in < 50% of cases"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Reactive periductal glands"
                  },
                  {
                    "text": "Pancreatic ductal carcinoma: Indistinguishable histologically and immunophenotypically"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Extrahepatic cholangiocarcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant biliary epithelial neoplasm arising from right or left hepatic duct, common hepatic duct, or common bile duct"
                  },
                  {
                    "text": "Perihilar: Arises in extrahepatic bile ducts upstream from origin of cystic duct (70-80%)Klatskin tumor: Perihilar tumor occurring at confluence of right and left hepatic ducts",
                    "sub_points": [
                      "Klatskin tumor: Perihilar tumor occurring at confluence of right and left hepatic ducts"
                    ]
                  },
                  {
                    "text": "Distal: Arises in common bile duct, including intrapancreatic portion, above ampulla of Vater (20-30%)"
                  },
                  {
                    "text": "Diffuse (~ 2%)"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Developmental (choledochal cyst, abnormal choledochopancreatic junction)"
                  },
                  {
                    "text": "Primary sclerosing cholangitis"
                  },
                  {
                    "text": "Parasitic infection (i.e., flukes)"
                  },
                  {
                    "text": "Familial adenomatous polyposis"
                  },
                  {
                    "text": "Molecular alterations [KRASmutations (30%), overexpression of p53 oncoprotein (50%)]"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.53-2.00 per 100,000 in population"
                  }
                ],
                "Age": [
                  {
                    "text": "Primarily 6th and 7th decades of life"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slight male predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific symptoms: Abdominal pain, malaise, anorexia, nausea/vomiting, weight loss"
                  },
                  {
                    "text": "Signs of biliary obstruction: Jaundice, pruritus, acholic stools, dark urine"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated serum CA19-9, CEA-M, CA125"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery plus chemoradiation"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Poor; overall 10% 5-year survival"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Duct dilation indicative of downstream obstruction"
                  }
                ],
                "CT and MR Findings": [
                  {
                    "text": "Infiltrative pattern (duct wall thickening, obliteration of duct lumen) or mass lesion"
                  }
                ],
                "ERCP Findings": [
                  {
                    "text": "Bile duct stricture"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Polypoid, nodular, constricting/stenotic, or diffusely infiltrating"
                  },
                  {
                    "text": "Firm, white, gritty, cut surface"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Very variable morphologic appearance with numerous histologic variantsGlands may be well formed, irregular, abortive, cribriforming, or form papillary structuresRandomly and haphazardly infiltrate duct wall; often widely spacedIndividual infiltrating cells may be present as wellCytologic featuresDeceptively bland to overtly high-grade nucleiRaisinoid nuclei with nuclear groovesNuclear anisocytosisAcidophilic, basophilic, granular, pale, clear, foamy, or microvesicular cytoplasm",
                    "sub_points": [
                      "Glands may be well formed, irregular, abortive, cribriforming, or form papillary structuresRandomly and haphazardly infiltrate duct wall; often widely spacedIndividual infiltrating cells may be present as well",
                      "Randomly and haphazardly infiltrate duct wall; often widely spaced",
                      "Individual infiltrating cells may be present as well",
                      "Cytologic featuresDeceptively bland to overtly high-grade nucleiRaisinoid nuclei with nuclear groovesNuclear anisocytosisAcidophilic, basophilic, granular, pale, clear, foamy, or microvesicular cytoplasm",
                      "Deceptively bland to overtly high-grade nucleiRaisinoid nuclei with nuclear groovesNuclear anisocytosis",
                      "Raisinoid nuclei with nuclear grooves",
                      "Nuclear anisocytosis",
                      "Acidophilic, basophilic, granular, pale, clear, foamy, or microvesicular cytoplasm"
                    ]
                  },
                  {
                    "text": "Prominent desmoplastic stroma"
                  },
                  {
                    "text": "Varying amounts of intraluminal or extracellular mucin and tumor necrosis"
                  },
                  {
                    "text": "Frequent lymphovascular &/or perineural invasion"
                  },
                  {
                    "text": "Frequent association with epithelial dysplasia or carcinoma in situ"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive: CK-PAN, CK7, CK19, CEA-M, CA19-9, MUC1, and MUC5ACCK20, CDX-2 positive in < 50% of cases",
                    "sub_points": [
                      "CK20, CDX-2 positive in < 50% of cases"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Reactive Periductal Glands": [
                  {
                    "text": "Preserved lobular architecture with uniform, noninfiltrating glands; often history of stent"
                  }
                ],
                "Secondary Involvement by Pancreatic Ductal Adenocarcinoma": [
                  {
                    "text": "Indistinguishable histologically and immunophenotypically; clinical history, image findings helpful"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Squamous/Adenosquamous Carcinoma, Gallbladder": {
            "name": "Squamous/Adenosquamous Carcinoma, Gallbladder",
            "url": "https://app.pathprimer.com/document/bce953bb-bdac-43af-bb20-4e72857552ec/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasms of gallbladder composed of either pure squamous component, or both squamous and glandular components"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Neoplastic transformation from squamous metaplasia of gallbladder mucosaMetaplasia → dysplasia → carcinoma sequence",
                    "sub_points": [
                      "Metaplasia → dysplasia → carcinoma sequence"
                    ]
                  },
                  {
                    "text": "Progression from preexisting adenocarcinomaConsidered \"metaplastic carcinoma\" like that in breast",
                    "sub_points": [
                      "Considered \"metaplastic carcinoma\" like that in breast"
                    ]
                  },
                  {
                    "text": "Gallstones present in 40-68% of cases"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Median overall survival: 9 months (13 if R0 resection)"
                  },
                  {
                    "text": "Worse prognosis than conventional gallbladder adenocarcinoma stage by stage"
                  },
                  {
                    "text": "No difference between pure squamous and adenosquamous"
                  },
                  {
                    "text": "Determined by stage, histologic grade, patient's age, tumor size, and margin status"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "White-tan, firm or friable, intraluminal fungating mass"
                  },
                  {
                    "text": "Diffuse thickening and induration of gallbladder wall"
                  },
                  {
                    "text": "May involve adjacent organs, including liver, colon, stomach, duodenum, omentum, pancreas, extrahepatic bile ducts, hepatic arteries"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Squamous cell carcinomaComposed entirely of squamous componentGrading based on degree of keratinization, cytologic atypia, and mitotic activitySpindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcoma",
                    "sub_points": [
                      "Composed entirely of squamous component",
                      "Grading based on degree of keratinization, cytologic atypia, and mitotic activity",
                      "Spindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcoma"
                    ]
                  },
                  {
                    "text": "Adenosquamous carcinoma has both malignant glandular and squamous componentsGlandular component: Any amountSimilar to conventional gallbladder adenocarcinomaSquamous component: > 25% of tumor volumeSeparate foci or admixed with glandular component",
                    "sub_points": [
                      "Glandular component: Any amountSimilar to conventional gallbladder adenocarcinoma",
                      "Similar to conventional gallbladder adenocarcinoma",
                      "Squamous component: > 25% of tumor volumeSeparate foci or admixed with glandular component",
                      "Separate foci or admixed with glandular component"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Metastatic squamous cell carcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasms of gallbladder composed of either pure squamous component, or both squamous and glandular components"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Histogenesis": [
                  {
                    "text": "Neoplastic transformation from squamous metaplasia of gallbladder mucosaMetaplasia → dysplasia → carcinoma sequence",
                    "sub_points": [
                      "Metaplasia → dysplasia → carcinoma sequence"
                    ]
                  },
                  {
                    "text": "Progression from preexisting adenocarcinomaConsidered \"metaplastic carcinoma\" similar to breast",
                    "sub_points": [
                      "Considered \"metaplastic carcinoma\" similar to breast"
                    ]
                  }
                ],
                "Association": [
                  {
                    "text": "Gallstones present in 40-68% of cases"
                  },
                  {
                    "text": "Parasitic infection reported in rare cases"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1-4% of all gallbladder carcinomas"
                  },
                  {
                    "text": "Pure squamous vs. adenosquamous: 1.0:1.9"
                  }
                ],
                "Age": [
                  {
                    "text": "Median age: 71 years (range: 26-89 years)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain, jaundice, weight loss, abdominal mass"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cholecystectomy ± partial hepatectomyExtended resections may be necessary depending on adjacent organ involvementResectability rate at diagnosis: ~ 50%",
                    "sub_points": [
                      "Extended resections may be necessary depending on adjacent organ involvement",
                      "Resectability rate at diagnosis: ~ 50%"
                    ]
                  },
                  {
                    "text": "Chemoradiation therapy may be beneficial"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Determined by stage, histologic grade, patient's age, tumor size, and margin statusMedian overall survival: 9 months (13 months if R0 resection)Worse than conventional gallbladder adenocarcinoma stage for stage",
                    "sub_points": [
                      "Median overall survival: 9 months (13 months if R0 resection)",
                      "Worse than conventional gallbladder adenocarcinoma stage for stage"
                    ]
                  },
                  {
                    "text": "No difference between pure squamous and adenosquamous"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "White-tan, firm or friable, intraluminal, fungating massMost common in fundus",
                    "sub_points": [
                      "Most common in fundus"
                    ]
                  },
                  {
                    "text": "Diffuse thickening and induration of gallbladder wallMay be indistinguishable from cholecystitis",
                    "sub_points": [
                      "May be indistinguishable from cholecystitis"
                    ]
                  },
                  {
                    "text": "May involve adjacent organs, including liver, colon, stomach, duodenum, omentum, pancreas, extrahepatic bile ducts, hepatic arteries"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Squamous cell carcinomaComposed entirely of squamous componentAdjacent gallbladder mucosa may show squamous metaplasia ± dysplasiaGrading based on degree of keratinization, cytologic atypia, and mitotic activityWell differentiatedNests or sheets of large cells with prominent cytoplasmic keratinization and keratin pearlsMinimal cytologic atypia; low mitotic activityModerately differentiatedMixture of nonkeratinizing, basal-type, and keratinizing cellsMitosis and cytologic atypia easily appreciablePoorly differentiatedPredominantly nonkeratinizing, basal-type cellsPunctuating keratinizing or parakeratotic cells occasionally seenCentral necrosis is commonSpindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcomaHighest grade is assigned for tumors showing variable differentiation",
                    "sub_points": [
                      "Composed entirely of squamous componentAdjacent gallbladder mucosa may show squamous metaplasia ± dysplasia",
                      "Adjacent gallbladder mucosa may show squamous metaplasia ± dysplasia",
                      "Grading based on degree of keratinization, cytologic atypia, and mitotic activityWell differentiatedNests or sheets of large cells with prominent cytoplasmic keratinization and keratin pearlsMinimal cytologic atypia; low mitotic activityModerately differentiatedMixture of nonkeratinizing, basal-type, and keratinizing cellsMitosis and cytologic atypia easily appreciablePoorly differentiatedPredominantly nonkeratinizing, basal-type cellsPunctuating keratinizing or parakeratotic cells occasionally seenCentral necrosis is commonSpindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcomaHighest grade is assigned for tumors showing variable differentiation",
                      "Well differentiatedNests or sheets of large cells with prominent cytoplasmic keratinization and keratin pearlsMinimal cytologic atypia; low mitotic activity",
                      "Nests or sheets of large cells with prominent cytoplasmic keratinization and keratin pearls",
                      "Minimal cytologic atypia; low mitotic activity",
                      "Moderately differentiatedMixture of nonkeratinizing, basal-type, and keratinizing cellsMitosis and cytologic atypia easily appreciable",
                      "Mixture of nonkeratinizing, basal-type, and keratinizing cells",
                      "Mitosis and cytologic atypia easily appreciable",
                      "Poorly differentiatedPredominantly nonkeratinizing, basal-type cellsPunctuating keratinizing or parakeratotic cells occasionally seenCentral necrosis is commonSpindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcoma",
                      "Predominantly nonkeratinizing, basal-type cells",
                      "Punctuating keratinizing or parakeratotic cells occasionally seen",
                      "Central necrosis is common",
                      "Spindle cells may predominate (sarcomatoid) and may be confused with high-grade sarcoma",
                      "Highest grade is assigned for tumors showing variable differentiation"
                    ]
                  },
                  {
                    "text": "Adenosquamous carcinoma has both malignant glandular and squamous componentsGlandular component: Any amountSimilar to conventional gallbladder adenocarcinomaCan be biliary, intestinal, or clear cell typeSquamous component: > 25% of tumor volumeMay form separate foci or admixed with glandular component",
                    "sub_points": [
                      "Glandular component: Any amountSimilar to conventional gallbladder adenocarcinomaCan be biliary, intestinal, or clear cell type",
                      "Similar to conventional gallbladder adenocarcinomaCan be biliary, intestinal, or clear cell type",
                      "Can be biliary, intestinal, or clear cell type",
                      "Squamous component: > 25% of tumor volumeMay form separate foci or admixed with glandular component",
                      "May form separate foci or admixed with glandular component"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Proportion of cells with glandular or squamous features varies according to amount in tumor and sampling"
                  },
                  {
                    "text": "Pure squamous cell carcinoma may be due to undersampling of adenosquamous carcinoma, and metastatic squamous cell carcinoma must be considered"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "MucicarmineHelp identify intracytoplasmic mucin to confirm presence of glandular component",
                    "sub_points": [
                      "Help identify intracytoplasmic mucin to confirm presence of glandular component"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "p40, CK5/6, p63Positive in squamous component",
                    "sub_points": [
                      "Positive in squamous component"
                    ]
                  },
                  {
                    "text": "CK7, CK19, CEAPositive in glandular component",
                    "sub_points": [
                      "Positive in glandular component"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Metastatic Squamous Cell Carcinoma": [
                  {
                    "text": "Documented history in other locations"
                  }
                ],
                "Adenocarcinoma With Focal (< 25%) Squamous Differentiation": [
                  {
                    "text": "Seen in ~5% of gallbladder adenocarcinoma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Pure squamous cell carcinoma of gallbladder is rare, and metastasis should be ruled out"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Carcinoid Tumor": {
            "name": "Carcinoid Tumor",
            "url": "https://app.pathprimer.com/document/63220a83-7f1f-4973-b6bc-93d4eddac865/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Facts": {
                "Clinical Issues": [
                  {
                    "text": "Rare primary neoplasm of biliary tract"
                  },
                  {
                    "text": "All tumors have metastatic potential"
                  },
                  {
                    "text": "Risk is mostly dependent on location in GI tract, size, and depth of invasion"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Uniform cells in insular, trabecular, and nesting patterns of growth within fibrous stroma"
                  },
                  {
                    "text": "Round, uniform nuclei with finely stippled chromatin (\"salt and pepper\")"
                  },
                  {
                    "text": "Scant mitoses, ≤ 2 mitotic figures per 10 HPF"
                  },
                  {
                    "text": "Minimal or no necrosis"
                  },
                  {
                    "text": "Diffuse reactivity with neuroendocrine markers (chromogranin, synaptophysin, and neuron-specific enolase)"
                  }
                ]
              },
              "Terminology": {
                "Synonyms": [
                  {
                    "text": "Well-differentiated neuroendocrine tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Neoplasm of diffuse endocrine cell system"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare primary neoplasm of biliary tractMost common location in biliary tract is gallbladder",
                    "sub_points": [
                      "Most common location in biliary tract is gallbladder"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Mean age at presentation is 60 years"
                  }
                ],
                "Gender": [
                  {
                    "text": "Slightly more common in females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "May have symptoms of biliary obstruction, particularly those arising in extrahepatic bile ducts"
                  },
                  {
                    "text": "May be discovered incidentallySmall tumors may remain undetected for long periods",
                    "sub_points": [
                      "Small tumors may remain undetected for long periods"
                    ]
                  },
                  {
                    "text": "Most discovered in patients who present with acute or chronic cholecystitis secondary to cholelithiasis"
                  },
                  {
                    "text": "Some are associated with von Hippel-Lindau syndrome, multiple endocrine neoplasia syndrome (MEN-1), or Zollinger-Ellison syndrome"
                  },
                  {
                    "text": "Not typically associated with carcinoid syndrome"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Varied, depending on extent of diseaseSimple cholecystectomy to extensive surgical resections, including regional lymph node dissections and hepatic lobectomy",
                    "sub_points": [
                      "Simple cholecystectomy to extensive surgical resections, including regional lymph node dissections and hepatic lobectomy"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Similar behavior to carcinoid tumors occurring in other parts of GI tractAll tumors have metastatic potentialRisk is dependent on location in GI tract, size, and depth of invasionTumors > 2 cm are more likely to metastasize",
                    "sub_points": [
                      "All tumors have metastatic potentialRisk is dependent on location in GI tract, size, and depth of invasionTumors > 2 cm are more likely to metastasize",
                      "Risk is dependent on location in GI tract, size, and depth of invasion",
                      "Tumors > 2 cm are more likely to metastasize"
                    ]
                  },
                  {
                    "text": "Overall 5-year survival rate of patients with biliary carcinoid tumor is around 40%"
                  }
                ]
              },
              "Image Findings": {
                "General Features": [
                  {
                    "text": "Difficult to detect radiographically, mainly due to small size"
                  },
                  {
                    "text": "Occasionally discovered by ultrasound or computed tomography (CT) scan"
                  },
                  {
                    "text": "May be detected by octreotide scan"
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Nodular or polypoid lesionsCan arise in any part of gallbladder",
                    "sub_points": [
                      "Can arise in any part of gallbladder"
                    ]
                  },
                  {
                    "text": "Cut surface usually solid, homogeneous, and white-yellow"
                  },
                  {
                    "text": "May be infiltrative and extend into adjacent liver"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Uniform cells in insular, trabecular, and nesting patternsOccasional tubule formationCarcinoid tumors may show pseudogland formation, which should not be interpreted as adenocarcinomaFocal signet ring cell morphology may be seenRound, uniform nuclei with finely stippled chromatin (\"salt and pepper\")Inconspicuous nucleoliSmall amount of eosinophilic and granular cytoplasmSome may show signet ring cell morphologyMinimal nuclear atypiaScant mitoses, ≤ 2 mitotic figures per 10 HPFMinimal or no necrosis",
                    "sub_points": [
                      "Occasional tubule formationCarcinoid tumors may show pseudogland formation, which should not be interpreted as adenocarcinomaFocal signet ring cell morphology may be seen",
                      "Carcinoid tumors may show pseudogland formation, which should not be interpreted as adenocarcinoma",
                      "Focal signet ring cell morphology may be seen",
                      "Round, uniform nuclei with finely stippled chromatin (\"salt and pepper\")Inconspicuous nucleoliSmall amount of eosinophilic and granular cytoplasmSome may show signet ring cell morphologyMinimal nuclear atypiaScant mitoses, ≤ 2 mitotic figures per 10 HPFMinimal or no necrosis",
                      "Inconspicuous nucleoli",
                      "Small amount of eosinophilic and granular cytoplasm",
                      "Some may show signet ring cell morphology",
                      "Minimal nuclear atypia",
                      "Scant mitoses, ≤ 2 mitotic figures per 10 HPF",
                      "Minimal or no necrosis"
                    ]
                  },
                  {
                    "text": "Prominent fibrous stroma"
                  },
                  {
                    "text": "Mucosa adjacent to tumor may show hyperplasia"
                  },
                  {
                    "text": "VariantsTubular variant of carcinoid tumor has been described, similar to that in appendixClear cell variant, especially those associated with von Hippel-Lindau syndromeMixed (composite) carcinoid-adenocarcinomaClassic carcinoid tumor mixed with adenocarcinoma",
                    "sub_points": [
                      "Tubular variant of carcinoid tumor has been described, similar to that in appendix",
                      "Clear cell variant, especially those associated with von Hippel-Lindau syndrome",
                      "Mixed (composite) carcinoid-adenocarcinomaClassic carcinoid tumor mixed with adenocarcinoma",
                      "Classic carcinoid tumor mixed with adenocarcinoma"
                    ]
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "Diffuse reactivity with neuroendocrine markersChromogranin, synaptophysin, and neuron-specific enolase",
                    "sub_points": [
                      "Chromogranin, synaptophysin, and neuron-specific enolase"
                    ]
                  },
                  {
                    "text": "Some tumors also express reactivity for serotonin, somatostatin, pancreatic polypeptide, or gastrinUsually, tumors express > 1 substance",
                    "sub_points": [
                      "Usually, tumors express > 1 substance"
                    ]
                  }
                ]
              },
              "Differential Diagnosis": {
                "High-Grade Neuroendocrine Carcinoma": [
                  {
                    "text": "Increased mitotic activity (> 10 per 10 HPF), necrosis, or both"
                  }
                ],
                "Well-Differentiated Adenocarcinoma": [
                  {
                    "text": "Tubular variant of carcinoid tumor should show positive staining with neuroendocrine markers"
                  },
                  {
                    "text": "Adenocarcinoma strongly keratin positiveSome carcinoid tumors show keratin positivity as well",
                    "sub_points": [
                      "Some carcinoid tumors show keratin positivity as well"
                    ]
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Correlation between immunohistochemical expression of peptide hormones and serologic levels has not been determined"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Poorly Differentiated Neuroendocrine Carcinoma, Gallbladder": {
            "name": "Poorly Differentiated Neuroendocrine Carcinoma, Gallbladder",
            "url": "https://app.pathprimer.com/document/cc89ebbc-b43b-474e-a505-a8e91e71a1be/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Facts": {
                "Terminology": [
                  {
                    "text": "Similar to small cell carcinomas in other organs"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Highly aggressive neoplasm"
                  }
                ],
                "Microscopic Features": [
                  {
                    "text": "Round to spindled blue cells with hyperchromatic nuclei, finely dispersed chromatin, nuclear moulding"
                  },
                  {
                    "text": "Abundant necrosis and numerous mitoses"
                  },
                  {
                    "text": "May have foci of adenocarcinoma, squamous cell carcinoma, &/or mucosal dysplasia/carcinoma in situ"
                  },
                  {
                    "text": "Cytokeratin positive; many are negative for neuroendocrine markers"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Important to make diagnosis so that patients get the correct chemotherapeutic regimen"
                  }
                ]
              },
              "Terminology": {
                "Abbreviations": [
                  {
                    "text": "Poorly differentiated neuroendocrine carcinoma (PDNC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Small cell carcinoma"
                  },
                  {
                    "text": "Small cell undifferentiated carcinoma"
                  },
                  {
                    "text": "Oat cell carcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Most are similar to small cell counterpart in other organs, but some tumors have a large cell phenotype"
                  }
                ]
              },
              "Etiology/Pathogenesis": {
                "Unknown": [
                  {
                    "text": "Associated with gallstones"
                  }
                ]
              },
              "Clinical Issues": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Very rare< 5% of gallbladder carcinomasMore common in gallbladder than extrahepatic biliary tree",
                    "sub_points": [
                      "< 5% of gallbladder carcinomas",
                      "More common in gallbladder than extrahepatic biliary tree"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Older adults (6th to 7th decade of life; mean age at presentation is 67)"
                  }
                ],
                "Gender": [
                  {
                    "text": "Some sources report female predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to other types of gallbladder carcinoma"
                  },
                  {
                    "text": "Rare syndrome of ectopic hormone production may give rise to Cushing syndrome"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Chemotherapy regimen similar to that of PDNC of lung"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "DismalAggressive neoplasm that behaves similarly to counterparts in other organsMany patients die within 6 months",
                    "sub_points": [
                      "Aggressive neoplasm that behaves similarly to counterparts in other organs",
                      "Many patients die within 6 months"
                    ]
                  }
                ]
              },
              "Macroscopic Features": {
                "General Features": [
                  {
                    "text": "Similar to other invasive carcinomas of gallbladderRange from thickening of wall to bulging nodular mass",
                    "sub_points": [
                      "Range from thickening of wall to bulging nodular mass"
                    ]
                  },
                  {
                    "text": "Abundant necrosis is common"
                  }
                ]
              },
              "Microscopic Pathology": {
                "Histologic Features": [
                  {
                    "text": "Similar to PDNC in other organsSmall, round to spindled blue cellsHyperchromatic nuclei with finely dispersed chromatinNuclear mouldingInconspicuous nucleoliScant eosinophilic cytoplasmTumor may grow in solid, nested, or trabecular patternsSubmucosal rather than mucosal growth is very commonAbundant necrosisViable tumor may be limited to areas around blood vesselsWalls of vessels may show deeply basophilic DNA deposition (Azzopardi effect)Numerous mitoses",
                    "sub_points": [
                      "Small, round to spindled blue cellsHyperchromatic nuclei with finely dispersed chromatinNuclear mouldingInconspicuous nucleoliScant eosinophilic cytoplasm",
                      "Hyperchromatic nuclei with finely dispersed chromatin",
                      "Nuclear moulding",
                      "Inconspicuous nucleoli",
                      "Scant eosinophilic cytoplasm",
                      "Tumor may grow in solid, nested, or trabecular patternsSubmucosal rather than mucosal growth is very common",
                      "Submucosal rather than mucosal growth is very common",
                      "Abundant necrosisViable tumor may be limited to areas around blood vesselsWalls of vessels may show deeply basophilic DNA deposition (Azzopardi effect)",
                      "Viable tumor may be limited to areas around blood vessels",
                      "Walls of vessels may show deeply basophilic DNA deposition (Azzopardi effect)",
                      "Numerous mitoses"
                    ]
                  },
                  {
                    "text": "May be associated with conventional adenocarcinoma, squamous cell carcinoma, &/or mucosal dysplasia/carcinoma in situ"
                  }
                ]
              },
              "Ancillary Tests": {
                "Immunohistochemistry": [
                  {
                    "text": "May be positive for synaptophysin, chromogranin, NSEMore than half are negative for neuroendocrine markers in some reports; thus morphology is more important than immunophenotype",
                    "sub_points": [
                      "More than half are negative for neuroendocrine markers in some reports; thus morphology is more important than immunophenotype"
                    ]
                  },
                  {
                    "text": "Virtually all are cytokeratin positive"
                  }
                ]
              },
              "Differential Diagnosis": {
                "Metastatic Poorly Differentiated Neuroendocrine Carcinoma": [
                  {
                    "text": "May require imaging studies to distinguish primary vs. secondary PDNC"
                  },
                  {
                    "text": "Cannot be distinguished on histologic grounds"
                  }
                ],
                "Undifferentiated Carcinoma of Gallbladder": [
                  {
                    "text": "Often consist of poorly differentiated glandular structures combined with spindled cells and giant cells"
                  },
                  {
                    "text": "Vesicular nuclei and prominent nucleoli"
                  }
                ],
                "Carcinoid Tumor of Gallbladder": [
                  {
                    "text": "Lack typical nuclear features of PDNC, necrosis, and mitotic activity"
                  },
                  {
                    "text": "Usually small submucosal nodules rather than infiltrative, destructive lesions"
                  },
                  {
                    "text": "Crucial distinction since behavior is very different"
                  }
                ],
                "Lymphoma": [
                  {
                    "text": "Marks with B- or T-cell markers; cytokeratin negative"
                  },
                  {
                    "text": "Lacks characteristic nuclear features, including moulding"
                  }
                ]
              },
              "Diagnostic Checklist": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Important to diagnose this subtype so that patients get correct chemotherapy"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Granular Cell Tumor": {
            "name": "Granular Cell Tumor",
            "url": "https://app.pathprimer.com/document/51ab9d06-67ea-426e-88ad-006059c98967/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign tumor with schwannian differentiationMost common nonepithelial tumor of extrahepatic bile ducts",
                    "sub_points": [
                      "Most common nonepithelial tumor of extrahepatic bile ducts"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Occur most often in young Black womenMean age: 34.7 years",
                    "sub_points": [
                      "Mean age: 34.7 years"
                    ]
                  },
                  {
                    "text": "Most frequent location is common bile duct"
                  },
                  {
                    "text": "Often discovered incidentally"
                  },
                  {
                    "text": "Usually cured by surgical excisionMalignant granular cell tumors (GCTs) extremely rare in biliary tract",
                    "sub_points": [
                      "Malignant granular cell tumors (GCTs) extremely rare in biliary tract"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Often grows concentrically around bile duct, compressing lumen"
                  },
                  {
                    "text": "Usually < 3 cm in greatest dimension"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Nests or sheets of infiltrating cellsCells may be separated by collagenous bandsOval to polygonal cellsAbundant pink granular cytoplasm with small hyperchromatic nuclei",
                    "sub_points": [
                      "Cells may be separated by collagenous bands",
                      "Oval to polygonal cells",
                      "Abundant pink granular cytoplasm with small hyperchromatic nuclei"
                    ]
                  },
                  {
                    "text": "Can be associated with marked atypia of overlying biliary surface epitheliumMay mimic malignancyImportant to recognize underlying GCT",
                    "sub_points": [
                      "May mimic malignancy",
                      "Important to recognize underlying GCT"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Positive for S100, PAS; diastase resistant"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Gastrointestinal stromal tumor"
                  },
                  {
                    "text": "Sclerosing cholangitis"
                  },
                  {
                    "text": "Cholangiocarcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Granular cell tumor (GCT)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Granular cell myoblastoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign tumor with schwannian differentiation"
                  },
                  {
                    "text": "Most common nonepithelial tumor of extrahepatic bile ducts"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Young patientsMean: 34.7 years; range: 11-61 years",
                    "sub_points": [
                      "Mean: 34.7 years; range: 11-61 years"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "More common in women"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "More common in Black patients"
                  }
                ],
                "Site": [
                  {
                    "text": "Occurs most frequently in common bile ductMajority of tumors at or near confluence of cystic (37%), hepatic (15%), and common bile ducts (50%)Rarely (4%) involves gallbladder",
                    "sub_points": [
                      "Majority of tumors at or near confluence of cystic (37%), hepatic (15%), and common bile ducts (50%)",
                      "Rarely (4%) involves gallbladder"
                    ]
                  },
                  {
                    "text": "May be multicentric"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Common bile duct or hepatic duct tumors typically present with obstructive signs/symptomsJaundiceHepatomegalyRight upper quadrant pain",
                    "sub_points": [
                      "Jaundice",
                      "Hepatomegaly",
                      "Right upper quadrant pain"
                    ]
                  },
                  {
                    "text": "Cystic duct tumors more often present with biliary colic, occasionally cholecystitis"
                  },
                  {
                    "text": "Often discovered incidentally"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cured by complete surgical excisionUsually amenable to simple excisionRecurrence rare",
                    "sub_points": [
                      "Usually amenable to simple excision",
                      "Recurrence rare"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign; malignant GCT extremely rare in biliary tract"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Ultrasound, percutaneous transhepatic cholangiography, or endoscopic retrograde cholangiopancreatography may be usefulMay mimic cholangiocarcinoma or sclerosing cholangitis radiographically",
                    "sub_points": [
                      "May mimic cholangiocarcinoma or sclerosing cholangitis radiographically"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Firm, yellow-tan to yellow-white, ill-defined massOften grows concentrically around bile duct, compressing lumen",
                    "sub_points": [
                      "Often grows concentrically around bile duct, compressing lumen"
                    ]
                  },
                  {
                    "text": "Usually < 3 cm in greatest dimension"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Nests or sheets of cells infiltrating soft tissueCells may be separated by collagenous bandsOlder lesions may contain more connective tissue than tumor cellsMay cluster around or infiltrate peripheral nerves",
                    "sub_points": [
                      "Cells may be separated by collagenous bandsOlder lesions may contain more connective tissue than tumor cells",
                      "Older lesions may contain more connective tissue than tumor cells",
                      "May cluster around or infiltrate peripheral nerves"
                    ]
                  },
                  {
                    "text": "Large oval to polygonal cellsAbundant acidophilic (pink) granular cytoplasm with occasional globulesSmall hyperchromatic nucleiOccasionally, spindled granular cells may be seen",
                    "sub_points": [
                      "Abundant acidophilic (pink) granular cytoplasm with occasional globules",
                      "Small hyperchromatic nuclei",
                      "Occasionally, spindled granular cells may be seen"
                    ]
                  },
                  {
                    "text": "May be associated with marked proliferation and atypia of overlying biliary surface epitheliumEpithelial reaction can mimic dysplasia or carcinoma",
                    "sub_points": [
                      "Epithelial reaction can mimic dysplasia or carcinoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS positive, diastase resistant"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Immunoreactivity with S100, CD68, myelin proteins, and inhibin; cytokeratin negative"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Gastrointestinal Stromal Tumor": [
                  {
                    "text": "Extremely rare in biliary tree"
                  },
                  {
                    "text": "Spindle and epithelioid cells lack granular cytoplasm"
                  },
                  {
                    "text": "Immunohistochemically positive for C-kit and DOG1"
                  }
                ],
                "Sclerosing Cholangitis": [
                  {
                    "text": "GCT can mimic sclerosing cholangitis radiographically"
                  },
                  {
                    "text": "Features periductal fibrosis and fibrous obliteration of bile ducts"
                  }
                ],
                "Cholangiocarcinoma": [
                  {
                    "text": "GCT may have striking associated overlying epithelial cell proliferation with atypia but is cytokeratin negative"
                  },
                  {
                    "text": "Important to recognize underlying associated GCT and lack of invasive glandular component"
                  }
                ],
                "Leiomyoma": [
                  {
                    "text": "Spindled cells with fascicular growth pattern"
                  },
                  {
                    "text": "Positive smooth muscle markers, negative S100"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Embryonal Rhabdomyosarcoma": {
            "name": "Embryonal Rhabdomyosarcoma",
            "url": "https://app.pathprimer.com/document/07b11459-4ca9-4737-9ac3-b2df56e00f57/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Clinical Issues": [
                  {
                    "text": "Most frequently described in children, in extrahepatic biliary tree0.5% of all rhabdomyosarcomas occurring in childrenMost common malignant neoplasm of extrahepatic biliary tree in children",
                    "sub_points": [
                      "0.5% of all rhabdomyosarcomas occurring in children",
                      "Most common malignant neoplasm of extrahepatic biliary tree in children"
                    ]
                  },
                  {
                    "text": "Occasionally seen in adults, usually in gallbladder"
                  },
                  {
                    "text": "Long-term survival can be achieved with modern multimodality therapyEstimated 5-year survival rate: 66%",
                    "sub_points": [
                      "Estimated 5-year survival rate: 66%"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "More common in biliary tree than in gallbladderCommon bile duct is most frequent locationAlso reported in hepatic ducts, cystic duct, and ampulla of Vater",
                    "sub_points": [
                      "Common bile duct is most frequent location",
                      "Also reported in hepatic ducts, cystic duct, and ampulla of Vater"
                    ]
                  },
                  {
                    "text": "Polypoid or grape-like (botryoid) gelatinous masses in lumen of bile duct or gallbladder"
                  },
                  {
                    "text": "May extend into liver or adhere to adjacent organs, such as duodenum, stomach, and pancreas"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tumor cells densely packed beneath single layer of biliary epithelium to form characteristic cambium layer"
                  },
                  {
                    "text": "Tumor cells typically have small round or ovoid hyperchromatic nuclei and variable amounts of eosinophilic cytoplasm"
                  },
                  {
                    "text": "Spindled cells may be present and can be prominent"
                  },
                  {
                    "text": "Varying numbers of rhabdomyoblastsLarge round or elongated cells with abundant eosinophilic granular or fibrillar cytoplasmElongated cells are referred to as strap cellsMay show cytoplasmic cross striations",
                    "sub_points": [
                      "Large round or elongated cells with abundant eosinophilic granular or fibrillar cytoplasm",
                      "Elongated cells are referred to as strap cellsMay show cytoplasmic cross striations",
                      "May show cytoplasmic cross striations"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Myogenic differentiation shown by positive immunostains for myogenin, MYOD1, desmin, muscle-specific actin, etc."
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Rhabdomyosarcoma (RMS)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Primary RMS, embryonal type, arising in biliary tree and gallbladder"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Biliary RMS is most frequently described in childrenMean age: 3-4 years (range: 16 months to 11 years)Most common malignant neoplasm of extrahepatic biliary tree in children",
                    "sub_points": [
                      "Mean age: 3-4 years (range: 16 months to 11 years)",
                      "Most common malignant neoplasm of extrahepatic biliary tree in children"
                    ]
                  },
                  {
                    "text": "Occasionally seen in adults, usually in gallbladder"
                  }
                ],
                "Sex": [
                  {
                    "text": "No predilection"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Signs of progressive biliary obstructionJaundice, acholic stools",
                    "sub_points": [
                      "Jaundice, acholic stools"
                    ]
                  },
                  {
                    "text": "Abdominal distention &/or pain"
                  },
                  {
                    "text": "Fever, anorexia"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery, chemotherapy, radiotherapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Generally poorMetastasis occurs in 40% of casesDeath usually results from local complicationsLong-term survival can be achieved with modern multimodality therapyEstimated 5-year survival rate: 66%",
                    "sub_points": [
                      "Metastasis occurs in 40% of cases",
                      "Death usually results from local complications",
                      "Long-term survival can be achieved with modern multimodality therapyEstimated 5-year survival rate: 66%",
                      "Estimated 5-year survival rate: 66%"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "More common in biliary tree than in gallbladderCommon bile duct is most frequent locationAlso reported in hepatic ducts, cystic duct, and ampulla of Vater",
                    "sub_points": [
                      "Common bile duct is most frequent location",
                      "Also reported in hepatic ducts, cystic duct, and ampulla of Vater"
                    ]
                  },
                  {
                    "text": "Polypoid or grape-like (botryoid) gelatinous masses in lumen of bile duct or gallbladderResembles sarcoma botryoides commonly seen in vagina and urinary bladder",
                    "sub_points": [
                      "Resembles sarcoma botryoides commonly seen in vagina and urinary bladder"
                    ]
                  },
                  {
                    "text": "May extend into liver or adhere to adjacent organs, such as duodenum, stomach, and pancreas"
                  },
                  {
                    "text": "Can be as large as 20 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Resembles botryoid-type embryonal RMS elsewhere in bodySingle layer of biliary epithelium covering tumorEpithelium may be intact, ulcerated, or inflamedTumor cells typically have small round or ovoid hyperchromatic nuclei and variable amounts of eosinophilic cytoplasmTumor cells densely packed beneath epithelium to form characteristic cambium layerUsually hypocellular with loose myxoid stroma deeper in lesionSpindled cells may be present and can be prominentMitotic and apoptotic counts may be very highVarying numbers of rhabdomyoblastsLarge, round or elongated cells with abundant eosinophilic granular or fibrillar cytoplasmElongated cells are referred to as strap cellsMay show cytoplasmic cross striationsMore common in cases with prominent spindled cell component",
                    "sub_points": [
                      "Single layer of biliary epithelium covering tumorEpithelium may be intact, ulcerated, or inflamed",
                      "Epithelium may be intact, ulcerated, or inflamed",
                      "Tumor cells typically have small round or ovoid hyperchromatic nuclei and variable amounts of eosinophilic cytoplasmTumor cells densely packed beneath epithelium to form characteristic cambium layerUsually hypocellular with loose myxoid stroma deeper in lesionSpindled cells may be present and can be prominentMitotic and apoptotic counts may be very high",
                      "Tumor cells densely packed beneath epithelium to form characteristic cambium layer",
                      "Usually hypocellular with loose myxoid stroma deeper in lesion",
                      "Spindled cells may be present and can be prominent",
                      "Mitotic and apoptotic counts may be very high",
                      "Varying numbers of rhabdomyoblastsLarge, round or elongated cells with abundant eosinophilic granular or fibrillar cytoplasmElongated cells are referred to as strap cellsMay show cytoplasmic cross striationsMore common in cases with prominent spindled cell component",
                      "Large, round or elongated cells with abundant eosinophilic granular or fibrillar cytoplasm",
                      "Elongated cells are referred to as strap cellsMay show cytoplasmic cross striationsMore common in cases with prominent spindled cell component",
                      "May show cytoplasmic cross striations",
                      "More common in cases with prominent spindled cell component"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Myogenic differentiation shown by positive stains for myogenin, MYOD1, desmin, muscle-specific actin, etc."
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Sarcomatoid Carcinoma": [
                  {
                    "text": "Lacks cambium layer and rhabdomyoblasts"
                  },
                  {
                    "text": "Lacks myogenic differentiation by immunohistochemistry"
                  },
                  {
                    "text": "Positive for cytokeratins"
                  }
                ],
                "Leiomyosarcoma": [
                  {
                    "text": "Lacks cambium layer and rhabdomyoblasts"
                  },
                  {
                    "text": "Does not mark with myogenin and MYOD1"
                  }
                ],
                "Hepatic Undifferentiated Embryonal Sarcoma": [
                  {
                    "text": "Typically shows marked nuclear pleomorphism"
                  },
                  {
                    "text": "Cytoplasmic hyaline globules frequently present"
                  },
                  {
                    "text": "Lacks myogenin and MYOD1 positivity"
                  }
                ],
                "Primitive Neuroectodermal Tumor": [
                  {
                    "text": "May have pseudorosette formation"
                  },
                  {
                    "text": "Lacks cambium layer and rhabdomyoblasts"
                  },
                  {
                    "text": "CD99 positive (RMS usually negative)"
                  },
                  {
                    "text": "HasEWSR-1translocation"
                  }
                ],
                "Angiosarcoma": [
                  {
                    "text": "Lacks cambium layer and rhabdomyoblasts"
                  },
                  {
                    "text": "Marks with endothelial markers, such as ERG"
                  }
                ],
                "Kaposi Sarcoma": [
                  {
                    "text": "Marks with endothelial markers, and HHV8"
                  },
                  {
                    "text": "Seen in immunocompromised patients"
                  }
                ],
                "Inflammatory Pseudotumor": [
                  {
                    "text": "Lacks cambium layer and rhabdomyoblasts"
                  },
                  {
                    "text": "More inflammation than RMS"
                  },
                  {
                    "text": "Lacks myogenin and MYOD1 positivity"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Small hyperchromatic cells forming cambium layer beneath biliary epithelium"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Adenomyoma": {
            "name": "Adenomyoma",
            "url": "https://app.pathprimer.com/document/cd22a106-0f47-44bc-a50d-fe5d56fb4cf0/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Adenomyomatous hyperplasia: Cystically dilated Rokitansky-Aschoff sinus associated with thickened muscularis"
                  },
                  {
                    "text": "Adenomyomatosis: Diffuse form"
                  },
                  {
                    "text": "Adenomyoma: Localized/mass-forming"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Herniation of surface epithelium through muscle layer presumably reflects elevated intracholecystic pressure"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Predominantly affects adults with female predominance"
                  },
                  {
                    "text": "Symptoms reflect chronic cholecystitis"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Localized or diffuse mural thickening"
                  },
                  {
                    "text": "Cut surface appears trabecular with multiple cysts"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Branching &/or cystic herniations of biliary epitheliumMay show pyloric or intestinal metaplasia or dysplasia",
                    "sub_points": [
                      "May show pyloric or intestinal metaplasia or dysplasia"
                    ]
                  },
                  {
                    "text": "Hypertrophy of muscularisMay undergo extensive fibrosis over time",
                    "sub_points": [
                      "May undergo extensive fibrosis over time"
                    ]
                  },
                  {
                    "text": "Background of chronic cholecystitis"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "AdenocarcinomaInflammation and rupture of dilated sinuses may produce detached epithelial fragments and extruded mucin that appear infiltrativeCytologic features of malignancy are entirely lacking in adenomyomaRim of lamina propria often associated with sinus epitheliumClose proximity to nerves should not be interpreted as malignant",
                    "sub_points": [
                      "Inflammation and rupture of dilated sinuses may produce detached epithelial fragments and extruded mucin that appear infiltrativeCytologic features of malignancy are entirely lacking in adenomyomaRim of lamina propria often associated with sinus epitheliumClose proximity to nerves should not be interpreted as malignant",
                      "Cytologic features of malignancy are entirely lacking in adenomyoma",
                      "Rim of lamina propria often associated with sinus epithelium",
                      "Close proximity to nerves should not be interpreted as malignant"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "AdenomyomaAdenomyomatous polyp",
                    "sub_points": [
                      "Adenomyomatous polyp"
                    ]
                  },
                  {
                    "text": "AdenomyomatosisAdenomyosisDiverticular disease of gallbladderIntramural diverticulosisCholecystitis cysticaCholecystitis glandularis proliferans",
                    "sub_points": [
                      "Adenomyosis",
                      "Diverticular disease of gallbladder",
                      "Intramural diverticulosis",
                      "Cholecystitis cystica",
                      "Cholecystitis glandularis proliferans"
                    ]
                  },
                  {
                    "text": "Adenomyomatous hyperplasia, adenomyoma, and adenomyomatosis often used interchangeably"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Rokitansky-Aschoff sinusHerniation of gallbladder surface epithelium into or through muscularis",
                    "sub_points": [
                      "Herniation of gallbladder surface epithelium into or through muscularis"
                    ]
                  },
                  {
                    "text": "Adenomyomatous hyperplasiaCystically dilated Rokitansky-Aschoff sinus associated with thickened muscularisAdenomyomatosisDiffuse or segmental adenomyomatous hyperplasiaAdenomyomaLocalized, mass-forming adenomyomatous hyperplasia",
                    "sub_points": [
                      "Cystically dilated Rokitansky-Aschoff sinus associated with thickened muscularis",
                      "AdenomyomatosisDiffuse or segmental adenomyomatous hyperplasia",
                      "Diffuse or segmental adenomyomatous hyperplasia",
                      "AdenomyomaLocalized, mass-forming adenomyomatous hyperplasia",
                      "Localized, mass-forming adenomyomatous hyperplasia"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Acquired Lesion": [
                  {
                    "text": "Most cases are associated with chronic cholecystitis"
                  },
                  {
                    "text": "90% of affected individuals also have cholelithiasis"
                  },
                  {
                    "text": "Presumably reflects elevated intracholecystic pressure"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Overall ~ 4,500 cases diagnosed in USA each year"
                  },
                  {
                    "text": "Adenomyoma: represents 15-25% of benign gallbladder polyps"
                  },
                  {
                    "text": "Adenomyomatosis: present in ~ 1-10% of cholecystectomy specimens, depending on series"
                  }
                ],
                "Age": [
                  {
                    "text": "Predominantly affects adults, although also reported in children"
                  }
                ],
                "Sex": [
                  {
                    "text": "F:M = 3:1"
                  }
                ],
                "Site": [
                  {
                    "text": "Most often occurs in fundus, within muscular wall"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms reflect chronic cholecystitisRight upper quadrant pain, bloating, nausea, vomiting",
                    "sub_points": [
                      "Right upper quadrant pain, bloating, nausea, vomiting"
                    ]
                  }
                ],
                "Natural History": [
                  {
                    "text": "Benign"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Cholecystectomy is curative"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Adenomyomatosis: Diffuse or segmental gallbladder wall thickening"
                  },
                  {
                    "text": "Adenomyoma: Fundus-based intramural or polypoid mass"
                  },
                  {
                    "text": "Accurate diagnosis relies on identification of diverticula or cystic spaces within lesion"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Adenomyomatosis: Firm intramural area of thickeningDiffuse type: Entire wall is involved from cystic duct to fundusSegmental type: Involves circumferential band or segment",
                    "sub_points": [
                      "Diffuse type: Entire wall is involved from cystic duct to fundus",
                      "Segmental type: Involves circumferential band or segment"
                    ]
                  },
                  {
                    "text": "Adenomyoma: Solitary lesion at fundus"
                  },
                  {
                    "text": "Cut surface reveals trabecular appearance due to multiple cysts representing dilated glandsCysts often contain inspissated bile and bile concretions",
                    "sub_points": [
                      "Cysts often contain inspissated bile and bile concretions"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Adenomyomas measure 0.5-2.5 cm (average size: 1.5 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Branching &/or cystically Rokitansky-Aschoff sinusesEpithelium usually identical to that seen in normal biliary mucosaMay show reactive and metaplastic changes (usually pyloric or intestinal metaplasia) or dysplasiaRarely, glands are seen in close proximity to nerves, simulating perineural invasion",
                    "sub_points": [
                      "Epithelium usually identical to that seen in normal biliary mucosaMay show reactive and metaplastic changes (usually pyloric or intestinal metaplasia) or dysplasia",
                      "May show reactive and metaplastic changes (usually pyloric or intestinal metaplasia) or dysplasia",
                      "Rarely, glands are seen in close proximity to nerves, simulating perineural invasion"
                    ]
                  },
                  {
                    "text": "Hypertrophy of muscularis is invariably presentMay undergo extensive fibrosis over time",
                    "sub_points": [
                      "May undergo extensive fibrosis over time"
                    ]
                  },
                  {
                    "text": "Background of chronic cholecystitis with or without acute or xanthogranulomatous features"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adenocarcinoma": [
                  {
                    "text": "Epithelial elements penetrating smooth muscle may be confused with adenocarcinomaInflammation and rupture of sinuses may produce detached epithelial fragments and extruded mucin that appear infiltrativeCytologic features of malignancy are entirely lacking in adenomyomaRim of lamina propria often associated with sinus epithelium",
                    "sub_points": [
                      "Inflammation and rupture of sinuses may produce detached epithelial fragments and extruded mucin that appear infiltrative",
                      "Cytologic features of malignancy are entirely lacking in adenomyoma",
                      "Rim of lamina propria often associated with sinus epithelium"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Bland-appearing epithelium and cystically dilated glands set in thickened smooth muscle"
                  },
                  {
                    "text": "Associated with chronic cholecystitis and cholelithiasis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gallbladder Cancer Protocol": {
            "name": "Gallbladder Cancer Protocol",
            "url": "https://app.pathprimer.com/document/212e8ecf-262c-4e55-9609-24edc701b6b5/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Key Staging Parameters": {
                "Primary Tumor": [
                  {
                    "text": "Depth of invasion"
                  },
                  {
                    "text": "Extent of spread to other structuresLiver is common site of involvementNot considered distant metastasisInvasion of hilar structures (common bile duct, hepatic artery, portal vein) renders tumors locally unresectableDuodenum, transverse colon also at risk for direct invasionDirect invasion of adjacent organs (colon, duodenum, stomach, common bile duct, abdominal wall, diaphragm) not considered distant metastasis but rather T3 or T4 stage depending on number of organs/structures involvedT3: 1 organ/structure involvedT4: ≥ 2 organs/structures involved",
                    "sub_points": [
                      "Liver is common site of involvementNot considered distant metastasis",
                      "Not considered distant metastasis",
                      "Invasion of hilar structures (common bile duct, hepatic artery, portal vein) renders tumors locally unresectable",
                      "Duodenum, transverse colon also at risk for direct invasion",
                      "Direct invasion of adjacent organs (colon, duodenum, stomach, common bile duct, abdominal wall, diaphragm) not considered distant metastasis but rather T3 or T4 stage depending on number of organs/structures involvedT3: 1 organ/structure involvedT4: ≥ 2 organs/structures involved",
                      "T3: 1 organ/structure involved",
                      "T4: ≥ 2 organs/structures involved"
                    ]
                  }
                ],
                "Lymph Node Status": [
                  {
                    "text": "Regional nodesHepatic hilumIncluding those along common bile duct, hepatic artery, portal vein, cystic duct",
                    "sub_points": [
                      "Hepatic hilumIncluding those along common bile duct, hepatic artery, portal vein, cystic duct",
                      "Including those along common bile duct, hepatic artery, portal vein, cystic duct"
                    ]
                  },
                  {
                    "text": "Distant nodesCeliacPeriduodenalPeripancreaticSuperior mesenteric artery",
                    "sub_points": [
                      "Celiac",
                      "Periduodenal",
                      "Peripancreatic",
                      "Superior mesenteric artery"
                    ]
                  }
                ]
              },
              "Important Prognostic Factors": {
                "T1 Tumors": [
                  {
                    "text": "50% 5-year survival"
                  }
                ],
                "T2 Tumors": [
                  {
                    "text": "29% 5-year survivalT2 and T3 tumors usually offered 2nd operation to resect involved liver and achieve negative cystic duct margin status",
                    "sub_points": [
                      "T2 and T3 tumors usually offered 2nd operation to resect involved liver and achieve negative cystic duct margin status"
                    ]
                  }
                ],
                "Lymph Node Metastases or Locally Advanced Tumors": [
                  {
                    "text": "Very low long-term survivalSite-specific prognostic featuresHistologic typeGradeVascular invasion",
                    "sub_points": [
                      "Site-specific prognostic featuresHistologic typeGradeVascular invasion",
                      "Histologic type",
                      "Grade",
                      "Vascular invasion"
                    ]
                  }
                ],
                "Histologic Tumor Types": [
                  {
                    "text": "Papillary carcinoma: Best prognosis"
                  },
                  {
                    "text": "Small cell carcinoma, undifferentiated carcinoma: Worst prognosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Perihilar Bile Duct Cancer Protocol": {
            "name": "Perihilar Bile Duct Cancer Protocol",
            "url": "https://app.pathprimer.com/document/48f740f1-2587-48ae-bf2d-41746a2b2609/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "Definitions": {
                "Proximal or Perihilar Carcinomas (Klatskin Tumor)": [
                  {
                    "text": "Involve confluence of right &/or left hepatic ducts at hilum of liver"
                  },
                  {
                    "text": "Perihilar is defined as proximal to origin of cystic ductMay extend to involve right or left hepatic duct or both50-70% of biliary carcinomas",
                    "sub_points": [
                      "May extend to involve right or left hepatic duct or both",
                      "50-70% of biliary carcinomas"
                    ]
                  },
                  {
                    "text": "In most patients, tumor is unresectable at diagnosis and thus is not pathologically stagedTNM classification therefore applies to clinical, radiographic, and pathologic variables",
                    "sub_points": [
                      "TNM classification therefore applies to clinical, radiographic, and pathologic variables"
                    ]
                  }
                ]
              },
              "Prognostic Indicators": {
                "Adverse Indicators": [
                  {
                    "text": "High histologic tumor grade"
                  },
                  {
                    "text": "Vascular invasion"
                  },
                  {
                    "text": "Lymph node metastasis"
                  },
                  {
                    "text": "Elevated CA19-9"
                  },
                  {
                    "text": "Elevated bilirubin"
                  },
                  {
                    "text": "Lobar atrophy"
                  }
                ],
                "Positive Indicators": [
                  {
                    "text": "Complete resection with negative margins is best predictor of long-term survivalOften difficult given proximity to hepatic artery, portal vein, and liver parenchyma at hilum",
                    "sub_points": [
                      "Often difficult given proximity to hepatic artery, portal vein, and liver parenchyma at hilum"
                    ]
                  },
                  {
                    "text": "Papillary tumors have better prognosis than nodular or sclerosing carcinomas"
                  },
                  {
                    "text": "Patients with liver parenchymal involvement (T2) now believed to have better survival than those with unilateral vascular invasion (T3)"
                  }
                ]
              },
              "Lymph Nodes": {
                "General": [
                  {
                    "text": "Frequency of lymph node metastases increases with T classificationOccur in approximately 30-50% of patients overallHilar, pericholedochal nodes in hepatoduodenal ligament most often involved",
                    "sub_points": [
                      "Occur in approximately 30-50% of patients overall",
                      "Hilar, pericholedochal nodes in hepatoduodenal ligament most often involved"
                    ]
                  }
                ],
                "Regional Nodes (N1)": [
                  {
                    "text": "Cystic duct"
                  },
                  {
                    "text": "Common bile duct"
                  },
                  {
                    "text": "Hepatic artery"
                  },
                  {
                    "text": "Portal vein nodes"
                  }
                ],
                "Distant Nodes (N2)": [
                  {
                    "text": "Periaortic, pericaval, superior mesenteric, celiac artery nodes"
                  }
                ]
              },
              "Metastases": {
                "Liver Most Common Site": [
                  {
                    "text": "Tumor spreads throughBile duct radicalsLymphaticsNerves",
                    "sub_points": [
                      "Bile duct radicals",
                      "Lymphatics",
                      "Nerves"
                    ]
                  },
                  {
                    "text": "Spread to other organs rare, especially outside abdomen"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Distal Extrahepatic Bile Duct Cancer Protocol": {
            "name": "Distal Extrahepatic Bile Duct Cancer Protocol",
            "url": "https://app.pathprimer.com/document/bff2a36a-2b75-4704-acaa-9ffe4b751205/lesson/5eb11774-2db3-489a-b79c-044e292c0e4f",
            "content": {
              "General Comments": {
                "Anatomic Considerations": [
                  {
                    "text": "20-30% of extrahepatic bile duct malignancies are distalStaged separately from perihilar and intrahepatic malignanciesDistal tumors defined as those arising between junction of cystic duct/common bile duct (CBD) and ampulla of VaterIncludes tumors arising in choledochal cysts and the intrapancreatic portion of common bile ductMay be grossly difficult to determine if tumors arise from the intrapancreatic CBD, pancreas, or ampulla; distinction important for staging",
                    "sub_points": [
                      "Staged separately from perihilar and intrahepatic malignancies",
                      "Distal tumors defined as those arising between junction of cystic duct/common bile duct (CBD) and ampulla of Vater",
                      "Includes tumors arising in choledochal cysts and the intrapancreatic portion of common bile ductMay be grossly difficult to determine if tumors arise from the intrapancreatic CBD, pancreas, or ampulla; distinction important for staging",
                      "May be grossly difficult to determine if tumors arise from the intrapancreatic CBD, pancreas, or ampulla; distinction important for staging"
                    ]
                  },
                  {
                    "text": "Distal bile duct anatomyWall composed of submucosal connective tissue and muscleMuscle fibers most prominent in distal bile ductExtrahepatic ducts lack serosa but are surrounded by variable amounts of periductal adipose tissueInvasion of this adipose tissue is considered T2 disease",
                    "sub_points": [
                      "Wall composed of submucosal connective tissue and muscle",
                      "Muscle fibers most prominent in distal bile duct",
                      "Extrahepatic ducts lack serosa but are surrounded by variable amounts of periductal adipose tissueInvasion of this adipose tissue is considered T2 disease",
                      "Invasion of this adipose tissue is considered T2 disease"
                    ]
                  }
                ],
                "Staging": [
                  {
                    "text": "Usually occurs following surgery and pathologic examinationMinority of patients deemed unresectable due to local extensionTreated without pathologic staging",
                    "sub_points": [
                      "Minority of patients deemed unresectable due to local extension",
                      "Treated without pathologic staging"
                    ]
                  }
                ],
                "Prognostic Factors": [
                  {
                    "text": "Extent of resection and margin status is most important stage-independent prognostic factorShould be carefully documented in report",
                    "sub_points": [
                      "Should be carefully documented in report"
                    ]
                  },
                  {
                    "text": "Adverse prognostic factorsHistologic typePapillary carcinomas have more favorable outcomeTumor gradeVascular invasionLymphatic invasionPerineural invasionLymph node metastasesElevated CEA and CA19-9",
                    "sub_points": [
                      "Histologic typePapillary carcinomas have more favorable outcome",
                      "Papillary carcinomas have more favorable outcome",
                      "Tumor grade",
                      "Vascular invasion",
                      "Lymphatic invasion",
                      "Perineural invasion",
                      "Lymph node metastases",
                      "Elevated CEA and CA19-9"
                    ]
                  }
                ],
                "Lymph Nodes": [
                  {
                    "text": "Need minimum of 12 lymph nodes"
                  },
                  {
                    "text": "Regional nodesCommon bile ductHepatic arteryCeliac trunkPosterior pancreaticoduodenalAnterior pancreaticoduodenalSuperior mesenteric veinRight lateral wall of superior mesenteric artery",
                    "sub_points": [
                      "Common bile duct",
                      "Hepatic artery",
                      "Celiac trunk",
                      "Posterior pancreaticoduodenal",
                      "Anterior pancreaticoduodenal",
                      "Superior mesenteric vein",
                      "Right lateral wall of superior mesenteric artery"
                    ]
                  }
                ],
                "Metastases": [
                  {
                    "text": "Regional spreadPancreasDuodenumStomachColonOmentum",
                    "sub_points": [
                      "Pancreas",
                      "Duodenum",
                      "Stomach",
                      "Colon",
                      "Omentum"
                    ]
                  },
                  {
                    "text": "Distant metastasesLiver, lungs, peritoneumUsually late in course of disease",
                    "sub_points": [
                      "Liver, lungs, peritoneum",
                      "Usually late in course of disease"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Pancreas: Nonneoplastic Lesions": {
        "name": "Pancreas: Nonneoplastic Lesions",
        "url": "https://app.pathprimer.com/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
        "topics": {
          "Congenital Pancreatic Cyst": {
            "name": "Congenital Pancreatic Cyst",
            "url": "https://app.pathprimer.com/document/8e49f83c-b95b-46d3-8821-ecf2864fd36a/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Developmental anomaly of pancreatic ductal systemPresumably due to failure of embryonic pancreatic ducts to regress when they are replaced by permanent ones, leading to their obstruction and cyst formation in uteroMay be associated with other congenital anomalies, such as von Hippel-Lindau disease, polycystic kidney disease, etc.",
                    "sub_points": [
                      "Presumably due to failure of embryonic pancreatic ducts to regress when they are replaced by permanent ones, leading to their obstruction and cyst formation in utero",
                      "May be associated with other congenital anomalies, such as von Hippel-Lindau disease, polycystic kidney disease, etc."
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Exceedingly rare"
                  },
                  {
                    "text": "May be found at any age but usually in children < 2 years"
                  },
                  {
                    "text": "Often incidental finding but may show signs and symptoms of GI or biliary obstruction or pancreatitis due to pressure on adjacent organs"
                  },
                  {
                    "text": "Any location within pancreas but more common in body or tail"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually single, unilocular, thin-walled cystic lesionTypically 1-2 cm in size but can be larger",
                    "sub_points": [
                      "Typically 1-2 cm in size but can be larger"
                    ]
                  },
                  {
                    "text": "Can be multiple, multilocularMay diffusely involve entire pancreasMore common in patients with von Hippel-Lindau or polycystic kidney disease",
                    "sub_points": [
                      "May diffusely involve entire pancreas",
                      "More common in patients with von Hippel-Lindau or polycystic kidney disease"
                    ]
                  },
                  {
                    "text": "Does not communicate with pancreatic ductal system"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cysts are lined by single layer of non-mucin-producing epithelium that can be flattened, cuboidal to columnar"
                  },
                  {
                    "text": "Fibrous or fibroinflammatory cyst wall"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Enteric duplication cyst"
                  },
                  {
                    "text": "Retention cyst"
                  },
                  {
                    "text": "Acinar cystic transformation"
                  },
                  {
                    "text": "Serous cystadenoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Dysgenetic cyst"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Rare, benign, congenital, epithelial-lined intrapancreatic cyst that does not communicate with ductal system"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Developmental anomaly of pancreatic ductal systemPresumably due to failure of embryonic pancreatic ducts to regress when they are replaced by permanent ones, leading to their obstruction and cyst formation in utero",
                    "sub_points": [
                      "Presumably due to failure of embryonic pancreatic ducts to regress when they are replaced by permanent ones, leading to their obstruction and cyst formation in utero"
                    ]
                  },
                  {
                    "text": "May be associated with other congenital anomaliesvon Hippel-Lindau diseasePolycystic kidney diseaseOral-facial-digital syndrome type 1Jeune syndromeMeckel-Gruber syndromeBeckwith-Wiedemann syndromeOther congenital anomalies: Anorectal malformation, polydactyly, short-limb dwarfism, renal tubular ectasia",
                    "sub_points": [
                      "von Hippel-Lindau disease",
                      "Polycystic kidney disease",
                      "Oral-facial-digital syndrome type 1",
                      "Jeune syndrome",
                      "Meckel-Gruber syndrome",
                      "Beckwith-Wiedemann syndrome",
                      "Other congenital anomalies: Anorectal malformation, polydactyly, short-limb dwarfism, renal tubular ectasia"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Exceedingly rare"
                  }
                ],
                "Age": [
                  {
                    "text": "May be found at any age but usually in children < 2 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance"
                  }
                ],
                "Site": [
                  {
                    "text": "Any location within pancreas but more common in body or tail"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often asymptomaticUsually found incidentally, such as by antenatal ultrasound",
                    "sub_points": [
                      "Usually found incidentally, such as by antenatal ultrasound"
                    ]
                  },
                  {
                    "text": "Abdominal mass or distention when cyst is largeSigns and symptoms of upper GI or biliary obstruction or pancreatitis due to pressure on adjacent organs",
                    "sub_points": [
                      "Signs and symptoms of upper GI or biliary obstruction or pancreatitis due to pressure on adjacent organs"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Cyst fluid shows high amylase levels"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Complete cystectomy or distal pancreatectomy for lesions in pancreatic body or tail"
                  },
                  {
                    "text": "Internal drainage via cystoduodenostomy or Roux-en-Y cystojejunostomy for lesions in pancreatic head"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Good"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Solitary or multiple cystic lesions in pancreas"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually single, unilocular, thin-walled cystic lesionTypically 1-2 cm in size but can be larger",
                    "sub_points": [
                      "Typically 1-2 cm in size but can be larger"
                    ]
                  },
                  {
                    "text": "Can be multiple or multilocularMay diffusely involve entire pancreasMore common in patients with von Hippel-Lindau or polycystic kidney disease",
                    "sub_points": [
                      "May diffusely involve entire pancreasMore common in patients with von Hippel-Lindau or polycystic kidney disease",
                      "More common in patients with von Hippel-Lindau or polycystic kidney disease"
                    ]
                  },
                  {
                    "text": "Do not communicate with pancreatic ductal system"
                  },
                  {
                    "text": "Serous cyst fluid"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cysts are lined by single layer of non-mucin-producing epithelium that can be flattened, cuboidal to columnar"
                  },
                  {
                    "text": "Fibrous or fibroinflammatory cyst wall"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pancreatic Cysts Associated With Hereditary Disorders or Congenital Syndromes": [
                  {
                    "text": "Entities with multiple pancreatic cysts or polycystic pancreas"
                  }
                ],
                "Enteric Duplication Cyst": [
                  {
                    "text": "More common in pancreatic head; may communicate with pancreatic duct"
                  },
                  {
                    "text": "Unilocular cyst lined by variety of epithelial cell types surrounded by smooth muscle, recapitulating normal gutSmall intestinal, gastric, squamous, respiratory, or ciliated",
                    "sub_points": [
                      "Small intestinal, gastric, squamous, respiratory, or ciliated"
                    ]
                  }
                ],
                "Retention Cyst": [
                  {
                    "text": "Associated with pancreatic duct obstruction, usually seen in setting of chronic pancreatitis, stones, mucus plug, or mass lesion"
                  },
                  {
                    "text": "Communicates with ductal system"
                  }
                ],
                "Acinar Cystic Transformation": [
                  {
                    "text": "Lined by 1-2 layers of flattened or cuboidal epithelium showing acinar and ductal differentiation"
                  },
                  {
                    "text": "Residual pancreatic elements often present between larger cysts"
                  }
                ],
                "Serous Cystadenoma": [
                  {
                    "text": "Can be macrocystic or even unilocular"
                  },
                  {
                    "text": "Lined by single layer of cuboidal to flattened epithelium with clear cytoplasm"
                  }
                ],
                "Cystic Fibrosis": [
                  {
                    "text": "Dilatation of acini and ductules with eosinophilic secretions"
                  },
                  {
                    "text": "Acinar and lobular atrophy with replacement by adipose tissue"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Cystic Fibrosis, Pancreatic": {
            "name": "Cystic Fibrosis, Pancreatic",
            "url": "https://app.pathprimer.com/document/600dbf61-5ae8-4dde-bd20-94a86f11ad6c/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Genetic disorder affecting fluid secretion in exocrine glands and epithelial cells lining respiratory, pancreaticobiliary, gastrointestinal, and reproductive tracts"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations of cystic fibrosis transmembrane conductance regulator (CFTR) gene on chromosome 7q31.2Encodes chloride ion channel protein that regulates fluid balance across epithelial cellsMost common mutation is ΔF508, seen in 70% of cystic fibrosis (CF) patientsDefective chloride transport leads to thick and tenacious fluid secretionsBlockage of exocrine pancreatic ductsDamage of pancreatic tissue by accumulated digestive enzymes",
                    "sub_points": [
                      "Encodes chloride ion channel protein that regulates fluid balance across epithelial cells",
                      "Most common mutation is ΔF508, seen in 70% of cystic fibrosis (CF) patients",
                      "Defective chloride transport leads to thick and tenacious fluid secretionsBlockage of exocrine pancreatic ductsDamage of pancreatic tissue by accumulated digestive enzymes",
                      "Blockage of exocrine pancreatic ducts",
                      "Damage of pancreatic tissue by accumulated digestive enzymes"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Most common autosomal recessive disorder in White patients, affecting 1:3,500 newborns"
                  },
                  {
                    "text": "Exocrine pancreatic insufficiency occurs in majority (85-90%) of CF patients"
                  },
                  {
                    "text": "Pancreas abnormalities can be seen as early as 32-38 weeks of gestation and progressively worsen with age"
                  },
                  {
                    "text": "Malabsorption due to exocrine pancreatic insufficiencySteatorrhea, deficiency of fat-soluble vitamins, failure to thrive",
                    "sub_points": [
                      "Steatorrhea, deficiency of fat-soluble vitamins, failure to thrive"
                    ]
                  },
                  {
                    "text": "Average life expectancy is 37-48 years in developed countries and continues to increaseLung problems responsible for 80% deaths",
                    "sub_points": [
                      "Lung problems responsible for 80% deaths"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Small, firm, and nodular pancreas, often with cystic spaces and fatty replacement"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Accumulation of inspissated eosinophilic secretions in ectatic pancreatic ducts"
                  },
                  {
                    "text": "Acinar atrophy, cyst formation, fibrosis, and fatty replacement"
                  },
                  {
                    "text": "Islets of Langerhans are well preserved initially but may decrease in number at later stage of disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Cystic fibrosis (CF)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Mucoviscidosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Genetic disorder affecting fluid secretion in exocrine glands and epithelial cells lining respiratory, pancreaticobiliary, gastrointestinal, and reproductive tracts"
                  },
                  {
                    "text": "Disease name refers to pathologic findings of cysts and fibrosis in pancreas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mutations of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene": [
                  {
                    "text": "CFTRgene located on chromosome 7q31.2"
                  },
                  {
                    "text": "Encodes chloride ion channel protein that regulates fluid balance across epithelial cells"
                  },
                  {
                    "text": "> 2,000 mutations have been identifiedMost common mutation is ΔF508, seen in 70% of CF patientsDefective chloride transport leads to thick and tenacious fluid secretionsBlockage of exocrine pancreatic ductsDamage of pancreatic tissue by accumulated digestive enzymes",
                    "sub_points": [
                      "Most common mutation is ΔF508, seen in 70% of CF patients",
                      "Defective chloride transport leads to thick and tenacious fluid secretionsBlockage of exocrine pancreatic ductsDamage of pancreatic tissue by accumulated digestive enzymes",
                      "Blockage of exocrine pancreatic ducts",
                      "Damage of pancreatic tissue by accumulated digestive enzymes"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Most common autosomal recessive disorder in White patients, affecting 1:3,500 newborns"
                  },
                  {
                    "text": "Less common in other ethnic populations"
                  },
                  {
                    "text": "Exocrine pancreatic insufficiency occurs in majority (85-90%) of CF patients"
                  }
                ],
                "Age": [
                  {
                    "text": "Pancreas abnormalities can be seen as early as 32-38 weeks of gestation and progressively worsen with age"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Malabsorption due to exocrine pancreatic insufficiencySteatorrheaDeficiency of fat-soluble vitamins A, D, E, and KFailure to thrive with poor weight gain",
                    "sub_points": [
                      "Steatorrhea",
                      "Deficiency of fat-soluble vitamins A, D, E, and K",
                      "Failure to thrive with poor weight gain"
                    ]
                  },
                  {
                    "text": "Insulin-dependent diabetes mellitus occurs in 25% of CF patients, mostly as adults"
                  },
                  {
                    "text": "Extrapancreatic presentationsRecurrent respiratory infections beginning at early ageMeconium ileusSalty skin tasteMale infertility",
                    "sub_points": [
                      "Recurrent respiratory infections beginning at early age",
                      "Meconium ileus",
                      "Salty skin taste",
                      "Male infertility"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Sweat chloride test"
                  },
                  {
                    "text": "Genetic testing"
                  },
                  {
                    "text": "Newborn screening for early diagnosis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Enzyme replacement"
                  },
                  {
                    "text": "Vitamin and mineral supplementation"
                  },
                  {
                    "text": "Antibiotics for infections"
                  },
                  {
                    "text": "Pancreas or multivisceral transplantation"
                  },
                  {
                    "text": "Potential benefit of gene therapy and targeted therapy with small molecules"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Average life expectancy is 37-48 years in developed countries and continues to increase"
                  },
                  {
                    "text": "Lung problems responsible for 80% of deaths"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Atrophic pancreatic parenchyma, fatty replacement, and cyst formation"
                  },
                  {
                    "text": "Stricture of intrapancreatic common bile duct"
                  },
                  {
                    "text": "Cholelithiasis"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Small, firm, and nodular pancreas, often with cystic spaces and fatty replacement"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Accumulation of inspissated eosinophilic secretions in ectatic pancreatic ductsMay be laminated or calcified",
                    "sub_points": [
                      "May be laminated or calcified"
                    ]
                  },
                  {
                    "text": "Acinar atrophy, cyst formation, fibrosis, and fatty replacementFlattening of ductal epithelial cells; squamous metaplasia may be seenComplete or near complete cystic transformation leads to pancreatic cystosisExtensive fatty replacement may lead to lipomatous hypertrophy",
                    "sub_points": [
                      "Flattening of ductal epithelial cells; squamous metaplasia may be seen",
                      "Complete or near complete cystic transformation leads to pancreatic cystosis",
                      "Extensive fatty replacement may lead to lipomatous hypertrophy"
                    ]
                  },
                  {
                    "text": "Islets of Langerhans are well preserved initially but may decrease in number at later stage of disease"
                  },
                  {
                    "text": "Inflammatory cells, such as lymphocytes and neutrophils, may be seen in fibrous tissue"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Forms of Chronic Pancreatitis": [
                  {
                    "text": "Older age at onset"
                  },
                  {
                    "text": "Lack of extrapancreatic signs and symptoms of CF"
                  }
                ],
                "Cystic Pancreatic Lesions": [
                  {
                    "text": "Usually occurring at older age"
                  },
                  {
                    "text": "Lack of extrapancreatic signs and symptoms of CF"
                  },
                  {
                    "text": "Cysts are usually larger and lack eosinophilic secretions"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Nesidioblastosis": {
            "name": "Nesidioblastosis",
            "url": "https://app.pathprimer.com/document/d8c96733-c288-46d9-b576-c08f4f5eb672/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Pathologic changes in pancreatic islets associated with functional dysregulation of β cells that lead to persistent hyperinsulinemic hypoglycemia"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "NeonatesMutations ofABCC8orKCNJ11genes encoding subunits of ATP-sensitive potassium channel in majority of casesMutations ofGCK,GLUD1,HADH,HK1,PGM1,SLC16A1,HNF1A,HNF4A, orUCP2genes",
                    "sub_points": [
                      "Mutations ofABCC8orKCNJ11genes encoding subunits of ATP-sensitive potassium channel in majority of cases",
                      "Mutations ofGCK,GLUD1,HADH,HK1,PGM1,SLC16A1,HNF1A,HNF4A, orUCP2genes"
                    ]
                  },
                  {
                    "text": "AdultsMetabolic and hormonal changes due to substantial weight loss after gastric bypass surgeryIdiopathic",
                    "sub_points": [
                      "Metabolic and hormonal changes due to substantial weight loss after gastric bypass surgery",
                      "Idiopathic"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Symptoms and signs of hypoglycemia"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Neonatal focal nesidioblastosis (NB)Nodular lesion consisting of confluent clusters of endocrine cells (adenomatous hyperplasia)Presence of enlarged, hyperchromatic islet cell nuclei within lesionNormal islets with no nuclear enlargement outside lesion",
                    "sub_points": [
                      "Nodular lesion consisting of confluent clusters of endocrine cells (adenomatous hyperplasia)",
                      "Presence of enlarged, hyperchromatic islet cell nuclei within lesion",
                      "Normal islets with no nuclear enlargement outside lesion"
                    ]
                  },
                  {
                    "text": "Neonatal diffuse NBEnlarged, hyperchromatic islet cell nuclei throughout entire pancreas",
                    "sub_points": [
                      "Enlarged, hyperchromatic islet cell nuclei throughout entire pancreas"
                    ]
                  },
                  {
                    "text": "Adult NBSimilar to neonatal diffuse NB",
                    "sub_points": [
                      "Similar to neonatal diffuse NB"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Sequencing of NB-related genes helps diagnosis, classification, and treatment decision"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Insulinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Nesidioblastosis (NB)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Hyperinsulinemic hypoglycemia, congenital hyperinsulinism"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Pathologic changes in pancreatic islets associated with functional dysregulation of β cells that lead to persistent hyperinsulinemic hypoglycemia"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neonatal NB": [
                  {
                    "text": "Mutations ofABCC8orKCNJ11genes encoding subunits of ATP-sensitive potassium channelDiffuse NB: Homozygous recessive, dominant, or compound heterozygousABCC8 orKCNJ11mutationsFocal NB: Heterozygous paternally inheritedABCC8 orKCNJ11mutations, and somatic loss of maternal 11p15Rarely, paternal allele duplication of chromosome 11",
                    "sub_points": [
                      "Diffuse NB: Homozygous recessive, dominant, or compound heterozygousABCC8 orKCNJ11mutations",
                      "Focal NB: Heterozygous paternally inheritedABCC8 orKCNJ11mutations, and somatic loss of maternal 11p15Rarely, paternal allele duplication of chromosome 11",
                      "Rarely, paternal allele duplication of chromosome 11"
                    ]
                  },
                  {
                    "text": "Other uncommon genetic causesMutations ofGCK,GLUD1,HADH,HK1,PGM1,SLC16A1,HNF1A,HNF4A, orUCP2genes",
                    "sub_points": [
                      "Mutations ofGCK,GLUD1,HADH,HK1,PGM1,SLC16A1,HNF1A,HNF4A, orUCP2genes"
                    ]
                  }
                ],
                "Adult NB": [
                  {
                    "text": "Metabolic and hormonal changes due to substantial weight loss after gastric bypass surgery"
                  },
                  {
                    "text": "Idiopathic"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Neonatal NBFamilial: 1 in 2,700 birthsSporadic: 1 in 28,000-50,000 births",
                    "sub_points": [
                      "Familial: 1 in 2,700 births",
                      "Sporadic: 1 in 28,000-50,000 births"
                    ]
                  },
                  {
                    "text": "Adult NBUnknown but thought to be low",
                    "sub_points": [
                      "Unknown but thought to be low"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Symptoms and signs of hypoglycemiaUsually postprandial for adult NB",
                    "sub_points": [
                      "Usually postprandial for adult NB"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "High serum insulin &/or C-peptide levels in presence of hypoglycemia"
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Focal neonatal NBLimited resection or partial pancreatectomy",
                    "sub_points": [
                      "Limited resection or partial pancreatectomy"
                    ]
                  },
                  {
                    "text": "Diffuse neonatal and adult NBTotal or near-total (95-98%) pancreatectomy",
                    "sub_points": [
                      "Total or near-total (95-98%) pancreatectomy"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Diazoxide as 1st choice for diffuse neonatal NBEffective in only minority of patients with specific mutations",
                    "sub_points": [
                      "Effective in only minority of patients with specific mutations"
                    ]
                  },
                  {
                    "text": "Octreotide or lanreotide with variable success"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Resection is curative for focal neonatal NB"
                  },
                  {
                    "text": "Insulin-dependent diabetes results from total pancreatectomy"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Neonatal focal NB may produce detectable nodule (typically < 1 cm), rarely multifocal"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Focal neonatal NBNodular lesion consisting of confluent clusters of endocrine cells (adenomatous hyperplasia)All types of endocrine cells are represented, but percentage of β cells is higher than normal (70-90% vs. 50%)Presence of enlarged, hyperchromatic islet cell nucleiPresence of intermixed exocrine cellsNormal islets with no nuclear enlargement outside lesion",
                    "sub_points": [
                      "Nodular lesion consisting of confluent clusters of endocrine cells (adenomatous hyperplasia)All types of endocrine cells are represented, but percentage of β cells is higher than normal (70-90% vs. 50%)Presence of enlarged, hyperchromatic islet cell nucleiPresence of intermixed exocrine cells",
                      "All types of endocrine cells are represented, but percentage of β cells is higher than normal (70-90% vs. 50%)",
                      "Presence of enlarged, hyperchromatic islet cell nuclei",
                      "Presence of intermixed exocrine cells",
                      "Normal islets with no nuclear enlargement outside lesion"
                    ]
                  },
                  {
                    "text": "Diffuse neonatal NBEnlarged, hyperchromatic islet cell nuclei throughout entire pancreas",
                    "sub_points": [
                      "Enlarged, hyperchromatic islet cell nuclei throughout entire pancreas"
                    ]
                  },
                  {
                    "text": "Adult NBSimilar to diffuse neonatal NB",
                    "sub_points": [
                      "Similar to diffuse neonatal NB"
                    ]
                  },
                  {
                    "text": "Other described islet abnormalitiesIncreased islet numberEnlarged islet size (> 300 μm)Irregular islet contourDuctuloinsular complex (close association of islet and duct)",
                    "sub_points": [
                      "Increased islet number",
                      "Enlarged islet size (> 300 μm)",
                      "Irregular islet contour",
                      "Ductuloinsular complex (close association of islet and duct)"
                    ]
                  },
                  {
                    "text": "Frozen sections to guide extent of resectionMultiple random pancreatic samples need to be examined if focal lesion is not identifiedPresence of enlarged islet cell nuclei indicates diffuse NB; absence suggests focal NB",
                    "sub_points": [
                      "Multiple random pancreatic samples need to be examined if focal lesion is not identified",
                      "Presence of enlarged islet cell nuclei indicates diffuse NB; absence suggests focal NB"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Chromogranin highlights confluent islets in focal NB"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Sequencing of NB-related genes helps diagnosis, classification, and treatment"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Insulinoma": [
                  {
                    "text": "Well-demarcated lesion composed solely of endocrine cells"
                  },
                  {
                    "text": "Does not express other hormones, only insulin"
                  },
                  {
                    "text": "Usually presents with fasting hypoglycemia"
                  }
                ],
                "Normal Pancreas": [
                  {
                    "text": "Islets in neonates (particularly those of diabetic mothers) are more prominent than in later life"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Frozen sections to guide extent of resectionMultiple random pancreatic samples need to be examined if focal lesion cannot be identifiedPresence of enlarged islet cell nuclei indicates diffuse formAbsence of enlarged islet cell nuclei suggests focal form",
                    "sub_points": [
                      "Multiple random pancreatic samples need to be examined if focal lesion cannot be identified",
                      "Presence of enlarged islet cell nuclei indicates diffuse form",
                      "Absence of enlarged islet cell nuclei suggests focal form"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Choledochal Cyst": {
            "name": "Choledochal Cyst",
            "url": "https://app.pathprimer.com/document/a29579e7-fede-4224-b575-87f53159f016/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Nonobstructive cystic dilatation of extrahepatic biliary treeVariants include concomitant (type IVa) or exclusive (type V) intrahepatic biliary dilatation",
                    "sub_points": [
                      "Variants include concomitant (type IVa) or exclusive (type V) intrahepatic biliary dilatation"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Both congenital and acquired forms described"
                  },
                  {
                    "text": "No specific inheritance pattern"
                  },
                  {
                    "text": "Most patients have abnormal pancreaticobiliary junction"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Much more common in Asia, particularly Japan, than West"
                  },
                  {
                    "text": "Usually presents in childhood before age 10"
                  },
                  {
                    "text": "75% of patients are female"
                  },
                  {
                    "text": "Classic presentation (right upper quadrant mass, pain, jaundice) rare"
                  },
                  {
                    "text": "Vague, episodic abdominal pain"
                  },
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Incidental mass on imaging in asymptomatic patients"
                  },
                  {
                    "text": "20x increased risk of malignancy over general populationCarcinoma may develop in remaining biliary tree years after excision of cyst",
                    "sub_points": [
                      "Carcinoma may develop in remaining biliary tree years after excision of cyst"
                    ]
                  }
                ],
                "Imaging": [
                  {
                    "text": "Cholangiography is definitive diagnostic procedure"
                  },
                  {
                    "text": "Type I (Todani classification, segmental or diffuse fusiform dilatation of common bile duct) most common (75-95%)"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Thick-walled fibrotic cyst, few centimeters to >15 cm"
                  },
                  {
                    "text": "May contain bile, mucus, stones"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Thickened, fibrotic cyst wall"
                  },
                  {
                    "text": "Chronic inflammation often present"
                  },
                  {
                    "text": "Biliary epithelial lining may be intact or damaged, attenuated, denuded, or absent altogether"
                  },
                  {
                    "text": "Intestinal or squamous metaplasia may be present"
                  },
                  {
                    "text": "Dysplasia or malignancy may be present"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Nonobstructive cystic dilatation of extrahepatic biliary treeVariants include concomitant (type IVa) or exclusive (type V) intrahepatic biliary dilatation",
                    "sub_points": [
                      "Variants include concomitant (type IVa) or exclusive (type V) intrahepatic biliary dilatation"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Both congenital and acquired forms described"
                  },
                  {
                    "text": "No specific inheritance pattern"
                  },
                  {
                    "text": "Most patients have abnormal pancreaticobiliary junctionDistal common bile duct and pancreatic duct join to form long common channel before entering ampulla of VaterMay allow pancreatic secretions to reflux into bile ducts, causing damage and weakening of duct walls and subsequent dilatation",
                    "sub_points": [
                      "Distal common bile duct and pancreatic duct join to form long common channel before entering ampulla of Vater",
                      "May allow pancreatic secretions to reflux into bile ducts, causing damage and weakening of duct walls and subsequent dilatation"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Much more common in Asia, particularly Japan, than West1 in 100,000 to 150,000 live births in West1 in 1000 in Japan",
                    "sub_points": [
                      "1 in 100,000 to 150,000 live births in West",
                      "1 in 1000 in Japan"
                    ]
                  },
                  {
                    "text": "Can present at any age; most cases present before age 10"
                  },
                  {
                    "text": "75% of patients are female"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Classic presentation (right upper quadrant mass, pain, jaundice) rare"
                  },
                  {
                    "text": "Vague, episodic abdominal pain"
                  },
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Incidental mass on imaging in asymptomatic patients"
                  },
                  {
                    "text": "Gastric outlet obstruction, type III (choledochocele)"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Complete excision"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Variable clinical course depending on complicationsInfants at particular risk for chronic low-grade biliary obstruction leading to cirrhosisBile duct perforation, choledocholithiasis, bacterial cholangitis20x increased risk of malignancy over general populationRisk increases with ageCarcinoma may develop in remaining biliary tree years after excision of cyst",
                    "sub_points": [
                      "Infants at particular risk for chronic low-grade biliary obstruction leading to cirrhosis",
                      "Bile duct perforation, choledocholithiasis, bacterial cholangitis",
                      "20x increased risk of malignancy over general populationRisk increases with ageCarcinoma may develop in remaining biliary tree years after excision of cyst",
                      "Risk increases with age",
                      "Carcinoma may develop in remaining biliary tree years after excision of cyst"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Cholangiography is gold standard diagnostic procedure"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Thick-walled fibrotic cyst, few centimeters to >15 cmMay contain bile, mucus, stones",
                    "sub_points": [
                      "May contain bile, mucus, stones"
                    ]
                  }
                ],
                "Anatomic (Todani) Classification": [
                  {
                    "text": "Type I: Segmental or diffuse fusiform dilatation of common bile ductMost common (75-95% of cases)",
                    "sub_points": [
                      "Most common (75-95% of cases)"
                    ]
                  },
                  {
                    "text": "Type II: Supraduodenal diverticulum of common bile duct, usually lateral wall"
                  },
                  {
                    "text": "Type III: Cyst (choledochocele) within duodenal wall"
                  },
                  {
                    "text": "Type IV: Multiple extrahepatic cystsIVa: With Caroli disease-like dilatation of intrahepatic bile ductsIVb: Cysts exclusively extrahepatic",
                    "sub_points": [
                      "IVa: With Caroli disease-like dilatation of intrahepatic bile ducts",
                      "IVb: Cysts exclusively extrahepatic"
                    ]
                  },
                  {
                    "text": "Type V: Dilatation of intrahepatic ducts, equivalent to Caroli disease, without extrahepatic cysts"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Thickened, fibrotic cyst wallChronic inflammation often present",
                    "sub_points": [
                      "Chronic inflammation often present"
                    ]
                  },
                  {
                    "text": "Biliary epithelial lining may be intact or damaged, attenuated, denuded, or absent altogetherIntestinal or squamous metaplasia may be presentDysplasia or malignancy may be present",
                    "sub_points": [
                      "Intestinal or squamous metaplasia may be present",
                      "Dysplasia or malignancy may be present"
                    ]
                  },
                  {
                    "text": "Liver biopsy may show changes of acute or chronic biliary obstruction, including biliary cirrhosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Cystic Biliary Atresia": [
                  {
                    "text": "Clinically and histologically (on liver biopsy) difficult to distinguish from choledochal cyst in infants"
                  },
                  {
                    "text": "Radiographic studies required"
                  },
                  {
                    "text": "Cyst of biliary atresia lacks epithelium and inflammation; has cicatricial layer with myofibroblastic hyperplasia"
                  }
                ],
                "Other Causes of Biliary Obstruction": [
                  {
                    "text": "Changes on liver biopsy often similar"
                  },
                  {
                    "text": "Imaging required to detect choledochal cyst"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acute Pancreatitis": {
            "name": "Acute Pancreatitis",
            "url": "https://app.pathprimer.com/document/01c53506-8495-4dd8-8c22-b265b8aa535f/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Acute inflammation of pancreas"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Gallstone and alcoholic pancreatitis account for 70-80% of cases"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Acute upper abdominal pain with nausea and vomiting"
                  },
                  {
                    "text": "Elevated serum amylase and lipase"
                  },
                  {
                    "text": "Treatment includes supportive care and infection prevention"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Pancreas enlarged and swollen in mild pancreatitis"
                  },
                  {
                    "text": "Foci of fat necrosis (yellow-white, waxy, or chalky consistency)"
                  },
                  {
                    "text": "Larger confluent areas of fat necrosis and parenchymal necrosis in severe necrotizing pancreatitis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Severe acute pancreatitisLarge areas of fat necrosis along with variable parenchymal necrosisSaponificationHemorrhage, vascular thrombosis",
                    "sub_points": [
                      "Large areas of fat necrosis along with variable parenchymal necrosis",
                      "Saponification",
                      "Hemorrhage, vascular thrombosis"
                    ]
                  },
                  {
                    "text": "Mild acute pancreatitis is most often clinical (rather than morphologic) diagnosisSpotty peripancreatic or perilobular fat necrosis and interstitial acute inflammation",
                    "sub_points": [
                      "Spotty peripancreatic or perilobular fat necrosis and interstitial acute inflammation"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Chronic pancreatitisFibrosis, chronic inflammation, lacks inflammatory component",
                    "sub_points": [
                      "Fibrosis, chronic inflammation, lacks inflammatory component"
                    ]
                  },
                  {
                    "text": "Autoimmune pancreatitisProminent lymphoplasmacytic infiltrate and storiform fibrosis",
                    "sub_points": [
                      "Prominent lymphoplasmacytic infiltrate and storiform fibrosis"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute inflammatory process involving pancreas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Mechanical": [
                  {
                    "text": "Gallstones (most common cause, accounting for 35-60% of cases), biliary sludge, periampullary diverticulum, neoplasms, duodenal stricture or obstruction"
                  }
                ],
                "Toxic": [
                  {
                    "text": "Ethanol (2nd most common cause), methanol, scorpion venom, organophosphate poisoning"
                  }
                ],
                "Trauma": [
                  {
                    "text": "Blunt or penetrating abdominal injury, iatrogenic injury during procedure"
                  }
                ],
                "Metabolic": [
                  {
                    "text": "Hypertriglyceridemia, hypercalcemia"
                  }
                ],
                "Vascular": [
                  {
                    "text": "Ischemia, intraoperative hypotension, hemorrhagic shock, atheroembolism, vasculitis"
                  }
                ],
                "Genetic": [
                  {
                    "text": "Hereditary pancreatitis: Mutations of serine protease 1 gene (PRSS1), serine protease inhibitor Kazal type 1 (SPINK1), and cystic fibrosis transmembrane conductance regulator (CFTR)"
                  }
                ],
                "Drug Induced": [
                  {
                    "text": "Numerous drugs implicated"
                  }
                ],
                "Infectious Agents": [
                  {
                    "text": "Virus: Mumps, coxsackievirus, CMV, varicella-zoster, HSV, HIV"
                  },
                  {
                    "text": "Bacteria:Mycoplasma,Legionella,Leptospira,Salmonella"
                  },
                  {
                    "text": "Parasites:Toxoplasma,Cryptosporidium,Ascaris"
                  }
                ],
                "Congenital": [
                  {
                    "text": "Choledochocele type V"
                  }
                ],
                "Miscellaneous": [
                  {
                    "text": "Post ERCP, pregnancy, renal transplant, α-1-antitrypsin deficiency"
                  }
                ],
                "Idiopathic": [
                  {
                    "text": "10-25% of patients have no identifiable cause"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [
                  {
                    "text": "Occurs at any ageMost common in adults in 3rd to 6th decade of lifeOccurrence during 1st decade suggests hereditary cause, infection, or trauma",
                    "sub_points": [
                      "Most common in adults in 3rd to 6th decade of life",
                      "Occurrence during 1st decade suggests hereditary cause, infection, or trauma"
                    ]
                  },
                  {
                    "text": "Gallstone pancreatitis more common in women between 50-60 years of age"
                  },
                  {
                    "text": "Alcoholic pancreatitis more common in men"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Acute upper abdominal pain, nausea, vomiting"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated amylase and lipase"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Mild cases usually recover within 5-7 days"
                  },
                  {
                    "text": "Severe necrotizing pancreatitis associated with high rate of complication and significant mortality"
                  },
                  {
                    "text": "Common sequelae are pancreatic abscess and pseudocyst"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Supportive care, infection prevention"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Mortality in USA ranges from 2-10%"
                  },
                  {
                    "text": "Severe disease has higher mortality of 17%"
                  }
                ],
                "Revised Atlanta Classification": [
                  {
                    "text": "Two types: Interstitial edematous vs. necrotizing"
                  },
                  {
                    "text": "Severity grade: Mild, moderately severe, and severe"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Mild Acute Pancreatitis": [
                  {
                    "text": "Enlarged and swollen with foci of fat necrosis (yellow-white, waxy, or chalky consistency)"
                  }
                ],
                "Severe Acute Pancreatitis": [
                  {
                    "text": "Larger confluent areas of fat necrosis and parenchymal necrosis"
                  },
                  {
                    "text": "Hemorrhage can encase pancreas and simulate hematoma"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Mild acute pancreatitisSpotty peripancreatic or perilobular fat necrosis (saponification)Interstitial acute inflammationUsually clinical rather than morphologic diagnosis",
                    "sub_points": [
                      "Spotty peripancreatic or perilobular fat necrosis (saponification)",
                      "Interstitial acute inflammation",
                      "Usually clinical rather than morphologic diagnosis"
                    ]
                  },
                  {
                    "text": "Severe acute pancreatitisLarge areas of fat necrosis and variable pancreatic parenchymal necrosisNecrotic areas may have abundant neutrophils that can involve duct luminaViable acinar lumina may be widened and contain secretory materialHemorrhage and usually venous thrombosisFat necrosis may extend to omentum, retroperitoneum, bone marrow, subcutaneous tissue",
                    "sub_points": [
                      "Large areas of fat necrosis and variable pancreatic parenchymal necrosis",
                      "Necrotic areas may have abundant neutrophils that can involve duct lumina",
                      "Viable acinar lumina may be widened and contain secretory material",
                      "Hemorrhage and usually venous thrombosis",
                      "Fat necrosis may extend to omentum, retroperitoneum, bone marrow, subcutaneous tissue"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Pancreatitis": [
                  {
                    "text": "Fibrosis, acinar atrophy, and chronic inflammation"
                  },
                  {
                    "text": "Lacks necrosis, acute inflammation"
                  }
                ],
                "Autoimmune Pancreatitis": [
                  {
                    "text": "Prominent lymphoplasmacytic infiltrate, storiform fibrosis"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Chronic Pancreatitis": {
            "name": "Chronic Pancreatitis",
            "url": "https://app.pathprimer.com/document/c45c7289-1f84-4068-968b-c461292ed31d/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Progressive inflammatory disorder of pancreas resulting in scarring, gland destruction, and functional impairment"
                  },
                  {
                    "text": "Mechanistic definition: Chronic pancreatitis is pathologic fibroinflammatory syndrome of pancreas in individuals with genetic, environmental &/or other risk factors who develop persistent pathologic responses to parenchymal injury or stress"
                  },
                  {
                    "text": "Characteristics of end-stage disease: Pancreatic atrophy, fibrosis, pain syndromes, duct distortion and strictures, calcifications, pancreatic exocrine dysfunction, pancreatic endocrine dysfunction, and dysplasia"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Alcohol is by far most common cause of chronic pancreatitis (CP) in resource-rich countries"
                  },
                  {
                    "text": "Mutations in several genes are associated with high risk of developing CP"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Abdominal pain is most common presenting symptom"
                  },
                  {
                    "text": "Steatorrhea"
                  },
                  {
                    "text": "Diabetes mellitus"
                  },
                  {
                    "text": "Weight loss"
                  },
                  {
                    "text": "Abdominal pain (most common presenting symptom)"
                  },
                  {
                    "text": "Often follows recurrent attacks of acute pancreatitis"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Diagnosis of CP is usually made on cross-sectional imaging (CT/MR); endoscopic ultrasonography (EUS) and pancreatic function tests play complementary role"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Firm, indurated, and fibrotic pancreas"
                  },
                  {
                    "text": "Grossly affected area should be thoroughly sampled to exclude pancreatic adenocarcinoma, which can mimic CP on imaging and grosslyPancreatic adenocarcinoma and CP may coexist",
                    "sub_points": [
                      "Pancreatic adenocarcinoma and CP may coexist"
                    ]
                  },
                  {
                    "text": "Findings may be diffuse, focal, or segmental"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Fibrosis and chronic inflammationVariable extent and distribution of fibrosisIrregular atrophy and obliteration of pancreatic acini and ductsRetention of normal lobular pancreatic architectureLobular architecture aids histologic distinction from pancreatic adenocarcinoma",
                    "sub_points": [
                      "Variable extent and distribution of fibrosis",
                      "Irregular atrophy and obliteration of pancreatic acini and ducts",
                      "Retention of normal lobular pancreatic architectureLobular architecture aids histologic distinction from pancreatic adenocarcinoma",
                      "Lobular architecture aids histologic distinction from pancreatic adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Pancreatic duct alterations related to fibrosis and destructionDuct epithelium may show atrophy, reactive, or hyperplastic changesSquamous, mucinous, or pyloric metaplasia",
                    "sub_points": [
                      "Duct epithelium may show atrophy, reactive, or hyperplastic changes",
                      "Squamous, mucinous, or pyloric metaplasia"
                    ]
                  },
                  {
                    "text": "Islets of Langerhans usually preserved, may show pseudohyperplasia"
                  },
                  {
                    "text": "Triad of featuresFibrosisDuct dilatation/distortionLoss of acinar tissue (atrophy)",
                    "sub_points": [
                      "Fibrosis",
                      "Duct dilatation/distortion",
                      "Loss of acinar tissue (atrophy)"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic adenocarcinoma"
                  },
                  {
                    "text": "Autoimmune pancreatitis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Chronic pancreatitis (CP)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Mechanistic definition: CP is pathologic fibroinflammatory syndrome of pancreas in individuals with genetic, environmental &/or other risk factors who develop persistent pathologic responses to parenchymal injury or stressCharacteristics of end-stage disease: Pancreatic atrophy, fibrosis, pain syndromes, duct distortion and strictures, calcifications, pancreatic exocrine dysfunction, pancreatic endocrine dysfunction, and dysplasia",
                    "sub_points": [
                      "Characteristics of end-stage disease: Pancreatic atrophy, fibrosis, pain syndromes, duct distortion and strictures, calcifications, pancreatic exocrine dysfunction, pancreatic endocrine dysfunction, and dysplasia"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Developmental Anomaly": [
                  {
                    "text": "Pancreas divisum"
                  },
                  {
                    "text": "Annular pancreas"
                  }
                ],
                "Anatomic": [
                  {
                    "text": "Duct obstruction (stones, masses, sphincter of Oddi disorders, trauma)"
                  }
                ],
                "Toxic/Metabolic": [
                  {
                    "text": "Alcohol (heavy drinking)By far most common cause of CP in resource-rich countriesModerate drinking is associated with lower risk",
                    "sub_points": [
                      "By far most common cause of CP in resource-rich countries",
                      "Moderate drinking is associated with lower risk"
                    ]
                  },
                  {
                    "text": "Smoking"
                  },
                  {
                    "text": "Hypercalcemia"
                  },
                  {
                    "text": "Hypertriglyceridemia"
                  },
                  {
                    "text": "Chronic renal failure"
                  },
                  {
                    "text": "Medications and toxins"
                  }
                ],
                "Genetic": [
                  {
                    "text": "Mutations in several genes are associated with high risk of developing CPTrypsinogen gene (PRSS1) accounts for 60-80% of hereditary CP casesCystic fibrosis transmembrane conductance regulator gene (CFTR)Serine protease inhibitor Kazal type 1 gene (SPINK1)Chymotrypsin C (CTRC)Carboxyl ester lipase (CEL)Carboxypeptidase A1 (CPA1)",
                    "sub_points": [
                      "Trypsinogen gene (PRSS1) accounts for 60-80% of hereditary CP cases",
                      "Cystic fibrosis transmembrane conductance regulator gene (CFTR)",
                      "Serine protease inhibitor Kazal type 1 gene (SPINK1)",
                      "Chymotrypsin C (CTRC)",
                      "Carboxyl ester lipase (CEL)",
                      "Carboxypeptidase A1 (CPA1)"
                    ]
                  },
                  {
                    "text": "Genetic testing is recommended in patients with possible CP in which etiology is unclear, especially in younger patients"
                  }
                ],
                "Autoimmune": [
                  {
                    "text": "Autoimmune pancreatitis (AIP) type 1 and type 2"
                  }
                ],
                "Other": [
                  {
                    "text": "In general, caused by repeated bouts of inflammation"
                  },
                  {
                    "text": "Up to 25% of cases are idiopathic"
                  }
                ],
                "Risk Factors: TIGAR-O System": [
                  {
                    "text": "Toxic-metabolic,Idiopathic,Genetic,Autoimmune,Recurrent,Obstructive"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Alcohol-related CP usually affects adults > 40 years of age"
                  },
                  {
                    "text": "Genetic causes can occur in younger adults and children"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain (most common presenting symptom)"
                  },
                  {
                    "text": "SteatorrheaAssociated with malabsorption due to impaired pancreatic enzyme secretion",
                    "sub_points": [
                      "Associated with malabsorption due to impaired pancreatic enzyme secretion"
                    ]
                  },
                  {
                    "text": "Diabetes mellitus, if advanced disease"
                  },
                  {
                    "text": "Weight loss"
                  },
                  {
                    "text": "Nausea"
                  },
                  {
                    "text": "Vomiting"
                  },
                  {
                    "text": "Often follows recurrent attacks of acute pancreatitis"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Chronic, progressive disease leading to permanent loss of pancreatic functionLoss of pancreatic enzyme secretions leads to malabsorption and steatorrheaPancreatic endocrine insufficiencyDiabetes more common in late disease",
                    "sub_points": [
                      "Loss of pancreatic enzyme secretions leads to malabsorption and steatorrhea",
                      "Pancreatic endocrine insufficiencyDiabetes more common in late disease",
                      "Diabetes more common in late disease"
                    ]
                  },
                  {
                    "text": "Symptoms may wax and wane over course of disease"
                  },
                  {
                    "text": "Complications of advanced diseasePortal vein thrombosisSplenic vein thrombosisJaundicePancreatic ascitesPancreatic pseudocysts",
                    "sub_points": [
                      "Portal vein thrombosis",
                      "Splenic vein thrombosis",
                      "Jaundice",
                      "Pancreatic ascites",
                      "Pancreatic pseudocysts"
                    ]
                  }
                ],
                "Treatment": [],
                "Options, risks, complications": [
                  {
                    "text": "Alcohol and smoking cessation"
                  },
                  {
                    "text": "To relieve chronic pain, decompression of pancreatic duct by endoscopic or surgical techniques can be used"
                  },
                  {
                    "text": "Endoscopic pancreatic duct drainage procedure is often 1st line of therapy"
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Surgery is often reserved for failed endoscopic treatments or patients who are unwilling to undergo multiple endoscopic procedures"
                  },
                  {
                    "text": "Total pancreatectomy is only cure for CPUnattractive option due to inherent complications and difficulty in patient selectionSurgical decompression/partial resection of pancreas can provide long-term pain relief",
                    "sub_points": [
                      "Unattractive option due to inherent complications and difficulty in patient selection",
                      "Surgical decompression/partial resection of pancreas can provide long-term pain relief"
                    ]
                  }
                ],
                "Drugs": [
                  {
                    "text": "Antioxidants (limited utility for pain management)"
                  },
                  {
                    "text": "Opiates (when all other reasonable therapeutic options have been exhausted)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "CP is risk factor for pancreatic cancerLifetime risk variesPatients with hereditary pancreatitis have 40% lifetime pancreatic cancer risk",
                    "sub_points": [
                      "Lifetime risk varies",
                      "Patients with hereditary pancreatitis have 40% lifetime pancreatic cancer risk"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Diagnosis of CP is usually made on cross-sectional imaging (CT/MR); endoscopic ultrasonography (EUS) and pancreatic function tests play complementary role"
                  }
                ],
                "MR Findings": [
                  {
                    "text": "Main pancreatic duct may have beaded appearance (due to alternating stenoses and dilatation), pancreatic duct stones appear as round filling defects"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Dilated main pancreatic duct, pancreatic calcifications, enlargement or atrophy, beaded appearance of main duct, pancreatic pseudocysts, parenchymal cysts of varying sizes"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Findings may be diffuse, focal, or segmentalUsually, affected area is enlarged but may be shrunken in advanced CP",
                    "sub_points": [
                      "Usually, affected area is enlarged but may be shrunken in advanced CP"
                    ]
                  },
                  {
                    "text": "Firm, indurated, and fibrotic pancreas"
                  },
                  {
                    "text": "Cystically dilated pancreatic ductsMay contain calcified protein concretions or calculi",
                    "sub_points": [
                      "May contain calcified protein concretions or calculi"
                    ]
                  },
                  {
                    "text": "Pseudocysts may be evidentVariably sized, thick-walled cysts containing blood and necrotic debris",
                    "sub_points": [
                      "Variably sized, thick-walled cysts containing blood and necrotic debris"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Triad of featuresFibrosisInterlobular and intralobular fibrosis (often dense)Chronic inflammation usually mildLoss of acinar tissue (atrophy)Duct dilatation/distortionOften contain eosinophilic proteinaceous debris &/or calcifications and stones",
                    "sub_points": [
                      "FibrosisInterlobular and intralobular fibrosis (often dense)Chronic inflammation usually mild",
                      "Interlobular and intralobular fibrosis (often dense)",
                      "Chronic inflammation usually mild",
                      "Loss of acinar tissue (atrophy)",
                      "Duct dilatation/distortionOften contain eosinophilic proteinaceous debris &/or calcifications and stones",
                      "Often contain eosinophilic proteinaceous debris &/or calcifications and stones"
                    ]
                  },
                  {
                    "text": "Islets of Langerhans usually relatively well preservedIslets may become lost or atrophic in advanced CPMay also show pseudohyperplasia as result of parenchymal loss",
                    "sub_points": [
                      "Islets may become lost or atrophic in advanced CP",
                      "May also show pseudohyperplasia as result of parenchymal loss"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pancreatic Adenocarcinoma": [
                  {
                    "text": "Invasive growth pattern (vs. retained lobular architecture in CP)Adenocarcinoma has irregularly distributed glands with infiltrative growth patternBland-appearing glands adjacent to muscular arteries likely represent adenocarcinomaPerineural invasion and angiolymphatic space invasion are features of malignancyBland-appearing glands in peripancreatic soft tissue may represent intravascular growth by adenocarcinoma",
                    "sub_points": [
                      "Adenocarcinoma has irregularly distributed glands with infiltrative growth pattern",
                      "Bland-appearing glands adjacent to muscular arteries likely represent adenocarcinoma",
                      "Perineural invasion and angiolymphatic space invasion are features of malignancyBland-appearing glands in peripancreatic soft tissue may represent intravascular growth by adenocarcinoma",
                      "Bland-appearing glands in peripancreatic soft tissue may represent intravascular growth by adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Malignant glands tend to be irregular and dilated (vs. round or tubular glands in CP)Single cell infiltration is feature of adenocarcinomaNecrotic debris may be seen in malignant glands but is not usually seen in residual ducts in CPResidual islet cells may appear singly or in irregular clusters, including in and around nerves, and should not be interpreted as evidence of cancer",
                    "sub_points": [
                      "Single cell infiltration is feature of adenocarcinoma",
                      "Necrotic debris may be seen in malignant glands but is not usually seen in residual ducts in CP",
                      "Residual islet cells may appear singly or in irregular clusters, including in and around nerves, and should not be interpreted as evidence of cancer"
                    ]
                  },
                  {
                    "text": "Cytologic features of malignancyNuclei are larger, more irregular, more hyperchromatic in adenocarcinoma, and show greater variation in sizeMitotic activity and atypical mitotic features are absent in CP",
                    "sub_points": [
                      "Nuclei are larger, more irregular, more hyperchromatic in adenocarcinoma, and show greater variation in size",
                      "Mitotic activity and atypical mitotic features are absent in CP"
                    ]
                  }
                ],
                "Autoimmune Pancreatitis": [
                  {
                    "text": "More densely cellular inflammatory infiltrates than in CPPeriductal inflammation consisting of large numbers of lymphocytes and plasma cellsInjury and destruction of duct epithelium with neutrophilic infiltrate in type 2 AIPObliterative phlebitis of small to medium-sized veins in type 1 AIP",
                    "sub_points": [
                      "Periductal inflammation consisting of large numbers of lymphocytes and plasma cellsInjury and destruction of duct epithelium with neutrophilic infiltrate in type 2 AIP",
                      "Injury and destruction of duct epithelium with neutrophilic infiltrate in type 2 AIP",
                      "Obliterative phlebitis of small to medium-sized veins in type 1 AIP"
                    ]
                  },
                  {
                    "text": "Stones and calcifications are usually absent in AIP"
                  },
                  {
                    "text": "Serum IgG4 elevation and increased IgG4(+) plasma cells in most patients with type 1 AIP"
                  }
                ],
                "Paraduodenal (\"Groove\") Pancreatitis": [
                  {
                    "text": "Variant of CP"
                  },
                  {
                    "text": "Tends to affect males, aged 40-50, with history of alcohol abuse"
                  },
                  {
                    "text": "Process often centered around accessory ampulla"
                  },
                  {
                    "text": "Grossly and microscopically, duodenal wall is often markedly hypertrophic and contains cystic structures (dilated and inflamed ducts creating adenomyomatous-like appearance)Larger cysts are often denuded (pseudocysts)",
                    "sub_points": [
                      "Larger cysts are often denuded (pseudocysts)"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Triad of features: Fibrosis, loss of acinar tissue, and duct dilatation/distortion"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Autoimmune Pancreatitis": {
            "name": "Autoimmune Pancreatitis",
            "url": "https://app.pathprimer.com/document/57b8ad8e-d2d8-4387-ad9e-669e74f10910/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Fibroinflammatory disease of presumed autoimmune etiology that affects pancreasOften associated with elevated serum IgG4Similar fibroinflammatory process often affects other organs, such as bile ducts, salivary glands, retroperitoneum, and lymph nodes",
                    "sub_points": [
                      "Often associated with elevated serum IgG4",
                      "Similar fibroinflammatory process often affects other organs, such as bile ducts, salivary glands, retroperitoneum, and lymph nodes"
                    ]
                  },
                  {
                    "text": "Associated with many other autoimmune diseases; ANA often positive"
                  },
                  {
                    "text": "There are 2 distinct subtypes or autoimmune pancreatitis (AIP): Type 1 (IgG4-related; LPSP) and type 2 (neutrophil-rich; IDCP)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Nonspecific: Jaundice, weight loss, vague abdominal pain"
                  },
                  {
                    "text": "Elevated serum IgG4 (not invariably present, and not diagnostic of autoimmune pancreatitis)More common in type 1 than type 2 AIP",
                    "sub_points": [
                      "More common in type 1 than type 2 AIP"
                    ]
                  },
                  {
                    "text": "Steroid therapy is usually very effectiveRecurrence reported in 6-26%",
                    "sub_points": [
                      "Recurrence reported in 6-26%"
                    ]
                  },
                  {
                    "text": "Often mimics pancreatic adenocarcinoma clinically and radiographically"
                  },
                  {
                    "text": "Type 1 AIP: Most commonly affects men in their 60'sElevated serum IgG4 level (> 140 mg/dL): 80% of cases",
                    "sub_points": [
                      "Elevated serum IgG4 level (> 140 mg/dL): 80% of cases"
                    ]
                  },
                  {
                    "text": "Type 2 AIP: Most common in men and women in their 40'sCan only be diagnosed definitively by histologic examination",
                    "sub_points": [
                      "Can only be diagnosed definitively by histologic examination"
                    ]
                  },
                  {
                    "text": "Steroid therapy is usually very effective"
                  }
                ],
                "Imaging": [
                  {
                    "text": "Type 1 AIP: Diffusely enlarged, sausage-shaped pancreas; can be mass-forming"
                  },
                  {
                    "text": "Type 2 AIP: Focal, mass-like lesion; diffuse involvement less common"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Enlarged, firm pancreas ± mass lesion; may mimic adenocarcinomaUsually head is most prominently involved",
                    "sub_points": [
                      "Usually head is most prominently involved"
                    ]
                  },
                  {
                    "text": "Stenosis of pancreatic duct and intrapancreatic common bile duct are common"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Dense, lymphoplasmacytic infiltration centered around main and interlobular pancreatic ducts"
                  },
                  {
                    "text": "Periductal, lobular, and perilobular fibrosis"
                  },
                  {
                    "text": "Obliterative phlebitis and venulitis"
                  },
                  {
                    "text": "2 main typesType 1: Lobular and interlobular distribution, obliterative phlebitis, numerous IgG4(+) plasma cellsType 2: Duct-centric distribution, granulocytic epithelial lesions, only rare IgG(+) plasma cells",
                    "sub_points": [
                      "Type 1: Lobular and interlobular distribution, obliterative phlebitis, numerous IgG4(+) plasma cells",
                      "Type 2: Duct-centric distribution, granulocytic epithelial lesions, only rare IgG(+) plasma cells"
                    ]
                  },
                  {
                    "text": "Type 1 AIPInflammatory infiltrate: Lymphoplasmacytic, scattered eosinophils, rare neutrophilsPancreatic ducts: Dense periductal inflammation without epithelial damageLobules: Destructive lymphoplasmacytic infiltrate with storiform fibrosisVeins: Obliterative phlebitisIgG4 cells: Abundant (biopsy, > 10 cells/HPF; resection, > 50 cells/HPF; IgG4(+):IgG(+) ratio > 40%)",
                    "sub_points": [
                      "Inflammatory infiltrate: Lymphoplasmacytic, scattered eosinophils, rare neutrophils",
                      "Pancreatic ducts: Dense periductal inflammation without epithelial damage",
                      "Lobules: Destructive lymphoplasmacytic infiltrate with storiform fibrosis",
                      "Veins: Obliterative phlebitis",
                      "IgG4 cells: Abundant (biopsy, > 10 cells/HPF; resection, > 50 cells/HPF; IgG4(+):IgG(+) ratio > 40%)"
                    ]
                  },
                  {
                    "text": "Type 2 AIPInflammatory infiltrate: Lymphoplasmacytic with neutrophilsPancreatic ducts: Dense periductal inflammation with duct destruction containing neutrophils (granulocytic epithelial lesion)Lobules: Patchy lymphoplasmacytic infiltration often admixed with neutrophils (abscesses)Veins are rarely involved and IgG4 cells are typically rare to none",
                    "sub_points": [
                      "Inflammatory infiltrate: Lymphoplasmacytic with neutrophils",
                      "Pancreatic ducts: Dense periductal inflammation with duct destruction containing neutrophils (granulocytic epithelial lesion)",
                      "Lobules: Patchy lymphoplasmacytic infiltration often admixed with neutrophils (abscesses)",
                      "Veins are rarely involved and IgG4 cells are typically rare to none"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic ductal adenocarcinoma"
                  },
                  {
                    "text": "\"Usual\" chronic pancreatitis"
                  },
                  {
                    "text": "Paraduodenal pancreatitis (groove pancreatitis)"
                  },
                  {
                    "text": "Rosai-Dorfman disease"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Autoimmune pancreatitis (AIP)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Lymphoplasmacytic sclerosing pancreatitis (LPSP)"
                  },
                  {
                    "text": "Idiopathic duct-centric chronic pancreatitis (IDCP)"
                  },
                  {
                    "text": "Primary sclerosing pancreatitis"
                  },
                  {
                    "text": "IgG4-related pancreatitis (type 1 only)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Tumefactive fibroinflammatory disease of pancreasOther organs can also be affected",
                    "sub_points": [
                      "Other organs can also be affected"
                    ]
                  },
                  {
                    "text": "Associated with many other autoimmune diseases"
                  },
                  {
                    "text": "Specific antigenic trigger unknown"
                  },
                  {
                    "text": "There are 2 distinct subtypes: Type 1 (IgG4-related; LPSP) and type 2 (neutrophil-rich; IDCP)Type 1 can be associated with systemic IgG4-related disease",
                    "sub_points": [
                      "Type 1 can be associated with systemic IgG4-related disease"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Type 1 AIP: Most commonly affects men in their 60'sPainless obstructive jaundice; other organs may be involved",
                    "sub_points": [
                      "Painless obstructive jaundice; other organs may be involved"
                    ]
                  },
                  {
                    "text": "Type 2 AIP: Most common in men and women in their 40'sAcute pancreatitis, abdominal pain; other organs not involved but can be associated with inflammatory bowel disease (in 15-30%)",
                    "sub_points": [
                      "Acute pancreatitis, abdominal pain; other organs not involved but can be associated with inflammatory bowel disease (in 15-30%)"
                    ]
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated serum IgG4 level (> 140 mg/dL): 80% of cases of type 1 AIPSeldom increased in type 2 AIP",
                    "sub_points": [
                      "Seldom increased in type 2 AIP"
                    ]
                  },
                  {
                    "text": "Elevated pancreatic enzymes"
                  },
                  {
                    "text": "ANA often positive"
                  },
                  {
                    "text": "Type 2 AIP can only be diagnosed definitively by histologic examination"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgically resected when differentiation from pancreatic cancer is difficult or impossible"
                  },
                  {
                    "text": "Steroids are very effective for both subtypes"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Steroid therapy is usually very effectiveNatural regression seen in some casesType 1 AIP has high rate of recurrence or relapse (30-50%)",
                    "sub_points": [
                      "Natural regression seen in some cases",
                      "Type 1 AIP has high rate of recurrence or relapse (30-50%)"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Diffusely or segmentally enlarged gland with delayed enhancement"
                  },
                  {
                    "text": "Segmental or diffuse, irregular duct with narrowing"
                  },
                  {
                    "text": "Type 1 AIP: Diffusely enlarged, sausage-shaped pancreas; can be mass-forming"
                  },
                  {
                    "text": "Type 2 AIP: Focal, mass-like lesion; diffuse involvement less common"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solid, \"fish-flesh\" cut surfaceUsually head is most prominently involved",
                    "sub_points": [
                      "Usually head is most prominently involved"
                    ]
                  },
                  {
                    "text": "Discrete mass lesion variably present"
                  },
                  {
                    "text": "Stenosis of pancreatic duct and intrapancreatic common bile duct are common in type 1 AIP"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Dense, lymphoplasmacytic infiltration centered around main and interlobular pancreatic ductsSmaller ducts more involved in advanced disease",
                    "sub_points": [
                      "Smaller ducts more involved in advanced disease"
                    ]
                  },
                  {
                    "text": "Infiltrate may compress lumen and cause infolding of epithelium"
                  },
                  {
                    "text": "Ductal epithelium may be detached &/or destroyed"
                  },
                  {
                    "text": "Type 1 AIPInflammatory infiltrate: Lymphoplasmacytic, scattered eosinophils, rare neutrophilsMarked lobularandinterlobular fibroinflammatory processPlasma cells and eosinophil infiltratesVenulitis and obliterative phlebitisLymphoid aggregates with variably present germinal centersOften extends into peripancreatic tissueNumerous IgG4(+) plasma cells (on average > 10/HPF)Type 2 AIP(IDCP)Fibroinflammatory process with duct-centric distributionMinimal intralobular fibroblastic proliferationGranulocytic epithelial lesions are frequent, consisting of neutrophilic exocytosis, microabscesses, and ductular destruction with reactive epithelial changesOnly rare IgG4(+) plasma cellsPancreatic ducts: Dense periductal inflammation without epithelial damageLobules: Destructive lymphoplasmacytic infiltrate with storiform fibrosisVeins: Obliterative phlebitisPeripancreatic fat: May be involvedIgG4 cells: Abundant (biopsy, > 10 cells/HPF; resection, > 50 cells/HPF; IgG4(+):IgG(+) ratio > 40%)",
                    "sub_points": [
                      "Inflammatory infiltrate: Lymphoplasmacytic, scattered eosinophils, rare neutrophilsMarked lobularandinterlobular fibroinflammatory processPlasma cells and eosinophil infiltratesVenulitis and obliterative phlebitisLymphoid aggregates with variably present germinal centersOften extends into peripancreatic tissueNumerous IgG4(+) plasma cells (on average > 10/HPF)",
                      "Marked lobularandinterlobular fibroinflammatory process",
                      "Plasma cells and eosinophil infiltrates",
                      "Venulitis and obliterative phlebitis",
                      "Lymphoid aggregates with variably present germinal centers",
                      "Often extends into peripancreatic tissue",
                      "Numerous IgG4(+) plasma cells (on average > 10/HPF)",
                      "Type 2 AIP(IDCP)Fibroinflammatory process with duct-centric distributionMinimal intralobular fibroblastic proliferationGranulocytic epithelial lesions are frequent, consisting of neutrophilic exocytosis, microabscesses, and ductular destruction with reactive epithelial changesOnly rare IgG4(+) plasma cells",
                      "Fibroinflammatory process with duct-centric distribution",
                      "Minimal intralobular fibroblastic proliferation",
                      "Granulocytic epithelial lesions are frequent, consisting of neutrophilic exocytosis, microabscesses, and ductular destruction with reactive epithelial changes",
                      "Only rare IgG4(+) plasma cells",
                      "Pancreatic ducts: Dense periductal inflammation without epithelial damage",
                      "Lobules: Destructive lymphoplasmacytic infiltrate with storiform fibrosis",
                      "Veins: Obliterative phlebitis",
                      "Peripancreatic fat: May be involved",
                      "IgG4 cells: Abundant (biopsy, > 10 cells/HPF; resection, > 50 cells/HPF; IgG4(+):IgG(+) ratio > 40%)"
                    ]
                  },
                  {
                    "text": "Type 2 AIPInflammatory infiltrate: Lymphoplasmacytic with neutrophilsPancreatic ducts: Dense periductal inflammation with duct destruction containing neutrophils (granulocytic epithelial lesion)Lobules: Patchy lymphoplasmacytic infiltration often admixed with neutrophils (abscesses)Veins: Rarely involvedPeripancreatic fat: Usually uninvolvedIgG4 cells: Typically rare to none",
                    "sub_points": [
                      "Inflammatory infiltrate: Lymphoplasmacytic with neutrophils",
                      "Pancreatic ducts: Dense periductal inflammation with duct destruction containing neutrophils (granulocytic epithelial lesion)",
                      "Lobules: Patchy lymphoplasmacytic infiltration often admixed with neutrophils (abscesses)",
                      "Veins: Rarely involved",
                      "Peripancreatic fat: Usually uninvolved",
                      "IgG4 cells: Typically rare to none"
                    ]
                  },
                  {
                    "text": "PitfallsPancreatic adenocarcinoma can be associated with increased numbers of IgG4(+) cellsIncreased IgG4(+) cells in duodenal biopsies are not specific for AIP",
                    "sub_points": [
                      "Pancreatic adenocarcinoma can be associated with increased numbers of IgG4(+) cells",
                      "Increased IgG4(+) cells in duodenal biopsies are not specific for AIP"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pancreatic Adenocarcinoma": [
                  {
                    "text": "AIP can mimic adenocarcinoma grossly and radiographically"
                  }
                ],
                "\"Usual\" Chronic Pancreatitis": [
                  {
                    "text": "Stones &/or calcifications can be present (absent in AIP)"
                  },
                  {
                    "text": "Irregularly distributed fibrosis with spotty chronic inflammation (usually lymphocytic), no phlebitis, IgG4 not elevated"
                  }
                ],
                "Paraduodenal Pancreatitis (Groove Pancreatitis)": [
                  {
                    "text": "Mass-like inflammatory process often centered around accessory ampulla"
                  }
                ],
                "Rosai-Dorfman Disease": [
                  {
                    "text": "Overlapping morphologic features with type 1 AIP, including lymphoplasmacytic inflammation, storiform fibrosis, and vasculitis"
                  },
                  {
                    "text": "Perform S100 immunostain"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Often mimics pancreatic adenocarcinoma clinically and radiographically"
                  },
                  {
                    "text": "Associated with IgG4"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Infectious Pancreatitis": {
            "name": "Infectious Pancreatitis",
            "url": "https://app.pathprimer.com/document/a303770b-ef6b-48e6-81f9-304243294960/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Primary infection of pancreas is very rareShould be considered in immunocompromised patients with pancreatitisPancreatic involvement is usually mild in cases of systemic infectionCan be caused by virus, bacteria, fungus, or parasite",
                    "sub_points": [
                      "Should be considered in immunocompromised patients with pancreatitis",
                      "Pancreatic involvement is usually mild in cases of systemic infection",
                      "Can be caused by virus, bacteria, fungus, or parasite"
                    ]
                  },
                  {
                    "text": "Acute infection of pancreas is usually secondary eventOccurs in 40-70% of patients with necrotizing pancreatitisUsually due to gram-negative aerobic bacteriaMay also be caused by fungal infection, typicallyCandida",
                    "sub_points": [
                      "Occurs in 40-70% of patients with necrotizing pancreatitis",
                      "Usually due to gram-negative aerobic bacteriaMay also be caused by fungal infection, typicallyCandida",
                      "May also be caused by fungal infection, typicallyCandida"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Many different viruses, parasites, bacteria, and fungiVirusesMumps, coxsackievirus, CMVMumps can cause severe pancreatitisBacteriaMany different pathogens, typically gram negative (Escherichia coli)FungiCandidaspecies most commonParasitesAscaris,Clonorchis,Toxoplasma",
                    "sub_points": [
                      "VirusesMumps, coxsackievirus, CMVMumps can cause severe pancreatitis",
                      "Mumps, coxsackievirus, CMVMumps can cause severe pancreatitis",
                      "Mumps can cause severe pancreatitis",
                      "BacteriaMany different pathogens, typically gram negative (Escherichia coli)",
                      "Many different pathogens, typically gram negative (Escherichia coli)",
                      "FungiCandidaspecies most common",
                      "Candidaspecies most common",
                      "ParasitesAscaris,Clonorchis,Toxoplasma",
                      "Ascaris,Clonorchis,Toxoplasma"
                    ]
                  },
                  {
                    "text": "Many cases associated with immune compromise"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Presentation, treatment, prognosis depend on specific infection and clinical scenario"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Gross and histologic findings are not well described"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Acute infection of pancreas is usually secondaryOccurs in 40-70% of patients with necrotizing pancreatitisUsually due to gram-negative aerobic bacteriaFungi (typicallyCandida) may also superinfect acute pancreatitis",
                    "sub_points": [
                      "Occurs in 40-70% of patients with necrotizing pancreatitis",
                      "Usually due to gram-negative aerobic bacteria",
                      "Fungi (typicallyCandida) may also superinfect acute pancreatitis"
                    ]
                  },
                  {
                    "text": "Primary infection of pancreas by virus, bacteria, fungus, or parasite is very rarePancreatic involvement is usually not significant in overall context of systemic infectionException is mumps, which can cause severe pancreatitis",
                    "sub_points": [
                      "Pancreatic involvement is usually not significant in overall context of systemic infectionException is mumps, which can cause severe pancreatitis",
                      "Exception is mumps, which can cause severe pancreatitis"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Infectious Agents": [
                  {
                    "text": "VirusesMumpsCoxsackievirus BCMVUsually seen in context of immunosuppression (AIDS or other causes) and in neonatesEpstein-Barr virus (EBV)RubellaArbovirusFulminant hepatitis B",
                    "sub_points": [
                      "Mumps",
                      "Coxsackievirus B",
                      "CMVUsually seen in context of immunosuppression (AIDS or other causes) and in neonates",
                      "Usually seen in context of immunosuppression (AIDS or other causes) and in neonates",
                      "Epstein-Barr virus (EBV)",
                      "Rubella",
                      "Arbovirus",
                      "Fulminant hepatitis B"
                    ]
                  },
                  {
                    "text": "ParasitesToxoplasma gondiiClonorchisMigrates to pancreas from liver in ~ 1/3 of hepatic clonorchiasis casesAscarisCan migrate into pancreatic duct, causing acute obstructionEchinococcusVery rare cause of pancreatitisHydatid cysts rupture in pancreas, leading to inflammation",
                    "sub_points": [
                      "Toxoplasma gondii",
                      "ClonorchisMigrates to pancreas from liver in ~ 1/3 of hepatic clonorchiasis cases",
                      "Migrates to pancreas from liver in ~ 1/3 of hepatic clonorchiasis cases",
                      "AscarisCan migrate into pancreatic duct, causing acute obstruction",
                      "Can migrate into pancreatic duct, causing acute obstruction",
                      "EchinococcusVery rare cause of pancreatitisHydatid cysts rupture in pancreas, leading to inflammation",
                      "Very rare cause of pancreatitis",
                      "Hydatid cysts rupture in pancreas, leading to inflammation"
                    ]
                  },
                  {
                    "text": "BacteriaTreponema pallidum(syphilis)Mycobacterium tuberculosisPancreatic tuberculosis is rare but reportedLeptospirasp. (leptospirosis)Actinomycosis can cause mass suspicious for cancer",
                    "sub_points": [
                      "Treponema pallidum(syphilis)",
                      "Mycobacterium tuberculosisPancreatic tuberculosis is rare but reported",
                      "Pancreatic tuberculosis is rare but reported",
                      "Leptospirasp. (leptospirosis)",
                      "Actinomycosis can cause mass suspicious for cancer"
                    ]
                  },
                  {
                    "text": "FungiCandidaAspergillus",
                    "sub_points": [
                      "Candida",
                      "Aspergillus"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Depends on specific infectious agent"
                  },
                  {
                    "text": "Patients with viral infections may have prodrome of diarrhea"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serologies, blood cultures, molecular tests for specific infectious organisms may be useful"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Depends on specific infection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Depends on specific infectionPancreatic involvement is usually not clinically significant in cases of systemic infectionMumps can cause severe pancreatitisAbscesses, bacterial superinfection, and parenchymal atrophy are complications of echinococcal infection of pancreas",
                    "sub_points": [
                      "Pancreatic involvement is usually not clinically significant in cases of systemic infectionMumps can cause severe pancreatitisAbscesses, bacterial superinfection, and parenchymal atrophy are complications of echinococcal infection of pancreas",
                      "Mumps can cause severe pancreatitis",
                      "Abscesses, bacterial superinfection, and parenchymal atrophy are complications of echinococcal infection of pancreas"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Gross findings are not well described"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Histologic findings are not well described in generalSpotty acinar or ductal cell death, without fat necrosis or ductal necrosis, has been described in cases of viral pancreatitis and some bacterial infections",
                    "sub_points": [
                      "Spotty acinar or ductal cell death, without fat necrosis or ductal necrosis, has been described in cases of viral pancreatitis and some bacterial infections"
                    ]
                  },
                  {
                    "text": "Viral inclusions, parasites, fungi, or bacteria may be seen in some cases"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Causes of Acute Pancreatitis": [
                  {
                    "text": "Alcohol"
                  },
                  {
                    "text": "Gallstones/obstruction"
                  },
                  {
                    "text": "Hyperlipidemia"
                  },
                  {
                    "text": "Drugs"
                  },
                  {
                    "text": "Anatomic abnormalities"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Actinomycosis can mimic pancreatic cancer by causing mass"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Very rare, but infection should be considered in immunocompromised patients with pancreatitis"
                  },
                  {
                    "text": "Secondary infection of acute necrotizing pancreatitis is much more common"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Groove Pancreatitis": {
            "name": "Groove Pancreatitis",
            "url": "https://app.pathprimer.com/document/2c2f4317-6430-4479-bde4-1993d1581e00/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Distinct form of pancreatitis that results in fibrosis of paraduodenal region in vicinity of minor ampulla"
                  },
                  {
                    "text": "Significant because dense fibrosis and irregular borders can mimic neoplasm"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Disease develops in individuals with anomalies of minor ampulla, conceivably leading to outflow obstruction, with alcohol as precipitating factor"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Typically occurs in men with history of alcohol use"
                  },
                  {
                    "text": "Symptoms include abdominal pain, vomiting, and weight loss"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Thickening and fibrosis of duodenum wall and paraduodenal pancreas with cyst formationChanges are centered around minor papilla and involve \"groove\" between pancreas and duodenumMay mimic pancreatic neoplasm, including cystic neoplasm",
                    "sub_points": [
                      "Changes are centered around minor papilla and involve \"groove\" between pancreas and duodenum",
                      "May mimic pancreatic neoplasm, including cystic neoplasm"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Duodenal wall around minor ampulla is thickened with marked fibrosis and muscular hypertrophy involving muscular propria and adjacent head of pancreasFibrosis extends into head of pancreas and may involve common bile ductDuodenal fibrosis is frequently accompanied by cysts lined by granulation tissue",
                    "sub_points": [
                      "Fibrosis extends into head of pancreas and may involve common bile duct",
                      "Duodenal fibrosis is frequently accompanied by cysts lined by granulation tissue"
                    ]
                  },
                  {
                    "text": "Nonparaduodenal pancreas frequently shows dilated ducts with inspissated secretions and prominent interlobular fibrosis"
                  },
                  {
                    "text": "Brunner gland hyperplasia is commonly seen"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Paraduodenal pancreatitis"
                  },
                  {
                    "text": "Cystic dystrophy of heterotopic pancreas"
                  },
                  {
                    "text": "Paraduodenal wall cyst"
                  },
                  {
                    "text": "Pancreatic hamartoma of duodenum"
                  },
                  {
                    "text": "Myoadenomatosis"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Distinct form of chronic pancreatitis that results in fibrosis of paraduodenal region in vicinity of minor ampulla"
                  },
                  {
                    "text": "Significant because dense fibrosis and irregular borders can mimic neoplasm"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Combination of Factors": [
                  {
                    "text": "Developmental anomalies and environmental exposureAnatomical/functional variations in region of minor papilla, such as pancreatic divisum, predispose to development of groove pancreatitis",
                    "sub_points": [
                      "Anatomical/functional variations in region of minor papilla, such as pancreatic divisum, predispose to development of groove pancreatitis"
                    ]
                  },
                  {
                    "text": "History of alcohol use is common"
                  },
                  {
                    "text": "Likely that disease develops in individuals with anomalies of minor ampulla, conceivably leading to outflow obstruction, with alcohol as precipitating factor"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon"
                  }
                ],
                "Age": [
                  {
                    "text": "Middle age"
                  }
                ],
                "Sex": [
                  {
                    "text": "Predominantly male"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain"
                  },
                  {
                    "text": "Vomiting caused by stenosis of duodenum"
                  },
                  {
                    "text": "Weight loss"
                  },
                  {
                    "text": "Jaundice is rare"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Whipple resection may be required to exclude malignancy"
                  },
                  {
                    "text": "Conservative medical treatment in majority of cases"
                  }
                ]
              },
              "IMAGING": {
                "Ultrasonographic Findings": [
                  {
                    "text": "Hypoechoic area is seen between duodenal wall and pancreatic parenchyma on endoscopic ultrasoundNarrowing of duodenal wall &/or common bile duct may be seen",
                    "sub_points": [
                      "Narrowing of duodenal wall &/or common bile duct may be seen"
                    ]
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Hypodense lesion between pancreatic head and duodenum"
                  },
                  {
                    "text": "Variably present, cyst-like changes in duodenal wall or groove area"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Changes are centered around minor papilla and involve \"groove\" between pancreas and duodenum"
                  },
                  {
                    "text": "Thickening and fibrosis of duodenum and paraduodenal pancreas may be mistaken for pancreatic carcinoma"
                  },
                  {
                    "text": "~ 1/2 of lesions are cystic, and some may mimic pancreatic cystic neoplasm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Duodenal wall around minor papilla is thickened with marked fibrosis and muscular hypertrophy involving muscular propria"
                  },
                  {
                    "text": "Fibrosis extends into head of pancreas and may involve common bile duct"
                  },
                  {
                    "text": "Duodenal fibrosis is frequently accompanied by cyst formationSmaller cysts may be lined by inflamed and reactive ductal epitheliumLarger cysts are lined by inflammatory granulation tissue",
                    "sub_points": [
                      "Smaller cysts may be lined by inflamed and reactive ductal epithelium",
                      "Larger cysts are lined by inflammatory granulation tissue"
                    ]
                  },
                  {
                    "text": "Brunner gland hyperplasia is commonly seen"
                  },
                  {
                    "text": "Nonparaduodenal pancreas frequently shows dilated ducts with inspissated secretions and prominent interlobular fibrosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Pancreatitis": [
                  {
                    "text": "Typically, chronic pancreatitis typically diffusely involves pancreas and lacks duodenal wall changes that are characteristic of groove pancreatitis"
                  }
                ],
                "Autoimmune Pancreatitis": [
                  {
                    "text": "Lacks paraduodenal accentuation of groove pancreatitis"
                  },
                  {
                    "text": "Periductal inflammation, obliterative phlebitis, and storiform fibroinflammatory proliferation are characteristic of autoimmune pancreatitisEither entirely absent or only focally seen in groove pancreatitis",
                    "sub_points": [
                      "Either entirely absent or only focally seen in groove pancreatitis"
                    ]
                  },
                  {
                    "text": "Elevated numbers of IgG4(+) plasma cells (> 10/HPF) are invariably seen in type 1 autoimmune pancreatitis"
                  }
                ],
                "Pancreatic Adenocarcinoma": [
                  {
                    "text": "Clinically and radiologically, groove pancreatitis may be indistinguishable from pancreatic carcinomaHistologically, lack of malignancy is obviousAlthough occasional reactive and entrapped ducts may appear worrisome",
                    "sub_points": [
                      "Histologically, lack of malignancy is obvious",
                      "Although occasional reactive and entrapped ducts may appear worrisome"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pseudocysts": {
            "name": "Pseudocysts",
            "url": "https://app.pathprimer.com/document/d50ed4d0-34c9-4a6d-b706-44243ab8891e/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Pancreatic or peripancreatic collection of fluid rich in pancreatic enzymes"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Occurs in patients with acute or chronic pancreatitis, biliary disease, surgery, or other trauma"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Spontaneous resolution occurs in 40-50% of patients"
                  },
                  {
                    "text": "Drainage (endoscopic, percutaneous, or surgical) if symptomatic, infected, or increasing in size"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Contain fluid, sometimes with blood and debris"
                  },
                  {
                    "text": "Usually unilocular cyst with thick, fibrous wall and shaggy, irregular inner surface"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "No epithelial lining"
                  },
                  {
                    "text": "Wall composed of granulation tissue and fibrosis"
                  },
                  {
                    "text": "Background pancreas will frequently show acute or chronic pancreatitis"
                  },
                  {
                    "text": "Thorough sampling of cyst wall is required to exclude cystic neoplasm"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Pseudocysts show elevated levels of amylase (> 250 IU/mL) and low levels of CEA (< 200 ng/mL)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Intraductal papillary-mucinous neoplasm and mucinous cystic neoplasm"
                  },
                  {
                    "text": "Cystic degeneration in adenocarcinoma or other pancreatic neoplasm"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Cystic lesion without epithelial lining arising in background of pancreatitis"
                  },
                  {
                    "text": "Thorough sampling of cyst wall is required before diagnosis of pseudocyst is rendered"
                  },
                  {
                    "text": "Pseudocysts lack epithelial lining"
                  },
                  {
                    "text": "Thorough sampling of cyst wall is required to exclude cystic neoplasm"
                  },
                  {
                    "text": "If clinical concern is for mucinous cyst, entire cyst may need to be submitted"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Cystic collection of pancreatic or peripancreatic fluid rich in pancreatic enzymes"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Risk Factors": [
                  {
                    "text": "Acute or chronic pancreatitis"
                  },
                  {
                    "text": "Can occur with biliary disease, surgery, or other trauma"
                  },
                  {
                    "text": "Rarely, may develop adjacent to pancreatic mass lesion, including adenocarcinoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Historically thought to represent 80% of all pancreatic cystsHigh-resolution imaging now suggests neoplastic pancreatic cysts more common than pseudocysts",
                    "sub_points": [
                      "High-resolution imaging now suggests neoplastic pancreatic cysts more common than pseudocysts"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Young to middle-aged adults"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance associated with alcohol-related pancreatitis"
                  },
                  {
                    "text": "Female predominance associated with gallstone-related pancreatitis"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Recurrent abdominal pain, early satiety, nausea, and vomiting"
                  },
                  {
                    "text": "Typically in patient with history of pancreatitis"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Spontaneous resolution occurs in 40-50% of patients"
                  },
                  {
                    "text": "Drainage (endoscopic, percutaneous, or surgical) if symptomatic, infected, or increasing in size"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Round, fluid-filled structure surrounded by thick, dense wall seen on CT"
                  },
                  {
                    "text": "Endoscopic ultrasound may be useful to confirm and distinguish from other pancreatic cysts"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually unilocular cyst with thick, fibrous wall and shaggy, irregular inner surface"
                  },
                  {
                    "text": "Contain fluid, sometimes with blood and debris"
                  },
                  {
                    "text": "Pseudocysts can be component of paraduodenal (groove) pancreatitis"
                  }
                ],
                "Size": [
                  {
                    "text": "Can measure > 20 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "No epithelial lining"
                  },
                  {
                    "text": "Wall composed of granulation tissue and fibrosis"
                  },
                  {
                    "text": "Hemosiderin, blood pigments, and debris frequently seen in lumen and wall"
                  },
                  {
                    "text": "Background pancreas will frequently show acute or chronic pancreatitis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Fluid Analysis": [
                  {
                    "text": "Cyst fluid contains elevated levels of amylase (> 250 IU/mL) and low levels of CEA (< 200 ng/mL)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Intraductal Papillary-Mucinous Neoplasm and Mucinous Cystic Neoplasm": [
                  {
                    "text": "Absence of epithelial lining and ovarian-type stroma is key to diagnosis of pseudocyst"
                  },
                  {
                    "text": "Both intraductal papillary-mucinous neoplasm and mucinous cystic neoplasm are lined by mucinous epithelium, at least focallyOvarian-type stroma supports diagnosis of mucinous cystic neoplasmExuberant fibroblastic tissue in wall of pseudocyst occasionally mimics ovarian-type stroma",
                    "sub_points": [
                      "Ovarian-type stroma supports diagnosis of mucinous cystic neoplasmExuberant fibroblastic tissue in wall of pseudocyst occasionally mimics ovarian-type stroma",
                      "Exuberant fibroblastic tissue in wall of pseudocyst occasionally mimics ovarian-type stroma"
                    ]
                  },
                  {
                    "text": "Elevated cyst fluid CEA (> 200 ng/mL) is strongly suggestive of mucinous neoplasm"
                  }
                ],
                "Other Cystic Tumors": [
                  {
                    "text": "Serous cystadenoma, solid pseudopapillary tumor, and cystic variant of pancreatic neuroendocrine tumorUnilocular serous cystadenomas may be largely denuded of neoplastic cells and mimic pseudocystSolid pseudopapillary tumors and pancreatic endocrine neoplasms show monotonous round neoplastic cells within cyst",
                    "sub_points": [
                      "Unilocular serous cystadenomas may be largely denuded of neoplastic cells and mimic pseudocyst",
                      "Solid pseudopapillary tumors and pancreatic endocrine neoplasms show monotonous round neoplastic cells within cyst"
                    ]
                  }
                ],
                "Pseudocyst Adjacent to Pancreatic Neoplasms": [
                  {
                    "text": "Pancreatic ductal adenocarcinomas can rarely show extensive cystic change"
                  },
                  {
                    "text": "Invasive carcinoma is generally recognized grossly adjacent to pseudocyst"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Cystic lesion in background of pancreatitis"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Pseudocysts lack epithelial liningThorough sampling of cyst wall is required to exclude cystic neoplasmIf clinical concern is for mucinous cyst, entire cyst may need to be submitted",
                    "sub_points": [
                      "Thorough sampling of cyst wall is required to exclude cystic neoplasmIf clinical concern is for mucinous cyst, entire cyst may need to be submitted",
                      "If clinical concern is for mucinous cyst, entire cyst may need to be submitted"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Lymphoepithelial Cyst of the Pancreas": {
            "name": "Lymphoepithelial Cyst of the Pancreas",
            "url": "https://app.pathprimer.com/document/620ebe63-eccd-4cb6-98b0-80582722bf5f/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Not associated with conditions related to lymphoepithelial cysts of salivary gland"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Nonneoplastic cystic lesion of the pancreas composed predominantly of squamous epithelial and lymphoid elements"
                  },
                  {
                    "text": "Rare, accounting for 0.5% of pancreatic cystic lesions"
                  },
                  {
                    "text": "Malignant transformation has not been described"
                  },
                  {
                    "text": "Resection is curative"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Multilocular or unilocular cystic lesions"
                  },
                  {
                    "text": "Smooth or finely granular lining with serous to soft, friable/caseous contents"
                  },
                  {
                    "text": "Cyst wall may be surrounded by band of tan tissue"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Squamous-lined cysts with dense band of lymphoid tissueUsually stratified squamous epithelium ± keratinizationCuboidal or transitional-like epithelium may be presentOther elements variably present, including sebaceous glands and mucinous cellsCyst wall contains distinct band of dense lymphoid tissue with scattered germinal centers",
                    "sub_points": [
                      "Usually stratified squamous epithelium ± keratinization",
                      "Cuboidal or transitional-like epithelium may be present",
                      "Other elements variably present, including sebaceous glands and mucinous cells",
                      "Cyst wall contains distinct band of dense lymphoid tissue with scattered germinal centers"
                    ]
                  },
                  {
                    "text": "Adjacent pancreas is often unremarkable"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Cystic entities lined by squamous epitheliumEpidermoid cyst in intrapancreatic spleen is surrounded by splenic tissueDermoid cyst has dermal appendages (including sebaceous glands) but should lack dense lymphoid tissueSquamoid cyst is small without associated lymphoid tissue",
                    "sub_points": [
                      "Epidermoid cyst in intrapancreatic spleen is surrounded by splenic tissue",
                      "Dermoid cyst has dermal appendages (including sebaceous glands) but should lack dense lymphoid tissue",
                      "Squamoid cyst is small without associated lymphoid tissue"
                    ]
                  },
                  {
                    "text": "Lymphangioma has endothelial lining and aggregates of lymphoid tissue rather than thick band of lymphoid tissueAggregates of lymphoid tissue rather than thick band of lymphoid tissue",
                    "sub_points": [
                      "Aggregates of lymphoid tissue rather than thick band of lymphoid tissue"
                    ]
                  },
                  {
                    "text": "Multilocular cyst with endothelial lining"
                  },
                  {
                    "text": "Pseudocyst lacks epithelial lining"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Lymphoepithelial cyst (LEC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nonneoplastic cyst with lymphoid and squamous epithelial components"
                  },
                  {
                    "text": "Not associated with conditions related to lymphoepithelial cysts of salivary gland, such as autoimmune disorders, HIV infection, or lymphoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, accounting for 0.5% of pancreatic cystic lesions"
                  }
                ],
                "Age": [
                  {
                    "text": "20-82 years (median: 55 years)"
                  }
                ],
                "Sex": [
                  {
                    "text": "M:F = 4:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Often asymptomatic and incidentally discovered"
                  },
                  {
                    "text": "Vague intermittent abdominal pain"
                  },
                  {
                    "text": "Nausea/vomiting/diarrhea"
                  },
                  {
                    "text": "Abdominal mass"
                  },
                  {
                    "text": "Weight loss"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Pitfall: LECs can have elevated cyst fluid CEA levels"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Many can be safely treated conservatively"
                  },
                  {
                    "text": "Resection limited to symptomatic cases or if diagnosis is uncertain"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Resection is curative"
                  },
                  {
                    "text": "Malignant transformation has not been described"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Most LECs are found incidentally for unrelated reasons"
                  },
                  {
                    "text": "Imaging studies cannot consistently separate LECs from neoplastic mucinous cystsLECs can appear cystic or solid",
                    "sub_points": [
                      "LECs can appear cystic or solid"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Can occur anywhere in pancreas"
                  },
                  {
                    "text": "Often exophytic"
                  },
                  {
                    "text": "Can be multilocular or unilocular"
                  },
                  {
                    "text": "Cyst contents often cheesy/caseous; can be serous"
                  },
                  {
                    "text": "Smooth or finely granular cyst lining"
                  },
                  {
                    "text": "If lymphoid tissue is prominent, may see band of soft, tan tissue surrounding cyst wall"
                  }
                ],
                "Size": [
                  {
                    "text": "0.5-17 cm (median: 4.5 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Cyst liningUsually stratified squamous epithelium ± keratinizationCharacteristic squamous cells &/or keratinous material are not always presentCuboidal or transitional-like epithelium may be presentSebaceous and mucinous goblet cells can be presentInflammation, reactive epithelial changes variably present",
                    "sub_points": [
                      "Usually stratified squamous epithelium ± keratinizationCharacteristic squamous cells &/or keratinous material are not always present",
                      "Characteristic squamous cells &/or keratinous material are not always present",
                      "Cuboidal or transitional-like epithelium may be present",
                      "Sebaceous and mucinous goblet cells can be present",
                      "Inflammation, reactive epithelial changes variably present"
                    ]
                  },
                  {
                    "text": "Thin cyst wall &/or trabeculae1-3 mm in thicknessDense, distinct band of lymphoid tissue with scattered germinal centersIntervening germinal center formation by B cells",
                    "sub_points": [
                      "1-3 mm in thickness",
                      "Dense, distinct band of lymphoid tissue with scattered germinal centersIntervening germinal center formation by B cells",
                      "Intervening germinal center formation by B cells"
                    ]
                  },
                  {
                    "text": "Variably present featuresEpithelioid granulomasFoamy histiocytesFat necrosis, cholesterol cleftsStromal hyalinization",
                    "sub_points": [
                      "Epithelioid granulomas",
                      "Foamy histiocytes",
                      "Fat necrosis, cholesterol clefts",
                      "Stromal hyalinization"
                    ]
                  },
                  {
                    "text": "Adjacent pancreas is often unremarkable"
                  },
                  {
                    "text": "Some appear to have arisen in peripancreatic lymph node"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Epidermoid Cyst of Intrapancreatic Accessory Spleen or Heterotopic Spleen": [
                  {
                    "text": "Occurs exclusively in tail of pancreas"
                  },
                  {
                    "text": "Similarly lined by stratified squamous epithelium"
                  },
                  {
                    "text": "Surrounded by normal-appearing splenic tissueVarying amounts of red and white pulp, latter may be sparse",
                    "sub_points": [
                      "Varying amounts of red and white pulp, latter may be sparse"
                    ]
                  }
                ],
                "Dermoid Cyst": [
                  {
                    "text": "Difficult to distinguish if composed predominantly of epidermal elementsPresence of dermal appendages or hair shaftsSebaceous glands or hair follicles",
                    "sub_points": [
                      "Presence of dermal appendages or hair shaftsSebaceous glands or hair follicles",
                      "Sebaceous glands or hair follicles"
                    ]
                  }
                ],
                "Squamoid Cyst of Pancreatic Duct": [
                  {
                    "text": "Relatively small, unilocular cyst lined by squamous or transitional epithelium without keratinizationOften cystically dilated duct surrounded by pancreatic acinar tissue",
                    "sub_points": [
                      "Often cystically dilated duct surrounded by pancreatic acinar tissue"
                    ]
                  },
                  {
                    "text": "Lumen may contain acidophilic secretions that form concretions"
                  }
                ],
                "Lymphangioma": [
                  {
                    "text": "Multilocular cyst with endothelial lining"
                  },
                  {
                    "text": "Scattered aggregates of lymphoid tissue rather than thick band of lymphoid tissue"
                  }
                ],
                "Pseudocyst": [
                  {
                    "text": "No epithelial liningSample entire cyst wall before rendering this diagnosis",
                    "sub_points": [
                      "Sample entire cyst wall before rendering this diagnosis"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Diabetes Mellitus": {
            "name": "Diabetes Mellitus",
            "url": "https://app.pathprimer.com/document/412bdd15-cac1-43f2-b7db-0888b59c4703/lesson/5dae41dd-207a-4fb1-bd49-567dfc15b9a4",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Heterogeneous group of metabolic diseases characterized by hyperglycemia, generally classified as types 1 and 2Type 1: Absolute insulin deficiencyType 2: Insulin resistance and inadequate secretion",
                    "sub_points": [
                      "Type 1: Absolute insulin deficiency",
                      "Type 2: Insulin resistance and inadequate secretion"
                    ]
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Unknown and multifactorialPossible autoimmune causesSome genetic causesDiseases of exocrine pancreas",
                    "sub_points": [
                      "Possible autoimmune causes",
                      "Some genetic causes",
                      "Diseases of exocrine pancreas"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Laboratory testsElevated random plasma and fasting glucose, hemoglobin A1c",
                    "sub_points": [
                      "Elevated random plasma and fasting glucose, hemoglobin A1c"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Decreased size and weight (type 1 > type 2)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Type 1Variation in islet size and shape with irregularly shaped isletsReduced or absent β cellsVariably present islet inflammationAmyloidosis almost never seen in type 1 diabetes",
                    "sub_points": [
                      "Variation in islet size and shape with irregularly shaped islets",
                      "Reduced or absent β cells",
                      "Variably present islet inflammation",
                      "Amyloidosis almost never seen in type 1 diabetes"
                    ]
                  },
                  {
                    "text": "Type 2Islet amyloidosisReduction in both α and β cellsIslets reduced in number but unchanged in size",
                    "sub_points": [
                      "Islet amyloidosis",
                      "Reduction in both α and β cells",
                      "Islets reduced in number but unchanged in size"
                    ]
                  },
                  {
                    "text": "Both typesInterlobular and interacinar fibrosisExocrine atrophy",
                    "sub_points": [
                      "Interlobular and interacinar fibrosis",
                      "Exocrine atrophy"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Normal aging may also result in decreased size and weight of pancreas, islet amyloidosis"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Diabetes mellitus (DM)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Heterogeneous group of metabolic diseases characterized by hyperglycemiaResult of defects in insulin secretion, insulin activity, or both",
                    "sub_points": [
                      "Result of defects in insulin secretion, insulin activity, or both"
                    ]
                  },
                  {
                    "text": "General classificationType 1: Absolute insulin deficiencyType 2: Insulin resistance and inadequate secretion resulting in relative insulin deficiency",
                    "sub_points": [
                      "Type 1: Absolute insulin deficiency",
                      "Type 2: Insulin resistance and inadequate secretion resulting in relative insulin deficiency"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown and Multifactorial": [
                  {
                    "text": "Possible autoimmune causes"
                  },
                  {
                    "text": "Some genetic causes (defects of B-cell function or insulin action)"
                  },
                  {
                    "text": "Diseases of exocrine pancreasPancreatitisTrauma/surgeryCystic fibrosis",
                    "sub_points": [
                      "Pancreatitis",
                      "Trauma/surgery",
                      "Cystic fibrosis"
                    ]
                  },
                  {
                    "text": "Nonpancreatic endocrine diseases"
                  },
                  {
                    "text": "Drug- or chemical-related causes"
                  },
                  {
                    "text": "Infections"
                  },
                  {
                    "text": "Gestational diabetes"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "Polyuria and polydipsia"
                  },
                  {
                    "text": "Unexplained weight loss"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated random plasma glucose (> 200 mg/dL)"
                  },
                  {
                    "text": "Elevated fasting plasma glucose (> 126 mg/dL)"
                  },
                  {
                    "text": "Abnormal glucose tolerance test"
                  },
                  {
                    "text": "Elevated hemoglobin A1c"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Diet modification and weight reduction"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Exogenous insulin"
                  },
                  {
                    "text": "Oral hypoglycemics"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Chronic, progressive disease with multisystemic complications"
                  }
                ]
              },
              "MACROSCOPIC": {
                "Type 1 Diabetes": [
                  {
                    "text": "Early in disease courseNormal size, weight, consistency of pancreas",
                    "sub_points": [
                      "Normal size, weight, consistency of pancreas"
                    ]
                  },
                  {
                    "text": "Later in disease courseDecrease in size and weightMay decrease by as much as 1/2 of normalFirm consistency due to fibrosisMore extreme loss of size than seen in type 2 DM",
                    "sub_points": [
                      "Decrease in size and weightMay decrease by as much as 1/2 of normal",
                      "May decrease by as much as 1/2 of normal",
                      "Firm consistency due to fibrosis",
                      "More extreme loss of size than seen in type 2 DM"
                    ]
                  }
                ],
                "Type 2 Diabetes": [
                  {
                    "text": "Reduced size and weight of pancreasSometimes due to fatty infiltration (lipomatosis)",
                    "sub_points": [
                      "Sometimes due to fatty infiltration (lipomatosis)"
                    ]
                  },
                  {
                    "text": "Irregular, serrated border"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Type 1Very variable depending on duration of diseaseEarly in disease course (6 months to 1 year)Variation in islet size and shape with irregularly shaped isletsReduced β cells by immunohistochemistryLymphocytic inflammation of islets; may be patchy, not always presentLater in disease course (1 year and longer)Interlobular and interacinar fibrosis with exocrine atrophyComplete or near absence of β cellsVariably present diabetic angiopathyIslet amyloidosis is almost never seen in type 1 diabetes",
                    "sub_points": [
                      "Very variable depending on duration of disease",
                      "Early in disease course (6 months to 1 year)Variation in islet size and shape with irregularly shaped isletsReduced β cells by immunohistochemistryLymphocytic inflammation of islets; may be patchy, not always present",
                      "Variation in islet size and shape with irregularly shaped islets",
                      "Reduced β cells by immunohistochemistry",
                      "Lymphocytic inflammation of islets; may be patchy, not always present",
                      "Later in disease course (1 year and longer)Interlobular and interacinar fibrosis with exocrine atrophyComplete or near absence of β cellsVariably present diabetic angiopathyIslet amyloidosis is almost never seen in type 1 diabetes",
                      "Interlobular and interacinar fibrosis with exocrine atrophy",
                      "Complete or near absence of β cells",
                      "Variably present diabetic angiopathy",
                      "Islet amyloidosis is almost never seen in type 1 diabetes"
                    ]
                  },
                  {
                    "text": "Type 2Reduced acinar componentPerilobular and intraacinar fibrosisReduction in number and density of isletsUnchanged islet sizeReduction in both β and α cells by immunohistochemistryAmyloidosis of isletsIncreases with length of disease duration, severity of disease, and treatment with insulinForms cords and nodules in perisinusoidal spacesRepresents concentrated form of islet amyloid polypeptide, which appears to be result of, rather than cause of, DM",
                    "sub_points": [
                      "Reduced acinar component",
                      "Perilobular and intraacinar fibrosis",
                      "Reduction in number and density of isletsUnchanged islet size",
                      "Unchanged islet size",
                      "Reduction in both β and α cells by immunohistochemistry",
                      "Amyloidosis of isletsIncreases with length of disease duration, severity of disease, and treatment with insulinForms cords and nodules in perisinusoidal spacesRepresents concentrated form of islet amyloid polypeptide, which appears to be result of, rather than cause of, DM",
                      "Increases with length of disease duration, severity of disease, and treatment with insulin",
                      "Forms cords and nodules in perisinusoidal spaces",
                      "Represents concentrated form of islet amyloid polypeptide, which appears to be result of, rather than cause of, DM"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Normal Aging": [
                  {
                    "text": "Aging also causes decreased size and weight of pancreas"
                  },
                  {
                    "text": "Islet amyloidosis present in 4-23% of elderly persons without diabetesMay represent prediabetesCorrelates with serum glucose tests, clinical data",
                    "sub_points": [
                      "May represent prediabetes",
                      "Correlates with serum glucose tests, clinical data"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Type 1 diabetes (variable morphologic findings depending on duration of disease): Fibrosis, islet number and density reduced, loss of β cells, usually no amyloid"
                  },
                  {
                    "text": "Type 2 diabetes: Fibrosis, reduction of islet mass, but no size reduction of islets (look similar to nondiabetics), amyloidosis of islets that contain insulin-producing β cells, reduced β and α cells"
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      },
      "Pancreas and Ampulla: Tumors": {
        "name": "Pancreas and Ampulla: Tumors",
        "url": "https://app.pathprimer.com/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
        "topics": {
          "Pancreatic Intraepithelial Neoplasia": {
            "name": "Pancreatic Intraepithelial Neoplasia",
            "url": "https://app.pathprimer.com/document/8bf56792-d896-47a0-91ee-16fb0fb525f7/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Noninvasive pancreatic intraductal epithelial proliferation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "High-grade pancreatic intraepithelial neoplasia (PanIN) indicates elevated risk for pancreatic adenocarcinoma"
                  },
                  {
                    "text": "High-grade PanIN at surgical margin may warrant further resection, but some reports have suggested no adverse consequence of PanIN-3 at resection margin"
                  },
                  {
                    "text": "Low-grade PanIN: Commonly found in resected pancreas; significance unclear"
                  },
                  {
                    "text": "High-grade PanIN occurs concurrently with ductal adenocarcinoma, rarely (< 5%) encountered in specimens resected for benign lesions or chronic pancreatitis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Involved ducts are typically < 5 mm in diameter"
                  },
                  {
                    "text": "Low-grade PanINFlat or short papillary mucinous epithelium with mild to moderate nuclear atypia and no architectural complexity",
                    "sub_points": [
                      "Flat or short papillary mucinous epithelium with mild to moderate nuclear atypia and no architectural complexity"
                    ]
                  },
                  {
                    "text": "High-grade PanINPapillary or cribriforming mucinous epithelium with marked nuclear atypia, loss of polarity, macronucleoli, and frequent mitoses",
                    "sub_points": [
                      "Papillary or cribriforming mucinous epithelium with marked nuclear atypia, loss of polarity, macronucleoli, and frequent mitoses"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Intraductal papillary mucinous neoplasm"
                  },
                  {
                    "text": "Reactive ductal epithelial changes"
                  },
                  {
                    "text": "Intraductal spread of invasive carcinoma (cancerization of ducts) for high-grade PanIN"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "High-grade PanIN should be noted in pathology reports, especially in absence of invasive carcinoma"
                  },
                  {
                    "text": "Low-grade PanIN does not need to be reported, does not affect surgical management"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pancreatic intraepithelial neoplasia (PanIN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Dysplasia, carcinoma in situ"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Noninvasive pancreatic intraductal epithelial proliferation, likely precursor of pancreatic ductal adenocarcinoma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Molecular Progression": [
                  {
                    "text": "Early: Telomerase shortening,KRAS2activation"
                  },
                  {
                    "text": "Intermediate: Inactivation of p16/CDKN2A"
                  },
                  {
                    "text": "Late: Inactivation ofTP53,DPC4/SMAD4"
                  },
                  {
                    "text": "p16 inactivation is seen in ~ 30-50% low-grade, 70% high-grade, 95% ductal adenocarcinomas"
                  },
                  {
                    "text": "KRASmutation is seen in ~ 40-80% low-grade, > 80% high-grade, > 90% ductal adenocarcinomas"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Natural History": [
                  {
                    "text": "Low-grade PanIN: Commonly found in resected pancreas; significance unclear"
                  },
                  {
                    "text": "High-grade PanIN: Associated with significant risk of progression to pancreatic ductal adenocarcinoma"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Management of isolated high-grade PanIN not established; surveillance of these patients is advocated"
                  },
                  {
                    "text": "High-grade PanIN at surgical margin of resected malignancy (i.e., ductal adenocarcinoma) may warrant further resection"
                  }
                ],
                "Incidence": [
                  {
                    "text": "Low-grade PanIN sharply increases after age 40"
                  },
                  {
                    "text": "High-grade PanIN occurs concurrently with ductal adenocarcinoma, rarely (< 5%) encountered in specimens resected for benign lesions or chronic pancreatitis"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "PanIN lesions are typically small and thus radiologically undetectable"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Not visible grossly"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Involved ducts are typically < 5 mm in diameterBoth main pancreatic duct and branch ducts may be involvedOften multifocal",
                    "sub_points": [
                      "Both main pancreatic duct and branch ducts may be involved",
                      "Often multifocal"
                    ]
                  },
                  {
                    "text": "Flat or short papilla, occasionally complex architectural patterns"
                  },
                  {
                    "text": "Often abundant supranuclear mucin without intraluminal mucin"
                  }
                ],
                "Grading PanIN": [
                  {
                    "text": "Low gradeIncludes prior PanIN-1 and PanIN-2Mild to moderate nuclear atypiaFindings range from columnar epithelium with small, bland, basally oriented nuclei and abundant supranuclear mucin to slightly enlarged nuclei showing nuclear crowding, hyperchromasia, and less mucin without architectural complexityNo atypical mitosesOften flat but can contain short papilla",
                    "sub_points": [
                      "Includes prior PanIN-1 and PanIN-2",
                      "Mild to moderate nuclear atypiaFindings range from columnar epithelium with small, bland, basally oriented nuclei and abundant supranuclear mucin to slightly enlarged nuclei showing nuclear crowding, hyperchromasia, and less mucin without architectural complexityNo atypical mitoses",
                      "Findings range from columnar epithelium with small, bland, basally oriented nuclei and abundant supranuclear mucin to slightly enlarged nuclei showing nuclear crowding, hyperchromasia, and less mucin without architectural complexity",
                      "No atypical mitoses",
                      "Often flat but can contain short papilla"
                    ]
                  },
                  {
                    "text": "High gradeIncludes prior PanIN-3 and carcinoma in situMarked nuclear atypia, loss of polarity, macronucleoli, frequent mitosesUsually papillary and micropapillary with cribriforming architecture and luminal necrosisResembles invasive carcinoma but it is confined to basement membrane (hence prior term carcinoma in situ)",
                    "sub_points": [
                      "Includes prior PanIN-3 and carcinoma in situ",
                      "Marked nuclear atypia, loss of polarity, macronucleoli, frequent mitoses",
                      "Usually papillary and micropapillary with cribriforming architecture and luminal necrosis",
                      "Resembles invasive carcinoma but it is confined to basement membrane (hence prior term carcinoma in situ)"
                    ]
                  },
                  {
                    "text": "Histologic variantsIntestinal type: Goblet cells and nuclear pseudostratificationFoamy cell type: Cells with foamy cytoplasmOncocytic type: Abundant granular cytoplasm with prominent nucleoli",
                    "sub_points": [
                      "Intestinal type: Goblet cells and nuclear pseudostratification",
                      "Foamy cell type: Cells with foamy cytoplasm",
                      "Oncocytic type: Abundant granular cytoplasm with prominent nucleoli"
                    ]
                  },
                  {
                    "text": "PanIN may be surrounded by parenchymal atrophy (lobulocentric atrophy)Multifocal lobulocentric atrophy common in patients with family history of pancreatic cancer",
                    "sub_points": [
                      "Multifocal lobulocentric atrophy common in patients with family history of pancreatic cancer"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Intraductal Papillary Mucinous Neoplasm": [
                  {
                    "text": "Usually > 1 cm, visible lesion on imaging favors intraductal papillary mucinous neoplasm (IPMN)"
                  },
                  {
                    "text": "Papillae are usually taller and more complex"
                  },
                  {
                    "text": "\"Incipient IPMN\" proposed for lesions 0.5-1.0 cm with intestinal/oncocytic features orGNASmutation"
                  }
                ],
                "Reactive Ductal Epithelial Changes": [
                  {
                    "text": "Associated with inflammation"
                  },
                  {
                    "text": "Usually lack significant architectural atypia"
                  }
                ],
                "Intraductal Spread of Invasive Carcinoma (Cancerization of Ducts)": [
                  {
                    "text": "Spread of invasive carcinoma along preexisting ducts"
                  },
                  {
                    "text": "Key differential diagnosis for high-grade PanIN"
                  },
                  {
                    "text": "Abrupt transition from normal to markedly atypical epithelium"
                  },
                  {
                    "text": "Continuity of carcinoma with involved duct"
                  },
                  {
                    "text": "When an adenocarcinoma is present in same specimen, cancerization of pancreatic ducts is more common than high-grade PanIN"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "High-grade PanIN should be noted in pathology reports, especially in absence of invasive carcinoma"
                  },
                  {
                    "text": "High-grade PanIN should be reported at frozen section"
                  },
                  {
                    "text": "Some studies show no adverse consequence of high-grade PanIN at resection margin"
                  },
                  {
                    "text": "Low-grade PanIN does not need to be reported, as it does not affect surgical management"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ductal Adenocarcinoma, Including Histologic Subtypes": {
            "name": "Ductal Adenocarcinoma, Including Histologic Subtypes",
            "url": "https://app.pathprimer.com/document/23fa5023-3e22-4215-bfd8-52eee6974fee/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm of pancreatic ductal origin"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Several hereditary, medical, and environmental/occupational risk factors"
                  },
                  {
                    "text": "Key driver mutations:KRAS,TP53,SMAD4/DPC4, andCDKN2A"
                  },
                  {
                    "text": "At least 4 distinct molecular subtypes have been identified using genomic analysis"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Nonspecific symptoms often means delay in diagnosis"
                  },
                  {
                    "text": "Treatment of choice is resection; however, most cases are unresectable at presentation"
                  },
                  {
                    "text": "Chemotherapy is often given before resection, after resection, or both"
                  },
                  {
                    "text": "Dismal prognosis: 5-year survival < 5%"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Majority arise in head of pancreas"
                  },
                  {
                    "text": "Poorly defined, firm, white mass with intense fibrotic reaction"
                  },
                  {
                    "text": "Fibrosis may make carcinoma difficult to distinguish from background pancreatitis"
                  },
                  {
                    "text": "May cause stenosis of common bile duct"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Conventional pancreatic ductal adenocarcinoma has wide differentiation spectrum: Very well to poorly differentiatedTypically composed of small, haphazardly infiltrating, mucin-producing glands embedded in dense desmoplastic stroma",
                    "sub_points": [
                      "Typically composed of small, haphazardly infiltrating, mucin-producing glands embedded in dense desmoplastic stroma"
                    ]
                  },
                  {
                    "text": "Perineural invasion, angiolymphatic invasion, and background chronic pancreatitis are very common"
                  },
                  {
                    "text": "Tumor cells may grow along basement membrane of pancreatic and bile ducts (cancerization)"
                  },
                  {
                    "text": "Several histologic variants/patterns exist"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pancreatic ductal adenocarcinoma (PDAC)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Pancreatic adenocarcinoma"
                  },
                  {
                    "text": "Duct cell adenocarcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasm of pancreatic ductal origin90% of all pancreatic neoplasms",
                    "sub_points": [
                      "90% of all pancreatic neoplasms"
                    ]
                  },
                  {
                    "text": "Predominantly glandular differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Hereditary Risk Factors": [
                  {
                    "text": "Family history of pancreatic cancer"
                  },
                  {
                    "text": "Hereditary pancreatitis"
                  },
                  {
                    "text": "Peutz-Jeghers syndrome"
                  },
                  {
                    "text": "Familial atypical multiple mole melanoma syndrome"
                  },
                  {
                    "text": "Hereditary breast and ovarian cancer syndrome"
                  },
                  {
                    "text": "Hereditary nonpolyposis colorectal cancer syndrome (Lynch syndrome)"
                  }
                ],
                "Medical Risk Factors": [
                  {
                    "text": "Chronic pancreatitis"
                  },
                  {
                    "text": "Diabetes mellitus"
                  },
                  {
                    "text": "Previous cholecystectomy or partial gastrectomy"
                  },
                  {
                    "text": "Obesity"
                  }
                ],
                "Environmental and Occupational Risk Factors": [
                  {
                    "text": "Cigarette smoking approximately doubles risk"
                  },
                  {
                    "text": "Diet high in meat, saturated fats, nitrates"
                  },
                  {
                    "text": "Chemicals (solvents, DDT, gasoline)"
                  },
                  {
                    "text": "Occupational (coal gas workers, metal working, hide tanning, dry cleaning)"
                  },
                  {
                    "text": "Heavy alcohol consumption"
                  }
                ],
                "Precursor Lesions": [
                  {
                    "text": "Pancreatic intraepithelial neoplasia"
                  }
                ],
                "Molecular Carcinogenesis/Classification": [
                  {
                    "text": "Driver gene alterations includeKRASactivating mutation and inactivating mutations ofTP53,SMAD4, andCDKN2A",
                    "sub_points": [
                      "KRASactivating mutation and inactivating mutations ofTP53,SMAD4, andCDKN2A"
                    ]
                  },
                  {
                    "text": "At least 4 distinct molecular subtypes have been identified using genomic analysisAssociated with prognosis and therapeutic responseBasal-like and classic subtypes are described in most studiesExocrine-like and immunogenic subtypes may reflect acinar cell contamination or inflammatory infiltrateSubtyping PDAC needs further validation but holds promise for defining personalized treatment strategies",
                    "sub_points": [
                      "Associated with prognosis and therapeutic response",
                      "Basal-like and classic subtypes are described in most studies",
                      "Exocrine-like and immunogenic subtypes may reflect acinar cell contamination or inflammatory infiltrate",
                      "Subtyping PDAC needs further validation but holds promise for defining personalized treatment strategies"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Age": [
                  {
                    "text": "Majority of cases occur between 60 and 80 yearsRare before 40 years of age",
                    "sub_points": [
                      "Rare before 40 years of age"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Slight male predominance"
                  }
                ],
                "Ethnicity": [
                  {
                    "text": "In USA, higher rates in Black people than in White people"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific symptoms may delay diagnosisEpigastric pain, weight lossBiliary obstruction, painless jaundice",
                    "sub_points": [
                      "Epigastric pain, weight loss",
                      "Biliary obstruction, painless jaundice"
                    ]
                  },
                  {
                    "text": "Disease associationsTrousseau syndrome (migratory thrombophlebitis)Diabetes mellitusSister Mary Joseph sign (palpable periumbilical nodules)Courvoisier sign (distended, palpable gallbladder)",
                    "sub_points": [
                      "Trousseau syndrome (migratory thrombophlebitis)",
                      "Diabetes mellitus",
                      "Sister Mary Joseph sign (palpable periumbilical nodules)",
                      "Courvoisier sign (distended, palpable gallbladder)"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "ResectionOnly 10-20% of cases resectable at diagnosis",
                    "sub_points": [
                      "Only 10-20% of cases resectable at diagnosis"
                    ]
                  },
                  {
                    "text": "Chemotherapy before resection, after resection, or bothCommon regimens: FOLFIRINOX (folate, 5-fluorouracil, irinotecan, oxaliplatin), gemcitabine/nab-paclitaxelNeoadjuvant therapy associated with higher survival",
                    "sub_points": [
                      "Common regimens: FOLFIRINOX (folate, 5-fluorouracil, irinotecan, oxaliplatin), gemcitabine/nab-paclitaxel",
                      "Neoadjuvant therapy associated with higher survival"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dismal; 5-year survival < 5%"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "CT scan commonly used for diagnosis and staging"
                  },
                  {
                    "text": "MR angiography can help to determine resectability"
                  },
                  {
                    "text": "Endoscopic US with biopsy reliable for diagnosis and staging"
                  },
                  {
                    "text": "ERCP/MRCP helps visualize ductal system"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Majority arise in head of pancreasMinority in body/tail, or diffusely involve gland",
                    "sub_points": [
                      "Minority in body/tail, or diffusely involve gland"
                    ]
                  },
                  {
                    "text": "Solitary (majority) or multifocal"
                  },
                  {
                    "text": "Firm, solid, poorly defined, white-yellow massMay have cystic degenerationOften very fibrotic and hence dense, firm white appearanceFibrosis may make carcinoma difficult to distinguish from background pancreatitis",
                    "sub_points": [
                      "May have cystic degeneration",
                      "Often very fibrotic and hence dense, firm white appearance",
                      "Fibrosis may make carcinoma difficult to distinguish from background pancreatitis"
                    ]
                  },
                  {
                    "text": "Pancreatic duct may be dilated"
                  },
                  {
                    "text": "May cause stenosis of common bile duct"
                  },
                  {
                    "text": "Tumors often grossly extend beyond pancreas"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Conventional PDAC has wide differentiation spectrum: Very well to poorly differentiatedGlands grow in haphazard fashion and are very infiltrative",
                    "sub_points": [
                      "Glands grow in haphazard fashion and are very infiltrative"
                    ]
                  },
                  {
                    "text": "Usually well to moderately differentiated with gland formationMucin-producing glands are often haphazardly distributed throughout desmoplastic stromaNuclei typically show at least mild enlargement, crowding, and some overlapping with mild pleomorphismNuclear pleomorphism can be pronounced, and large nucleoli may be present in poorly differentiated tumorsIrregular chromatin distributionIrregular nuclear contour",
                    "sub_points": [
                      "Mucin-producing glands are often haphazardly distributed throughout desmoplastic stroma",
                      "Nuclei typically show at least mild enlargement, crowding, and some overlapping with mild pleomorphism",
                      "Nuclear pleomorphism can be pronounced, and large nucleoli may be present in poorly differentiated tumors",
                      "Irregular chromatin distribution",
                      "Irregular nuclear contour"
                    ]
                  },
                  {
                    "text": "Dense desmoplastic stromaFibroblasts and other inflammatory cellsTumor cells may comprise small component compared to desmoplastic reaction",
                    "sub_points": [
                      "Fibroblasts and other inflammatory cells",
                      "Tumor cells may comprise small component compared to desmoplastic reaction"
                    ]
                  },
                  {
                    "text": "Mucin production"
                  },
                  {
                    "text": "Perineural and angiolymphatic invasion common"
                  },
                  {
                    "text": "Tumor may infiltrate blood vessels and cause thrombi"
                  },
                  {
                    "text": "Tumor cells may grow along basement membrane of pancreatic and bile ducts (cancerization)"
                  },
                  {
                    "text": "Associated pancreatitis is commonParenchymal atrophy, fibrosis, islet cell clustering (pseudohyperplasia)",
                    "sub_points": [
                      "Parenchymal atrophy, fibrosis, islet cell clustering (pseudohyperplasia)"
                    ]
                  }
                ],
                "Histologic Subtypes (WHO, 5th Edition)": [
                  {
                    "text": "Colloid carcinoma≥ 80% of neoplastic epithelium is suspended in extracellular mucin poolsAlmost always arises in association with intestinal-type intraductal papillary mucinous neoplasmPositive for CDX2 and MUC2",
                    "sub_points": [
                      "≥ 80% of neoplastic epithelium is suspended in extracellular mucin pools",
                      "Almost always arises in association with intestinal-type intraductal papillary mucinous neoplasm",
                      "Positive for CDX2 and MUC2"
                    ]
                  },
                  {
                    "text": "Poorly cohesive (signet-ring cell) carcinoma≥ 80% of neoplasm consists of individual, poorly cohesive cells, often with intracytoplasmic mucin vacuoles that displace nucleus to peripheryExtracellular mucin is often presentPancreatic involvement by gastric primary needs to be excluded",
                    "sub_points": [
                      "≥ 80% of neoplasm consists of individual, poorly cohesive cells, often with intracytoplasmic mucin vacuoles that displace nucleus to periphery",
                      "Extracellular mucin is often present",
                      "Pancreatic involvement by gastric primary needs to be excluded"
                    ]
                  },
                  {
                    "text": "Adenosquamous carcinomaGlandular and squamous differentiation",
                    "sub_points": [
                      "Glandular and squamous differentiation"
                    ]
                  },
                  {
                    "text": "Medullary carcinomaSyncytial growth with pushing rather than infiltrating bordersInflammatory infiltrate rather than desmoplastic stromaAssociated with microsatellite instability, Lynch syndrome, Epstein-Barr virus, wild-typeKRASgeneBetter prognosis than conventional ductal adenocarcinoma",
                    "sub_points": [
                      "Syncytial growth with pushing rather than infiltrating borders",
                      "Inflammatory infiltrate rather than desmoplastic stroma",
                      "Associated with microsatellite instability, Lynch syndrome, Epstein-Barr virus, wild-typeKRASgene",
                      "Better prognosis than conventional ductal adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Hepatoid carcinoma≥ 50% of neoplasm displays histologic and IHC evidence of hepatocellular differentiationHepatocellular markers positive: Arginase-1, Hep-Par1Can occur in association with ductal adenocarcinoma, acinar cell carcinoma, or neuroendocrine carcinomaMetastasis from liver primary should be excluded",
                    "sub_points": [
                      "≥ 50% of neoplasm displays histologic and IHC evidence of hepatocellular differentiation",
                      "Hepatocellular markers positive: Arginase-1, Hep-Par1",
                      "Can occur in association with ductal adenocarcinoma, acinar cell carcinoma, or neuroendocrine carcinoma",
                      "Metastasis from liver primary should be excluded"
                    ]
                  },
                  {
                    "text": "Undifferentiated2 distinct entities: Undifferentiated carcinoma (absence of osteoclast-like giant cells) and undifferentiated carcinoma with osteoclast-like giant cells",
                    "sub_points": [
                      "2 distinct entities: Undifferentiated carcinoma (absence of osteoclast-like giant cells) and undifferentiated carcinoma with osteoclast-like giant cells"
                    ]
                  },
                  {
                    "text": "Carcinomas with mixed differentiation: By definition, each component should comprise at least 30% of tumor\"Collision tumors\" have 2 topographically separate neoplasms and are not considered \"mixed\"Mixed acinar-ductal carcinomaMixed ductal-neuroendocrine carcinomaMixed acinar-ductal-neuroendocrine carcinoma",
                    "sub_points": [
                      "\"Collision tumors\" have 2 topographically separate neoplasms and are not considered \"mixed\"",
                      "Mixed acinar-ductal carcinoma",
                      "Mixed ductal-neuroendocrine carcinoma",
                      "Mixed acinar-ductal-neuroendocrine carcinoma"
                    ]
                  }
                ],
                "Additional Histologic Patterns": [
                  {
                    "text": "Foamy glandDeceptively bland, benign-appearing cells with microvesicular cytoplasmApical condensation of cytoplasm creates distinct pink brush border-like zone at luminal surfaceBasally oriented nuclei are often small, hyperchromatic, and wrinkled",
                    "sub_points": [
                      "Deceptively bland, benign-appearing cells with microvesicular cytoplasm",
                      "Apical condensation of cytoplasm creates distinct pink brush border-like zone at luminal surface",
                      "Basally oriented nuclei are often small, hyperchromatic, and wrinkled"
                    ]
                  },
                  {
                    "text": "Large ductLarge, dilated, invasive glands, often with simple architecture\"Swiss cheese\" cut surface grosslyCan mimic benign retention cysts or benign dilated pancreatic ducts",
                    "sub_points": [
                      "Large, dilated, invasive glands, often with simple architecture",
                      "\"Swiss cheese\" cut surface grossly",
                      "Can mimic benign retention cysts or benign dilated pancreatic ducts"
                    ]
                  },
                  {
                    "text": "VacuolatedCribriform nests of neoplastic signet-ring-shaped cells",
                    "sub_points": [
                      "Cribriform nests of neoplastic signet-ring-shaped cells"
                    ]
                  },
                  {
                    "text": "Clear cellClear cytoplasm, resembles renal cell carcinoma",
                    "sub_points": [
                      "Clear cytoplasm, resembles renal cell carcinoma"
                    ]
                  },
                  {
                    "text": "Micropapillary≥ 50% of neoplasm consists of small solid nests of cells suspended within lacunaeMore commonly focal finding in PDAC",
                    "sub_points": [
                      "≥ 50% of neoplasm consists of small solid nests of cells suspended within lacunae",
                      "More commonly focal finding in PDAC"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive for cytokeratins 7, 8, 18, 19 and apomucins MUC1, MUC4, MUC5AC, MUC6"
                  },
                  {
                    "text": "Positive for CEA, CA19-9, CA125, B72.3, claudin-4, fascin, mesothelin, S100 protein"
                  },
                  {
                    "text": "Loss of nuclear expression of p16 (75%) and DPC4/SMAD4 (55%)"
                  },
                  {
                    "text": "Overexpression of p53 (50-75%)"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Chronic Pancreatitis": [
                  {
                    "text": "Often involves younger patients (< 40 years)"
                  },
                  {
                    "text": "Diffuse scarring of gland without discrete mass"
                  },
                  {
                    "text": "Relatively preserved lobular architecture"
                  }
                ],
                "Normal/Reactive Duct Changes": [
                  {
                    "text": "Very well-differentiated tumors mimic normal or reactive ducts"
                  },
                  {
                    "text": "These features favor PDACSmall glands adjacent to muscular arteries without intervening stroma or aciniIncomplete gland formationDisorganized, haphazard growth of neoplastic glands; loss of lobular architecture4x variation in nuclear size within same gland",
                    "sub_points": [
                      "Small glands adjacent to muscular arteries without intervening stroma or acini",
                      "Incomplete gland formation",
                      "Disorganized, haphazard growth of neoplastic glands; loss of lobular architecture",
                      "4x variation in nuclear size within same gland"
                    ]
                  }
                ],
                "Ampullary/Periampullary Carcinoma": [
                  {
                    "text": "Gross examination is key: Epicenter of mass determines site of primary"
                  },
                  {
                    "text": "Precursor lesions help differentiate ampullary tumors from PDAC"
                  },
                  {
                    "text": "Strong diffuse staining for CK20, CDX2 favors intestinal origin"
                  }
                ],
                "Acinar Cell Carcinoma": [
                  {
                    "text": "Malignant exocrine carcinoma with acinar differentiation"
                  },
                  {
                    "text": "Eosinophilic granular cytoplasm"
                  },
                  {
                    "text": "Basally located nuclei with single prominent nucleoli"
                  },
                  {
                    "text": "Positive for trypsin and chymotrypsin; negative for CK7"
                  }
                ],
                "Neuroendocrine Neoplasms": [
                  {
                    "text": "Nesting/trabecular pattern, hyalinized stroma"
                  },
                  {
                    "text": "Uniform nuclei, salt and pepper chromatin (low-grade neuroendocrine tumor)"
                  },
                  {
                    "text": "Positive for chromogranin, synaptophysin"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Perineural or angiolymphatic invasion in retroperitoneal soft tissue margin is underrecognized basis for surgical failure> 1/2 of patients have extrapancreatic nerve involvement in this area",
                    "sub_points": [
                      "> 1/2 of patients have extrapancreatic nerve involvement in this area"
                    ]
                  },
                  {
                    "text": "Lymph node metastases present at time of surgery in 70-80% of patients"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Perineural invasion, angiolymphatic invasion and glands adjacent to medium-sized arteries are helpful findings, especially when evaluating pancreatic and bile duct margins intraoperatively"
                  },
                  {
                    "text": "Awareness of histologic variants is especially helpful on challenging biopsy or cytology samples"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Undifferentiated Carcinoma": {
            "name": "Undifferentiated Carcinoma",
            "url": "https://app.pathprimer.com/document/c2093450-56d7-477e-9ce3-beab3927026c/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm with significant component showing no definite differentiationWide range of morphologic findings ranging from pleomorphic epithelioid cells to multinucleated giant cells to spindle cells",
                    "sub_points": [
                      "Wide range of morphologic findings ranging from pleomorphic epithelioid cells to multinucleated giant cells to spindle cells"
                    ]
                  },
                  {
                    "text": "2 distinct entities: Undifferentiated carcinoma (absence of osteoclast-like giant cells) and undifferentiated carcinoma with osteoclast-like giant cells"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare"
                  },
                  {
                    "text": "Dismal prognosis for undifferentiated carcinoma (average survival time of 5 months)"
                  },
                  {
                    "text": "Unpredictable survival for undifferentiated carcinoma with osteoclast-like giant cells (patients may survive many years)"
                  },
                  {
                    "text": "Surgical resection is treatment of choice"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Large, fleshy mass, often with hemorrhage and necrosis, that invades adjacent organs"
                  },
                  {
                    "text": "Can present as cystic mass"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Undifferentiated carcinoma (absence of osteoclast-like giant cells) has 3 recognized morphologic patterns: Anaplastic, sarcomatoid and carcinosarcoma"
                  },
                  {
                    "text": "Undifferentiated carcinoma with osteoclast-like giant cells contains mixture of 3 cell types: Nonneoplastic osteoclast-like giant cells, mononuclear histiocytes, and neoplastic atypical mononuclear cells"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "CK7, CK8, CK18, and CK19 can be positive but usually focal"
                  },
                  {
                    "text": "Neoplastic spindle cells may express SMA but not desmin"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Melanoma"
                  },
                  {
                    "text": "Choriocarcinoma"
                  },
                  {
                    "text": "Metastatic undifferentiated carcinoma"
                  },
                  {
                    "text": "Other causes of multinucleated giant cells"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Pleomorphic carcinoma, pleomorphic large cell carcinoma, pleomorphic giant cell carcinoma"
                  },
                  {
                    "text": "Undifferentiated carcinoma with osteoclast-like giant cellsGiant cell tumor of pancreasOsteoclast-like giant cell tumor of pancreas",
                    "sub_points": [
                      "Giant cell tumor of pancreas",
                      "Osteoclast-like giant cell tumor of pancreas"
                    ]
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasm with significant component showing no definite differentiationWide range of morphologic findings ranging from pleomorphic epithelioid cells to multinucleated giant cells to spindle cellsMultiple patterns often present within same tumor",
                    "sub_points": [
                      "Wide range of morphologic findings ranging from pleomorphic epithelioid cells to multinucleated giant cells to spindle cells",
                      "Multiple patterns often present within same tumor"
                    ]
                  },
                  {
                    "text": "2 distinct entities: Undifferentiated carcinoma (absence of osteoclast-like giant cells) and undifferentiated carcinoma with osteoclast-like giant cells"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare (< 1% of pancreatic neoplasms)"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 25-96 years; average: 60s"
                  }
                ],
                "Sex": [
                  {
                    "text": "Undifferentiated carcinoma: 3:1 male predominance"
                  },
                  {
                    "text": "Undifferentiated carcinoma with osteoclast-like giant cells: Slight female predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain, palpable mass, jaundice, if tumor is in pancreatic head"
                  },
                  {
                    "text": "Weight loss, fatigue, nausea, vomiting"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection with curative intent (but vast majority present with unresectable tumors)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Dismal for undifferentiated carcinoma (average survival time of 5 months)"
                  },
                  {
                    "text": "Unpredictable survival for undifferentiated carcinoma with osteoclast-like giant cells (patients may survive many years)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Very large, fleshy mass with hemorrhage and necrosisAverage: 9-10 cm; anywhere in pancreas",
                    "sub_points": [
                      "Average: 9-10 cm; anywhere in pancreas"
                    ]
                  },
                  {
                    "text": "Often infiltrates adjacent organs"
                  },
                  {
                    "text": "Can present as cystic mass"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Undifferentiated carcinoma (absence of osteoclast-like giant cells) has 3 recognized morphologic patterns: anaplastic, sarcomatoid, and carcinosarcomaAnaplastic patternRelatively pleomorphic, mononuclear cells and multinucleated giant cells with bizarre nuclei, abundant eosinophilic cytoplasm, and numerous mitosesMay be associated with dense neutrophilic infiltrate, cannibalism/emperipolesis of tumor cellsMinimal stroma and scant desmoplasia, extensive necrosis and hemorrhageSarcomatoid patternPlump spindle cells in fascicular or herringbone pattern with relatively minimal stromaSignificant atypia, mitoses, and extensive necrosisRhabdoid features may be seenHeterologous elements, such as bone, cartilage, and striated muscle, may be seen in some casesCarcinosarcoma patternBiphasic pattern with both epithelial/glandular and sarcomatoid componentsEach component should comprise at least 30% of tumor",
                    "sub_points": [
                      "Anaplastic patternRelatively pleomorphic, mononuclear cells and multinucleated giant cells with bizarre nuclei, abundant eosinophilic cytoplasm, and numerous mitosesMay be associated with dense neutrophilic infiltrate, cannibalism/emperipolesis of tumor cellsMinimal stroma and scant desmoplasia, extensive necrosis and hemorrhage",
                      "Relatively pleomorphic, mononuclear cells and multinucleated giant cells with bizarre nuclei, abundant eosinophilic cytoplasm, and numerous mitoses",
                      "May be associated with dense neutrophilic infiltrate, cannibalism/emperipolesis of tumor cells",
                      "Minimal stroma and scant desmoplasia, extensive necrosis and hemorrhage",
                      "Sarcomatoid patternPlump spindle cells in fascicular or herringbone pattern with relatively minimal stromaSignificant atypia, mitoses, and extensive necrosisRhabdoid features may be seenHeterologous elements, such as bone, cartilage, and striated muscle, may be seen in some cases",
                      "Plump spindle cells in fascicular or herringbone pattern with relatively minimal stroma",
                      "Significant atypia, mitoses, and extensive necrosis",
                      "Rhabdoid features may be seen",
                      "Heterologous elements, such as bone, cartilage, and striated muscle, may be seen in some cases",
                      "Carcinosarcoma patternBiphasic pattern with both epithelial/glandular and sarcomatoid componentsEach component should comprise at least 30% of tumor",
                      "Biphasic pattern with both epithelial/glandular and sarcomatoid components",
                      "Each component should comprise at least 30% of tumor"
                    ]
                  },
                  {
                    "text": "Undifferentiated carcinoma with osteoclast-like giant cellsMixture of 3 cell types: nonneoplastic osteoclast-like giant cells and mononuclear histiocytes admixed with neoplastic atypical mononuclear cellsBenign-appearing multinucleated osteoclast-like giant cells may have phagocytic activityUndifferentiated round to spindled atypical mononuclear cells have mitotic activityMay contain osteoid or focal chondroid differentiationOften associated with mucinous cystic neoplasm or conventional adenocarcinoma",
                    "sub_points": [
                      "Mixture of 3 cell types: nonneoplastic osteoclast-like giant cells and mononuclear histiocytes admixed with neoplastic atypical mononuclear cellsBenign-appearing multinucleated osteoclast-like giant cells may have phagocytic activityUndifferentiated round to spindled atypical mononuclear cells have mitotic activity",
                      "Benign-appearing multinucleated osteoclast-like giant cells may have phagocytic activity",
                      "Undifferentiated round to spindled atypical mononuclear cells have mitotic activity",
                      "May contain osteoid or focal chondroid differentiation",
                      "Often associated with mucinous cystic neoplasm or conventional adenocarcinoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7, CK8, CK18, and CK19 can be positive but usually focal"
                  },
                  {
                    "text": "Majority also express CEA, CA19-9, MUC1"
                  },
                  {
                    "text": "Neoplastic spindle cells may express SMA but not desmin"
                  },
                  {
                    "text": "CD68, KP1, CD45, and α-1-antitrypsin can be positive in osteoclast-like giant cells"
                  },
                  {
                    "text": "Sarcomatoid/rhabdoid pattern often shows nuclear loss of SMARCB1"
                  },
                  {
                    "text": "PD-L1 expression by tumor cells is associated with poor prognosis in undifferentiated carcinoma with osteoclast-like giant cells"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Melanoma": [
                  {
                    "text": "Tumors with prominent anaplastic large cell component can mimic melanoma"
                  },
                  {
                    "text": "S100, HMB-45, Melan-A positive"
                  }
                ],
                "Choriocarcinoma": [
                  {
                    "text": "Tumors with prominent anaplastic large cell component can mimic choriocarcinoma"
                  },
                  {
                    "text": "β-hCG positive"
                  },
                  {
                    "text": "Affects younger patients"
                  }
                ],
                "Metastatic Undifferentiated Carcinoma": [
                  {
                    "text": "Less often associated with other pancreatic tumors, such as mucinous cystic neoplasm"
                  },
                  {
                    "text": "Imaging may be required to confirm primary site"
                  }
                ],
                "Other Causes of Multinucleated Giant Cells": [
                  {
                    "text": "Pseudocysts, infection, reaction to tumor, other malignant neoplasms (lymphoma, sarcoma)Giant cells in these conditions are either benign or malignant, but both populations are not present",
                    "sub_points": [
                      "Giant cells in these conditions are either benign or malignant, but both populations are not present"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Squamous/Adenosquamous Carcinoma, Pancreas": {
            "name": "Squamous/Adenosquamous Carcinoma, Pancreas",
            "url": "https://app.pathprimer.com/document/97da31e9-82e7-433d-bce1-2d935a3d314e/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Uncommon variant of pancreatic cancer with both glandular and squamous differentiation"
                  },
                  {
                    "text": "Pure squamous cell carcinoma of pancreas is vanishingly rare"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Similar to conventional ductal adenocarcinoma of pancreas"
                  },
                  {
                    "text": "Extremely poor prognosis with median survival of 9 months"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Composed of at least 30% malignant squamous cell carcinoma mixed with adenocarcinoma"
                  },
                  {
                    "text": "Glandular component usually consists of conventional ductal adenocarcinoma"
                  },
                  {
                    "text": "Squamous cell carcinoma shows nests or sheets of neoplastic cells with whorls, keratin pearls, individual cell keratinization, and/or intercellular bridges"
                  },
                  {
                    "text": "The 2 components can be intimately admixed or topographically separate"
                  },
                  {
                    "text": "On cytology or biopsy specimens, pure squamous cell carcinoma may reflect undersampling of adenosquamous carcinoma or metastatic squamous cell carcinoma from another organ"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "p63, p40 are (+) in squamous component"
                  },
                  {
                    "text": "CK7, CK20, CEA, and CA19-9 usually restricted to glandular component"
                  },
                  {
                    "text": "SMAD 4 is occasionally lost"
                  },
                  {
                    "text": "Strong p53 expression"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Metastatic squamous cell carcinoma"
                  },
                  {
                    "text": "Pancreatoblastoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "None; there are no longer any related terminology/synonyms"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Uncommon variant of pancreatic cancer with both glandular and squamous differentiationPure squamous cell carcinoma of pancreas is vanishingly rare",
                    "sub_points": [
                      "Pure squamous cell carcinoma of pancreas is vanishingly rare"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Neoplastic": [
                  {
                    "text": "Genomic analysis has classified adenosquamous carcinoma into molecular subtype of pancreatic cancer (\"basal-type\") that has worse prognosis and is distinctly different from classic ductal adenocarcinoma"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Adenosquamous carcinoma accounts for 3-4% of malignancies of exocrine pancreas"
                  },
                  {
                    "text": "Pure squamous cell carcinoma reportedly accounts for up to 0.7% of pancreatic carcinoma"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 63 years"
                  },
                  {
                    "text": "Range: 28-86 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "M:F = 1.5:1.0"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to conventional ductal adenocarcinoma of pancreasWeight lossPainless jaundiceOther abdominal symptoms",
                    "sub_points": [
                      "Weight loss",
                      "Painless jaundice",
                      "Other abdominal symptoms"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Extremely poor, with median survival period of 9 months"
                  },
                  {
                    "text": "Mean survival of 11 months, even in patients with surgically resectable tumors"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Similar to conventional pancreatic ductal adenocarcinoma"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Ill-defined, tan to white mass, often necrotic with cystic component"
                  },
                  {
                    "text": "Most arise in head of pancreas but can also arise in body or tail, or even diffusely involve entire gland"
                  }
                ],
                "Size": [
                  {
                    "text": "Large (mean: ~ 6 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Adenosquamous carcinoma is composed of at least 30% malignant squamous cell carcinoma mixed with adenocarcinomaGlandular component usually consists of conventional ductal adenocarcinomaMay have clear cell or signet ring cell componentsSquamous cell carcinoma shows nests or sheets of neoplastic cells with whorls, keratin pearls, individual cell keratinization, &/or intercellular bridgesThe 2 components can be intimately admixed or topographically separate",
                    "sub_points": [
                      "Glandular component usually consists of conventional ductal adenocarcinomaMay have clear cell or signet ring cell components",
                      "May have clear cell or signet ring cell components",
                      "Squamous cell carcinoma shows nests or sheets of neoplastic cells with whorls, keratin pearls, individual cell keratinization, &/or intercellular bridges",
                      "The 2 components can be intimately admixed or topographically separate"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Various proportions of cells with glandular or squamous features on smear"
                  },
                  {
                    "text": "Pure squamous cell carcinoma may reflect undersampling of adenosquamous cell carcinoma, or metastatic squamous cell carcinoma from another organ"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "MucicarmineReactivity: (+) in glandular componentStaining pattern: Intracytoplasmic mucin",
                    "sub_points": [
                      "Reactivity: (+) in glandular component",
                      "Staining pattern: Intracytoplasmic mucin"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "p63, p40 (+) in squamous component"
                  },
                  {
                    "text": "CK7, CK20, CEA, and CA19-9 usually restricted to glandular component"
                  },
                  {
                    "text": "SMAD4 is occasionally lost"
                  },
                  {
                    "text": "p16 (-)"
                  },
                  {
                    "text": "Strong p53 expression"
                  },
                  {
                    "text": "MUC1 (+) in both components"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Metastatic Squamous Cell Carcinoma": [
                  {
                    "text": "Clinical history of extrapancreatic squamous cell carcinoma"
                  },
                  {
                    "text": "Absence of glandular differentiation"
                  }
                ],
                "Pancreatoblastoma": [
                  {
                    "text": "Predominant acinar component in addition to squamoid nests ± glandular elements"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Pure squamous cell carcinomas of pancreas are extremely rareAdequate sectioning may reveal glandular component in tumors with dominant squamous morphology",
                    "sub_points": [
                      "Adequate sectioning may reveal glandular component in tumors with dominant squamous morphology"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Serous Cystadenoma": {
            "name": "Serous Cystadenoma",
            "url": "https://app.pathprimer.com/document/768af8b5-ede5-48a9-9624-9bf92b0c989a/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign, cystic epithelial neoplasm presumably originating from centroacinar cell/intercalated duct system"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Discovered because of abdominal mass &/or pain or incidentally"
                  },
                  {
                    "text": "Most commonly in women in 6th decade of life"
                  },
                  {
                    "text": "10% of surgically resected cystic pancreatic lesions"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Discrete, well-demarcated lesion composed of numerous thin-walled cysts filled with serous fluid (microcystic)"
                  },
                  {
                    "text": "Less common variants: Solid, oligocystic (macrocystic)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cysts typically lined by single layer of cuboidal to flat epithelial cellsClear to pale cytoplasm with sharp cell borderSmall, round to oval, uniform nucleiPeriodic acid-Schiff without diastase has granular cytoplasmic staining",
                    "sub_points": [
                      "Clear to pale cytoplasm with sharp cell border",
                      "Small, round to oval, uniform nuclei",
                      "Periodic acid-Schiff without diastase has granular cytoplasmic staining"
                    ]
                  },
                  {
                    "text": "Exuberant rich capillary network immediately adjacent to epithelium"
                  },
                  {
                    "text": "May have stellate scar that can be calcified"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Immunohistochemical reactivityCytokeratin, α-inhibin, calponin, GLUT1, MUC6 (+)",
                    "sub_points": [
                      "Cytokeratin, α-inhibin, calponin, GLUT1, MUC6 (+)"
                    ]
                  },
                  {
                    "text": "Genetic testingvon Hippel-Lindau (VHL) gene alteration detected in 30-90% of sporadic cases",
                    "sub_points": [
                      "von Hippel-Lindau (VHL) gene alteration detected in 30-90% of sporadic cases"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "VHL-associated pancreatic cysts"
                  },
                  {
                    "text": "Serous cystadenocarcinoma"
                  },
                  {
                    "text": "Pseudocyst"
                  },
                  {
                    "text": "Mucinous cystic neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Serous cystadenoma (SCA)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Serous microcystic adenoma"
                  },
                  {
                    "text": "Clear cell or glycogen-rich adenoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Benign, cystic epithelial neoplasmPresumably originates from centroacinar cell/intercalated duct system",
                    "sub_points": [
                      "Presumably originates from centroacinar cell/intercalated duct system"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "No Uniform Consensus on Cellular Origin": [
                  {
                    "text": "Acinar, centroacinar, and ductal origins have all been consideredSome immunohistochemical and ultrastructural features suggest centroacinar cell origin",
                    "sub_points": [
                      "Some immunohistochemical and ultrastructural features suggest centroacinar cell origin"
                    ]
                  }
                ],
                "Associated with von Hippel Lindau (VHL) syndrome": [
                  {
                    "text": "Most SCA are sporadic, but majority of VHL patients develop SCA"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "10% of surgically resected cystic pancreatic lesions"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 58 years; range: 18-91 years"
                  },
                  {
                    "text": "Rarely reported in infants (oligocystic variant)"
                  }
                ],
                "Sex": [
                  {
                    "text": "F:M ratio 3:1"
                  }
                ],
                "Site": [
                  {
                    "text": "Anywhere in pancreas"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Majority are asymptomatic, incidentally discovered"
                  },
                  {
                    "text": "Abdominal mass &/or pain, more likely in SCA > 4 cm"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection if symptomatic"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent, SCA recurs in < 2% of cases"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "CT scan: Multilocular, well-defined mass, central scar in 1/3 of cases"
                  },
                  {
                    "text": "Endoscopic ultrasound: Echogenic multiloculated cystic mass (\"honeycombed\"); may be calcified, resulting in sunburst appearance"
                  },
                  {
                    "text": "MR: Hypointense on T1 and hyperintense on T2-weighted images; septa well visualized in latter"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Discrete, well-demarcated, slightly bosselated tumorVariably sized, thin-walled cysts filled with clear, watery, or straw-colored fluidNo communication of cyst to pancreatic ductal system",
                    "sub_points": [
                      "Variably sized, thin-walled cysts filled with clear, watery, or straw-colored fluid",
                      "No communication of cyst to pancreatic ductal system"
                    ]
                  },
                  {
                    "text": "Microcystic (most common growth pattern)Sponge-like or honeycomb appearanceNumerous tightly packed cysts, 0.1 to < 1 cmCentral stellate fibrous scar, which may be calcified",
                    "sub_points": [
                      "Sponge-like or honeycomb appearance",
                      "Numerous tightly packed cysts, 0.1 to < 1 cm",
                      "Central stellate fibrous scar, which may be calcified"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Usually < 5 cm but can be up to 25 cm"
                  }
                ],
                "Variants": [
                  {
                    "text": "Solid variantWell-demarcated, solid mass with thick, fibrous bands",
                    "sub_points": [
                      "Well-demarcated, solid mass with thick, fibrous bands"
                    ]
                  },
                  {
                    "text": "Oligocystic (macrocystic, megacystic) variant (20% of cases)Larger (peripheral) admixed with smaller cysts (central)No central scarOften in pancreatic head",
                    "sub_points": [
                      "Larger (peripheral) admixed with smaller cysts (central)",
                      "No central scar",
                      "Often in pancreatic head"
                    ]
                  },
                  {
                    "text": "VHL-associated SCAs are multiple and may diffusely involve pancreas"
                  },
                  {
                    "text": "Mixed serous-neuroendocrine neoplasm: RareNeuroendocrine elements may be distinct or intermingled with SCA",
                    "sub_points": [
                      "Neuroendocrine elements may be distinct or intermingled with SCA"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Variably sized cysts lined by single-layered cuboidal/flat epitheliumRarely, microscopic papillary tufts without fibrovascular cores or true papillae with fibrovascular coresSolid variant can have solid nests of cells and small acini",
                    "sub_points": [
                      "Rarely, microscopic papillary tufts without fibrovascular cores or true papillae with fibrovascular cores",
                      "Solid variant can have solid nests of cells and small acini"
                    ]
                  },
                  {
                    "text": "Cells are uniform and lack atypia and mitotic activityClear to pale cytoplasm, abundant cytoplasmic glycogenRarely have eosinophilic (oncocyte-like) cytoplasmWell-defined cytoplasmic bordersSmall, round to oval, uniform nucleiDense, homogeneous chromatinCan have nuclear enlargementInconspicuous nucleoliSmall subset with atypical cytologic features: Not reliable predictor of aggressive behavior",
                    "sub_points": [
                      "Clear to pale cytoplasm, abundant cytoplasmic glycogen",
                      "Rarely have eosinophilic (oncocyte-like) cytoplasm",
                      "Well-defined cytoplasmic borders",
                      "Small, round to oval, uniform nucleiDense, homogeneous chromatinCan have nuclear enlargementInconspicuous nucleoli",
                      "Dense, homogeneous chromatin",
                      "Can have nuclear enlargement",
                      "Inconspicuous nucleoli",
                      "Small subset with atypical cytologic features: Not reliable predictor of aggressive behavior"
                    ]
                  },
                  {
                    "text": "Rich capillary network intimately admixed with epitheliumRed blood cells appear interspersed with epithelium",
                    "sub_points": [
                      "Red blood cells appear interspersed with epithelium"
                    ]
                  },
                  {
                    "text": "Can have stellate scar, which may become calcified"
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "All variants are cytologically similarNo atypia, necrosis, or mitotic activity",
                    "sub_points": [
                      "No atypia, necrosis, or mitotic activity"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Cytology": [
                  {
                    "text": "Clear, thin fluid; may be bloody"
                  },
                  {
                    "text": "Generally paucicellular or acellular"
                  },
                  {
                    "text": "Epithelial cells form small groups and flat sheets, should be distinguished from gastrointestinal epithelium"
                  }
                ],
                "Histochemistry": [
                  {
                    "text": "Granular cytoplasmic positivity with periodic acid-Schiff stain"
                  },
                  {
                    "text": "Negative with periodic acid-Schiff with diastase stain"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Cytokeratin and GLUT1 (+)Inhibin has been reported to be positive in 80% of cases",
                    "sub_points": [
                      "Inhibin has been reported to be positive in 80% of cases"
                    ]
                  },
                  {
                    "text": "Vimentin, CEA, HMB-45, Melan-A, MUC5, chromogranin, trypsin (-)"
                  },
                  {
                    "text": "Usually MUC2, synaptophysin (-)Positive in < 5% of SCA",
                    "sub_points": [
                      "Positive in < 5% of SCA"
                    ]
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "VHLgene alteration detected in 30-90% of sporadic casesLoss of heterozygosity at chromosome 3p25VHLgene germline mutation",
                    "sub_points": [
                      "Loss of heterozygosity at chromosome 3p25",
                      "VHLgene germline mutation"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "von Hippel-Lindau-Associated Pancreatic Cysts": [
                  {
                    "text": "Autosomal dominant disorder characterized by clear cell neoplasms"
                  },
                  {
                    "text": "Histologically identical to SCA but distribution differsDoes not form distinct lesionIrregularly scattered cysts in pancreas, multifocal or diffuse",
                    "sub_points": [
                      "Does not form distinct lesion",
                      "Irregularly scattered cysts in pancreas, multifocal or diffuse"
                    ]
                  },
                  {
                    "text": "Some classify these together with nonsyndromic SCA; others designate them separately"
                  }
                ],
                "Serous Cystadenocarcinoma": [
                  {
                    "text": "Extremely rare, morphologically indistinguishable from SCA"
                  },
                  {
                    "text": "Direct invasion, perineural/vascular/adjacent lymph node involvement not sufficient for diagnosis"
                  },
                  {
                    "text": "Metastasis required for diagnosis; liver is most common site"
                  }
                ],
                "Pseudocyst": [
                  {
                    "text": "Unilocular cyst with thick, fibrous wall"
                  },
                  {
                    "text": "Sample entire cyst before rendering this diagnosis"
                  },
                  {
                    "text": "Oligocystic SCA with epithelial denudation following biopsy can mimic pseudocyst"
                  }
                ],
                "Mucinous Cystic Neoplasm": [
                  {
                    "text": "Often in female patients in pancreatic tail"
                  },
                  {
                    "text": "Multilocular, thick-walled cyst with mucoid material"
                  },
                  {
                    "text": "Ovarian-type stroma and overlying mucinous epithelium with variable degree of cytologic atypia"
                  },
                  {
                    "text": "Serous macrocystic adenoma can radiographically resemble mucinous cystic neoplasm"
                  }
                ],
                "Lymphangioma": [
                  {
                    "text": "Multilocular cyst lined by endothelial cells and lymphoid aggregates"
                  },
                  {
                    "text": "Immunoreactive for CD34, CD31, and D2-40"
                  },
                  {
                    "text": "SCA with attenuated epithelial lining can mimic this entity"
                  }
                ],
                "Metastatic Clear Cell Renal Cell Carcinoma": [
                  {
                    "text": "Glycogen-rich clear cells and CA9 positivity"
                  },
                  {
                    "text": "Cytologic atypia, and positive for PAX2, PAX8, renal cell carcinoma (RCC) help to identify RCC"
                  }
                ],
                "Combined Well-Differentiated Endocrine Neoplasm/Serous Cystadenoma": [
                  {
                    "text": "Occurs in patients with VHL syndrome"
                  },
                  {
                    "text": "Combination of adjacent or admixed, low-grade pancreatic neuroendocrine tumor and SCA"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acinar Cell Cystadenoma": {
            "name": "Acinar Cell Cystadenoma",
            "url": "https://app.pathprimer.com/document/23d90198-9fbc-4b4d-9a2b-9b44e93bfbe1/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Benign nonneoplastic pancreatic cyst lined by acinar cells"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Young to middle-agedReported range: 10-80 years",
                    "sub_points": [
                      "Reported range: 10-80 years"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Unilocular to multilocular thin-walled cyst(s) filled with serous fluid"
                  },
                  {
                    "text": "Size range: 1.5-20 cm"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Cysts lined by single layer of cuboidal epithelium without multilayering"
                  },
                  {
                    "text": "Incipient acinar structures frequently seen within lining epithelium"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Lining cells are positive for PAS-D, trypsin, BCL10, chymotrypsin"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Serous cystadenomaAlso lined by single layer of clear, glycogen-filled cuboidal cells that are PAS+Lacks incipient acinar structures, negative for trypsin and PAS-D",
                    "sub_points": [
                      "Also lined by single layer of clear, glycogen-filled cuboidal cells that are PAS+",
                      "Lacks incipient acinar structures, negative for trypsin and PAS-D"
                    ]
                  },
                  {
                    "text": "Retention cystLacks morphological or immunohistochemical evidence of acinar cell differentiation",
                    "sub_points": [
                      "Lacks morphological or immunohistochemical evidence of acinar cell differentiation"
                    ]
                  },
                  {
                    "text": "Intraductal papillary-mucinous neoplasmNeoplastic cysts lined by mucinous epithelium; communicates with pancreatic ducts",
                    "sub_points": [
                      "Neoplastic cysts lined by mucinous epithelium; communicates with pancreatic ducts"
                    ]
                  },
                  {
                    "text": "Mucinous cystic neoplasmMucinous epithelium with ovarian-type stroma",
                    "sub_points": [
                      "Mucinous epithelium with ovarian-type stroma"
                    ]
                  },
                  {
                    "text": "Acinar cell cystadenocarcinoma and acinar cell carcinomaSheets of neoplastic cells with nuclear atypia and many mitoses",
                    "sub_points": [
                      "Sheets of neoplastic cells with nuclear atypia and many mitoses"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Acinar cystic transformation (ACT)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Nonneoplastic pancreatic cyst lined by cells of acinar differentiation"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Causes": [
                  {
                    "text": "Unknown, but may be obstruction-related"
                  }
                ],
                "Pathogenesis": [
                  {
                    "text": "Pancreatic acini dilate then fuse with smaller bile ductules and larger ducts, possibly secondary to obstructionGenetic studies indicate ACT is a nonneoplastic processKRAS, GNAS, TP53, CDKN2A, SMAD4alterations typical of pancreatic ductal adenocarcinoma and its precursor cystic tumors are not present in ACT",
                    "sub_points": [
                      "Genetic studies indicate ACT is a nonneoplastic processKRAS, GNAS, TP53, CDKN2A, SMAD4alterations typical of pancreatic ductal adenocarcinoma and its precursor cystic tumors are not present in ACT",
                      "KRAS, GNAS, TP53, CDKN2A, SMAD4alterations typical of pancreatic ductal adenocarcinoma and its precursor cystic tumors are not present in ACT"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "75 cases described"
                  }
                ],
                "Age": [
                  {
                    "text": "Young to middle-aged, range 10-80 years (mean 43)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance (3:1 ratio)"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Abdominal pain, palpable mass, or asymptomaticMay be incidentally found in pancreas resections for other reasons",
                    "sub_points": [
                      "May be incidentally found in pancreas resections for other reasons"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection is curative"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Benign cyst without risk of malignant transformationRisk for patient is complications related to surgery",
                    "sub_points": [
                      "Risk for patient is complications related to surgery"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Unilocular to multilocular cyst without solid areas or papillary projections"
                  },
                  {
                    "text": "Occasionally multiple cysts can diffusely involve pancreas"
                  },
                  {
                    "text": "Occasionally mistaken for intraductal papillary mucinous neoplasms with mural nodules, which are actually pseudopapillary structures due to incomplete fibrous septa formation"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "More common in pancreatic headSome cases may involve entire pancreas",
                    "sub_points": [
                      "Some cases may involve entire pancreas"
                    ]
                  },
                  {
                    "text": "Unilocular to multilocular, thin-walled cyst(s) filled with clear, serous fluid"
                  },
                  {
                    "text": "Mural nodules uncommon"
                  },
                  {
                    "text": "No dilatation of main pancreatic ductUsually no communication with main pancreatic duct",
                    "sub_points": [
                      "Usually no communication with main pancreatic duct"
                    ]
                  }
                ],
                "Sections to Be Submitted": [
                  {
                    "text": "Entire cyst should be submitted for histologic evaluation"
                  },
                  {
                    "text": "Sample pancreas generously in the absence of an obvious cause for obstructionAs ACT may be secondary to obstruction, extensive sampling helps exclude a neoplastic cause for obstruction (such as neuroendocrine tumor or adenocarcinoma)",
                    "sub_points": [
                      "As ACT may be secondary to obstruction, extensive sampling helps exclude a neoplastic cause for obstruction (such as neuroendocrine tumor or adenocarcinoma)"
                    ]
                  }
                ],
                "Size": [
                  {
                    "text": "Mean size 5.8 cm (range 1.5-20 cm)"
                  },
                  {
                    "text": "Incidentally detected cases may not be seen grossly (<1.0 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Unilocular cystSingle layer of acinar cells overlying hyalinized cyst wallVery little ductal epithelium is present",
                    "sub_points": [
                      "Single layer of acinar cells overlying hyalinized cyst wallVery little ductal epithelium is present",
                      "Very little ductal epithelium is present"
                    ]
                  },
                  {
                    "text": "Multilocular cystsCysts of varying sizes with incomplete septa that can look like pseudopapillary projectionsDilated clusters of acini interconnect and open into larger cystsResidual pancreatic elements are present between cystsSingle layer of cuboidal epithelium without multilayering or pseudostratificationBasally oriented nuclei and pale or granular apical cytoplasm with deeply eosinophilic granulesNo nuclear atypia or mitotic activityIncipient acinar structures can be seen within cyst lining, as can areas of ductal differentiationIntraluminal cyst contents may contain eosinophilic secretions",
                    "sub_points": [
                      "Cysts of varying sizes with incomplete septa that can look like pseudopapillary projectionsDilated clusters of acini interconnect and open into larger cystsResidual pancreatic elements are present between cysts",
                      "Dilated clusters of acini interconnect and open into larger cysts",
                      "Residual pancreatic elements are present between cysts",
                      "Single layer of cuboidal epithelium without multilayering or pseudostratificationBasally oriented nuclei and pale or granular apical cytoplasm with deeply eosinophilic granulesNo nuclear atypia or mitotic activityIncipient acinar structures can be seen within cyst lining, as can areas of ductal differentiation",
                      "Basally oriented nuclei and pale or granular apical cytoplasm with deeply eosinophilic granules",
                      "No nuclear atypia or mitotic activity",
                      "Incipient acinar structures can be seen within cyst lining, as can areas of ductal differentiation",
                      "Intraluminal cyst contents may contain eosinophilic secretions"
                    ]
                  },
                  {
                    "text": "Background pancreas usually shows atrophy and fibrosis"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS-D positive in apical cytoplasm of lining cells"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "BCL10, trypsin, chymotrypsin highlight acinar epitheliumNegative for chromogranin and synaptophysin",
                    "sub_points": [
                      "Negative for chromogranin and synaptophysin"
                    ]
                  },
                  {
                    "text": "CK19 highlights ductal epithelium"
                  }
                ],
                "Electron Microscopy": [
                  {
                    "text": "Cyst lining cells show apical, round, electron-dense granules measuring 200-800 nm that resemble normal pancreatic zymogen granules"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Serous Cystadenoma": [
                  {
                    "text": "Also lined by single layer of cuboidal epitheliumLining cells have clear cytoplasm due to glycogen",
                    "sub_points": [
                      "Lining cells have clear cytoplasm due to glycogen"
                    ]
                  },
                  {
                    "text": "PAS+, but negative for PAS-D (unlike ACT)"
                  },
                  {
                    "text": "Serous cystadenoma lacks intracellular granules, vs. apical PAS-D+ granules seen in ACT"
                  },
                  {
                    "text": "Serous cystadenoma lacks incipient acinar structures, negative for trypsin on immunohistochemistry"
                  }
                ],
                "Retention Cyst": [
                  {
                    "text": "Lacks morphologic or immunohistochemical evidence of acinar cell differentiation"
                  }
                ],
                "Intraductal Papillary-Mucinous Neoplasm and Mucinous Cystic Neoplasm": [
                  {
                    "text": "Neoplastic cysts lined by mucinous epithelium, not acinar epithelium"
                  },
                  {
                    "text": "Intraductal Papillary Mucinous Neoplasm communicates with pancreatic ducts"
                  },
                  {
                    "text": "Mucinous cystic neoplasm has ovarian-type stroma"
                  }
                ],
                "Acinar Cell Cystadenocarcinoma and Acinar Cell Carcinoma": [
                  {
                    "text": "Both lesions show sheets of neoplastic cells with nuclear atypia and many mitoses"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Solid Pseudopapillary Neoplasm": {
            "name": "Solid Pseudopapillary Neoplasm",
            "url": "https://app.pathprimer.com/document/e113f8ca-63fc-4274-be21-95f42dec4010/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Solid pseudopapillary neoplasm"
                  },
                  {
                    "text": "Low-grade malignant neoplasm of uncertain cellular differentiation"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "CTNNB1mutations"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Occurs predominately in young female patients"
                  },
                  {
                    "text": "Presents with nonspecific symptoms related to intraabdominal mass"
                  },
                  {
                    "text": "Can be located in head, body, or tail of pancreas"
                  },
                  {
                    "text": "Indolent behavior"
                  },
                  {
                    "text": "Metastasis in 10-15% of cases to liver, peritoneum, and lymph node"
                  },
                  {
                    "text": "> 80% are cured with surgical resection"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Well-demarcated, large mass"
                  },
                  {
                    "text": "Solid, monomorphic sheets of polygonal cells"
                  },
                  {
                    "text": "Delicate vessels surrounded by hyalinized or myxoid stroma"
                  },
                  {
                    "text": "Characteristic degenerative change leading to pseudopapillae"
                  },
                  {
                    "text": "Cytoplasmic eosinophilic hyaline globules, PAS-D positive"
                  },
                  {
                    "text": "Uniform round to oval nuclei with finely dispersed chromatin"
                  },
                  {
                    "text": "Neoplastic cells often have nuclear grooves"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Immunohistochemistry: Nuclear β-catenin, loss of membrane E-cadherin, nuclear progesterone receptor, positive TFE3 and SOX11"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic neuroendocrine tumor"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Solid pseudopapillary neoplasm (SPN)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Solid and papillary epithelial neoplasm"
                  },
                  {
                    "text": "Solid pseudopapillary tumor"
                  },
                  {
                    "text": "Solid cystic tumor"
                  },
                  {
                    "text": "Papillary cystic tumor"
                  },
                  {
                    "text": "Frantz tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Low-grade malignant neoplasm of uncertain cellular differentiation"
                  },
                  {
                    "text": "Originally described in 1959"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Cellular Lineage": [
                  {
                    "text": "Uncertain, electron microscopy shows evidence of epithelial differentiation"
                  }
                ],
                "Molecular": [
                  {
                    "text": "CTNNB1(β-catenin) mutations in nearly all cases"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Uncommon (1-2% of all exocrine pancreatic neoplasms)"
                  }
                ],
                "Age": [
                  {
                    "text": "Most patients in 20s and 30sMean age: 25-35 yearsOverall age range: 7-79 years",
                    "sub_points": [
                      "Mean age: 25-35 years",
                      "Overall age range: 7-79 years"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "Female predominance (M:F = 1:9-20)"
                  }
                ],
                "Site": [
                  {
                    "text": "Evenly distributed throughout pancreas"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific symptoms related to intraabdominal massVague abdominal pain, weight loss, anorexia",
                    "sub_points": [
                      "Vague abdominal pain, weight loss, anorexia"
                    ]
                  },
                  {
                    "text": "May have palpable abdominal mass"
                  },
                  {
                    "text": "Up to 1/3 of cases discovered incidentally"
                  },
                  {
                    "text": "Complications: Rupture, hemoperitoneum"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Serum oncomarkers, laboratory tests usually normal"
                  }
                ],
                "Natural History": [
                  {
                    "text": "Most are indolent and grow slowly"
                  },
                  {
                    "text": "May directly invade stomach, duodenum, spleen"
                  },
                  {
                    "text": "Metastasis10-15% of casesLiver, peritoneum, lymph nodesPeritoneal metastases more common in patients with trauma, rupture, or drainage of neoplasm",
                    "sub_points": [
                      "10-15% of cases",
                      "Liver, peritoneum, lymph nodesPeritoneal metastases more common in patients with trauma, rupture, or drainage of neoplasm",
                      "Peritoneal metastases more common in patients with trauma, rupture, or drainage of neoplasm"
                    ]
                  },
                  {
                    "text": "Rare, clinically aggressive variant"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection is treatment of choice"
                  },
                  {
                    "text": "Diabetes can occur after resection, especially in pediatric setting"
                  },
                  {
                    "text": "Can recur if incompletely resected"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent> 80% cured with surgical resection10-15% of cases have metastases or recurrence",
                    "sub_points": [
                      "> 80% cured with surgical resection",
                      "10-15% of cases have metastases or recurrence"
                    ]
                  },
                  {
                    "text": "Unresectability and metastasis are adverse prognostic features; even patients with metastases have favorable long-term survival"
                  },
                  {
                    "text": "Older age, aneuploidy, increased mitoses, increased nuclear diameter proposed but not well-established indicators of aggressive behavior"
                  },
                  {
                    "text": "Perineural invasion, angioinvasion, local invasion do not predict outcome"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Well-circumscribed, smaller neoplasms appear solid"
                  },
                  {
                    "text": "Larger neoplasms show solid and cystic appearance"
                  },
                  {
                    "text": "Calcifications in ~ 30%"
                  }
                ],
                "Ultrasonographic Findings": [
                  {
                    "text": "Well-demarcated, heterogeneous mass"
                  },
                  {
                    "text": "Variable echo texture"
                  }
                ],
                "CT Findings": [
                  {
                    "text": "Heterogeneous, early weak enhancement with gradual increase in enhancement in hepatic venous phase"
                  },
                  {
                    "text": "Areas with differing attenuation"
                  },
                  {
                    "text": "Variably present fluid/debris levels"
                  },
                  {
                    "text": "Pancreatic and bile ducts not dilated"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Large solitary massRarely multipleWell-circumscribed, can be encapsulatedSolid to cystic, usually mixedCystic areas often contain friable, necrotic materialMinority of neoplasms are almost completely solid or completely cysticWhite-gray to yellow cut surface",
                    "sub_points": [
                      "Rarely multiple",
                      "Well-circumscribed, can be encapsulated",
                      "Solid to cystic, usually mixedCystic areas often contain friable, necrotic materialMinority of neoplasms are almost completely solid or completely cystic",
                      "Cystic areas often contain friable, necrotic material",
                      "Minority of neoplasms are almost completely solid or completely cystic",
                      "White-gray to yellow cut surface"
                    ]
                  },
                  {
                    "text": "Evenly distributed throughout pancreas"
                  }
                ],
                "Size": [
                  {
                    "text": "Range: 1.5-25 cm"
                  },
                  {
                    "text": "Mean diameter: 9-10 cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Solid monomorphic sheets of polygonal cellsAdmixed delicate vessels surrounded by hyalinized or myxoid stromaTrue glandular lumina not present",
                    "sub_points": [
                      "Admixed delicate vessels surrounded by hyalinized or myxoid stroma",
                      "True glandular lumina not present"
                    ]
                  },
                  {
                    "text": "Infrequent mitotic figures"
                  },
                  {
                    "text": "Perineural and true vascular invasion are rare"
                  },
                  {
                    "text": "Marked degenerative changes leading to pseudopapillae formation"
                  },
                  {
                    "text": "Other degenerative features: Foamy macrophages, cholesterol clefts, hemorrhage, lipofuscin or melanin pigment, calcification/ossification"
                  },
                  {
                    "text": "Areas of infarction, true neoplasm necrosis is rare"
                  },
                  {
                    "text": "Interface with normal pancreasInfiltration of adjacent parenchyma is common\"Blood lakes\" common at periphery of neoplasmMay have fibrous capsule",
                    "sub_points": [
                      "Infiltration of adjacent parenchyma is common",
                      "\"Blood lakes\" common at periphery of neoplasm",
                      "May have fibrous capsule"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Nuclei can be oriented away from vessels with zone of cytoplasm separating nuclei from capillariesUniform and round to oval with finely dispersed nuclear chromatinOften with longitudinal nuclear grooves",
                    "sub_points": [
                      "Uniform and round to oval with finely dispersed nuclear chromatin",
                      "Often with longitudinal nuclear grooves"
                    ]
                  },
                  {
                    "text": "Moderate amount of eosinophilic cytoplasm but can be clear with vacuoles"
                  },
                  {
                    "text": "Cytoplasmic eosinophilic hyaline globules"
                  },
                  {
                    "text": "High-grade malignant transformation: Rare occurrenceSheets of neoplasm cells with marked atypia, high mitosesSarcomatoid features may be present",
                    "sub_points": [
                      "Sheets of neoplasm cells with marked atypia, high mitoses",
                      "Sarcomatoid features may be present"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "PAS-D(+) cytoplasmic eosinophilic hyaline globules"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Most commonly used antibodiesNuclear staining with β-cateninNuclear staining with progesterone receptor; estrogen receptor negativeE-cadherin: Loss of membrane staining (using antibodies to extracellular domain)Pankeratin is variably positive",
                    "sub_points": [
                      "Nuclear staining with β-catenin",
                      "Nuclear staining with progesterone receptor; estrogen receptor negative",
                      "E-cadherin: Loss of membrane staining (using antibodies to extracellular domain)",
                      "Pankeratin is variably positive"
                    ]
                  },
                  {
                    "text": "Other immunostaining featuresSynaptophysin can be positive; chromogranin and trypsin are negativePositive for cyclin-D1, CD10 (cytoplasmic or perinuclear), CD99 (dot-like), vimentin, CD56, α-1-antitrypsinTFE3 and SOX11 positive in most casesKIT positive in 1/2 of cases (noKITmutation)",
                    "sub_points": [
                      "Synaptophysin can be positive; chromogranin and trypsin are negative",
                      "Positive for cyclin-D1, CD10 (cytoplasmic or perinuclear), CD99 (dot-like), vimentin, CD56, α-1-antitrypsin",
                      "TFE3 and SOX11 positive in most cases",
                      "KIT positive in 1/2 of cases (noKITmutation)"
                    ]
                  }
                ],
                "Molecular Genetics": [
                  {
                    "text": "Missense mutations in exon 3 ofCTNNB1in nearly all cases"
                  },
                  {
                    "text": "Prevents degradation of β-catenin protein and leads to its nuclear translocation"
                  },
                  {
                    "text": "No EWS-FLI1 translocation despite FLI1 staining on immunohistochemistry"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pseudocyst": [
                  {
                    "text": "No epithelial lining"
                  },
                  {
                    "text": "More common in men"
                  },
                  {
                    "text": "History of pancreatitis, elevated amylase"
                  },
                  {
                    "text": "High levels of amylase in cyst fluid"
                  }
                ],
                "Pancreatic Neuroendocrine Tumor": [
                  {
                    "text": "Salt and pepper chromatin (low-grade tumors)"
                  },
                  {
                    "text": "Positive for keratin, synaptophysin, and chromogranin; membranous staining with E-cadherin"
                  },
                  {
                    "text": "No nuclear β-catenin; TFE3 and SOX11 typically negative"
                  },
                  {
                    "text": "CD10 and progesterone receptor can be positive"
                  }
                ],
                "Acinar Cell Carcinoma": [
                  {
                    "text": "Typically solid neoplasm"
                  },
                  {
                    "text": "Cytologically differentCohesive cellsGranular cytoplasmMore nuclear pleomorphism and mitosesProminent nucleoliLumina can be present",
                    "sub_points": [
                      "Cohesive cellsGranular cytoplasmMore nuclear pleomorphism and mitosesProminent nucleoli",
                      "Granular cytoplasm",
                      "More nuclear pleomorphism and mitoses",
                      "Prominent nucleoli",
                      "Lumina can be present"
                    ]
                  },
                  {
                    "text": "Keratin, trypsin, &/or chymotrypsin, BCL10 positive"
                  },
                  {
                    "text": "No nuclear β-catenin; can be positive for α-1-antitrypsin"
                  }
                ],
                "Serous Neoplasms": [
                  {
                    "text": "Lined by single layer of clear cells"
                  },
                  {
                    "text": "PAS positive, diastase sensitive due to glycogen content"
                  },
                  {
                    "text": "Keratin and GLUT1 positive; no nuclear β-catenin"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Typically in young women"
                  },
                  {
                    "text": "Solid and cystic gross appearance"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Nuclear staining for β-catenin"
                  },
                  {
                    "text": "Nuclear grooves, pseudopapillae are characteristic"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Mucinous Cystic Neoplasm, Pancreas": {
            "name": "Mucinous Cystic Neoplasm, Pancreas",
            "url": "https://app.pathprimer.com/document/5b17c11d-3cb7-48a3-8faa-62de3f5e3a4d/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Neoplasm composed of mucin-producing epithelial cells associated with ovarian-type stroma"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "KRASmutations but notGNASmutations"
                  },
                  {
                    "text": "Primordial germ cells that help form gonads may be responsible for mucinous cystic neoplasm (MCN)MCN may arise from primordial germ cells that aberrantly stopped near developing pancreas during migration to gonads",
                    "sub_points": [
                      "MCN may arise from primordial germ cells that aberrantly stopped near developing pancreas during migration to gonads"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "16% of resected pancreatic cysts"
                  },
                  {
                    "text": "Average age at diagnosis: 40-50 years"
                  },
                  {
                    "text": "Predominantly femaleF:M = 20:1",
                    "sub_points": [
                      "F:M = 20:1"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "90% of MCNs arise in body or tail of pancreas"
                  },
                  {
                    "text": "Usually solitary and largeMean: 7-10 cm",
                    "sub_points": [
                      "Mean: 7-10 cm"
                    ]
                  },
                  {
                    "text": "Usually multiloculated with thick walls; filled with thick, tenacious, mucoid material"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Ovarian-type stroma is required for diagnosisBroad areas of stroma may be hyalinizedStroma often expresses ER, PR, inhibin, and CD10",
                    "sub_points": [
                      "Broad areas of stroma may be hyalinized",
                      "Stroma often expresses ER, PR, inhibin, and CD10"
                    ]
                  },
                  {
                    "text": "Tall, columnar, mucin-producing epitheliumLow- and high-grade dysplasia depending on degree of cytologic atypiaInvasive components can be very focal",
                    "sub_points": [
                      "Low- and high-grade dysplasia depending on degree of cytologic atypia",
                      "Invasive components can be very focal"
                    ]
                  },
                  {
                    "text": "Invasive carcinoma, usually pancreaticobiliary type, is present in 15% of cases"
                  },
                  {
                    "text": "Sample generouslyTo look for invasive carcinomaTo look for ovarian-type stroma or epithelium in extensively fibrotic and denuded cysts",
                    "sub_points": [
                      "To look for invasive carcinoma",
                      "To look for ovarian-type stroma or epithelium in extensively fibrotic and denuded cysts"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Mucinous cystic neoplasm (MCN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Cystic neoplasm with mucin-producing epithelial lining and ovarian-type stroma"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Molecular Changes": [
                  {
                    "text": "KRASmutations but notGNASmutations"
                  },
                  {
                    "text": "TP53mutation andSMAD4(DPC4) loss usually seen only in advanced MCN (high-grade dysplasia, carcinoma)"
                  }
                ],
                "Proposed Pathogenesis": [
                  {
                    "text": "MCN may arise from primordial germ cells that aberrantly stopped near developing pancreas during migration to gonadsAre in close proximity to duct system of developing pancreas during week 5 of embryogenesisPrimordial germ cells descend to gonads, proliferating en route",
                    "sub_points": [
                      "Are in close proximity to duct system of developing pancreas during week 5 of embryogenesis",
                      "Primordial germ cells descend to gonads, proliferating en route"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "16% of resected pancreatic cystic lesions"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 14-95 years (average at diagnosis: 40-50)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Predominantly female (F:M = 20:1)"
                  },
                  {
                    "text": "Rare in malesOccasionally reported in males with morbid obesity or chronic alcoholism histories",
                    "sub_points": [
                      "Occasionally reported in males with morbid obesity or chronic alcoholism histories"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Vague abdominal symptoms (pain and fullness) with compression of adjacent organs and tissues"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Excellent prognosis for patients with MCN without invasion"
                  },
                  {
                    "text": "5-year survival rate of 50% for MCN with invasive adenocarcinomaSize and extent of invasion (confined to pancreas vs. beyond tumor capsule) and age of patient (lower survival rate > 50 years) correlate with survival",
                    "sub_points": [
                      "Size and extent of invasion (confined to pancreas vs. beyond tumor capsule) and age of patient (lower survival rate > 50 years) correlate with survival"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Large, well-demarcated, thick-walled, multilocular cystic mass with peripheral calcification (20%)"
                  },
                  {
                    "text": "Mural nodules and papillary excrescences more common in MCN with invasive component"
                  }
                ],
                "ERCP Findings": [
                  {
                    "text": "Main pancreatic duct and large interlobular ducts do not communicate with cysts in majority of cases"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "90% in tail or body of pancreas"
                  },
                  {
                    "text": "Solitary and large (mean: 7-10 cm)"
                  },
                  {
                    "text": "Multiloculated with thick walls; filled with thick, tenacious, mucoid material"
                  },
                  {
                    "text": "Intracystic papillary excrescences &/or mural nodules suggestive of high-grade dysplasia or invasion"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Thick-walled cysts separated from adjacent nonneoplastic pancreatic parenchyma by fibrous tissue"
                  },
                  {
                    "text": "Ovarian-type stroma required for diagnosis of MCNCan be difficult to identify in largely hyalinized cyst wallsStroma often expresses ER, PR, FOXL2, CD10Supports role of female hormones in its pathogenesisFocal inhibin and SF-1 expression can also be seen in ovarian-type stroma",
                    "sub_points": [
                      "Can be difficult to identify in largely hyalinized cyst walls",
                      "Stroma often expresses ER, PR, FOXL2, CD10Supports role of female hormones in its pathogenesisFocal inhibin and SF-1 expression can also be seen in ovarian-type stroma",
                      "Supports role of female hormones in its pathogenesis",
                      "Focal inhibin and SF-1 expression can also be seen in ovarian-type stroma"
                    ]
                  },
                  {
                    "text": "Cyst lining: Cuboidal or columnar, mucin-producing epitheliumOften denudedSeveral sections may be needed to demonstrate epithelial liningMay have foci of flat or cuboidal cells of pancreatobiliary type2-tiered dysplasia classification: Low and high grade",
                    "sub_points": [
                      "Often denudedSeveral sections may be needed to demonstrate epithelial lining",
                      "Several sections may be needed to demonstrate epithelial lining",
                      "May have foci of flat or cuboidal cells of pancreatobiliary type",
                      "2-tiered dysplasia classification: Low and high grade"
                    ]
                  },
                  {
                    "text": "Invasive carcinoma is present in 15% of MCNsLarge size (> 5 cm) and intracystic mural nodules > 1 cm are associated with invasive componentMost are adenocarcinomas of pancreaticobiliary type (ductal type)",
                    "sub_points": [
                      "Large size (> 5 cm) and intracystic mural nodules > 1 cm are associated with invasive component",
                      "Most are adenocarcinomas of pancreaticobiliary type (ductal type)"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pseudocyst": [
                  {
                    "text": "More common in men than women; associated with pancreatitis and elevated serum amylase levels"
                  },
                  {
                    "text": "Epithelial lining and ovarian-type stroma help diagnose MCN"
                  }
                ],
                "Intraductal Papillary Mucinous Neoplasms": [
                  {
                    "text": "More common in men"
                  },
                  {
                    "text": "Often demonstrate communication with pancreatic duct system and lack ovarian-type stroma"
                  },
                  {
                    "text": "Present in head of gland more frequently than body/tail"
                  },
                  {
                    "text": "GNASmutations in pancreatic fluid analysis rather thanKRAS"
                  }
                ],
                "Serous Cystic Neoplasm": [
                  {
                    "text": "Smaller cysts, central stellate scar, and glycogen-rich cuboidal lining cells"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Invasive components can be very focal; thus, submission of entire neoplasm is recommended"
                  },
                  {
                    "text": "Staging of MCNs with associated invasive carcinoma follows same staging system applied to carcinomas of exocrine pancreasOnly size of invasive component should be used to determine T staging, not entire cyst sizeIf cancer is multifocal, guidelines recommend reporting both largest cancer focus and combined size of all invasive foci, due to lack of data on outcome",
                    "sub_points": [
                      "Only size of invasive component should be used to determine T staging, not entire cyst size",
                      "If cancer is multifocal, guidelines recommend reporting both largest cancer focus and combined size of all invasive foci, due to lack of data on outcome"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Ovarian-type stroma required for diagnosis of MCN"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intraductal Papillary Mucinous Neoplasm": {
            "name": "Intraductal Papillary Mucinous Neoplasm",
            "url": "https://app.pathprimer.com/document/1523abc0-0de9-4251-88a6-69bf31164f84/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Grossly visible, mucin-producing, epithelial neoplasm present within main pancreatic duct &/or its branchesClassified as main duct, branch duct, or mixed duct type",
                    "sub_points": [
                      "Classified as main duct, branch duct, or mixed duct type"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "20-50% of resected cystic pancreatic tumorsIncidence increasing due to increased incidental detection on imaging for other reasons",
                    "sub_points": [
                      "Incidence increasing due to increased incidental detection on imaging for other reasons"
                    ]
                  },
                  {
                    "text": "Most patients are asymptomaticSymptoms associated with intermittent pancreatic ductal obstruction by tenacious mucin &/or low-grade pancreatitis",
                    "sub_points": [
                      "Symptoms associated with intermittent pancreatic ductal obstruction by tenacious mucin &/or low-grade pancreatitis"
                    ]
                  },
                  {
                    "text": "Average age at presentation: Mid-60s"
                  },
                  {
                    "text": "Prognosis better than conventional ductal adenocarcinomaNoninvasive tumors: 5-year survival rate: > 90%Invasive tumors: 5-year survival rate: 36-90%Typically significantly better than pancreatic ductal adenocarcinomaInvasive components may be very focal, requiring submission of entire lesion",
                    "sub_points": [
                      "Noninvasive tumors: 5-year survival rate: > 90%",
                      "Invasive tumors: 5-year survival rate: 36-90%Typically significantly better than pancreatic ductal adenocarcinoma",
                      "Typically significantly better than pancreatic ductal adenocarcinoma",
                      "Invasive components may be very focal, requiring submission of entire lesion"
                    ]
                  },
                  {
                    "text": "Surgical resection treatment of choiceVast majority surgically resectable",
                    "sub_points": [
                      "Vast majority surgically resectable"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Most common in pancreatic head"
                  },
                  {
                    "text": "Often involve only portion of pancreatic duct but may be multifocal or involve entire duct"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Composed of flat or papillary mucinous epithelium"
                  },
                  {
                    "text": "3 epithelial subtypesGastricIntestinalPancreatobiliary",
                    "sub_points": [
                      "Gastric",
                      "Intestinal",
                      "Pancreatobiliary"
                    ]
                  },
                  {
                    "text": "2-tiered dysplasia grading systemLow-grade dysplasiaHigh-grade dysplasia",
                    "sub_points": [
                      "Low-grade dysplasia",
                      "High-grade dysplasia"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Intraductal papillary mucinous neoplasm (IPMN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Grossly visible, > 5-mm (usually > 10-mm), mucin-producing epithelial neoplasm present within main pancreatic duct &/or its branches"
                  },
                  {
                    "text": "IPMNs are classified according to pattern of duct involvement into main duct, branch duct, or mixed duct type"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Molecular Features": [
                  {
                    "text": "GNASandKRASmutations common"
                  },
                  {
                    "text": "RNF43mutations in minority"
                  },
                  {
                    "text": "Loss of p16 increases with grade of dysplasia"
                  },
                  {
                    "text": "SMAD4(DPC4) loss uncommon in IPMN but can be lost in associated invasive component"
                  }
                ],
                "Risk Factors": [
                  {
                    "text": "History of diabetes"
                  },
                  {
                    "text": "Family history of pancreatic ductal adenocarcinoma (associated with branch duct IPMN)"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "20-50% of resected cystic pancreatic tumorsIncidence increasing due to increased incidental detection on imaging for other reasonsPrevalence increases with age",
                    "sub_points": [
                      "Incidence increasing due to increased incidental detection on imaging for other reasons",
                      "Prevalence increases with age"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 25-94 years (average: Mid-60s)"
                  }
                ],
                "Sex": [
                  {
                    "text": "Slightly more common in men but varies according to ethnicity"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Usually asymptomatic"
                  },
                  {
                    "text": "Symptomatic patients present with vague complaints related to duct obstruction/low-grade pancreatitisAbdominal &/or back painAnorexia, weight loss",
                    "sub_points": [
                      "Abdominal &/or back pain",
                      "Anorexia, weight loss"
                    ]
                  },
                  {
                    "text": "Symptoms often present for months to years before diagnosis established"
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Mucin extravasation from patulous ampulla of Vater in ~ 25% of cases, essentially diagnostic of intestinal-type IPMN"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Cyst fluid analysis, elevated CEA level, molecular studies"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection is treatment of choice80-98% of IPMNs are surgically resectable",
                    "sub_points": [
                      "80-98% of IPMNs are surgically resectable"
                    ]
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Noninvasive tumors: 5-year survival rate: > 90%"
                  },
                  {
                    "text": "Invasive tumors: 5-year survival rate: 36-90%Still significantly better than that of conventional pancreatic ductal adenocarcinoma",
                    "sub_points": [
                      "Still significantly better than that of conventional pancreatic ductal adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Increased incidence of synchronous or metachronous malignancies, particularly stomach and colon"
                  },
                  {
                    "text": "Can recur due to multifocal disease (often undetected at initial work-up)"
                  }
                ]
              },
              "IMAGING": {
                "CT Findings": [
                  {
                    "text": "Main duct or mixed duct typesMarkedly dilated main duct often associated with dilated large branch ducts",
                    "sub_points": [
                      "Markedly dilated main duct often associated with dilated large branch ducts"
                    ]
                  },
                  {
                    "text": "Branch duct typeSingle or numerous cysts that represent dilated branch ducts",
                    "sub_points": [
                      "Single or numerous cysts that represent dilated branch ducts"
                    ]
                  }
                ],
                "ERCP Findings": [
                  {
                    "text": "Dilated main pancreatic duct &/or branch ducts in absence of stricture"
                  },
                  {
                    "text": "Filling defects due to papillary projections of neoplasm &/or mucus plugs"
                  }
                ],
                "MRCP Findings": [
                  {
                    "text": "In addition to dilated ducts, mural nodules better visualizedIndicative of higher grade lesion",
                    "sub_points": [
                      "Indicative of higher grade lesion"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Most common in pancreatic headOften involve only portion of pancreatic ductMay be multifocal; entire pancreas may be involved",
                    "sub_points": [
                      "Often involve only portion of pancreatic duct",
                      "May be multifocal; entire pancreas may be involved"
                    ]
                  },
                  {
                    "text": "Main duct and mixed duct typesFlorid papillary projections, often in background of dilated ducts with mucin",
                    "sub_points": [
                      "Florid papillary projections, often in background of dilated ducts with mucin"
                    ]
                  },
                  {
                    "text": "Branch duct typeSingle or multiple peripheral cysts that connect to main duct, often with smooth lining",
                    "sub_points": [
                      "Single or multiple peripheral cysts that connect to main duct, often with smooth lining"
                    ]
                  },
                  {
                    "text": "Mural nodules &/or solid components may be seen in IPMNs that contain high-grade dysplasia &/or invasion"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Flat (undulating) or papillary mucinous epithelium"
                  },
                  {
                    "text": "Fibrotic stroma (loose or dense fibrosis; not ovarian-type stroma)"
                  },
                  {
                    "text": "3 epithelial subtypesGastric type (most common)Histologically low gradeBasally located nucleiSlightly eosinophilic cytoplasmAbundant apical cytoplasmic mucinUsually sole epithelial type in branch duct IPMNs, mixed with other epithelial types in main/combined typesIntestinal typeVillous papillae with basophilic cytoplasmEnlarged, oval, hyperchromatic nuclei with pseudostratificationOften have foci of high-grade dysplasiaPancreatobiliary type (uncommon)Thin, branching papillaeAmphophilic cytoplasmEnlarged, hyperchromatic nucleiOften associated with high-grade dysplasia",
                    "sub_points": [
                      "Gastric type (most common)Histologically low gradeBasally located nucleiSlightly eosinophilic cytoplasmAbundant apical cytoplasmic mucinUsually sole epithelial type in branch duct IPMNs, mixed with other epithelial types in main/combined types",
                      "Histologically low grade",
                      "Basally located nuclei",
                      "Slightly eosinophilic cytoplasm",
                      "Abundant apical cytoplasmic mucin",
                      "Usually sole epithelial type in branch duct IPMNs, mixed with other epithelial types in main/combined types",
                      "Intestinal typeVillous papillae with basophilic cytoplasmEnlarged, oval, hyperchromatic nuclei with pseudostratificationOften have foci of high-grade dysplasia",
                      "Villous papillae with basophilic cytoplasm",
                      "Enlarged, oval, hyperchromatic nuclei with pseudostratification",
                      "Often have foci of high-grade dysplasia",
                      "Pancreatobiliary type (uncommon)Thin, branching papillaeAmphophilic cytoplasmEnlarged, hyperchromatic nucleiOften associated with high-grade dysplasia",
                      "Thin, branching papillae",
                      "Amphophilic cytoplasm",
                      "Enlarged, hyperchromatic nuclei",
                      "Often associated with high-grade dysplasia"
                    ]
                  },
                  {
                    "text": "2-tiered dysplasia grading systemLow-grade dysplasiaUniform cellsOnly mild atypiaNo architectural complexityLesions previously classified as moderate- or intermediate-grade dysplasia now included hereHigh-grade dysplasia/carcinoma in situMarked architectural complexityMarked nuclear atypiaLoss of nuclear polarityIncreased mitosesDifferent grades of dysplasia often present within same IPMN",
                    "sub_points": [
                      "Low-grade dysplasiaUniform cellsOnly mild atypiaNo architectural complexityLesions previously classified as moderate- or intermediate-grade dysplasia now included here",
                      "Uniform cells",
                      "Only mild atypia",
                      "No architectural complexity",
                      "Lesions previously classified as moderate- or intermediate-grade dysplasia now included here",
                      "High-grade dysplasia/carcinoma in situMarked architectural complexityMarked nuclear atypiaLoss of nuclear polarityIncreased mitoses",
                      "Marked architectural complexity",
                      "Marked nuclear atypia",
                      "Loss of nuclear polarity",
                      "Increased mitoses",
                      "Different grades of dysplasia often present within same IPMN"
                    ]
                  },
                  {
                    "text": "35% of main duct IPMNs have associated invasive component; 15% of branch duct lesionsInvasive carcinomas arising in IPMNs often have tubular features, reminiscent of pancreatic ductal adenocarcinoma, or colloid featuresIntestinal-type IPMNs associated with colloid carcinomaPancreatobiliary-type IPMNs associated with tubular adenocarcinomaInvasive carcinoma arising in association with gastric-type IPMN is rare; if present, has tubular features",
                    "sub_points": [
                      "Invasive carcinomas arising in IPMNs often have tubular features, reminiscent of pancreatic ductal adenocarcinoma, or colloid featuresIntestinal-type IPMNs associated with colloid carcinomaPancreatobiliary-type IPMNs associated with tubular adenocarcinomaInvasive carcinoma arising in association with gastric-type IPMN is rare; if present, has tubular features",
                      "Intestinal-type IPMNs associated with colloid carcinoma",
                      "Pancreatobiliary-type IPMNs associated with tubular adenocarcinoma",
                      "Invasive carcinoma arising in association with gastric-type IPMN is rare; if present, has tubular features"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Small clusters and flat sheets of glandular epithelial cells± intracytoplasmic mucin",
                    "sub_points": [
                      "± intracytoplasmic mucin"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Mucinous Cystic Neoplasm": [
                  {
                    "text": "Usually involves body/tail of pancreas"
                  },
                  {
                    "text": "Does not communicate with pancreatic ducts"
                  },
                  {
                    "text": "Younger women"
                  },
                  {
                    "text": "Presence of ovarian-like stroma required for diagnosis"
                  },
                  {
                    "text": "GNASmutations are uncommon"
                  }
                ],
                "Pancreatic Intraepithelial Neoplasia": [
                  {
                    "text": "Does not produce grossly visible lesion"
                  },
                  {
                    "text": "Smaller than IPMN (usually < 5 mm in diameter)"
                  },
                  {
                    "text": "Overlap between these lesions can be difficult to resolve, especially at margins"
                  }
                ],
                "Serous Cystic Neoplasm": [
                  {
                    "text": "Often seen in women"
                  },
                  {
                    "text": "Microcysts lined by bland cuboidal epithelial cells with cytoplasmic glycogen"
                  },
                  {
                    "text": "Central scar seen in majority"
                  },
                  {
                    "text": "Does not communicate with pancreatic ducts"
                  }
                ],
                "Retention Cyst": [
                  {
                    "text": "Usually unilocular and lined by nonmucinous, pancreatic duct epithelium"
                  }
                ],
                "Simple Mucinous Cyst": [
                  {
                    "text": "Macroscopic cysts > 1 cm in size with single layer of flat, gastric-type mucinous lining that does not communicate with pancreatic duct"
                  },
                  {
                    "text": "Unilocular or multilocular with clear or serous fluid"
                  },
                  {
                    "text": "Lack cytologic atypia"
                  },
                  {
                    "text": "Many consider simple mucinous cyst as early low-grade mucinous neoplasm"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Invasive components may be very focal, thus, submission of entire lesion is necessary"
                  },
                  {
                    "text": "Careful gross examination to document communication between tumor and pancreatic ductal system essential"
                  },
                  {
                    "text": "Intraoperative surgical margin evaluationLow-grade lesions at margin not clinically actionableSurgeon may resect more pancreas if high-grade dysplasia is present at margin",
                    "sub_points": [
                      "Low-grade lesions at margin not clinically actionable",
                      "Surgeon may resect more pancreas if high-grade dysplasia is present at margin"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "In reporting IPMN, start with entity (IPMN), followed by grade and morphologic type (gastric, intestinal, or pancreatobiliary), size, and involved portion of ducts (main, branch or mixed; if relevant)"
                  },
                  {
                    "text": "When reporting invasion in IPMNs, either \"IPMN with associated invasive carcinoma\" or \"invasive carcinoma with associated IPMN\" can be usedInvasive carcinoma can arise independently in pancreas that also contains IPMNIf primary pancreatic ductal adenocarcinoma is large, cysts may be present due to secondary obstruction of ductsIf uncertain, report invasive carcinoma separate from cystic component and address possibility that cancer could be arising from IPMN, or there could be separate (concomitant) IPMN",
                    "sub_points": [
                      "Invasive carcinoma can arise independently in pancreas that also contains IPMN",
                      "If primary pancreatic ductal adenocarcinoma is large, cysts may be present due to secondary obstruction of ducts",
                      "If uncertain, report invasive carcinoma separate from cystic component and address possibility that cancer could be arising from IPMN, or there could be separate (concomitant) IPMN"
                    ]
                  }
                ]
              },
              "REPORTING": {
                "Staging": [
                  {
                    "text": "Only invasive carcinoma is stagedIf multifocal invasion is present, it is recommended to report size of largest focus and also estimate extent of overall invasive component",
                    "sub_points": [
                      "If multifocal invasion is present, it is recommended to report size of largest focus and also estimate extent of overall invasive component"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intraductal Oncocytic Papillary Neoplasm": {
            "name": "Intraductal Oncocytic Papillary Neoplasm",
            "url": "https://app.pathprimer.com/document/05621ec5-cdcb-47a0-8f80-32b956090770/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Grossly cystic neoplasm with intraductal growth pattern and oncocytic epithelium"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare: Account for 4.5% of all intraductal neoplasms of pancreas"
                  },
                  {
                    "text": "Age range: 36-87 years (median: 59 years)"
                  },
                  {
                    "text": "More common in females"
                  },
                  {
                    "text": "Surgical resection is treatment of choice"
                  },
                  {
                    "text": "Although 30% of IOPNs are associated with invasive component, 5-year survival rate approaches 100%"
                  },
                  {
                    "text": "Local recurrence is common (as many as 45%) and can occur years after initial resection"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Soft red-brown or tan-red papillary masses within dilated pancreatic duct(s)"
                  },
                  {
                    "text": "Range: 1.6-15 cm (average: 5.5 cm)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Oncocytic epithelium forms architecturally complex papillary growth pattern as well as areas of cribriforming and solid growthOften classified as having high-grade dysplasia given architectural complexity and cytologic atypia",
                    "sub_points": [
                      "Often classified as having high-grade dysplasia given architectural complexity and cytologic atypia"
                    ]
                  },
                  {
                    "text": "Neoplastic cells have abundant granular eosinophilic cytoplasm with large nuclei, prominent nucleoli"
                  },
                  {
                    "text": "Invasive carcinoma, often minimally invasive, present in 30%"
                  },
                  {
                    "text": "Stain strongly with MUC6"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "PRKACAandPRKACBgene fusions"
                  },
                  {
                    "text": "LackKRAS,GNAS, andRNF43mutations"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "IPMN (especially pancreatobiliary type)"
                  },
                  {
                    "text": "Other solid pancreatic neoplasms"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Intraductal oncocytic papillary neoplasm (IOPN)"
                  },
                  {
                    "text": "Intraductal papillary mucinous neoplasm (IPMN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Grossly cystic neoplasm consisting of architecturally complex papillary growth of oncocytic epithelium within pancreatic ducts"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare: Account for 4.5% of all intraductal neoplasms of pancreas"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 36-87 years (median: 59 years)"
                  }
                ],
                "Sex": [
                  {
                    "text": "More common in females"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to IPMNs"
                  },
                  {
                    "text": "Majority present with nonspecific symptoms, or are discovered incidentally during imaging study for another indication"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection is treatment of choice"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Although 30% of IOPNs are associated with invasive component, 5-year survival rate approaches 100%"
                  },
                  {
                    "text": "Local recurrence is common (as many as 45%) and can occur years after initial resection"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Large mass(es) within cystically dilated pancreatic duct(s)"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Soft red-brown or tan-red papillary masses within dilated pancreatic duct(s)"
                  }
                ],
                "Size": [
                  {
                    "text": "Range: 1.6-15 cm (average: 5.5 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Architecturally complex intraductal epithelial proliferation with arborizing papillae, cribriforming, and solid nestsOften classified as having high-grade dysplasia given architectural complexity and cytologic atypia",
                    "sub_points": [
                      "Often classified as having high-grade dysplasia given architectural complexity and cytologic atypia"
                    ]
                  },
                  {
                    "text": "Neoplastic epithelial cells exhibit abundant granular eosinophilic cytoplasm with large nuclei and prominent nucleoli"
                  },
                  {
                    "text": "Both intracytoplasmic and intercellular lumina can be present, many containing mucin, with scattered goblet cells"
                  },
                  {
                    "text": "Stroma can be edematous or myxoid at tip &/or base of papillae"
                  },
                  {
                    "text": "Invasive carcinomas, often minimally invasive, are found in ~ 30% of cases, and some retain oncocytic features"
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Stain strongly with MUC6"
                  },
                  {
                    "text": "Variable staining with MUC1, MUC2, MUC5AC, CEA, CA19-9"
                  },
                  {
                    "text": "May have focal chromogranin, chymotrypsin positivity"
                  },
                  {
                    "text": "Hepatocyte antigen is often (+)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Genetic Testing": [
                  {
                    "text": "PRKACAandPRKACBgene fusions"
                  },
                  {
                    "text": "Harbor mutations involvingARHGAP26,ASXL1,EPHA8, andERBB4"
                  },
                  {
                    "text": "LackKRAS,GNAS, andRNF43mutations, unlike IPMN"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Other Types of Intraductal Papillary Mucinous Neoplasm": [
                  {
                    "text": "Complex architecture and eosinophilic cytoplasm are distinct from gastric- or intestinal-type epithelium"
                  },
                  {
                    "text": "Overlap with pancreatobiliary-type IPMN, but abundant granular eosinophilic cytoplasm should be prominent feature in cases designated IOPN"
                  }
                ],
                "Other Solid Pancreatic Neoplasms": [
                  {
                    "text": "If solid growth pattern predominatesPancreatic neuroendocrine neoplasmDiffusely (+) for chromogranin, synaptophysinAcinar cell carcinomaImmunoreactivity to trypsin, chymotrypsin, BCL10PAS-D(+) granules may be seen in apical aspect of gland-forming cellsSolid pseudopapillary neoplasmTypically in young female patientsMark with CD10, nuclear expression of β-catenin",
                    "sub_points": [
                      "Pancreatic neuroendocrine neoplasmDiffusely (+) for chromogranin, synaptophysin",
                      "Diffusely (+) for chromogranin, synaptophysin",
                      "Acinar cell carcinomaImmunoreactivity to trypsin, chymotrypsin, BCL10PAS-D(+) granules may be seen in apical aspect of gland-forming cells",
                      "Immunoreactivity to trypsin, chymotrypsin, BCL10",
                      "PAS-D(+) granules may be seen in apical aspect of gland-forming cells",
                      "Solid pseudopapillary neoplasmTypically in young female patientsMark with CD10, nuclear expression of β-catenin",
                      "Typically in young female patients",
                      "Mark with CD10, nuclear expression of β-catenin"
                    ]
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Similar to IPMN in many aspects but with prominent oncocytic features"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Intraductal Tubulopapillary Neoplasm": {
            "name": "Intraductal Tubulopapillary Neoplasm",
            "url": "https://app.pathprimer.com/document/88ba99ba-eae5-4d00-946c-168accb22da9/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Solid epithelial neoplasm composed of back-to-back tubular glands and papillae that grows within and obstructs pancreatic ductsNo grossly visible mucin",
                    "sub_points": [
                      "No grossly visible mucin"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Very rare entity"
                  },
                  {
                    "text": "Majority are discovered incidentally"
                  },
                  {
                    "text": "Average age: 56 years"
                  },
                  {
                    "text": "PresentationSimilar to intraductal papillary mucinous neoplasms (IPMNs)Symptomatic cases present with abdominal painMajority discovered incidentally",
                    "sub_points": [
                      "Similar to intraductal papillary mucinous neoplasms (IPMNs)Symptomatic cases present with abdominal painMajority discovered incidentally",
                      "Symptomatic cases present with abdominal pain",
                      "Majority discovered incidentally"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Average size: 3 cm"
                  }
                ],
                "Molecular": [
                  {
                    "text": "NoKRASorGNASmutations"
                  },
                  {
                    "text": "Alterations in chromatin remodeling genes,PI3Kpathway genes"
                  },
                  {
                    "text": "May harborMCL1amplification orFGFR2fusions"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tubular or tubulopapillary growthScant or absent mucin",
                    "sub_points": [
                      "Scant or absent mucin"
                    ]
                  },
                  {
                    "text": "Usually harbor high-grade dysplasia with numerous mitoses and necrosis"
                  },
                  {
                    "text": "Invasive component may be similar to intraductal component or highly infiltrative"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "IPMN"
                  },
                  {
                    "text": "Acinar cell carcinoma, intraductal variant"
                  },
                  {
                    "text": "Pancreatic ductal adenocarcinoma"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Intraductal tubulopapillary neoplasm (ITPN)"
                  },
                  {
                    "text": "Intraductal papillary mucinous neoplasm (IPMN)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Grossly visible, solid intraductal massComposed of packed glands/tubules with focal tubulopapillary growthLacks overt mucin production",
                    "sub_points": [
                      "Composed of packed glands/tubules with focal tubulopapillary growth",
                      "Lacks overt mucin production"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare entity (account for <1% of all pancreatic exocrine neoplasms and 3% of pancreatic intraductal neoplasms)"
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 36-79 years"
                  },
                  {
                    "text": "Average: 56 years"
                  }
                ],
                "Sex": [
                  {
                    "text": "Equal distribution"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Similar to IPMNsSymptomatic cases present with abdominal painMajority discovered incidentally",
                    "sub_points": [
                      "Symptomatic cases present with abdominal pain",
                      "Majority discovered incidentally"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Pancreatectomy with curative intent is treatment of choice"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Limited follow-up data suggest relatively indolent course, especially if no invasive component"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Dilated and irregular main pancreatic duct"
                  },
                  {
                    "text": "Lack of low-attenuation mucin"
                  },
                  {
                    "text": "2-tone duct sign on CT/MR and cork-of-wine-bottle sign on MR cholangiopancreatography/ERCP"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solid mass that fills and expands pancreatic duct(s)Often pedunculated, but pedicle may be difficult to identifyNo visible mucin",
                    "sub_points": [
                      "Often pedunculated, but pedicle may be difficult to identify",
                      "No visible mucin"
                    ]
                  },
                  {
                    "text": "Most tumors involve head of pancreas, but can occur throughout"
                  }
                ],
                "Size": [
                  {
                    "text": "Range: 1-15 cm; mean 4.5cm"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Closely packed glands/tubulesMonotonous cuboidal to columnar cells, with enlarged nuclei and eosinophilic to amphophilic cytoplasmMay resemble pyloric gland adenoma, acinar cell carcinoma, neuroendocrine tumor, and even, follicular variant of papillary thyroid carcinomaSolid &/or cribriform areas may be presentPapillary structures may be presentScarce or absent cytoplasmic mucin",
                    "sub_points": [
                      "Monotonous cuboidal to columnar cells, with enlarged nuclei and eosinophilic to amphophilic cytoplasmMay resemble pyloric gland adenoma, acinar cell carcinoma, neuroendocrine tumor, and even, follicular variant of papillary thyroid carcinoma",
                      "May resemble pyloric gland adenoma, acinar cell carcinoma, neuroendocrine tumor, and even, follicular variant of papillary thyroid carcinoma",
                      "Solid &/or cribriform areas may be present",
                      "Papillary structures may be present",
                      "Scarce or absent cytoplasmic mucin"
                    ]
                  },
                  {
                    "text": "Usually exhibit high-grade dysplasiaAbundant mitoses and necrosis (including comedo-type necrosis)",
                    "sub_points": [
                      "Abundant mitoses and necrosis (including comedo-type necrosis)"
                    ]
                  },
                  {
                    "text": "Invasive component (common) may resemble intraductal components (tubulopapillary pattern) or may be composed of infiltrating ducts typical of pancreatic ductal adenocarcinoma"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "CK7 and CK19 (+); CK20(-)"
                  },
                  {
                    "text": "MUC1(+), variable staining with MUC6; MUC2 and MUC5AC (-)"
                  },
                  {
                    "text": "Markers for pancreatic acinar differentiation, such as trypsin, chymotrypsin, BCL10, are negative"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "NoKRASorGNASmutations (unlike IPMN)"
                  },
                  {
                    "text": "Alterations in chromatin remodeling genes,PI3Kpathway genes"
                  },
                  {
                    "text": "May harborMCL1amplification orFGFR2fusions"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Intraductal Papillary Mucinous Neoplasm": [
                  {
                    "text": "Dilated pancreatic ducts filled with mucin"
                  },
                  {
                    "text": "Tall, columnar epithelium with obvious cytoplasmic mucin"
                  },
                  {
                    "text": "Well-developed papillae with no necrosis"
                  },
                  {
                    "text": "Consistent marking with MUC5AC"
                  }
                ],
                "Acinar Cell Carcinoma, Intraductal Variant": [
                  {
                    "text": "Positive for exocrine markers, including trypsin, BCL10"
                  },
                  {
                    "text": "Solid, nested pattern with granular cytoplasm"
                  }
                ],
                "Pancreatic Ductal Adenocarcinoma": [
                  {
                    "text": "Does not have prominent intraductal growth pattern"
                  },
                  {
                    "text": "Very infiltrative and destructive"
                  },
                  {
                    "text": "Marked desmoplastic stroma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Intraductal growth is similar to IPMNs, but solid mass, lack of mucin, and presence of tubular growth pattern are distinct from IPMN"
                  },
                  {
                    "text": "Important to note intraductal growth grossly"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Dermoid Cyst": {
            "name": "Dermoid Cyst",
            "url": "https://app.pathprimer.com/document/758dc80b-b9d4-4989-ac27-88564b07054b/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Squamous-lined cyst with differentiation along multiple germlinesPancreatic dermoid cysts only contain ectodermal elements",
                    "sub_points": [
                      "Pancreatic dermoid cysts only contain ectodermal elements"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Extremely rareOnly handful of cases reported",
                    "sub_points": [
                      "Only handful of cases reported"
                    ]
                  },
                  {
                    "text": "Patients present with nonspecific gastrointestinal symptomsMay present with palpable mass",
                    "sub_points": [
                      "May present with palpable mass"
                    ]
                  },
                  {
                    "text": "No known malignant potential"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Often unilocular tumorVariegated solid and cystic",
                    "sub_points": [
                      "Variegated solid and cystic"
                    ]
                  },
                  {
                    "text": "Involves head, body, or tail of pancreas"
                  },
                  {
                    "text": "Does not communicate with main pancreatic duct"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Similar to dermoid cysts of other organsMultilayered mature squamous epithelium without atypiaAdnexal structures present, such as sebaceous glands and hair folliclesMesodermal tissue, such as cartilage, is only rarely present in pancreas",
                    "sub_points": [
                      "Multilayered mature squamous epithelium without atypia",
                      "Adnexal structures present, such as sebaceous glands and hair follicles",
                      "Mesodermal tissue, such as cartilage, is only rarely present in pancreas"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Lymphoepithelial cystSignificant overlap between lymphoepithelial cyst and dermoid cyst",
                    "sub_points": [
                      "Significant overlap between lymphoepithelial cyst and dermoid cyst"
                    ]
                  },
                  {
                    "text": "Epidermoid cyst in intrapancreatic splenic tissue"
                  },
                  {
                    "text": "Pancreatic squamous cyst"
                  },
                  {
                    "text": "Retention cyst"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Mature cystic teratoma"
                  },
                  {
                    "text": "Monodermal teratoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Squamous-lined cyst with differentiation along multiple germlinesPancreatic dermoid cysts contain only ectodermal elements",
                    "sub_points": [
                      "Pancreatic dermoid cysts contain only ectodermal elements"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Extremely rareOnly handful of cases reported",
                    "sub_points": [
                      "Only handful of cases reported"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Range: 2-53 yearsMean: 29 years",
                    "sub_points": [
                      "Mean: 29 years"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "No sex predominance"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific gastrointestinal symptomsNausea and vomitingMalaiseEpigastric painWeight lossDyspepsia",
                    "sub_points": [
                      "Nausea and vomiting",
                      "Malaise",
                      "Epigastric pain",
                      "Weight loss",
                      "Dyspepsia"
                    ]
                  },
                  {
                    "text": "Palpable mass"
                  },
                  {
                    "text": "Often found incidentally"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery"
                  },
                  {
                    "text": "Nonoperative management is feasible in cases with definite preoperative diagnosis"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "No known malignant potential"
                  }
                ]
              },
              "IMAGING": {
                "General Features": [
                  {
                    "text": "Variegated solid/cystic mass, sometimes with calcification"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Cystic tumorOften unilocularMay have solid appearance in areasContents appear pasty or cheesyInvolves head, body, or tail of pancreasDoes not communicate with pancreatic ductal system",
                    "sub_points": [
                      "Often unilocular",
                      "May have solid appearance in areas",
                      "Contents appear pasty or cheesy",
                      "Involves head, body, or tail of pancreas",
                      "Does not communicate with pancreatic ductal system"
                    ]
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Similar to dermoid cysts of other organsMultilayered mature squamous epithelium without atypiaAdnexal structures present, such as sebaceous glands and hair folliclesOther cell types (e.g., mucus cells, respiratory epithelium)",
                    "sub_points": [
                      "Multilayered mature squamous epithelium without atypia",
                      "Adnexal structures present, such as sebaceous glands and hair follicles",
                      "Other cell types (e.g., mucus cells, respiratory epithelium)"
                    ]
                  },
                  {
                    "text": "Pancreatic dermoid cysts are predominantly monodermalMesodermal tissue, such as cartilage, is only rarely present",
                    "sub_points": [
                      "Mesodermal tissue, such as cartilage, is only rarely present"
                    ]
                  }
                ],
                "Cytologic Features": [
                  {
                    "text": "Anucleated squamous cells"
                  },
                  {
                    "text": "Necrotic debris"
                  },
                  {
                    "text": "May have prominent lymphoid component"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Lymphoepithelial Cyst": [
                  {
                    "text": "Lined by squamous epithelium with prominent (band-like) layer of dense lymphoid tissue"
                  },
                  {
                    "text": "Occasionally, sebaceous glands and rare mucus cells may be found, but other adnexal structures are absent"
                  },
                  {
                    "text": "There is significant overlap between lymphoepithelial cysts and dermoid cystsExtensive sebaceous differentiation, presence of hair, and lack of dense lymphoid stroma support dermoid cyst",
                    "sub_points": [
                      "Extensive sebaceous differentiation, presence of hair, and lack of dense lymphoid stroma support dermoid cyst"
                    ]
                  }
                ],
                "Epidermoid Cyst in Intrapancreatic Splenic Tissue": [
                  {
                    "text": "Splenic pulp is present"
                  }
                ],
                "Pancreatic Squamous Cyst": [
                  {
                    "text": "Lined by squamous epithelium but lacks adnexal structures"
                  }
                ],
                "Serous Cystadenoma": [
                  {
                    "text": "Lined by single, occasionally multilayered, epithelium with clear cytoplasm"
                  },
                  {
                    "text": "Lacks adnexal structures, lymphoid tissue, and mesodermal elements"
                  }
                ],
                "Mucinous Cystic Neoplasm and Intraductal Papillary Mucinous Neoplasm": [
                  {
                    "text": "Mucin-producing cells dominate epithelium lining"
                  },
                  {
                    "text": "Lacks squamous, adnexal, and lymphoid components"
                  },
                  {
                    "text": "Intraductal papillary mucinous neoplasm communicates with pancreatic duct"
                  }
                ],
                "Retention Cyst": [
                  {
                    "text": "Lined by simple cuboidal epithelium"
                  },
                  {
                    "text": "When present, squamous differentiation is focal"
                  },
                  {
                    "text": "Lacks lymphoid stroma, adnexal structures"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Acinar Cell Carcinoma": {
            "name": "Acinar Cell Carcinoma",
            "url": "https://app.pathprimer.com/document/ff00d95c-7e9f-4139-a084-ef83b2601fc6/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Rare, highly aggressive malignant exocrine carcinoma with acinar differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "1-2% of primary pancreatic neoplasms"
                  },
                  {
                    "text": "5th and 7th decades of life (mean: 58 years)"
                  },
                  {
                    "text": "Highly aggressive tumor with high rate of recurrenceMinority of patients have associated lipase hypersecretion paraneoplastic syndrome",
                    "sub_points": [
                      "Minority of patients have associated lipase hypersecretion paraneoplastic syndrome"
                    ]
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Solid, well-circumscribed, fleshy mass"
                  },
                  {
                    "text": "Average 10 cm in diameter (range: 2-30 cm)"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Densely cellular with multiple architectural patterns, most commonly acinar or solid"
                  },
                  {
                    "text": "Uniform nuclei with central prominent nucleolusEosinophilic, finely granular cytoplasm",
                    "sub_points": [
                      "Eosinophilic, finely granular cytoplasm"
                    ]
                  },
                  {
                    "text": "Minimal to moderate finely granular, eosinophilic to amphophilic cytoplasm"
                  },
                  {
                    "text": "Typically have minimal stroma"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "ImmunohistochemistryBCL10, trypsin, chymotrypsin are most sensitiveCK7, CK8/18, possible focal synaptophysin/chromogranin staining",
                    "sub_points": [
                      "BCL10, trypsin, chymotrypsin are most sensitive",
                      "CK7, CK8/18, possible focal synaptophysin/chromogranin staining"
                    ]
                  },
                  {
                    "text": "PAS positive, resistant to diastase digestionMany have insufficient quantities of zymogen granules, resulting in negative stain",
                    "sub_points": [
                      "Many have insufficient quantities of zymogen granules, resulting in negative stain"
                    ]
                  },
                  {
                    "text": "Alterations in Wnt signaling and chromosomal 11p loss are common in acinar cell carcinoma"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic neuroendocrine tumor, pancreatoblastoma, solid pseudopapillary neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Acinar cell carcinoma (ACC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant exocrine carcinoma with acinar differentiationProduces pancreatic exocrine enzymes in zymogen granules",
                    "sub_points": [
                      "Produces pancreatic exocrine enzymes in zymogen granules"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "1-2% of primary pancreatic neoplasms in adults"
                  }
                ],
                "Age": [
                  {
                    "text": "Between 5th and 7th decades of life (mean: 58 years)"
                  },
                  {
                    "text": "Rare in children"
                  }
                ],
                "Sex": [
                  {
                    "text": "Male predominance with M:F ratio of 2.1-3.6:1"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Nonspecific symptoms (abdominal pain, weight loss)"
                  },
                  {
                    "text": "Associated with lipase hypersecretion paraneoplastic syndrome (10-15%), causing subcutaneous fat necrosis and polyarthralgia"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "Elevated serum lipase in lipase hypersecretion syndrome"
                  },
                  {
                    "text": "Elevated α-fetoprotein in younger patients"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgical resection and adjuvant therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Highly aggressive tumor with high rate of recurrenceMost patients have metastatic disease at presentation, usually to lymph nodes and liverOverall 5-year survival is 6-36%",
                    "sub_points": [
                      "Most patients have metastatic disease at presentation, usually to lymph nodes and liver",
                      "Overall 5-year survival is 6-36%"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Most frequently occur in head, followed by tail and body"
                  },
                  {
                    "text": "Solid, well-circumscribed mass; capsular invasion commonAverage of 10 cm in diameter (range: 2-30 cm)",
                    "sub_points": [
                      "Average of 10 cm in diameter (range: 2-30 cm)"
                    ]
                  },
                  {
                    "text": "Solid, fleshy, lobulated, tan to red cut surface"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Densely cellular tumor with several architectural patternsAcinar: Minute lumina with basally located nuclei and apical cytoplasm, mimicking normal aciniGlandular: Dilated acinar lumensTrabecular: Interlacing ribbons of cells with nuclei oriented toward periphery; can mimic neuroendocrine tumorSolidSheets and nests of cells without lumensBasal nuclear palisading along stromal interfaceCan also resemble neuroendocrine tumor",
                    "sub_points": [
                      "Acinar: Minute lumina with basally located nuclei and apical cytoplasm, mimicking normal acini",
                      "Glandular: Dilated acinar lumens",
                      "Trabecular: Interlacing ribbons of cells with nuclei oriented toward periphery; can mimic neuroendocrine tumor",
                      "SolidSheets and nests of cells without lumensBasal nuclear palisading along stromal interfaceCan also resemble neuroendocrine tumor",
                      "Sheets and nests of cells without lumens",
                      "Basal nuclear palisading along stromal interface",
                      "Can also resemble neuroendocrine tumor"
                    ]
                  },
                  {
                    "text": "Typically stroma is minimal, without desmoplasia"
                  },
                  {
                    "text": "Cytologic featuresUniform nuclei with vesicular chromatinOften single prominent central nucleolusMinimal to moderate finely granular, eosinophilic to amphophilic cytoplasm ± zymogen granules",
                    "sub_points": [
                      "Uniform nuclei with vesicular chromatin",
                      "Often single prominent central nucleolus",
                      "Minimal to moderate finely granular, eosinophilic to amphophilic cytoplasm ± zymogen granules"
                    ]
                  },
                  {
                    "text": "Mitotic rate is generally high, and Ki-67 index is usually > 20-30%"
                  },
                  {
                    "text": "Vascular invasion common"
                  },
                  {
                    "text": "Variably present features:Cystic growth (acinar cell cystadenocarcinoma)Intraductal growthOncocytic cytoplasmThis variant may not mark with trypsinRarely signet ring, clear, spindle or pleomorphic cell features",
                    "sub_points": [
                      "Cystic growth (acinar cell cystadenocarcinoma)",
                      "Intraductal growth",
                      "Oncocytic cytoplasmThis variant may not mark with trypsin",
                      "This variant may not mark with trypsin",
                      "Rarely signet ring, clear, spindle or pleomorphic cell features"
                    ]
                  },
                  {
                    "text": "Mixed acinar-neuroendocrine carcinoma and mixed acinar-ductal carcinoma require ≥ 30% of each component"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Histochemistry": [
                  {
                    "text": "Variably positive for PAS, resistant to diastase digestionMany ACCs have insufficient quantities of zymogen granules, resulting in negative stain",
                    "sub_points": [
                      "Many ACCs have insufficient quantities of zymogen granules, resulting in negative stain"
                    ]
                  }
                ],
                "Immunohistochemistry": [
                  {
                    "text": "Positive for BCL10, CK8/18, trypsin (97%), chymotrypsin (66-95%), lipase (70-84%)"
                  },
                  {
                    "text": "May have focal synaptophysin or chromogranin immunoreactivity"
                  },
                  {
                    "text": "Amylase, CK7, CK20, glypican-3, and α-fetoprotein can be positive"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Alterations in Wnt/β-catenin (APC) pathway (24%) and chromosomal 11p loss of heterozygosity (50%) are common, similar to pancreatoblastoma"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pancreatic Neuroendocrine Tumor": [
                  {
                    "text": "Salt and pepper chromatin"
                  },
                  {
                    "text": "Diffusely, rather than focally, positive for synaptophysin and chromogranin"
                  },
                  {
                    "text": "A high proliferative rate may indicate acinar cell carcinoma (ACC) and not pancreatic neuroendocrine tumor; confirmatory immunohistochemical stains are needed"
                  }
                ],
                "Pancreatoblastoma": [
                  {
                    "text": "More common in early childhood; distinctive squamous nests"
                  }
                ],
                "Solid Pseudopapillary Neoplasm": [
                  {
                    "text": "Characteristic degenerative pseudopapillary formation"
                  },
                  {
                    "text": "Immunoreactive for β-catenin, not BCL10, trypsin, or chymotrypsin"
                  }
                ],
                "Intraductal Tubulopapillary Neoplasm": [
                  {
                    "text": "ACC can form polypoid intraductal mass"
                  },
                  {
                    "text": "Positive staining for trypsin is critical to confirm ACC"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Pancreatoblastoma": {
            "name": "Pancreatoblastoma",
            "url": "https://app.pathprimer.com/document/1e7feb94-e6b2-4241-8ed5-85c7f0b17952/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm with multiple lines of differentiation"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Rare overall, but most common malignant pancreatic neoplasm of childhood2/3 of pancreatoblastoma occur in children, 1/3 in adultsMean age at diagnosis is 2.4 years in children and 40 years in adults",
                    "sub_points": [
                      "2/3 of pancreatoblastoma occur in children, 1/3 in adults",
                      "Mean age at diagnosis is 2.4 years in children and 40 years in adults"
                    ]
                  },
                  {
                    "text": "Presents as abdominal mass, often palpable in children, and abdominal pain25-30% have elevated α-fetoprotein",
                    "sub_points": [
                      "25-30% have elevated α-fetoprotein"
                    ]
                  },
                  {
                    "text": "Overall survival only 50%Prognosis worse in adults",
                    "sub_points": [
                      "Prognosis worse in adults"
                    ]
                  },
                  {
                    "text": "Frequent alterations in Wnt/β-catenin (APC) pathway and chromosome 11p loss of heterozygosity"
                  }
                ],
                "Macroscopic": [
                  {
                    "text": "Usually solitary"
                  },
                  {
                    "text": "Well circumscribed"
                  },
                  {
                    "text": "Lobulated"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Lobular growth pattern with distinct fibrous bands"
                  },
                  {
                    "text": "Variable histologic findingsAcinar pattern usually predominantSquamoid nests virtually always presentNeuroendocrine component variably presentVariable stromal componentPrimitive component variably presentRarely contains focal ductal component",
                    "sub_points": [
                      "Acinar pattern usually predominant",
                      "Squamoid nests virtually always present",
                      "Neuroendocrine component variably present",
                      "Variable stromal component",
                      "Primitive component variably present",
                      "Rarely contains focal ductal component"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acinar cell carcinoma"
                  },
                  {
                    "text": "Pancreatic neuroendocrine tumor"
                  },
                  {
                    "text": "Solid pseudopapillary neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Pancreatoblastoma (PB)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasm with multiple lines of differentiation"
                  },
                  {
                    "text": "Frequent alterations in β-catenin/APCpathway and chromosome 11p loss of heterozygosityAberrant activation of Wnt/β-catenin pathway with concurrent dysregulation ofIGF2",
                    "sub_points": [
                      "Aberrant activation of Wnt/β-catenin pathway with concurrent dysregulation ofIGF2"
                    ]
                  },
                  {
                    "text": "Minority associated withSMAD4(DPC4) alterations"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare overall, but most common malignant pancreatic neoplasm of childhood25% of pancreatic tumors in pediatric populationMostly sporadic but may be associated with Beckwith-Wiedemann or familial adenomatous polyposis syndromesNo sex predominanceMore common in Asian patients",
                    "sub_points": [
                      "25% of pancreatic tumors in pediatric population",
                      "Mostly sporadic but may be associated with Beckwith-Wiedemann or familial adenomatous polyposis syndromes",
                      "No sex predominance",
                      "More common in Asian patients"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "2/3 occur in children, 1/3 in adultsBimodal distribution; mean at diagnosis is 2.4 years in children and 40 years in adults",
                    "sub_points": [
                      "Bimodal distribution; mean at diagnosis is 2.4 years in children and 40 years in adults"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Upper abdominal mass; large and often palpable in children"
                  },
                  {
                    "text": "Abdominal pain, weight loss"
                  },
                  {
                    "text": "Jaundice is rare"
                  }
                ],
                "Laboratory Tests": [
                  {
                    "text": "25-30% have elevated α-fetoprotein (AFP), especially in children"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Surgery is treatment of choice; chemotherapy and radiation for unresectable disease or recurrence"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Aggressive neoplasm (local invasion, metastasis, recurrence)1/3 have metastases at time of diagnosis (usually liver, lymph nodes, lungs, peritoneum)Overall survival only 50%Prognosis worse for adults than children",
                    "sub_points": [
                      "1/3 have metastases at time of diagnosis (usually liver, lymph nodes, lungs, peritoneum)",
                      "Overall survival only 50%Prognosis worse for adults than children",
                      "Prognosis worse for adults than children"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Usually large, solitary, and lobulatedMean size: 10-11 cm",
                    "sub_points": [
                      "Mean size: 10-11 cm"
                    ]
                  },
                  {
                    "text": "Equally distributed between head and tail"
                  },
                  {
                    "text": "Well circumscribed and at least partially encapsulated"
                  },
                  {
                    "text": "Gray, tan, or yellow cut surface with variably present necrosis"
                  },
                  {
                    "text": "Cystic in patients with Beckwith-Wiedemann syndrome"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Lobular growth pattern with distinct fibrous bands"
                  },
                  {
                    "text": "Variable histologic patternsAcinar pattern is usually predominantCells polarized around small lumina; uniform basal nuclei with single nucleolusSquamoid nests are key diagnostic featureVirtually always present, usually in center of tumor lobulesWhorled, plump, sometimes spindled cells with eosinophilic cytoplasmVariably present keratinizationNeuroendocrine component is present in 50-65% of tumorsNeuroendocrine cells either scattered within acini or form trabeculae or nestsStromal componentRanges from paucicellular to highly cellularMay contain foci of cartilage or osseous differentiationOccasional primitive component featuring small, monotonous, immature, blast-like cellsRarely contains ductal component; if present, usually focal",
                    "sub_points": [
                      "Acinar pattern is usually predominantCells polarized around small lumina; uniform basal nuclei with single nucleolus",
                      "Cells polarized around small lumina; uniform basal nuclei with single nucleolus",
                      "Squamoid nests are key diagnostic featureVirtually always present, usually in center of tumor lobulesWhorled, plump, sometimes spindled cells with eosinophilic cytoplasmVariably present keratinization",
                      "Virtually always present, usually in center of tumor lobules",
                      "Whorled, plump, sometimes spindled cells with eosinophilic cytoplasm",
                      "Variably present keratinization",
                      "Neuroendocrine component is present in 50-65% of tumorsNeuroendocrine cells either scattered within acini or form trabeculae or nests",
                      "Neuroendocrine cells either scattered within acini or form trabeculae or nests",
                      "Stromal componentRanges from paucicellular to highly cellularMay contain foci of cartilage or osseous differentiation",
                      "Ranges from paucicellular to highly cellular",
                      "May contain foci of cartilage or osseous differentiation",
                      "Occasional primitive component featuring small, monotonous, immature, blast-like cells",
                      "Rarely contains ductal component; if present, usually focal"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Acinar component stains with BCL10, trypsin, chymotrypsin, PAS-D, keratins (7, 8, 18, 19, CAM5.2, AE1/AE3); may stain with AFP"
                  },
                  {
                    "text": "Neuroendocrine component stains with synaptophysin, chromogranin"
                  },
                  {
                    "text": "Squamoid nests are often not immunoreactive; may have nuclear β-catenin immunoreactivity"
                  }
                ],
                "Genetic Testing": [
                  {
                    "text": "Allelic loss of chromosome arm 11p (> 80%)"
                  },
                  {
                    "text": "Alterations in Wnt/β-catenin (APC) pathway (50-80%) with concurrent dysregulation ofIGF2"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acinar Cell Carcinoma": [
                  {
                    "text": "Usually older adults; lacks squamoid nests and prominent stromal component"
                  }
                ],
                "Pancreatic Neuroendocrine Tumor": [
                  {
                    "text": "Uniform neuroendocrine differentiation, negative for acinar markers, lacks squamoid nests"
                  }
                ],
                "Solid Pseudopapillary Neoplasm": [
                  {
                    "text": "Pseudopapillary pattern, foamy macrophages, cholesterol clefts; lacks squamoid nests"
                  },
                  {
                    "text": "Usually in young adult female patients"
                  },
                  {
                    "text": "CD10 positive; negative for pancreatic enzyme stains"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Well-Differentiated Neuroendocrine Tumor, Pancreas": {
            "name": "Well-Differentiated Neuroendocrine Tumor, Pancreas",
            "url": "https://app.pathprimer.com/document/e80fdc34-3296-433a-9142-a78e36a427a7/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Etiology/Pathogenesis": [
                  {
                    "text": "Syndromic: MEN1, von Hippel-Lindau syndrome, tuberous sclerosis, neurofibromatosis type 1, familial insulinomatosis, glucagon cell hyperplasia and neoplasia"
                  },
                  {
                    "text": "Majority are nonsyndromic and sporadic"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Surgical resection for tumors confined to pancreas"
                  },
                  {
                    "text": "Long-acting somatostatin analogs for metastatic tumors"
                  },
                  {
                    "text": "Inhibitors of VEGF, tyrosine kinase, and mTOR pathway"
                  },
                  {
                    "text": "Role of platinum therapy in G3 NETs unclear, may be useful if Ki-67 index > 55%"
                  },
                  {
                    "text": "Majority are asymptomatic and detected by imaging"
                  },
                  {
                    "text": "Peak incidence between 30-60 years; no significant sex predilection"
                  }
                ],
                "Imaging": [
                  {
                    "text": "SSTR PET/CT: PET with Gallium-labeled somatostatin analogs is preferred imaging modality"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Monotonous population of round to cuboidal cells"
                  },
                  {
                    "text": "Amyloid deposits in insulinoma"
                  },
                  {
                    "text": "Adverse prognostic features: Size > 2 cm, necrosis, vascular invasion, perineural invasion, high tumor grade"
                  },
                  {
                    "text": "Coarse nuclear chromatin with salt and pepper appearance"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Chromogranin, synaptophysin, INSM1"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Acinar cell carcinoma"
                  },
                  {
                    "text": "Solid pseudopapillary neoplasm"
                  },
                  {
                    "text": "Neuroendocrine carcinoma"
                  }
                ],
                "Grading": [
                  {
                    "text": "Grade 1: Mitoses < 2 per 2 mm² &/or Ki-67 index < 3%"
                  },
                  {
                    "text": "Grade 2: Mitoses 2-20 per 2 mm² &/or Ki-67 index 3-20%"
                  },
                  {
                    "text": "Grade 3: Mitoses > 20 per 2 mm² &/or Ki-67 index > 20%"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Neuroendocrine tumor (NET)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Pancreatic NET"
                  },
                  {
                    "text": "Pancreatic endocrine tumor"
                  },
                  {
                    "text": "Islet cell tumor"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Well-differentiated NET of pancreas"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Syndromic: 10-20%": [
                  {
                    "text": "Multiple endocrine neoplasia type 1 (MEN1)"
                  },
                  {
                    "text": "Associated with von Hippel-Lindau syndrome, tuberous sclerosis, neurofibromatosis type 1, familial insulinomatosis, glucagon cell hyperplasia/neoplasia"
                  }
                ],
                "Sporadic": [
                  {
                    "text": "Majority of cases are nonsyndromic and sporadic"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Presentation": [
                  {
                    "text": "EpidemiologyPeak incidence between 30-60 years; no significant sex predilection",
                    "sub_points": [
                      "Peak incidence between 30-60 years; no significant sex predilection"
                    ]
                  },
                  {
                    "text": "Majority are asymptomatic and detected by imaging"
                  },
                  {
                    "text": "Endocrine functionFunctioning tumorsInsulinoma: Hyperinsulinemic hypoglycemiaGlucagonoma: Diabetes mellitus, skin rash, weight loss (glucagonoma syndrome)Somatostatinoma: Diabetes, cholelithiasis, diarrheaGastrinoma: Zollinger-Ellison syndromeVIPoma: Water diarrhea, hypokalemia, and achlorhydria (WDHA syndrome)ACTH-producing tumor: Cushing syndromeSerotonin-producing: Carcinoid syndrome (only with liver metastasis)Nonfunctioning tumors comprise > 60% of NETs",
                    "sub_points": [
                      "Functioning tumorsInsulinoma: Hyperinsulinemic hypoglycemiaGlucagonoma: Diabetes mellitus, skin rash, weight loss (glucagonoma syndrome)Somatostatinoma: Diabetes, cholelithiasis, diarrheaGastrinoma: Zollinger-Ellison syndromeVIPoma: Water diarrhea, hypokalemia, and achlorhydria (WDHA syndrome)ACTH-producing tumor: Cushing syndromeSerotonin-producing: Carcinoid syndrome (only with liver metastasis)",
                      "Insulinoma: Hyperinsulinemic hypoglycemia",
                      "Glucagonoma: Diabetes mellitus, skin rash, weight loss (glucagonoma syndrome)",
                      "Somatostatinoma: Diabetes, cholelithiasis, diarrhea",
                      "Gastrinoma: Zollinger-Ellison syndrome",
                      "VIPoma: Water diarrhea, hypokalemia, and achlorhydria (WDHA syndrome)",
                      "ACTH-producing tumor: Cushing syndrome",
                      "Serotonin-producing: Carcinoid syndrome (only with liver metastasis)",
                      "Nonfunctioning tumors comprise > 60% of NETs"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Options for liver metastasesResection of primary; surgical debulking of metastasisLong-acting somatostatin analogs (octreotide and lanreotide)Liver-directed therapy (embolization, chemoembolization, radiofrequency ablation)Novel agents, such as inhibitors of VEGF, tyrosine kinase, and mTOR pathwayChemotherapy, i.e., temozolomide and carboplatin, especially for grade 3 NETsRole of platinum therapy in grade 3 NETs unclear, has been advocated for cases with Ki-67 index > 55%",
                    "sub_points": [
                      "Resection of primary; surgical debulking of metastasis",
                      "Long-acting somatostatin analogs (octreotide and lanreotide)",
                      "Liver-directed therapy (embolization, chemoembolization, radiofrequency ablation)",
                      "Novel agents, such as inhibitors of VEGF, tyrosine kinase, and mTOR pathway",
                      "Chemotherapy, i.e., temozolomide and carboplatin, especially for grade 3 NETsRole of platinum therapy in grade 3 NETs unclear, has been advocated for cases with Ki-67 index > 55%",
                      "Role of platinum therapy in grade 3 NETs unclear, has been advocated for cases with Ki-67 index > 55%"
                    ]
                  }
                ],
                "Surgical approaches": [
                  {
                    "text": "Resection is mainstay of therapy for tumors confined to pancreas"
                  },
                  {
                    "text": "Enucleation restricted to small tumors (typically < 2 cm)"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-year survival 30-40%"
                  },
                  {
                    "text": "Features associated with adverse outcomeSize > 2 cm, necrosis, high grade, lymphovascular invasion, perineural invasion",
                    "sub_points": [
                      "Size > 2 cm, necrosis, high grade, lymphovascular invasion, perineural invasion"
                    ]
                  },
                  {
                    "text": "Prognosis of grade 3 NET intermediate between grade 1/grade 2 NET and neuroendocrine carcinoma"
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "CT: Solid, or less commonly, solid and cystic, well-circumscribed, enhancing lesion"
                  },
                  {
                    "text": "Somatostatin receptor scintigraphy (SRS) highlights NETs, as most are positive for somatostatin receptors (SSTR)Octeotride, which is somatostatin analog, is commonly used (octeotride scan)",
                    "sub_points": [
                      "Octeotride, which is somatostatin analog, is commonly used (octeotride scan)"
                    ]
                  },
                  {
                    "text": "SSTR PET/CT: PET with Gallium-labeled somatostatin analogsPreferred option for NET imaging due to higher sensitivity compared to SRSCommonly used analogs are DOTATATE and DOTATOC",
                    "sub_points": [
                      "Preferred option for NET imaging due to higher sensitivity compared to SRS",
                      "Commonly used analogs are DOTATATE and DOTATOC"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solid, round to oval, well-circumscribed mass"
                  },
                  {
                    "text": "Cystic change can occur, either single or multilocular"
                  }
                ],
                "Size": [
                  {
                    "text": "Tumors < 0.5 cm are termed microadenomas"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Monotonous population of round to cuboidal cells"
                  },
                  {
                    "text": "Coarse nuclear chromatin with salt and pepper appearance"
                  },
                  {
                    "text": "Prominent nuclear atypia and large nucleoli are uncommon"
                  },
                  {
                    "text": "Oncocytic, vacuolated, lipid-rich, pleomorphic, and rhabdoid appearance can be presentOncocytic variant often has prominent nucleoliClear cell variant is common in von Hippel Lindau diseaseScattered pleomorphic cells, often with degenerative changes; occasionally these can be prominent",
                    "sub_points": [
                      "Oncocytic variant often has prominent nucleoli",
                      "Clear cell variant is common in von Hippel Lindau disease",
                      "Scattered pleomorphic cells, often with degenerative changes; occasionally these can be prominent"
                    ]
                  },
                  {
                    "text": "Highly vascular stroma with thin-walled vessels in close approximation to tumor nestsStromal hyalinization is common; desmoplastic stroma typically absent",
                    "sub_points": [
                      "Stromal hyalinization is common; desmoplastic stroma typically absent"
                    ]
                  },
                  {
                    "text": "Functional tumorsNo distinctive features in most casesAmyloid deposits (islet amyloid polypeptide) typical of insulinomaGlandular architecture with psammomatous calcification in somatostatinoma",
                    "sub_points": [
                      "No distinctive features in most cases",
                      "Amyloid deposits (islet amyloid polypeptide) typical of insulinoma",
                      "Glandular architecture with psammomatous calcification in somatostatinoma"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Positive staining with at least 1 neuroendocrine marker is essential (but not sufficient) for diagnosisChromogranin more specific but less sensitive (~ 75%); synaptophysin has higher sensitivity (> 95%)Insulinoma-associated protein 1 (INSM1) is newer marker with sensitivity of 80-90%",
                    "sub_points": [
                      "Chromogranin more specific but less sensitive (~ 75%); synaptophysin has higher sensitivity (> 95%)",
                      "Insulinoma-associated protein 1 (INSM1) is newer marker with sensitivity of 80-90%"
                    ]
                  },
                  {
                    "text": "CD56, CD57 may be positive but less specific for neuroendocrine differentiation"
                  },
                  {
                    "text": "Orthopedia homeobox (OTP) is another new marker that has not been widely studied"
                  },
                  {
                    "text": "Pancytokeratin, CK7, CK8, CK18, CK19 usually positive"
                  },
                  {
                    "text": "Ki-67: Used for grading"
                  },
                  {
                    "text": "Immunohistochemistry for peptide hormonesRarely required for diagnosis; functional tumors diagnosed based on clinical presentation, not immunohistochemistryNonfunctional tumors may stain for multiple peptides",
                    "sub_points": [
                      "Rarely required for diagnosis; functional tumors diagnosed based on clinical presentation, not immunohistochemistry",
                      "Nonfunctional tumors may stain for multiple peptides"
                    ]
                  },
                  {
                    "text": "Somatostatin receptor 2A (SSTR2A)Positive in 70-80% of cases; high expression associated with favorable outcomeDecision to treat with somatostatin analogs usually dictated by somatostatin receptor-based imaging rather than immunohistochemistry",
                    "sub_points": [
                      "Positive in 70-80% of cases; high expression associated with favorable outcome",
                      "Decision to treat with somatostatin analogs usually dictated by somatostatin receptor-based imaging rather than immunohistochemistry"
                    ]
                  },
                  {
                    "text": "DAXX/ATRXGenes involved in chromatin remodeling; mutated in 20-40% of pancreatic NETsMutations correlate with loss of immunohistochemical expressionIdentifies NETs with poor prognosis; can help in determining pancreatic origin, as these mutations are not observed in other NETs",
                    "sub_points": [
                      "Genes involved in chromatin remodeling; mutated in 20-40% of pancreatic NETs",
                      "Mutations correlate with loss of immunohistochemical expression",
                      "Identifies NETs with poor prognosis; can help in determining pancreatic origin, as these mutations are not observed in other NETs"
                    ]
                  },
                  {
                    "text": "Metastatic pancreatic NETsPositivity for islet 1 (ISL1), PDX-1, or NESP55 support primary pancreatic NET, but not widely availablePAX8(+) in 50-60% of metastatic pancreatic NETsTTF-1(-); CDX-2(-), or patchy positiveImmunohistochemistry may not be able to confirm pancreatic origin in many cases",
                    "sub_points": [
                      "Positivity for islet 1 (ISL1), PDX-1, or NESP55 support primary pancreatic NET, but not widely available",
                      "PAX8(+) in 50-60% of metastatic pancreatic NETs",
                      "TTF-1(-); CDX-2(-), or patchy positive",
                      "Immunohistochemistry may not be able to confirm pancreatic origin in many cases"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Acinar Cell Carcinoma": [
                  {
                    "text": "Prominent nucleoli, high mitotic activity"
                  },
                  {
                    "text": "Cytoplasmic PAS(+) diastase-resistant granules"
                  },
                  {
                    "text": "Trypsin, chymotrypsin, BCL10(+)"
                  }
                ],
                "Solid Pseudopapillary Neoplasm": [
                  {
                    "text": "Pseudopapillary pattern rare in NET"
                  },
                  {
                    "text": "Distinctive oval nuclei with fine, evenly distributed chromatin and longitudinal nuclear grooves"
                  },
                  {
                    "text": "Nuclear β-catenin (+), loss of membranous E-cadherin"
                  },
                  {
                    "text": "Synaptophysin can be (+), but chromogranin is (-)"
                  }
                ],
                "Neuroendocrine Carcinoma": [
                  {
                    "text": "Large or small cell: Distinction based on morphology"
                  },
                  {
                    "text": "Immunohistochemistry: Loss of Rb, diffuse strong p53, diffuse strong p16"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Functional tumors defined on basis of clinical symptoms, not immunohistochemical findings"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Multiple tumors suggest syndrome, such as multiple endocrine neoplasia or von Hippel-Lindau syndrome"
                  },
                  {
                    "text": "Rarely, tumors < 2 cm without any aggressive features still metastasize"
                  }
                ]
              },
              "GRADING": {
                "Based on Mitoses &/or Ki-67 Index": [
                  {
                    "text": "Mitotic count based on counting 10 mm² in area of highest mitotic activity, reported as number of mitoses per 2 mm²"
                  },
                  {
                    "text": "Ki-67 index: Percentage of positive tumor cells in area of highest nuclear labeling based on 500-2,000 tumor cells"
                  },
                  {
                    "text": "Visual estimation is prone to error, and actual counting is recommended"
                  },
                  {
                    "text": "Discordance between mitoses and Ki-67 is seen in 1/3 of cases; higher Ki-67 index determines grade in most of these cases"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Poorly Differentiated Neuroendocrine Carcinoma, Pancreas": {
            "name": "Poorly Differentiated Neuroendocrine Carcinoma, Pancreas",
            "url": "https://app.pathprimer.com/document/3b9d4b1f-d181-46b2-9864-52e098620aea/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Poorly differentiated neuroendocrine carcinoma (NEC)"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Mutations inRB1andTP53common"
                  },
                  {
                    "text": "Mutations commonly seen in neuroendocrine tumor (NET) (MEN1,DAXX,ATRX) are typically absent"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Very aggressive neoplasms"
                  },
                  {
                    "text": "Platinum-based chemotherapy (cisplatin or carboplatin) with etoposide"
                  },
                  {
                    "text": "Favorable parameters: Localized disease, Ki-67 index < 55%, absence ofKRASandRB1mutations"
                  },
                  {
                    "text": "NEC with Ki-67 index > 55%,KRASmutation orRB1mutation may respond better to platinum-based therapy"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Small cell variantResembles small cell carcinomas of lungScant cytoplasm, hyperchromatic nuclei, prominent nuclear moulding",
                    "sub_points": [
                      "Resembles small cell carcinomas of lung",
                      "Scant cytoplasm, hyperchromatic nuclei, prominent nuclear moulding"
                    ]
                  },
                  {
                    "text": "Large cell variantResembles large cell NEC of lung",
                    "sub_points": [
                      "Resembles large cell NEC of lung"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Neuroendocrine markers, keratin positive"
                  },
                  {
                    "text": "Mitoses and Ki-67 index should be counted in areas with highest proliferation (\"hot spots\")"
                  },
                  {
                    "text": "Diffuse strong p53 (> 90%) and loss of Rb (60-70%)"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Pancreatic NETFavors G3 NET: Well-differentiated morphology, intact Rb, wild-type p53, Ki-67 index < 55%, loss of ATRX or DAXX favor G3 NET",
                    "sub_points": [
                      "Favors G3 NET: Well-differentiated morphology, intact Rb, wild-type p53, Ki-67 index < 55%, loss of ATRX or DAXX favor G3 NET"
                    ]
                  },
                  {
                    "text": "Poorly differentiated adenocarcinoma"
                  },
                  {
                    "text": "Acinar cell carcinoma"
                  },
                  {
                    "text": "Mixed neuroendocrine nonneuroendocrine neoplasm"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Neuroendocrine carcinoma (NEC)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Poorly differentiated carcinoma with morphologic and immunohistochemical features of neuroendocrine differentiation"
                  },
                  {
                    "text": "High grade by definition, featuring at least 1 of followingMitoses typically > 20 in 2 mm²Ki-67 labeling index > 20%",
                    "sub_points": [
                      "Mitoses typically > 20 in 2 mm²",
                      "Ki-67 labeling index > 20%"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Unknown": [
                  {
                    "text": "Do not arise from well-differentiated neuroendocrine tumors (NETs) in most cases"
                  },
                  {
                    "text": "Genetic changes in small and large cell NEC are similar, both are distinct from NETMutations inRB1andTP53are commonKRASmutations in 40-50% of casesMutations commonly seen in NET (MEN1,DAXX,ATRX) are typically absentAbnormalities in cell cycle regulatory proteins, such as amplification ofCCNE1,CCND, andCDK4in small subset of cases",
                    "sub_points": [
                      "Mutations inRB1andTP53are common",
                      "KRASmutations in 40-50% of cases",
                      "Mutations commonly seen in NET (MEN1,DAXX,ATRX) are typically absent",
                      "Abnormalities in cell cycle regulatory proteins, such as amplification ofCCNE1,CCND, andCDK4in small subset of cases"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare, constituting 2-3% of all pancreatic neuroendocrine neoplasms"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice"
                  },
                  {
                    "text": "Back pain"
                  },
                  {
                    "text": "Vast majority are nonfunctional"
                  },
                  {
                    "text": "Small minority of small cell NEC can present with hormonal symptomsCushing syndromeHypercalcemia",
                    "sub_points": [
                      "Cushing syndrome",
                      "Hypercalcemia"
                    ]
                  }
                ],
                "Treatment": [],
                "Surgical approaches": [
                  {
                    "text": "Radical pancreatic surgery for localized disease"
                  },
                  {
                    "text": "Many patients unresectable at diagnosis"
                  }
                ],
                "Drugs": [
                  {
                    "text": "Platinum-based chemotherapy (cisplatin or carboplatin) with etoposideNEC with Ki-67 index > 55%,KRASmutation orRB1mutation may respond better to platinum-based therapy",
                    "sub_points": [
                      "NEC with Ki-67 index > 55%,KRASmutation orRB1mutation may respond better to platinum-based therapy"
                    ]
                  },
                  {
                    "text": "Alkylating agent temozolomide-based regimen (with capecitabine or bevacizumab) often used as 2nd-line therapy"
                  },
                  {
                    "text": "Cisplatin with irinotecan also used for metastatic disease"
                  },
                  {
                    "text": "Immunotherapy with PD-1/PD-L1 inhibitors may be effective, especially in small subset with microsatellite instability"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Aggressive neoplasmsSurvival typically few months, less than ductal adenocarcinoma of pancreas",
                    "sub_points": [
                      "Survival typically few months, less than ductal adenocarcinoma of pancreas"
                    ]
                  },
                  {
                    "text": "Favorable parametersPositivity for both synaptophysin and chromogranin on immunohistochemistryLocalized diseaseKi-67 index < 55%Absence ofKRASandRB1mutations",
                    "sub_points": [
                      "Positivity for both synaptophysin and chromogranin on immunohistochemistry",
                      "Localized disease",
                      "Ki-67 index < 55%",
                      "Absence ofKRASandRB1mutations"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "Radiographic Findings": [
                  {
                    "text": "Somatostatin receptor-based imaging is negative in majority of NECsPositive in 40-50% of NECs compared to 80-90% of NETs",
                    "sub_points": [
                      "Positive in 40-50% of NECs compared to 80-90% of NETs"
                    ]
                  },
                  {
                    "text": "PET/CT using fluorodeoxyglucose (FDG PET/CT)Helps to visualize tumors with high glucose turnoverNECs have high proliferation and show high uptake of labeled glucose, making this technique very sensitive for detection of metastasis",
                    "sub_points": [
                      "Helps to visualize tumors with high glucose turnover",
                      "NECs have high proliferation and show high uptake of labeled glucose, making this technique very sensitive for detection of metastasis"
                    ]
                  }
                ]
              },
              "MACROSCOPIC": {
                "Size": [
                  {
                    "text": "Typically large, solid white to tan tumors"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Small cell variantResembles small cell carcinoma of lungDiffuse sheet-like arrangement of tumor cellsCytologic featuresSmall- to medium-sized cellsScant cytoplasmHyperchromatic nuclei, gritty chromatinProminent nuclear moldingInconspicuous nucleoliNecrosis invariably seen; varies from punctate foci to geographic necrosisExtensive vascular and perineural invasion is commonMitotic figures typically > 20 in 2 mm²Mitoses should be counted in areas with highest proliferation (\"hot spots\")",
                    "sub_points": [
                      "Resembles small cell carcinoma of lung",
                      "Diffuse sheet-like arrangement of tumor cellsCytologic featuresSmall- to medium-sized cellsScant cytoplasmHyperchromatic nuclei, gritty chromatinProminent nuclear moldingInconspicuous nucleoli",
                      "Cytologic featuresSmall- to medium-sized cellsScant cytoplasmHyperchromatic nuclei, gritty chromatinProminent nuclear moldingInconspicuous nucleoli",
                      "Small- to medium-sized cells",
                      "Scant cytoplasm",
                      "Hyperchromatic nuclei, gritty chromatin",
                      "Prominent nuclear molding",
                      "Inconspicuous nucleoli",
                      "Necrosis invariably seen; varies from punctate foci to geographic necrosis",
                      "Extensive vascular and perineural invasion is common",
                      "Mitotic figures typically > 20 in 2 mm²Mitoses should be counted in areas with highest proliferation (\"hot spots\")",
                      "Mitoses should be counted in areas with highest proliferation (\"hot spots\")"
                    ]
                  },
                  {
                    "text": "Large cell variantResembles large cell NEC of lungNeuroendocrine architecture: Nests and trabeculaeCytologic featuresMedium- to large-sized cellsModerate to abundant eosinophilic cytoplasmVesicular nuclei, prominent nucleoliGland formation is not typical but can be seenVascular invasion and necrosis often present",
                    "sub_points": [
                      "Resembles large cell NEC of lung",
                      "Neuroendocrine architecture: Nests and trabeculaeCytologic featuresMedium- to large-sized cellsModerate to abundant eosinophilic cytoplasmVesicular nuclei, prominent nucleoliGland formation is not typical but can be seen",
                      "Cytologic featuresMedium- to large-sized cellsModerate to abundant eosinophilic cytoplasmVesicular nuclei, prominent nucleoli",
                      "Medium- to large-sized cells",
                      "Moderate to abundant eosinophilic cytoplasm",
                      "Vesicular nuclei, prominent nucleoli",
                      "Gland formation is not typical but can be seen",
                      "Vascular invasion and necrosis often present"
                    ]
                  },
                  {
                    "text": "NEC are high grade by definition (G3 designation not necessary)"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Chromogranin and synaptophysinPositive but reactivity may be focal &/or weakNot required for diagnosis of small cell NEC if morphology is typicalPositivity for at least 1 marker required for diagnosis of large cell NECInsulinoma associated protein 1 (INSM1) is newer marker with sensitivity of 70-80% for NEC",
                    "sub_points": [
                      "Positive but reactivity may be focal &/or weak",
                      "Not required for diagnosis of small cell NEC if morphology is typical",
                      "Positivity for at least 1 marker required for diagnosis of large cell NEC",
                      "Insulinoma associated protein 1 (INSM1) is newer marker with sensitivity of 70-80% for NEC"
                    ]
                  },
                  {
                    "text": "Cytokeratin positive"
                  },
                  {
                    "text": "Ki-67 proliferation index\"Eyeballing\" should not be used except for in cases with very high proliferative indexBest determined by counting in static images in \"hot spot\" areasCounting of overlapping cells and lymphocytes are pitfalls with automated image analysis systemsFree internet resource is available (ImmunoRatio) but needs to be used with cautionHeterogeneity in tumor may lead to undergrading in biopsies",
                    "sub_points": [
                      "\"Eyeballing\" should not be used except for in cases with very high proliferative index",
                      "Best determined by counting in static images in \"hot spot\" areas",
                      "Counting of overlapping cells and lymphocytes are pitfalls with automated image analysis systems",
                      "Free internet resource is available (ImmunoRatio) but needs to be used with caution",
                      "Heterogeneity in tumor may lead to undergrading in biopsies"
                    ]
                  },
                  {
                    "text": "Diffuse strong p53 (> 90%) and loss of Rb (60-70%)"
                  },
                  {
                    "text": "p16 may be diffuse positive or lost"
                  },
                  {
                    "text": "Loss of DNA mismatch repair proteins in small subset; stains have been advocated in all cases due to potential response to immunotherapy"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Pancreatic Neuroendocrine Tumor": [
                  {
                    "text": "Lacks nuclear features of small cell or large cell NEC"
                  },
                  {
                    "text": "Rb intact and wild-type p53 in vast majority of cases"
                  },
                  {
                    "text": "ATRX/DAXX may be lost"
                  },
                  {
                    "text": "Distinction of G3 NET and large cell NEC can be challengingFeatures favoring G3 NETMorphology: Absence of marked atypia, lack of uniformly prominent nucleoli, thin-walled vessels in close proximity to tumor nests, hyalinized stroma without desmoplasia, nested architecture without diffuse growth pattern, mitoses < 20 in 2 mm²Immunohistochemistry: Rb intact, p53 wild-type, Ki-67 index < 55%, loss of ATRX or DAXXDiffuse p53 (small subset), Rb loss (rare) can occur in G3 NETGenetics:MEN1,DAXX,ATRXmutation (absence ofKRAS,TP53, andRB1mutation)Imaging: Positive on somatostatin receptor imaging, not FDG avid on PET",
                    "sub_points": [
                      "Features favoring G3 NETMorphology: Absence of marked atypia, lack of uniformly prominent nucleoli, thin-walled vessels in close proximity to tumor nests, hyalinized stroma without desmoplasia, nested architecture without diffuse growth pattern, mitoses < 20 in 2 mm²Immunohistochemistry: Rb intact, p53 wild-type, Ki-67 index < 55%, loss of ATRX or DAXXDiffuse p53 (small subset), Rb loss (rare) can occur in G3 NETGenetics:MEN1,DAXX,ATRXmutation (absence ofKRAS,TP53, andRB1mutation)Imaging: Positive on somatostatin receptor imaging, not FDG avid on PET",
                      "Morphology: Absence of marked atypia, lack of uniformly prominent nucleoli, thin-walled vessels in close proximity to tumor nests, hyalinized stroma without desmoplasia, nested architecture without diffuse growth pattern, mitoses < 20 in 2 mm²",
                      "Immunohistochemistry: Rb intact, p53 wild-type, Ki-67 index < 55%, loss of ATRX or DAXXDiffuse p53 (small subset), Rb loss (rare) can occur in G3 NET",
                      "Diffuse p53 (small subset), Rb loss (rare) can occur in G3 NET",
                      "Genetics:MEN1,DAXX,ATRXmutation (absence ofKRAS,TP53, andRB1mutation)",
                      "Imaging: Positive on somatostatin receptor imaging, not FDG avid on PET"
                    ]
                  }
                ],
                "Poorly Differentiated Adenocarcinoma": [
                  {
                    "text": "Lacks histologic and immunohistochemical evidence of neuroendocrine differentiation"
                  },
                  {
                    "text": "Focal staining with neuroendocrine markers is common; rare case with diffuse staining"
                  },
                  {
                    "text": "Gland formation and mucin usually present"
                  },
                  {
                    "text": "Rb intact"
                  }
                ],
                "Metastatic Neuroendocrine Carcinoma": [
                  {
                    "text": "Small cell carcinoma of lung is TTF-1 positiveExtrapulmonary small cell carcinomas can be TTF-1 positive and does not confirm pulmonary origin",
                    "sub_points": [
                      "Extrapulmonary small cell carcinomas can be TTF-1 positive and does not confirm pulmonary origin"
                    ]
                  },
                  {
                    "text": "Merkel cell carcinomaTTF-1 negative, CK20 dot-like, Merkel cell polyomavirus positive",
                    "sub_points": [
                      "TTF-1 negative, CK20 dot-like, Merkel cell polyomavirus positive"
                    ]
                  }
                ],
                "Other Malignant Round Cell Tumors": [
                  {
                    "text": "Rhabdomyosarcoma: Desmin and myogenin positive"
                  },
                  {
                    "text": "Desmoplastic round cell tumor: Cytokeratin, desmin positive"
                  },
                  {
                    "text": "Primitive neuroectodermal tumor: CD99 positive"
                  }
                ],
                "Acinar Cell Carcinoma": [
                  {
                    "text": "Morphology can resemble large cell NEC"
                  },
                  {
                    "text": "Immunohistochemistry for trypsin or chymotrypsin confirms diagnosis"
                  },
                  {
                    "text": "Neuroendocrine markers negative or show patchy staining"
                  }
                ],
                "Mixed Neuroendocrine Nonneuroendocrine Neoplasm": [
                  {
                    "text": "Each component constitutes at least 30% of tumor (arbitrary criterion used in WHO 2019 scheme)Admixed adenocarcinoma component (adenoneuroendocrine carcinoma)Admixed acinar cell carcinoma component (mixed acinar-NEC)",
                    "sub_points": [
                      "Admixed adenocarcinoma component (adenoneuroendocrine carcinoma)",
                      "Admixed acinar cell carcinoma component (mixed acinar-NEC)"
                    ]
                  }
                ],
                "Poorly Differentiated Squamous Cell Carcinoma": [
                  {
                    "text": "Lacks histologic and immunohistochemical evidence of neuroendocrine differentiation"
                  },
                  {
                    "text": "Positive staining for p63 &/or p40"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Important to make accurate diagnosis to enable proper treatment (platinum-based chemotherapy)"
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Tumors resemble their pulmonary counterparts"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Endocrine Pancreas Cancer Protocol": {
            "name": "Endocrine Pancreas Cancer Protocol",
            "url": "https://app.pathprimer.com/document/c1d2537b-a8fc-4dac-b6df-b07b25ccd734/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "Pancreatic Neuroendocrine Tumors": {
                "Staging": [
                  {
                    "text": "Same staging protocol as pancreatic exocrine tumorsPrognostic significance of tumor size, presence of lymph node metastases remains unclearUse of this staging system will allow standardization of reporting and collection of survival data for these tumors",
                    "sub_points": [
                      "Prognostic significance of tumor size, presence of lymph node metastases remains unclear",
                      "Use of this staging system will allow standardization of reporting and collection of survival data for these tumors"
                    ]
                  },
                  {
                    "text": "Histologic prognostic factorsTumor differentiationMitotic count",
                    "sub_points": [
                      "Tumor differentiation",
                      "Mitotic count"
                    ]
                  },
                  {
                    "text": "Clinical prognostic factorsDistant metastasesTumor functional statusPatient age",
                    "sub_points": [
                      "Distant metastases",
                      "Tumor functional status",
                      "Patient age"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Exocrine Pancreas Cancer Protocol": {
            "name": "Exocrine Pancreas Cancer Protocol",
            "url": "https://app.pathprimer.com/document/18bd120a-2c5b-4dcd-b4f3-4bca552b63fc/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "Anatomic Site of Tumor": {
                "Head of Pancreas": [
                  {
                    "text": "Tumors arise to right of confluence of superior mesenteric vein and portal vein"
                  },
                  {
                    "text": "Includes tumors of uncinate process"
                  },
                  {
                    "text": "Most pancreatic carcinomas arise in this location"
                  },
                  {
                    "text": "Tumors often present with obstructive jaundice"
                  }
                ],
                "Body of Pancreas": [
                  {
                    "text": "Tumors located between left edge of superior mesenteric vein/portal vein confluence and left edge of aorta"
                  },
                  {
                    "text": "Often present late in course of disease"
                  }
                ],
                "Tail of Pancreas": [
                  {
                    "text": "Those tumors arising to left of left edge of aorta"
                  },
                  {
                    "text": "Often present late in course of disease"
                  }
                ]
              },
              "Staging": {
                "Clinical": [
                  {
                    "text": "Usually based on CT or MR findings"
                  },
                  {
                    "text": "Endoscopic ultrasound may also be helpful"
                  }
                ],
                "Pathologic": [
                  {
                    "text": "Depending on surgical procedure performed, evaluation of margins (bile duct, pancreatic duct, and superior mesenteric artery [retroperitoneal or uncinate]) is critical"
                  },
                  {
                    "text": "Most local recurrences are in soft tissue of pancreatic bed along retroperitoneal margin"
                  }
                ],
                "Lymph Nodes": [
                  {
                    "text": "Tumors of pancreatic head and neckRegional nodes include those along common bile duct, hepatic artery, portal vein, superior mesenteric vein, right lateral wall of superior mesenteric artery, and posterior and anterior pancreaticoduodenal arcades",
                    "sub_points": [
                      "Regional nodes include those along common bile duct, hepatic artery, portal vein, superior mesenteric vein, right lateral wall of superior mesenteric artery, and posterior and anterior pancreaticoduodenal arcades"
                    ]
                  },
                  {
                    "text": "Tumors of pancreatic body and tailRegional nodes include those along hepatic artery, celiac axis, splenic artery, and splenic hilum",
                    "sub_points": [
                      "Regional nodes include those along hepatic artery, celiac axis, splenic artery, and splenic hilum"
                    ]
                  },
                  {
                    "text": "Minimum of 12 lymph nodes required for staging"
                  }
                ],
                "Vascular Involvement": [
                  {
                    "text": "Superior mesenteric vein or portal veinUsually T3Resectable at some centersPrognostic significance unknown",
                    "sub_points": [
                      "Usually T3Resectable at some centersPrognostic significance unknown",
                      "Resectable at some centers",
                      "Prognostic significance unknown"
                    ]
                  },
                  {
                    "text": "Celiac axis or superior mesenteric arteryClassified as T4Unresectable",
                    "sub_points": [
                      "Classified as T4",
                      "Unresectable"
                    ]
                  }
                ],
                "Metastases": [
                  {
                    "text": "Distant spreadCommon at presentationLiver, peritoneal cavity, lungs are common sitesPositive peritoneal cytology also considered M1 disease",
                    "sub_points": [
                      "Common at presentationLiver, peritoneal cavity, lungs are common sitesPositive peritoneal cytology also considered M1 disease",
                      "Liver, peritoneal cavity, lungs are common sites",
                      "Positive peritoneal cytology also considered M1 disease"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ampullary Adenoma": {
            "name": "Ampullary Adenoma",
            "url": "https://app.pathprimer.com/document/a480d569-ef8c-4d34-892c-0e8ec1f4e157/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Polypoid premalignant epithelial lesion of ampulla of VaterIntestinal-type adenomaIntraampullary papillary-tubular neoplasm (IAPN)",
                    "sub_points": [
                      "Intestinal-type adenoma",
                      "Intraampullary papillary-tubular neoplasm (IAPN)"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "0.04-0.12% of individuals based on autopsy dataSeen in 50-100% of patients with familial adenomatous polyposis and Gardner syndrome",
                    "sub_points": [
                      "Seen in 50-100% of patients with familial adenomatous polyposis and Gardner syndrome"
                    ]
                  },
                  {
                    "text": "Precursor of ampullary adenocarcinoma124x increased risk in syndromic patientsUp to 78% of resected IAPN cases show associated invasive carcinoma",
                    "sub_points": [
                      "124x increased risk in syndromic patients",
                      "Up to 78% of resected IAPN cases show associated invasive carcinoma"
                    ]
                  },
                  {
                    "text": "Mean age: 61 years (range: 27-85) for sporadic patients"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Intestinal-type adenomaTubular, tubulovillous, or villousTall columnar cells with predominantly basally located, elongated, hyperchromatic, and pseudostratified nuclei",
                    "sub_points": [
                      "Tubular, tubulovillous, or villous",
                      "Tall columnar cells with predominantly basally located, elongated, hyperchromatic, and pseudostratified nuclei"
                    ]
                  },
                  {
                    "text": "Intraampullary papillary-tubular neoplasmCompact tubular &/or papillary structures, with minimal or no intervening stromaClosely resembling intraductal tubulopapillary neoplasm of pancreas and bile ductNeoplastic cells may show intestinal, pancreaticobiliary, or mixed phenotype",
                    "sub_points": [
                      "Compact tubular &/or papillary structures, with minimal or no intervening stromaClosely resembling intraductal tubulopapillary neoplasm of pancreas and bile duct",
                      "Closely resembling intraductal tubulopapillary neoplasm of pancreas and bile duct",
                      "Neoplastic cells may show intestinal, pancreaticobiliary, or mixed phenotype"
                    ]
                  },
                  {
                    "text": "Areas of high-grade dysplasia may be present> 80% of IAPN cases show at least focal high-grade dysplasia",
                    "sub_points": [
                      "> 80% of IAPN cases show at least focal high-grade dysplasia"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Reactive epithelial atypia"
                  },
                  {
                    "text": "Invasive ampullary adenocarcinomaExtension of adenomatous epithelium into underlying periampullary glands and ducts may mimic invasion",
                    "sub_points": [
                      "Extension of adenomatous epithelium into underlying periampullary glands and ducts may mimic invasion"
                    ]
                  },
                  {
                    "text": "Flat intraepithelial neoplasia (dysplasia)"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Definitions": [
                  {
                    "text": "Polypoid premalignant epithelial lesion of ampulla of VaterIntestinal-type adenomaIntraampullary papillary-tubular neoplasm (IAPN)Defined by exophytic mass lesion located almost exclusively within ampullaPredominantly (> 75%) within dilated ampullary channel &/or very distal end of bile duct or pancreatic ductMinimal (< 25%) involvement of duodenal papillaMinimal (< 25%) intramucosal extension into bile duct or pancreatic duct",
                    "sub_points": [
                      "Intestinal-type adenoma",
                      "Intraampullary papillary-tubular neoplasm (IAPN)Defined by exophytic mass lesion located almost exclusively within ampullaPredominantly (> 75%) within dilated ampullary channel &/or very distal end of bile duct or pancreatic ductMinimal (< 25%) involvement of duodenal papillaMinimal (< 25%) intramucosal extension into bile duct or pancreatic duct",
                      "Defined by exophytic mass lesion located almost exclusively within ampullaPredominantly (> 75%) within dilated ampullary channel &/or very distal end of bile duct or pancreatic ductMinimal (< 25%) involvement of duodenal papillaMinimal (< 25%) intramucosal extension into bile duct or pancreatic duct",
                      "Predominantly (> 75%) within dilated ampullary channel &/or very distal end of bile duct or pancreatic duct",
                      "Minimal (< 25%) involvement of duodenal papilla",
                      "Minimal (< 25%) intramucosal extension into bile duct or pancreatic duct"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.04-0.12% of individuals based on autopsy dataMost are sporadicSeen in 50-100% of patients with familial adenomatous polyposis and Gardner syndromeMost common site of extracolonic polyps in syndromic patients",
                    "sub_points": [
                      "Most are sporadic",
                      "Seen in 50-100% of patients with familial adenomatous polyposis and Gardner syndromeMost common site of extracolonic polyps in syndromic patients",
                      "Most common site of extracolonic polyps in syndromic patients"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 61 years (range: 27-85) for sporadic patients41 years for syndromic patients",
                    "sub_points": [
                      "41 years for syndromic patients"
                    ]
                  }
                ],
                "Sex": [
                  {
                    "text": "M:F = 1:2.6 in sporadic setting"
                  },
                  {
                    "text": "No gender predominance in syndromic setting"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Signs and symptoms of biliary or pancreatic obstructionPainless jaundice (seen in 50-75% of patients), abdominal pain, nausea, vomiting, weight lossCholangitis &/or pancreatitis occasionally seen",
                    "sub_points": [
                      "Painless jaundice (seen in 50-75% of patients), abdominal pain, nausea, vomiting, weight loss",
                      "Cholangitis &/or pancreatitis occasionally seen"
                    ]
                  },
                  {
                    "text": "Asymptomatic, particularly in syndromic patients"
                  }
                ],
                "Endoscopic Findings": [
                  {
                    "text": "Soft polyp, plaque with regular margins, or prominence or mucosal thickening of papilla for intestinal-type adenoma"
                  },
                  {
                    "text": "Usually 1-3 cm in size in symptomatic casesOften also have multiple duodenal polyps",
                    "sub_points": [
                      "Often also have multiple duodenal polyps"
                    ]
                  },
                  {
                    "text": "Mean size for IAPN: 2.7 cm (0.8-6.7 cm)"
                  },
                  {
                    "text": "May extend into distal bile duct &/or pancreatic duct"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Polypectomy with close endoscopic surveillance"
                  },
                  {
                    "text": "Local excision including ampullectomy"
                  },
                  {
                    "text": "Pancreatoduodenectomy for larger lesions or lesions containing carcinoma"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Cured by complete excision"
                  },
                  {
                    "text": "May recur after local excision in up to 33% of patients"
                  },
                  {
                    "text": "Precursor of ampullary adenocarcinoma124x increased risk in syndromic patientsUp to 78% of resected IAPN cases show associated invasive carcinoma",
                    "sub_points": [
                      "124x increased risk in syndromic patients",
                      "Up to 78% of resected IAPN cases show associated invasive carcinoma"
                    ]
                  }
                ],
                "Endoscopic Surveillance Following Local Excision": [
                  {
                    "text": "Initial surveillance within 1-6 months"
                  },
                  {
                    "text": "Then every 3-12 months for next 2 years"
                  },
                  {
                    "text": "Less frequent intervals thereafter"
                  }
                ]
              },
              "IMAGING": {
                "Endoscopic Ultrasound": [
                  {
                    "text": "Provides information regarding depth of lesion and locoregional lymph node status"
                  }
                ],
                "Endoscopic Retrograde Cholangiopancreatography": [
                  {
                    "text": "Provides information regarding extent of ingrowth of lesion into bile duct &/or pancreatic duct"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "IAPN is defined by exophytic lesion located almost exclusively within ampulla"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Intestinal-type adenomaTubular adenomaSimple tubular glands resembling basal portions of normal intestinal crypts; < 25% of villous componentTubulovillous adenoma> 25% of both tubular and villous componentsVillous adenoma> 75% of villous component; usually sessileTall columnar cells with predominantly basally located, elongated, hyperchromatic, and pseudostratified nucleiMay show increased apoptotic activityPaneth, goblet, and endocrine cells are common",
                    "sub_points": [
                      "Tubular adenomaSimple tubular glands resembling basal portions of normal intestinal crypts; < 25% of villous component",
                      "Simple tubular glands resembling basal portions of normal intestinal crypts; < 25% of villous component",
                      "Tubulovillous adenoma> 25% of both tubular and villous components",
                      "> 25% of both tubular and villous components",
                      "Villous adenoma> 75% of villous component; usually sessile",
                      "> 75% of villous component; usually sessile",
                      "Tall columnar cells with predominantly basally located, elongated, hyperchromatic, and pseudostratified nucleiMay show increased apoptotic activityPaneth, goblet, and endocrine cells are common",
                      "May show increased apoptotic activity",
                      "Paneth, goblet, and endocrine cells are common"
                    ]
                  },
                  {
                    "text": "Intraampullary papillary-tubular neoplasmCompact tubular &/or papillary structures, with minimal or no intervening stromaClosely resembling intraductal tubulopapillary neoplasm of pancreas and bile ductCan be predominantly (> 75%) papillary or tubularNeoplastic cells may show intestinal, pancreaticobiliary, or mixed phenotype",
                    "sub_points": [
                      "Compact tubular &/or papillary structures, with minimal or no intervening stromaClosely resembling intraductal tubulopapillary neoplasm of pancreas and bile ductCan be predominantly (> 75%) papillary or tubular",
                      "Closely resembling intraductal tubulopapillary neoplasm of pancreas and bile duct",
                      "Can be predominantly (> 75%) papillary or tubular",
                      "Neoplastic cells may show intestinal, pancreaticobiliary, or mixed phenotype"
                    ]
                  },
                  {
                    "text": "DysplasiaLow-grade dysplasia by definitionAreas of high-grade dysplasia may be presentComplex glandular architecture such as cribriformingMarked nuclear atypia with rounded nuclei, prominent nucleoli, and loss of nuclear polarity> 80% of IAPN cases show at least focal high-grade dysplasia",
                    "sub_points": [
                      "Low-grade dysplasia by definition",
                      "Areas of high-grade dysplasia may be presentComplex glandular architecture such as cribriformingMarked nuclear atypia with rounded nuclei, prominent nucleoli, and loss of nuclear polarity> 80% of IAPN cases show at least focal high-grade dysplasia",
                      "Complex glandular architecture such as cribriforming",
                      "Marked nuclear atypia with rounded nuclei, prominent nucleoli, and loss of nuclear polarity",
                      "> 80% of IAPN cases show at least focal high-grade dysplasia"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Reactive Epithelial Atypia": [
                  {
                    "text": "Large nuclei with open chromatin and visible nucleoli"
                  },
                  {
                    "text": "Lack of nuclear pseudostratification"
                  },
                  {
                    "text": "May show gastric foveolar metaplasia"
                  },
                  {
                    "text": "Presence of inflammation"
                  },
                  {
                    "text": "History of procedure such as biliary stent placement"
                  }
                ],
                "Invasive Ampullary Adenocarcinoma": [
                  {
                    "text": "Extension of adenomatous epithelium into underlying periampullary glands and ducts may mimic invasion"
                  }
                ],
                "Flat Intraepithelial Neoplasia (Dysplasia)": [
                  {
                    "text": "Lack of polypoid or mass lesion on endoscopy"
                  }
                ],
                "Invasive Pancreaticobiliary Adenocarcinoma": [
                  {
                    "text": "Can mimic adenoma if invading ampulla with colonization of ampullary mucosa"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Degree of dysplasia may vary in different areas within 1 tumor, and invasive carcinoma, if present, may be focal"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ampullary Adenocarcinoma and Histologic Subtypes": {
            "name": "Ampullary Adenocarcinoma and Histologic Subtypes",
            "url": "https://app.pathprimer.com/document/a14854d4-609c-490d-98e6-7083ce57fe6b/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Malignant epithelial neoplasm originating in ampulla of Vater"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Intraampullary: Arise from intraampullary papillary-tubular neoplasm or ampullary ducts (pancreaticobiliary type)"
                  },
                  {
                    "text": "Periampullary: Arise from duodenal surface of papilla (often from intestinal type adenoma)"
                  },
                  {
                    "text": "Intra- and periampullary (mixed type)"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "5-year overall survival rate after resection: 30-70%"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "2 main histologic typesIntestinal-type adenocarcinomaMost commonSimilar to adenocarcinoma of colon and small bowelPancreaticobiliary-type adenocarcinoma2nd most commonSimilar to pancreatic ductal, bile duct, or gallbladder adenocarcinoma",
                    "sub_points": [
                      "Intestinal-type adenocarcinomaMost commonSimilar to adenocarcinoma of colon and small bowel",
                      "Most common",
                      "Similar to adenocarcinoma of colon and small bowel",
                      "Pancreaticobiliary-type adenocarcinoma2nd most commonSimilar to pancreatic ductal, bile duct, or gallbladder adenocarcinoma",
                      "2nd most common",
                      "Similar to pancreatic ductal, bile duct, or gallbladder adenocarcinoma"
                    ]
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "Intestinal typeCK20, CDX2, or MUC2 (+), MUC1(-)CK20, CDX2, and MUC2 (+), irrespective of MUC1",
                    "sub_points": [
                      "CK20, CDX2, or MUC2 (+), MUC1(-)",
                      "CK20, CDX2, and MUC2 (+), irrespective of MUC1"
                    ]
                  },
                  {
                    "text": "Pancreaticobiliary typeMUC1(+), CDX2 and MUC2 (-), irrespective of CK20",
                    "sub_points": [
                      "MUC1(+), CDX2 and MUC2 (-), irrespective of CK20"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Adenocarcinomas of pancreatic head, distal common bile duct, and duodenum"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Important to distinguish intestinal type from pancreaticobiliary type because of better prognosisClassified according to predominant component",
                    "sub_points": [
                      "Classified according to predominant component"
                    ]
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Periampullary adenocarcinoma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Malignant epithelial neoplasm originating in ampulla of VaterCentered on, circumferentially surrounding, or completely replacing ampulla",
                    "sub_points": [
                      "Centered on, circumferentially surrounding, or completely replacing ampulla"
                    ]
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Histogenesis": [
                  {
                    "text": "Intraampullary: Arise from intraampullary papillary-tubular neoplasm or ampullary ducts (pancreaticobiliary type)"
                  },
                  {
                    "text": "Periampullary: Arise from duodenal surface of papilla (often from intestinal-type adenoma)"
                  },
                  {
                    "text": "Intra- and periampullary (mixed type)"
                  }
                ],
                "Predisposing Syndromes": [
                  {
                    "text": "Familial adenomatous polyposis, Lynch syndrome, Peutz-Jeghers syndrome"
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.7 and 0.4 cases per 100,000 males and females, respectively"
                  },
                  {
                    "text": "0.2-0.5% of all gastrointestinal malignancies"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 66 years (range: 29-85 years)Younger in patients with predisposing syndromes",
                    "sub_points": [
                      "Younger in patients with predisposing syndromes"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "Jaundice, abdominal pain, pancreatitis, weight loss"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Resection (Whipple procedure)"
                  },
                  {
                    "text": "Chemoradiation therapy"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "5-year overall survival rate after resection: 30-70%Determined by histologic type, grade, stage, perineural invasion, and adjuvant chemotherapy",
                    "sub_points": [
                      "Determined by histologic type, grade, stage, perineural invasion, and adjuvant chemotherapy"
                    ]
                  },
                  {
                    "text": "Intestinal-type histology is associated with favorable outcome in comparison to pancreatobiliary type"
                  },
                  {
                    "text": "CDX-1/2 expression independent marker of favorable outcome"
                  }
                ]
              },
              "IMAGING": {
                "Endoscopic Findings": [
                  {
                    "text": "Exophytic or ulcerated mass in ampullary region"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Exophytic &/or ulcerated mass in ampullary region"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Intestinal-type adenocarcinomaMost common typeSimilar to adenocarcinoma of colon and small bowelFrequently associated with intestinal-type adenoma",
                    "sub_points": [
                      "Most common type",
                      "Similar to adenocarcinoma of colon and small bowel",
                      "Frequently associated with intestinal-type adenoma"
                    ]
                  },
                  {
                    "text": "Pancreaticobiliary-type adenocarcinoma2nd most common typeSimilar to pancreatic ductal or bile duct adenocarcinomaMicropapillary growth pattern in < 5% of cases",
                    "sub_points": [
                      "2nd most common type",
                      "Similar to pancreatic ductal or bile duct adenocarcinoma",
                      "Micropapillary growth pattern in < 5% of cases"
                    ]
                  },
                  {
                    "text": "Tubular adenocarcinoma with mixed featuresAmbiguous features that are difficult to classify definitely as intestinal or pancreaticobiliary type",
                    "sub_points": [
                      "Ambiguous features that are difficult to classify definitely as intestinal or pancreaticobiliary type"
                    ]
                  },
                  {
                    "text": "Mucinous adenocarcinomaMucinous component constitutes > 50% of tumorExtracellular mucin pools with floating tumor cellsMay have minor component of signet ring cellsVariant of intestinal-type adenocarcinoma",
                    "sub_points": [
                      "Mucinous component constitutes > 50% of tumorExtracellular mucin pools with floating tumor cells",
                      "Extracellular mucin pools with floating tumor cells",
                      "May have minor component of signet ring cells",
                      "Variant of intestinal-type adenocarcinoma"
                    ]
                  },
                  {
                    "text": "Poorly cohesive carcinomaSingle or small aggregates of tumor cells without well-formed glandsCan be either signet ring cell or non-signet-ring cell typeAlso termed \"signet ring cell carcinoma\" if signet ring cells constitute > 50% of tumorSignet ring cells show abundant intracytoplasmic mucin that pushes nuclei to periphery",
                    "sub_points": [
                      "Single or small aggregates of tumor cells without well-formed glands",
                      "Can be either signet ring cell or non-signet-ring cell typeAlso termed \"signet ring cell carcinoma\" if signet ring cells constitute > 50% of tumorSignet ring cells show abundant intracytoplasmic mucin that pushes nuclei to periphery",
                      "Also termed \"signet ring cell carcinoma\" if signet ring cells constitute > 50% of tumorSignet ring cells show abundant intracytoplasmic mucin that pushes nuclei to periphery",
                      "Signet ring cells show abundant intracytoplasmic mucin that pushes nuclei to periphery"
                    ]
                  },
                  {
                    "text": "Medullary carcinoma (adenocarcinoma with lymphoid stroma)Syncytial growth pattern with pushing bordersTumor-infiltrating lymphocytesTypically MSI-high",
                    "sub_points": [
                      "Syncytial growth pattern with pushing borders",
                      "Tumor-infiltrating lymphocytes",
                      "Typically MSI-high"
                    ]
                  },
                  {
                    "text": "Papillary adenocarcinomaArise from intraampullary papillary-tubular neoplasmInvasive component rarely maintains papillary pattern",
                    "sub_points": [
                      "Arise from intraampullary papillary-tubular neoplasm",
                      "Invasive component rarely maintains papillary pattern"
                    ]
                  },
                  {
                    "text": "Adenosquamous carcinomaCombination of both malignant squamous (> 25%) and glandular (any amount) componentsRule out metastasis if pure squamous carcinoma",
                    "sub_points": [
                      "Combination of both malignant squamous (> 25%) and glandular (any amount) components",
                      "Rule out metastasis if pure squamous carcinoma"
                    ]
                  },
                  {
                    "text": "Undifferentiated carcinomaMay be small cell (nonneuroendocrine) or spindle cell predominantOsteoclast-like giant cells are present in rare casesMay show rhabdoid/plasmacytoid phenotype in association with SW1/SNF deficiencyLoss of nuclear expression of INI1 (SMARCB1), BRG1 (SMARCA4), or other members of SW1/SNF family",
                    "sub_points": [
                      "May be small cell (nonneuroendocrine) or spindle cell predominant",
                      "Osteoclast-like giant cells are present in rare cases",
                      "May show rhabdoid/plasmacytoid phenotype in association with SW1/SNF deficiencyLoss of nuclear expression of INI1 (SMARCB1), BRG1 (SMARCA4), or other members of SW1/SNF family",
                      "Loss of nuclear expression of INI1 (SMARCB1), BRG1 (SMARCA4), or other members of SW1/SNF family"
                    ]
                  },
                  {
                    "text": "Poorly differentiated neuroendocrine carcinomaSmall cell carcinomaLarge cell neuroendocrine carcinoma",
                    "sub_points": [
                      "Small cell carcinoma",
                      "Large cell neuroendocrine carcinoma"
                    ]
                  },
                  {
                    "text": "Clear cell carcinomaResembling clear cell renal cell carcinomaPresence of cytoplasmic mucin in some tumor cells",
                    "sub_points": [
                      "Resembling clear cell renal cell carcinoma",
                      "Presence of cytoplasmic mucin in some tumor cells"
                    ]
                  },
                  {
                    "text": "Hepatoid adenocarcinomaResembling hepatocellular carcinomaAdenocarcinoma component may be present",
                    "sub_points": [
                      "Resembling hepatocellular carcinoma",
                      "Adenocarcinoma component may be present"
                    ]
                  },
                  {
                    "text": "Mixed neuroendocrine/nonneuroendocrine neoplasmDiscrete adenocarcinomatous and neuroendocrine components each constituting ≥ 30% of neoplasm",
                    "sub_points": [
                      "Discrete adenocarcinomatous and neuroendocrine components each constituting ≥ 30% of neoplasm"
                    ]
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "Intestinal typeCK20, CDX2, or MUC2 (+), MUC1(-)CK20, CDX2, and MUC2 (+), irrespective of MUC1",
                    "sub_points": [
                      "CK20, CDX2, or MUC2 (+), MUC1(-)",
                      "CK20, CDX2, and MUC2 (+), irrespective of MUC1"
                    ]
                  },
                  {
                    "text": "Pancreaticobiliary typeMUC1(+), CDX2 and MUC2 (-), irrespective of CK20",
                    "sub_points": [
                      "MUC1(+), CDX2 and MUC2 (-), irrespective of CK20"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Adenocarcinomas of Pancreatic Head, Distal Common Bile Duct, and Duodenum": [
                  {
                    "text": "Cross sections to include ampulla, duodenum, pancreatic duct, and bile duct may help demonstrate relationship of carcinoma to these structures"
                  },
                  {
                    "text": "Look for residual ampullary adenomaColonization of ampullary mucosa by invasive carcinoma of pancreas or bile duct can occur",
                    "sub_points": [
                      "Colonization of ampullary mucosa by invasive carcinoma of pancreas or bile duct can occur"
                    ]
                  }
                ],
                "Pancreatic Adenocarcinoma": [
                  {
                    "text": "Vast majority exhibit pancreatobiliary-type histology"
                  },
                  {
                    "text": "Pancreatic adenocarcinoma usually arises from main pancreatic duct; ampullary involvement represents peripheral extension"
                  },
                  {
                    "text": "No associated ampullary adenoma"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Clinically Relevant Pathologic Features": [
                  {
                    "text": "Important to distinguish intestinal type from pancreaticobiliary type because of better prognosisClassified according to predominant component",
                    "sub_points": [
                      "Classified according to predominant component"
                    ]
                  }
                ],
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Cross sections including ampulla, pancreatic duct, and bile duct may help demonstrate relationship of carcinoma to these structures"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Well-Differentiated Neuroendocrine Tumor, Ampulla": {
            "name": "Well-Differentiated Neuroendocrine Tumor, Ampulla",
            "url": "https://app.pathprimer.com/document/edf3ac4e-2f0a-4d86-9af3-d5d84a88de56/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Well-differentiated epithelial neoplasms with morphologic and immunohistochemical features of neuroendocrine differentiation arising in ampulla of Vater and periampullary region"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Association with neurofibromatosis type 1 or multiple endocrine neoplasia type 1 in some cases"
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Tumor grade and distant metastasis are most useful predictors for outcomes82% and 71% 5- and 10-year survival rates, respectively",
                    "sub_points": [
                      "82% and 71% 5- and 10-year survival rates, respectively"
                    ]
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Tumor cells arranged in nested, trabecular, insular, ribbon-like, glandular, or cribriform patternsPsammoma bodies may be seen in somatostatin-producing tumors",
                    "sub_points": [
                      "Psammoma bodies may be seen in somatostatin-producing tumors"
                    ]
                  },
                  {
                    "text": "Small, relatively uniform tumor cells with round to oval nuclei, coarsely clumped (salt and pepper) chromatin, inconspicuous nucleoli, and moderate amounts of granular eosinophilic cytoplasm"
                  }
                ],
                "Ancillary Tests": [
                  {
                    "text": "(+) for neuroendocrine markers synaptophysin, chromogranin, &/or INSM1"
                  },
                  {
                    "text": "Immunohistochemical detection of hormone production for tumor classification is not recommended"
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Poorly differentiated neuroendocrine carcinoma"
                  },
                  {
                    "text": "Gangliocytic paraganglioma"
                  }
                ],
                "Grading": [
                  {
                    "text": "Grade 1 (low): Mitosis < 2 per 2 mm², &/or Ki-67 < 3%"
                  },
                  {
                    "text": "Grade 2 (intermediate): Mitosis 2-20 per 2 mm², &/or Ki-67 3-20%"
                  },
                  {
                    "text": "Grade 3 (high): Mitosis > 20 per 2 mm², &/or Ki-67 > 20%"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Abbreviations": [
                  {
                    "text": "Well-differentiated neuroendocrine tumor (NET)"
                  }
                ],
                "Synonyms": [
                  {
                    "text": "Carcinoid tumor (acceptable but not preferred)"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Well-differentiated epithelial neoplasms with morphologic and immunohistochemical features of neuroendocrine differentiation arising in ampulla of Vater and periampullary region"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Disease Association": [
                  {
                    "text": "Neurofibromatosis type 1Somatostatin-producing tumors are most common",
                    "sub_points": [
                      "Somatostatin-producing tumors are most common"
                    ]
                  },
                  {
                    "text": "Multiple endocrine neoplasia type 1Gastrin-producing tumors are most common",
                    "sub_points": [
                      "Gastrin-producing tumors are most common"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "0.3% of all gastrointestinal NETs"
                  },
                  {
                    "text": "< 2% of all tumors of ampullary region"
                  }
                ],
                "Age": [
                  {
                    "text": "Mean: 62 years (range: 30-76)"
                  }
                ],
                "Sex": [
                  {
                    "text": "No sex predilection"
                  }
                ],
                "Presentation": [
                  {
                    "text": "Obstructive jaundice, pancreatitis, abdominal pain"
                  },
                  {
                    "text": "Hormonal hypersecretion syndromes are rare"
                  },
                  {
                    "text": "Asymptomatic, incidentally discovered"
                  }
                ],
                "Treatment": [
                  {
                    "text": "Pancreaticoduodenectomy (Whipple procedure)"
                  },
                  {
                    "text": "Local excision (ampullectomy) in selected cases"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Tumor grade and distant metastasis are most useful predictors82% and 71% 5- and 10-year survival rates, respectivelyTumors < 2 cm or limited to ampulla have better prognosisLymph node metastasis does not appear to influence overall and disease-free survival ratesLiver is most common site of distant metastasis",
                    "sub_points": [
                      "82% and 71% 5- and 10-year survival rates, respectively",
                      "Tumors < 2 cm or limited to ampulla have better prognosis",
                      "Lymph node metastasis does not appear to influence overall and disease-free survival rates",
                      "Liver is most common site of distant metastasis"
                    ]
                  }
                ]
              },
              "IMAGING": {
                "CT and Octreotide Scan": [
                  {
                    "text": "Help metastatic work-up once diagnosis is established"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Solitary submucosal polypoid lesion or bulge with intact or flattened mucosa"
                  },
                  {
                    "text": "Mean size: 1.8 cm (range: 0.2-5.0 cm)"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "Tumor cells arranged in nested, trabecular, insular, ribbon-like, glandular, or cribriform patternsSomatostatin-producing tumors may show predominantly glandular patternPsammoma bodies may be present in glandular lumina in some cases",
                    "sub_points": [
                      "Somatostatin-producing tumors may show predominantly glandular patternPsammoma bodies may be present in glandular lumina in some cases",
                      "Psammoma bodies may be present in glandular lumina in some cases"
                    ]
                  },
                  {
                    "text": "Small, relatively uniform tumor cells with round to oval nuclei, coarsely clumped (salt and pepper) chromatin, inconspicuous nucleoli, and moderate amounts of granular eosinophilic cytoplasm"
                  },
                  {
                    "text": "Variable mitotic activity"
                  },
                  {
                    "text": "Punctate necrosis may be seen"
                  },
                  {
                    "text": "Amyloid deposition may occur occasionally"
                  }
                ]
              },
              "ANCILLARY TESTS": {
                "Immunohistochemistry": [
                  {
                    "text": "(+) for neuroendocrine markers synaptophysin, chromogranin, &/or INSM1Chromogranin (+) in only 50% of somatostatin-producing NETs",
                    "sub_points": [
                      "Chromogranin (+) in only 50% of somatostatin-producing NETs"
                    ]
                  },
                  {
                    "text": "Pankeratins (+)"
                  },
                  {
                    "text": "Immunohistochemical detection of hormone production for tumor classification is not recommendedDoes not correlate with clinical syndromes or prognosisMajority of NETs are nonfunctional",
                    "sub_points": [
                      "Does not correlate with clinical syndromes or prognosis",
                      "Majority of NETs are nonfunctional"
                    ]
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Poorly Differentiated Neuroendocrine Carcinoma": [
                  {
                    "text": "Large or small cell carcinoma morphology"
                  },
                  {
                    "text": "Often growing in sheets; less nested pattern"
                  },
                  {
                    "text": "Usually more abundant necrosis"
                  },
                  {
                    "text": "Loss of RB, &/or aberrant p53 expression may be useful"
                  }
                ],
                "Gangliocytic Paraganglioma": [
                  {
                    "text": "Triphasic elements, including ganglion or ganglion-like cells, spindled cells with schwannian differentiation, and epithelioid neuroendocrine cells"
                  },
                  {
                    "text": "S100 immunostain is helpfulHighlights spindled cells and sustentacular network surrounding neuroendocrine cell nests",
                    "sub_points": [
                      "Highlights spindled cells and sustentacular network surrounding neuroendocrine cell nests"
                    ]
                  }
                ],
                "Ampullary Adenoma or Adenocarcinoma": [
                  {
                    "text": "More prominent glandular pattern"
                  },
                  {
                    "text": "(-) or focally (+) for neuroendocrine markers"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Somatostatin-producing endocrine cells are normally present in ampullary region"
                  }
                ]
              },
              "GRADING": {
                "Mitotic Rate and Ki-67 Labeling Index": [
                  {
                    "text": "Grade 1 (low): Mitosis < 2 per 2 mm², &/or Ki-67 < 3%"
                  },
                  {
                    "text": "Grade 2 (intermediate): Mitosis 2-20 per 2 mm², &/or Ki-67 3-20%"
                  },
                  {
                    "text": "Grade 3 (high): Mitosis > 20 per 2 mm², &/or Ki-67 > 20%"
                  },
                  {
                    "text": "RecommendationMitotic rate: Counting 10 mm² (42 HPF if using microscope with field diameter of 0.55 mm) in areas with highest mitotic activity, divide by 5Ki-67 index: Count minimum of 500 tumor cells in areas with highest nuclear labeling",
                    "sub_points": [
                      "Mitotic rate: Counting 10 mm² (42 HPF if using microscope with field diameter of 0.55 mm) in areas with highest mitotic activity, divide by 5",
                      "Ki-67 index: Count minimum of 500 tumor cells in areas with highest nuclear labeling"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Gangliocytic Paraganglioma": {
            "name": "Gangliocytic Paraganglioma",
            "url": "https://app.pathprimer.com/document/013e60b4-4a21-43d2-8d79-5121c3df3708/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "KEY FACTS": {
                "Terminology": [
                  {
                    "text": "Uncommon (~ 1% of ampullary neoplasms)"
                  },
                  {
                    "text": "Some cases associated with neurofibromatosis type 1"
                  }
                ],
                "Etiology/Pathogenesis": [
                  {
                    "text": "Several theoriesProgenitor neural crest cellsEmbryonic celiac ganglionEndodermally derived epithelial cells originating from ventral primordium of pancreas (hamartomatous proliferation)Pancreatic tumor composed of ganglion-islet cell complexes",
                    "sub_points": [
                      "Progenitor neural crest cells",
                      "Embryonic celiac ganglion",
                      "Endodermally derived epithelial cells originating from ventral primordium of pancreas (hamartomatous proliferation)",
                      "Pancreatic tumor composed of ganglion-islet cell complexes"
                    ]
                  }
                ],
                "Clinical Issues": [
                  {
                    "text": "Uncommon"
                  },
                  {
                    "text": "3rd-9th decades (mean age: 6th decade)"
                  },
                  {
                    "text": "Men slightly outnumber women"
                  },
                  {
                    "text": "Most commonly involve ampulla/periampullary duodenum"
                  },
                  {
                    "text": "Clinically benign, even with metastasis"
                  }
                ],
                "Microscopic": [
                  {
                    "text": "Triphasic"
                  },
                  {
                    "text": "Epithelioid cellsEpithelioid, spindled, and ganglion-like cells present in varying proportionsEpithelioid cells can resemble neuroendocrine tumor or paragangliomaMark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratin",
                    "sub_points": [
                      "Epithelioid, spindled, and ganglion-like cells present in varying proportionsEpithelioid cells can resemble neuroendocrine tumor or paragangliomaMark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratin",
                      "Epithelioid cells can resemble neuroendocrine tumor or paraganglioma",
                      "Mark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratin"
                    ]
                  },
                  {
                    "text": "Ganglion-like cellsAbundant granular cytoplasm with large, eccentric nuclei and prominent nucleoliPositive for synaptophysin, NSE; variable marking with somatostatin and pancreatic polypeptide",
                    "sub_points": [
                      "Abundant granular cytoplasm with large, eccentric nuclei and prominent nucleoli",
                      "Positive for synaptophysin, NSE; variable marking with somatostatin and pancreatic polypeptide"
                    ]
                  },
                  {
                    "text": "Spindled cellsIndistinguishable from Schwann cells; positive for S100",
                    "sub_points": [
                      "Indistinguishable from Schwann cells; positive for S100"
                    ]
                  }
                ],
                "Top Differential Diagnoses": [
                  {
                    "text": "Well-differentiated neuroendocrine tumor"
                  },
                  {
                    "text": "Ampullary carcinoma"
                  },
                  {
                    "text": "Ganglioneuroma"
                  },
                  {
                    "text": "Neurofibroma"
                  },
                  {
                    "text": "Gastrointestinal stromal tumor"
                  }
                ],
                "Diagnostic Checklist": [
                  {
                    "text": "Submucosal tumor"
                  },
                  {
                    "text": "3 components: Epithelioid, spindled, ganglion-like cells"
                  }
                ]
              },
              "TERMINOLOGY": {
                "Synonyms": [
                  {
                    "text": "Nonchromaffin paraganglioma"
                  }
                ],
                "Definitions": [
                  {
                    "text": "Triphasic neoplasm of epithelioid, ganglion-like cells, and spindle-shaped nerve sheath elements"
                  }
                ]
              },
              "ETIOLOGY/PATHOGENESIS": {
                "Origin": [
                  {
                    "text": "Unclear; several theoriesEctodermally derived: Progenitor neural crest cell originEmbryonic celiac ganglionHamartomatous: Endodermally derived cells from ventral primordium of pancreas mixed with neuroectodermal ganglion and Schwann cellsPancreatic origin, arising from ganglion-islet cell complexesSecondary involvement of duodenum",
                    "sub_points": [
                      "Ectodermally derived: Progenitor neural crest cell origin",
                      "Embryonic celiac ganglion",
                      "Hamartomatous: Endodermally derived cells from ventral primordium of pancreas mixed with neuroectodermal ganglion and Schwann cells",
                      "Pancreatic origin, arising from ganglion-islet cell complexesSecondary involvement of duodenum",
                      "Secondary involvement of duodenum"
                    ]
                  }
                ]
              },
              "CLINICAL ISSUES": {
                "Epidemiology": [],
                "Incidence": [
                  {
                    "text": "Rare (1.2% of ampullary neoplasms in 1 series)Associated with neurofibromatosis type 1 in some cases",
                    "sub_points": [
                      "Associated with neurofibromatosis type 1 in some cases"
                    ]
                  }
                ],
                "Age": [
                  {
                    "text": "3rd-9th decades; mean: 6th decade"
                  }
                ],
                "Sex": [
                  {
                    "text": "M > F (1.8:1.0)"
                  }
                ],
                "Site": [
                  {
                    "text": "Most involve 2nd portion of duodenum, periampullary/ampullary areaExtraduodenal sites include jejunum, pylorus, and lung",
                    "sub_points": [
                      "Extraduodenal sites include jejunum, pylorus, and lung"
                    ]
                  }
                ],
                "Presentation": [
                  {
                    "text": "VariableGastrointestinal bleeding (most common; 44%)Abdominal pain (33%)Can be incidental endoscopic findingObstructive jaundice (less frequent)",
                    "sub_points": [
                      "Gastrointestinal bleeding (most common; 44%)",
                      "Abdominal pain (33%)",
                      "Can be incidental endoscopic finding",
                      "Obstructive jaundice (less frequent)"
                    ]
                  }
                ],
                "Treatment": [
                  {
                    "text": "Endoscopic mucosal resection for smaller lesions"
                  },
                  {
                    "text": "Surgical resection (Whipple procedure) for larger lesions"
                  }
                ],
                "Prognosis": [
                  {
                    "text": "Vast majority benignRecurrence uncommon; regional lymph node metastases (6.9%), especially tumors > 2 cm",
                    "sub_points": [
                      "Recurrence uncommon; regional lymph node metastases (6.9%), especially tumors > 2 cm"
                    ]
                  },
                  {
                    "text": "Rare reports of death"
                  }
                ]
              },
              "MACROSCOPIC": {
                "General Features": [
                  {
                    "text": "Submucosal tumor, sessile or polypoid"
                  },
                  {
                    "text": "Ulceration of overlying mucosa common"
                  },
                  {
                    "text": "Yellow to white, moderately firm"
                  }
                ],
                "Size": [
                  {
                    "text": "1-4 cm; larger tumors are occasionally seen"
                  }
                ]
              },
              "MICROSCOPIC": {
                "Histologic Features": [
                  {
                    "text": "3 components in varying proportionsEpithelioid cellsResemble neuroendocrine tumor or paragangliomaSmall, monotonous cells with round nuclei, small nucleoli, stippled chromatin, eosinophilic cytoplasmForm nests, anastomosing cords, and trabeculaeMark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratinGanglion-like cellsAbundant granular cytoplasm with large, eccentric nuclei and prominent nucleoliCan look like normal ganglion cells or transitional epithelioid cells with less cytoplasm and inconspicuous nucleoliPositive for synaptophysin, NSE; variable marking with somatostatin and pancreatic polypeptideSpindled cellsIndistinguishable from Schwann cellsElongated cells with tapered ends, faintly eosinophilic cytoplasm, elongated nucleiPositive for S100, NSE, neurofilamentS100 may reveal sustentacular-like cells surrounding nests of epithelioid cells",
                    "sub_points": [
                      "Epithelioid cellsResemble neuroendocrine tumor or paragangliomaSmall, monotonous cells with round nuclei, small nucleoli, stippled chromatin, eosinophilic cytoplasmForm nests, anastomosing cords, and trabeculaeMark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratin",
                      "Resemble neuroendocrine tumor or paragangliomaSmall, monotonous cells with round nuclei, small nucleoli, stippled chromatin, eosinophilic cytoplasm",
                      "Small, monotonous cells with round nuclei, small nucleoli, stippled chromatin, eosinophilic cytoplasm",
                      "Form nests, anastomosing cords, and trabeculae",
                      "Mark with NSE, synaptophysin, somatostatin, chromogranin; variable positivity for keratin",
                      "Ganglion-like cellsAbundant granular cytoplasm with large, eccentric nuclei and prominent nucleoliCan look like normal ganglion cells or transitional epithelioid cells with less cytoplasm and inconspicuous nucleoliPositive for synaptophysin, NSE; variable marking with somatostatin and pancreatic polypeptide",
                      "Abundant granular cytoplasm with large, eccentric nuclei and prominent nucleoli",
                      "Can look like normal ganglion cells or transitional epithelioid cells with less cytoplasm and inconspicuous nucleoli",
                      "Positive for synaptophysin, NSE; variable marking with somatostatin and pancreatic polypeptide",
                      "Spindled cellsIndistinguishable from Schwann cellsElongated cells with tapered ends, faintly eosinophilic cytoplasm, elongated nucleiPositive for S100, NSE, neurofilament",
                      "Indistinguishable from Schwann cells",
                      "Elongated cells with tapered ends, faintly eosinophilic cytoplasm, elongated nuclei",
                      "Positive for S100, NSE, neurofilament",
                      "S100 may reveal sustentacular-like cells surrounding nests of epithelioid cells"
                    ]
                  },
                  {
                    "text": "Growth pattern may be well circumscribed or infiltrative with entrapment of smooth muscle or ductular structures"
                  },
                  {
                    "text": "Often no mitoses or necrosis"
                  }
                ]
              },
              "DIFFERENTIAL DIAGNOSIS": {
                "Well-Differentiated Neuroendocrine Tumor": [
                  {
                    "text": "Positive for pancreatic polypeptide, keratins"
                  },
                  {
                    "text": "Lacks ganglion-like and spindled cells"
                  }
                ],
                "Ampullary Carcinoma": [
                  {
                    "text": "Nuclear atypia, mitoses, necrosis, and architectural complexity"
                  },
                  {
                    "text": "Lacks ganglion-like and spindled cells"
                  },
                  {
                    "text": "Strongly positive for keratins"
                  }
                ],
                "Ganglioneuroma": [
                  {
                    "text": "Lacks epithelioid component"
                  }
                ],
                "Neurofibroma": [
                  {
                    "text": "Lacks epithelioid and ganglion-like cells"
                  }
                ],
                "Gastrointestinal Stromal Tumor": [
                  {
                    "text": "CD117 or DOG1 positive"
                  }
                ]
              },
              "DIAGNOSTIC CHECKLIST": {
                "Pathologic Interpretation Pearls": [
                  {
                    "text": "Periampullary tumors with any of 3 elements should be carefully examined for other components"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Ampulla of Vater Cancer Protocol": {
            "name": "Ampulla of Vater Cancer Protocol",
            "url": "https://app.pathprimer.com/document/da931e44-284a-47aa-9bd0-1051eed66fb3/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "Prognostic Features": {
                "Survival": [
                  {
                    "text": "Ampullary/periampullary adenocarcinoma has superior survival when compared to pancreatic or common bile duct adenocarcinomaObstruction of bile duct and jaundice tend to occur early due to strategic location of ampulla",
                    "sub_points": [
                      "Obstruction of bile duct and jaundice tend to occur early due to strategic location of ampulla"
                    ]
                  },
                  {
                    "text": "Because of superior prognosis, ampullary adenocarcinoma must be distinguished from pancreatic ductal, common bile duct, and duodenal adenocarcinomasMay be very difficult to determine exact primary site in large tumors",
                    "sub_points": [
                      "May be very difficult to determine exact primary site in large tumors"
                    ]
                  }
                ],
                "Primary Tumor": [
                  {
                    "text": "Assessment based on surgical resectionCompleteness of resection has significant prognostic implicationsPositive resection margin(s) associated with less favorable outcome",
                    "sub_points": [
                      "Completeness of resection has significant prognostic implications",
                      "Positive resection margin(s) associated with less favorable outcome"
                    ]
                  },
                  {
                    "text": "Local extensionMain staging parameters depend on extension into the duodenal wall, pancreas, or peripancreatic soft tissue and other organsEven T4 tumors are usually resectable",
                    "sub_points": [
                      "Main staging parameters depend on extension into the duodenal wall, pancreas, or peripancreatic soft tissue and other organsEven T4 tumors are usually resectable",
                      "Even T4 tumors are usually resectable"
                    ]
                  },
                  {
                    "text": "Other adverse prognostic factorsPoorly differentiated histologyPapillary tumors associated with better prognosis, converselyPerineural invasionPrognostic significance of CEA and CA19-9 unclear, but can be used to monitor treatment",
                    "sub_points": [
                      "Poorly differentiated histologyPapillary tumors associated with better prognosis, conversely",
                      "Papillary tumors associated with better prognosis, conversely",
                      "Perineural invasion",
                      "Prognostic significance of CEA and CA19-9 unclear, but can be used to monitor treatment"
                    ]
                  }
                ],
                "Lymph Nodes": [
                  {
                    "text": "Regional lymph nodesPeripancreaticInclude nodes along hepatic artery, portal veinPositive regional nodes have significant negative affect on survivalMinimum of 12 nodes should be examined",
                    "sub_points": [
                      "PeripancreaticInclude nodes along hepatic artery, portal vein",
                      "Include nodes along hepatic artery, portal vein",
                      "Positive regional nodes have significant negative affect on survival",
                      "Minimum of 12 nodes should be examined"
                    ]
                  }
                ],
                "Distant Metastases": [
                  {
                    "text": "Most common sites are liver, peritoneum"
                  },
                  {
                    "text": "Less common sites include lung, pleura"
                  }
                ]
              },
              "Selected References": {}
            }
          },
          "Specimen Handling, Whipple": {
            "name": "Specimen Handling, Whipple",
            "url": "https://app.pathprimer.com/document/4371d88e-c990-4096-9cb4-1da12d89750f/lesson/1d192092-b72b-4c21-9eb2-b7e48b2ba6f8",
            "content": {
              "Whipple (Pancreaticoduodenectomy) Procedure": {
                "Major Components": [
                  {
                    "text": "DuodenumMay or may not include pylorus/distal stomach, depending on whether it was pylorus-sparing procedure",
                    "sub_points": [
                      "May or may not include pylorus/distal stomach, depending on whether it was pylorus-sparing procedure"
                    ]
                  },
                  {
                    "text": "Ampulla of Vater"
                  },
                  {
                    "text": "Common bile duct"
                  },
                  {
                    "text": "Pancreas"
                  }
                ],
                "Anatomic Orientation": [
                  {
                    "text": "DuodenumFree proximal end usually shorter than free distal segmentSmall portion of stomach may be attached to proximal endDistal end may be either duodenum or jejunum",
                    "sub_points": [
                      "Free proximal end usually shorter than free distal segment",
                      "Small portion of stomach may be attached to proximal end",
                      "Distal end may be either duodenum or jejunum"
                    ]
                  },
                  {
                    "text": "Common bile ductSometimes green in colorPosterior and superior to pancreasMay be easier to identify from ampulla than from transected endIf gallbladder is present, can identify insertion of cystic duct and follow to common bile duct",
                    "sub_points": [
                      "Sometimes green in color",
                      "Posterior and superior to pancreas",
                      "May be easier to identify from ampulla than from transected end",
                      "If gallbladder is present, can identify insertion of cystic duct and follow to common bile duct"
                    ]
                  },
                  {
                    "text": "Ampulla of VaterUsually obvious within duodenum, unless obscured by tumorAccessory ampulla drains accessory duct of Santorini",
                    "sub_points": [
                      "Usually obvious within duodenum, unless obscured by tumor",
                      "Accessory ampulla drains accessory duct of Santorini"
                    ]
                  },
                  {
                    "text": "PancreasGeneral anatomic featuresRetroperitoneal organ located in C-groove of 2nd part of duodenumAnterior to pancreas is free space (omental bursa/lesser sac), and then posterior aspect of stomachAnatomic divisions of pancreasHead: To right of superior mesenteric vein/portal vein confluence; includes uncinate processNeck: Constricted region to left of headBody: Between superior mesenteric vein/portal vein confluence and aortaTail: Between aorta and splenic hilumPancreatic ductUsually main pancreatic duct drains bulk of gland into duodenum at major duodenal papilla (ampulla) along with common bile ductNormal diameter is < 1 cm",
                    "sub_points": [
                      "General anatomic featuresRetroperitoneal organ located in C-groove of 2nd part of duodenumAnterior to pancreas is free space (omental bursa/lesser sac), and then posterior aspect of stomach",
                      "Retroperitoneal organ located in C-groove of 2nd part of duodenum",
                      "Anterior to pancreas is free space (omental bursa/lesser sac), and then posterior aspect of stomach",
                      "Anatomic divisions of pancreasHead: To right of superior mesenteric vein/portal vein confluence; includes uncinate processNeck: Constricted region to left of headBody: Between superior mesenteric vein/portal vein confluence and aortaTail: Between aorta and splenic hilum",
                      "Head: To right of superior mesenteric vein/portal vein confluence; includes uncinate process",
                      "Neck: Constricted region to left of head",
                      "Body: Between superior mesenteric vein/portal vein confluence and aorta",
                      "Tail: Between aorta and splenic hilum",
                      "Pancreatic ductUsually main pancreatic duct drains bulk of gland into duodenum at major duodenal papilla (ampulla) along with common bile ductNormal diameter is < 1 cm",
                      "Usually main pancreatic duct drains bulk of gland into duodenum at major duodenal papilla (ampulla) along with common bile duct",
                      "Normal diameter is < 1 cm"
                    ]
                  }
                ],
                "Specimen Orientation": [
                  {
                    "text": "Adsay trapezoid method of orientationUseful method to identify essential margins/surfacesPlace proximal intestinal margin to left, distal intestinal margin to right, and medial aspect of pancreas facing toward youVisualize trapezoidLeft nonparallel side represents pancreatic neck marginRight nonparallel side is uncinate marginSpace between sides is vascular grooveAnterior surface is base, and posterior surface is parallel opposite side",
                    "sub_points": [
                      "Useful method to identify essential margins/surfaces",
                      "Place proximal intestinal margin to left, distal intestinal margin to right, and medial aspect of pancreas facing toward you",
                      "Visualize trapezoidLeft nonparallel side represents pancreatic neck marginRight nonparallel side is uncinate marginSpace between sides is vascular grooveAnterior surface is base, and posterior surface is parallel opposite side",
                      "Left nonparallel side represents pancreatic neck margin",
                      "Right nonparallel side is uncinate margin",
                      "Space between sides is vascular groove",
                      "Anterior surface is base, and posterior surface is parallel opposite side"
                    ]
                  },
                  {
                    "text": "Hand method of orientationCurled left hand resembles pancreas enveloping superior mesenteric artery and portal veinThumb is uncinate process; flat fingers are neck, body, tail",
                    "sub_points": [
                      "Curled left hand resembles pancreas enveloping superior mesenteric artery and portal vein",
                      "Thumb is uncinate process; flat fingers are neck, body, tail"
                    ]
                  }
                ],
                "Surgical Margins": [
                  {
                    "text": "Common bile duct (shave margin)"
                  },
                  {
                    "text": "Pancreatic parenchymal (shave margin to include duct)CAP calls this distal marginAJCC calls this pancreatic neck margin",
                    "sub_points": [
                      "CAP calls this distal margin",
                      "AJCC calls this pancreatic neck margin"
                    ]
                  },
                  {
                    "text": "Uncinate/retroperitoneal (perpendicular margin)CAP: UncinateAJCC: RetroperitonealShould be inked, sectioned perpendicularly, and entire area submittedAdditional lymph nodes often found if this method is used",
                    "sub_points": [
                      "CAP: Uncinate",
                      "AJCC: Retroperitoneal",
                      "Should be inked, sectioned perpendicularly, and entire area submitted",
                      "Additional lymph nodes often found if this method is used"
                    ]
                  },
                  {
                    "text": "Proximal duodenal (or gastric) and distal intestinalUsually shaved but can be perpendicular if close to lesion",
                    "sub_points": [
                      "Usually shaved but can be perpendicular if close to lesion"
                    ]
                  },
                  {
                    "text": "Anterior surface isnotsurgical margin (because it is covered by smooth layer of peritoneum)Anterior pancreatic surface bulges",
                    "sub_points": [
                      "Anterior pancreatic surface bulges"
                    ]
                  },
                  {
                    "text": "Posterior surface: Controversial as to whether it is surgical marginPosterior pancreatic surface is flatConsists of soft tissue between anterior surface of inferior vena cava and posterior aspect of pancreatic head and duodenumDuring surgery, this is peeled off anterior surface of inferior vena cava",
                    "sub_points": [
                      "Posterior pancreatic surface is flat",
                      "Consists of soft tissue between anterior surface of inferior vena cava and posterior aspect of pancreatic head and duodenum",
                      "During surgery, this is peeled off anterior surface of inferior vena cava"
                    ]
                  },
                  {
                    "text": "Vascular groove or bed: Controversial as to whether it is surgical marginDefined as indentation of superior mesenteric vein to portal vein confluenceConcave and smooth and glistening aspect of specimen between pancreatic neck and uncinate marginsPortion of vein (patch or segment) may be present; should be indicated by surgeon",
                    "sub_points": [
                      "Defined as indentation of superior mesenteric vein to portal vein confluence",
                      "Concave and smooth and glistening aspect of specimen between pancreatic neck and uncinate margins",
                      "Portion of vein (patch or segment) may be present; should be indicated by surgeon"
                    ]
                  }
                ],
                "Dissection": [
                  {
                    "text": "Measure dimensions of important structures"
                  },
                  {
                    "text": "Ink surface of pancreas and uncinate/retroperitoneal margin areaKeep colors consistent: Bile duct green, pancreatic yellow, retroperitoneal black, vascular groove blue, anterior and posterior surface orange",
                    "sub_points": [
                      "Keep colors consistent: Bile duct green, pancreatic yellow, retroperitoneal black, vascular groove blue, anterior and posterior surface orange"
                    ]
                  },
                  {
                    "text": "Take margins (as above)If performing orange-peeling method of lymph node dissection (see below), sample these tissues at this time",
                    "sub_points": [
                      "If performing orange-peeling method of lymph node dissection (see below), sample these tissues at this time"
                    ]
                  },
                  {
                    "text": "Open duodenum along side opposite pancreasDocument any lesionsIf tumor involves ampulla, determine epicenter of tumorIs papilla or adjacent duodenal mucosa involved by tumor?Does tumor expand ampulla or form thick, rind-like mass along duct?Note presence of tenacious mucin extruding through papilla (diagnostic of intraductal papillary mucinous tumor)",
                    "sub_points": [
                      "Document any lesions",
                      "If tumor involves ampulla, determine epicenter of tumorIs papilla or adjacent duodenal mucosa involved by tumor?Does tumor expand ampulla or form thick, rind-like mass along duct?",
                      "Is papilla or adjacent duodenal mucosa involved by tumor?",
                      "Does tumor expand ampulla or form thick, rind-like mass along duct?",
                      "Note presence of tenacious mucin extruding through papilla (diagnostic of intraductal papillary mucinous tumor)"
                    ]
                  },
                  {
                    "text": "Section pancreasCannulate common bile duct and pancreatic duct with probes, then make single cut that bivalves pancreas and ducts through plane that goes through both ducts (cut along probes)When probe is inserted into pancreatic duct at pancreatic neck margin, it may easily pass into accessory duct and out accessory papilla, especially if main duct is obstructed by tumorAlternative, axial method: Section pancreas perpendicularly to longitudinal aspect of descending duodenum (2nd part of duodenum)Alternative method: Open common bile duct with small scissorsMay be easier to start at proximal end since duct is often dilatedExtend incision down through ampulla of VaterNote any strictures or masses in bile duct or ampullaInk common bile duct (green) and pancreatic duct (yellow) to identify them on microscopic sections",
                    "sub_points": [
                      "Cannulate common bile duct and pancreatic duct with probes, then make single cut that bivalves pancreas and ducts through plane that goes through both ducts (cut along probes)When probe is inserted into pancreatic duct at pancreatic neck margin, it may easily pass into accessory duct and out accessory papilla, especially if main duct is obstructed by tumor",
                      "When probe is inserted into pancreatic duct at pancreatic neck margin, it may easily pass into accessory duct and out accessory papilla, especially if main duct is obstructed by tumor",
                      "Alternative, axial method: Section pancreas perpendicularly to longitudinal aspect of descending duodenum (2nd part of duodenum)",
                      "Alternative method: Open common bile duct with small scissorsMay be easier to start at proximal end since duct is often dilatedExtend incision down through ampulla of VaterNote any strictures or masses in bile duct or ampulla",
                      "May be easier to start at proximal end since duct is often dilated",
                      "Extend incision down through ampulla of Vater",
                      "Note any strictures or masses in bile duct or ampulla",
                      "Ink common bile duct (green) and pancreatic duct (yellow) to identify them on microscopic sections"
                    ]
                  },
                  {
                    "text": "Examine pancreas\"Bread-loaf\" pancreas into thin slides perpendicular to long axis of duodenumLeave each slide thinly attached to duodenum for orientationAscertain if ducts are dilated, stenotic, or thickenedNote if there is cystic tumor communicating with pancreatic duct (main or branch ducts)Note luminal contents of ductsNote if tumor extends into peripancreatic soft tissue grossly",
                    "sub_points": [
                      "\"Bread-loaf\" pancreas into thin slides perpendicular to long axis of duodenumLeave each slide thinly attached to duodenum for orientation",
                      "Leave each slide thinly attached to duodenum for orientation",
                      "Ascertain if ducts are dilated, stenotic, or thickened",
                      "Note if there is cystic tumor communicating with pancreatic duct (main or branch ducts)",
                      "Note luminal contents of ducts",
                      "Note if tumor extends into peripancreatic soft tissue grossly"
                    ]
                  },
                  {
                    "text": "Find lymph nodesOrange-peeling method of lymph node dissection approach involves shaving off free surfaces of pancreatic head, separating them into 7 arbitrary regions: Pericommon bile duct, anterior pancreaticoduodenal, superior pancreatic, inferior pancreatic, posterior pancreatic, posterior pancreaticoduodenal; this is done prior to sectioning pancreas",
                    "sub_points": [
                      "Orange-peeling method of lymph node dissection approach involves shaving off free surfaces of pancreatic head, separating them into 7 arbitrary regions: Pericommon bile duct, anterior pancreaticoduodenal, superior pancreatic, inferior pancreatic, posterior pancreatic, posterior pancreaticoduodenal; this is done prior to sectioning pancreas"
                    ]
                  },
                  {
                    "text": "Main questions to answer during dissectionIs there tumor?Where is tumor?What is site of origin, and what structures are involved?How big is tumor?What is appearance of tumor (solid, cystic, etc.)?If tumor is cystic, document cyst contents: If multi-/unilocular, size of cysts, and presence of mural nodulesIf cystic tumor is mucinous, tumor should be thoroughly, if not entirely, submittedHow many lymph nodes are there, and what is their gross appearance?",
                    "sub_points": [
                      "Is there tumor?",
                      "Where is tumor?What is site of origin, and what structures are involved?",
                      "What is site of origin, and what structures are involved?",
                      "How big is tumor?",
                      "What is appearance of tumor (solid, cystic, etc.)?If tumor is cystic, document cyst contents: If multi-/unilocular, size of cysts, and presence of mural nodulesIf cystic tumor is mucinous, tumor should be thoroughly, if not entirely, submitted",
                      "If tumor is cystic, document cyst contents: If multi-/unilocular, size of cysts, and presence of mural nodules",
                      "If cystic tumor is mucinous, tumor should be thoroughly, if not entirely, submitted",
                      "How many lymph nodes are there, and what is their gross appearance?"
                    ]
                  }
                ],
                "Histologic Sections": [
                  {
                    "text": "Margins (as above)"
                  },
                  {
                    "text": "TumorDemonstrate relationship to ampulla, pancreas, pancreatic duct, common bile duct, and duodenumSection(s) along long axis of bile duct  to include duodenum, ampulla, bile duct, and pancreas all in 1 section can be very helpfulSections of interface between tumor and normal parenchymaSections of normal uninvolved parenchymaAt least 1 section from anterior and posterior halvesSections of ampulla and accessory ampulla if presentIf tumor is close to anterior or posterior surface, include section of inked surface (prior to dissecting for lymph nodes)",
                    "sub_points": [
                      "Demonstrate relationship to ampulla, pancreas, pancreatic duct, common bile duct, and duodenumSection(s) along long axis of bile duct  to include duodenum, ampulla, bile duct, and pancreas all in 1 section can be very helpful",
                      "Section(s) along long axis of bile duct  to include duodenum, ampulla, bile duct, and pancreas all in 1 section can be very helpful",
                      "Sections of interface between tumor and normal parenchyma",
                      "Sections of normal uninvolved parenchymaAt least 1 section from anterior and posterior halves",
                      "At least 1 section from anterior and posterior halves",
                      "Sections of ampulla and accessory ampulla if present",
                      "If tumor is close to anterior or posterior surface, include section of inked surface (prior to dissecting for lymph nodes)"
                    ]
                  }
                ]
              },
              "Selected References": {}
            }
          }
        }
      }
    }
  }
}